Psyllid ID: psy3182
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 255 | 2.2.26 [Sep-21-2011] | |||||||
| Q03042 | 768 | cGMP-dependent protein ki | yes | N/A | 0.654 | 0.217 | 0.537 | 6e-54 | |
| P0C605 | 671 | cGMP-dependent protein ki | no | N/A | 0.517 | 0.196 | 0.563 | 5e-49 | |
| Q13976 | 671 | cGMP-dependent protein ki | no | N/A | 0.517 | 0.196 | 0.563 | 5e-49 | |
| O77676 | 671 | cGMP-dependent protein ki | yes | N/A | 0.517 | 0.196 | 0.563 | 5e-49 | |
| P00516 | 671 | cGMP-dependent protein ki | yes | N/A | 0.517 | 0.196 | 0.563 | 6e-49 | |
| Q03043 | 1088 | cGMP-dependent protein ki | no | N/A | 0.517 | 0.121 | 0.552 | 1e-48 | |
| P32023 | 934 | cGMP-dependent protein ki | no | N/A | 0.517 | 0.141 | 0.552 | 1e-48 | |
| Q13237 | 762 | cGMP-dependent protein ki | no | N/A | 0.517 | 0.173 | 0.546 | 8e-47 | |
| Q64595 | 762 | cGMP-dependent protein ki | no | N/A | 0.517 | 0.173 | 0.546 | 1e-46 | |
| Q61410 | 762 | cGMP-dependent protein ki | no | N/A | 0.517 | 0.173 | 0.546 | 1e-46 |
| >sp|Q03042|KGP1_DROME cGMP-dependent protein kinase, isozyme 1 OS=Drosophila melanogaster GN=Pkg21D PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 211 bits (536), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 114/212 (53%), Positives = 135/212 (63%), Gaps = 45/212 (21%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
AL+ L R IV D K E + R ++ L SR RLY+TF+D KYVYMLLEAC+
Sbjct: 486 ALKCLKKRHIV--DTKQEEHIFSER-HIMLSSRSPFI--CRLYRTFRDEKYVYMLLEACM 540
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLL 155
GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPENL+
Sbjct: 541 GGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQAFEYLHARGIIYRDLKPENLM 589
Query: 156 LDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215
LD RGYVK+ VDFGF+K +G S KTWTFCGTP
Sbjct: 590 LDERGYVKI----------------------------VDFGFAKQIGTSS-KTWTFCGTP 620
Query: 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
EYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 621 EYVAPEIILNKGHDRAVDYWALGILIHELLNG 652
|
Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 2 |
| >sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus GN=Prkg1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 97/172 (56%), Positives = 117/172 (68%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 423 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTR-----------FYTACVVEA 471
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH++GI++RDLKPENL+LD+RGY KL VDF
Sbjct: 472 FAYLHSKGIIYRDLKPENLILDHRGYAKL----------------------------VDF 503
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K +G G KTWTFCGTPEYVAPEII N+GHD + DYW+LGILM+ELLTG
Sbjct: 504 GFAKKIGF-GKKTWTFCGTPEYVAPEIILNKGHDISADYWSLGILMYELLTG 554
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q13976|KGP1_HUMAN cGMP-dependent protein kinase 1 OS=Homo sapiens GN=PRKG1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 97/172 (56%), Positives = 117/172 (68%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 423 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTR-----------FYTACVVEA 471
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH++GI++RDLKPENL+LD+RGY KL VDF
Sbjct: 472 FAYLHSKGIIYRDLKPENLILDHRGYAKL----------------------------VDF 503
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K +G G KTWTFCGTPEYVAPEII N+GHD + DYW+LGILM+ELLTG
Sbjct: 504 GFAKKIGF-GKKTWTFCGTPEYVAPEIILNKGHDISADYWSLGILMYELLTG 554
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|O77676|KGP1_RABIT cGMP-dependent protein kinase 1 OS=Oryctolagus cuniculus GN=PRKG1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 97/172 (56%), Positives = 117/172 (68%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 423 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTR-----------FYTACVVEA 471
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH++GI++RDLKPENL+LD+RGY KL VDF
Sbjct: 472 FAYLHSKGIIYRDLKPENLILDHRGYAKL----------------------------VDF 503
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K +G G KTWTFCGTPEYVAPEII N+GHD + DYW+LGILM+ELLTG
Sbjct: 504 GFAKKIGF-GKKTWTFCGTPEYVAPEIILNKGHDISADYWSLGILMYELLTG 554
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus GN=PRKG1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 97/172 (56%), Positives = 117/172 (68%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 423 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTR-----------FYTACVVEA 471
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH++GI++RDLKPENL+LD+RGY KL VDF
Sbjct: 472 FAYLHSKGIIYRDLKPENLILDHRGYAKL----------------------------VDF 503
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K +G G KTWTFCGTPEYVAPEII N+GHD + DYW+LGILM+ELLTG
Sbjct: 504 GFAKKIGF-GKKTWTFCGTPEYVAPEIILNKGHDISADYWSLGILMYELLTG 554
|
Serine/threonine protein kinasethat acts as key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smoth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates MRVI1/IRAG and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling alters also gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q03043|KGP24_DROME cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B OS=Drosophila melanogaster GN=for PE=1 SV=3 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 95/172 (55%), Positives = 115/172 (66%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L+KTFKD KY+YML+E+CLGGE+WTILR++ FDD+ F TACV+EA D
Sbjct: 840 KLFKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDSTTRFYTACVVEAFD--------- 890
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH+R I++RDLKPENLLL+ RGYVKL VDF
Sbjct: 891 --YLHSRNIIYRDLKPENLLLNERGYVKL----------------------------VDF 920
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K L +G KTWTFCGTPEYVAPE+I NRGHD + DYW+LG+LM ELLTG
Sbjct: 921 GFAKKL-QTGRKTWTFCGTPEYVAPEVILNRGHDISADYWSLGVLMFELLTG 971
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|P32023|KGP25_DROME cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 OS=Drosophila melanogaster GN=for PE=2 SV=3 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 95/172 (55%), Positives = 115/172 (66%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L+KTFKD KY+YML+E+CLGGE+WTILR++ FDD+ F TACV+EA D
Sbjct: 686 KLFKTFKDKKYLYMLMESCLGGELWTILRDKGNFDDSTTRFYTACVVEAFD--------- 736
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH+R I++RDLKPENLLL+ RGYVKL VDF
Sbjct: 737 --YLHSRNIIYRDLKPENLLLNERGYVKL----------------------------VDF 766
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K L +G KTWTFCGTPEYVAPE+I NRGHD + DYW+LG+LM ELLTG
Sbjct: 767 GFAKKL-QTGRKTWTFCGTPEYVAPEVILNRGHDISADYWSLGVLMFELLTG 817
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q13237|KGP2_HUMAN cGMP-dependent protein kinase 2 OS=Homo sapiens GN=PRKG2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 94/172 (54%), Positives = 115/172 (66%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+TFKD+KYVYMLLEACLGGE+W+ILR+R FD+ + F ACV EA D
Sbjct: 515 KLYRTFKDNKYVYMLLEACLGGELWSILRDRGSFDEPTSKFCVACVTEAFD--------- 565
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH GI++RDLKPENL+LD GY+KL VDF
Sbjct: 566 --YLHRLGIIYRDLKPENLILDAEGYLKL----------------------------VDF 595
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K +G SG KTWTFCGTPEYVAPE+I N+GHD +VD+W+LGIL++ELLTG
Sbjct: 596 GFAKKIG-SGQKTWTFCGTPEYVAPEVILNKGHDFSVDFWSLGILVYELLTG 646
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q64595|KGP2_RAT cGMP-dependent protein kinase 2 OS=Rattus norvegicus GN=Prkg2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 94/172 (54%), Positives = 115/172 (66%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+TFKD+KYVYMLLEACLGGE+W+ILR+R FD+ + F ACV EA D
Sbjct: 515 KLYRTFKDNKYVYMLLEACLGGELWSILRDRGSFDEPTSKFCVACVTEAFD--------- 565
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH GI++RDLKPENL+LD GY+KL VDF
Sbjct: 566 --YLHRLGIIYRDLKPENLILDADGYLKL----------------------------VDF 595
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K +G SG KTWTFCGTPEYVAPE+I N+GHD +VD+W+LGIL++ELLTG
Sbjct: 596 GFAKKIG-SGQKTWTFCGTPEYVAPEVILNKGHDFSVDFWSLGILVYELLTG 646
|
Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
| >sp|Q61410|KGP2_MOUSE cGMP-dependent protein kinase 2 OS=Mus musculus GN=Prkg2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 94/172 (54%), Positives = 115/172 (66%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+TFKD+KYVYMLLEACLGGE+W+ILR+R FD+ + F ACV EA D
Sbjct: 515 KLYRTFKDNKYVYMLLEACLGGELWSILRDRGSFDEPTSKFCVACVTEAFD--------- 565
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH GI++RDLKPENL+LD GY+KL VDF
Sbjct: 566 --YLHLLGIIYRDLKPENLILDADGYLKL----------------------------VDF 595
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K +G SG KTWTFCGTPEYVAPE+I N+GHD +VD+W+LGIL++ELLTG
Sbjct: 596 GFAKKIG-SGQKTWTFCGTPEYVAPEVILNKGHDFSVDFWSLGILVYELLTG 646
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 255 | ||||||
| 91094575 | 948 | PREDICTED: similar to cgmp-dependent pro | 0.678 | 0.182 | 0.531 | 1e-54 | |
| 242024535 | 1045 | cGMP-dependent protein kinase, isozyme, | 0.521 | 0.127 | 0.635 | 3e-53 | |
| 195032899 | 766 | GH10498 [Drosophila grimshawi] gi|193904 | 0.517 | 0.172 | 0.598 | 2e-52 | |
| 17137294 | 768 | cGMP-dependent protein kinase 21D [Droso | 0.654 | 0.217 | 0.537 | 3e-52 | |
| 1401293 | 768 | cGMP-dependent protein kinase [Drosophil | 0.654 | 0.217 | 0.537 | 4e-52 | |
| 195350187 | 768 | GM16646 [Drosophila sechellia] gi|194123 | 0.654 | 0.217 | 0.537 | 5e-52 | |
| 195575619 | 768 | GD22942 [Drosophila simulans] gi|1941896 | 0.654 | 0.217 | 0.537 | 5e-52 | |
| 195082943 | 501 | GH23242 [Drosophila grimshawi] gi|193905 | 0.662 | 0.337 | 0.532 | 5e-52 | |
| 158293332 | 1289 | AGAP008585-PA [Anopheles gambiae str. PE | 0.521 | 0.103 | 0.601 | 6e-52 | |
| 195470342 | 768 | GE15942 [Drosophila yakuba] gi|194173568 | 0.654 | 0.217 | 0.537 | 7e-52 |
| >gi|91094575|ref|XP_968718.1| PREDICTED: similar to cgmp-dependent protein kinase [Tribolium castaneum] gi|270016394|gb|EFA12840.1| hypothetical protein TcasGA2_TC006940 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 219 bits (557), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 118/222 (53%), Positives = 143/222 (64%), Gaps = 49/222 (22%)
Query: 34 IEALEYLHTRGIVF--RDLKPENLLLDNRGYVKLVSRK------KKTRQTRLYKTFKDSK 85
+E ++Y+H + F + LK ++++ D + + S + + + R+YKTFKDSK
Sbjct: 651 VELVQYVHNPSLTFALKCLKKQHIV-DTQQQDHIFSERNIMMSCRSSFICRMYKTFKDSK 709
Query: 86 YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145
YVYMLLEACLGGEVWTILR+R CFD++ FIT CV+EA D YLH+RGI+
Sbjct: 710 YVYMLLEACLGGEVWTILRDRGCFDEDTTKFITGCVLEAFD-----------YLHSRGII 758
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG 205
+RDLKPENLLLD GYVKL VDFGFSK LG+S
Sbjct: 759 YRDLKPENLLLDANGYVKL----------------------------VDFGFSKRLGYSS 790
Query: 206 CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
KTWTFCGTPEYVAPE I N+GHDRAVDYWALGILMHELLTG
Sbjct: 791 -KTWTFCGTPEYVAPETILNKGHDRAVDYWALGILMHELLTG 831
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242024535|ref|XP_002432683.1| cGMP-dependent protein kinase, isozyme, putative [Pediculus humanus corporis] gi|212518153|gb|EEB19945.1| cGMP-dependent protein kinase, isozyme, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 214 bits (544), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 110/173 (63%), Positives = 119/173 (68%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKYVYML EA LGGEVWTILRE+ CFDD FITACVI EA
Sbjct: 798 RLYRTFKDSKYVYMLQEALLGGEVWTILREKGCFDDYTTKFITACVI-----------EA 846
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLHTRGIV+RDLKPENLLLD+ GY KL VDF
Sbjct: 847 FEYLHTRGIVYRDLKPENLLLDSIGYTKL----------------------------VDF 878
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
GFSK +G S KTWTFCGTPEY+APEII N+GHDRAVDYW+LGILMHELLTG+
Sbjct: 879 GFSKRIGFS-SKTWTFCGTPEYLAPEIILNKGHDRAVDYWSLGILMHELLTGI 930
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195032899|ref|XP_001988582.1| GH10498 [Drosophila grimshawi] gi|193904582|gb|EDW03449.1| GH10498 [Drosophila grimshawi] | Back alignment and taxonomy information |
|---|
Score = 211 bits (538), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 103/172 (59%), Positives = 119/172 (69%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TF+D KYVYMLLEAC+GGE+WT+LR+R F+DNAA FI CV++A
Sbjct: 519 RLYRTFRDEKYVYMLLEACMGGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQA 567
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH RGI++RDLKPENL+LD RGYVKL VDF
Sbjct: 568 FEYLHARGILYRDLKPENLMLDERGYVKL----------------------------VDF 599
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+KH+G S KTWTFCGTPEYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 600 GFAKHIG-SSTKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIHELLNG 650
|
Source: Drosophila grimshawi Species: Drosophila grimshawi Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|17137294|ref|NP_477213.1| cGMP-dependent protein kinase 21D [Drosophila melanogaster] gi|17380465|sp|Q03042.2|KGP1_DROME RecName: Full=cGMP-dependent protein kinase, isozyme 1; Short=cGK gi|157202|gb|AAA28453.1| cGMP-dependent protein kinase [Drosophila melanogaster] gi|7296166|gb|AAF51459.1| cGMP-dependent protein kinase 21D [Drosophila melanogaster] gi|16182546|gb|AAL13517.1| GH03852p [Drosophila melanogaster] gi|220945298|gb|ACL85192.1| Pkg21D-PA [synthetic construct] gi|220955046|gb|ACL90066.1| Pkg21D-PA [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 211 bits (536), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 114/212 (53%), Positives = 135/212 (63%), Gaps = 45/212 (21%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
AL+ L R IV D K E + R ++ L SR RLY+TF+D KYVYMLLEAC+
Sbjct: 486 ALKCLKKRHIV--DTKQEEHIFSER-HIMLSSRSPFI--CRLYRTFRDEKYVYMLLEACM 540
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLL 155
GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPENL+
Sbjct: 541 GGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQAFEYLHARGIIYRDLKPENLM 589
Query: 156 LDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215
LD RGYVK+ VDFGF+K +G S KTWTFCGTP
Sbjct: 590 LDERGYVKI----------------------------VDFGFAKQIGTSS-KTWTFCGTP 620
Query: 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
EYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 621 EYVAPEIILNKGHDRAVDYWALGILIHELLNG 652
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|1401293|gb|AAB03405.1| cGMP-dependent protein kinase [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 210 bits (535), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 114/212 (53%), Positives = 135/212 (63%), Gaps = 45/212 (21%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
AL+ L R IV D K E + R ++ L SR RLY+TF+D KYVYMLLEAC+
Sbjct: 486 ALKCLKKRHIV--DTKQEEHIFSER-HIMLSSRSPFI--CRLYRTFRDEKYVYMLLEACM 540
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLL 155
GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPENL+
Sbjct: 541 GGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQAFEYLHARGIIYRDLKPENLM 589
Query: 156 LDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215
LD RGYVK+ VDFGF+K +G S KTWTFCGTP
Sbjct: 590 LDERGYVKI----------------------------VDFGFAKQIGTSS-KTWTFCGTP 620
Query: 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
EYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 621 EYVAPEIILNKGHDRAVDYWALGILIHELLNG 652
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195350187|ref|XP_002041623.1| GM16646 [Drosophila sechellia] gi|194123396|gb|EDW45439.1| GM16646 [Drosophila sechellia] | Back alignment and taxonomy information |
|---|
Score = 210 bits (534), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 114/212 (53%), Positives = 135/212 (63%), Gaps = 45/212 (21%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
AL+ L R IV D K E + R ++ L SR RLY+TF+D KYVYMLLEAC+
Sbjct: 486 ALKCLKKRHIV--DTKQEEHIFSER-HIMLSSRSPFI--CRLYRTFRDEKYVYMLLEACM 540
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLL 155
GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPENL+
Sbjct: 541 GGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQAFEYLHARGIIYRDLKPENLM 589
Query: 156 LDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215
LD RGYVK+ VDFGF+K +G S KTWTFCGTP
Sbjct: 590 LDERGYVKI----------------------------VDFGFAKQIGTSS-KTWTFCGTP 620
Query: 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
EYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 621 EYVAPEIILNKGHDRAVDYWALGILIHELLNG 652
|
Source: Drosophila sechellia Species: Drosophila sechellia Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195575619|ref|XP_002077675.1| GD22942 [Drosophila simulans] gi|194189684|gb|EDX03260.1| GD22942 [Drosophila simulans] | Back alignment and taxonomy information |
|---|
Score = 210 bits (534), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 114/212 (53%), Positives = 135/212 (63%), Gaps = 45/212 (21%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
AL+ L R IV D K E + R ++ L SR RLY+TF+D KYVYMLLEAC+
Sbjct: 486 ALKCLKKRHIV--DTKQEEHIFSER-HIMLSSRSPFI--CRLYRTFRDEKYVYMLLEACM 540
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLL 155
GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPENL+
Sbjct: 541 GGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQAFEYLHARGIIYRDLKPENLM 589
Query: 156 LDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215
LD RGYVK+ VDFGF+K +G S KTWTFCGTP
Sbjct: 590 LDERGYVKI----------------------------VDFGFAKQIGTSS-KTWTFCGTP 620
Query: 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
EYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 621 EYVAPEIILNKGHDRAVDYWALGILIHELLNG 652
|
Source: Drosophila simulans Species: Drosophila simulans Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195082943|ref|XP_001997378.1| GH23242 [Drosophila grimshawi] gi|193905750|gb|EDW04617.1| GH23242 [Drosophila grimshawi] | Back alignment and taxonomy information |
|---|
Score = 210 bits (534), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 114/214 (53%), Positives = 136/214 (63%), Gaps = 45/214 (21%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEA 93
I AL+ L + IV D K E+ + R ++ K RLY+TF+D KYVYMLLEA
Sbjct: 217 IFALKCLKKQHIV--DTKQEDHIYSERS---IMLSSKSPFICRLYRTFRDEKYVYMLLEA 271
Query: 94 CLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPEN 153
C+GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPEN
Sbjct: 272 CMGGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQAFEYLHARGILYRDLKPEN 320
Query: 154 LLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG 213
L+LD RGYVKL VDFGF+KH+G S KTWTFCG
Sbjct: 321 LMLDERGYVKL----------------------------VDFGFAKHIG-SSTKTWTFCG 351
Query: 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
TPEYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 352 TPEYVAPEIILNKGHDRAVDYWALGILIHELLNG 385
|
Source: Drosophila grimshawi Species: Drosophila grimshawi Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|158293332|ref|XP_314690.4| AGAP008585-PA [Anopheles gambiae str. PEST] gi|157016654|gb|EAA10189.4| AGAP008585-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 209 bits (533), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 104/173 (60%), Positives = 121/173 (69%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+T+KD+K+VYMLLEAC+GGEVWTILR+R F+D+ A FI ACV++A DF
Sbjct: 1042 RLYRTYKDAKFVYMLLEACMGGEVWTILRDRVTFEDSTAKFIVACVLQAFDF-------- 1093
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LH RGIV+RDLKPENLLLD RGY KL VDF
Sbjct: 1094 ---LHARGIVYRDLKPENLLLDARGYAKL----------------------------VDF 1122
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
GFSK +G+S KTWTFCGTPEYVAPEII N+GHDR+VDYWALGIL+HELLTG+
Sbjct: 1123 GFSKFIGYS-SKTWTFCGTPEYVAPEIILNKGHDRSVDYWALGILIHELLTGI 1174
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195470342|ref|XP_002087467.1| GE15942 [Drosophila yakuba] gi|194173568|gb|EDW87179.1| GE15942 [Drosophila yakuba] | Back alignment and taxonomy information |
|---|
Score = 209 bits (533), Expect = 7e-52, Method: Compositional matrix adjust.
Identities = 114/212 (53%), Positives = 135/212 (63%), Gaps = 45/212 (21%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
AL+ L R IV D K E + R ++ L SR RLY+TF+D KYVYMLLEAC+
Sbjct: 486 ALKCLKKRHIV--DTKQEEHIFSER-HIMLSSRSPFI--CRLYRTFRDEKYVYMLLEACM 540
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLL 155
GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPENL+
Sbjct: 541 GGEIWTMLRDRGSFEDNAAQ-----------FIIGCVLQAFEYLHARGIIYRDLKPENLM 589
Query: 156 LDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215
LD RGYVK+ VDFGF+K +G S KTWTFCGTP
Sbjct: 590 LDERGYVKI----------------------------VDFGFAKQIGTS-TKTWTFCGTP 620
Query: 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
EYVAPEII N+GHDRAVDYWALGIL+HELL G
Sbjct: 621 EYVAPEIILNKGHDRAVDYWALGILIHELLNG 652
|
Source: Drosophila yakuba Species: Drosophila yakuba Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 255 | ||||||
| FB|FBgn0000442 | 768 | Pkg21D "cGMP-dependent protein | 0.450 | 0.149 | 0.534 | 1.9e-27 | |
| UNIPROTKB|F1NSH0 | 300 | F1NSH0 "Uncharacterized protei | 0.305 | 0.26 | 0.617 | 1.1e-25 | |
| UNIPROTKB|Q5JP05 | 283 | PRKG1 "cGMP-dependent protein | 0.305 | 0.275 | 0.617 | 1.1e-25 | |
| UNIPROTKB|F5GYC4 | 710 | RPS6KA3 "Ribosomal protein S6 | 0.290 | 0.104 | 0.428 | 5.1e-11 | |
| UNIPROTKB|B4DG22 | 711 | RPS6KA3 "cDNA FLJ56618, highly | 0.290 | 0.104 | 0.428 | 5.1e-11 | |
| UNIPROTKB|F1SD02 | 459 | PRKG1 "Uncharacterized protein | 0.305 | 0.169 | 0.617 | 2.1e-25 | |
| RGD|1587390 | 459 | Prkg1 "protein kinase, cGMP-de | 0.305 | 0.169 | 0.617 | 2.1e-25 | |
| UNIPROTKB|B7Z3B5 | 644 | RPS6KA2 "Ribosomal protein S6 | 0.294 | 0.116 | 0.407 | 8.4e-11 | |
| UNIPROTKB|F1MDQ6 | 609 | PRKG2 "Uncharacterized protein | 0.305 | 0.128 | 0.606 | 2.8e-25 | |
| UNIPROTKB|Q15349 | 733 | RPS6KA2 "Ribosomal protein S6 | 0.294 | 0.102 | 0.407 | 1e-10 |
| FB|FBgn0000442 Pkg21D "cGMP-dependent protein kinase 21D" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 317 (116.6 bits), Expect = 1.9e-27, P = 1.9e-27
Identities = 70/131 (53%), Positives = 87/131 (66%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEA 93
I AL+ L R IV D K E + R ++ L SR RLY+TF+D KYVYMLLEA
Sbjct: 484 IFALKCLKKRHIV--DTKQEEHIFSER-HIMLSSRSPFI--CRLYRTFRDEKYVYMLLEA 538
Query: 94 CLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPEN 153
C+GGE+WT+LR+R F+DNAA FI CV++A EYLH RGI++RDLKPEN
Sbjct: 539 CMGGEIWTMLRDRGSFEDNAAQFIIGCVLQAF-----------EYLHARGIIYRDLKPEN 587
Query: 154 LLLDNRGYVKL 164
L+LD RGYVK+
Sbjct: 588 LMLDERGYVKI 598
|
|
| UNIPROTKB|F1NSH0 F1NSH0 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 1.1e-25, P = 1.1e-25
Identities = 55/89 (61%), Positives = 69/89 (77%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 46 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAF---------- 95
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
YLH++GI++RDLKPENL+LD+RGY KL
Sbjct: 96 -AYLHSKGIIYRDLKPENLILDHRGYAKL 123
|
|
| UNIPROTKB|Q5JP05 PRKG1 "cGMP-dependent protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 1.1e-25, P = 1.1e-25
Identities = 55/89 (61%), Positives = 69/89 (77%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 35 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAF---------- 84
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
YLH++GI++RDLKPENL+LD+RGY KL
Sbjct: 85 -AYLHSKGIIYRDLKPENLILDHRGYAKL 112
|
|
| UNIPROTKB|F5GYC4 RPS6KA3 "Ribosomal protein S6 kinase alpha-3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 175 (66.7 bits), Expect = 5.1e-11, P = 5.1e-11
Identities = 33/77 (42%), Positives = 50/77 (64%)
Query: 173 IIREGAKGDSFFIISGGQVKV-DFGFSKH-LGHSGCKTWTFCGTPEYVAPEIIKNRGHDR 230
II K ++ + G +K+ DFG SK + H K ++FCGT EY+APE++ RGH +
Sbjct: 160 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQ 218
Query: 231 AVDYWALGILMHELLTG 247
+ D+W+ G+LM E+LTG
Sbjct: 219 SADWWSFGVLMFEMLTG 235
|
|
| UNIPROTKB|B4DG22 RPS6KA3 "cDNA FLJ56618, highly similar to Ribosomal protein S6 kinase alpha-3 (EC 2.7.11.1)" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 175 (66.7 bits), Expect = 5.1e-11, P = 5.1e-11
Identities = 33/77 (42%), Positives = 50/77 (64%)
Query: 173 IIREGAKGDSFFIISGGQVKV-DFGFSKH-LGHSGCKTWTFCGTPEYVAPEIIKNRGHDR 230
II K ++ + G +K+ DFG SK + H K ++FCGT EY+APE++ RGH +
Sbjct: 161 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQ 219
Query: 231 AVDYWALGILMHELLTG 247
+ D+W+ G+LM E+LTG
Sbjct: 220 SADWWSFGVLMFEMLTG 236
|
|
| UNIPROTKB|F1SD02 PRKG1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 2.1e-25, P = 2.1e-25
Identities = 55/89 (61%), Positives = 69/89 (77%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 211 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAF---------- 260
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
YLH++GI++RDLKPENL+LD+RGY KL
Sbjct: 261 -AYLHSKGIIYRDLKPENLILDHRGYAKL 288
|
|
| RGD|1587390 Prkg1 "protein kinase, cGMP-dependent, type 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 2.1e-25, P = 2.1e-25
Identities = 55/89 (61%), Positives = 69/89 (77%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TFKDSKY+YML+EACLGGE+WTILR+R F+D+ F TACV+EA
Sbjct: 211 RLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAF---------- 260
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
YLH++GI++RDLKPENL+LD+RGY KL
Sbjct: 261 -AYLHSKGIIYRDLKPENLILDHRGYAKL 288
|
|
| UNIPROTKB|B7Z3B5 RPS6KA2 "Ribosomal protein S6 kinase alpha-2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 173 (66.0 bits), Expect = 8.4e-11, P = 8.4e-11
Identities = 31/76 (40%), Positives = 48/76 (63%)
Query: 173 IIREGAKGDSFFIISGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRA 231
II K ++ + G +K+ DFG SK + ++FCGT EY+APE++ RGH ++
Sbjct: 91 IIYRDLKPENILLDEEGHIKITDFGLSKEAIDHDKRAYSFCGTIEYMAPEVVNRRGHTQS 150
Query: 232 VDYWALGILMHELLTG 247
D+W+ G+LM E+LTG
Sbjct: 151 ADWWSFGVLMFEMLTG 166
|
|
| UNIPROTKB|F1MDQ6 PRKG2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 273 (101.2 bits), Expect = 2.8e-25, Sum P(2) = 2.8e-25
Identities = 54/89 (60%), Positives = 67/89 (75%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+TFKD+KYVYMLLEACLGGE+W+ILR+R FD+ + F CV ACV EA
Sbjct: 362 KLYRTFKDNKYVYMLLEACLGGELWSILRDRGSFDEPTSKF---CV--------ACVTEA 410
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
+YLH GI++RDLKPENL+LD GY+KL
Sbjct: 411 FDYLHRLGIIYRDLKPENLILDAEGYLKL 439
|
|
| UNIPROTKB|Q15349 RPS6KA2 "Ribosomal protein S6 kinase alpha-2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 173 (66.0 bits), Expect = 1.0e-10, P = 1.0e-10
Identities = 31/76 (40%), Positives = 48/76 (63%)
Query: 173 IIREGAKGDSFFIISGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRA 231
II K ++ + G +K+ DFG SK + ++FCGT EY+APE++ RGH ++
Sbjct: 180 IIYRDLKPENILLDEEGHIKITDFGLSKEAIDHDKRAYSFCGTIEYMAPEVVNRRGHTQS 239
Query: 232 VDYWALGILMHELLTG 247
D+W+ G+LM E+LTG
Sbjct: 240 ADWWSFGVLMFEMLTG 255
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P00516 | KGP1_BOVIN | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5639 | 0.5176 | 0.1967 | yes | N/A |
| Q03042 | KGP1_DROME | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5377 | 0.6549 | 0.2174 | yes | N/A |
| O76360 | EGL4_CAEEL | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5406 | 0.5176 | 0.1692 | yes | N/A |
| O77676 | KGP1_RABIT | 2, ., 7, ., 1, 1, ., 1, 2 | 0.5639 | 0.5176 | 0.1967 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 255 | |||
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-75 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-55 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-46 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-42 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-41 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-36 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-33 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-33 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-33 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-29 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-29 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-28 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-28 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-27 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-27 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-26 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-26 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-23 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-23 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-20 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-20 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-19 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-19 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-10 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-07 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-07 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-06 | |
| smart00100 | 120 | smart00100, cNMP, Cyclic nucleotide-monophosphate | 3e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-06 | |
| cd00038 | 115 | cd00038, CAP_ED, effector domain of the CAP family | 5e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-04 | |
| pfam00027 | 91 | pfam00027, cNMP_binding, Cyclic nucleotide-binding | 7e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.001 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.001 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.001 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.001 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.001 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.001 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.001 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.002 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.002 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.002 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.002 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 0.002 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.002 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.003 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.003 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.003 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.003 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.003 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.003 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.004 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.004 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.004 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.004 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.004 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.004 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.004 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.004 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 0.004 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.004 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 9e-75
Identities = 96/173 (55%), Positives = 114/173 (65%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+TFKD KY+YML+E CLGGE+WTILR+R FD+ A F ACV+ A
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF---------- 106
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH RGI++RDLKPENLLLD+ GYVKL VDF
Sbjct: 107 -EYLHNRGIIYRDLKPENLLLDSNGYVKL----------------------------VDF 137
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
GF+K L SG KTWTFCGTPEYVAPEII N+G+D +VDYW+LGIL++ELLTG
Sbjct: 138 GFAKKLK-SGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 5e-55
Identities = 64/172 (37%), Positives = 98/172 (56%), Gaps = 39/172 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L+ F+ + +Y++LE GGE+++ L + F + A F A ++ AL
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLAL---------- 106
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH+ GI++RDLKPEN+LLD G++KL DF
Sbjct: 107 -EYLHSLGIIYRDLKPENILLDADGHIKL----------------------------TDF 137
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G +K L G +T TFCGTPEY+APE++ +G+ +AVD+W+LG+L++E+LTG
Sbjct: 138 GLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-54
Identities = 69/173 (39%), Positives = 99/173 (57%), Gaps = 42/173 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
LY +F+D +Y+++E GGE+++ LR+ F + A F A V+ AL
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL--------- 114
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
EYLH+ IV+RDLKPENLLLD+ GY+K+ D
Sbjct: 115 --EYLHSLDIVYRDLKPENLLLDSDGYIKI----------------------------TD 144
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FGF+K + +T+T CGTPEY+APEII ++G+ +AVD+WALGIL++E+L G
Sbjct: 145 FGFAKRVKG---RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-46
Identities = 65/172 (37%), Positives = 97/172 (56%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY F+D +Y+++E C GG+++ +L++R ++ A F ++ AL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSAL---------- 110
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH++GIV RDLKPEN+LLD G+VKL DF
Sbjct: 111 -EYLHSKGIVHRDLKPENILLDEDGHVKL----------------------------ADF 141
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G ++ L G K TF GTPEY+APE++ +G+ +AVD W+LG++++ELLTG
Sbjct: 142 GLARQL-DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-45
Identities = 70/172 (40%), Positives = 102/172 (59%), Gaps = 42/172 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL+ T D +++YML+E GGE+++ LR F ++ F + ++ C A
Sbjct: 65 RLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV--------C---A 113
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LEYLH++ IV+RDLKPEN+LLD G++KL DF
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKL----------------------------TDF 145
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K L +TWT CGTPEY+APE+I+++GH++AVD+WALGIL++E+L G
Sbjct: 146 GFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-42
Identities = 58/173 (33%), Positives = 85/173 (49%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL F+D ++Y+++E C GG+++ L ++ A I ++ L
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGL---------- 111
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH+ GI+ RDLKPEN+LLD G VK+ DF
Sbjct: 112 -EYLHSNGIIHRDLKPENILLDENGVVKI----------------------------ADF 142
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIK-NRGHDRAVDYWALGILMHELLTG 247
G +K L S TF GTP Y+APE++ G+ VD W+LG++++ELLTG
Sbjct: 143 GLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 65/171 (38%), Positives = 99/171 (57%), Gaps = 42/171 (24%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
+ +F+D VY LLE +GGE++T LR+ F ++ A F A ++ A
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF----------- 131
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
EYLH++ I++RDLKPENLLLDN+G+VK+ DFG
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKV----------------------------TDFG 163
Query: 197 FSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
F+K + +T+T CGTPEY+APE+I+++GH +AVD+W +G+L++E + G
Sbjct: 164 FAKKVPD---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 55/181 (30%), Positives = 91/181 (50%), Gaps = 47/181 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY +F+ K +Y+++E GG++ ++L D++ A A ++ AL
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLAL---------- 106
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH+ GI+ RDLKP+N+L+D+ G++KL DF
Sbjct: 107 -EYLHSNGIIHRDLKPDNILIDSNGHLKL----------------------------TDF 137
Query: 196 GFSK--------HLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G SK +L + GTP+Y+APE+I +GH + VD+W+LG +++E L G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 248 M 248
+
Sbjct: 198 I 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-37
Identities = 62/190 (32%), Positives = 95/190 (50%), Gaps = 33/190 (17%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY TF+D + +Y +LE GE+ +R+ D+ F A E L A
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA---EILL--------A 114
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPA---GHYIIREGAKGDSFFIISGGQV 191
LEYLH++GI+ RDLKPEN+LLD ++K+ +F A E KGD+ I S +
Sbjct: 115 LEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE- 173
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG---- 247
+ + +F GT EYV+PE++ + ++ D WALG +++++LTG
Sbjct: 174 -----------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 248 --MKESNVFQ 255
E FQ
Sbjct: 223 RGSNEYLTFQ 232
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 8e-36
Identities = 60/180 (33%), Positives = 93/180 (51%), Gaps = 26/180 (14%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFITACVIE 134
LY +F+ Y+ ++++ C GGE++ +L+ + C + A F A E V+
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA---E--------VLL 114
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFY-------PAGHYIIREGAKGDSFFIIS 187
ALEYLH GIV+RDLKPEN+LL G++ L + + + KG ++
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ F ++ +F GT EY+APE+I GH AVD+W LGIL++E+L G
Sbjct: 175 SIPSET-FSEE-----PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 66/171 (38%), Positives = 91/171 (53%), Gaps = 39/171 (22%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
L F+ +Y++LE GGE++ L F ++ TAC F + + AL
Sbjct: 65 LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMED-----TAC------FYLSEISLAL 113
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
E+LH +GI++RDLKPEN+LLD +G+VKL DFG
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKL----------------------------TDFG 145
Query: 197 FSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K H G T TFCGT EY+APEI+ GH +AVD+W+LG LM+++LTG
Sbjct: 146 LCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-33
Identities = 48/172 (27%), Positives = 88/172 (51%), Gaps = 42/172 (24%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEV-WTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ +F+D + +Y++++ LGG++ + + ++ F + E + F ++ A
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSE-----------EQVKFWICEIVLA 112
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LEYLH++GI+ RD+KP+N+LLD +G+V + DF
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHI----------------------------TDF 144
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ + T + GTP Y+APE++ +G+ AVD+W+LG+ +E L G
Sbjct: 145 NIATKV-TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 67/171 (39%), Positives = 93/171 (54%), Gaps = 42/171 (24%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
LY +FKD Y+Y++LE +GGE +T LR F ++ F A ++ L F
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV--LIF--------- 144
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
EYL + IV+RDLKPENLLLD G++K+ DFG
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKM----------------------------TDFG 176
Query: 197 FSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
F+K + +T+T CGTPEY+APEI+ N GH +A D+W LGI ++E+L G
Sbjct: 177 FAKVV---DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-33
Identities = 46/66 (69%), Positives = 54/66 (81%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
ML+E CLGGE+WTILR+R FD+ A F ACV+ A EYLH RGI++RDLKPENLLLD+
Sbjct: 70 MLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN 129
Query: 61 GYVKLV 66
GYVKLV
Sbjct: 130 GYVKLV 135
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 58/172 (33%), Positives = 91/172 (52%), Gaps = 39/172 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L+ F+ +Y++L+ GG+++T L + F + E + F A + A
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-----------EDVKFYLAELALA 110
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L++LH+ GI++RDLKPEN+LLD G++KL DF
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKL----------------------------TDF 142
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G SK K ++FCGT EY+APE++ RGH ++ D+W+ G+LM E+LTG
Sbjct: 143 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-31
Identities = 60/174 (34%), Positives = 92/174 (52%), Gaps = 42/174 (24%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
L+ F+ ++++L+ GGE++T L +R F ++ A ++ ALD
Sbjct: 70 LHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD---------- 119
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
+LH GI++RD+K EN+LLD+ G+V L DFG
Sbjct: 120 -HLHQLGIIYRDIKLENILLDSEGHVVL----------------------------TDFG 150
Query: 197 FSKH-LGHSGCKTWTFCGTPEYVAPEIIK--NRGHDRAVDYWALGILMHELLTG 247
SK L + ++FCGT EY+APE+I+ + GHD+AVD+W+LG+L ELLTG
Sbjct: 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 56/173 (32%), Positives = 88/173 (50%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+L+ F+ ++ ++E GG++ ++ FD+ A F A ++ L F
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF------- 111
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LH RGI++RDLK +N+LLD+ G++K+ D
Sbjct: 112 ----LHERGIIYRDLKLDNVLLDSEGHIKI----------------------------AD 139
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K G T TFCGTP+Y+APEI+ + + AVD+WALG+L++E+L G
Sbjct: 140 FGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-29
Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 50/196 (25%)
Query: 54 NLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA 113
N+LL N + LV L+ +F+ + +Y +L+ GGE++ L+ F +
Sbjct: 47 NVLLKNVKHPFLVG---------LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR 97
Query: 114 ASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYI 173
A F A + A AL YLH+ I++RDLKPEN+LLD++G+V L
Sbjct: 98 ARFYAAEI--------AS---ALGYLHSLNIIYRDLKPENILLDSQGHVVL--------- 137
Query: 174 IREGAKGDSFFIISGGQVKVDFGFSKH-LGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232
DFG K + HS T TFCGTPEY+APE+++ + +DR V
Sbjct: 138 -------------------TDFGLCKEGIEHSK-TTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 233 DYWALGILMHELLTGM 248
D+W LG +++E+L G+
Sbjct: 178 DWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-29
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 40/171 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY F+D ++Y+++E C GG + +L+E + + I ++E
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSE----------DEILRILLQILEG 104
Query: 136 LEYLHTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LEYLH+ GI+ RDLKPEN+LLD+ G VKL D
Sbjct: 105 LEYLHSNGIIHRDLKPENILLDSDNGKVKL----------------------------AD 136
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH-DRAVDYWALGILMHEL 244
FG SK L T GTP Y+APE++ +G+ D W+LG++++EL
Sbjct: 137 FGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 59/173 (34%), Positives = 86/173 (49%), Gaps = 44/173 (25%)
Query: 77 LYKTFKDSKYVYMLLEACLGGE-VWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ F+ +V ++E GG+ + I + F + A F ACV+ L
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDV--FSEPRAVFYAACVVLGL---------- 114
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+YLH IV+RDLK +NLLLD G+VK+ DF
Sbjct: 115 -QYLHENKIVYRDLKLDNLLLDTEGFVKI----------------------------ADF 145
Query: 196 GFSKH-LGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G K +G G +T TFCGTPE++APE++ + RAVD+W LG+L++E+L G
Sbjct: 146 GLCKEGMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 64/173 (36%), Positives = 95/173 (54%), Gaps = 41/173 (23%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
L+ F+ ++++L+ GGE++T L +R F + + + F + +I AL
Sbjct: 70 LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----------DEVRFYSGEIILAL 118
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
E+LH GIV+RD+K EN+LLD+ G+V L DFG
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVL----------------------------TDFG 150
Query: 197 FSKH-LGHSGCKTWTFCGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTG 247
SK L +T++FCGT EY+APEII+ + GH +AVD+W+LGIL+ ELLTG
Sbjct: 151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 43/213 (20%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
A++ L + I+ + K +N ++ R L+ K L+ +F+ ++ +Y +L+
Sbjct: 24 AVKVLQKKTILKK--KEQNHIMAERNV--LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLL 155
GGE++ L+ CF + A F A V A A+ YLH+ I++RDLKPEN+L
Sbjct: 80 GGELFFHLQRERCFLEPRARFYAAEV--------AS---AIGYLHSLNIIYRDLKPENIL 128
Query: 156 LDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215
LD++G+V L DFG K T TFCGTP
Sbjct: 129 LDSQGHVVL----------------------------TDFGLCKEGVEPEETTSTFCGTP 160
Query: 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
EY+APE+++ +DR VD+W LG +++E+L G+
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 55/173 (31%), Positives = 85/173 (49%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T L +F+ + ++E GGE++ L F ++ A F A ++ AL
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG-------- 109
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
YLH+ +V+RDLK ENL+LD G++K+ D
Sbjct: 110 ---YLHSCDVVYRDLKLENLMLDKDGHIKI----------------------------TD 138
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K G TFCGTPEY+APE++++ + RAVD+W LG++M+E++ G
Sbjct: 139 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 56/173 (32%), Positives = 89/173 (51%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+LY F+ ++ ++E GG++ +++ FD+ A F A + AL F
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMF------- 111
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LH +GI++RDLK +N+LLD+ G+ KL D
Sbjct: 112 ----LHDKGIIYRDLKLDNVLLDHEGHCKL----------------------------AD 139
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K +G T TFCGTP+Y+APEI++ + +VD+WA+G+L++E+L G
Sbjct: 140 FGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-27
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 48/199 (24%)
Query: 50 LKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCF 109
+ N+LL N + LV L+ +F+ + +Y +L+ GGE++ L+ CF
Sbjct: 43 MSERNVLLKNVKHPFLVG---------LHFSFQTADKLYFVLDYINGGELFYHLQRERCF 93
Query: 110 DDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPA 169
+ A F A + AL YLH+ IV+RDLKPEN+LLD++G++ L
Sbjct: 94 LEPRARFYAAEIASALG-----------YLHSLNIVYRDLKPENILLDSQGHIVL----- 137
Query: 170 GHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229
DFG K T TFCGTPEY+APE++ + +D
Sbjct: 138 -----------------------TDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 230 RAVDYWALGILMHELLTGM 248
R VD+W LG +++E+L G+
Sbjct: 175 RTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 9e-27
Identities = 59/169 (34%), Positives = 89/169 (52%), Gaps = 39/169 (23%)
Query: 80 TFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139
+F+ + +Y++L GGE++ L+ FD + A F TA ++ AL E L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCAL-----------ENL 109
Query: 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSK 199
H +++RDLKPEN+LLD +G++ L DFG K
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIAL----------------------------CDFGLCK 141
Query: 200 HLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
KT TFCGTPEY+APE++ G+ +AVD+W LG+L++E+LTG+
Sbjct: 142 LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T L+ TF+ ++++ ++E GG++ ++ FD+ A F A +I L F
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQF------- 111
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LH +GI++RDLK +N+LLD G++K+ D
Sbjct: 112 ----LHKKGIIYRDLKLDNVLLDKDGHIKI----------------------------AD 139
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K + K TFCGTP+Y+APEI+K + ++ +VD+W+ G+L++E+L G
Sbjct: 140 FGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 58/174 (33%), Positives = 87/174 (50%), Gaps = 41/174 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEV-WTILRERTCFDDNAASFITACVIEALDFITACVI 133
T L+ F+ ++ ++E GG++ + I R R FD+ + F A V AL F
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMF------ 111
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
LH G+++RDLK +N+LLD G+ KL
Sbjct: 112 -----LHRHGVIYRDLKLDNILLDAEGHCKL----------------------------A 138
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG K +G T TFCGTP+Y+APEI++ + +VD+WALG+LM+E++ G
Sbjct: 139 DFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 41/168 (24%)
Query: 82 KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141
++ + + LE GG + ++L++ + VI T ++E L YLH+
Sbjct: 71 EEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP--------VIRKY---TRQILEGLAYLHS 119
Query: 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHL 201
GIV RD+K N+L+D+ G VKL DFG +K L
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKL----------------------------ADFGCAKRL 151
Query: 202 G--HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G +G T + GTP ++APE+I+ + RA D W+LG + E+ TG
Sbjct: 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 20/178 (11%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+LY +F+D +++Y+++E GG++ +L + F + A F A ++ ALD
Sbjct: 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD-------- 115
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+H G + RD+KP+N+L+D G++KL +F + D + ++ +
Sbjct: 116 ---SVHKLGFIHRDIKPDNILIDADGHIKLADFGLC----KKMNKAKDREYYLNDSHNLL 168
Query: 194 DFGFSKHLGHSGCKTWTFC----GTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ GTP+Y+APE+++ + D+W+LG++++E+L G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 58/174 (33%), Positives = 88/174 (50%), Gaps = 41/174 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALDFITACVI 133
T L F+ + ++E GGE++ L RER ++ A F A ++
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR------------FYGAEIV 105
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
ALEYLH+R +V+RD+K ENL+LD G++K+
Sbjct: 106 SALEYLHSRDVVYRDIKLENLMLDKDGHIKI----------------------------T 137
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG K G TFCGTPEY+APE++++ + RAVD+W LG++M+E++ G
Sbjct: 138 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-26
Identities = 59/174 (33%), Positives = 93/174 (53%), Gaps = 42/174 (24%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
L+ F+ ++++L+ GGE++T L +R F + E + V+ AL
Sbjct: 70 LHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ----------EVQIYSGEIVL-AL 118
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
E+LH GI++RD+K EN+LLD+ G+V L DFG
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVL----------------------------TDFG 150
Query: 197 FSKH-LGHSGCKTWTFCGTPEYVAPEIIK--NRGHDRAVDYWALGILMHELLTG 247
SK + ++FCGT EY+AP+I++ + GHD+AVD+W++G+LM+ELLTG
Sbjct: 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-26
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 41/173 (23%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEA 135
Y ++ +++++E C GG + +L+ ++ +++ +++ L
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGL---------- 111
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH+ GI+ RD+K N+LL + G VKL +DF
Sbjct: 112 -EYLHSNGIIHRDIKAANILLTSDGEVKL----------------------------IDF 142
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
G S L T GTP ++APE+I + +D D W+LGI EL G
Sbjct: 143 GLSAQL-SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-26
Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 45/173 (26%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN-AASFITACVIEALDFITACVIE 134
+LY +F+ Y+Y+++E GG+ ++++ ++ A +I V+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVL------------ 108
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+E LH RGI+ RD+KPENLL+D G++KL D
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLIDQTGHLKL----------------------------TD 140
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S+ +G + F GTP+Y+APE I G D+ D+W+LG ++ E L G
Sbjct: 141 FGLSR----NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 48/195 (24%)
Query: 54 NLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA 113
N+LL N + LV L+ +F+ ++ +Y +L+ GGE++ L+ F +
Sbjct: 47 NVLLKNVKHPFLVG---------LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR 97
Query: 114 ASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYI 173
A F A + AL YLH+ IV+RDLKPEN+LLD++G+V L
Sbjct: 98 ARFYAAEIASALG-----------YLHSINIVYRDLKPENILLDSQGHVVL--------- 137
Query: 174 IREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVD 233
DFG K T TFCGTPEY+APE+I+ + +D VD
Sbjct: 138 -------------------TDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178
Query: 234 YWALGILMHELLTGM 248
+W LG +++E+L G+
Sbjct: 179 WWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 43/178 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTC----FDDNAASFITACVIEALDFITAC 131
+ Y++F++ + +++E GG++ ++++ F + + LD+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE----------QILDWFVQL 112
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ AL+YLH+R I+ RD+KP+N+ L + G VKL G
Sbjct: 113 CL-ALKYLHSRKILHRDIKPQNIFLTSNGLVKL-----G--------------------- 145
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
DFG SK L + T GTP Y++PE+ +N+ ++ D W+LG +++EL T
Sbjct: 146 --DFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 59/186 (31%), Positives = 90/186 (48%), Gaps = 54/186 (29%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
++ +F+ +++ M++E GG+ T+L+ I A ++ A + AL
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKN-----------IGALPVDMARMYFAETVLAL 114
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
EYLH GIV RDLKP+NLL+ + G++KL DFG
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKL----------------------------TDFG 146
Query: 197 FSK----------HLGHSGCKTWTF-----CGTPEYVAPEIIKNRGHDRAVDYWALGILM 241
SK + GH T F CGTPEY+APE+I +G+ + VD+WA+GI++
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206
Query: 242 HELLTG 247
+E L G
Sbjct: 207 YEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 48/176 (27%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+L F+D +Y+Y+ +E GG+ T+L ++ A F A + EA+D
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD-------- 115
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LH G + RDLKPEN L+D G++KL D
Sbjct: 116 ---ALHELGYIHRDLKPENFLIDASGHIKL----------------------------TD 144
Query: 195 FGFSK---HLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG SK +S G+P+Y+APE+++ +G+D VDYW+LG +++E L G
Sbjct: 145 FGLSKGIVTYANS------VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-24
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+L+ F+ +Y ++E GG++ +++ F + A F A + L F
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFF------- 116
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LH++GI++RDLK +N++LD G++K+ D
Sbjct: 117 ----LHSKGIIYRDLKLDNVMLDAEGHIKI----------------------------AD 144
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K G T TFCGTP+Y+APEII + + ++VD+WA G+L++E+L G
Sbjct: 145 FGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-24
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 45/213 (21%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACL 95
A++ L IV +D + + L +NR ++ + T L +F+ + ++E
Sbjct: 24 AMKILKKEVIVAKD-EVAHTLTENR----VLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78
Query: 96 GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT-RGIVFRDLKPENL 154
GGE++ L F ++ A F A ++ ALD YLH+ + +V+RDLK ENL
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAEIVSALD-----------YLHSEKNVVYRDLKLENL 127
Query: 155 LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214
+LD G++K+ DFG K G TFCGT
Sbjct: 128 MLDKDGHIKI----------------------------TDFGLCKEGIKDGATMKTFCGT 159
Query: 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
PEY+APE++++ + RAVD+W LG++M+E++ G
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-24
Identities = 46/121 (38%), Positives = 65/121 (53%), Gaps = 28/121 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F +A + AL +LH RGI++RDLK +N+LLD G++KL
Sbjct: 100 FYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKL---------------------- 137
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D+G K G T TFCGTP Y+APEI++ + +VD+WALG+LM E++
Sbjct: 138 ------TDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 247 G 247
G
Sbjct: 192 G 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-23
Identities = 56/173 (32%), Positives = 89/173 (51%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T LY TF+ + ++ ++E GG++ ++ FD A+F A +I L F
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQF------- 111
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LH++GIV+RDLK +N+LLD G++K+ D
Sbjct: 112 ----LHSKGIVYRDLKLDNILLDTDGHIKI----------------------------AD 139
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K KT TFCGTP+Y+APEI+ + ++ +VD+W+ G+L++E+L G
Sbjct: 140 FGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-23
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 42/205 (20%)
Query: 43 RGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTI 102
+ +V +D E +++ R L + K T+L+ F+ +Y ++E GG++
Sbjct: 35 KDVVIQDDDVECTMVEKR---VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYH 91
Query: 103 LRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYV 162
+++ F + A F A + L F LH RGI++RDLK +N++LD+ G++
Sbjct: 92 IQQVGKFKEPQAVFYAAEISVGLFF-----------LHRRGIIYRDLKLDNVMLDSEGHI 140
Query: 163 KLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222
K+ DFG K G T TFCGTP+Y+APEI
Sbjct: 141 KI----------------------------ADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 223 IKNRGHDRAVDYWALGILMHELLTG 247
I + + ++VD+WA G+L++E+L G
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-23
Identities = 58/181 (32%), Positives = 87/181 (48%), Gaps = 42/181 (23%)
Query: 70 KKTRQ---TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALD 126
K TR T L +F+ + ++E GGE++ L F ++ F A ++ ALD
Sbjct: 50 KNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD 109
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
YLH+ IV+RDLK ENL+LD G++K+
Sbjct: 110 -----------YLHSGKIVYRDLKLENLMLDKDGHIKI---------------------- 136
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG K TFCGTPEY+APE++++ + RAVD+W LG++M+E++
Sbjct: 137 ------TDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
Query: 247 G 247
G
Sbjct: 191 G 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-23
Identities = 52/181 (28%), Positives = 93/181 (51%), Gaps = 22/181 (12%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+++ +F+D +Y+++E GG++ T+L ++ + F A + A+D I
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI------- 117
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
H G + RD+KP+NLLLD++G+VKL + G + A F+ + DF
Sbjct: 118 ----HQLGFIHRDIKPDNLLLDSKGHVKLSDF--GLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 196 GFSKHLGHSGCKTW---------TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
F +TW + GTP+Y+APE+ G+++ D+W+LG++M+E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 247 G 247
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-23
Identities = 31/65 (47%), Positives = 46/65 (70%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE+++ L + F + A F A ++ ALEYLH+ GI++RDLKPEN+LLD
Sbjct: 70 LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD 129
Query: 61 GYVKL 65
G++KL
Sbjct: 130 GHIKL 134
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 6e-23
Identities = 57/174 (32%), Positives = 79/174 (45%), Gaps = 42/174 (24%)
Query: 75 TRLYKTF-KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVI 133
T+ Y +F K SK +++++E C GG +L+ D+ +FI + V+
Sbjct: 62 TKYYGSFLKGSK-LWIIMEYCGGGSCLDLLKPGK-LDETYIAFIL------RE-----VL 108
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
LEYLH G + RD+K N+LL G VKL
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKL----------------------------A 140
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG S L + K TF GTP ++APE+IK G+D D W+LGI EL G
Sbjct: 141 DFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 22/181 (12%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+++ +F+D + +Y+++E GG++ T+L ++ + A F A + A+D I
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI------- 117
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
H G + RD+KP+NLLLD +G+VKL + G + A F+ DF
Sbjct: 118 ----HQLGFIHRDIKPDNLLLDAKGHVKLSDF--GLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 196 GFSKHLGHSGCKTW---------TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
F +TW + GTP+Y+APE+ G+++ D+W+LG++M+E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 247 G 247
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-22
Identities = 51/173 (29%), Positives = 92/173 (53%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T LY TF+ ++++ ++E GG++ ++++ FD A+F A ++ C
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIV--------C--- 107
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L++LH++GI++RDLK +N++LD G++K+ D
Sbjct: 108 GLQFLHSKGIIYRDLKLDNVMLDRDGHIKI----------------------------AD 139
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K + TFCGTP+Y+APEI++ + +VD+W+ G+L++E+L G
Sbjct: 140 FGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 39/191 (20%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY +F+D Y+Y+++E GG++ T+L ++ F + F A I A+D I
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI------- 117
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL----------EFYPAGHYIIREGAKGDSFFI 185
H G + RD+KP+NLLLD +G++KL + + Y I A +F
Sbjct: 118 ----HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF-- 171
Query: 186 ISGGQVKVDFGFSKHLGHSGCKTW---------TFCGTPEYVAPEIIKNRGHDRAVDYWA 236
+DF +TW + GTP+Y+APE+ G+++ D+W+
Sbjct: 172 -------LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 237 LGILMHELLTG 247
LG++M+E+L G
Sbjct: 225 LGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-22
Identities = 55/172 (31%), Positives = 88/172 (51%), Gaps = 41/172 (23%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEV-WTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ F+ ++ ++E GG++ + + R+R +++A F +A + A
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR------------FYSAEISLA 108
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L YLH RGI++RDLK +N+LLD+ G++KL D+
Sbjct: 109 LNYLHERGIIYRDLKLDNVLLDSEGHIKL----------------------------TDY 140
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G K G T TFCGTP Y+APEI++ + +VD+WALG+LM E++ G
Sbjct: 141 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-22
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+L+ F+ +Y ++E GG++ +++ F + A F A + L F
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFF------- 116
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LH++GI++RDLK +N++LD+ G++K+ D
Sbjct: 117 ----LHSKGIIYRDLKLDNVMLDSEGHIKI----------------------------AD 144
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K G T TFCGTP+Y+APEII + + ++VD+WA G+L++E+L G
Sbjct: 145 FGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-22
Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 45/177 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L+ F+D KY+YM++E GG++ ++ + A F TA V+ A
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWAR------------FYTAEVVLA 154
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L+ +H+ G + RD+KP+N+LLD G++KL DF
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKL----------------------------ADF 186
Query: 196 GFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNRGHD----RAVDYWALGILMHELLTG 247
G + +G + T GTP+Y++PE++K++G D R D+W++G+ ++E+L G
Sbjct: 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 6e-22
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 41/168 (24%)
Query: 81 FKDSKYVYMLLEACLGGEVWTILRERTCFDDN-AASFITACVIEALDFITACVIEALEYL 139
+ S +Y++LE G + I+++ F ++ A ++ V++ L YL
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ------------VLQGLAYL 115
Query: 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSK 199
H +G++ RD+K N+L G VKL DFG +
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKL----------------------------ADFGVAT 147
Query: 200 HLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
L + GTP ++APE+I+ G A D W+LG + ELLTG
Sbjct: 148 KLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 6e-22
Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 39/171 (22%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
L+ F+ + +++++E GG++ ++ + + A F A + C+ AL
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEI---------CI--AL 109
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
+LH RGI++RDLK +N+LLD G++KL D+G
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDADGHIKL----------------------------TDYG 141
Query: 197 FSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K G T TFCGTP Y+APEI++ + +VD+WALG+LM E++ G
Sbjct: 142 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 5e-21
Identities = 33/66 (50%), Positives = 47/66 (71%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GGE+++ LR+ F + A F A V+ ALEYLH+ IV+RDLKPENLLLD+
Sbjct: 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD 137
Query: 61 GYVKLV 66
GY+K+
Sbjct: 138 GYIKIT 143
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 50/170 (29%)
Query: 87 VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVF 146
VY+ +E C GG + +L D++ VI T ++E L YLH+ GIV
Sbjct: 74 VYIFMEYCSGGTLEELLEHGRILDEH--------VIRVY---TLQLLEGLAYLHSHGIVH 122
Query: 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG---- 202
RD+KP N+ LD+ G +KL DFG + L
Sbjct: 123 RDIKPANIFLDHNGVIKL----------------------------GDFGCAVKLKNNTT 154
Query: 203 --HSGCKTWTFCGTPEYVAPEIIKN---RGHDRAVDYWALGILMHELLTG 247
++ GTP Y+APE+I +GH RA D W+LG ++ E+ TG
Sbjct: 155 TMGEEVQSLA--GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 89.4 bits (220), Expect = 1e-20
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 52/187 (27%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALDFITAC 131
+LY F+D +Y+++E GG + +L++ ++ A FI A ++ AL
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL------ 114
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
EYLH++GI+ RD+KPEN+LLD G V
Sbjct: 115 -----EYLHSKGIIHRDIKPENILLD----------------------------RDGRVV 141
Query: 192 K-VDFGFSKHLGHSGCKTW------TFCGTPEYVAPEIIKNRGH---DRAVDYWALGILM 241
K +DFG +K L G + T GTP Y+APE++ + D W+LGI +
Sbjct: 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201
Query: 242 HELLTGM 248
+ELLTG+
Sbjct: 202 YELLTGL 208
|
Length = 384 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 55/169 (32%), Positives = 85/169 (50%), Gaps = 40/169 (23%)
Query: 80 TFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139
+F+ +Y++ + GGE++ L++ F ++ A F +I V+ ALE+L
Sbjct: 64 SFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF----------YIAELVL-ALEHL 112
Query: 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSK 199
H IV+RDLKPEN+LLD G++ L DFG SK
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIAL----------------------------CDFGLSK 144
Query: 200 HLGHSGCKTWTFCGTPEYVAPEI-IKNRGHDRAVDYWALGILMHELLTG 247
T TFCGT EY+APE+ + +G+ + VD+W+LG+L+ E+ G
Sbjct: 145 ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-20
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 36/193 (18%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
LY +F+D++Y+Y+++E GG++ T+L + F ++ F ++ CV+ A+
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF----------YMAECVL-AI 114
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFY--PAGHYIIREGA------KGDSFFIISG 188
E +H G + RD+KP+N+L+D G++KL + G + + A +G S
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 189 GQ--VKVDFGFSKHLGHSG---CKTW---------TFCGTPEYVAPEIIKNRGHDRAVDY 234
+ V VD S +L S TW + GTP+Y+APEI +G+ + D+
Sbjct: 175 NRNSVAVD---SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 235 WALGILMHELLTG 247
W+LG +M E L G
Sbjct: 232 WSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 2e-19
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E C GG+++ L ++ A I ++ LEYLH+ GI+ RDLKPEN+LLD
Sbjct: 75 LVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDEN 134
Query: 61 GYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
G VK+ +++K + TF + + YM E LGG +
Sbjct: 135 GVVKIADFGLAKKLLKSSSS-LTTFVGTPW-YMAPEVLLGGNGYG 177
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 3e-19
Identities = 31/65 (47%), Positives = 48/65 (73%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E C GG+++ +L++R ++ A F ++ ALEYLH++GIV RDLKPEN+LLD
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDED 133
Query: 61 GYVKL 65
G+VKL
Sbjct: 134 GHVKL 138
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-19
Identities = 42/121 (34%), Positives = 62/121 (51%), Gaps = 29/121 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F A +I LE+LH R IV+RDLKPEN+LLD+ G V++
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRIS--------------------- 137
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D G + L G K GTP Y+APE+++ +D +VD++ALG ++E++
Sbjct: 138 -------DLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189
Query: 247 G 247
G
Sbjct: 190 G 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-19
Identities = 42/119 (35%), Positives = 64/119 (53%), Gaps = 28/119 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F TA +I LE+LH R I++RDLKPEN+LLDN G V++
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRIS--------------------- 139
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
D G + L KT + GTP ++APE+++ +D +VDY+ALG+ ++E++
Sbjct: 140 -------DLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 49/179 (27%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFD--DNAASFITACVIEALDFITACVI 133
+L+ F+D KY+YM++E GG++ ++ +D + A F TA V+ ALD I
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAI----- 158
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
H+ G++ RD+KP+N+LLD G++KL
Sbjct: 159 ------HSMGLIHRDVKPDNMLLDKHGHLKL----------------------------A 184
Query: 194 DFGFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNRGHD----RAVDYWALGILMHELLTG 247
DFG + +G + T GTP+Y++PE++K++G D R D+W++G+ + E+L G
Sbjct: 185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 6e-19
Identities = 27/65 (41%), Positives = 41/65 (63%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+LE GE+ +R+ D+ F A ++ ALEYLH++GI+ RDLKPEN+LLD
Sbjct: 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD 138
Query: 61 GYVKL 65
++K+
Sbjct: 139 MHIKI 143
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-19
Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 49/179 (27%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFD--DNAASFITACVIEALDFITACVI 133
+L+ F+D +Y+YM++E GG++ ++ +D + A F TA V+ ALD I
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAI----- 158
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
H+ G + RD+KP+N+LLD G++KL
Sbjct: 159 ------HSMGFIHRDVKPDNMLLDKSGHLKL----------------------------A 184
Query: 194 DFGFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNRGHD----RAVDYWALGILMHELLTG 247
DFG + G + T GTP+Y++PE++K++G D R D+W++G+ ++E+L G
Sbjct: 185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-18
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 38/172 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
Y ++ +++++E GG + I+ + F I E V++
Sbjct: 79 DYYDSYLVGDELWVVMEYMDGGSLTDIITQ--NFVRMNEPQIAYVCRE--------VLQG 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LEYLH++ ++ RD+K +N+LL G VKL DF
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKL----------------------------ADF 160
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+ L K + GTP ++APE+IK + + VD W+LGI+ E+ G
Sbjct: 161 GFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 55/225 (24%), Positives = 111/225 (49%), Gaps = 37/225 (16%)
Query: 48 RDLKPENLLLDNR-GYVK----LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTI 102
+ L+ +++LL N+ +VK +++ RLY +F+D +Y +++ GG++ ++
Sbjct: 32 KTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 103 LRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYV 162
L F ++ A F A + C +E++ H G + RD+KP+N+L+D G++
Sbjct: 92 LIRMGIFPEDLARFYIAELT--------CAVESV---HKMGFIHRDIKPDNILIDRDGHI 140
Query: 163 KL---------------EFYPAGHYIIREGAK-----GDSFFIISGGQVKVDFGFSKHLG 202
KL ++Y +G ++ ++ GD G ++K
Sbjct: 141 KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLK-PLERRAARQ 199
Query: 203 HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
H C + GTP Y+APE++ G+ + D+W++G++++E+L G
Sbjct: 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 44/196 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY +F+D +Y +++ GG++ ++L F+++ A F A + C A
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAEL--------TC---A 113
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL-EF-----YPAGHYIIREGAKGDSFFIISGG 189
+E +H G + RD+KP+N+L+D G++KL +F + H DS + G
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH---------DSKYYQKGD 164
Query: 190 QVKVD-FGFSKHLG-----------------HSGCKTWTFCGTPEYVAPEIIKNRGHDRA 231
+ D S+ H C + GTP Y+APE++ G+ +
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224
Query: 232 VDYWALGILMHELLTG 247
D+W++G++++E+L G
Sbjct: 225 CDWWSVGVILYEMLVG 240
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-18
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 43/169 (25%)
Query: 81 FKDSKYVYMLLEACLGGEVWTI--LRERTCFDDNAASFITACVIEALDFITACVIEALEY 138
FK++ ++++E C G V I + +T ++ A I ++ LEY
Sbjct: 68 FKNTDL-WIVMEYCGAGSVSDIMKITNKTLTEEEIA------------AILYQTLKGLEY 114
Query: 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFS 198
LH+ + RD+K N+LL+ G KL DFG S
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQAKL----------------------------ADFGVS 146
Query: 199 KHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
L + K T GTP ++APE+I+ G++ D W+LGI E+ G
Sbjct: 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 3e-18
Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ Y F + ++LE GG + +L++ + L +I +++
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV-----------LAYIARQILKG 111
Query: 136 LEYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L+YLHT R I+ RD+KP NLL++++G VK I+ D
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVK----------------------IA------D 143
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG SK L ++ + TF GT Y++PE I+ + A D W+LG+ + E G
Sbjct: 144 FGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 41/175 (23%)
Query: 78 YKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137
Y +F +++++ GG + I++ + I A V++ V++ LE
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAII-ATVLKE-------VLKGLE 116
Query: 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGF 197
YLH+ G + RD+K N+LL G VK+ DFG
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKI----------------------------ADFGV 148
Query: 198 SKHLGHSGCKTW----TFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
S L G +T TF GTP ++APE+++ G+D D W+ GI EL TG
Sbjct: 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-17
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 40/172 (23%)
Query: 82 KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141
+ ++ +Y+++E C GG++ ++++ C + +I I +T ++ AL H
Sbjct: 71 RSNQTLYIVMEYCEGGDLAQLIQK--CKKER--KYIEEEFI--WRILTQLLL-ALYECHN 123
Query: 142 RG-----IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
R ++ RDLKP N+ LD VKL G DFG
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKL-----G-----------------------DFG 155
Query: 197 FSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
+K LGH T+ GTP Y++PE + + +D D W+LG L++EL
Sbjct: 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 47/192 (24%), Positives = 93/192 (48%), Gaps = 32/192 (16%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY +F+D +Y +++ GG++ ++L F + A F A + A+
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI---------- 114
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL---------------EFYPAGHYIIREGAKG 180
E +H G + RD+KP+N+L+D G++KL ++Y G +I ++ +
Sbjct: 115 -ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 181 DSFF-----IISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYW 235
+ G ++K + H C + GTP Y+APE++ +G+ + D+W
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATK-QHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 236 ALGILMHELLTG 247
++G+++ E+L G
Sbjct: 233 SVGVILFEMLVG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-17
Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 43/187 (22%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI 122
+ L+S+ + + T ++ +Y+ LE GG + +L++ F + VI
Sbjct: 53 IALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP--------VI 104
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
T ++ LEYLH R V RD+K N+L+D G VKL
Sbjct: 105 RLY---TRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKL------------------ 143
Query: 183 FFIISGGQVKVDFGFSKHL-GHSGCKTWTFCGTPEYVAPEIIKNRG-HDRAVDYWALGIL 240
DFG +K + S K +F G+P ++APE+I +G + A D W+LG
Sbjct: 144 ----------ADFGMAKQVVEFSFAK--SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 241 MHELLTG 247
+ E+ TG
Sbjct: 192 VLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 26/66 (39%), Positives = 45/66 (68%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG++ ++L D++ A A ++ ALEYLH+ GI+ RDLKP+N+L+D+
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN 129
Query: 61 GYVKLV 66
G++KL
Sbjct: 130 GHLKLT 135
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-17
Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 47/181 (25%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALDFITACVI 133
+L F+D +Y+++E GG++ ++L R FD++ A F A ++ A+
Sbjct: 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI-------- 115
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+H G V RD+KPEN+L+D G++KL
Sbjct: 116 ---HSVHQMGYVHRDIKPENVLIDRTGHIKL----------------------------A 144
Query: 194 DFGFSKHLGHSGCKTWTF-CGTPEYVAPEIIK------NRGHDRAVDYWALGILMHELLT 246
DFG + L + GTP+Y+APE++ + D+W+LG++ +E++
Sbjct: 145 DFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204
Query: 247 G 247
G
Sbjct: 205 G 205
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-17
Identities = 31/65 (47%), Positives = 46/65 (70%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
ML+E GGE+++ LR F ++ F + ++ ALEYLH++ IV+RDLKPEN+LLD
Sbjct: 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE 137
Query: 61 GYVKL 65
G++KL
Sbjct: 138 GHIKL 142
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 34/65 (52%), Positives = 49/65 (75%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
LLE +GGE++T LR+ F ++ A F A ++ A EYLH++ I++RDLKPENLLLDN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK 154
Query: 61 GYVKL 65
G+VK+
Sbjct: 155 GHVKV 159
|
Length = 329 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 43/172 (25%)
Query: 78 YKTFKDSKYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALDFITACVIEAL 136
Y F ++ + + +E GG + IL+E + + L I V++ L
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE-----------RILGKIAVAVLKGL 113
Query: 137 EYLH-TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH I+ RD+KP N+L+++RG +KL DF
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQIKL----------------------------CDF 145
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G S L +S KT F GT Y+APE I+ + D W+LG+ + EL TG
Sbjct: 146 GVSGQLVNSLAKT--FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 41/174 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+ Y ++ +++++E GG V T+++ + S I E V+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIR---E--------VLV 112
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
AL+Y+H G++ RD+K N+L+ N G VKL D
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKL----------------------------CD 144
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
FG + L + K TF GTP ++APE+I + +D D W+LGI ++E+ TG
Sbjct: 145 FGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-16
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 45/171 (26%)
Query: 83 DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142
D+ ++ + LE GG V +L +N +F V +F+ +++ L YLH R
Sbjct: 77 DADHLNIFLEYVPGGSVAALL-------NNYGAFEETLV---RNFVRQ-ILKGLNYLHNR 125
Query: 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHL- 201
GI+ RD+K N+L+DN+G +K+ DFG SK L
Sbjct: 126 GIIHRDIKGANILVDNKGGIKIS----------------------------DFGISKKLE 157
Query: 202 -----GHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ + G+ ++APE++K + R D W+LG L+ E+LTG
Sbjct: 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-16
Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 43/172 (25%)
Query: 78 YKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFITACVIEA 135
Y+ F + K + +++E GG + +++R + D++ L F ++ A
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED----------TILHFFVQILL-A 113
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
L ++HT+ I+ RDLK +N+LLD V VK+ D
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMV----------------------------VKIGD 145
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
FG SK L S K +T GTP Y++PE+ + + +++ D WALG +++EL +
Sbjct: 146 FGISKILS-SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-16
Identities = 39/117 (33%), Positives = 55/117 (47%), Gaps = 30/117 (25%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
I V++ L YLH+R I+ RD+KP N+LL +G VKL
Sbjct: 110 IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKL----------------------- 146
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
DFG S L +S TF GT Y+APE I+ + + D W+LG+ + E+
Sbjct: 147 -----CDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 30/66 (45%), Positives = 44/66 (66%), Gaps = 2/66 (3%)
Query: 2 LLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++ C GGE++ +L+ + C + A F A V+ ALEYLH GIV+RDLKPEN+LL
Sbjct: 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138
Query: 60 RGYVKL 65
G++ L
Sbjct: 139 SGHIML 144
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 38/121 (31%), Positives = 52/121 (42%), Gaps = 31/121 (25%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
++ ++ L YLH G + RD+K N+LL G VKL
Sbjct: 105 YVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKL---------------------- 142
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHE 243
DFG S L + K +F GTP ++APE+ + G+D D WALGI E
Sbjct: 143 ------ADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
Query: 244 L 244
L
Sbjct: 197 L 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 30/117 (25%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
V+ A+ ++H++ ++ RD+K N+LL + G VKL
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG-------------------------- 185
Query: 192 KVDFGFSKHLGH--SGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFGFSK S TFCGTP YVAPEI + + + + D ++LG+L++ELLT
Sbjct: 186 --DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-15
Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 42/187 (22%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI 122
++L+ + R + Y +D + + + +E GG V L+ + T ++
Sbjct: 55 IQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL 114
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
E + EYLH+ IV RD+K N+L D+ G VKL
Sbjct: 115 EGV-----------EYLHSNMIVHRDIKGANILRDSAGNVKLG----------------- 146
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTW---TFCGTPEYVAPEIIKNRGHDRAVDYWALGI 239
DFG SK L + GTP +++PE+I G+ R D W++G
Sbjct: 147 -----------DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGC 195
Query: 240 LMHELLT 246
+ E+LT
Sbjct: 196 TVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-15
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 40/161 (24%)
Query: 87 VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVF 146
+++++E GG + ++ E TC D+ I A E L +ALE+LH+ ++
Sbjct: 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQ---IAAVCRECL--------QALEFLHSNQVIH 138
Query: 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC 206
RD+K +N+LL G VKL DFGF +
Sbjct: 139 RDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQS 170
Query: 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K T GTP ++APE++ + + VD W+LGI+ E++ G
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-15
Identities = 24/79 (30%), Positives = 48/79 (60%), Gaps = 6/79 (7%)
Query: 1 MLLEACLGGEV-WTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++++ LGG++ + + ++ F + F ++ ALEYLH++GI+ RD+KP+N+LLD
Sbjct: 77 LVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE 135
Query: 60 RGYVKL----VSRKKKTRQ 74
+G+V + ++ K
Sbjct: 136 QGHVHITDFNIATKVTPDT 154
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-15
Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 44/179 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T L+ F+D +Y++++ +GG++ T+L + F+D + F A ++
Sbjct: 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPE-------DMARFYLAEMVL 113
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
A++ +H G V RD+KP+N+LLD G+++L D
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRL----------------------------AD 145
Query: 195 FGFSKHLGHSG-CKTWTFCGTPEYVAPEIIK----NRGH-DRAVDYWALGILMHELLTG 247
FG L G ++ GTP+Y++PEI++ +G D+W+LG+ M+E+L G
Sbjct: 146 FGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 42/195 (21%)
Query: 63 VKLVSRKKKTRQTRLY------KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-- 114
VK++ +K+ R+ L+ + ++ V M +G E+W ++ F A
Sbjct: 51 VKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME----FLQGGALT 106
Query: 115 SFITACVIEALDFITAC--VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHY 172
++ + T C V++AL YLH++G++ RD+K +++LL G VKL
Sbjct: 107 DIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLS------- 159
Query: 173 IIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232
DFGF + K + GTP ++APE+I + V
Sbjct: 160 ---------------------DFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 233 DYWALGILMHELLTG 247
D W+LGI++ E++ G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 42/195 (21%)
Query: 63 VKLVSRKKKTRQTRLY------KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-- 114
VK + +K+ R+ L+ + + V M +G E+W ++ F + A
Sbjct: 52 VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME----FLEGGALT 107
Query: 115 SFITACVIEALDFITAC--VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHY 172
+T + T C V+ AL YLH +G++ RD+K +++LL + G +KL
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLS------- 160
Query: 173 IIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232
DFGF + K + GTP ++APE+I + V
Sbjct: 161 ---------------------DFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 233 DYWALGILMHELLTG 247
D W+LGI++ E++ G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 45/202 (22%)
Query: 49 DLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC 108
++ E L D + ++S K LY+ + +++L+E C GG + +I+ E
Sbjct: 39 QIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE--- 95
Query: 109 FDDNAASFITACVIEA-LDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFY 167
+ + E + ++ ++EAL +LH+ ++ RDLK N+LL G VKL
Sbjct: 96 --------LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKL--- 144
Query: 168 PAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII---- 223
DFG S + K TF GTP ++APE++
Sbjct: 145 -------------------------ADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 224 -KNRGHDRAVDYWALGILMHEL 244
K+ +D D W+LGI + EL
Sbjct: 180 FKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 40/161 (24%)
Query: 87 VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVF 146
+++++E GG + ++ E TC D+ + I A E L +ALE+LH ++
Sbjct: 91 LFVVMEYLAGGSLTDVVTE-TCMDE---AQIAAVCRECL--------QALEFLHANQVIH 138
Query: 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC 206
RD+K +N+LL G VKL DFGF +
Sbjct: 139 RDIKSDNVLLGMDGSVKL----------------------------TDFGFCAQITPEQS 170
Query: 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K T GTP ++APE++ + + VD W+LGI+ E++ G
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 30/65 (46%), Positives = 45/65 (69%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ L F ++ A F + + ALE+LH +GI++RDLKPEN+LLD +
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ 136
Query: 61 GYVKL 65
G+VKL
Sbjct: 137 GHVKL 141
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-14
Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 40/195 (20%)
Query: 53 ENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN 112
E+ + D + + ++S+ T+ Y ++ +++++E GG +LR FD+
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-FDE- 100
Query: 113 AASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHY 172
F A +++ +++ L+YLH+ + RD+K N+LL +G VKL
Sbjct: 101 ---FQIATMLKE-------ILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKL-------- 142
Query: 173 IIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232
DFG + L + K TF GTP ++APE+I+ +D
Sbjct: 143 --------------------ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 233 DYWALGILMHELLTG 247
D W+LGI EL G
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 5e-14
Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 40/161 (24%)
Query: 87 VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVF 146
+++++E GG + ++ E TC D+ + + ++ALDF LH+ ++
Sbjct: 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDF-----------LHSNQVIH 138
Query: 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC 206
RD+K +N+LL G VKL DFGF +
Sbjct: 139 RDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQS 170
Query: 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K T GTP ++APE++ + + VD W+LGI+ E++ G
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-14
Identities = 49/190 (25%), Positives = 92/190 (48%), Gaps = 39/190 (20%)
Query: 58 DNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI 117
++R V ++S K + ++F+++ +Y++++ C GG+++ + NA +
Sbjct: 45 ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGV 96
Query: 118 TACVIEALD-FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIRE 176
+ LD F+ C+ AL+++H R I+ RD+K +N+ L G +KL
Sbjct: 97 LFPEDQILDWFVQICL--ALKHVHDRKILHRDIKSQNIFLTKDGTIKLG----------- 143
Query: 177 GAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWA 236
DFG ++ L + T GTP Y++PEI +NR ++ D WA
Sbjct: 144 -----------------DFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWA 186
Query: 237 LGILMHELLT 246
LG +++E+ T
Sbjct: 187 LGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-13
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 40/161 (24%)
Query: 87 VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVF 146
+++++E GG + ++ E TC D+ I A E L +ALE+LH+ ++
Sbjct: 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQ---IAAVCRECL--------QALEFLHSNQVIH 139
Query: 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC 206
RD+K +N+LL G VKL DFGF +
Sbjct: 140 RDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQS 171
Query: 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K T GTP ++APE++ + + VD W+LGI+ E++ G
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 29/121 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F A + LE LH IV+RDLKPEN+LLD+ G++++
Sbjct: 106 FYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRIS--------------------- 144
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D G + + G GT Y+APE++KN + + D+W LG L++E++
Sbjct: 145 -------DLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE 196
Query: 247 G 247
G
Sbjct: 197 G 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACV 121
+ L S K + + ++ + + +E GG + +LR + DN + I
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTII---- 111
Query: 122 IEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKG 180
F T ++E L+YLH IV RD+K +N+L++ G VK+
Sbjct: 112 -----FYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKIS--------------- 151
Query: 181 DSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN--RGHDRAVDYWALG 238
DFG SK L T TF GT +Y+APE+I RG+ D W+LG
Sbjct: 152 -------------DFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG 198
Query: 239 ILMHELLTG 247
+ E+ TG
Sbjct: 199 CTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 44/130 (33%), Positives = 61/130 (46%), Gaps = 34/130 (26%)
Query: 123 EALDFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGD 181
+ L I +++ALEYLH++ ++ RD+KP N+L++ G VKL
Sbjct: 103 DILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKL----------------- 145
Query: 182 SFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII----KNRGHDRAVDYWAL 237
DFG S +L S KT G Y+APE I +G+D D W+L
Sbjct: 146 -----------CDFGISGYLVDSVAKTID-AGCKPYMAPERINPELNQKGYDVKSDVWSL 193
Query: 238 GILMHELLTG 247
GI M EL TG
Sbjct: 194 GITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 42/195 (21%)
Query: 63 VKLVSRKKKTRQTRLY------KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-- 114
VK + +K+ R+ L+ + ++ V M +G E+W ++ F + A
Sbjct: 49 VKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME----FLEGGALT 104
Query: 115 SFITACVIEALDFITAC--VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHY 172
+T + T C V++AL +LH +G++ RD+K +++LL + G VKL
Sbjct: 105 DIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLS------- 157
Query: 173 IIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232
DFGF + + + GTP ++APE+I + V
Sbjct: 158 ---------------------DFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 233 DYWALGILMHELLTG 247
D W+LGI++ E++ G
Sbjct: 197 DIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 43/166 (25%)
Query: 86 YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145
Y+ + LE GG + + LR F++ F T V+E L YLH++GI+
Sbjct: 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL-----------AYLHSKGIL 130
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG--H 203
RDLK +NLL+D G K IS DFG SK +
Sbjct: 131 HRDLKADNLLVDADGICK----------------------IS------DFGISKKSDDIY 162
Query: 204 SGCKTWTFCGTPEYVAPEIIKN--RGHDRAVDYWALGILMHELLTG 247
+ + G+ ++APE+I + +G+ VD W+LG ++ E+ G
Sbjct: 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-13
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 40/173 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
TR Y ++ +++++E GG +L+ + A+ + +++
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILRE------------ILK 112
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L+YLH+ + RD+K N+LL +G VKL D
Sbjct: 113 GLDYLHSERKIHRDIKAANVLLSEQGDVKL----------------------------AD 144
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + L + K TF GTP ++APE+IK +D D W+LGI EL G
Sbjct: 145 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 11/88 (12%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
LY + + + VY+++E +GG+V ++L FD+ A + V ALD
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD---------- 118
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKL 164
YLH GI+ RDLKP+N+L+ N G++KL
Sbjct: 119 -YLHRHGIIHRDLKPDNMLISNEGHIKL 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 44/179 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T L+ F+D Y+Y++++ +GG++ T+L + F+D + F A ++
Sbjct: 64 TTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPE-------DMARFYIAEMVL 113
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
A+ +H V RD+KP+N+LLD G+++L D
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRL----------------------------AD 145
Query: 195 FGFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNR-----GHDRAVDYWALGILMHELLTG 247
FG + G ++ GTP+Y++PEI++ + D+W+LG+ M+E+L G
Sbjct: 146 FGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 36/117 (30%), Positives = 53/117 (45%), Gaps = 32/117 (27%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L+ LH + I+ RDLK N+LL ++ V
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILL-----------------------------VANDLV 142
Query: 192 KV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K+ D G SK L + KT GTP Y+APE+ K R + D W+LG L++E+ T
Sbjct: 143 KIGDLGISKVLKKNMAKTQI--GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-13
Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E C GG + +L+ ++ +++ +++ LEYLH+ GI+ RD+K N+LL +
Sbjct: 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS 133
Query: 60 RGYVKL----VSRKKKTRQTRLYKTFKDSKYVYM 89
G VKL +S + + R T + Y +M
Sbjct: 134 DGEVKLIDFGLSAQLSDTKAR--NTMVGTPY-WM 164
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-13
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 42/195 (21%)
Query: 63 VKLVSRKKKTRQTRLY------KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-- 114
VK + +K+ R+ L+ + ++ V M +G E+W ++ F + A
Sbjct: 50 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME----FLEGGALT 105
Query: 115 SFITACVIEALDFITAC--VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHY 172
+T + C V++AL LH +G++ RD+K +++LL + G VKL
Sbjct: 106 DIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLS------- 158
Query: 173 IIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232
DFGF + + + GTP ++APE+I + V
Sbjct: 159 ---------------------DFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 233 DYWALGILMHELLTG 247
D W+LGI++ E++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-13
Identities = 45/189 (23%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 58 DNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI 117
D+R L+++ K ++F+ ++Y+++E C GG++ ++ F
Sbjct: 44 DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK-----LQRGKLFP 98
Query: 118 TACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREG 177
+++ F+ C+ ++++H + ++ RD+K +N+ L G VKL
Sbjct: 99 EDTILQW--FVQMCL--GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLG------------ 142
Query: 178 AKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWAL 237
DFG ++ L G T+ GTP YV PEI +N ++ D W+L
Sbjct: 143 ----------------DFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186
Query: 238 GILMHELLT 246
G +++EL T
Sbjct: 187 GCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 45/175 (25%)
Query: 78 YKTFKDSKYVYMLLEACLGG----EVWTILRERTCFDDNAASFITACVIEALDFITACVI 133
+ FK + +++E GG ++ L+E F + + ++ ALD +
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV----- 185
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
H+R ++ RDLK N+ L G +KL
Sbjct: 186 ------HSRKMMHRDLKSANIFLMPTGIIKLG---------------------------- 211
Query: 194 DFGFSKHLGHSGC--KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFGFSK S +FCGTP Y+APE+ + + + + D W+LG++++ELLT
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-13
Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 45/176 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALDFITACV 132
R Y++F D + +++E G++ +L R R +D F FI +
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF----------FIQILL 112
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
L +LH++ I+ RD+K NL LD D VK
Sbjct: 113 --GLAHLHSKKILHRDIKSLNLFLD---------------------AYD--------NVK 141
Query: 193 V-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ D G +K L + T GTP Y++PE+ +++ ++ D WALG++++E TG
Sbjct: 142 IGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-13
Identities = 43/129 (33%), Positives = 55/129 (42%), Gaps = 33/129 (25%)
Query: 123 EALDFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGD 181
E L I ++AL YL I+ RD+KP N+LLD G +KL
Sbjct: 107 EILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL----------------- 149
Query: 182 SFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII---KNRGHDRAVDYWALG 238
DFG S L S KT G Y+APE I G+D D W+LG
Sbjct: 150 -----------CDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLG 197
Query: 239 ILMHELLTG 247
I ++E+ TG
Sbjct: 198 ITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 12/110 (10%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
LE GG + ++L++ + T ++E L YLH+ GIV RD+K N+L+D+ G
Sbjct: 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG 138
Query: 62 YVKLV----SRKKKTRQTRLY-KTFKDSKYVYMLLEACLGGE------VW 100
VKL +++ +T + + + Y +M E G E +W
Sbjct: 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPY-WMAPEVIRGEEYGRAADIW 187
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 52/183 (28%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDD----NAASFITACVIEALDFITA 130
T L+ F+D +Y++++ +GG++ T+L + F+D + A F A ++ A+D
Sbjct: 64 TTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAID---- 116
Query: 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
+ L Y+H RD+KP+N+L+D G+++L
Sbjct: 117 -SVHQLHYVH------RDIKPDNILMDMNGHIRL-------------------------- 143
Query: 191 VKVDFGFSKHLGHSG-CKTWTFCGTPEYVAPEIIK--NRGHDR---AVDYWALGILMHEL 244
DFG L G ++ GTP+Y++PEI++ G + D+W+LG+ M+E+
Sbjct: 144 --ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201
Query: 245 LTG 247
L G
Sbjct: 202 LYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 29/121 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F A + LE LH IV+RDLKPEN+LLD+ G++++
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRIS--------------------- 144
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D G + H+ G GT Y+APE++KN + + D+WALG L++E++
Sbjct: 145 -------DLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 196
Query: 247 G 247
G
Sbjct: 197 G 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 34/88 (38%), Positives = 49/88 (55%), Gaps = 1/88 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE +GGE +T LR F ++ F A ++ EYL + IV+RDLKPENLLLD
Sbjct: 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD 167
Query: 61 GYVKLVSRK-KKTRQTRLYKTFKDSKYV 87
G++K+ K TR Y +Y+
Sbjct: 168 GFIKMTDFGFAKVVDTRTYTLCGTPEYI 195
|
Length = 340 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-12
Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 42/196 (21%)
Query: 53 ENLLLDNRGYVKLVSRKKKTRQTRLYKTF-KDSKYVYMLLEACLGGEVWTILRERTCFDD 111
E+ + D + + ++S+ T+ Y ++ KD+K +++++E GG +L E D+
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWIIMEYLGGGSALDLL-EPGPLDE 100
Query: 112 NAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGH 171
+ I +++ LD YLH+ + RD+K N+LL G VKL
Sbjct: 101 TQIATILREILKGLD-----------YLHSEKKIHRDIKAANVLLSEHGEVKL------- 142
Query: 172 YIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRA 231
DFG + L + K TF GTP ++APE+IK +D
Sbjct: 143 ---------------------ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 232 VDYWALGILMHELLTG 247
D W+LGI EL G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 50/201 (24%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT-ILRERTCFDDNAASFITACV 121
V L+++ K + +F+++ +++++E C GG++ I R+R V
Sbjct: 50 VILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-------------V 96
Query: 122 IEALDFITACVIE---ALEYLHTRGIVFRDLKPENLLLDNRGYV-KLEFYPAGHYIIREG 177
+ + D I + ++ L+++H R I+ RD+K +N+ L G V KL
Sbjct: 97 LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLG------------ 144
Query: 178 AKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWAL 237
DFG ++ L S +T GTP Y++PEI +NR ++ D W+L
Sbjct: 145 ----------------DFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSL 188
Query: 238 GILMHELLTGMK---ESNVFQ 255
G +++EL T +K E N
Sbjct: 189 GCVLYELCT-LKHPFEGNNLH 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 35/117 (29%), Positives = 54/117 (46%), Gaps = 30/117 (25%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++A+ Y H+ I+ RD+KPEN+L+ G +KL
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILVSESGVLKL---------------------------- 141
Query: 193 VDFGFSKHLGHSGCKTWT-FCGTPEYVAPEI-IKNRGHDRAVDYWALGILMHELLTG 247
DFGF++ L T + T Y APE+ + + + + VD WA+G +M ELL G
Sbjct: 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 29/117 (24%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ +E+ H+ I+ RD+KPEN+L+ G VKL
Sbjct: 109 ILRGIEFCHSHNIIHRDIKPENILVSQSGVVKL--------------------------- 141
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPE-IIKNRGHDRAVDYWALGILMHELLTG 247
DFGF++ L G + T Y APE ++ + + RAVD WA+G L+ E+LTG
Sbjct: 142 -CDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 46/169 (27%), Positives = 70/169 (41%), Gaps = 37/169 (21%)
Query: 78 YKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137
Y F D + + +E GG ++ + + F V+ L I + A+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQ-----KGQLFEEEMVLWYLFQIVS----AVS 115
Query: 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGF 197
Y+H GI+ RD+K N+ L G +KL DFG
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLG----------------------------DFGI 147
Query: 198 SKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
SK LG T GTP Y++PE+ + ++ D WALG +++ELLT
Sbjct: 148 SKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 3e-12
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 37/119 (31%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLD---NRGYVKLEFYPAGHYIIREGAKGDSFFIISG 188
++EAL LH I+ D+K EN+L D +R Y+
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYL-------------------------- 151
Query: 189 GQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
D+G K +G C + GT +Y +PE IK +D + D+WA+G+L +ELLTG
Sbjct: 152 ----CDYGLCKIIGTPSC----YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-12
Identities = 36/121 (29%), Positives = 57/121 (47%), Gaps = 29/121 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F A ++ LE LH V+RDLKPEN+LLD+ G++++
Sbjct: 106 FYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRIS--------------------- 144
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D G + + G GT Y+APE++ N+ + + DYW LG L++E++
Sbjct: 145 -------DLGLAVKIPE-GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196
Query: 247 G 247
G
Sbjct: 197 G 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-12
Identities = 26/65 (40%), Positives = 44/65 (67%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GGE++T L +R F ++ A ++ AL++LH GI++RD+K EN+LLD+
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE 141
Query: 61 GYVKL 65
G+V L
Sbjct: 142 GHVVL 146
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 27/65 (41%), Positives = 43/65 (66%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E +GG+V ++L FD+ A + V AL+YLH GI+ RDLKP+N+L+ N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE 140
Query: 61 GYVKL 65
G++KL
Sbjct: 141 GHIKL 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-12
Identities = 24/64 (37%), Positives = 42/64 (65%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E GG++ ++ FD+ A F A ++ L++LH RGI++RDLK +N+LLD+ G+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH 134
Query: 63 VKLV 66
+K+
Sbjct: 135 IKIA 138
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-12
Identities = 27/58 (46%), Positives = 39/58 (67%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE++ L+ F + A F A + AL YLH+ I++RDLKPEN+LLD++G+V L
Sbjct: 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVL 137
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 9e-12
Identities = 33/114 (28%), Positives = 50/114 (43%), Gaps = 29/114 (25%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L + H+ GI+ RDLKPENLL++ G +KL D
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKL----------------------------AD 141
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
FG ++ G + T Y APE++ +G+ VD W++G + ELL+
Sbjct: 142 FGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 1e-11
Identities = 34/121 (28%), Positives = 54/121 (44%), Gaps = 39/121 (32%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ L Y H+ I+ RDLKP+N+L++ G +KL
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKL---------------------------- 139
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELLT 246
DFG ++ G T+ T E Y APEI+ ++ + AVD W++G + E++T
Sbjct: 140 ADFGLARAFGI---PLRTY--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
Query: 247 G 247
G
Sbjct: 195 G 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-11
Identities = 53/189 (28%), Positives = 80/189 (42%), Gaps = 44/189 (23%)
Query: 63 VKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITAC 120
++L+ + R + Y +D K + + +E GG V L+ A +T
Sbjct: 55 IQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK--------AYGALTES 106
Query: 121 VIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKG 180
V T ++E + YLH+ IV RD+K N+L D+ G VKL
Sbjct: 107 VTRKY---TRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLG--------------- 148
Query: 181 DSFFIISGGQVKVDFGFSKHLG---HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWAL 237
DFG SK L SG + GTP +++PE+I G+ R D W+L
Sbjct: 149 -------------DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195
Query: 238 GILMHELLT 246
G + E+LT
Sbjct: 196 GCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 43/125 (34%), Positives = 57/125 (45%), Gaps = 34/125 (27%)
Query: 128 ITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+T +++AL YL + G++ RD+KP N+LLD G VKL
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKL---------------------- 156
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII----KNRGHDRAVDYWALGILMH 242
DFG S L S KT + G Y+APE I N +D D W+LGI +
Sbjct: 157 ------CDFGISGRLVDSKAKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209
Query: 243 ELLTG 247
EL TG
Sbjct: 210 ELATG 214
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 25/58 (43%), Positives = 38/58 (65%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE++ L F ++ A F A ++ AL YLH+ +V+RDLK ENL+LD G++K+
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKI 136
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 30/116 (25%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ + Y+H GI+ RDLKP NLL+ G +K+
Sbjct: 110 KGVAYMHANGIMHRDLKPANLLISADGVLKI----------------------------A 141
Query: 194 DFGFSKHLGHSGCKTWTF-CGTPEYVAPEII-KNRGHDRAVDYWALGILMHELLTG 247
DFG ++ + ++ T Y APE++ R +D VD WA+G + ELL G
Sbjct: 142 DFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 37/121 (30%), Positives = 51/121 (42%), Gaps = 33/121 (27%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ L YLH ++ RD+K +N+LL VKL
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKL--------------------------- 154
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII-----KNRGHDRAVDYWALGILMHELLT 246
VDFG S L + + TF GTP ++APE+I + +D D W+LGI EL
Sbjct: 155 -VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213
Query: 247 G 247
G
Sbjct: 214 G 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 40/122 (32%), Positives = 61/122 (50%), Gaps = 31/122 (25%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F A +I LE++H R +V+RDLKP N+LLD G+V+ I
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR----------------------I 138
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII-KNRGHDRAVDYWALGILMHELL 245
S + D FSK H+ GT Y+APE++ K +D + D+++LG ++ +LL
Sbjct: 139 SDLGLACD--FSKKKPHAS------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
Query: 246 TG 247
G
Sbjct: 191 RG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 28/64 (43%), Positives = 39/64 (60%), Gaps = 3/64 (4%)
Query: 3 LEACLGGE-VWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
+E GG+ + I + F + A F ACV+ L+YLH IV+RDLK +NLLLD G
Sbjct: 81 MEYAAGGDLMMHIHTDV--FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG 138
Query: 62 YVKL 65
+VK+
Sbjct: 139 FVKI 142
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 28/58 (48%), Positives = 40/58 (68%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE++ L+ CF + A F A V A+ YLH+ I++RDLKPEN+LLD++G+V L
Sbjct: 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVL 137
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 27/64 (42%), Positives = 42/64 (65%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
++E GGE++ L F + A F A ++ ALEYLH+R +V+RD+K ENL+LD G
Sbjct: 73 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132
Query: 62 YVKL 65
++K+
Sbjct: 133 HIKI 136
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 4e-11
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 56/180 (31%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVI 133
+L + F+++ +Y + E + G ++ ++++R F ++ I +++ L I
Sbjct: 62 KLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI----- 115
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
H G RDLKPENLL+ VK+
Sbjct: 116 ------HKHGFFHRDLKPENLLVSGPEVVKI----------------------------A 141
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYV------APEII-KNRGHDRAVDYWALGILMHELLT 246
DFG ++ + S +T +YV APEI+ ++ + VD WALG +M EL T
Sbjct: 142 DFGLAREI-RS-RPPYT-----DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-11
Identities = 37/121 (30%), Positives = 56/121 (46%), Gaps = 29/121 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F A + LE L IV+RDLKPEN+LLD+RG++++
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRIS--------------------- 144
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D G + + G GT Y+APE+I N + + D+W LG L++E++
Sbjct: 145 -------DLGLAVQIPE-GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ 196
Query: 247 G 247
G
Sbjct: 197 G 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 41/127 (32%), Positives = 58/127 (45%), Gaps = 31/127 (24%)
Query: 122 IEALDFITACVIEALEYLH-TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKG 180
+E L I V+E L YL+ I+ RD+KP N+L+++RG +KL
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKL---------------- 145
Query: 181 DSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGIL 240
DFG S L +S T F GT Y++PE I+ + D W+LGI
Sbjct: 146 ------------CDFGVSGELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 241 MHELLTG 247
+ EL G
Sbjct: 192 IIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-11
Identities = 38/118 (32%), Positives = 55/118 (46%), Gaps = 31/118 (26%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++E + YLH+ IV RD+K N+L D+ G VKL
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLG-------------------------- 148
Query: 192 KVDFGFSKHLGH---SGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG SK L SG + GTP +++PE+I G+ R D W++G + E+LT
Sbjct: 149 --DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 28/58 (48%), Positives = 40/58 (68%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE++ L+ CF + A F A + AL YLH+ IV+RDLKPEN+LLD++G++ L
Sbjct: 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 137
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-11
Identities = 30/74 (40%), Positives = 43/74 (58%), Gaps = 6/74 (8%)
Query: 11 VWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL----- 65
++ + E F + A F TA +I LE+LH R I++RDLKPEN+LLDN G V++
Sbjct: 84 IYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGL 143
Query: 66 -VSRKKKTRQTRLY 78
V K +T+ Y
Sbjct: 144 AVELKDGQSKTKGY 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-11
Identities = 27/65 (41%), Positives = 44/65 (67%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GG+++T L + F + F A + AL++LH+ GI++RDLKPEN+LLD
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 134
Query: 61 GYVKL 65
G++KL
Sbjct: 135 GHIKL 139
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-11
Identities = 40/121 (33%), Positives = 53/121 (43%), Gaps = 30/121 (24%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
I V++ L YL + I+ RD+KP N+L++ RG VKL
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKL----------------------- 136
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG S L +S KT + GT Y+APE I + D W+LGI EL G
Sbjct: 137 -----CDFGVSTQLVNSIAKT--YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
Query: 248 M 248
Sbjct: 190 R 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-11
Identities = 29/65 (44%), Positives = 45/65 (69%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GGE++T L +R F ++ F + +I ALE+LH GIV+RD+K EN+LLD+
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE 141
Query: 61 GYVKL 65
G+V L
Sbjct: 142 GHVVL 146
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-11
Identities = 46/196 (23%), Positives = 77/196 (39%), Gaps = 61/196 (31%)
Query: 66 VSRKKKT-------RQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE-----RTCFDDNA 113
SR++ T L+K V+++L+ GG++W+ + + C A
Sbjct: 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWA 91
Query: 114 ASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYI 173
A + A L+ LH GIV RDL P N+LLD+RG+++L ++ +
Sbjct: 92 AEMVVA----------------LDALHREGIVCRDLNPNNILLDDRGHIQLTYF--SRWS 133
Query: 174 -IREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232
+ + G++ Y APE+ A
Sbjct: 134 EVEDSCDGEAV------------------------------ENMYCAPEVGGISEETEAC 163
Query: 233 DYWALGILMHELLTGM 248
D+W+LG ++ ELLTG
Sbjct: 164 DWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-11
Identities = 22/66 (33%), Positives = 41/66 (62%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG++ +L + F + A F A ++ AL+ +H G + RD+KP+N+L+D
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD 137
Query: 61 GYVKLV 66
G++KL
Sbjct: 138 GHIKLA 143
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-11
Identities = 34/121 (28%), Positives = 56/121 (46%), Gaps = 29/121 (23%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+A + + +LH+ IV+RD+KPEN+LLD++G +L
Sbjct: 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLS--------------------- 137
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D G + L G GT Y+APEI+K + VD++A+G ++E++
Sbjct: 138 -------DLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA 189
Query: 247 G 247
G
Sbjct: 190 G 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 27/58 (46%), Positives = 40/58 (68%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE++ L+ FD + A F TA ++ ALE LH +++RDLKPEN+LLD +G++ L
Sbjct: 77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIAL 134
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-10
Identities = 32/117 (27%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG++ T+L ++ + F A + A++ +H G + RD+KP+NLLLD++
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK 137
Query: 61 GYVK-----LVSRKKKTRQTRLYKTFKD---SKYVYMLLEACLGGEVWTILRERTCF 109
G+VK L + KK +T Y+ S + + + + E W R + F
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAF 194
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 32/122 (26%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F+ ++ L+Y+H+ GI+ RDLKP N+ ++ D I
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----------------------EDCELKI 159
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH-DRAVDYWALGILMHELL 245
+DFG ++H + + T Y APEI+ N H ++ VD W++G +M ELL
Sbjct: 160 ------LDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
Query: 246 TG 247
TG
Sbjct: 211 TG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 29/109 (26%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ Y+H R I+ RDLK +N+ L N +++ G DF
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN-------------LLKIG----------------DF 149
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
G S+ L S TF GTP Y++PE +K++G+D D W+LG +++E+
Sbjct: 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 31/121 (25%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+++ ++ L YLH++G + RD+K N+LL + G+VKL
Sbjct: 110 YVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKL---------------------- 147
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHE 243
DFG S + + K +F GTP ++APE+ + G+++ D WA+GI E
Sbjct: 148 ------ADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE 201
Query: 244 L 244
L
Sbjct: 202 L 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E C GG + +L D++ T ++E L YLH+ GIV RD+KP N+ LD+ G
Sbjct: 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV 137
Query: 63 VKLV---SRKKKTRQTRLY 78
+KL K T
Sbjct: 138 IKLGDFGCAVKLKNNTTTM 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 50/201 (24%), Positives = 79/201 (39%), Gaps = 43/201 (21%)
Query: 49 DLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC 108
D K E L D + +++ +L F +++L+E C GG V ++ E
Sbjct: 39 DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--- 95
Query: 109 FDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYP 168
+ + +EAL YLH I+ RDLK N+L G +KL
Sbjct: 96 -------LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKL---- 144
Query: 169 AGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII----- 223
DFG S + + +F GTP ++APE++
Sbjct: 145 ------------------------ADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 224 KNRGHDRAVDYWALGILMHEL 244
K+R +D D W+LGI + E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-10
Identities = 33/128 (25%), Positives = 53/128 (41%), Gaps = 39/128 (30%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+E L+YLH+ GI+ RD+K N+L++N G +KL
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKL---------------------------- 141
Query: 193 VDFGFSKHLGHSGCKTWT--FCGTPEYVAPEII---KNRGHDRAVDYWALGILMHELLTG 247
DFG ++ +T T Y PE++ + VD W++G ++ EL G
Sbjct: 142 ADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATR--YGPEVDMWSVGCILAELFLG 198
Query: 248 MKESNVFQ 255
+FQ
Sbjct: 199 ---KPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 36/115 (31%), Positives = 55/115 (47%), Gaps = 31/115 (26%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ L YLH++G + RD+K N+LL + G VKL
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDVKL---------------------------- 147
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHEL 244
DFG + + + K +F GTP ++APE+ KN G+++ D WA+GI EL
Sbjct: 148 ADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 30/111 (27%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV- 193
ALE++H++ I+ RD+KP N+ FI + G VK+
Sbjct: 118 ALEHMHSKRIMHRDIKPANV-----------------------------FITATGVVKLG 148
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
D G + + GTP Y++PE I G++ D W+LG L++E+
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 26/62 (41%), Positives = 36/62 (58%), Gaps = 8/62 (12%)
Query: 21 FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL--------VSRKKKT 72
F + A F A +I LE+LH R IV+RDLKPEN+LLD+ G V++ + KK
Sbjct: 92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI 151
Query: 73 RQ 74
+
Sbjct: 152 KG 153
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 6/49 (12%)
Query: 213 GTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN------VFQ 255
GTP+Y+APE++ + H AVD+WALG+ + E LTG+ N VFQ
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQ 590
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 12/120 (10%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F C +EY+H++G++ RDLKP+N+LL G V + + G I ++ + D
Sbjct: 119 FHKIC--ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW--GAAIFKKLEEED----- 169
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
+ +D S GTP+Y+APE + + D +ALG++++++LT
Sbjct: 170 ---LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 31/118 (26%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L+YLH I+ RDLK NLLL ++G +K+
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKI--------------------------- 149
Query: 192 KVDFGFSKHLGHSGCKTWTFC-GTPEYVAPEII-KNRGHDRAVDYWALGILMHELLTG 247
DFG ++ G K T T Y APE++ + A+D WA+G ++ ELL
Sbjct: 150 -ADFGLARTYGLP-AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-10
Identities = 23/58 (39%), Positives = 37/58 (63%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG+ ++++ ++ A A V+ +E LH RGI+ RD+KPENLL+D G++KL
Sbjct: 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKL 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 55/204 (26%)
Query: 59 NRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFIT 118
+R + ++ K+ R+ RL K K + +L +V+T R F+D +T
Sbjct: 51 SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-------DVFTPARSLEEFND--VYLVT 101
Query: 119 ACVIEALDFITAC--------------VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
+ L+ I C ++ L+Y+H+ I+ RDLKP NL ++ +K+
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161
Query: 165 EFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224
+DFG ++H + + T Y APEI+
Sbjct: 162 ----------------------------LDFGLARHTDD---EMTGYVATRWYRAPEIML 190
Query: 225 NRGH-DRAVDYWALGILMHELLTG 247
N H ++ VD W++G +M ELLTG
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 42/196 (21%)
Query: 53 ENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN 112
E L L+ R + LVS + F + +L+ GG++ L + F +
Sbjct: 38 ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE- 96
Query: 113 AASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHY 172
+ + F +I LE++H R +V+RDLKP N+LLD G+V+
Sbjct: 97 ----------KEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR--------- 137
Query: 173 IIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII-KNRGHDRA 231
IS + D FSK H+ GT Y+APE++ K +D +
Sbjct: 138 -------------ISDLGLACD--FSKKKPHAS------VGTHGYMAPEVLQKGTAYDSS 176
Query: 232 VDYWALGILMHELLTG 247
D+++LG ++ +LL G
Sbjct: 177 ADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 29/75 (38%), Positives = 43/75 (57%), Gaps = 4/75 (5%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ LE GG + + LR F++ F T V+E L YLH++GI+ RDLK +NLL+D
Sbjct: 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD 144
Query: 61 GYVKL----VSRKKK 71
G K+ +S+K
Sbjct: 145 GICKISDFGISKKSD 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 26/65 (40%), Positives = 43/65 (66%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GGE++T L +R F + + ++ ALE+LH GI++RD+K EN+LLD+
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN 141
Query: 61 GYVKL 65
G+V L
Sbjct: 142 GHVVL 146
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-10
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 3/97 (3%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ LE GG + +L++ F + T ++ LEYLH R V RD+K N+L+D
Sbjct: 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138
Query: 61 GYVKLVS--RKKKTRQTRLYKTFKDSKYVYMLLEACL 95
G VKL K+ + K+FK S Y +M E
Sbjct: 139 GVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIA 174
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 9e-10
Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 44/132 (33%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+I +++AL+Y+H+ ++ RDLKP N+LL++ VKL
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL---------------------- 148
Query: 187 SGGQVKVDFG----FSKHLGHSGCKTWTFCGTPEYVA------PEI-IKNRGHDRAVDYW 235
DFG S+ + T +YVA PEI + + + + VD W
Sbjct: 149 ------ADFGLARSLSELEENPENPVLT-----DYVATRWYRAPEILLGSTRYTKGVDMW 197
Query: 236 ALGILMHELLTG 247
++G ++ E+L G
Sbjct: 198 SVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 29/67 (43%), Positives = 43/67 (64%), Gaps = 2/67 (2%)
Query: 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E C GG + +L+E ++ I ++E LEYLH+ GI+ RDLKPEN+LLD+
Sbjct: 68 LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS 127
Query: 60 R-GYVKL 65
G VKL
Sbjct: 128 DNGKVKL 134
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 28/58 (48%), Positives = 39/58 (67%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE++ L+ F + A F A + AL YLH+ IV+RDLKPEN+LLD++G+V L
Sbjct: 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL 137
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 27/58 (46%), Positives = 40/58 (68%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE++ L++ F ++ A F A ++ ALE+LH IV+RDLKPEN+LLD G++ L
Sbjct: 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIAL 137
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 30/118 (25%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F+ C ALE++H+R ++ RD+KP N+ + G VKL
Sbjct: 112 FVQLC--SALEHMHSRRVMHRDIKPANVFITATGVVKLG--------------------- 148
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
D G + + GTP Y++PE I G++ D W+LG L++E+
Sbjct: 149 -------DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 34/125 (27%), Positives = 56/125 (44%), Gaps = 34/125 (27%)
Query: 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISG 188
T +++ + YLH +V RD+K N++L G +KL
Sbjct: 108 TKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKL------------------------ 143
Query: 189 GQVKVDFGFSKHL---GHSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
+DFG ++ L G G + + GTP ++APE+I G+ R D W++G +
Sbjct: 144 ----IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199
Query: 243 ELLTG 247
E+ TG
Sbjct: 200 EMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 46/168 (27%), Positives = 70/168 (41%), Gaps = 42/168 (25%)
Query: 92 EACLGGEVWTILRERTCFDDNAASFITACVI--EALD-----FITACVIEALEYLHTRGI 144
+ +GG++W +L C + + +I + LD +I + L++LH I
Sbjct: 92 DKLVGGQLWLVLE--LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI 149
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS 204
+ RD+K N+LL G VKL VDFG S L +
Sbjct: 150 IHRDVKGNNILLTTEGGVKL----------------------------VDFGVSAQLTST 181
Query: 205 GCKTWTFCGTPEYVAPEIIK-----NRGHDRAVDYWALGILMHELLTG 247
+ T GTP ++APE+I + +D D W+LGI EL G
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 23/58 (39%), Positives = 38/58 (65%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG++ T+L ++ F + F A I A++ +H G + RD+KP+NLLLD +G++KL
Sbjct: 85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKL 142
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 32/119 (26%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
F+ C A+E++H+R ++ RD+KP N+ FI
Sbjct: 112 FVQLC--SAVEHMHSRRVMHRDIKPANV-----------------------------FIT 140
Query: 187 SGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
+ G VK+ D G + + GTP Y++PE I G++ D W+LG L++E+
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 47/174 (27%), Positives = 71/174 (40%), Gaps = 40/174 (22%)
Query: 79 KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138
K K+ ++++LE C GG V +++ + I A +I + L++
Sbjct: 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA-------YILHEALMGLQH 139
Query: 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFS 198
LH + RD+K N+LL G VKL VDFG S
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKL----------------------------VDFGVS 171
Query: 199 KHLGHSGCKTWTFCGTPEYVAPEIIK-----NRGHDRAVDYWALGILMHELLTG 247
L + + T GTP ++APE+I + +D D W+LGI EL G
Sbjct: 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 44/169 (26%)
Query: 81 FKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140
+ D K +++++E C GG V I+ E D + I ++EAL+YLH
Sbjct: 79 YWDGK-LWIMIEFCPGGAVDAIMLE---LDRGLTE-------PQIQVICRQMLEALQYLH 127
Query: 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKH 200
+ I+ RDLK N+LL G +KL DFG S
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKL----------------------------ADFGVSAK 159
Query: 201 LGHSGCKTWTFCGTPEYVAPEII-----KNRGHDRAVDYWALGILMHEL 244
+ + +F GTP ++APE++ K+ +D D W+LGI + E+
Sbjct: 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 28/65 (43%), Positives = 40/65 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E GG+ T+L+ + A A + ALEYLH GIV RDLKP+NLL+ +
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM 137
Query: 61 GYVKL 65
G++KL
Sbjct: 138 GHIKL 142
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 5/86 (5%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG++ T+L ++ + A F A + A++ +H G + RD+KP+NLLLD +
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK 137
Query: 61 GYVK-----LVSRKKKTRQTRLYKTF 81
G+VK L + KK +T Y+
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNL 163
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 24/60 (40%), Positives = 39/60 (65%), Gaps = 1/60 (1%)
Query: 8 GGEVWTIL-RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66
GG++ ++L R FD++ A F A ++ A+ +H G V RD+KPEN+L+D G++KL
Sbjct: 85 GGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLA 144
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 36/121 (29%), Positives = 55/121 (45%), Gaps = 31/121 (25%)
Query: 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISG 188
T +++ + YLH+ IV RD+K N+L D+ G VKL
Sbjct: 112 TRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLG----------------------- 148
Query: 189 GQVKVDFGFSKHLG---HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
DFG SK + SG + GTP +++PE+I G+ R D W++ + E+L
Sbjct: 149 -----DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203
Query: 246 T 246
T
Sbjct: 204 T 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 25/64 (39%), Positives = 42/64 (65%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
++E GG++ +++ FD+ A F A + AL +LH +GI++RDLK +N+LLD+ G
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG 133
Query: 62 YVKL 65
+ KL
Sbjct: 134 HCKL 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 4e-09
Identities = 16/32 (50%), Positives = 25/32 (78%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+E L+YLH+ GI+ RD+K N+L++N G +KL
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 21/109 (19%)
Query: 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+L+E C GG + +I+ E + ++ ++EAL +LH+ ++ RDLK N+LL
Sbjct: 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138
Query: 60 RGYVKL----VSRK-KKTRQTR---------------LYKTFKDSKYVY 88
G VKL VS K K T Q R +TFKD+ Y Y
Sbjct: 139 DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 36/120 (30%), Positives = 50/120 (41%), Gaps = 35/120 (29%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
I ++ L YLH+ + RD+K N+LL G VKL
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKL----------------------- 156
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII--KNRGH-DRAVDYWALGILMHEL 244
DFG + + +F GTP ++APE+I + G D VD W+LGI EL
Sbjct: 157 -----ADFGSASLV----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-09
Identities = 23/58 (39%), Positives = 39/58 (67%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG++ ++ FD+ A F A +I L++LH +GI++RDLK +N+LLD G++K+
Sbjct: 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKI 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-09
Identities = 26/65 (40%), Positives = 41/65 (63%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GGE++ L F ++ F A ++ AL+YLH+ IV+RDLK ENL+LD
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131
Query: 61 GYVKL 65
G++K+
Sbjct: 132 GHIKI 136
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-09
Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 33/130 (25%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
E + +I ++ L +LH ++ RD+K +N+LL VKL
Sbjct: 111 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL------------------ 152
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK-----NRGHDRAVDYWAL 237
VDFG S L + + TF GTP ++APE+I + +D D W+L
Sbjct: 153 ----------VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202
Query: 238 GILMHELLTG 247
GI E+ G
Sbjct: 203 GITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 27/65 (41%), Positives = 41/65 (63%), Gaps = 2/65 (3%)
Query: 2 LLEACLGGEV-WTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GG++ + I R R FD+ + F A V AL +LH G+++RDLK +N+LLD
Sbjct: 74 VMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132
Query: 61 GYVKL 65
G+ KL
Sbjct: 133 GHCKL 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 42/189 (22%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI 122
++L++R R+ + + + +E GG V +L + F + +
Sbjct: 54 IRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA----VIINYT 109
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
E ++ L YLH I+ RD+K NLL+D+ G +R
Sbjct: 110 EQ-------LLRGLSYLHENQIIHRDVKGANLLIDSTGQ-----------RLR------- 144
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTF----CGTPEYVAPEIIKNRGHDRAVDYWALG 238
DFG + L G F GT ++APE+++ + R+ D W++G
Sbjct: 145 ---------IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG 195
Query: 239 ILMHELLTG 247
++ E+ T
Sbjct: 196 CVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 31/131 (23%), Positives = 56/131 (42%), Gaps = 44/131 (33%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+ ++ L+YLH+ ++ RDLKP N+L++
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVN----------------------------- 137
Query: 187 SGGQVKV-DFGFSKHLGHSGCKT--WTFCGTPEYV------APEIIKN-RGHDRAVDYWA 236
S +K+ DFG ++ + + T EYV APE++ + + +A+D W+
Sbjct: 138 SNCDLKICDFGLARGVDPDEDEKGFLT-----EYVVTRWYRAPELLLSSSRYTKAIDIWS 192
Query: 237 LGILMHELLTG 247
+G + ELLT
Sbjct: 193 VGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 36/126 (28%), Positives = 54/126 (42%), Gaps = 33/126 (26%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+I ++ L +LH ++ RD+K +N+LL VKL
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKL---------------------- 162
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK-----NRGHDRAVDYWALGILM 241
VDFG S L + + TF GTP ++APE+I + +D D W+LGI
Sbjct: 163 ------VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216
Query: 242 HELLTG 247
E+ G
Sbjct: 217 IEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 35/114 (30%), Positives = 49/114 (42%), Gaps = 33/114 (28%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LEYLH+ I+ RDLKP NLL+ + G +KL D
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKL----------------------------AD 145
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHELL 245
FG ++ G K T Y APE++ ++ G VD W++G + ELL
Sbjct: 146 FGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGV--GVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 24/58 (41%), Positives = 35/58 (60%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG+ T+L ++ A F A + EA++ LH G + RDLKPEN L+D G++KL
Sbjct: 85 GGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKL 142
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 26/65 (40%), Positives = 43/65 (66%), Gaps = 1/65 (1%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNR 60
++E GGE++ L F ++ A F A ++ AL+YLH+ + +V+RDLK ENL+LD
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132
Query: 61 GYVKL 65
G++K+
Sbjct: 133 GHIKI 137
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 54.0 bits (128), Expect = 2e-08
Identities = 28/70 (40%), Positives = 46/70 (65%), Gaps = 4/70 (5%)
Query: 1 MLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
+++E GG + +L++ ++ A FI A ++ ALEYLH++GI+ RD+KPEN+LL
Sbjct: 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL 134
Query: 58 D-NRGYVKLV 66
D + VKL+
Sbjct: 135 DRDGRVVKLI 144
|
Length = 384 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 22/45 (48%), Positives = 31/45 (68%)
Query: 21 FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
FD+ A F A + LE LH IV+RDLKPEN+LLD+ G++++
Sbjct: 99 FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-08
Identities = 14/32 (43%), Positives = 22/32 (68%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ L Y H+ I+ RDLKP+N+L++ G +KL
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKL 139
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 23/58 (39%), Positives = 36/58 (62%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG++ L + F + F A +I LE++H R +V+RDLKP N+LLD G+V++
Sbjct: 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 138
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 34/126 (26%), Positives = 61/126 (48%), Gaps = 32/126 (25%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
+ + ++ ++ L+Y+H+ GI+ RDLKP NL ++ +K+
Sbjct: 117 DKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKI------------------ 158
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH-DRAVDYWALGILM 241
+DFG ++H + + + T Y APE+I N H ++ VD W++G +M
Sbjct: 159 ----------LDFGLARH---ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205
Query: 242 HELLTG 247
E+LTG
Sbjct: 206 AEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 25/64 (39%), Positives = 35/64 (54%), Gaps = 1/64 (1%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
++E C GG +L+ D+ +FI V+ LEYLH G + RD+K N+LL G
Sbjct: 77 IMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG 135
Query: 62 YVKL 65
VKL
Sbjct: 136 DVKL 139
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 22/65 (33%), Positives = 41/65 (63%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG++ T+L + F ++ F A + A+E +H G + RD+KP+N+L+D
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG 137
Query: 61 GYVKL 65
G++KL
Sbjct: 138 GHIKL 142
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 23/67 (34%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLH-TRGIVFRDLKPENLLLD 58
+ +E GG + IL+E + + I V++ L YLH I+ RD+KP N+L++
Sbjct: 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135
Query: 59 NRGYVKL 65
+RG +KL
Sbjct: 136 SRGQIKL 142
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 31/122 (25%)
Query: 128 ITACVIEALEYLH-TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
I+ V+ L YL I+ RD+KP N+L+++RG +KL
Sbjct: 104 ISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKL---------------------- 141
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG S L S +F GT Y++PE ++ + D W+LG+ + E+
Sbjct: 142 ------CDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
Query: 247 GM 248
G
Sbjct: 194 GR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 33/117 (28%), Positives = 55/117 (47%), Gaps = 29/117 (24%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+I+A+ + H IV RD+KPENLL+ + +KL
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKL--------------------------- 141
Query: 192 KVDFGFSKHLGHSGCKTWT-FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFGF+++L +T + T Y +PE++ + +AVD W++G ++ EL G
Sbjct: 142 -CDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 37/160 (23%)
Query: 87 VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVF 146
+Y+++ C GG+++ L+E+ V+E F+ + AL+YLH + I+
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQ-----KGKLLPENQVVEW--FVQ--IAMALQYLHEKHILH 125
Query: 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC 206
RDLK +N+ L II+ G D G ++ L +
Sbjct: 126 RDLKTQNVFLTRTN------------IIKVG----------------DLGIARVLENQCD 157
Query: 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
T GTP Y++PE+ N+ ++ D WALG ++E+ T
Sbjct: 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-08
Identities = 25/65 (38%), Positives = 42/65 (64%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GG++ ++ + + A F +A + AL YLH RGI++RDLK +N+LLD+
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132
Query: 61 GYVKL 65
G++KL
Sbjct: 133 GHIKL 137
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 33/121 (27%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ + YLH R IV RD+KP NLL+++ VK+
Sbjct: 177 ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKI--------------------------- 209
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK---NRG-HD-RAVDYWALGILMHELLT 246
DFG S+ L + + GT Y++PE I N G +D A D W+LG+ + E
Sbjct: 210 -ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 247 G 247
G
Sbjct: 269 G 269
|
Length = 353 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 6e-08
Identities = 23/65 (35%), Positives = 42/65 (64%), Gaps = 1/65 (1%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNR 60
+LE GG + +L++ + ++I +++ L+YLHT R I+ RD+KP NLL++++
Sbjct: 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK 136
Query: 61 GYVKL 65
G VK+
Sbjct: 137 GEVKI 141
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-08
Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 29/121 (23%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
I ++A+ + H + RD+KPEN+L+ +G +KL
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKL----------------------- 141
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE-IIKNRGHDRAVDYWALGILMHELLT 246
DFGF++ L G + T Y APE ++ + + VD WA+G + ELLT
Sbjct: 142 -----CDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
Query: 247 G 247
G
Sbjct: 197 G 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-08
Identities = 25/73 (34%), Positives = 41/73 (56%), Gaps = 4/73 (5%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ LE GG V +L F++ +++ L YLH RGI+ RD+K N+L+DN+
Sbjct: 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK 142
Query: 61 GYVKL----VSRK 69
G +K+ +S+K
Sbjct: 143 GGIKISDFGISKK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 49/176 (27%), Positives = 70/176 (39%), Gaps = 45/176 (25%)
Query: 76 RLYKTF--KDSKYVYM-LLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITAC 131
R YKTF D Y+ M L+E GE + L+E+ F + I F+
Sbjct: 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI---------FVQMV 123
Query: 132 VIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
+ AL YLH + IV RDL P N++L V +
Sbjct: 124 L--ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI-------------------------- 155
Query: 191 VKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG +K K + GT Y PEI+KN + D WA G +++++ T
Sbjct: 156 --TDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 21/40 (52%), Positives = 30/40 (75%)
Query: 26 ASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
A F +A + AL +LH RGI++RDLK +N+LLD G++KL
Sbjct: 98 ARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKL 137
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 23/50 (46%), Positives = 37/50 (74%), Gaps = 2/50 (4%)
Query: 18 RTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++C FD A+F A +I L++LH++GIV+RDLK +N+LLD G++K+
Sbjct: 88 QSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKI 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 21/58 (36%), Positives = 38/58 (65%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG++ ++L F+++ A F A + A+E +H G + RD+KP+N+L+D G++KL
Sbjct: 85 GGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKL 142
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 21/66 (31%), Positives = 34/66 (51%), Gaps = 3/66 (4%)
Query: 2 LLEACLGGEVWTI--LRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++E C G V I + +T + + I ++ LEYLH+ + RD+K N+LL+
Sbjct: 76 VMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134
Query: 60 RGYVKL 65
G KL
Sbjct: 135 EGQAKL 140
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 17/51 (33%), Positives = 26/51 (50%), Gaps = 1/51 (1%)
Query: 16 RERTCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKL 65
++ + I ++AL YL I+ RD+KP N+LLD G +KL
Sbjct: 99 VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL 149
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 32/126 (25%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
+ + F+ +++ L+Y+H GI+ RDLKP NL ++ +K+
Sbjct: 118 DRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKI------------------ 159
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH-DRAVDYWALGILM 241
+DFG ++ + + + T Y APE+I N H + VD W++G +M
Sbjct: 160 ----------LDFGLARQ---TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206
Query: 242 HELLTG 247
E+LTG
Sbjct: 207 AEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 39/164 (23%), Positives = 64/164 (39%), Gaps = 36/164 (21%)
Query: 87 VYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145
+Y++LE GG++ LR+ F S ++ + + L F + + +EYL ++ V
Sbjct: 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS--LKDLLSFA-IQIAKGMEYLASKKFV 127
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG 205
RDL N L+ VK IS DFG S+ +
Sbjct: 128 HRDLAARNCLVGEDLVVK----------------------IS------DFGLSRDVYDDD 159
Query: 206 CKTWTFCGTPEYV---APEIIKNRGHDRAVDYWALGILMHELLT 246
G + APE +K+ D W+ G+L+ E+ T
Sbjct: 160 YYR-KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 22/64 (34%), Positives = 45/64 (70%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
++E GG++ ++++ FD A+F A ++ L++LH++GI++RDLK +N++LD G
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG 133
Query: 62 YVKL 65
++K+
Sbjct: 134 HIKI 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 20/40 (50%), Positives = 30/40 (75%)
Query: 26 ASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
A F TA V+ AL+ +H+ G + RD+KP+N+LLD G++KL
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 15/90 (16%)
Query: 1 MLLEACLGGEVWTILR---ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
+++ GG + I++ R D+ + + V++ LEYLH+ G + RD+K N+LL
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135
Query: 58 DNRGYVKL----VS--------RKKKTRQT 75
G VK+ VS R +K R+T
Sbjct: 136 GEDGSVKIADFGVSASLADGGDRTRKVRKT 165
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 14/84 (16%)
Query: 29 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL----VSRKKKTRQTRLYKTFKDS 84
I V++ L YLH+R I+ RD+KP N+LL +G VKL VS + TF +
Sbjct: 110 IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGT 166
Query: 85 KYVYMLLEACLGGE------VWTI 102
+ YM E G VW++
Sbjct: 167 SF-YMAPERIQGKPYSITSDVWSL 189
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 20/45 (44%), Positives = 31/45 (68%)
Query: 21 FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
F++ A F A ++ LE LH V+RDLKPEN+LLD+ G++++
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 23/64 (35%), Positives = 38/64 (59%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
+L+ GG++ L + F + F +I LE++H R +V+RDLKP N+LLD G
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134
Query: 62 YVKL 65
+V++
Sbjct: 135 HVRI 138
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 42/172 (24%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136
Y F + + +E GG + +L+E + E L ++ V+ L
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-----------EILGKVSIAVLRGL 116
Query: 137 EYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YL + I+ RD+KP N+L+++RG +KL DF
Sbjct: 117 AYLREKHQIMHRDVKPSNILVNSRGEIKL----------------------------CDF 148
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G S L S + F GT Y++PE ++ + D W++G+ + EL G
Sbjct: 149 GVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-07
Identities = 30/122 (24%), Positives = 41/122 (33%), Gaps = 45/122 (36%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+EYL ++ + RDL N L+ VK IS
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVK----------------------IS------ 144
Query: 194 DFGFSKHLG------HSGCK---TWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
DFG S+ L G K W APE +K D W+ G+L+ E+
Sbjct: 145 DFGLSRDLYDDDYYRKRGGKLPIRWM--------APESLKEGKFTSKSDVWSFGVLLWEI 196
Query: 245 LT 246
T
Sbjct: 197 FT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 22/45 (48%), Positives = 31/45 (68%)
Query: 21 FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
FD+ A F A + LE L IV+RDLKPEN+LLD+RG++++
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 33/126 (26%), Positives = 58/126 (46%), Gaps = 32/126 (25%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
E + F+ ++ L+Y+H+ GI+ RDLKP N+ ++ +++
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI------------------ 159
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH-DRAVDYWALGILM 241
+DFG ++ + + T Y APEI+ N H ++ VD W++G +M
Sbjct: 160 ----------LDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
Query: 242 HELLTG 247
ELL G
Sbjct: 207 AELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 39/115 (33%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+++LH+ IV RDLKP+N+L+ + G VK+ D
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKI----------------------------AD 150
Query: 195 FGFSKHLGHSGCKTWTFCGTPE-----YVAPEIIKNRGHDRAVDYWALGILMHEL 244
FG ++ ++ T Y APE++ + VD W++G + EL
Sbjct: 151 FGLARIY------SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 30/122 (24%), Positives = 41/122 (33%), Gaps = 45/122 (36%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+EYL ++ + RDL N L+ VK IS
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVK----------------------IS------ 145
Query: 194 DFGFSKHLG------HSGCK---TWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
DFG S+ L G K W APE +K D W+ G+L+ E+
Sbjct: 146 DFGLSRDLYDDDYYKVKGGKLPIRWM--------APESLKEGKFTSKSDVWSFGVLLWEI 197
Query: 245 LT 246
T
Sbjct: 198 FT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 33/130 (25%), Positives = 59/130 (45%), Gaps = 39/130 (30%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
E + ++ ++ +++LH+ GI+ RDLKP N+++ + +K+
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI------------------ 167
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEIIKNRGHDRAVDYWAL 237
+DFG ++ G S F TP Y APE+I G+ VD W++
Sbjct: 168 ----------LDFGLARTAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 238 GILMHELLTG 247
G +M E++ G
Sbjct: 212 GCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-07
Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 35/120 (29%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
IT ++ L YLH+ ++ RD+K N+LL G VKL
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKL----------------------- 166
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII--KNRG-HDRAVDYWALGILMHEL 244
DFG + + +F GTP ++APE+I + G +D VD W+LGI EL
Sbjct: 167 -----ADFGSASIASPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 18/116 (15%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
V++AL H +GIV RDLKP+N+++ G +R AK F I +
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTG-------------VRPHAKVLDFGIGTLLP- 133
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G + +T GTP Y APE ++ D +A G++ E LTG
Sbjct: 134 ----GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 24/65 (36%), Positives = 41/65 (63%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG++ ++ + + A F A + AL +LH RGI++RDLK +N+LLD
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD 132
Query: 61 GYVKL 65
G++KL
Sbjct: 133 GHIKL 137
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 23/65 (35%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG V T+++ + S I V+ AL+Y+H G++ RD+K N+L+ N
Sbjct: 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT 137
Query: 61 GYVKL 65
G VKL
Sbjct: 138 GNVKL 142
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-07
Identities = 23/65 (35%), Positives = 40/65 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GG++W+ + + + A ++ AL+ LH GIV RDL P N+LLD+R
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
Query: 61 GYVKL 65
G+++L
Sbjct: 122 GHIQL 126
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 33/121 (27%), Positives = 55/121 (45%), Gaps = 31/121 (25%)
Query: 128 ITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
++ VI+ L YL + I+ RD+KP N+L+++RG +KL
Sbjct: 108 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL---------------------- 145
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG S L S + F GT Y++PE ++ + D W++G+ + E+
Sbjct: 146 ------CDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197
Query: 247 G 247
G
Sbjct: 198 G 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-07
Identities = 31/123 (25%), Positives = 58/123 (47%), Gaps = 29/123 (23%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
E + ++ ++ +++LH+ GI+ RDLKP N+++ + +K+
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI------------------ 160
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
+DFG ++ G S T + T Y APE+I G+ VD W++G +M
Sbjct: 161 ----------LDFGLARTAGTSFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 243 ELL 245
E++
Sbjct: 210 EMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 20/64 (31%), Positives = 35/64 (54%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
+LE G + I+++ F ++ + V++ L YLH +G++ RD+K N+L G
Sbjct: 77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG 136
Query: 62 YVKL 65
VKL
Sbjct: 137 VVKL 140
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 21/45 (46%), Positives = 31/45 (68%)
Query: 21 FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
F++ A F A + LE LH IV+RDLKPEN+LLD+ G++++
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-07
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 35/120 (29%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
+T ++ L YLH+ ++ RD+K N+LL G VKL
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG---------------------- 157
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII--KNRG-HDRAVDYWALGILMHEL 244
DFG + + + F GTP ++APE+I + G +D VD W+LGI EL
Sbjct: 158 ------DFGSASIMAPAN----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 6e-07
Identities = 21/77 (27%), Positives = 43/77 (55%), Gaps = 9/77 (11%)
Query: 8 GGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL- 65
GG + I+ + ++ +++ V++ LEYLH++ ++ RD+K +N+LL G VKL
Sbjct: 99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLA 158
Query: 66 -------VSRKKKTRQT 75
++++K R +
Sbjct: 159 DFGFAAQLTKEKSKRNS 175
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 13/107 (12%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVS 67
GG V L+ + T ++E +EYLH+ IV RD+K N+L D+ G VKL
Sbjct: 88 GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGD 147
Query: 68 RKKKTR------QTRLYKTFKDSKYVYMLLEACLG------GEVWTI 102
R K+ + Y +M E G +VW++
Sbjct: 148 FGASKRLQTICSSGTGMKSVTGTPY-WMSPEVISGEGYGRKADVWSV 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 35/120 (29%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
IT ++ L YLH+ ++ RD+K N+LL G VKL
Sbjct: 126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKL----------------------- 162
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII--KNRG-HDRAVDYWALGILMHEL 244
DFG + + +F GTP ++APE+I + G +D VD W+LGI EL
Sbjct: 163 -----ADFGSASKSSPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-07
Identities = 42/137 (30%), Positives = 62/137 (45%), Gaps = 18/137 (13%)
Query: 127 FITACVIEALEYLH-------TRGIVFRDLKPENLL--LDNRGYVKLEFYPAGHYIIREG 177
FI V +EY+ G V + PE++L + L+F H II
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 178 AKGDSFFIISGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDY-- 234
K + + GQVK+ DFG S +L S KT C + Y+APE IK+ G ++ Y
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGPNQNPTYTV 186
Query: 235 ----WALGILMHELLTG 247
W+LG+ + E+ G
Sbjct: 187 QSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 18/45 (40%), Positives = 31/45 (68%)
Query: 21 FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
F + A F A + L +LH++GI++RDLK +N++LD G++K+
Sbjct: 98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKI 142
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 27/120 (22%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
I V+ A++YLH I+ RD+K EN+ +++ G V L + A +
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF--------------- 231
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
VD +K+ G W GT APE++ + AVD W+ GI++ E+ T
Sbjct: 232 ----PVDINANKYYG------WA--GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 7e-07
Identities = 39/182 (21%), Positives = 62/182 (34%), Gaps = 56/182 (30%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL + +Y++ E GG++ LR+ + + L + +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---------EKLTLKDLLQM-ALQIAKG 114
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+EYL ++ V RDL N L+ VK IS DF
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVK----------------------IS------DF 146
Query: 196 GFSKHLG-------HSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
G S+ + G K W APE +K+ D W+ G+L+ E+
Sbjct: 147 GLSRDIYEDDYYRKRGGGKLPIKWM--------APESLKDGKFTSKSDVWSFGVLLWEIF 198
Query: 246 TG 247
T
Sbjct: 199 TL 200
|
Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-07
Identities = 22/65 (33%), Positives = 40/65 (61%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG + ++ E TC D+ + + ++ALE+LH+ ++ RD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 151
Query: 61 GYVKL 65
G VKL
Sbjct: 152 GSVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 34/122 (27%), Positives = 59/122 (48%), Gaps = 36/122 (29%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L+Y+H+ ++ RDLKP NLLL+ +K+
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKI--------------------------- 147
Query: 192 KVDFGFSK-----HLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELL 245
DFG ++ H H+G T + T Y APEI+ N +G+ +A+D W++G ++ E+L
Sbjct: 148 -CDFGLARIADPEH-DHTGFLT-EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204
Query: 246 TG 247
+
Sbjct: 205 SN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 25/67 (37%), Positives = 44/67 (65%), Gaps = 5/67 (7%)
Query: 1 MLLEACLGGEVWTILRERTCFD--DNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
M++E GG++ ++ +D + A F TA V+ AL+ +H+ G++ RD+KP+N+LLD
Sbjct: 120 MVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176
Query: 59 NRGYVKL 65
G++KL
Sbjct: 177 KHGHLKL 183
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-06
Identities = 17/50 (34%), Positives = 27/50 (54%)
Query: 16 RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
R+ F ++ I +++ L ++H G RDLKPENLL+ VK+
Sbjct: 91 RKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKI 140
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 35/136 (25%), Positives = 62/136 (45%), Gaps = 38/136 (27%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
E + ++ ++ +++LH+ GI+ RDLKP N+++ + +K+
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI------------------ 164
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWT---FCGTPEYVAPEIIKNRGHDRAVDYWALGI 239
+DFG L + C + + T Y APE+I G+ VD W++G
Sbjct: 165 ----------LDFG----LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 210
Query: 240 LMHELLTGMKESNVFQ 255
+M EL+ G S +FQ
Sbjct: 211 IMGELVKG---SVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 2e-06
Identities = 17/30 (56%), Positives = 24/30 (80%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
AL+YLH+R I+ RD+KP+N+ L + G VKL
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKL 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 21/58 (36%), Positives = 37/58 (63%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG++ ++L F ++ A F A + A+E +H G + RD+KP+N+L+D G++KL
Sbjct: 85 GGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKL 142
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 42/182 (23%)
Query: 82 KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141
K ++ +Y+L+E C G++ +++ C+ A+ IT ++ AL Y H
Sbjct: 84 KANQKLYILMEFCDAGDLSRNIQK--CY-----KMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 142 -------RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV-KV 193
++ RDLKP+N+ L +I + A+ ++ ++G + K+
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLST----------GIRHIGKITAQANN---LNGRPIAKI 183
Query: 194 -DFGFSKHLG-----HSGCKTWTFCGTPEYVAPEII--KNRGHDRAVDYWALGILMHELL 245
DFG SK++G HS C GTP Y +PE++ + + +D D WALG +++EL
Sbjct: 184 GDFGLSKNIGIESMAHS-C-----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 246 TG 247
+G
Sbjct: 238 SG 239
|
Length = 1021 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 31/123 (25%), Positives = 51/123 (41%), Gaps = 43/123 (34%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++ + Y H+ ++ RDLKP+NLL+D G +KL
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKL--------------------------- 140
Query: 192 KVDFGFSKHLG-------HSGCKTWTFCGTPEYVAPEI-IKNRGHDRAVDYWALGILMHE 243
DFG ++ G H W Y APEI + +R + VD W++G + E
Sbjct: 141 -ADFGLARAFGVPVRTYTHEVVTLW-------YRAPEILLGSRQYSTPVDIWSIGCIFAE 192
Query: 244 LLT 246
++
Sbjct: 193 MVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 32/118 (27%), Positives = 53/118 (44%), Gaps = 39/118 (33%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+++LH+ GI+ RDLKP N+++ + +K+ +D
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LD 161
Query: 195 FGFSKHLGHSGCKTWTFCGTPE-----YVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG ++ G S F TP Y APE+I G+ VD W++G +M E++ G
Sbjct: 162 FGLARTAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 25/67 (37%), Positives = 43/67 (64%), Gaps = 5/67 (7%)
Query: 1 MLLEACLGGEVWTILRERTCFD--DNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
M++E GG++ ++ +D + A F TA V+ AL+ +H+ G + RD+KP+N+LLD
Sbjct: 120 MVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
Query: 59 NRGYVKL 65
G++KL
Sbjct: 177 KSGHLKL 183
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 3e-06
Identities = 17/30 (56%), Positives = 22/30 (73%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
LEYLH+ I+ RDLKP NLL+ + G +KL
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKL 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 35/125 (28%), Positives = 51/125 (40%), Gaps = 44/125 (35%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L+YLH+ GI+ RD+KP NLL+++ +K+
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKI--------------------------- 144
Query: 192 KVDFGF--------SKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDR-AVDYWALGILMH 242
DFG SKH+ T Y APEI+ H AVD W++G +
Sbjct: 145 -CDFGLARVEEPDESKHMTQE-------VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 243 ELLTG 247
ELL
Sbjct: 197 ELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|197516 smart00100, cNMP, Cyclic nucleotide-monophosphate binding domain | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-06
Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+F++L L + ++ YPAG IIR+G GDSF+II G+V+V
Sbjct: 1 LFKNL-DAEELRELADALEPVRYPAGEVIIRQGDVGDSFYIIVSGEVEV 48
|
Catabolite gene activator protein (CAP) is a prokaryotic homologue of eukaryotic cNMP-binding domains, present in ion channels, and cNMP-dependent kinases. Length = 120 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 43/123 (34%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++ L + H+ ++ RDLKP+NLL++ G +KL
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKL--------------------------- 141
Query: 192 KVDFGFSKHLG-------HSGCKTWTFCGTPEYVAPEI-IKNRGHDRAVDYWALGILMHE 243
DFG ++ G H W Y APEI + + + AVD W+LG + E
Sbjct: 142 -ADFGLARAFGVPVRTYTHEVVTLW-------YRAPEILLGCKYYSTAVDIWSLGCIFAE 193
Query: 244 LLT 246
++T
Sbjct: 194 MVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 23/56 (41%), Positives = 32/56 (57%), Gaps = 10/56 (17%)
Query: 29 ITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKL---------VSRKKKTRQ 74
+T +++AL YL + G++ RD+KP N+LLD G VKL V K KTR
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS 174
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 34/114 (29%), Positives = 50/114 (43%), Gaps = 26/114 (22%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++EAL YLH RGI+ RD+K EN+ LD L GD G
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVL---------------GD-----FGAAC 233
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
K+D H C W+ GT E +PE++ + D W+ G+++ E+
Sbjct: 234 KLD----AHPDTPQCYGWS--GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 5e-06
Identities = 22/65 (33%), Positives = 40/65 (61%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG + ++ E TC D+ + + ++ALE+LH+ ++ RD+K +N+LL
Sbjct: 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 61 GYVKL 65
G VKL
Sbjct: 153 GSVKL 157
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|237999 cd00038, CAP_ED, effector domain of the CAP family of transcription factors; members include CAP (or cAMP receptor protein (CRP)), which binds cAMP, FNR (fumarate and nitrate reduction), which uses an iron-sulfur cluster to sense oxygen) and CooA, a heme containing CO sensor | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-06
Identities = 16/49 (32%), Positives = 26/49 (53%), Gaps = 1/49 (2%)
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+F L + L + ++ +PAG IIR+G DS +I+ G V+V
Sbjct: 1 LFSGL-DDEELEELADALEERRFPAGEVIIRQGDPADSLYIVLSGSVEV 48
|
In all cases binding of the effector leads to conformational changes and the ability to activate transcription. Cyclic nucleotide-binding domain similar to CAP are also present in cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) and vertebrate cyclic nucleotide-gated ion-channels. Cyclic nucleotide-monophosphate binding domain; proteins that bind cyclic nucleotides (cAMP or cGMP) share a structural domain of about 120 residues; the best studied is the prokaryotic catabolite gene activator, CAP, where such a domain is known to be composed of three alpha-helices and a distinctive eight-stranded, antiparallel beta-barrel structure; three conserved glycine residues are thought to be essential for maintenance of the structural integrity of the beta-barrel; CooA is a homodimeric transcription factor that belongs to CAP family; cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) contain two tandem copies of the cyclic nucleotide-binding domain; cAPK's are composed of two different subunits, a catalytic chain and a regulatory chain, which contains both copies of the domain; cGPK's are single chain enzymes that include the two copies of the domain in their N-terminal section; also found in vertebrate cyclic nucleotide-gated ion-channels. Length = 115 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 33/125 (26%), Positives = 53/125 (42%), Gaps = 47/125 (37%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++ + + H+R ++ RDLKP+NLL+DN+G +KL
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKL--------------------------- 142
Query: 192 KVDFGFSKHLG-------HSGCKTWTFCGTPEYVAPEIIKNRGHDR---AVDYWALGILM 241
DFG ++ G H W Y APE++ G R VD W++G +
Sbjct: 143 -ADFGLARAFGIPVRVYTHEVVTLW-------YRAPEVL--LGSPRYSTPVDIWSIGTIF 192
Query: 242 HELLT 246
E+ T
Sbjct: 193 AEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 35/120 (29%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++ + + H ++ RDLKP+NLL++ RG +KL
Sbjct: 109 LLKGIAFCHENRVLHRDLKPQNLLINKRGELKL--------------------------- 141
Query: 192 KVDFGFSKHLGHSGCKTWTFCG---TPEYVAPEII-KNRGHDRAVDYWALGILMHELLTG 247
DFG ++ G TF T Y AP+++ +R + ++D W++G +M E++TG
Sbjct: 142 -ADFGLARAF---GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 21/58 (36%), Positives = 36/58 (62%)
Query: 8 GGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GG++ ++L F + A F A + A+E +H G + RD+KP+N+L+D G++KL
Sbjct: 85 GGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKL 142
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-06
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 4/40 (10%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL----VSR 68
++ + YLH R IV RD+KP NLL+++ VK+ VSR
Sbjct: 177 ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
|
Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 14/30 (46%), Positives = 23/30 (76%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+++LH+ IV RDLKP+N+L+ + G VK+
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKI 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 29/113 (25%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ L++LH IV RDLKPEN+L+ + G VKL
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKL---------------------------- 149
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
DFG ++ T T Y APE++ + VD W++G + E+
Sbjct: 150 ADFGLARIYSCQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 35/116 (30%), Positives = 50/116 (43%), Gaps = 31/116 (26%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ +LH I+ RDLK NLLL+NRG +K+
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKI----------------------------C 148
Query: 194 DFGFSKHLGHSGCKTWT-FCGTPEYVAPEIIKNRGH-DRAVDYWALGILMHELLTG 247
DFG ++ G S K +T T Y APE++ A+D W++G + ELLT
Sbjct: 149 DFGLAREYG-SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 31/115 (26%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L++LH+ +V RDLKP+N+L + S GQ+
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNIL-----------------------------VTSSGQI 149
Query: 192 KV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
K+ DFG ++ T + T Y APE++ + VD W++G + E+
Sbjct: 150 KLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 18/74 (24%)
Query: 9 GEVWTILRE--RTCFDD--------------NAASFITACVIEALEYLHTR-GIVFRDLK 51
G+VW I E T D + I +++ALEYLH++ ++ RD+K
Sbjct: 73 GDVW-ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK 131
Query: 52 PENLLLDNRGYVKL 65
P N+L++ G VKL
Sbjct: 132 PSNVLINRNGQVKL 145
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 8e-06
Identities = 16/38 (42%), Positives = 28/38 (73%)
Query: 28 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+I +++AL+Y+H+ ++ RDLKP N+LL++ VKL
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 30/117 (25%), Positives = 51/117 (43%), Gaps = 32/117 (27%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L+Y+H+ G+V RDLKP N+L++ +K+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKI--------------------------- 149
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
DFG ++ + + T Y APEI+ + +D VD W+ G + E+L G
Sbjct: 150 -CDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 32/115 (27%), Positives = 56/115 (48%), Gaps = 31/115 (26%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGY-VKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
AL Y+H++ I RDLKP+NLL+D + +KL
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKL----------------------------C 213
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEI-IKNRGHDRAVDYWALGILMHELLTG 247
DFG +K+L +G ++ ++ + Y APE+ + + +D W+LG ++ E++ G
Sbjct: 214 DFGSAKNL-LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 22/64 (34%), Positives = 41/64 (64%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
++E GG++ +++ F + A F A + L +LH RGI++RDLK +N++LD+ G
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG 138
Query: 62 YVKL 65
++K+
Sbjct: 139 HIKI 142
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-05
Identities = 22/65 (33%), Positives = 39/65 (60%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG + ++ E TC D+ + + ++ALE+LH ++ RD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD 151
Query: 61 GYVKL 65
G VKL
Sbjct: 152 GSVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 14/32 (43%), Positives = 23/32 (71%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++A+ Y H+ I+ RD+KPEN+L+ G +KL
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILVSESGVLKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 45/124 (36%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV- 193
L+Y+H+ ++ RDLKP NLL++ + ++K+
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVN-----------------------------ADCELKIC 147
Query: 194 DFGFSKHLGHSGCKTWTFCGTP---EYV------APEI-IKNRGHDRAVDYWALGILMHE 243
DFG ++ G EYV APEI + + + +A+D W++G ++ E
Sbjct: 148 DFGLAR-----GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE 202
Query: 244 LLTG 247
LL
Sbjct: 203 LLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 56/147 (38%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ + YLH+ ++ RDLKP N+L ++ EG + G V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANIL-----------------VMGEGPER--------GVV 151
Query: 192 KV-DFGFSKHLGHSGCKT-----------WTFCGTPEYVAPEIIKNRGH-DRAVDYWALG 238
K+ D G ++ ++ K W Y APE++ H +A+D WA+G
Sbjct: 152 KIGDLGLARLF-NAPLKPLADLDPVVVTIW-------YRAPELLLGARHYTKAIDIWAIG 203
Query: 239 ILMHELLT----------GMKESNVFQ 255
+ ELLT +K+SN FQ
Sbjct: 204 CIFAELLTLEPIFKGREAKIKKSNPFQ 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 31/118 (26%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ E + YLH++ + RDL N+LLDN VK+
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIG-------------------------- 149
Query: 192 KVDFGFSKHL--GHSGCKTWTFCGTPEY-VAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG +K + GH + +P + A E +K A D W+ G+ ++ELLT
Sbjct: 150 --DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 21/64 (32%), Positives = 42/64 (65%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
++E GG++ +++ F + A F A + L +LH++GI++RDLK +N++LD+ G
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG 138
Query: 62 YVKL 65
++K+
Sbjct: 139 HIKI 142
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 23/62 (37%), Positives = 40/62 (64%), Gaps = 7/62 (11%)
Query: 8 GGEVWTILRERTCFDD----NAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYV 63
GG++ T+L + F+D + A F A ++ A++ +H G V RD+KP+N+LLD G++
Sbjct: 85 GGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHI 141
Query: 64 KL 65
+L
Sbjct: 142 RL 143
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 21/65 (32%), Positives = 40/65 (61%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG + ++ E TC D+ + + ++AL++LH+ ++ RD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD 151
Query: 61 GYVKL 65
G VKL
Sbjct: 152 GSVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 18/48 (37%), Positives = 28/48 (58%), Gaps = 4/48 (8%)
Query: 35 EALEYLHTRGIVFRDLKPENLLLDNRGYVKL----VSRKKKTRQTRLY 78
+ + Y+H GI+ RDLKP NLL+ G +K+ ++R + RLY
Sbjct: 110 KGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 21/109 (19%)
Query: 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E C GG V I+ E + I ++EAL+YLH+ I+ RDLK N+LL
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145
Query: 60 RGYVKL----VSRKK-KTRQTR---------------LYKTFKDSKYVY 88
G +KL VS K KT Q R + +T KD+ Y Y
Sbjct: 146 DGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 29/118 (24%), Positives = 50/118 (42%), Gaps = 35/118 (29%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
L+Y+H+ ++ RDLKP N+ ++ V +K+ D
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLV----------------------------LKIGD 158
Query: 195 FGFSK----HLGHSGCKTWTFCGTPEYVAPEII-KNRGHDRAVDYWALGILMHELLTG 247
FG ++ H H G + T Y +P ++ + +A+D WA G + E+LTG
Sbjct: 159 FGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 29/114 (25%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++E L YLH + I+ RD+K EN+ +++ V + A + + A
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA------------- 212
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
G + GT E APE++ ++ D W+ GI++ E+L
Sbjct: 213 --FLGLA--------------GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 20/63 (31%), Positives = 37/63 (58%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E C GG + I ++ ++++ ++ L YLH++G + RD+K N+LL + G+
Sbjct: 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH 144
Query: 63 VKL 65
VKL
Sbjct: 145 VKL 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 15/33 (45%), Positives = 23/33 (69%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L+YLH I+ RDLK NLLL ++G +K+
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 17/32 (53%), Positives = 23/32 (71%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ L++LH IV RDLKPEN+L+ + G VKL
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKL 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 28/115 (24%), Positives = 50/115 (43%), Gaps = 33/115 (28%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L+Y+H+ ++ RDLKP NLL++ +++ DF
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIG----------------------------DF 151
Query: 196 GFSKHLGHSGCKTWTF----CGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELL 245
G ++ L S + F T Y APE++ + + A+D W++G + E+L
Sbjct: 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 40/168 (23%), Positives = 57/168 (33%), Gaps = 52/168 (30%)
Query: 83 DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIE-ALDFITACVIEALEYLHT 141
+Y++ E G + LR R A A + ALD V E +EYL
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSR-----GRAVITLAQQLGFALD-----VCEGMEYLEE 120
Query: 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSK-- 199
+ V RDL N+L+ K+ DFG +K
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVS----------------------------DFGLAKEA 152
Query: 200 HLGHSGCK---TWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
G K WT APE ++ + D W+ GIL+ E+
Sbjct: 153 SQGQDSGKLPVKWT--------APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 21/64 (32%), Positives = 33/64 (51%), Gaps = 1/64 (1%)
Query: 3 LEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
+E C GG + I + R + +++ ++ L YLH G + RD+K N+LL G
Sbjct: 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG 138
Query: 62 YVKL 65
VKL
Sbjct: 139 DVKL 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 23/70 (32%), Positives = 37/70 (52%), Gaps = 11/70 (15%)
Query: 7 LGGEVWTILR--ERTCFDD-------NAASFITAC--VIEALEYLHTRGIVFRDLKPENL 55
+G E+W ++ E D N T C V+ AL YLH +G++ RD+K +++
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI 149
Query: 56 LLDNRGYVKL 65
LL + G +KL
Sbjct: 150 LLTSDGRIKL 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 15/33 (45%), Positives = 27/33 (81%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+++ + + H+R ++ RDLKP+NLL+DN+G +KL
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKL 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 17/38 (44%), Positives = 28/38 (73%), Gaps = 2/38 (5%)
Query: 30 TAC--VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
T C V++AL +LH +G++ RD+K +++LL + G VKL
Sbjct: 119 TVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 16/30 (53%), Positives = 22/30 (73%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L + H+ GI+ RDLKPENLL++ G +KL
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKL 139
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 25/98 (25%), Positives = 48/98 (48%), Gaps = 14/98 (14%)
Query: 28 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL--------------VSRKKKTR 73
+A + + +LH+ IV+RD+KPEN+LLD++G +L ++++ T
Sbjct: 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158
Query: 74 QTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDD 111
+ K+ Y Y + +G ++ ++ RT F D
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 22/118 (18%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPAGHYIIREGAKGDSFFIISGGQV 191
+E + YLH I+ RD+K N+L+DN+G +K+ +F A Y +G +
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY---DGPPPN---------- 171
Query: 192 KVDFGFSKHLGHSGCKTWTFC-GTPEYVAPEII-KNRGHDRAVDYWALGILMHELLTG 247
K G G + +T T Y PE++ R + AVD W +G + E+ T
Sbjct: 172 ------PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 22/65 (33%), Positives = 41/65 (63%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+L+E GG + I+ + ++ A+ + V++AL YLH++G++ RD+K +++LL
Sbjct: 95 VLMEFLQGGALTDIVSQTRLNEEQIAT-VCESVLQALCYLHSQGVIHRDIKSDSILLTLD 153
Query: 61 GYVKL 65
G VKL
Sbjct: 154 GRVKL 158
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 14/33 (42%), Positives = 24/33 (72%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+++ + Y H+ ++ RDLKP+NLL+D G +KL
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-05
Identities = 17/33 (51%), Positives = 22/33 (66%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++EAL YLH RGI+ RD+K EN+ LD L
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVL 226
|
Length = 392 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-05
Identities = 21/49 (42%), Positives = 33/49 (67%), Gaps = 3/49 (6%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLD--NRGYVKLEFYPAGHYII 174
I ++ LEY+H GI D+KPEN+++D NRGY+ +++ A H+II
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI-IDYGIASHFII 178
|
Length = 294 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-05
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 44/125 (35%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++ + + H G++ RDLKP+NLL+D G +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDK----------------------------QKGLL 150
Query: 192 KV-DFGFS-------KHLGHSGCKTWTFCGTPEYVAPEIIKNRGH-DRAVDYWALGILMH 242
K+ D G K H W Y APE++ H VD W++G +
Sbjct: 151 KIADLGLGRAFSIPVKSYTHEIVTLW-------YRAPEVLLGSTHYSTPVDIWSVGCIFA 203
Query: 243 ELLTG 247
E+
Sbjct: 204 EMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 14/33 (42%), Positives = 23/33 (69%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ +E+ H+ I+ RD+KPEN+L+ G VKL
Sbjct: 109 ILRGIEFCHSHNIIHRDIKPENILVSQSGVVKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 28/90 (31%), Positives = 41/90 (45%), Gaps = 4/90 (4%)
Query: 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+L+E C GG V ++ E + + +EAL YLH I+ RDLK N+L
Sbjct: 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL 138
Query: 60 RGYVKLVS---RKKKTRQTRLYKTFKDSKY 86
G +KL K TR + +F + Y
Sbjct: 139 DGDIKLADFGVSAKNTRTIQRRDSFIGTPY 168
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 15/31 (48%), Positives = 21/31 (67%)
Query: 35 EALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ +LH I+ RDLK NLLL+NRG +K+
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKI 147
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 33/114 (28%), Positives = 44/114 (38%), Gaps = 31/114 (27%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++YL + V RDL N+LL N+ Y K+ DF
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKIS----------------------------DF 139
Query: 196 GFSKHLG--HSGCKTWTFCGTP-EYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
G SK LG S K + P ++ APE I R D W+ GI M E +
Sbjct: 140 GLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 30/120 (25%), Positives = 52/120 (43%), Gaps = 35/120 (29%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L Y H R I+ RDLKP+NLL++ +G +KL
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGELKL--------------------------- 144
Query: 192 KVDFGFSKHLGHSGCKTWTFCG---TPEYVAPEI-IKNRGHDRAVDYWALGILMHELLTG 247
DFG ++ T T+ T Y P++ + + + +D W +G +++E+ TG
Sbjct: 145 -ADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 35/121 (28%), Positives = 56/121 (46%), Gaps = 32/121 (26%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++ + YLH ++ RDLKP N+L+ G + G+V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPER-------------------------GRV 151
Query: 192 KV-DFGFSKHLGHSGCKTWT----FCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELL 245
K+ D GF++ L +S K T Y APE++ R + +A+D WA+G + ELL
Sbjct: 152 KIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
Query: 246 T 246
T
Sbjct: 211 T 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 35/121 (28%), Positives = 56/121 (46%), Gaps = 32/121 (26%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++ + YLH ++ RDLKP N+L+ G + G+V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPER-------------------------GRV 151
Query: 192 KV-DFGFSKHLGHSGCKTWT----FCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELL 245
K+ D GF++ L +S K T Y APE++ R + +A+D WA+G + ELL
Sbjct: 152 KIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
Query: 246 T 246
T
Sbjct: 211 T 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 14/30 (46%), Positives = 22/30 (73%), Gaps = 2/30 (6%)
Query: 28 FITACVIEALEYLHTRGIVFRDLKPENLLL 57
F C +EY+H++G++ RDLKP+N+LL
Sbjct: 119 FHKIC--ATIEYVHSKGVLHRDLKPDNILL 146
|
Length = 932 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 4/70 (5%)
Query: 1 MLLEACLGGEVWTI----LRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
++LE C GG V + L D+ S+I + L++LH I+ RD+K N+L
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160
Query: 57 LDNRGYVKLV 66
L G VKLV
Sbjct: 161 LTTEGGVKLV 170
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 19/49 (38%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVS---RKKKTRQTRLY 78
++ L Y H R I+ RDLKP+NLL++ +G +KL + K+ T+ Y
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 28/118 (23%), Positives = 48/118 (40%), Gaps = 35/118 (29%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ ++YL ++ + RDL N+L+++ VK IS
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVK----------------------IS------ 151
Query: 194 DFGFSKHLGHSGCKTWTFCGTPE-----YVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG +K L K + + P + APE ++ A D W+ G+ ++EL T
Sbjct: 152 DFGLAKVLPED--KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 44/124 (35%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
++ + Y H+ ++ RDLKP+NLL+D R +KL
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKL-------------------------- 144
Query: 191 VKVDFGFSKHLG-------HSGCKTWTFCGTPEYVAPEI-IKNRGHDRAVDYWALGILMH 242
DFG ++ G H W Y APEI + +R + VD W++G +
Sbjct: 145 --ADFGLARAFGIPVRTFTHEVVTLW-------YRAPEILLGSRHYSTPVDIWSVGCIFA 195
Query: 243 ELLT 246
E++
Sbjct: 196 EMVN 199
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 16/29 (55%), Positives = 21/29 (72%)
Query: 37 LEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L Y H R ++ RDLKP+NLL+ RG +KL
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKL 144
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 16/29 (55%), Positives = 21/29 (72%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
L Y H R ++ RDLKP+NLL+ RG +KL
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKL 144
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 31/120 (25%), Positives = 51/120 (42%), Gaps = 35/120 (29%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L Y H R ++ RDLKP+NLL++ RG +KL
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGELKL--------------------------- 145
Query: 192 KVDFGFSKHLGHSGCKTWTFCG---TPEYVAPEI-IKNRGHDRAVDYWALGILMHELLTG 247
DFG ++ T T+ T Y P+I + + + +D W +G + +E+ TG
Sbjct: 146 -ADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 22/69 (31%), Positives = 43/69 (62%), Gaps = 7/69 (10%)
Query: 1 MLLEACLGGEVWTILRERTCFDD----NAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
++++ +GG++ T+L + F+D + A F A ++ A+ +H V RD+KP+N+L
Sbjct: 78 LVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134
Query: 57 LDNRGYVKL 65
LD G+++L
Sbjct: 135 LDMNGHIRL 143
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 22/65 (33%), Positives = 34/65 (52%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ +E GG + L+ +N T ++E + YLH+ IV RD+K N+L D+
Sbjct: 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV 142
Query: 61 GYVKL 65
G VKL
Sbjct: 143 GNVKL 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 1 MLLEACLG--GEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+++E CLG ++ + ++ + AA I ++ L YLH+ + RD+K N+LL
Sbjct: 92 LVMEYCLGSASDILEVHKKPLQEVEIAA--ICHGALQGLAYLHSHERIHRDIKAGNILLT 149
Query: 59 NRGYVKL 65
G VKL
Sbjct: 150 EPGTVKL 156
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 20/61 (32%), Positives = 31/61 (50%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ +E GG V +L + F + T ++ L YLH I+ RD+K NLL+D+
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139
Query: 61 G 61
G
Sbjct: 140 G 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 19/49 (38%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVS---RKKKTRQTRLY 78
++ L Y H R ++ RDLKP+NLL++ RG +KL + K+ T+ Y
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 16/33 (48%), Positives = 24/33 (72%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
++ L Y H R ++ RDLKP+NLL++ RG +KL
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGELKL 145
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 30/132 (22%), Positives = 49/132 (37%), Gaps = 45/132 (34%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++ L LH + RDL P N+ ++++G K+
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKI--------------------------- 160
Query: 192 KVDFGFSKHLGHSGCKTWTFCG---------TPE-----YVAPEII--KNRGHDRAVDYW 235
DFG ++ G+ T + Y APE++ + H AVD W
Sbjct: 161 -ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHF-AVDMW 218
Query: 236 ALGILMHELLTG 247
++G + ELLTG
Sbjct: 219 SVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 17/44 (38%), Positives = 29/44 (65%), Gaps = 1/44 (2%)
Query: 22 DDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+D+ SF+ ++E L Y H + + RD+K N+LL+N+G +KL
Sbjct: 115 EDHIKSFMKQ-LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 22/73 (30%), Positives = 36/73 (49%), Gaps = 9/73 (12%)
Query: 2 LLEACLGGEVWTIL----RERTCFDDNAASFITACVIEALEYLHTRG-----IVFRDLKP 52
++E C GG++ ++ +ER ++ I ++ AL H R ++ RDLKP
Sbjct: 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP 138
Query: 53 ENLLLDNRGYVKL 65
N+ LD VKL
Sbjct: 139 ANIFLDANNNVKL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 11/70 (15%)
Query: 7 LGGEVWTILR--ERTCFDD-------NAASFITAC--VIEALEYLHTRGIVFRDLKPENL 55
+G E+W ++ E D N C V++AL LH +G++ RD+K +++
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147
Query: 56 LLDNRGYVKL 65
LL + G VKL
Sbjct: 148 LLTHDGRVKL 157
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 21/69 (30%), Positives = 44/69 (63%), Gaps = 7/69 (10%)
Query: 1 MLLEACLGGEVWTILRERTCFDD----NAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
++++ +GG++ T+L + F+D + A F A ++ A++ +H V RD+KP+N+L
Sbjct: 78 LVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 57 LDNRGYVKL 65
+D G+++L
Sbjct: 135 MDMNGHIRL 143
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 8/81 (9%)
Query: 29 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR-LYKTFKDSKYV 87
I V++ L YL + I+ RD+KP N+L++ RG VKL T+ + KT+ +
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN-A 158
Query: 88 YMLLEACLG------GEVWTI 102
YM E G +VW++
Sbjct: 159 YMAPERISGEQYGIHSDVWSL 179
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 17/49 (34%), Positives = 28/49 (57%)
Query: 17 ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
R D N T +++ + + H ++ RDLKP+NLL++ RG +KL
Sbjct: 93 VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKL 141
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 19/52 (36%), Positives = 29/52 (55%), Gaps = 2/52 (3%)
Query: 14 ILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD--NRGYV 63
I + C + I ++ LEY+H GI D+KPEN+++D NRGY+
Sbjct: 116 IFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 36/140 (25%), Positives = 60/140 (42%), Gaps = 41/140 (29%)
Query: 121 VIEALDFITA--------CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHY 172
VI+A D +T ++ AL+Y+HT + RDLKP+N+L + +K+
Sbjct: 93 VIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKI-------- 144
Query: 173 IIREGAKGDSFFIISGGQVKVDFGFSK-HLGHSGCKT-WT-FCGTPEYVAPEIIKN--RG 227
DFG ++ + WT + T Y APE+ +
Sbjct: 145 --------------------CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 184
Query: 228 HDRAVDYWALGILMHELLTG 247
+ A+D W++G + E+LTG
Sbjct: 185 YTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 44/192 (22%)
Query: 58 DNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI 117
D YV ++ K+ ++ + + ++ D Y EV +L D+ + +
Sbjct: 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSND---SEVKNLL------SDDGSEGL 234
Query: 118 TACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREG 177
T ++ L F T V +E+L ++ V RDL N+LL VK+
Sbjct: 235 T--TLDLLSF-TYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI------------- 278
Query: 178 AKGDSFFIISGGQVKVDFGFSKHLGHSG---CKTWTFCGTPEYVAPEIIKNRGHDRAVDY 234
DFG ++ + H K TF +++APE I + + D
Sbjct: 279 ---------------CDFGLARDIMHDSNYVSKGSTFLPV-KWMAPESIFDNLYTTLSDV 322
Query: 235 WALGILMHELLT 246
W+ GIL+ E+ +
Sbjct: 323 WSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 6e-04
Identities = 22/65 (33%), Positives = 34/65 (52%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ +E GG V L+ ++ T ++E + YLH+ IV RD+K N+L D+
Sbjct: 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA 142
Query: 61 GYVKL 65
G VKL
Sbjct: 143 GNVKL 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 20/63 (31%), Positives = 34/63 (53%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E C GG + I + +++ ++ L YLH++G + RD+K N+LL + G
Sbjct: 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD 144
Query: 63 VKL 65
VKL
Sbjct: 145 VKL 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 20/45 (44%), Positives = 26/45 (57%)
Query: 22 DDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66
D N + V+ L LH GIV RD+KPENLL+ G VK++
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKII 351
|
Length = 507 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 6e-04
Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 23 DNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+N F+ ++ L Y+H R I+ RDLKP+NLL+ + G +KL
Sbjct: 103 ENVKLFLFQ-LLRGLSYIHQRYILHRDLKPQNLLISDTGELKL 144
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 7e-04
Identities = 18/68 (26%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+++E C G V +++ ++ ++I ++ L +LH ++ RD+K +N+LL
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155
Query: 59 NRGYVKLV 66
VKLV
Sbjct: 156 ENAEVKLV 163
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215664 pfam00027, cNMP_binding, Cyclic nucleotide-binding domain | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 7e-04
Identities = 13/30 (43%), Positives = 17/30 (56%)
Query: 164 LEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
L + G I REG DS +I+ G+VKV
Sbjct: 1 LRSFKKGEVIFREGDPADSLYIVLSGKVKV 30
|
Length = 91 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 23/126 (18%)
Query: 124 ALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSF 183
A+ +I V++AL+Y+H G V R +K ++L+ G V L + +I G +
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR---- 157
Query: 184 FIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN--RGHDRAVDYWALGILM 241
++V F K+ W ++PE+++ +G+D D +++GI
Sbjct: 158 -------LRVVHDFPKY--SVKVLPW--------LSPEVLQQNLQGYDAKSDIYSVGITA 200
Query: 242 HELLTG 247
EL G
Sbjct: 201 CELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 16/33 (48%), Positives = 24/33 (72%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L Y H R ++ RDLKP+NLL++ RG +KL
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGELKL 145
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 27/116 (23%), Positives = 49/116 (42%), Gaps = 27/116 (23%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPAGHYIIREGAKGDSFFIISGGQV 191
+ L Y+H I+ RD+K N+L+ G +KL +F A + + + +K + + + V
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY---TNRVV 185
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLT 246
+ W Y PE++ R + +D W G +M E+ T
Sbjct: 186 TL---------------W-------YRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 4/70 (5%)
Query: 1 MLLEACLGGEVW----TILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
+++E C GG V + ++ + ++I + L YLH ++ RD+K +N+L
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNIL 145
Query: 57 LDNRGYVKLV 66
L VKLV
Sbjct: 146 LTKNAEVKLV 155
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.001
Identities = 11/31 (35%), Positives = 21/31 (67%)
Query: 28 FITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+ ++ L+YLH+ ++ RDLKP N+L++
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVN 137
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 16/38 (42%), Positives = 25/38 (65%), Gaps = 1/38 (2%)
Query: 29 ITACVIEALEYLH-TRGIVFRDLKPENLLLDNRGYVKL 65
I+ V+ L YL I+ RD+KP N+L+++RG +KL
Sbjct: 104 ISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKL 141
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 14/32 (43%), Positives = 23/32 (71%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+E + YLH I+ RD+K N+L+DN+G +K+
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKI 156
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 14/33 (42%), Positives = 23/33 (69%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
++E L Y H + + RD+K N+LL+N+G +KL
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 16/33 (48%), Positives = 24/33 (72%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
++ L Y+H R I+ RDLKP+NLL+ + G +KL
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLISDTGELKL 144
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 41/118 (34%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L+Y+H+ ++ RDLKP NLLL+ +K+ DF
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKI----------------------------CDF 152
Query: 196 GFSKHLGHSGCKTWTFCGTPEYV------APEIIKN-RGHDRAVDYWALGILMHELLT 246
G L + + F EYV APE++ N + A+D W++G + ELL
Sbjct: 153 G----LARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 33/139 (23%), Positives = 47/139 (33%), Gaps = 48/139 (34%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
V + YL ++ V RDL N+LL NR K IS
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVLLVNRHQAK----------------------IS---- 137
Query: 192 KVDFGFSKHLG--------HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DFG S+ LG + + W ++ APE I D W+ G+ + E
Sbjct: 138 --DFGMSRALGAGSDYYRATTAGR-WPL----KWYAPECINYGKFSSKSDVWSYGVTLWE 190
Query: 244 LLT-------GMKESNVFQ 255
+ MK + V
Sbjct: 191 AFSYGAKPYGEMKGAEVIA 209
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 21/65 (32%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG +LR FD+ + + +++ L+YLH+ + RD+K N+LL +
Sbjct: 79 IIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ 137
Query: 61 GYVKL 65
G VKL
Sbjct: 138 GDVKL 142
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 25/102 (24%), Positives = 49/102 (48%), Gaps = 8/102 (7%)
Query: 3 LEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+E GG ++ + + F++ + ++ A+ Y+H GI+ RD+K N+ L
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137
Query: 61 GYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGE 98
G +KL +S+ + + + +T + Y YM E C G +
Sbjct: 138 GLIKLGDFGISKILGS-EYSMAETVVGTPY-YMSPELCQGVK 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 21/65 (32%), Positives = 34/65 (52%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ +E GG + L+ +N T +++ + YLH+ IV RD+K N+L D+
Sbjct: 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA 142
Query: 61 GYVKL 65
G VKL
Sbjct: 143 GNVKL 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 20/65 (30%), Positives = 34/65 (52%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E CLG + + + + IT ++ L YLH+ ++ RD+K N+LL
Sbjct: 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161
Query: 61 GYVKL 65
G VKL
Sbjct: 162 GQVKL 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 19/65 (29%), Positives = 34/65 (52%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E CLG + + + + +T ++ L YLH+ ++ RD+K N+LL
Sbjct: 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
Query: 61 GYVKL 65
G VKL
Sbjct: 152 GLVKL 156
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 14/33 (42%), Positives = 25/33 (75%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L++LH+ +V RDLKP+N+L+ + G +KL
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 18/33 (54%), Positives = 22/33 (66%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
V+ L LH GIV RD+KPENLL+ G VK+
Sbjct: 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKI 350
|
Length = 507 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 30/123 (24%), Positives = 51/123 (41%), Gaps = 47/123 (38%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+++L+++H GI RD+KPEN+L+ + +KL
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKD-DILKL---------------------------- 140
Query: 193 VDFGFSKHLGHSGCKTWTFCGTP--EYV------APEIIKNRG-HDRAVDYWALGILMHE 243
DFG C+ + P EY+ APE + G + +D WA+G + E
Sbjct: 141 ADFG--------SCRG-IYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFE 191
Query: 244 LLT 246
+L+
Sbjct: 192 ILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 27/115 (23%), Positives = 44/115 (38%), Gaps = 27/115 (23%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
V E +EYL + RDL N L+ + G VK+ + Y++ D + SG +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL-----DDEYTSSSGAKF 163
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
V ++ PE+ + D W+ G+LM E+ T
Sbjct: 164 PV----------------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 37/147 (25%), Positives = 52/147 (35%), Gaps = 46/147 (31%)
Query: 122 IEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPA-----GHYIIR 175
+ L + A + E + YL +R + RDL N+L+ K+ +F A Y R
Sbjct: 102 LPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161
Query: 176 EGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYW 235
EGAK F I WT APE D W
Sbjct: 162 EGAK----FPIK---------------------WT--------APEAANYGRFTIKSDVW 188
Query: 236 ALGILMHELLT-------GMKESNVFQ 255
+ GIL+ E++T GM V +
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLE 215
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 22/69 (31%), Positives = 38/69 (55%), Gaps = 4/69 (5%)
Query: 1 MLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
+ +E GG + +LR + ++ F T ++E L+YLH IV RD+K +N+L+
Sbjct: 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141
Query: 58 DN-RGYVKL 65
+ G VK+
Sbjct: 142 NTYSGVVKI 150
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 13/33 (39%), Positives = 20/33 (60%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L+ LH + I+ RDLK N+LL VK+
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKI 144
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 29 ITACVIEALEYLH-TRGIVFRDLKPENLLLDNRGYVKL 65
I V+E L YL+ I+ RD+KP N+L+++RG +KL
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKL 145
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 16/38 (42%), Positives = 25/38 (65%), Gaps = 2/38 (5%)
Query: 28 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
F+ C ALE++H+R ++ RD+KP N+ + G VKL
Sbjct: 112 FVQLC--SALEHMHSRRVMHRDIKPANVFITATGVVKL 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.003
Identities = 13/37 (35%), Positives = 23/37 (62%)
Query: 29 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
I ++A+ + H + RD+KPEN+L+ +G +KL
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 14/29 (48%), Positives = 21/29 (72%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRG 61
V++AL H +GIV RDLKP+N+++ G
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTG 116
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 20/65 (30%), Positives = 34/65 (52%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E CLG + + + + IT ++ L YLH+ ++ RD+K N+LL
Sbjct: 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 157
Query: 61 GYVKL 65
G VKL
Sbjct: 158 GQVKL 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.003
Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 27/128 (21%)
Query: 124 ALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSF 183
A+ FI V+ AL+Y+H++G + R +K ++LL G V L +I+ G +
Sbjct: 102 AIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161
Query: 184 FIISGGQVKVDFGFS--KHLGHSGCKTWTFCGTPEYVAPEIIKN--RGHDRAVDYWALGI 239
DF S K+L W +PE+++ +G++ D +++GI
Sbjct: 162 H---------DFPKSSVKNL------PWL--------SPEVLQQNLQGYNEKSDIYSVGI 198
Query: 240 LMHELLTG 247
EL G
Sbjct: 199 TACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.003
Identities = 15/33 (45%), Positives = 23/33 (69%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L Y+H + I+ RDLKP+NLL+ G +KL
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGELKL 144
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.003
Identities = 15/33 (45%), Positives = 23/33 (69%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
++ L Y+H + I+ RDLKP+NLL+ G +KL
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGELKL 144
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.004
Identities = 18/45 (40%), Positives = 26/45 (57%), Gaps = 9/45 (20%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNR---------GYVKLVSRKKK 71
AL ++HT+ I+ RDLK +N+LLD G K++S K K
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 14/30 (46%), Positives = 22/30 (73%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
ALE++H++ I+ RD+KP N+ + G VKL
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKL 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 18/65 (27%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
L+ +G ++ I++ + DD+ F+ ++ L+Y+H+ I+ RDLKP NL ++
Sbjct: 99 LVTHLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157
Query: 62 YVKLV 66
+K++
Sbjct: 158 ELKIL 162
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 20/64 (31%), Positives = 36/64 (56%), Gaps = 1/64 (1%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRG 61
+E GG + +L+E + ++ V+ L YL + I+ RD+KP N+L+++RG
Sbjct: 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG 141
Query: 62 YVKL 65
+KL
Sbjct: 142 EIKL 145
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.004
Identities = 12/26 (46%), Positives = 21/26 (80%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLD 58
++ L+Y+H+ G+V RDLKP N+L++
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILIN 142
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 14/25 (56%), Positives = 19/25 (76%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNR 60
AL Y+H++ I RDLKP+NLL+D
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPN 206
|
Length = 440 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.004
Identities = 11/26 (42%), Positives = 21/26 (80%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDN 59
+++L+++H GI RD+KPEN+L+ +
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKD 135
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 13/33 (39%), Positives = 24/33 (72%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+++ L + H+ ++ RDLKP+NLL++ G +KL
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 13/33 (39%), Positives = 24/33 (72%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
+++ L + H+ ++ RDLKP+NLL++ G +KL
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 26/115 (22%), Positives = 46/115 (40%), Gaps = 27/115 (23%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
V E + YL ++ + RDL N L+D++G VK+ + Y++
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL----------------- 151
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
D ++ +G W+ PE++ D WA G+LM E+ +
Sbjct: 152 --DDEYTSSVGSKFPVRWS--------PPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 26/122 (21%), Positives = 50/122 (40%), Gaps = 40/122 (32%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL-------EFYPAGHYIIREGAKGDSFF 184
+ + YLH RG++ +D+ N ++D VK+ + +P ++ + GD+
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL-----GDN-- 178
Query: 185 IISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
VK ++A E + N+ + A D W+ G+L+ EL
Sbjct: 179 --ENRPVK------------------------WMALESLVNKEYSSASDVWSFGVLLWEL 212
Query: 245 LT 246
+T
Sbjct: 213 MT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 255 | |||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0582|consensus | 516 | 99.98 | ||
| KOG0593|consensus | 396 | 99.97 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| KOG0612|consensus | 1317 | 99.97 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| KOG0192|consensus | 362 | 99.97 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| KOG0607|consensus | 463 | 99.97 | ||
| KOG0604|consensus | 400 | 99.97 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| KOG0695|consensus | 593 | 99.97 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0585|consensus | 576 | 99.97 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| KOG4279|consensus | 1226 | 99.97 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG4721|consensus | 904 | 99.97 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0986|consensus | 591 | 99.97 | ||
| KOG0600|consensus | 560 | 99.97 | ||
| KOG0579|consensus | 1187 | 99.97 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0574|consensus | 502 | 99.97 | ||
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG0594|consensus | 323 | 99.97 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0663|consensus | 419 | 99.97 | ||
| KOG4717|consensus | 864 | 99.96 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4645|consensus | 1509 | 99.96 | ||
| KOG0661|consensus | 538 | 99.96 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0586|consensus | 596 | 99.96 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0659|consensus | 318 | 99.96 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0660|consensus | 359 | 99.96 | ||
| KOG4250|consensus | 732 | 99.96 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| KOG0658|consensus | 364 | 99.96 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| KOG0596|consensus | 677 | 99.96 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0667|consensus | 586 | 99.96 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| KOG0197|consensus | 468 | 99.95 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.95 | |
| KOG0577|consensus | 948 | 99.95 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| KOG4236|consensus | 888 | 99.95 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.94 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0584|consensus | 632 | 99.94 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG1989|consensus | 738 | 99.93 | ||
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG0587|consensus | 953 | 99.93 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| KOG1152|consensus | 772 | 99.93 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.93 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| KOG1187|consensus | 361 | 99.93 | ||
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| KOG0666|consensus | 438 | 99.93 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.93 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.93 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.92 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.92 | |
| KOG0194|consensus | 474 | 99.92 | ||
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.92 | |
| KOG1151|consensus | 775 | 99.92 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.92 | |
| KOG1026|consensus | 774 | 99.92 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| KOG0193|consensus | 678 | 99.92 | ||
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.92 | |
| KOG0983|consensus | 391 | 99.92 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.92 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| KOG0671|consensus | 415 | 99.91 | ||
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.91 | |
| KOG0665|consensus | 369 | 99.91 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.91 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.91 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| KOG0984|consensus | 282 | 99.91 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.91 | |
| KOG1095|consensus | 1025 | 99.91 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.9 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.9 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.9 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.9 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG2345|consensus | 302 | 99.9 | ||
| KOG0668|consensus | 338 | 99.9 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.9 | |
| KOG1006|consensus | 361 | 99.89 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.89 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.89 | |
| KOG0662|consensus | 292 | 99.89 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.88 | |
| KOG1094|consensus | 807 | 99.88 | ||
| KOG0669|consensus | 376 | 99.88 | ||
| KOG1035|consensus | 1351 | 99.88 | ||
| KOG4257|consensus | 974 | 99.87 | ||
| KOG1027|consensus | 903 | 99.87 | ||
| KOG0576|consensus | 829 | 99.87 | ||
| KOG0664|consensus | 449 | 99.86 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.86 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.85 | |
| KOG0199|consensus | 1039 | 99.85 | ||
| KOG4278|consensus | 1157 | 99.85 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| KOG0603|consensus | 612 | 99.84 | ||
| KOG0200|consensus | 609 | 99.83 | ||
| KOG0196|consensus | 996 | 99.83 | ||
| KOG0670|consensus | 752 | 99.82 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.82 | |
| KOG3653|consensus | 534 | 99.81 | ||
| KOG1025|consensus | 1177 | 99.8 | ||
| KOG1345|consensus | 378 | 99.8 | ||
| KOG0616|consensus | 355 | 99.8 | ||
| KOG1167|consensus | 418 | 99.78 | ||
| KOG0598|consensus | 357 | 99.77 | ||
| KOG0590|consensus | 601 | 99.77 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.77 | |
| KOG0581|consensus | 364 | 99.77 | ||
| KOG1290|consensus | 590 | 99.76 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG0614|consensus | 732 | 99.73 | ||
| KOG2052|consensus | 513 | 99.73 | ||
| KOG0595|consensus | 429 | 99.72 | ||
| KOG0583|consensus | 370 | 99.7 | ||
| KOG0615|consensus | 475 | 99.7 | ||
| KOG0592|consensus | 604 | 99.7 | ||
| KOG0606|consensus | 1205 | 99.66 | ||
| KOG1024|consensus | 563 | 99.66 | ||
| KOG0605|consensus | 550 | 99.66 | ||
| KOG0610|consensus | 459 | 99.66 | ||
| KOG1033|consensus | 516 | 99.65 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.63 | |
| KOG1164|consensus | 322 | 99.63 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.61 | |
| KOG0576|consensus | 829 | 99.61 | ||
| KOG0198|consensus | 313 | 99.6 | ||
| KOG0690|consensus | 516 | 99.58 | ||
| KOG0611|consensus | 668 | 99.57 | ||
| KOG0612|consensus | 1317 | 99.55 | ||
| KOG0694|consensus | 694 | 99.55 | ||
| KOG0588|consensus | 786 | 99.55 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.53 | |
| KOG0696|consensus | 683 | 99.53 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.52 | |
| KOG0578|consensus | 550 | 99.49 | ||
| KOG0192|consensus | 362 | 99.48 | ||
| KOG0580|consensus | 281 | 99.48 | ||
| KOG0585|consensus | 576 | 99.48 | ||
| KOG0604|consensus | 400 | 99.47 | ||
| KOG4158|consensus | 598 | 99.47 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.47 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.47 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.46 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.46 | |
| KOG0590|consensus | 601 | 99.46 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.46 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.45 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.45 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.45 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.45 | |
| KOG0608|consensus | 1034 | 99.45 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.44 | |
| KOG0589|consensus | 426 | 99.44 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.44 | |
| KOG0986|consensus | 591 | 99.44 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.44 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.44 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.44 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.43 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.43 | |
| KOG0599|consensus | 411 | 99.43 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.43 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.43 | |
| KOG0607|consensus | 463 | 99.43 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.43 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.43 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.43 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.43 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.42 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.42 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.42 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.42 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.42 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.41 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.41 | |
| KOG0591|consensus | 375 | 99.41 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.4 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.4 | |
| KOG0597|consensus | 808 | 99.4 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.4 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.4 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.4 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.4 | |
| KOG0575|consensus | 592 | 99.4 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.39 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.39 | |
| KOG1240|consensus | 1431 | 99.39 | ||
| KOG0606|consensus | 1205 | 99.39 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.39 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.38 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.38 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.38 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.38 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.38 | |
| KOG1165|consensus | 449 | 99.38 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.38 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.38 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.37 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.37 |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=308.34 Aligned_cols=176 Identities=41% Similarity=0.707 Sum_probs=155.2
Q ss_pred HHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCcc
Q psy3182 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN 112 (255)
Q Consensus 33 v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~ 112 (255)
-+.|+++|.++.|+-+ |- .-...++..++...+||.++.++.+||+.+.+|+|+||+.||+|+.+|.+++.|+|.
T Consensus 51 kiYAmKvl~K~~iv~~--~e---~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~ 125 (357)
T KOG0598|consen 51 KIYAMKVLKKKKIVEK--KE---VRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSED 125 (357)
T ss_pred ceeehhhhhhhHhhhh--hh---HHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchh
Confidence 3578888888888855 11 112234457788899999999999999999999999999999999999999999987
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeee
Q psy3182 113 AASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192 (255)
Q Consensus 113 ~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (255)
.++++ +++|+.||.|||++|||||||||+|||++..|++++.
T Consensus 126 ~arfY-----------laEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~Lt--------------------------- 167 (357)
T KOG0598|consen 126 RARFY-----------LAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLT--------------------------- 167 (357)
T ss_pred HHHHH-----------HHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEe---------------------------
Confidence 76555 4568999999999999999999999999999999994
Q ss_pred eeccccccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 193 VDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 193 ~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||+|+.....+..+.++|||+.|||||++.+.+|+..+||||||+++|||++|.+||.
T Consensus 168 -DFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 168 -DFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred -ccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 99999977777778889999999999999999999999999999999999999999985
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=285.51 Aligned_cols=148 Identities=47% Similarity=0.880 Sum_probs=136.7
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRG 143 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ 143 (255)
.++....||.+++++.+|+|.+++||||||..||+|++++++.++|++..++| +++||+.||+|||+++
T Consensus 96 ~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arF-----------YAAeivlAleylH~~~ 164 (355)
T KOG0616|consen 96 RVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARF-----------YAAEIVLALEYLHSLD 164 (355)
T ss_pred HHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHH-----------HHHHHHHHHHHHHhcC
Confidence 34566779999999999999999999999999999999999999999987754 4566999999999999
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII 223 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (255)
|++|||||+|||++.+|.+|+ .|||+|+.... +++|.||||.|+|||++
T Consensus 165 iiYRDLKPENiLlD~~G~iKi----------------------------tDFGFAK~v~~---rT~TlCGTPeYLAPEii 213 (355)
T KOG0616|consen 165 IIYRDLKPENLLLDQNGHIKI----------------------------TDFGFAKRVSG---RTWTLCGTPEYLAPEII 213 (355)
T ss_pred eeeccCChHHeeeccCCcEEE----------------------------EeccceEEecC---cEEEecCCccccChHHh
Confidence 999999999999999999999 59999998754 58899999999999999
Q ss_pred cCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 224 KNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 224 ~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.++|+.++|||||||++|||+.|.+||..
T Consensus 214 ~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 214 QSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred hcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 999999999999999999999999999963
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=290.14 Aligned_cols=152 Identities=32% Similarity=0.656 Sum_probs=136.0
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++++++.++|+|+|++++..++.+++|+|||||.||||.+++++++.+.|.. ++.+++|++.||++||
T Consensus 58 ~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t-----------~r~Fm~QLA~alq~L~ 126 (429)
T KOG0595|consen 58 SEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEAT-----------ARHFMQQLASALQFLH 126 (429)
T ss_pred HHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHH-----------HHHHHHHHHHHHHHHH
Confidence 46889999999999999999999999999999999999999999988776543 4567789999999999
Q ss_pred HcCcccccCCCCceeeCCCC------ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 141 TRGIVFRDLKPENLLLDNRG------YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
+++||||||||+|||++... .+|+ .|||+|+.+.. +....+.|||
T Consensus 127 ~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI----------------------------ADFGfAR~L~~-~~~a~tlcGS 177 (429)
T KOG0595|consen 127 ENNIIHRDLKPQNILLSTTARNDTSPVLKI----------------------------ADFGFARFLQP-GSMAETLCGS 177 (429)
T ss_pred HCCeeeccCCcceEEeccCCCCCCCceEEe----------------------------cccchhhhCCc-hhHHHHhhCC
Confidence 99999999999999998752 2333 59999999874 4456789999
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.|||||+++.+.|+.|+|+||+|+++|++++|..||.
T Consensus 178 plYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 178 PLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred ccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999999999999999999997
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=299.53 Aligned_cols=164 Identities=35% Similarity=0.624 Sum_probs=149.6
Q ss_pred CCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHH
Q psy3182 50 LKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFIT 129 (255)
Q Consensus 50 iK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (255)
++.........++|+|++.+.|+||+++|..|+|.+++||++|+|..|+|..+++++..++|.++ +++.
T Consensus 56 l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEa-----------ry~l 124 (592)
T KOG0575|consen 56 LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEA-----------RYFL 124 (592)
T ss_pred hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHH-----------HHHH
Confidence 33333334445678999999999999999999999999999999999999999999999998775 4566
Q ss_pred HHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccc
Q psy3182 130 ACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTW 209 (255)
Q Consensus 130 ~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~ 209 (255)
+||+.||.|||+++|||||||..|++++.+..+|+ .|||+|..+...+.+..
T Consensus 125 ~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKI----------------------------gDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 125 RQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKI----------------------------GDFGLATQLEYDGERKK 176 (592)
T ss_pred HHHHHHHHHHHhcCceecccchhheeecCcCcEEe----------------------------cccceeeeecCcccccc
Confidence 78999999999999999999999999999999999 49999999988878889
Q ss_pred ccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 210 TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.||||.|.|||++...+++..+||||+||++|.|+.|.+||.
T Consensus 177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 9999999999999999999999999999999999999999996
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=289.02 Aligned_cols=149 Identities=70% Similarity=1.241 Sum_probs=137.8
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
++-..+.+.|+++|.+|.|+.++||.||.|.||++|..++.++.|++..+.|+. .++++|++|||++||
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~-----------acv~EAfeYLH~k~i 541 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYV-----------ACVLEAFEYLHRKGI 541 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhH-----------HHHHHHHHHHHhcCc
Confidence 344556899999999999999999999999999999999999999998876555 458999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~ 224 (255)
|.|||||+|++++.+|..|+ +|||+++.++. +.+++|+||||.|.|||++.
T Consensus 542 IYRDLKPENllLd~~Gy~KL----------------------------VDFGFAKki~~-g~KTwTFcGTpEYVAPEIIL 592 (732)
T KOG0614|consen 542 IYRDLKPENLLLDNRGYLKL----------------------------VDFGFAKKIGS-GRKTWTFCGTPEYVAPEIIL 592 (732)
T ss_pred eeccCChhheeeccCCceEE----------------------------eehhhHHHhcc-CCceeeecCCcccccchhhh
Confidence 99999999999999999999 79999999866 45899999999999999999
Q ss_pred CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 225 NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 225 ~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+++++.++|.||||+++|||++|.+||..
T Consensus 593 nKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 593 NKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred ccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999999973
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=286.97 Aligned_cols=155 Identities=32% Similarity=0.633 Sum_probs=136.6
Q ss_pred cccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 58 DNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 58 ~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+..+++.++.++.||++++++++|.+.+..||||||+.||+|++.+...++.++... ..++.|++.|+.
T Consensus 222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~-----------K~~f~Qll~avk 290 (475)
T KOG0615|consen 222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLG-----------KLLFKQLLTAVK 290 (475)
T ss_pred hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchh-----------HHHHHHHHHHHH
Confidence 445788999999999999999999999999999999999999999999888887654 346788999999
Q ss_pred HHHHcCcccccCCCCceeeCCC---CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNR---GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|||++||+||||||+|||+..+ -.+|+ .|||+|+..+ ......|+|||
T Consensus 291 YLH~~GI~HRDiKPeNILl~~~~e~~llKI----------------------------tDFGlAK~~g-~~sfm~TlCGT 341 (475)
T KOG0615|consen 291 YLHSQGIIHRDIKPENILLSNDAEDCLLKI----------------------------TDFGLAKVSG-EGSFMKTLCGT 341 (475)
T ss_pred HHHHcCcccccCCcceEEeccCCcceEEEe----------------------------cccchhhccc-cceehhhhcCC
Confidence 9999999999999999999876 34555 4999999886 45577899999
Q ss_pred CCCcccccccCCCC---CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNRGH---DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~---~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.|.|||++...++ ..++|+||+||++|.+++|.+||.
T Consensus 342 psYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS 382 (475)
T KOG0615|consen 342 PSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFS 382 (475)
T ss_pred ccccChhheecCCeecccchheeeeccceEEEEeccCCCcc
Confidence 99999999987553 347899999999999999999996
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.75 Aligned_cols=145 Identities=38% Similarity=0.715 Sum_probs=128.5
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.||.+++||.+|+|+..+|+|+||+.+|||+++|++.+.|++..+ ++++++|+.||+|+|++|||||||
T Consensus 132 ~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~ca-----------R~YAAeIldAleylH~~GIIHRDl 200 (604)
T KOG0592|consen 132 GHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCA-----------RFYAAEILDALEYLHSNGIIHRDL 200 (604)
T ss_pred CCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHH-----------HHHHHHHHHHHHHHHhcCceeccC
Confidence 799999999999999999999999999999999999999998765 455667999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-------------ccccccccCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-------------CKTWTFCGTPE 216 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-------------~~~~~~~gt~~ 216 (255)
||+|||++.++.+++. |||.|+.++... ....+++||..
T Consensus 201 KPENILLd~dmhikIT----------------------------DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAe 252 (604)
T KOG0592|consen 201 KPENILLDKDGHIKIT----------------------------DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAE 252 (604)
T ss_pred ChhheeEcCCCcEEEe----------------------------eccccccCChhhccccCccCcccccCcccceeeeec
Confidence 9999999999999996 666555443211 11256999999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.+||++.....+.++|+|+|||++|+|+.|.+||+.
T Consensus 253 YVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 253 YVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred ccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 9999999999999999999999999999999999973
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=285.70 Aligned_cols=143 Identities=38% Similarity=0.725 Sum_probs=130.8
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
+||.++.+|..||+.+++|+||||+.|||++.+. ....|++..+. +++++|+.||.|||++|||+|||
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~-~~~~F~e~rar-----------fyaAev~l~L~fLH~~~IIYRDl 494 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI-HTDVFSEPRAR-----------FYAAEVVLGLQFLHENGIIYRDL 494 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEE-ecccccHHHHH-----------HHHHHHHHHHHHHHhcCceeeec
Confidence 7999999999999999999999999999955444 34678877654 45566999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
|.+|||++..|++|+ +|||+++.....+..++|+||||.|||||++.+..|+
T Consensus 495 KLdNiLLD~eGh~ki----------------------------ADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt 546 (694)
T KOG0694|consen 495 KLDNLLLDTEGHVKI----------------------------ADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYT 546 (694)
T ss_pred chhheEEcccCcEEe----------------------------cccccccccCCCCCccccccCChhhcChhhhccCccc
Confidence 999999999999999 5999999887777789999999999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 230 RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~ 252 (255)
.++|||||||++|||+.|.+||.
T Consensus 547 ~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 547 RAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred chhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999997
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.72 Aligned_cols=174 Identities=28% Similarity=0.521 Sum_probs=131.4
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
....+.+|+||.+|||.+++|+||||++|||+..+|.+.+.+++..+ ++++++.+.|++.+|+.|+|||
T Consensus 197 ~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~a-----------rfYiaE~vlAI~~iH~~gyIHR 265 (550)
T KOG0605|consen 197 EVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWA-----------RFYIAETVLAIESIHQLGYIHR 265 (550)
T ss_pred hcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHH-----------HHHHHHHHHHHHHHHHcCcccc
Confidence 35689999999999999999999999999999999999888887665 4555668889999999999999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeec-CCC----CCceeeeeCCeeeeecccc--ccCC------------CCCccc
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIRE-GAK----GDSFFIISGGQVKVDFGFS--KHLG------------HSGCKT 208 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~dfg~s--~~~~------------~~~~~~ 208 (255)
||||+|+|++..|++|+++|+...-+... ... +.......+.....||.-. .... ......
T Consensus 266 DIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a 345 (550)
T KOG0605|consen 266 DIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA 345 (550)
T ss_pred cCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence 99999999999999999999876433211 100 0000000011111233310 0000 011123
Q ss_pred cccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 209 WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 209 ~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
...+|||.|||||++.+.+|+..+||||||||+||||.|.+||.
T Consensus 346 ~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 346 YSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFC 389 (550)
T ss_pred hcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 45789999999999999999999999999999999999999996
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.36 Aligned_cols=154 Identities=34% Similarity=0.644 Sum_probs=136.7
Q ss_pred Cceeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.++.++.... ||||+++++++...+.+|+|||||.||+|++.+.+++.+.|.. .+.+++|++.|++||
T Consensus 68 rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~-----------ar~~F~Qlisav~y~ 136 (370)
T KOG0583|consen 68 REISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDE-----------ARKYFRQLISAVAYC 136 (370)
T ss_pred HHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHH-----------HHHHHHHHHHHHHHH
Confidence 3456777788 9999999999999999999999999999999999888777744 356778899999999
Q ss_pred HHcCcccccCCCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 140 HTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
|++||+||||||+|++++.+ +.+|+ .|||++...........+.||||.|+
T Consensus 137 H~~gi~HRDLK~ENilld~~~~~~Kl----------------------------~DFG~s~~~~~~~~~l~t~cGsp~Y~ 188 (370)
T KOG0583|consen 137 HSRGIVHRDLKPENILLDGNEGNLKL----------------------------SDFGLSAISPGEDGLLKTFCGSPAYA 188 (370)
T ss_pred HhCCEeeCCCCHHHEEecCCCCCEEE----------------------------eccccccccCCCCCcccCCCCCcccC
Confidence 99999999999999999998 89998 49999987743345667899999999
Q ss_pred ccccccCCC-CC-CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRG-HD-RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~-~~-~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+.. |+ .++|+||+||++|.|++|..||..
T Consensus 189 aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 189 APEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred CHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 999999987 86 689999999999999999999973
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=249.23 Aligned_cols=152 Identities=24% Similarity=0.456 Sum_probs=130.8
Q ss_pred ceeeeccccccccccccc-cccCccc-eeehhhhhcchhHHHHHHh----ccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYK-TFKDSKY-VYMLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~-~~~~~~~-~ylv~E~~~gg~l~~~l~~----~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++-+++.++||||+++|. .|..+.. ++++||+|.+|||.+.++. +..++|.. +=.++.|++.|
T Consensus 68 Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~-----------Vwk~f~QL~~A 136 (375)
T KOG0591|consen 68 EISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKT-----------VWKYFVQLCRA 136 (375)
T ss_pred HHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHH-----------HHHHHHHHHHH
Confidence 466788999999999998 5665555 8999999999999998863 22333322 22356789999
Q ss_pred HHHHHH--cC--cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccc
Q psy3182 136 LEYLHT--RG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTF 211 (255)
Q Consensus 136 l~ylH~--~~--iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~ 211 (255)
|..||+ .. |+||||||.||+++.+|.+|+. |||+++.+........++
T Consensus 137 L~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG----------------------------DfGL~r~l~s~~tfA~S~ 188 (375)
T KOG0591|consen 137 LYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG----------------------------DFGLGRFLSSKTTFAHSL 188 (375)
T ss_pred HHHHhccccccceeeccCcchheEEcCCCceeec----------------------------cchhHhHhcchhHHHHhh
Confidence 999998 44 9999999999999999999994 999999998877778889
Q ss_pred ccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||+||+||.+.+.+|+.+||+||+||++|||+.-.+||.
T Consensus 189 VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 189 VGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred cCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 99999999999999999999999999999999999999986
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=259.15 Aligned_cols=165 Identities=30% Similarity=0.545 Sum_probs=147.4
Q ss_pred CCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHH
Q psy3182 50 LKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFIT 129 (255)
Q Consensus 50 iK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (255)
||.+.-++..+.++.|++.+.||+|+.+|++|++.+.+.+||||..||+|++++.+++.++|..+ +.++
T Consensus 91 IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEa-----------RhfF 159 (668)
T KOG0611|consen 91 IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREA-----------RHFF 159 (668)
T ss_pred cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHH-----------HHHH
Confidence 34444456667788999999999999999999999999999999999999999999988887664 5667
Q ss_pred HHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccc
Q psy3182 130 ACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTW 209 (255)
Q Consensus 130 ~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~ 209 (255)
+||..|+.|||.++++|||||.+|||+++++.+|+ +|||+|..... .....
T Consensus 160 RQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKI----------------------------ADFGLSNly~~-~kfLq 210 (668)
T KOG0611|consen 160 RQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKI----------------------------ADFGLSNLYAD-KKFLQ 210 (668)
T ss_pred HHHHHHHHHHhhccceecccchhheeecCCCCeee----------------------------eccchhhhhcc-ccHHH
Confidence 88999999999999999999999999999999998 59999876644 34677
Q ss_pred ccccCCCCcccccccCCCCC-CcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 210 TFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~~~~~-~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
|+||+|.|.+||++.+.+|. +.+|.|||||++|.|..|..||+.|
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 99999999999999999985 6799999999999999999999976
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=264.21 Aligned_cols=155 Identities=29% Similarity=0.557 Sum_probs=140.7
Q ss_pred cccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 58 DNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 58 ~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+-+.++.|+..++|+|+++++++|++..++|+|.|||.| +|+.++...+++.|. .++.++.+++.||.
T Consensus 47 ~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe-----------~v~~~a~~LVsaL~ 114 (808)
T KOG0597|consen 47 NLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEE-----------QVRAIAYDLVSALY 114 (808)
T ss_pred HHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHH-----------HHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999998 999999988888764 35667788999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
|||+++|+|||+||+|||++..+.+|+ .|||+++..+....-.....|||.|
T Consensus 115 yLhs~rilhrd~kPqniLl~~~~~~Kl----------------------------cdFg~Ar~m~~~t~vltsikGtPlY 166 (808)
T KOG0597|consen 115 YLHSNRILHRDMKPQNILLEKGGTLKL----------------------------CDFGLARAMSTNTSVLTSIKGTPLY 166 (808)
T ss_pred HHHhcCcccccCCcceeeecCCCceee----------------------------chhhhhhhcccCceeeeeccCcccc
Confidence 999999999999999999999999999 4999999887665555667899999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||||+..+.+|+..+|+|||||++||+.+|.+||.
T Consensus 167 mAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 167 MAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred cCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 99999999999999999999999999999999985
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=266.50 Aligned_cols=158 Identities=31% Similarity=0.550 Sum_probs=140.5
Q ss_pred eeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 55 LLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 55 il~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
......+++-++.-+.|||+.++|+.+++.+.+|+++||+.||+|++++.+++.+.|.++. .+++||+.
T Consensus 55 ~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa-----------~ff~QIi~ 123 (786)
T KOG0588|consen 55 QPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAA-----------HFFRQILD 123 (786)
T ss_pred cccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHH-----------HHHHHHHH
Confidence 3445567788888899999999999999999999999999999999999999999987653 34678999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|+.|||..+|+||||||+|+|++..+.+|+ +|||+|... ..+....|.||+
T Consensus 124 gv~yCH~~~icHRDLKpENlLLd~~~nIKI----------------------------ADFGMAsLe-~~gklLeTSCGS 174 (786)
T KOG0588|consen 124 GVSYCHAFNICHRDLKPENLLLDVKNNIKI----------------------------ADFGMASLE-VPGKLLETSCGS 174 (786)
T ss_pred HHHHHhhhcceeccCCchhhhhhcccCEee----------------------------eccceeecc-cCCccccccCCC
Confidence 999999999999999999999999988888 599998643 334566789999
Q ss_pred CCCcccccccCCCCC-CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNRGHD-RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~-~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.|.|||++.|.+|+ .++||||+|||+|.|++|.-||+
T Consensus 175 PHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 175 PHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred cccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 999999999999985 68999999999999999999997
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=251.34 Aligned_cols=150 Identities=31% Similarity=0.492 Sum_probs=134.2
Q ss_pred ceeeeccccccccccccccccCccc-eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKY-VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~-~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....+|++|.+|+.|.++.. ++++|||+.||+|..++++.+.++|. .+..++.+|+.||.|||
T Consensus 127 El~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~-----------~L~~ia~~VL~GL~YLh 195 (364)
T KOG0581|consen 127 ELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEP-----------VLGKIARAVLRGLSYLH 195 (364)
T ss_pred HHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHH-----------HHHHHHHHHHHHHHHHh
Confidence 3556667789999999999999995 99999999999999999876666653 35678889999999999
Q ss_pred H-cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 T-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~-~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
. ++||||||||+|+|++..|.+|+ +|||+|+.+-.+ ...+++||..|||
T Consensus 196 ~~~~IIHRDIKPsNlLvNskGeVKi----------------------------cDFGVS~~lvnS--~a~tfvGT~~YMs 245 (364)
T KOG0581|consen 196 EERKIIHRDIKPSNLLVNSKGEVKI----------------------------CDFGVSGILVNS--IANTFVGTSAYMS 245 (364)
T ss_pred hccCeeeccCCHHHeeeccCCCEEe----------------------------ccccccHHhhhh--hcccccccccccC
Confidence 5 99999999999999999999999 599999988776 4568999999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||-+.+..|+.++||||||+.++|+.+|..|+-
T Consensus 246 PERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 246 PERISGESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred hhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence 999999999999999999999999999998764
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=260.80 Aligned_cols=151 Identities=27% Similarity=0.533 Sum_probs=136.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+|+|.++++|--.+.+|.||||+.||+|.+++.. ..++|. .+..|+++++.||+|||.
T Consensus 320 Ei~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-~~~~E~-----------qIA~Icre~l~aL~fLH~ 387 (550)
T KOG0578|consen 320 EILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-TRMTEG-----------QIAAICREILQGLKFLHA 387 (550)
T ss_pred HHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-ccccHH-----------HHHHHHHHHHHHHHHHHh
Confidence 35567788999999999999999999999999999999888874 334442 356678889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||||||||.+|||+..+|.+|+ .|||++.++.....++.+.+|||+|||||
T Consensus 388 ~gIiHrDIKSDnILL~~~g~vKl----------------------------tDFGFcaqi~~~~~KR~TmVGTPYWMAPE 439 (550)
T KOG0578|consen 388 RGIIHRDIKSDNILLTMDGSVKL----------------------------TDFGFCAQISEEQSKRSTMVGTPYWMAPE 439 (550)
T ss_pred cceeeeccccceeEeccCCcEEE----------------------------eeeeeeeccccccCccccccCCCCccchh
Confidence 99999999999999999999999 49999999988887888999999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++....|++++||||||++++||+.|.+||.
T Consensus 440 Vvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 440 VVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred hhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 9999999999999999999999999999975
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=235.69 Aligned_cols=154 Identities=31% Similarity=0.589 Sum_probs=132.7
Q ss_pred cCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+.++.|+..+.||||+++.++.....+.|||+|++.||+|+.-+..+-.++|.. ++.+++||++||.||
T Consensus 58 ~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~-----------aSH~~rQiLeal~yC 126 (355)
T KOG0033|consen 58 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-----------ASHCIQQILEALAYC 126 (355)
T ss_pred HHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHH-----------HHHHHHHHHHHHHHH
Confidence 345788999999999999999999999999999999999998777654444433 356778999999999
Q ss_pred HHcCcccccCCCCceeeCCC---CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNR---GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
|.+||||||+||+|+++... ..+|+ .+||++..++ ++.....++|||.
T Consensus 127 H~n~IvHRDvkP~nllLASK~~~A~vKL----------------------------~~FGvAi~l~-~g~~~~G~~GtP~ 177 (355)
T KOG0033|consen 127 HSNGIVHRDLKPENLLLASKAKGAAVKL----------------------------ADFGLAIEVN-DGEAWHGFAGTPG 177 (355)
T ss_pred HhcCceeccCChhheeeeeccCCCceee----------------------------cccceEEEeC-CccccccccCCCc
Confidence 99999999999999998654 23555 5999998887 4555567899999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||||++...+|+.++||||.||++|.|+.|.+||-.
T Consensus 178 fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 178 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred ccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999999863
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=245.50 Aligned_cols=179 Identities=34% Similarity=0.593 Sum_probs=133.5
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
.|++...||.++.||..|+++.+.+++||||.||||..+.+++. +|++ +++++++++|+.||+|||-
T Consensus 129 eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse-----------~~aRFYaAEvl~ALEYLHm 197 (459)
T KOG0610|consen 129 EILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSE-----------SAARFYAAEVLLALEYLHM 197 (459)
T ss_pred HHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccch-----------hhHHHHHHHHHHHHHHHHh
Confidence 35667899999999999999999999999999999999887654 3454 3456777889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCccee------eec----CCCCCceeee-----------eC--Ceeeeecccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYI------IRE----GAKGDSFFII-----------SG--GQVKVDFGFS 198 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~------~~~----~~~~~~~~~~-----------~~--~~~~~dfg~s 198 (255)
.|||.|||||+|||+.++|++.+++|...-.. ... ....+..... .+ ...+-|.+.+
T Consensus 198 lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~ 277 (459)
T KOG0610|consen 198 LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS 277 (459)
T ss_pred hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccc
Confidence 99999999999999999999999887432221 110 0000000000 00 0000122211
Q ss_pred ccC-----CCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 199 KHL-----GHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 199 ~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
... ...+.+...++||-.|+|||+|.+.+++.++|||+|||++|||+.|..||..
T Consensus 278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 111 1223455679999999999999999999999999999999999999999974
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=229.88 Aligned_cols=153 Identities=39% Similarity=0.681 Sum_probs=137.4
Q ss_pred ccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHH--hccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 59 NRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILR--ERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 59 ~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~--~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
-+.++.+-+.++||||.++|.+|-|+..+|+++||..+|+++..|+ +...+++..+. .++.|++.||
T Consensus 69 lrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a-----------~Yi~q~A~Al 137 (281)
T KOG0580|consen 69 LRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAA-----------TYIKQLANAL 137 (281)
T ss_pred hhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchh-----------HHHHHHHHHH
Confidence 3556888999999999999999999999999999999999999998 55567776553 3456799999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
.|||.++|||||+||+|+|++..+..|+ .|||.|...+ ..++.|.|||..
T Consensus 138 ~y~h~k~VIhRdiKpenlLlg~~~~lki----------------------------AdfGwsV~~p--~~kR~tlcgt~d 187 (281)
T KOG0580|consen 138 LYCHLKRVIHRDIKPENLLLGSAGELKI----------------------------ADFGWSVHAP--SNKRKTLCGTLD 187 (281)
T ss_pred HHhccCCcccCCCCHHHhccCCCCCeec----------------------------cCCCceeecC--CCCceeeecccc
Confidence 9999999999999999999999999998 4999987665 335678999999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+||++.+..++..+|+|++|++.||++.|.+||.
T Consensus 188 yl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 188 YLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred cCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence 999999999999999999999999999999999985
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=233.37 Aligned_cols=143 Identities=36% Similarity=0.655 Sum_probs=129.3
Q ss_pred ccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 69 KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
..||+|+.+.++|+++.++|+|.|.|..|+|++++.+...++|.. .+.|++|+++|++|+|.++|+|||
T Consensus 80 ~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~-----------tR~iMrqlfegVeylHa~~IVHRD 148 (411)
T KOG0599|consen 80 MGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKE-----------TRRIMRQLFEGVEYLHARNIVHRD 148 (411)
T ss_pred cCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHH-----------HHHHHHHHHHHHHHHHHhhhhhcc
Confidence 469999999999999999999999999999999999877666654 356888999999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC---
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN--- 225 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~--- 225 (255)
|||+|||++++..++++ |||+|.++.. +.+....||||+|+|||.+..
T Consensus 149 LKpENILlddn~~i~is----------------------------DFGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~ 199 (411)
T KOG0599|consen 149 LKPENILLDDNMNIKIS----------------------------DFGFACQLEP-GEKLRELCGTPGYLAPETIKCSMY 199 (411)
T ss_pred cChhheeeccccceEEe----------------------------ccceeeccCC-chhHHHhcCCCcccChhheeeecc
Confidence 99999999999999884 9999998865 456678999999999999863
Q ss_pred ---CCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 226 ---RGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 226 ---~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
.+|+..+|+||+||++|.|+.|.+||
T Consensus 200 e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 200 ENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred cCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 47889999999999999999999998
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=242.45 Aligned_cols=145 Identities=36% Similarity=0.666 Sum_probs=133.6
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
+-|..++++..|++-+.+|+||||+.||||.-.+.+-+.|.|..|.++. +.|+-||-|||++|||.|||
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYA-----------aEiaigLFFLh~kgIiYRDL 476 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYA-----------AEIAIGLFFLHSKGIIYRDL 476 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhh-----------HHHHHHhhhhhcCCeeeeec
Confidence 5678899999999999999999999999999999998999998876655 45888999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
|.+|++++..|.+|+ +|||+++.--.....+.|+||||.|+|||++..++|+
T Consensus 477 KLDNvmLd~eGHiKi----------------------------~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYg 528 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKI----------------------------ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYG 528 (683)
T ss_pred cccceEeccCCceEe----------------------------eecccccccccCCcceeeecCCCcccccceEEecccc
Confidence 999999999999999 5999998766666678899999999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++||||+||+||||+.|++||+.
T Consensus 529 ksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 529 KSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred cchhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999974
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=249.99 Aligned_cols=140 Identities=34% Similarity=0.567 Sum_probs=119.8
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+|++++++.+.+..+.|+|||.+.||.+.+.++....+. ..+..++++++.|+.|||++|++||||
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~------------~e~~~w~~~lv~Av~~LH~~gvvhRDL 441 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC------------SEASQWAAELVSAVDYLHEQGVVHRDL 441 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH------------HHHHHHHHHHHHHHHHHHhcCeeecCC
Confidence 47778888888899999999999999999998887654322 223456788999999999999999999
Q ss_pred CCCceee-CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 150 KPENLLL-DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 150 kp~nil~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
||+|||+ ++.+.+++ +|||.++....+ ..+.|=|..|.|||+....+|
T Consensus 442 kp~NIL~~~~~g~lrl----------------------------tyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~y 490 (612)
T KOG0603|consen 442 KPGNILLDGSAGHLRL----------------------------TYFGFWSELERS---CDTPALTLQYVAPEVLAIQEY 490 (612)
T ss_pred ChhheeecCCCCcEEE----------------------------EEechhhhCchh---hcccchhhcccChhhhccCCC
Confidence 9999999 57888888 599998877554 335567889999999999999
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 229 DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.++||||||++||+|++|..||.
T Consensus 491 t~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 491 TEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred CcchhhHHHHHHHHHHHhCCCccc
Confidence 999999999999999999999986
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=240.88 Aligned_cols=155 Identities=32% Similarity=0.544 Sum_probs=127.8
Q ss_pred cCceeeeccccccccccccccccCcc--ceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSK--YVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~--~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
..++++++++.|+|||+.+....... .++++|||+.||+|.+++++.+ .++|. .++.+++||++||
T Consensus 62 ~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~-----------~v~~ytr~iL~GL 130 (313)
T KOG0198|consen 62 EREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEP-----------LVRRYTRQILEGL 130 (313)
T ss_pred HHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHH-----------HHHHHHHHHHHHH
Confidence 45678889999999999999644443 6999999999999999999866 35543 4566788999999
Q ss_pred HHHHHcCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCC---CCccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGH---SGCKTWTFC 212 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~---~~~~~~~~~ 212 (255)
.|||++|+|||||||+|||++. ++.+|+ .|||.++.... .......+.
T Consensus 131 ~ylHs~g~vH~DiK~~NiLl~~~~~~~Kl----------------------------aDFG~a~~~~~~~~~~~~~~~~~ 182 (313)
T KOG0198|consen 131 AYLHSKGIVHCDIKPANILLDPSNGDVKL----------------------------ADFGLAKKLESKGTKSDSELSVQ 182 (313)
T ss_pred HHHHhCCEeccCcccceEEEeCCCCeEEe----------------------------ccCcccccccccccccccccccc
Confidence 9999999999999999999999 688888 49998876652 112234578
Q ss_pred cCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 213 GTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 213 gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||.|||||++.+ ..-+.++|+||+||++.||+||..|+..
T Consensus 183 Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 183 GTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred CCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 9999999999996 2233599999999999999999999865
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=247.12 Aligned_cols=153 Identities=36% Similarity=0.672 Sum_probs=134.0
Q ss_pred cCceeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 60 ~~~vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
..+++++.++. |+|++.+++.|++.+.+|+|||+|.||+|++.+.+. .++|.. ...+++|++.|+.|
T Consensus 83 ~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~d-----------a~~~~~~il~av~~ 150 (382)
T KOG0032|consen 83 RREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERD-----------AAGIIRQILEAVKY 150 (382)
T ss_pred HHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHH-----------HHHHHHHHHHHHHH
Confidence 45677888887 999999999999999999999999999999999876 355443 34567889999999
Q ss_pred HHHcCcccccCCCCceeeCCCC----ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRG----YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
||+.|++|||+||+|+|+.... .+++ +|||+|..... +....+.|||
T Consensus 151 lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~----------------------------~DFGla~~~~~-~~~~~~~~Gt 201 (382)
T KOG0032|consen 151 LHSLGVVHRDLKPENLLLASKDEGSGRIKL----------------------------IDFGLAKFIKP-GERLHTIVGT 201 (382)
T ss_pred HHhCCceeccCCHHHeeeccccCCCCcEEE----------------------------eeCCCceEccC-CceEeeecCC
Confidence 9999999999999999987642 3444 69999998877 5567789999
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.|+|||++.+.+|+..+|+||+||++|.|++|.+||..
T Consensus 202 p~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 202 PEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred ccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 999999999999999999999999999999999999974
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=242.09 Aligned_cols=153 Identities=33% Similarity=0.582 Sum_probs=138.9
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++.+++..+++++.++|.+|-.++.++++||||.||++.+.++....++|... ..+.++++.||.|+|
T Consensus 60 qei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i-----------~~ilre~l~~l~ylH 128 (467)
T KOG0201|consen 60 QEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEI-----------AVILREVLKGLDYLH 128 (467)
T ss_pred HHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCcccee-----------eeehHHHHHHhhhhh
Confidence 356778888999999999999999999999999999999999987666666543 345677999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
..+.||||||+.||++...|.+++ .|||++.++.....++.+++|||+||||
T Consensus 129 ~~~kiHrDIKaanil~s~~g~vkl----------------------------~DfgVa~ql~~~~~rr~tfvGTPfwMAP 180 (467)
T KOG0201|consen 129 SEKKIHRDIKAANILLSESGDVKL----------------------------ADFGVAGQLTNTVKRRKTFVGTPFWMAP 180 (467)
T ss_pred hcceecccccccceeEeccCcEEE----------------------------Eecceeeeeechhhccccccccccccch
Confidence 999999999999999999999988 5999999998887778899999999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+.+|+.++||||||++.|||++|.+|+.
T Consensus 181 EVI~~~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 181 EVIKQSGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred hhhccccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 99999999999999999999999999999975
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=246.90 Aligned_cols=202 Identities=25% Similarity=0.476 Sum_probs=142.2
Q ss_pred HHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCc
Q psy3182 32 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDD 111 (255)
Q Consensus 32 ~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~ 111 (255)
..+.|++.|.+..++.|.- ......+--|++...+.-+|+||.+|+|.+.+|+||||..|||+.++|.+.+-|.|
T Consensus 654 ~~lYAmKTLrKaDVl~rnQ-----vaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE 728 (1034)
T KOG0608|consen 654 RALYAMKTLRKADVLMRNQ-----VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEE 728 (1034)
T ss_pred hhHHHHhhhHHHHHHhhhh-----hhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHH
Confidence 3356666666655554421 11111112346666788899999999999999999999999999999998888887
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCee
Q psy3182 112 NAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191 (255)
Q Consensus 112 ~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (255)
..++ ++++.+..|+++.|..|+|||||||+|||++.+|.+|+.+|+.-.-+.+. -+..+...++..
T Consensus 729 ~LAR-----------FYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT---HdskYYq~gdH~ 794 (1034)
T KOG0608|consen 729 DLAR-----------FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT---HDSKYYQEGDHH 794 (1034)
T ss_pred HHHH-----------HHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec---cccccccCCCcc
Confidence 6654 45566889999999999999999999999999999999876542211110 000111111111
Q ss_pred eee-cccccc----------------CCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 192 KVD-FGFSKH----------------LGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 192 ~~d-fg~s~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..| +..+.. ..+..+....++||+.|+|||++...+|+..+||||.|||||||+.|.+||.
T Consensus 795 RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~ 872 (1034)
T KOG0608|consen 795 RQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFL 872 (1034)
T ss_pred ccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCcc
Confidence 111 100000 0011122345789999999999999999999999999999999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=243.26 Aligned_cols=177 Identities=26% Similarity=0.527 Sum_probs=126.5
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|+++++++..+++...+|++||||.||+|.+++.++..+++. .+..++.|++.||.|||++
T Consensus 52 ~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL~~lH~~ 120 (363)
T cd05628 52 RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE-----------ETQFYIAETVLAIDSIHQL 120 (363)
T ss_pred HHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHhC
Confidence 45566778999999999999999999999999999999999876655543 3455778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCC---------CCCcccccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG---------HSGCKTWTFCG 213 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~---------~~~~~~~~~~g 213 (255)
||+||||||+||+++.++.+++.+|+.+..+...... ......+.....++....... .......+.+|
T Consensus 121 givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 198 (363)
T cd05628 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT--EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVG 198 (363)
T ss_pred CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc--cccccccccccccccccccccccccchhhhccccccccccC
Confidence 9999999999999999999998644433221100000 000000000000000000000 00011235689
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 199 t~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred CccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=235.00 Aligned_cols=176 Identities=35% Similarity=0.607 Sum_probs=147.4
Q ss_pred HHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCcc
Q psy3182 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN 112 (255)
Q Consensus 33 v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~ 112 (255)
.+.|++-+.+.-|+.||--..- +. +-+++...+||....+-.+|++++.+++||||..||+|+-++.+...|+|.
T Consensus 194 k~YAiKIlkKeviiakdEVAHT--lT---E~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~ 268 (516)
T KOG0690|consen 194 KLYAIKILKKEVIIAKDEVAHT--LT---ENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSED 268 (516)
T ss_pred ceeehhhhhhhheeehHHhhhh--hh---HHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccch
Confidence 3455555555555544421111 11 123456678999999999999999999999999999999999888889988
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeee
Q psy3182 113 AASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192 (255)
Q Consensus 113 ~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (255)
.++|+.+ .|+.||.|||+++|+.||+|.+|++++.+|.+|+
T Consensus 269 RtRFYGa-----------EIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKi---------------------------- 309 (516)
T KOG0690|consen 269 RTRFYGA-----------EIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKI---------------------------- 309 (516)
T ss_pred hhhhhhH-----------HHHHHhhhhhhCCeeeeechhhhheeccCCceEe----------------------------
Confidence 8777665 4889999999999999999999999999999999
Q ss_pred eeccccccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 193 VDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 193 ~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|||+++..-..+..+.++||||.|+|||++....|+.++|||.+||++|||++|.-||-
T Consensus 310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 499999877666777889999999999999999999999999999999999999999985
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=243.88 Aligned_cols=155 Identities=26% Similarity=0.445 Sum_probs=137.5
Q ss_pred CceeeeccccccccccccccccCccc-eeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKY-VYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~-~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
.++.+++++.|||++.+.+.|..++. ++++|+||.||++.+.+.++. .|+|. .+..++-|++.|+.
T Consensus 52 ~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~-----------~i~~~~~Q~~~av~ 120 (426)
T KOG0589|consen 52 QEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEE-----------RILKWFVQILLAVN 120 (426)
T ss_pred HHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHH-----------HHHHHHHHHHHHHH
Confidence 45778899999999999999988887 999999999999999997654 23332 23445667999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
|||++.|.|||||+.||++..++.+++. |||+|+.++.......+.+|||.|
T Consensus 121 ylH~~~iLHRDlK~~Nifltk~~~VkLg----------------------------DfGlaK~l~~~~~~a~tvvGTp~Y 172 (426)
T KOG0589|consen 121 YLHENRVLHRDLKCANIFLTKDKKVKLG----------------------------DFGLAKILNPEDSLASTVVGTPYY 172 (426)
T ss_pred HHHhhhhhcccchhhhhhccccCceeec----------------------------chhhhhhcCCchhhhheecCCCcc
Confidence 9999999999999999999999988884 999999998876678889999999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
|+||++.+.+|+.++|+|||||++|||++=.++|..+
T Consensus 173 mcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 173 MCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred cCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 9999999999999999999999999999999998765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-33 Score=238.39 Aligned_cols=152 Identities=36% Similarity=0.651 Sum_probs=130.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+++.+.+|++|||+.||+|.+.+.+...+++. .+..++.|++.||.|||+
T Consensus 45 e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~L~~lH~ 113 (323)
T cd05571 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----------RARFYGAEIVSALGYLHS 113 (323)
T ss_pred HHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 355667778999999999999999999999999999999998876555432 345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++............+||+.|+|||
T Consensus 114 ~~ivHrDlkp~NIll~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~gt~~y~aPE 165 (323)
T cd05571 114 CDVVYRDLKLENLMLDKDGHIKI----------------------------TDFGLCKEGISDGATMKTFCGTPEYLAPE 165 (323)
T ss_pred CCeEeCCCCHHHEEECCCCCEEE----------------------------eeCCCCcccccCCCcccceecCccccChh
Confidence 99999999999999999888888 59998875433333444678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred hhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 9999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=232.73 Aligned_cols=157 Identities=31% Similarity=0.489 Sum_probs=131.1
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++.++...|||+++++.+|..+..+|.||-++.+|+++++++..- .+. .....+..|.+++++||.|||
T Consensus 73 kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~--~~G-------l~E~~Ia~iLre~LkaL~YLH 143 (516)
T KOG0582|consen 73 KEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY--PDG-------LEEASIATILREVLKALDYLH 143 (516)
T ss_pred HHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc--ccc-------ccHHHHHHHHHHHHHHHHHHH
Confidence 45677888899999999999999999999999999999999998532 111 112346678899999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---c-cccccCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---T-WTFCGTPE 216 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~-~~~~gt~~ 216 (255)
++|-||||+|+.|||++.+|.++++ |||++..+-.++.+ . .+++|||.
T Consensus 144 ~~G~IHRdvKAgnILi~~dG~VkLa----------------------------dFgvsa~l~~~G~R~~~rf~tfvgtp~ 195 (516)
T KOG0582|consen 144 QNGHIHRDVKAGNILIDSDGTVKLA----------------------------DFGVSASLFDSGDRQVTRFNTFVGTPC 195 (516)
T ss_pred hcCceecccccccEEEcCCCcEEEc----------------------------CceeeeeecccCceeeEeeccccCccc
Confidence 9999999999999999999999995 77766554433322 1 46799999
Q ss_pred CcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 217 YVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 217 y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
|||||++.+ .+|+.|+||||+|++..||.+|..||.-+
T Consensus 196 wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 196 WMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred ccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 999999654 68999999999999999999999999754
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-33 Score=225.22 Aligned_cols=151 Identities=27% Similarity=0.469 Sum_probs=129.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..++|+|+|.+.++|.....+++|+|||+..-| +.+.+.. ..+ .+.+..++.|++.|+.|||
T Consensus 51 EIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL-~eLe~~p~G~~-----------~~~vk~~l~Q~l~ai~~cH 118 (396)
T KOG0593|consen 51 EIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL-HELERYPNGVP-----------SELVKKYLYQLLKAIHFCH 118 (396)
T ss_pred HHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH-HHHHhccCCCC-----------HHHHHHHHHHHHHHhhhhh
Confidence 46778889999999999999999999999999987544 4444322 222 2446778899999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++++||||+||+|||++.++.+|+ +|||+|+.+...+.....++.|..|.||
T Consensus 119 k~n~IHRDIKPENILit~~gvvKL----------------------------CDFGFAR~L~~pgd~YTDYVATRWYRaP 170 (396)
T KOG0593|consen 119 KNNCIHRDIKPENILITQNGVVKL----------------------------CDFGFARTLSAPGDNYTDYVATRWYRAP 170 (396)
T ss_pred hcCeecccCChhheEEecCCcEEe----------------------------ccchhhHhhcCCcchhhhhhhhhhccCh
Confidence 999999999999999999999999 5999999988666666678999999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+ ..|+.++||||+||++.||++|.+-|.
T Consensus 171 ELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 171 ELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred hhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 99987 789999999999999999999987543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=241.69 Aligned_cols=180 Identities=24% Similarity=0.474 Sum_probs=128.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+++.+.+|+|||||.||+|.+.+.+...+++ +.+..++.|++.||.|||+
T Consensus 51 E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e-----------~~~~~~~~qi~~al~~lH~ 119 (382)
T cd05625 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE-----------DLARFYIAELTCAVESVHK 119 (382)
T ss_pred HHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 45667778899999999999999999999999999999999976554443 2345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCC----CCCceeeeeCCeeeeeccccc---------------cCC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGA----KGDSFFIISGGQVKVDFGFSK---------------HLG 202 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~dfg~s~---------------~~~ 202 (255)
+||+||||||+|||++.++.+++.+|+.+........ .........+......++-.. ...
T Consensus 120 ~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (382)
T cd05625 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199 (382)
T ss_pred CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence 9999999999999999999999976665432110000 000000000000000000000 000
Q ss_pred CCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 203 HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.......+.+||+.|+|||++.+..|+.++|+||+||++|||++|..||.
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (382)
T cd05625 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 249 (382)
T ss_pred cccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCC
Confidence 01111234689999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=233.95 Aligned_cols=152 Identities=39% Similarity=0.643 Sum_probs=130.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|+++++..+.+.+..|++|||+.||+|.+.+.+...+++. .+..++.|++.||.|||+
T Consensus 43 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~ 111 (312)
T cd05585 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-----------RARFYTAELLCALENLHK 111 (312)
T ss_pred HHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 345667778999999999999999999999999999999999876555443 234567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++..........+.+||+.|+|||
T Consensus 112 ~~i~HrDlkp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 163 (312)
T cd05585 112 FNVIYRDLKPENILLDYQGHIAL----------------------------CDFGLCKLNMKDDDKTNTFCGTPEYLAPE 163 (312)
T ss_pred CCeEeCCCCHHHeEECCCCcEEE----------------------------EECcccccCccCCCccccccCCcccCCHH
Confidence 99999999999999999888887 59998875433333344578999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 164 ~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred HHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence 9999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=254.70 Aligned_cols=146 Identities=34% Similarity=0.642 Sum_probs=125.9
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
....+-++.++..|+|..++||||||+.||||..++.+...+++.-+. |++..|..||.-+|+.|.|||
T Consensus 131 ~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~Ar-----------FY~aEiVlAldslH~mgyVHR 199 (1317)
T KOG0612|consen 131 FGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWAR-----------FYTAEIVLALDSLHSMGYVHR 199 (1317)
T ss_pred cCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHH-----------HHHHHHHHHHHHHHhccceec
Confidence 345677889999999999999999999999999999887767776554 445568899999999999999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcccccccC-
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVAPEIIKN- 225 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~aPE~~~~- 225 (255)
|+||+|+|++..|++++ +|||.+-.+...+ ....+.+|||.|.+||++..
T Consensus 200 DiKPDNvLld~~GHikL----------------------------ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 200 DIKPDNVLLDKSGHIKL----------------------------ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred cCCcceeEecccCcEee----------------------------ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhh
Confidence 99999999999999999 4999886665443 34557899999999999963
Q ss_pred ----CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 226 ----RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 226 ----~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..|+..+||||+||++|||+.|-.||-
T Consensus 252 ~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 252 GDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred cCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 458999999999999999999999985
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=233.50 Aligned_cols=152 Identities=37% Similarity=0.673 Sum_probs=130.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|+++++..|++.+.+|+||||+.||+|...+.+...+++ ..+..++.|++.||.|||+
T Consensus 45 E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~qi~~aL~~LH~ 113 (323)
T cd05595 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-----------ERARFYGAEIVSALEYLHS 113 (323)
T ss_pred HHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999988876555543 2345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||+++............+||+.|+|||
T Consensus 114 ~~ivH~Dlkp~NIll~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 165 (323)
T cd05595 114 RDVVYRDIKLENLMLDKDGHIKI----------------------------TDFGLCKEGISDGATMKTFCGTPEYLAPE 165 (323)
T ss_pred CCeEecCCCHHHEEEcCCCCEEe----------------------------cccHHhccccCCCCccccccCCcCcCCcc
Confidence 99999999999999999888888 59998775433333334578999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 9999899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=240.38 Aligned_cols=175 Identities=27% Similarity=0.516 Sum_probs=126.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+++.+.+|++||||.||+|.+++.....+++ +.++.++.|++.||+|||+
T Consensus 51 E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~-----------~~~~~~~~ql~~aL~~LH~ 119 (377)
T cd05629 51 ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE-----------DVTRFYMAECVLAIEAVHK 119 (377)
T ss_pred HHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 35566777899999999999999999999999999999999976555543 2345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCC--------CCcee---------eee-------CCeeeeeccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAK--------GDSFF---------IIS-------GGQVKVDFGF 197 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~--------~~~~~---------~~~-------~~~~~~dfg~ 197 (255)
+||+||||||+||+++.++.+++.+|+.+......... ..... ... ......+++.
T Consensus 120 ~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred CCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 99999999999999999999999766544321110000 00000 000 0000000000
Q ss_pred cccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 198 SKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 198 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+. .......+||+.|+|||++.+..++.++|+||+||++|||++|..||.
T Consensus 200 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (377)
T cd05629 200 NR-----RLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC 249 (377)
T ss_pred cc-----cccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCC
Confidence 00 000113579999999999999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=237.97 Aligned_cols=180 Identities=28% Similarity=0.527 Sum_probs=127.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+++.+.+|++||||.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 51 E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL~~lH~ 119 (364)
T cd05599 51 ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----------ETRFYIAETILAIDSIHK 119 (364)
T ss_pred HHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 455667778999999999999999999999999999999999876555443 345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCC--eeeeeccccccC---------CCCCccccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG--QVKVDFGFSKHL---------GHSGCKTWT 210 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~dfg~s~~~---------~~~~~~~~~ 210 (255)
+||+||||||+||+++.++.+++.+|+.+..+........ ....... ....++...... ........+
T Consensus 120 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (364)
T cd05599 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF-YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYS 198 (364)
T ss_pred CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc-cccccccccccccccccccccccccccchhhcccccccc
Confidence 9999999999999999999999865544332111000000 0000000 000000000000 000001224
Q ss_pred cccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 211 FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+||+.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 199 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred cccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence 5799999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=234.88 Aligned_cols=154 Identities=27% Similarity=0.443 Sum_probs=129.5
Q ss_pred CceeeeccccccccccccccccCcc-ceeehhhhhcchhHHHHHHhc--cCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSK-YVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~-~~ylv~E~~~gg~l~~~l~~~--~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
.++.++.+++|||++++++...+.. ...+||||+.+|+|..++.+. ..++.. ..-.++-||+.|+.
T Consensus 88 ~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~-----------~~l~~aldiArGm~ 156 (362)
T KOG0192|consen 88 REASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLK-----------VRLRIALDIARGME 156 (362)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHH-----------HHHHHHHHHHHHHH
Confidence 4577888899999999999999887 799999999999999999763 333321 12235668999999
Q ss_pred HHHHcC-cccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 138 YLHTRG-IVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~-iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|||+++ ||||||||+|+|++..+ .+|+ .|||+++.............||+
T Consensus 157 YLH~~~~iIHrDLK~~NiLv~~~~~~~KI----------------------------~DFGlsr~~~~~~~~~~~~~GT~ 208 (362)
T KOG0192|consen 157 YLHSEGPIIHRDLKSDNILVDLKGKTLKI----------------------------ADFGLSREKVISKTSMTSVAGTY 208 (362)
T ss_pred HHhcCCCeeecccChhhEEEcCCCCEEEE----------------------------CCCccceeeccccccccCCCCCc
Confidence 999999 99999999999999997 8888 49999987655422223368999
Q ss_pred CCccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIK--NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~--~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|||||++. ...|+.++|+||+|+++|||+||..||..
T Consensus 209 ~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 209 RWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred cccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 999999999 56999999999999999999999999874
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=236.35 Aligned_cols=150 Identities=44% Similarity=0.829 Sum_probs=130.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+++.+.+|++|||+.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 81 E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~ 149 (340)
T PTZ00426 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND-----------VGCFYAAQIVLIFEYLQS 149 (340)
T ss_pred HHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 455677788999999999999999999999999999999999876655432 345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++.... ...+.+||+.|||||
T Consensus 150 ~~ivHrDLkp~NILl~~~~~ikL----------------------------~DFG~a~~~~~---~~~~~~gt~~y~aPE 198 (340)
T PTZ00426 150 LNIVYRDLKPENLLLDKDGFIKM----------------------------TDFGFAKVVDT---RTYTLCGTPEYIAPE 198 (340)
T ss_pred CCeEccCCCHHHEEECCCCCEEE----------------------------ecCCCCeecCC---CcceecCChhhcCHH
Confidence 99999999999999999888888 59998876533 234578999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 199 ~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred HHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 99998899999999999999999999999863
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=239.31 Aligned_cols=181 Identities=24% Similarity=0.464 Sum_probs=128.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+++.+.+|++||||.||+|.+++.+...+++. .+..+++|++.||.|||+
T Consensus 51 E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~-----------~~~~~~~qi~~aL~~LH~ 119 (381)
T cd05626 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV-----------LARFYIAELTLAIESVHK 119 (381)
T ss_pred HHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 456677788999999999999999999999999999999999876555432 345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCC-----CCceeeee-------CCeeeeeccc-------cccCC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAK-----GDSFFIIS-------GGQVKVDFGF-------SKHLG 202 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~dfg~-------s~~~~ 202 (255)
+||+||||||+||+++..+.+++.+|+........... +....... ........+. .....
T Consensus 120 ~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (381)
T cd05626 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ 199 (381)
T ss_pred CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence 99999999999999999999999765543221000000 00000000 0000000000 00000
Q ss_pred CCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 203 HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.......+.+||+.|+|||++.+..++.++|+||+||++|||++|..||..
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcC
Confidence 001112356899999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=233.41 Aligned_cols=149 Identities=39% Similarity=0.686 Sum_probs=127.7
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ii 145 (255)
+....|+++++++..+++.+..|++|||+.||+|.+.+.+...+.+. .+..++.|++.||.|||++||+
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~qi~~~L~~lH~~gii 118 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----------RARFYAAEIASALGYLHSLNIV 118 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeE
Confidence 34567999999999999999999999999999999999765555432 3345678999999999999999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN 225 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (255)
||||||+||+++.++.+++ +|||+++............+||+.|+|||++.+
T Consensus 119 HrDlkp~Nili~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05602 119 YRDLKPENILLDSQGHIVL----------------------------TDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK 170 (325)
T ss_pred ecCCCHHHeEECCCCCEEE----------------------------ccCCCCcccccCCCCcccccCCccccCHHHHcC
Confidence 9999999999999888887 599988754333334456789999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 226 RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 226 ~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..++.++|+||+||++|+|++|..||..
T Consensus 171 ~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred CCCCCccccccccHHHHHHhcCCCCCCC
Confidence 9999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=233.55 Aligned_cols=152 Identities=36% Similarity=0.647 Sum_probs=129.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+++.+.+|+||||+.||+|...+.....+++. .+..++.|++.||.|||+
T Consensus 45 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL~~LH~ 113 (328)
T cd05593 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-----------RTRFYGAEIVSALDYLHS 113 (328)
T ss_pred HHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 345677778999999999999999999999999999999888765544432 344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ .|||+++............+||+.|+|||
T Consensus 114 ~~ivHrDikp~NIll~~~~~~kL----------------------------~DfG~~~~~~~~~~~~~~~~gt~~y~aPE 165 (328)
T cd05593 114 GKIVYRDLKLENLMLDKDGHIKI----------------------------TDFGLCKEGITDAATMKTFCGTPEYLAPE 165 (328)
T ss_pred CCeEecccCHHHeEECCCCcEEE----------------------------ecCcCCccCCCcccccccccCCcCccChh
Confidence 99999999999999999888888 59998875433333344578999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred hhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence 9999899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=221.57 Aligned_cols=146 Identities=30% Similarity=0.551 Sum_probs=120.5
Q ss_pred ccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 69 KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
..|+||++|.++|+|++.+|+|+|.+.||.|++.|.++.+|.|.+++ .++++|+.||.|||.+||.|||
T Consensus 133 qgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs-----------~vvkdia~aLdFlH~kgIAHRD 201 (463)
T KOG0607|consen 133 QGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREAS-----------RVVKDIASALDFLHTKGIAHRD 201 (463)
T ss_pred cCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHH-----------HHHHHHHHHHHHHhhcCccccc
Confidence 46999999999999999999999999999999999999999987764 4556799999999999999999
Q ss_pred CCCCceeeCCCCc---eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccC--CC-----CCccccccccCCCCc
Q psy3182 149 LKPENLLLDNRGY---VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHL--GH-----SGCKTWTFCGTPEYV 218 (255)
Q Consensus 149 lkp~nil~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~--~~-----~~~~~~~~~gt~~y~ 218 (255)
+||+|||...++. +|+. ||.+.... .. +.....+.||+..||
T Consensus 202 lKPENiLC~~pn~vsPvKiC----------------------------DfDLgSg~k~~~~~spastP~L~tPvGSAEfM 253 (463)
T KOG0607|consen 202 LKPENILCESPNKVSPVKIC----------------------------DFDLGSGIKLNNDCSPASTPELLTPVGSAEFM 253 (463)
T ss_pred CCccceeecCCCCcCceeee----------------------------ccccccccccCCCCCCCCCccccCcccchhhc
Confidence 9999999987654 4554 33332111 11 122345789999999
Q ss_pred cccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIK-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++. ...|+.++|.|||||++|.|++|.+||..
T Consensus 254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 999974 24689999999999999999999999963
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=219.95 Aligned_cols=144 Identities=33% Similarity=0.565 Sum_probs=122.2
Q ss_pred ccccccccccccccC----ccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 69 KKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
..|+|+|.+.+.|++ ...+.+|||.+.||+|++.+..++. |+|+++ ..|++||..|+.|||+.
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea-----------~eI~~qI~~Av~~lH~~ 180 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREA-----------SEIMKQIGLAVRYLHSM 180 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHH-----------HHHHHHHHHHHHHHHhc
Confidence 468999998877654 4678999999999999999987765 777654 35677899999999999
Q ss_pred CcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 143 GIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
+|.|||+||+|+|....+ .+|+ .|||+++.-... ....+.|-||+|.|
T Consensus 181 nIAHRDlKpENLLyt~t~~na~lKL----------------------------tDfGFAK~t~~~-~~L~TPc~TPyYva 231 (400)
T KOG0604|consen 181 NIAHRDLKPENLLYTTTSPNAPLKL----------------------------TDFGFAKETQEP-GDLMTPCFTPYYVA 231 (400)
T ss_pred chhhccCChhheeeecCCCCcceEe----------------------------cccccccccCCC-ccccCCcccccccC
Confidence 999999999999987543 4555 499999876543 34557899999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++....|+.++|+||+||++|.|++|.+||-
T Consensus 232 Pevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred HHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999999999999999999999999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=232.00 Aligned_cols=153 Identities=42% Similarity=0.691 Sum_probs=130.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|+|++++++.+.+++.+|++|||+.||+|.+.+.+...+.+. .+..++.|++.||.|||+
T Consensus 50 E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~ 118 (323)
T cd05584 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMED-----------TACFYLSEISLALEHLHQ 118 (323)
T ss_pred HHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999876554432 234567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ .|||+++............+||+.|+|||
T Consensus 119 ~~ivH~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 170 (323)
T cd05584 119 QGIIYRDLKPENILLDAQGHVKL----------------------------TDFGLCKESIHEGTVTHTFCGTIEYMAPE 170 (323)
T ss_pred CCeecCCCCHHHeEECCCCCEEE----------------------------eeCcCCeecccCCCcccccCCCccccChh
Confidence 99999999999999999988888 59998765433333344568999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 171 ~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred hccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 99998899999999999999999999999863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=239.34 Aligned_cols=180 Identities=23% Similarity=0.461 Sum_probs=127.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|+++++++..+++.+.+|++||||.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 51 E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~-----------~~~~~~~qi~~al~~lH~ 119 (376)
T cd05598 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED-----------LARFYIAELTCAIESVHK 119 (376)
T ss_pred HHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999876554432 345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCC----CCce---eeeeCCeeeeecc--------ccccCCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAK----GDSF---FIISGGQVKVDFG--------FSKHLGHSGC 206 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~----~~~~---~~~~~~~~~~dfg--------~s~~~~~~~~ 206 (255)
+||+||||||+||+++.++.+++.+|+.+......... .... ..........+.. ..........
T Consensus 120 ~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 99999999999999999999999755543211000000 0000 0000000000000 0000000011
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
...+.+||+.|||||++.+..++.++|+||+||++|+|++|..||.
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 245 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCC
Confidence 1234689999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=233.23 Aligned_cols=149 Identities=43% Similarity=0.817 Sum_probs=129.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+.+|++|||+.||+|.+.+.+...+++. .+..++.|++.||.|||+
T Consensus 68 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~ 136 (329)
T PTZ00263 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND-----------VAKFYHAELVLAFEYLHS 136 (329)
T ss_pred HHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999876554432 334567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ .|||+++..... ..+.+||+.|+|||
T Consensus 137 ~~ivH~dlkp~NIll~~~~~~kl----------------------------~Dfg~~~~~~~~---~~~~~gt~~y~aPE 185 (329)
T PTZ00263 137 KDIIYRDLKPENLLLDNKGHVKV----------------------------TDFGFAKKVPDR---TFTLCGTPEYLAPE 185 (329)
T ss_pred CCeeecCCCHHHEEECCCCCEEE----------------------------eeccCceEcCCC---cceecCChhhcCHH
Confidence 99999999999999999988888 599988765432 23568999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+|||||++|+|++|..||.
T Consensus 186 ~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred HHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 9999999999999999999999999999985
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=237.72 Aligned_cols=177 Identities=26% Similarity=0.508 Sum_probs=126.5
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++....|+++++++..+++.+.+|++||||.||+|.+++.+...+++. .+..++.|++.||.|||++
T Consensus 52 ~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~-----------~~~~~~~qi~~~L~~lH~~ 120 (360)
T cd05627 52 RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE-----------ATQFYIAETVLAIDAIHQL 120 (360)
T ss_pred HHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHHC
Confidence 45566678999999999999999999999999999999999876655443 3456778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeecccccc---------CCCCCcccccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKH---------LGHSGCKTWTFCG 213 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~---------~~~~~~~~~~~~g 213 (255)
||+||||||+||+++.++.+++.+|+.+..+................. .++.+... .........+.+|
T Consensus 121 givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 198 (360)
T cd05627 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP--SDFSFQNMNSKRKAETWKKNRRQLAYSTVG 198 (360)
T ss_pred CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCc--ccccccccccccccccccccccccccccCC
Confidence 999999999999999999999965544332110000000000000000 00000000 0000011234689
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 199 t~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred CccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=228.37 Aligned_cols=150 Identities=46% Similarity=0.852 Sum_probs=129.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|+|++++++.+.+.+.+|++|||+.||+|.+++.....+++. .+..++.|++.||.|||+
T Consensus 51 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~ 119 (291)
T cd05612 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----------TGLFYASEIVCALEYLHS 119 (291)
T ss_pred HHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677888999999999999999999999999999999999876555443 234567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||+++.... ...+.+||+.|+|||
T Consensus 120 ~~i~H~dlkp~NIli~~~~~~kl----------------------------~Dfg~~~~~~~---~~~~~~gt~~y~aPE 168 (291)
T cd05612 120 KEIVYRDLKPENILLDKEGHIKL----------------------------TDFGFAKKLRD---RTWTLCGTPEYLAPE 168 (291)
T ss_pred CCeeecCCCHHHeEECCCCCEEE----------------------------EecCcchhccC---CcccccCChhhcCHH
Confidence 99999999999999999888888 59998876533 233568999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 169 ~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=222.89 Aligned_cols=147 Identities=35% Similarity=0.657 Sum_probs=134.1
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
...||..+.++..|+++..+|+|.||+.||||.-.+.++..++|..++|+. ..|..||.|||++|||.|
T Consensus 307 asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys-----------~ei~lal~flh~rgiiyr 375 (593)
T KOG0695|consen 307 ASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS-----------AEICLALNFLHERGIIYR 375 (593)
T ss_pred ccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhh-----------HHHHHHHHHHhhcCeeee
Confidence 457899999999999999999999999999999888888888877666555 458889999999999999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCC
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG 227 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (255)
|||..|+|++..|.+|+. |+|.++.--..+..++|+||||.|.|||++++..
T Consensus 376 dlkldnvlldaeghiklt----------------------------dygmcke~l~~gd~tstfcgtpnyiapeilrgee 427 (593)
T KOG0695|consen 376 DLKLDNVLLDAEGHIKLT----------------------------DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 427 (593)
T ss_pred eccccceEEccCCceeec----------------------------ccchhhcCCCCCcccccccCCCcccchhhhcccc
Confidence 999999999999999994 9999887666677888999999999999999999
Q ss_pred CCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 228 HDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 228 ~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+.++|||+|||+++||+.|..||+.
T Consensus 428 ygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 428 YGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cCceehHHHHHHHHHHHHcCCCCcce
Confidence 99999999999999999999999974
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=228.63 Aligned_cols=146 Identities=36% Similarity=0.682 Sum_probs=125.8
Q ss_pred ccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 69 KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
..|++++++++.+++...+|++|||+.||+|...+.....+++. .+..++.|++.||.|||+++|+|||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~-----------~~~~~~~qi~~al~~LH~~~ivH~d 121 (316)
T cd05592 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-----------RARFYAAEIICGLQFLHKKGIIYRD 121 (316)
T ss_pred cCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 47999999999999999999999999999999998765555432 2345678899999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
|||+||+++.++.+++ +|||+++............+||+.|+|||++.+..+
T Consensus 122 lkp~Nill~~~~~~kL----------------------------~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05592 122 LKLDNVLLDKDGHIKI----------------------------ADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173 (316)
T ss_pred CCHHHeEECCCCCEEE----------------------------ccCcCCeECCCCCCccccccCCccccCHHHHcCCCC
Confidence 9999999999888888 599988765433334445789999999999999899
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 229 DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.++|+||+||++|+|++|..||..
T Consensus 174 ~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 174 NESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CCcccchhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=231.36 Aligned_cols=144 Identities=35% Similarity=0.663 Sum_probs=124.9
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+++.+.+|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++|++||||
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~-----------~~~~~~~qi~~~l~~lH~~~ivH~dl 122 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEE-----------HARFYSAEISLALNFLHERGIIYRDL 122 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 6999999999999999999999999999999888765555443 34456788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+..++
T Consensus 123 kp~Nili~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05588 123 KLDNVLLDAEGHIKL----------------------------TDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred CHHHeEECCCCCEEE----------------------------CcCccccccccCCCccccccCCccccCHHHHcCCCCC
Confidence 999999999888888 4999886533333344567899999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 230 RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~ 252 (255)
.++|+||+||++|+|++|..||.
T Consensus 175 ~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 175 FSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccceechHHHHHHHHHCCCCcc
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=230.28 Aligned_cols=149 Identities=40% Similarity=0.699 Sum_probs=127.1
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
++....|+|+++++..+++.+..|++|||+.||+|...+.+...+.+. .+..++.|++.||.|||++||
T Consensus 49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~L~~lH~~~i 117 (321)
T cd05603 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----------RARFYAAEVASAIGYLHSLNI 117 (321)
T ss_pred HHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCe
Confidence 345668999999999999999999999999999999888765555432 344567899999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~ 224 (255)
+||||||+||+++.++.+++ .|||+++............+||+.|+|||++.
T Consensus 118 vH~Dlkp~NIll~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05603 118 IYRDLKPENILLDSQGHVVL----------------------------TDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR 169 (321)
T ss_pred EeccCCHHHeEECCCCCEEE----------------------------ccCCCCccCCCCCCccccccCCcccCCHHHhc
Confidence 99999999999999988888 59998875433333344578999999999999
Q ss_pred CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 225 NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 225 ~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+..++.++|+||+||++|+|++|..||.
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred CCCCCCcCcccccchhhhhhhcCCCCCC
Confidence 9899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=232.21 Aligned_cols=154 Identities=33% Similarity=0.483 Sum_probs=123.0
Q ss_pred cCceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+.++.+++++.|+|+|+|++...| ++.+|||+|||..|.+... . -+... ...+..+.+.++++.||+
T Consensus 156 ~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~----p-~d~~e------ls~~~Ar~ylrDvv~GLE 224 (576)
T KOG0585|consen 156 RREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC----P-PDKPE------LSEQQARKYLRDVVLGLE 224 (576)
T ss_pred HHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC----C-CCccc------ccHHHHHHHHHHHHHHHH
Confidence 345778899999999999999887 4689999999999987321 1 11111 223456778899999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCC-----CCCccccccc
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG-----HSGCKTWTFC 212 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~-----~~~~~~~~~~ 212 (255)
|||.+|||||||||.|+|++..|.+|++ |||+|-... .........+
T Consensus 225 YLH~QgiiHRDIKPsNLLl~~~g~VKIs----------------------------DFGVs~~~~~~~~~~~d~~L~~tv 276 (576)
T KOG0585|consen 225 YLHYQGIIHRDIKPSNLLLSSDGTVKIS----------------------------DFGVSNEFPQGSDEGSDDQLSRTV 276 (576)
T ss_pred HHHhcCeeccccchhheEEcCCCcEEee----------------------------ccceeeecccCCccccHHHHhhcC
Confidence 9999999999999999999999999995 888876442 2222334468
Q ss_pred cCCCCcccccccC---CCC-CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 213 GTPEYVAPEIIKN---RGH-DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 213 gt~~y~aPE~~~~---~~~-~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||.|||||.+.+ ..+ +.+.|+||+||+||.|+.|.-||+
T Consensus 277 GTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 277 GTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred CCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 9999999999986 233 567899999999999999999997
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=228.68 Aligned_cols=145 Identities=37% Similarity=0.683 Sum_probs=125.6
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+.+.+.+|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++|++||||
T Consensus 54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~-----------~~~~~~~ql~~~L~~lH~~~ivH~dl 122 (320)
T cd05590 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----------RARFYAAEITSALMFLHDKGIIYRDL 122 (320)
T ss_pred CCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 6999999999999999999999999999999988776555543 33456788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++............+||+.|+|||++.+..++
T Consensus 123 kp~NIli~~~~~~kL----------------------------~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (320)
T cd05590 123 KLDNVLLDHEGHCKL----------------------------ADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174 (320)
T ss_pred CHHHeEECCCCcEEE----------------------------eeCCCCeecCcCCCcccccccCccccCHHHHcCCCCC
Confidence 999999999888888 5999877543333344567899999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|+||+||++|+|++|..||..
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 175 PSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred CccchhhhHHHHHHHhhCCCCCCC
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=235.82 Aligned_cols=150 Identities=33% Similarity=0.664 Sum_probs=125.6
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|++++++++.+++.+.+|+|||||.||+|.+++... .+++ +.+..++.|++.||.|||++
T Consensus 94 ~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~-----------~~~~~~~~qil~aL~~LH~~ 161 (370)
T cd05621 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPE-----------KWAKFYTAEVVLALDAIHSM 161 (370)
T ss_pred HHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 34455678999999999999999999999999999999988653 2332 23456778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE 221 (255)
||+||||||+||+++..+.+++ +|||++........ ...+.+||+.|||||
T Consensus 162 ~IvHrDLKp~NILl~~~~~~kL----------------------------~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE 213 (370)
T cd05621 162 GLIHRDVKPDNMLLDKHGHLKL----------------------------ADFGTCMKMDETGMVRCDTAVGTPDYISPE 213 (370)
T ss_pred CeEecCCCHHHEEECCCCCEEE----------------------------EecccceecccCCceecccCCCCcccCCHH
Confidence 9999999999999999988888 59998876543221 234678999999999
Q ss_pred cccCCC----CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRG----HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~----~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+.+ ++.++|+||+||++|+|++|..||.
T Consensus 214 ~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred HHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 997643 7889999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=227.57 Aligned_cols=145 Identities=34% Similarity=0.666 Sum_probs=124.2
Q ss_pred ccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 69 KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
..|++++++++.+++.+.+|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++||+|||
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~~~ivHrD 121 (316)
T cd05620 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY-----------RATFYAAEIVCGLQFLHSKGIIYRD 121 (316)
T ss_pred cCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeEecC
Confidence 47999999999999999999999999999999988765554432 2345678899999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
|||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+..+
T Consensus 122 lkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05620 122 LKLDNVMLDRDGHIKI----------------------------ADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173 (316)
T ss_pred CCHHHeEECCCCCEEe----------------------------CccCCCeecccCCCceeccCCCcCccCHHHHcCCCC
Confidence 9999999999888888 499987643322233446789999999999999999
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 229 DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.++|+||+||++|+|++|..||.
T Consensus 174 ~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 174 TFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CcccchhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=229.92 Aligned_cols=148 Identities=39% Similarity=0.679 Sum_probs=126.8
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ii 145 (255)
+....|+++++++..+++.+..|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++||+
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~~giv 118 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----------RARFYAAEIASALGYLHSLNII 118 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeE
Confidence 45668999999999999999999999999999999998766555432 2345678899999999999999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN 225 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (255)
||||||+||+++.++.+++ .|||+++............+||+.|+|||++.+
T Consensus 119 H~dikp~NIll~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 119 YRDLKPENILLDSQGHVVL----------------------------TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170 (323)
T ss_pred eCCCCHHHeEECCCCcEEE----------------------------eccCCCcccccCCCccccccCChhhcChhhhcC
Confidence 9999999999999988888 599988654333333445689999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 226 RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 226 ~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..++.++|+|||||++|+|++|..||.
T Consensus 171 ~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 171 QPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred CCCCccccccccchhhhhhhcCCCCCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=230.97 Aligned_cols=149 Identities=39% Similarity=0.667 Sum_probs=127.2
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ii 145 (255)
+....|+|+++++..+++.+..|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++||+
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~al~~lH~~giv 118 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----------RARFYAAEIASALGYLHSINIV 118 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCee
Confidence 45567999999999999999999999999999999888765554432 3445678899999999999999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN 225 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (255)
||||||+||+++.++.+++ +|||+++............+||+.|+|||++.+
T Consensus 119 H~Dlkp~NIll~~~~~~kL----------------------------~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05604 119 YRDLKPENILLDSQGHVVL----------------------------TDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170 (325)
T ss_pred ecCCCHHHeEECCCCCEEE----------------------------eecCCcccCCCCCCCcccccCChhhCCHHHHcC
Confidence 9999999999999988888 599988754333333445789999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 226 RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 226 ~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..++.++|+||+||++|+|++|..||..
T Consensus 171 ~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred CCCCCcCccccccceehhhhcCCCCCCC
Confidence 9999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=232.03 Aligned_cols=152 Identities=36% Similarity=0.669 Sum_probs=128.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+.+.+.+|+||||+.||+|...+.+...+++. .+..++.|++.||.|||+
T Consensus 45 e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL~~lH~ 113 (325)
T cd05594 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----------RARFYGAEIVSALDYLHS 113 (325)
T ss_pred HHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 345566778999999999999999999999999999999988765544432 345567889999999997
Q ss_pred -cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 -RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 -~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+||+||||||+||+++.++.+++ +|||+++..........+.+||+.|+||
T Consensus 114 ~~~ivHrDikp~NIll~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (325)
T cd05594 114 EKNVVYRDLKLENLMLDKDGHIKI----------------------------TDFGLCKEGIKDGATMKTFCGTPEYLAP 165 (325)
T ss_pred cCCEEecCCCCCeEEECCCCCEEE----------------------------ecCCCCeecCCCCcccccccCCcccCCH
Confidence 79999999999999999988888 5999886543333334456899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..++.++|+||+||++|+|++|..||.
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred HHHccCCCCCccccccccceeeeeccCCCCCC
Confidence 99999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=241.30 Aligned_cols=155 Identities=34% Similarity=0.560 Sum_probs=137.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHh-ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~-~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++.+.++|.||+++.+++..+.++-++||.++||+|.++++. .+++.+++ +.+.++.+||++||.|||
T Consensus 622 EIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNE---------stm~fYtkQILeGLkYLH 692 (1226)
T KOG4279|consen 622 EIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNE---------STMNFYTKQILEGLKYLH 692 (1226)
T ss_pred HHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccch---------hHHHHHHHHHHHHhhhhh
Confidence 46778899999999999999999999999999999999999974 45665443 356788899999999999
Q ss_pred HcCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
++.|+|||||-+|+|+.. .|.+|++ |||.|+.+...+..+.|+.||..|||
T Consensus 693 en~IVHRDIKGDNVLvNTySGvlKIS----------------------------DFGTsKRLAginP~TETFTGTLQYMA 744 (1226)
T KOG4279|consen 693 ENKIVHRDIKGDNVLVNTYSGVLKIS----------------------------DFGTSKRLAGINPCTETFTGTLQYMA 744 (1226)
T ss_pred hcceeeccccCCcEEEeeccceEEec----------------------------ccccchhhccCCccccccccchhhhC
Confidence 999999999999999864 5777774 99999999888888889999999999
Q ss_pred cccccC--CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKN--RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.. ++|+.++||||+||++.||.||.+||..
T Consensus 745 PEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 745 PEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred hHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 999964 6899999999999999999999999964
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=227.41 Aligned_cols=145 Identities=38% Similarity=0.655 Sum_probs=125.0
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+++.+..|+||||+.||+|...+.+...+++. .+..++.|++.||.|||++||+||||
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~~~ivHrDi 122 (321)
T cd05591 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP-----------RSRFYAAEVTLALMFLHRHGVIYRDL 122 (321)
T ss_pred CCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 6999999999999999999999999999999988766555432 23456778999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++............+||+.|+|||++.+..++
T Consensus 123 kp~Nill~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05591 123 KLDNILLDAEGHCKL----------------------------ADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG 174 (321)
T ss_pred CHHHeEECCCCCEEE----------------------------eecccceecccCCccccccccCccccCHHHHcCCCCC
Confidence 999999999988888 5999886543333334457899999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|+||+||++|+|++|..||..
T Consensus 175 ~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 175 PSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred CccceechhHHHHHHhcCCCCCCC
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=227.17 Aligned_cols=145 Identities=36% Similarity=0.657 Sum_probs=124.7
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+++++++..+++.+.+|+||||+.||+|...+.....+++. .+..++.|++.||.|||++||+||||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~~~ivHrDl 127 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-----------HAVFYAAEIAIGLFFLHSKGIIYRDL 127 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCEEecCC
Confidence 5788888999999999999999999999999998776555542 34456788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ .|||+++............+||+.|+|||++.+..++
T Consensus 128 kp~Nill~~~~~~kL----------------------------~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05616 128 KLDNVMLDSEGHIKI----------------------------ADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred CHHHeEECCCCcEEE----------------------------ccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCC
Confidence 999999999988888 4999887544333344467899999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|+||+||++|+|++|..||..
T Consensus 180 ~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 180 KSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred CccchhchhHHHHHHHhCCCCCCC
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=235.58 Aligned_cols=179 Identities=28% Similarity=0.504 Sum_probs=144.7
Q ss_pred HHHHHHHH--hCCCccc-CCCCcceeecccC-----ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHh
Q psy3182 34 IEALEYLH--TRGIVFR-DLKPENLLLDNRG-----YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE 105 (255)
Q Consensus 34 ~~~l~~lh--~~~i~~r-diK~~nil~~~~~-----~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~ 105 (255)
+.-|+++- ++|.|.+ .++-+.+.+++-+ ++|=+.+++|+||+.+..++.....+.++||||..|.|+.+|+.
T Consensus 126 IsELeWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka 205 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA 205 (904)
T ss_pred hhhhhhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc
Confidence 34445553 3555543 4555555444333 35557789999999999999999999999999999999999997
Q ss_pred ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceee
Q psy3182 106 RTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFI 185 (255)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 185 (255)
....... .+.....+|+.|+.|||.+.|||||||.-|||+..+..+|++
T Consensus 206 ~~~itp~-----------llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIs-------------------- 254 (904)
T KOG4721|consen 206 GRPITPS-----------LLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKIS-------------------- 254 (904)
T ss_pred cCccCHH-----------HHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEec--------------------
Confidence 6655432 233345679999999999999999999999999999988884
Q ss_pred eeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 186 ISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 186 ~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||.++..... .....++||..|||||+|+..+.+.|+||||+||+||||+||--|+.
T Consensus 255 --------DFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 255 --------DFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred --------cccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 99998877554 33457899999999999999999999999999999999999998875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=227.88 Aligned_cols=144 Identities=36% Similarity=0.664 Sum_probs=124.6
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+++.+.+|+||||+.||+|...+.+...+++ +.+..++.|++.||.|||++|++||||
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-----------~~~~~~~~qi~~al~~lH~~~ivHrDl 122 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE-----------EHARFYAAEICIALNFLHERGIIYRDL 122 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 589999999999999999999999999999988876555543 334567789999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+..++
T Consensus 123 kp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 123 KLDNVLLDADGHIKL----------------------------TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred CHHHEEEeCCCCEEE----------------------------eccccceeccCCCCceecccCCcccCCHHHHCCCCCC
Confidence 999999999888888 5999887543333334567899999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 230 RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~ 252 (255)
.++|+||+||++|+|++|..||.
T Consensus 175 ~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 175 FSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred chheeehhHHHHHHHHhCCCCCC
Confidence 99999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=229.46 Aligned_cols=148 Identities=35% Similarity=0.681 Sum_probs=128.1
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|+++++++..+++.+..|++|||+.||+|.+++.....+++. .+..++.|++.||.|||++
T Consensus 52 ~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~-----------~~~~~~~qi~~~l~~lH~~ 120 (333)
T cd05600 52 RDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----------HARFYMAEMFEAVDALHEL 120 (333)
T ss_pred HHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHC
Confidence 45566677999999999999999999999999999999999765554432 3345678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++||||||+||+++..+.+++ +|||+++.... ...+.+||+.|+|||+
T Consensus 121 ~ivH~dlkp~Nil~~~~~~~kL----------------------------~Dfg~a~~~~~---~~~~~~gt~~y~aPE~ 169 (333)
T cd05600 121 GYIHRDLKPENFLIDASGHIKL----------------------------TDFGLSKGIVT---YANSVVGSPDYMAPEV 169 (333)
T ss_pred CccccCCCHHHEEECCCCCEEE----------------------------EeCcCCccccc---ccCCcccCccccChhH
Confidence 9999999999999999888888 59998876533 2345689999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+||++|+|++|..||.
T Consensus 170 ~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred hcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=226.93 Aligned_cols=149 Identities=35% Similarity=0.633 Sum_probs=123.7
Q ss_pred eccccc-cccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 66 VSRKKK-TRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 66 ~~~~~h-~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
+....| +++++++..+.+.+.+|++|||+.||+|.+.+.....+++. .+..++.|++.||.|||++||
T Consensus 54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~-----------~~~~~~~qi~~al~~lH~~~i 122 (324)
T cd05587 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----------HAVFYAAEIAIGLFFLHSKGI 122 (324)
T ss_pred HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCe
Confidence 344444 45788889999999999999999999999998766555432 234567789999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~ 224 (255)
+||||||+||+++.++.+++ +|||+++............+||+.|+|||++.
T Consensus 123 vH~dlkp~Nill~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 123 IYRDLKLDNVMLDAEGHIKI----------------------------ADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred EecCCCHHHeEEcCCCCEEE----------------------------eecCcceecCCCCCceeeecCCccccChhhhc
Confidence 99999999999999888888 59998765433233344578999999999999
Q ss_pred CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 225 NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 225 ~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+..++.++|+||+||++|+|++|..||..
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=225.50 Aligned_cols=146 Identities=37% Similarity=0.672 Sum_probs=124.9
Q ss_pred ccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 69 KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
..|++++++++.+.+.+.+|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++|++|||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~-----------~~~~~~~qi~~al~~LH~~~ivHrd 121 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----------RATFYAAEIICGLQFLHSKGIVYRD 121 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 47999999999999999999999999999999999765444432 2345678899999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
|||+||+++.++.+++ .|||+++..........+.+||+.|+|||++.+..+
T Consensus 122 ikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05619 122 LKLDNILLDTDGHIKI----------------------------ADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173 (316)
T ss_pred CCHHHEEECCCCCEEE----------------------------ccCCcceECCCCCCceeeecCCccccCHHHHcCCCC
Confidence 9999999999888888 499987654333333446789999999999999999
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 229 DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.++|+||+||++|+|++|..||..
T Consensus 174 ~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 174 NTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CchhhhhhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=227.63 Aligned_cols=144 Identities=36% Similarity=0.670 Sum_probs=124.9
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+++.+..|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++||+||||
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~-----------~~~~i~~qi~~~l~~lH~~~ivH~Di 122 (329)
T cd05618 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----------HARFYSAEISLALNYLHERGIIYRDL 122 (329)
T ss_pred CCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 6999999999999999999999999999999888765544432 34556788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++............+||+.|+|||++.+..++
T Consensus 123 kp~Nili~~~~~~kL----------------------------~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05618 123 KLDNVLLDSEGHIKL----------------------------TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred CHHHEEECCCCCEEE----------------------------eeCCccccccCCCCccccccCCccccCHHHHcCCCCC
Confidence 999999999988888 5999887543333344467899999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 230 RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~ 252 (255)
.++|+||+||++|+|++|..||.
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 175 FSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccceecccHHHHHHhhCCCCCc
Confidence 99999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=232.05 Aligned_cols=149 Identities=32% Similarity=0.660 Sum_probs=124.4
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRG 143 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ 143 (255)
+++....|+++++++..+++.+..|++||||.||+|.++++.. .+++ ..+..++.|++.||.|||++|
T Consensus 95 ~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~-----------~~~~~~~~qi~~aL~~LH~~~ 162 (371)
T cd05622 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPE-----------KWARFYTAEVVLALDAIHSMG 162 (371)
T ss_pred HHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCH-----------HHHHHHHHHHHHHHHHHHHCC
Confidence 3455568999999999999999999999999999999988653 2332 234556788999999999999
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEI 222 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE~ 222 (255)
|+||||||+||+++.++.+++ +|||+++....... ...+.+||+.|||||+
T Consensus 163 ivHrDLkp~NIll~~~~~ikL----------------------------~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~ 214 (371)
T cd05622 163 FIHRDVKPDNMLLDKSGHLKL----------------------------ADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214 (371)
T ss_pred EEeCCCCHHHEEECCCCCEEE----------------------------EeCCceeEcCcCCcccccCcccCccccCHHH
Confidence 999999999999999988888 59998876543322 2345689999999999
Q ss_pred ccCCC----CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRG----HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~----~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+.. ++.++|+||+||++|+|++|..||.
T Consensus 215 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred HhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 97643 7889999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=226.10 Aligned_cols=149 Identities=38% Similarity=0.694 Sum_probs=126.5
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
++....|+|++++++.+.+....|+||||+.||+|...+.+ ..+++ ..+..++.|++.||.|||++|+
T Consensus 55 ~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~-----------~~~~~~~~qi~~al~~lH~~~i 122 (324)
T cd05589 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSE-----------PRAVFYAACVVLGLQYLHENKI 122 (324)
T ss_pred hccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCH-----------HHHHHHHHHHHHHHHHHHhCCe
Confidence 34567899999999999999999999999999999888764 23333 2334567889999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~ 224 (255)
+||||||+||+++.++.+++ +|||+++..........+.+||+.|||||++.
T Consensus 123 vHrdlkp~Nill~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 174 (324)
T cd05589 123 VYRDLKLDNLLLDTEGFVKI----------------------------ADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174 (324)
T ss_pred EecCCCHHHeEECCCCcEEe----------------------------CcccCCccCCCCCCcccccccCccccCHhHhc
Confidence 99999999999999988888 59998765443333445678999999999999
Q ss_pred CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 225 NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 225 ~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+..++.++|+||+||++|+|++|..||..
T Consensus 175 ~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred CCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=228.09 Aligned_cols=181 Identities=29% Similarity=0.446 Sum_probs=145.4
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc
Q psy3182 28 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT 107 (255)
Q Consensus 28 ~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~ 107 (255)
...+..+.|.+.|.++.|--|. -+.+-+.+ -+++++...+.+|.+-..|++.+.+.+||..+.||||--+|-..+
T Consensus 206 vraTGKMYAcKkL~KKRiKkr~--ge~maLnE---k~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g 280 (591)
T KOG0986|consen 206 VRATGKMYACKKLDKKRIKKRK--GETMALNE---KQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG 280 (591)
T ss_pred EecchhhHHHHHHHHHHHHHhh--hhHHhhHH---HHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC
Confidence 3345557777777776665442 23322222 345666677899999999999999999999999999977775544
Q ss_pred --CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceee
Q psy3182 108 --CFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFI 185 (255)
Q Consensus 108 --~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 185 (255)
.|++..+. +++++|+.||++||+.+|+.||+||+|||+++.|++.++
T Consensus 281 ~~gF~e~ra~-----------FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRIS-------------------- 329 (591)
T KOG0986|consen 281 NPGFDEQRAR-----------FYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRIS-------------------- 329 (591)
T ss_pred CCCCchHHHH-----------HHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEee--------------------
Confidence 67776654 555679999999999999999999999999999999995
Q ss_pred eeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 186 ISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 186 ~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+|+|.........+ ..+||.+|||||++.+..|+.++|||||||++|||+.|..||.-
T Consensus 330 --------DLGLAvei~~g~~~~-~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 330 --------DLGLAVEIPEGKPIR-GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred --------ccceEEecCCCCccc-cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 999987775544333 34899999999999998999999999999999999999999963
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=231.83 Aligned_cols=152 Identities=26% Similarity=0.465 Sum_probs=126.6
Q ss_pred CceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHh-ccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~-~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
.+|+|+.++.|+||++|.+...+. ..+|||+||+.. ||..++.. ...|++ ..+..+++|++.||+
T Consensus 165 REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~-----------~qIKc~mkQLl~Gl~ 232 (560)
T KOG0600|consen 165 REIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTE-----------PQIKCYMKQLLEGLE 232 (560)
T ss_pred HHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccCh-----------HHHHHHHHHHHHHHH
Confidence 468999999999999998865544 789999999864 88777764 223333 346778899999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPE 216 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~ 216 (255)
|||++||+|||||..|||++++|.+|+ .|||+|+........ ....+-|..
T Consensus 233 ~cH~~gvlHRDIK~SNiLidn~G~LKi----------------------------aDFGLAr~y~~~~~~~~T~rVvTLW 284 (560)
T KOG0600|consen 233 YCHSRGVLHRDIKGSNILIDNNGVLKI----------------------------ADFGLARFYTPSGSAPYTSRVVTLW 284 (560)
T ss_pred HHhhcCeeeccccccceEEcCCCCEEe----------------------------ccccceeeccCCCCcccccceEEee
Confidence 999999999999999999999999999 499999866554433 334567899
Q ss_pred CcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.|||.+.| ..|+.++|+||+|||+.||+.|.+.|.
T Consensus 285 YRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 285 YRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred ccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 999999988 579999999999999999999998664
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=234.05 Aligned_cols=165 Identities=28% Similarity=0.463 Sum_probs=141.2
Q ss_pred CCCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHH
Q psy3182 49 DLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDF 127 (255)
Q Consensus 49 diK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~ 127 (255)
++|.+.-|-+.--++.|++..+||++++|++.|.-.+.+||..|||.||-+..++..-+. ++ .+.++.
T Consensus 66 etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~Lt-----------E~QIqv 134 (1187)
T KOG0579|consen 66 ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLT-----------EDQIQV 134 (1187)
T ss_pred cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccc-----------hHHHHH
Confidence 556666666666678889999999999999999999999999999999999887765332 23 245778
Q ss_pred HHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc
Q psy3182 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK 207 (255)
Q Consensus 128 i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~ 207 (255)
++.|++.||.|||+++|||||||..|||+..+|.+++ +|||+|........+
T Consensus 135 vc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirL----------------------------ADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 135 VCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRL----------------------------ADFGVSAKNKSTRQK 186 (1187)
T ss_pred HHHHHHHHHHHHhhcchhhhhccccceEEEecCcEee----------------------------ecccccccchhHHhh
Confidence 8899999999999999999999999999999999988 599998766555566
Q ss_pred ccccccCCCCccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 208 TWTFCGTPEYVAPEIIK-----NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 208 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..+++|||+|||||++. ..+|+.++||||||++|.||..|-+|-.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 77899999999999975 4789999999999999999999988754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=228.89 Aligned_cols=153 Identities=38% Similarity=0.702 Sum_probs=131.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+++....|++|||+.||+|.+.+.+...+++ +.+..++.|++.||.|||+
T Consensus 48 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~qi~~~l~~lH~ 116 (318)
T cd05582 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-----------EDVKFYLAELALALDHLHS 116 (318)
T ss_pred HHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667788899999999999999999999999999999999876554443 2345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ .|||+++............+||+.|+|||
T Consensus 117 ~~i~H~dlkp~Nil~~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE 168 (318)
T cd05582 117 LGIIYRDLKPENILLDEEGHIKL----------------------------TDFGLSKESIDHEKKAYSFCGTVEYMAPE 168 (318)
T ss_pred CCEecCCCCHHHeEECCCCcEEE----------------------------eeccCCcccCCCCCceecccCChhhcCHH
Confidence 99999999999999999888887 59998876544434445678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 169 ~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred HHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 99998899999999999999999999999863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=223.99 Aligned_cols=145 Identities=37% Similarity=0.660 Sum_probs=123.5
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+++++++..+++.+.+|+||||+.||+|...+.+...+++. .+..++.|++.||.|||++|++||||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~-----------~~~~i~~qi~~al~~lH~~~ivHrDi 127 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----------QAVFYAAEISVGLFFLHRRGIIYRDL 127 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 3567778899999999999999999999999998776555543 23456788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ .|||+++............+||+.|+|||++.+..++
T Consensus 128 kp~Nill~~~~~ikL----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05615 128 KLDNVMLDSEGHIKI----------------------------ADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred CHHHeEECCCCCEEE----------------------------eccccccccCCCCccccCccCCccccCHHHHcCCCCC
Confidence 999999999888888 5999887544333334456799999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|+||+||++|+|++|..||..
T Consensus 180 ~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 180 KSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred CccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=235.87 Aligned_cols=152 Identities=29% Similarity=0.526 Sum_probs=128.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc----CCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT----CFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~----~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
++.+++...|+|++++++.+++.+..|+||||+.||+|.+.+..+. .++ ...+..++.|++.||.
T Consensus 115 E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~-----------~~~~~~i~~qi~~aL~ 183 (478)
T PTZ00267 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-----------EYEVGLLFYQIVLALD 183 (478)
T ss_pred HHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHH
Confidence 4556777899999999999999999999999999999998876421 122 1234557789999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~ 215 (255)
|+|+++|+||||||+||+++..+.+++ +|||+++....... ...+.+||+
T Consensus 184 ~lH~~~ivHrDlkp~NIll~~~~~~kL----------------------------~DFgla~~~~~~~~~~~~~~~~gt~ 235 (478)
T PTZ00267 184 EVHSRKMMHRDLKSANIFLMPTGIIKL----------------------------GDFGFSKQYSDSVSLDVASSFCGTP 235 (478)
T ss_pred HHHhCCEEECCcCHHhEEECCCCcEEE----------------------------EeCcCceecCCccccccccccCCCc
Confidence 999999999999999999999888888 59999876543221 234568999
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 236 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 236 YYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred cccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999999999986
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=219.32 Aligned_cols=152 Identities=28% Similarity=0.527 Sum_probs=135.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++...+.+.++++|.+|-..+.+|+|||||-.|++.++++.+. .+.| +.+..+.+..++||+|||
T Consensus 78 EISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E-----------~EIs~iL~~TLKGL~YLH 146 (502)
T KOG0574|consen 78 EISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSE-----------QEISAVLRDTLKGLQYLH 146 (502)
T ss_pred HHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccH-----------HHHHHHHHHHHhHHHHHH
Confidence 4556777788999999999988889999999999999999997543 3333 345566778899999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
...-||||||..|||+..+|..|+ .|||++.++.....++.+..|||+||||
T Consensus 147 ~~~KIHRDIKAGNILLNT~G~AKL----------------------------ADFGVAGQLTDTMAKRNTVIGTPFWMAP 198 (502)
T KOG0574|consen 147 DLKKIHRDIKAGNILLNTDGIAKL----------------------------ADFGVAGQLTDTMAKRNTVIGTPFWMAP 198 (502)
T ss_pred HHHHHHhhcccccEEEcccchhhh----------------------------hhccccchhhhhHHhhCccccCcccccH
Confidence 999999999999999999999998 4999999998888888899999999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++..-+|+.++||||||+...||..|.+|+.
T Consensus 199 EVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 199 EVIEEIGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred HHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence 99999999999999999999999999999975
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=229.63 Aligned_cols=151 Identities=32% Similarity=0.615 Sum_probs=124.8
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++....|+++++++..+++.+.+|++|||+.||+|.+++.+. .+++ +.+..++.|++.||.|||++
T Consensus 94 ~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~l~~-----------~~~~~~~~qi~~aL~~LH~~ 161 (370)
T cd05596 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPE-----------KWARFYTAEVVLALDAIHSM 161 (370)
T ss_pred HHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc-CCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 34456678999999999999999999999999999999988653 2332 23445677899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE 221 (255)
||+||||||+||+++.++.+++ +|||.+........ ...+.+||+.|+|||
T Consensus 162 ~ivHrDLkp~NILl~~~~~~kL----------------------------~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE 213 (370)
T cd05596 162 GFIHRDVKPDNMLLDKSGHLKL----------------------------ADFGTCMKMDANGMVRCDTAVGTPDYISPE 213 (370)
T ss_pred CeeccCCCHHHEEEcCCCCEEE----------------------------EeccceeeccCCCcccCCCCCCCcCeECHH
Confidence 9999999999999999998888 59998876543221 233568999999999
Q ss_pred cccCC----CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNR----GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~----~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+. .++.++|+||+||++|+|++|..||..
T Consensus 214 ~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred HhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 98753 378899999999999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=228.26 Aligned_cols=153 Identities=29% Similarity=0.632 Sum_probs=127.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+++.+..|+||||+.||+|.+++.+...+++ ..+..++.|++.||.|||+
T Consensus 51 e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~i~~qi~~aL~~LH~ 119 (350)
T cd05573 51 ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-----------ETARFYIAELVLALDSVHK 119 (350)
T ss_pred HHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34566777899999999999999999999999999999999987644443 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----------------
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---------------- 205 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---------------- 205 (255)
+|++||||||+||+++.++.+++. |||.+.......
T Consensus 120 ~giiH~Dlkp~NIll~~~~~~kL~----------------------------Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (350)
T cd05573 120 LGFIHRDIKPDNILIDADGHIKLA----------------------------DFGLCKKMNKAKDREYYLNDSHNLLFRD 171 (350)
T ss_pred CCeeccCCCHHHeEECCCCCEEee----------------------------cCCCCccCcccCcccccccccccccccc
Confidence 999999999999999999988885 555554332221
Q ss_pred -------------ccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 206 -------------CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 206 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.......||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred cccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 122346799999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=225.63 Aligned_cols=151 Identities=42% Similarity=0.722 Sum_probs=125.7
Q ss_pred eeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++... .|+++++++..+++.+.+|++|||+.||+|.+.+.++..+++ +.+..++.|++.||.|||+
T Consensus 55 ~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----------~~~~~~~~qi~~~l~~lH~ 123 (332)
T cd05614 55 RNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----------DEVRFYSGEIILALEHLHK 123 (332)
T ss_pred HHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 3445555 489999999999999999999999999999999987655543 2345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-CccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-GCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-~~~~~~~~gt~~y~aP 220 (255)
+||+||||||+||+++.++.+++ +|||+++..... .......+||+.||||
T Consensus 124 ~~ivHrDlkp~Nili~~~~~~kl----------------------------~DfG~~~~~~~~~~~~~~~~~gt~~y~aP 175 (332)
T cd05614 124 LGIVYRDIKLENILLDSEGHVVL----------------------------TDFGLSKEFLSEEKERTYSFCGTIEYMAP 175 (332)
T ss_pred CCcEecCCCHHHeEECCCCCEEE----------------------------eeCcCCccccccCCCccccccCCccccCH
Confidence 99999999999999999888888 599988754322 2233456899999999
Q ss_pred ccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+. .++.++|+||+||++|+|++|..||.
T Consensus 176 E~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred HHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 999875 57889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=227.30 Aligned_cols=144 Identities=38% Similarity=0.640 Sum_probs=123.4
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+++++++..+++.+.+|++|||+.||+|...+.+...+++. .+..++.|++.||.|||++||+||||
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~qil~al~~LH~~~ivHrDl 122 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----------RAKFYIAELVLALEHLHKYDIVYRDL 122 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeEeccC
Confidence 6999999999999999999999999999999998876655542 34557788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC-CCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGH 228 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 228 (255)
||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+ ..+
T Consensus 123 kp~Nili~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (330)
T cd05586 123 KPENILLDATGHIAL----------------------------CDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174 (330)
T ss_pred CHHHeEECCCCCEEE----------------------------ecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCC
Confidence 999999999888887 599988654333333446789999999999975 458
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 229 DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.++|+||+||++|+|++|..||.
T Consensus 175 ~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 175 TKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred CCccceeccccEEEEeccCCCCCC
Confidence 899999999999999999999985
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=216.25 Aligned_cols=155 Identities=25% Similarity=0.371 Sum_probs=127.4
Q ss_pred ceeeeccccccc-cccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTR-QTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 62 ~vkl~~~~~h~~-iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
++-++..+.|+| ++++++.+.+.+ .+|+++||+. -||-.++....... .......++.+++|++.
T Consensus 60 Eisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-------~g~~~~~ik~~m~Qll~ 131 (323)
T KOG0594|consen 60 EISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKP-------QGLPPRLIKSFMRQLLR 131 (323)
T ss_pred HHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccc-------cCCCHHHHHHHHHHHHH
Confidence 345677888998 999999998877 8999999984 47887776543211 00111456788999999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
||.|||+++|+||||||+|++++..|.+|+ +|||+|+..+.........++|
T Consensus 132 gl~~~H~~~IlHRDLKPQNlLi~~~G~lKl----------------------------aDFGlAra~~ip~~~yt~evvT 183 (323)
T KOG0594|consen 132 GLAFLHSHGILHRDLKPQNLLISSSGVLKL----------------------------ADFGLARAFSIPMRTYTPEVVT 183 (323)
T ss_pred HHHHHHhCCeecccCCcceEEECCCCcEee----------------------------eccchHHHhcCCcccccccEEE
Confidence 999999999999999999999999999999 5999998776554445567899
Q ss_pred CCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..|.|||++.+. .|+..+||||+|||++||+++.+-|.
T Consensus 184 lWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp 222 (323)
T KOG0594|consen 184 LWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP 222 (323)
T ss_pred eeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence 999999999885 79999999999999999999887654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=221.49 Aligned_cols=145 Identities=38% Similarity=0.689 Sum_probs=124.6
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+.+.+.+|++|||+.||+|...+.+...+++. .+..++.|++.||.|||+++++||||
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-----------~~~~~~~qi~~~l~~LH~~~ivH~dl 122 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----------RARFYAAEIVLGLQFLHERGIIYRDL 122 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHhCCeEccCC
Confidence 6999999999999999999999999999999988766555433 33456788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ .|||+++............+||+.|+|||++.+..++
T Consensus 123 kp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 174 (318)
T cd05570 123 KLDNVLLDSEGHIKI----------------------------ADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174 (318)
T ss_pred CHHHeEECCCCcEEe----------------------------cccCCCeecCcCCCcccceecCccccCHHHhcCCCCC
Confidence 999999999988888 4999876533333334456899999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|+||+||++|+|++|..||..
T Consensus 175 ~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 175 PAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred cchhhhhHHHHHHHHhhCCCCCCC
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=214.32 Aligned_cols=151 Identities=23% Similarity=0.390 Sum_probs=126.4
Q ss_pred ceeeeccccccccccccccc--cCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTF--KDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~--~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++.+..|+||+.+-+.. .+-+.+|||||||.. ||.+++.... +|.. .++..+..|++.|++|
T Consensus 125 EIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~-----------~evK~L~~QlL~glk~ 192 (419)
T KOG0663|consen 125 EINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLP-----------GEVKTLMLQLLRGLKH 192 (419)
T ss_pred HHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCch-----------HHHHHHHHHHHHHHHH
Confidence 45567778899999987754 455679999999965 8888886543 3333 3456778899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
||.+.|+||||||+|+|+...|.+|+ +|||+|+..+.........+-|..|.
T Consensus 193 lH~~wilHRDLK~SNLLm~~~G~lKi----------------------------aDFGLAR~ygsp~k~~T~lVVTLWYR 244 (419)
T KOG0663|consen 193 LHDNWILHRDLKTSNLLLSHKGILKI----------------------------ADFGLAREYGSPLKPYTPLVVTLWYR 244 (419)
T ss_pred HhhceeEecccchhheeeccCCcEEe----------------------------cccchhhhhcCCcccCcceEEEeeec
Confidence 99999999999999999999999999 59999999887766666677899999
Q ss_pred ccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||.+.+ ..|+.++|+||+|||+.||+++.+-|.
T Consensus 245 aPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 245 APELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred CHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 9999987 679999999999999999999987654
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=224.50 Aligned_cols=150 Identities=33% Similarity=0.573 Sum_probs=127.8
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.+.-..|||++++|++..+++.+|+++|.-.||||+++|-++. .+.| +..+.+++||+.|+.|||+
T Consensus 68 VRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E-----------~La~kYF~QI~~AI~YCHq 136 (864)
T KOG4717|consen 68 VRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNE-----------DLAKKYFAQIVHAISYCHQ 136 (864)
T ss_pred HHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccH-----------HHHHHHHHHHHHHHHHHhh
Confidence 444555679999999999999999999999999999999987643 2332 3345678899999999999
Q ss_pred cCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
-.++||||||+|+.+.. -|.+|+ .|||++..... +.+..+.||+..|-||
T Consensus 137 LHVVHRDLKPENVVFFEKlGlVKL----------------------------TDFGFSNkf~P-G~kL~TsCGSLAYSAP 187 (864)
T KOG4717|consen 137 LHVVHRDLKPENVVFFEKLGLVKL----------------------------TDFGFSNKFQP-GKKLTTSCGSLAYSAP 187 (864)
T ss_pred hhhhcccCCcceeEEeeecCceEe----------------------------eeccccccCCC-cchhhcccchhhccCc
Confidence 99999999999987654 577787 49999977654 4567789999999999
Q ss_pred ccccCCCCC-CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHD-RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~-~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..|+ +++||||||||+|-|.+|..||.
T Consensus 188 EILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 188 EILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred hhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 999999887 57899999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=218.05 Aligned_cols=151 Identities=28% Similarity=0.474 Sum_probs=126.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++....|+++++++..+.+.+..+++|||+.||+|...+.... .+++ ..+..++.|++.||.||
T Consensus 50 E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~-----------~~~~~~~~qi~~~l~~l 118 (285)
T cd05631 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE-----------QRAIFYAAELCCGLEDL 118 (285)
T ss_pred HHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 4667778889999999999999999999999999999988775432 1222 23445678899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|+++|+||||||+||+++.++.+++ .|||++....... .....+||+.|+|
T Consensus 119 H~~~iiH~dikp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~g~~~y~a 169 (285)
T cd05631 119 QRERIVYRDLKPENILLDDRGHIRI----------------------------SDLGLAVQIPEGE-TVRGRVGTVGYMA 169 (285)
T ss_pred HhCCEEeCCCCHHHEEECCCCCEEE----------------------------eeCCCcEEcCCCC-eecCCCCCCCccC
Confidence 9999999999999999998888887 5999887653322 2234579999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++|..||.
T Consensus 170 PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred HhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=216.34 Aligned_cols=156 Identities=29% Similarity=0.481 Sum_probs=127.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+++++++..+.+...+|++|||+.||+|...+........ ......+..++.|++.||.|||+
T Consensus 43 E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~ 115 (280)
T cd05608 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP-------GFPEPRACFYTAQIISGLEHLHQ 115 (280)
T ss_pred HHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999887743211000 01122345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++|+||||||+||+++.++.+++ +|||.+..............||+.|+|||
T Consensus 116 ~~i~H~dlkp~Nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~g~~~y~aPE 167 (280)
T cd05608 116 RRIIYRDLKPENVLLDNDGNVRI----------------------------SDLGLAVELKDGQSKTKGYAGTPGFMAPE 167 (280)
T ss_pred CCcccCCCCHHHEEECCCCCEEE----------------------------eeCccceecCCCCccccccCCCcCccCHH
Confidence 99999999999999998888877 59998876544433344568999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 168 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=249.00 Aligned_cols=155 Identities=33% Similarity=0.583 Sum_probs=129.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++++..++|||++++|..--+.+.+|+.||||.||+|.+.+......+|. ..+.+..|+++|+.|||
T Consensus 1283 eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~-----------vt~vyt~qll~gla~LH 1351 (1509)
T KOG4645|consen 1283 EEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEM-----------VTRVYTKQLLEGLAYLH 1351 (1509)
T ss_pred HHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhh-----------HHHHHHHHHHHHHHHHH
Confidence 3467788999999999999999999999999999999999998764433432 23556778999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----ccccccccCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----CKTWTFCGTPE 216 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~~~~~~~gt~~ 216 (255)
++||+|||+||+||+++.+|.+|+. |||.|....... .......|||.
T Consensus 1352 ~~gIVHRDIK~aNI~Ld~~g~iK~~----------------------------DFGsa~ki~~~~~~~~~el~~~~GT~~ 1403 (1509)
T KOG4645|consen 1352 EHGIVHRDIKPANILLDFNGLIKYG----------------------------DFGSAVKIKNNAQTMPGELQSMMGTPM 1403 (1509)
T ss_pred hcCceecCCCccceeeecCCcEEee----------------------------cccceeEecCchhcCCHHHHhhcCCch
Confidence 9999999999999999999999984 777665543321 12335789999
Q ss_pred CcccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 217 YVAPEIIKN---RGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 217 y~aPE~~~~---~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
|||||++.+ .+...+.|||||||++.||+||..|+..|
T Consensus 1404 YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1404 YMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred hcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 999999975 56888999999999999999999998754
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=220.75 Aligned_cols=150 Identities=25% Similarity=0.452 Sum_probs=126.5
Q ss_pred Cceeeecccc-ccccccccccccCcc-ceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKK-KTRQTRLYKTFKDSK-YVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 61 ~~vkl~~~~~-h~~iv~l~~~~~~~~-~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
.++|-+.++. |+|++++++.+.+.+ .+|+||||+.. +|+++++.+.. |++ +.++.|+.||+.||+
T Consensus 57 REvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse-----------~~irnim~QilqGL~ 124 (538)
T KOG0661|consen 57 REVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSE-----------SDIRNIMYQILQGLA 124 (538)
T ss_pred HHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCH-----------HHHHHHHHHHHHHHH
Confidence 3466677777 999999999999988 99999998865 79999987643 333 457788999999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
|+|.+|+.|||+||||||+..+..+|+ +|||+|+....... ...++.|..|
T Consensus 125 hiHk~GfFHRDlKPENiLi~~~~~iKi----------------------------aDFGLARev~SkpP-YTeYVSTRWY 175 (538)
T KOG0661|consen 125 HIHKHGFFHRDLKPENILISGNDVIKI----------------------------ADFGLAREVRSKPP-YTEYVSTRWY 175 (538)
T ss_pred HHHhcCcccccCChhheEecccceeEe----------------------------cccccccccccCCC-cchhhhcccc
Confidence 999999999999999999998888888 49999998765443 3357899999
Q ss_pred cccccccC-CCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 218 VAPEIIKN-RGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 218 ~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
+|||++.. ..|+.++|+||+||+++|+.+=.+-|
T Consensus 176 RAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 176 RAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred cchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 99999875 56899999999999999998766544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=217.17 Aligned_cols=153 Identities=22% Similarity=0.360 Sum_probs=125.9
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++.++..+.|+|++++++.+.+.+..|++|||+.| +|.+.+...... .....+..++.|++.||.|||
T Consensus 52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~----------~~~~~~~~~~~qi~~aL~~LH 120 (288)
T cd07871 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNL----------MSMHNVKIFMFQLLRGLSYCH 120 (288)
T ss_pred HHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCC----------CCHHHHHHHHHHHHHHHHHHH
Confidence 356778888999999999999999999999999975 888888653321 012334567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ +|||.++.............||+.|+||
T Consensus 121 ~~~ivH~dlkp~Nil~~~~~~~kl----------------------------~DfG~~~~~~~~~~~~~~~~~~~~y~aP 172 (288)
T cd07871 121 KRKILHRDLKPQNLLINEKGELKL----------------------------ADFGLARAKSVPTKTYSNEVVTLWYRPP 172 (288)
T ss_pred hCCcccCCCCHHHEEECCCCCEEE----------------------------CcCcceeeccCCCccccCceecccccCh
Confidence 999999999999999999888888 4999887654333333456789999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 173 E~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred HHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99875 568999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-31 Score=229.63 Aligned_cols=152 Identities=32% Similarity=0.603 Sum_probs=135.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.||||+++|.....+..+|+||||+.||++++++.+.+...+..+ +.++.|++.|++|||
T Consensus 104 rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~a-----------r~~F~q~vsaveYcH 172 (596)
T KOG0586|consen 104 REVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEA-----------RAKFRQIVSAVEYCH 172 (596)
T ss_pred HHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhh-----------hhhhHHHHHHHHHHh
Confidence 346677788999999999999999999999999999999999999887766433 446678999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++|+|||||.+|++++.+..+|+ .|||+|..+. .+....++||+|.|.||
T Consensus 173 ~k~ivHrdLk~eNilL~~~mnikI----------------------------aDfgfS~~~~-~~~~lqt~cgsppyAaP 223 (596)
T KOG0586|consen 173 SKNIVHRDLKAENILLDENMNIKI----------------------------ADFGFSTFFD-YGLMLQTFCGSPPYAAP 223 (596)
T ss_pred hcceeccccchhhcccccccceee----------------------------eccccceeec-ccccccccCCCCCccCh
Confidence 999999999999999999988888 4999998776 34566789999999999
Q ss_pred ccccCCCCC-CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHD-RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~-~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+..+..|+ +.+|+||+|+++|.|++|.-||+
T Consensus 224 El~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 224 ELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred HhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 999998875 67999999999999999999997
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=218.01 Aligned_cols=152 Identities=21% Similarity=0.367 Sum_probs=124.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++..+.|+|++++++.+.+....|++|||+. +++.+.+.+.. .++ .+.+..++.|++.||.|||
T Consensus 53 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~-----------~~~~~~~~~qi~~al~~lH 120 (303)
T cd07869 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLH-----------PENVKLFLFQLLRGLSYIH 120 (303)
T ss_pred HHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4667778899999999999999999999999995 67877776532 222 2334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ .|||.++............+||+.|+||
T Consensus 121 ~~~ivH~dlkp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 172 (303)
T cd07869 121 QRYILHRDLKPQNLLISDTGELKL----------------------------ADFGLARAKSVPSHTYSNEVVTLWYRPP 172 (303)
T ss_pred HCCeecCCCCHHHEEECCCCCEEE----------------------------CCCCcceeccCCCccCCCCcccCCCCCh
Confidence 999999999999999999888888 4999876543333333446789999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 173 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99876 4588899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=223.32 Aligned_cols=150 Identities=29% Similarity=0.570 Sum_probs=124.2
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
.++....|+++++++..+++.+..|++|||+.||+|.+++.+. ..+++ +.+..++.|++.||.|+|++
T Consensus 53 ~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~-----------~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 53 NVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE-----------DMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred HHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 3455567999999999999999999999999999999999763 33332 23455678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE 221 (255)
||+||||||+||+++.++.+++ +|||+++....... .....+||+.|+|||
T Consensus 122 ~iiHrDlkp~Nill~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE 173 (331)
T cd05624 122 HYVHRDIKPDNVLLDMNGHIRL----------------------------ADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173 (331)
T ss_pred CeeeccCchHHEEEcCCCCEEE----------------------------EeccceeeccCCCceeeccccCCcccCCHH
Confidence 9999999999999999888888 59998876544322 223467999999999
Q ss_pred cccC-----CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN-----RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~-----~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 174 ~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred HHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 9875 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=224.70 Aligned_cols=151 Identities=25% Similarity=0.380 Sum_probs=125.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.|......++++|++. ++|...+.....++. ..+..++.|++.||.|||+
T Consensus 133 E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~-----------~~~~~i~~qi~~aL~ylH~ 200 (391)
T PHA03212 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAI-----------CDILAIERSVLRAIQYLHE 200 (391)
T ss_pred HHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 5677888999999999999999999999999985 688888876544332 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-CccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-GCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-~~~~~~~~gt~~y~aP 220 (255)
+||+||||||+||+++..+.+++ +|||+++..... .......+||+.|+||
T Consensus 201 ~~IvHrDiKP~NIll~~~~~vkL----------------------------~DFG~a~~~~~~~~~~~~~~~gt~~y~aP 252 (391)
T PHA03212 201 NRIIHRDIKAENIFINHPGDVCL----------------------------GDFGAACFPVDINANKYYGWAGTIATNAP 252 (391)
T ss_pred CCcccCCCChHhEEEcCCCCEEE----------------------------EeCCcccccccccccccccccCccCCCCh
Confidence 99999999999999999888887 599988643221 2233456899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..++.++|+||+||++|+|++|..||.
T Consensus 253 E~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 253 ELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 99999999999999999999999999997753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=221.44 Aligned_cols=152 Identities=30% Similarity=0.563 Sum_probs=124.0
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+.++....|+++++++..+++..++|+||||+.||+|.+++.+. ..+++ +.+..++.|++.||.|||+
T Consensus 52 ~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~-----------~~~~~~~~qi~~~l~~lH~ 120 (331)
T cd05597 52 RDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE-----------DMARFYLAEMVLAIDSVHQ 120 (331)
T ss_pred HHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 34455668999999999999999999999999999999998753 22332 2345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
++|+||||||+||+++.++.+++ +|||++........ .....+||+.||||
T Consensus 121 ~~ivH~dlkp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP 172 (331)
T cd05597 121 LGYVHRDIKPDNVLLDKNGHIRL----------------------------ADFGSCLRLLADGTVQSNVAVGTPDYISP 172 (331)
T ss_pred CCeEECCCCHHHEEECCCCCEEE----------------------------EECCceeecCCCCCccccceeccccccCH
Confidence 99999999999999999888888 59998765543222 22235799999999
Q ss_pred ccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKN-----RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~-----~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.. ..++.++|+||+||++|+|++|..||..
T Consensus 173 E~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred HHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 99973 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=221.72 Aligned_cols=150 Identities=29% Similarity=0.553 Sum_probs=123.5
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
.++....|+++++++..+++.+.+|+||||+.||+|.+++.+. ..+++ ..+..++.|++.||.|||++
T Consensus 53 ~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~-----------~~~~~~~~qi~~al~~lH~~ 121 (332)
T cd05623 53 DVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE-----------DMARFYLAEMVIAIDSVHQL 121 (332)
T ss_pred HHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 3455668999999999999999999999999999999999763 23332 23456778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE 221 (255)
+|+||||||+||+++.++.+++ .|||++........ .....+||+.|+|||
T Consensus 122 ~iiHrDlkp~Nili~~~~~~kL----------------------------~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE 173 (332)
T cd05623 122 HYVHRDIKPDNILMDMNGHIRL----------------------------ADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173 (332)
T ss_pred CeEecCCCHHHEEECCCCCEEE----------------------------eecchheecccCCcceecccccCccccCHH
Confidence 9999999999999998888888 59998865433222 223467999999999
Q ss_pred ccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIK-----NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++. ...++.++|+||+||++|+|++|..||.
T Consensus 174 ~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred HHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 986 3468889999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=204.95 Aligned_cols=179 Identities=23% Similarity=0.361 Sum_probs=142.5
Q ss_pred HHHHHHHHhCCCcccCCCCccee----ecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCC
Q psy3182 34 IEALEYLHTRGIVFRDLKPENLL----LDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCF 109 (255)
Q Consensus 34 ~~~l~~lh~~~i~~rdiK~~nil----~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~ 109 (255)
.+|.+....+.|+.+.||..|.- ...-.++|++..++|+|++.+.+.|-+.+.+.+|+||++ .||...++.....
T Consensus 19 yka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~ 97 (318)
T KOG0659|consen 19 YKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNII 97 (318)
T ss_pred EEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccc
Confidence 33433444456667777776532 333357899999999999999999999999999999985 5888888754321
Q ss_pred CccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCC
Q psy3182 110 DDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG 189 (255)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (255)
.....+..++.++++|++|||++.|+|||+||.|+|++.+|.+|+
T Consensus 98 ----------l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKi------------------------- 142 (318)
T KOG0659|consen 98 ----------LSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKI------------------------- 142 (318)
T ss_pred ----------cCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEe-------------------------
Confidence 122346677888999999999999999999999999999999999
Q ss_pred eeeeeccccccCCCCCccccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 190 QVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 190 ~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
.|||+++..+.........+-|..|.|||.+.| +.|+..+|+||+||++.||+-|.+=|
T Consensus 143 ---ADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f 202 (318)
T KOG0659|consen 143 ---ADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF 202 (318)
T ss_pred ---ecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence 499999887665443333477899999999977 68999999999999999999988643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=212.24 Aligned_cols=155 Identities=25% Similarity=0.370 Sum_probs=127.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|+|++++++.+++....|++|||+.||+|.+.+........ ..+.+..++.|++.||.|||+
T Consensus 43 E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~---------~~~~~~~~~~qi~~al~~lH~ 113 (277)
T cd05607 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL---------EMERVIHYSAQITCGILHLHS 113 (277)
T ss_pred HHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCC---------CHHHHHHHHHHHHHHHHHHHH
Confidence 34567778899999999999999999999999999999888764332111 122344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+....... ......||+.|+|||
T Consensus 114 ~~ivH~dikp~Nili~~~~~~~l----------------------------~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE 164 (277)
T cd05607 114 MDIVYRDMKPENVLLDDQGNCRL----------------------------SDLGLAVELKDGK-TITQRAGTNGYMAPE 164 (277)
T ss_pred CCEEEccCChHhEEEcCCCCEEE----------------------------eeceeeeecCCCc-eeeccCCCCCccCHH
Confidence 99999999999999999888877 5999876654322 222357899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
++.+..++.++|+||+||++|+|++|..||..+
T Consensus 165 ~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred HHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 999888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=213.42 Aligned_cols=153 Identities=25% Similarity=0.419 Sum_probs=125.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++....|+|++++++.+++.+.+|++|||+.++.+..+......+++ +.+..++.|++.||.|||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~qi~~~L~~lH 117 (287)
T cd07848 49 RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-----------EKVRSYIYQLIKAIHWCH 117 (287)
T ss_pred HHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 356677888999999999999999999999999999876554433222222 334567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~a 219 (255)
+++++||||||+||+++.++.+++ .|||.+....... .......||+.|+|
T Consensus 118 ~~~i~H~dlkp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 169 (287)
T cd07848 118 KNDIVHRDIKPENLLISHNDVLKL----------------------------CDFGFARNLSEGSNANYTEYVATRWYRS 169 (287)
T ss_pred HCCeecCCCCHHHEEEcCCCcEEE----------------------------eeccCcccccccccccccccccccccCC
Confidence 999999999999999999888887 4999887654322 12234579999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++|..||.
T Consensus 170 PE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 170 PELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred cHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 999998889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=221.92 Aligned_cols=151 Identities=30% Similarity=0.563 Sum_probs=125.7
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++....|+++++++..+++.+..|++|||+.||+|.+++.+. ..+++ +.+..++.|++.||.|||+
T Consensus 52 ~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~-----------~~~~~~~~qi~~aL~~lH~ 120 (330)
T cd05601 52 RDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE-----------DMAQFYLAELVLAIHSVHQ 120 (330)
T ss_pred HHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45566678999999999999999999999999999999999765 33333 2345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
++|+||||||+||+++..+.+++ +|||.+........ .....+||+.|+||
T Consensus 121 ~~i~H~Dlkp~NIll~~~~~~kL----------------------------~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 172 (330)
T cd05601 121 MGYVHRDIKPENVLIDRTGHIKL----------------------------ADFGSAARLTANKMVNSKLPVGTPDYIAP 172 (330)
T ss_pred CCeEcccCchHheEECCCCCEEe----------------------------ccCCCCeECCCCCceeeecccCCccccCH
Confidence 99999999999999999988888 59998876543322 22335799999999
Q ss_pred cccc------CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIK------NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~------~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++. ...++.++|+||+||++|+|++|..||.
T Consensus 173 E~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred HHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 9986 4567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=217.63 Aligned_cols=164 Identities=21% Similarity=0.370 Sum_probs=123.1
Q ss_pred ceeeeccc-cccccccccccccC-ccceeehhhhhcchhHHHHHHhccCC----Cccch---------------------
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKD-SKYVYMLLEACLGGEVWTILRERTCF----DDNAA--------------------- 114 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~-~~~~ylv~E~~~gg~l~~~l~~~~~~----~~~~~--------------------- 114 (255)
+++++... .|+|++++++.+.+ ...+|++|||+.||+|.+++...... .+...
T Consensus 60 E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (338)
T cd05102 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEA 139 (338)
T ss_pred HHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccccc
Confidence 45566666 79999999987765 44689999999999999998753211 00000
Q ss_pred --------------------------hhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccC
Q psy3182 115 --------------------------SFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYP 168 (255)
Q Consensus 115 --------------------------~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~ 168 (255)
.+......+.+..++.|++.||.|||++||+||||||+||+++.++.+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl---- 215 (338)
T cd05102 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI---- 215 (338)
T ss_pred ccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEE----
Confidence 00011223345567889999999999999999999999999998888887
Q ss_pred CcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc
Q psy3182 169 AGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246 (255)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~ 246 (255)
.|||+++....... ...+..+++.|+|||++.+..++.++|+||+||++|||++
T Consensus 216 ------------------------~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 216 ------------------------CDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred ------------------------eecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 59998875432211 1223346678999999999899999999999999999996
Q ss_pred -CCCCCcC
Q psy3182 247 -GMKESNV 253 (255)
Q Consensus 247 -G~~~~~~ 253 (255)
|..||..
T Consensus 272 ~g~~pf~~ 279 (338)
T cd05102 272 LGASPYPG 279 (338)
T ss_pred CCCCCCCC
Confidence 9988863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=216.92 Aligned_cols=161 Identities=26% Similarity=0.420 Sum_probs=122.0
Q ss_pred CceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++++.++.|+|++++++.+.+ +..+|+++||+. +++++++.......... .......+.+..++.|++.||.|
T Consensus 47 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~al~~ 123 (317)
T cd07868 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANK--KPVQLPRGMVKSLLYQILDGIHY 123 (317)
T ss_pred HHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccC--CcccCCHHHHHHHHHHHHHHHHH
Confidence 45778888999999999998743 567899999985 58888776432111100 00112234567788999999999
Q ss_pred HHHcCcccccCCCCceeeC----CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC---cccccc
Q psy3182 139 LHTRGIVFRDLKPENLLLD----NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---CKTWTF 211 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---~~~~~~ 211 (255)
||++||+||||||+||++. ..+.+++ .|||.++...... ......
T Consensus 124 LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~ 175 (317)
T cd07868 124 LHANWVLHRDLKPANILVMGEGPERGRVKI----------------------------ADMGFARLFNSPLKPLADLDPV 175 (317)
T ss_pred HHhCCEEcCCCCHHHEEEecCCCCcCcEEE----------------------------eecCceeccCCCCccccccCCc
Confidence 9999999999999999994 3445666 5999887654321 122346
Q ss_pred ccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 79999999999977 468999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=210.39 Aligned_cols=152 Identities=26% Similarity=0.489 Sum_probs=126.4
Q ss_pred CceeeeccccccccccccccccC-----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD-----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~-----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
.++|++.+.+|+|++.+++.+.. -+-+|+|+|++ +.||..+++.+..+++. -.+++..|++.|
T Consensus 70 RElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~-----------H~q~f~YQiLrg 137 (359)
T KOG0660|consen 70 RELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDD-----------HAQYFLYQILRG 137 (359)
T ss_pred HHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHH-----------HHHHHHHHHHHh
Confidence 35788889999999999887765 45689999987 78999999876655443 345677889999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--Ccccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~g 213 (255)
|.|+|+.+|+||||||.|++++.+..+|+ .|||+|+..... .......+-
T Consensus 138 LKyiHSAnViHRDLKPsNll~n~~c~lKI----------------------------~DFGLAR~~~~~~~~~~mTeYVa 189 (359)
T KOG0660|consen 138 LKYIHSANVIHRDLKPSNLLLNADCDLKI----------------------------CDFGLARYLDKFFEDGFMTEYVA 189 (359)
T ss_pred cchhhcccccccccchhheeeccCCCEEe----------------------------ccccceeeccccCcccchhccee
Confidence 99999999999999999999999988888 499999877432 222345678
Q ss_pred CCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|..|.|||++.. ..|+.++||||+|||+.||++|.+-|.
T Consensus 190 TRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 190 TRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred eeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 999999999865 789999999999999999999997654
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=225.15 Aligned_cols=161 Identities=25% Similarity=0.432 Sum_probs=125.2
Q ss_pred ceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++.+++|+|||++++.-++.. .-.++||||.||||+..+++- |+.. .....++..+..++..|
T Consensus 61 EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P----EN~~----GLpE~e~l~lL~d~~~a 132 (732)
T KOG4250|consen 61 EIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP----ENAY----GLPESEFLDLLSDLVSA 132 (732)
T ss_pred HHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc----cccc----CCCHHHHHHHHHHHHHH
Confidence 356788889999999998766654 458999999999999999741 1111 11122344466779999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
+.|||++||+||||||.||++..... +..++ +..|||.|+.+.... ...+++||+
T Consensus 133 l~~LrEn~IvHRDlKP~NIvl~~Ged------------------gq~Iy------KLtDfG~Arel~d~s-~~~S~vGT~ 187 (732)
T KOG4250|consen 133 LRHLRENGIVHRDLKPGNIVLQIGED------------------GQSIY------KLTDFGAARELDDNS-LFTSLVGTE 187 (732)
T ss_pred HHHHHHcCceeccCCCCcEEEeecCC------------------CceEE------eeecccccccCCCCC-eeeeecCch
Confidence 99999999999999999998754321 11111 125999999887654 555789999
Q ss_pred CCccccccc-CCCCCCcchHHHHHHHHHHHhcCCCCCcCCC
Q psy3182 216 EYVAPEIIK-NRGHDRAVDYWALGILMHELLTGMKESNVFQ 255 (255)
Q Consensus 216 ~y~aPE~~~-~~~~~~~~DiWslGvil~ell~G~~~~~~~~ 255 (255)
.|++||+.. ++.|+..+|.||+||++|+.+||..||..|+
T Consensus 188 ~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 188 EYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred hhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 999999998 5889999999999999999999999998874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=215.36 Aligned_cols=150 Identities=28% Similarity=0.488 Sum_probs=127.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++|||+.||+|.+++.+...+++ ..+..++.|++.||.|||+
T Consensus 53 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~ 121 (331)
T cd06649 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-----------EILGKVSIAVLRGLAYLRE 121 (331)
T ss_pred HHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHhh
Confidence 45667788899999999999999999999999999999999976544432 2345567789999999998
Q ss_pred c-CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 R-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~-~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+ +|+||||||+||+++.++.+++ .|||++...... ......||+.|+||
T Consensus 122 ~~~ivH~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~--~~~~~~g~~~y~aP 171 (331)
T cd06649 122 KHQIMHRDVKPSNILVNSRGEIKL----------------------------CDFGVSGQLIDS--MANSFVGTRSYMSP 171 (331)
T ss_pred cCCEEcCCCChhhEEEcCCCcEEE----------------------------ccCccccccccc--ccccCCCCcCcCCH
Confidence 6 6999999999999999888887 499988665332 22346799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..++.++|+||+||++|+|++|..||.
T Consensus 172 E~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred hHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999899999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=216.37 Aligned_cols=151 Identities=24% Similarity=0.404 Sum_probs=120.8
Q ss_pred ceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++..++|+|++++++.+... ..+|++|||| +++|.+.+.+...+++ +.+..++.|++.||
T Consensus 49 E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~aL 116 (338)
T cd07859 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTP-----------EHHQFFLYQLLRAL 116 (338)
T ss_pred HHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCH-----------HHHHHHHHHHHHHH
Confidence 45677788899999998776432 3589999999 4689888876544433 33456778999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---ccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~g 213 (255)
.|||++||+||||||+||+++.++.+++ .|||+++....... .....+|
T Consensus 117 ~~LH~~~ivH~dlkp~NIll~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd07859 117 KYIHTANVFHRDLKPKNILANADCKLKI----------------------------CDFGLARVAFNDTPTAIFWTDYVA 168 (338)
T ss_pred HHHHHCCeecCCCCHHHeEECCCCcEEE----------------------------ccCccccccccccCccccccCCCC
Confidence 9999999999999999999999988888 48888765422111 1124579
Q ss_pred CCCCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 169 t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred CCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 999999999876 678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=209.76 Aligned_cols=151 Identities=28% Similarity=0.474 Sum_probs=122.1
Q ss_pred CceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHh----ccCCCccchhhHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALDFITAC 131 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~----~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (255)
.+++++..++|||++++...|..+ -++-+||||++ .+|.+.++. +..++.- .++.+..|
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~-----------~iKLYt~Q 133 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLL-----------EIKLYTYQ 133 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCcee-----------eeHHHHHH
Confidence 467888899999999987665432 25679999985 488888874 2223322 24567789
Q ss_pred HHHHHHHHHHcCcccccCCCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc
Q psy3182 132 VIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT 210 (255)
Q Consensus 132 il~~l~ylH~~~iiHrdlkp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~ 210 (255)
+.+||.|||+.||+||||||+|+|++.. |.+|+ +|||.|+.+...... .+
T Consensus 134 lfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKi----------------------------cDFGSAK~L~~~epn-iS 184 (364)
T KOG0658|consen 134 LFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKI----------------------------CDFGSAKVLVKGEPN-IS 184 (364)
T ss_pred HHHHHHHHHhcCcccCCCChheEEEcCCCCeEEe----------------------------ccCCcceeeccCCCc-ee
Confidence 9999999999999999999999999986 78888 499999888665444 45
Q ss_pred cccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 211 FCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..-|.+|+|||.+.+ ..|+.+.|+||.||++.||+-|.+-|.
T Consensus 185 YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 185 YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 667999999999987 679999999999999999999997664
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=234.09 Aligned_cols=160 Identities=24% Similarity=0.346 Sum_probs=125.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc---CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT---CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~---~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++.+.. .+.+.. ........+..++.|++.||.|
T Consensus 52 Ei~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~---~~~lsv~~iL~I~~QIa~AL~y 128 (932)
T PRK13184 52 EAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL---AEKTSVGAFLSIFHKICATIEY 128 (932)
T ss_pred HHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhh---hcccCHHHHHHHHHHHHHHHHH
Confidence 4667778899999999999999999999999999999999886421 111110 0111122344577899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCC---------------
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGH--------------- 203 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~--------------- 203 (255)
+|++||+||||||+||+++..+.+++. |||.++....
T Consensus 129 LHs~GIIHRDLKPeNILLd~dg~vKLi----------------------------DFGLAk~i~~~~~~~~~l~~~~~~s 180 (932)
T PRK13184 129 VHSKGVLHRDLKPDNILLGLFGEVVIL----------------------------DWGAAIFKKLEEEDLLDIDVDERNI 180 (932)
T ss_pred HHHCCccccCCchheEEEcCCCCEEEE----------------------------ecCcceecccccccccccccccccc
Confidence 999999999999999999998888884 6665543311
Q ss_pred ---CCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 204 ---SGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 204 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
........+||+.|||||++.+..++.++|+||+||++|+|++|..||.
T Consensus 181 ~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred cccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 0011223579999999999999999999999999999999999999985
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=218.51 Aligned_cols=155 Identities=28% Similarity=0.506 Sum_probs=124.7
Q ss_pred cCceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 60 ~~~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.++++++.++ .|.+++++|++--.++++||||| |-.-||-.+|++.....+.. .++++-.|+|.|+.+
T Consensus 407 ~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE-~Gd~DL~kiL~k~~~~~~~~----------~lk~ywkqML~aV~~ 475 (677)
T KOG0596|consen 407 RNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME-CGDIDLNKILKKKKSIDPDW----------FLKFYWKQMLLAVKT 475 (677)
T ss_pred HHHHHHHHHhcCCceEEEEeeeeccCceEEEEee-cccccHHHHHHhccCCCchH----------HHHHHHHHHHHHHHH
Confidence 3456666544 47899999999889999999999 45679999998766544321 457788899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPE 216 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~ 216 (255)
.|+.||||.||||.|+|+- .|.+|+ +|||.|........ ...+.+||+.
T Consensus 476 IH~~gIVHSDLKPANFLlV-kG~LKL----------------------------IDFGIA~aI~~DTTsI~kdsQvGT~N 526 (677)
T KOG0596|consen 476 IHQHGIVHSDLKPANFLLV-KGRLKL----------------------------IDFGIANAIQPDTTSIVKDSQVGTVN 526 (677)
T ss_pred HHHhceeecCCCcccEEEE-eeeEEe----------------------------eeechhcccCccccceeeccccCccc
Confidence 9999999999999998874 466676 79999987765432 2345799999
Q ss_pred CcccccccCCC-----------CCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 217 YVAPEIIKNRG-----------HDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 217 y~aPE~~~~~~-----------~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
||+||.+.... .+.++||||||||+|+|+.|.+||--|
T Consensus 527 YMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 527 YMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred ccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 99999986433 457899999999999999999999754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=218.66 Aligned_cols=164 Identities=20% Similarity=0.296 Sum_probs=125.6
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCC-Ccc---------------------------
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCF-DDN--------------------------- 112 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~-~~~--------------------------- 112 (255)
+++++..+ .|+|++++++.+.+...+|++||||.+|+|.+++++.... ...
T Consensus 91 E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (374)
T cd05106 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSD 170 (374)
T ss_pred HHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccc
Confidence 45566666 7999999999999999999999999999999998653210 000
Q ss_pred -------------------------------chhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCc
Q psy3182 113 -------------------------------AASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 161 (255)
Q Consensus 113 -------------------------------~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~ 161 (255)
..........+.+..++.|++.||.|||++|++||||||+||+++..+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~ 250 (374)
T cd05106 171 SGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV 250 (374)
T ss_pred ccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe
Confidence 0000011233455678899999999999999999999999999998887
Q ss_pred eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCcccccccCCCCCCcchHHHHHH
Q psy3182 162 VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYVAPEIIKNRGHDRAVDYWALGI 239 (255)
Q Consensus 162 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGv 239 (255)
+++ .|||+++........ ..+..+++.|||||++.+..++.++|+||+||
T Consensus 251 ~kL----------------------------~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGv 302 (374)
T cd05106 251 AKI----------------------------CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302 (374)
T ss_pred EEE----------------------------eeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHH
Confidence 777 499988765332111 11233556799999999888999999999999
Q ss_pred HHHHHhc-CCCCCcC
Q psy3182 240 LMHELLT-GMKESNV 253 (255)
Q Consensus 240 il~ell~-G~~~~~~ 253 (255)
++|+|++ |..||..
T Consensus 303 il~ellt~G~~Pf~~ 317 (374)
T cd05106 303 LLWEIFSLGKSPYPG 317 (374)
T ss_pred HHHHHHhCCCCCCcc
Confidence 9999997 9999853
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=222.68 Aligned_cols=141 Identities=29% Similarity=0.491 Sum_probs=119.1
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
...|++++++.|...+++++|.|.+ +-+|+++++... |.. .....++.+++||+.||.+||+.||||+||
T Consensus 246 ~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~-f~G--------lsl~~ir~~~~Qil~~L~~L~~l~IIHcDL 315 (586)
T KOG0667|consen 246 DKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNK-FRG--------LSLPLVRKFAQQILTALLFLHELGIIHCDL 315 (586)
T ss_pred CCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcC-CCC--------CCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3568899999999999999999965 679999998653 222 224567888999999999999999999999
Q ss_pred CCCceeeCCCCc--eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCC
Q psy3182 150 KPENLLLDNRGY--VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG 227 (255)
Q Consensus 150 kp~nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (255)
||||||+.+.+. +|+ +|||.|...... ..+.+-+.+|+|||++.|.+
T Consensus 316 KPENILL~~~~r~~vKV----------------------------IDFGSSc~~~q~---vytYiQSRfYRAPEVILGlp 364 (586)
T KOG0667|consen 316 KPENILLKDPKRSRIKV----------------------------IDFGSSCFESQR---VYTYIQSRFYRAPEVILGLP 364 (586)
T ss_pred ChhheeeccCCcCceeE----------------------------EecccccccCCc---ceeeeeccccccchhhccCC
Confidence 999999987653 444 799998776543 33778899999999999999
Q ss_pred CCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 228 HDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 228 ~~~~~DiWslGvil~ell~G~~~~ 251 (255)
|+.+.||||||||++||.+|.+-|
T Consensus 365 Y~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 365 YDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred CCCccceeehhhhHHhHhcCcccc
Confidence 999999999999999999997544
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-29 Score=217.75 Aligned_cols=153 Identities=24% Similarity=0.332 Sum_probs=127.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.....+|++||++. ++|.+++.....+++ ..+..++.|++.||.|||
T Consensus 135 ~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~-----------~~~~~i~~ql~~aL~~LH 202 (392)
T PHA03207 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPL-----------EQAITIQRRLLEALAYLH 202 (392)
T ss_pred HHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 35677888899999999999999999999999985 688888865444432 234567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++..+.+++ +|||++........ ......||+.|+
T Consensus 203 ~~givHrDlkp~Nill~~~~~~~l----------------------------~DfG~a~~~~~~~~~~~~~~~~gt~~y~ 254 (392)
T PHA03207 203 GRGIIHRDVKTENIFLDEPENAVL----------------------------GDFGAACKLDAHPDTPQCYGWSGTLETN 254 (392)
T ss_pred HCCccccCCCHHHEEEcCCCCEEE----------------------------ccCccccccCcccccccccccccccCcc
Confidence 999999999999999999888887 59998865543221 223467999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+..|+.++|+||+||++|+|++|..||..
T Consensus 255 aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred CHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999999999853
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=209.66 Aligned_cols=151 Identities=16% Similarity=0.231 Sum_probs=124.9
Q ss_pred CceeeeccccccccccccccccC----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++.++.+..|+|++++++.+.+ ...++++|||+.||+|.+++.++..++.. ....++.+++.|+
T Consensus 67 ~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~-----------~~~~i~~~i~~~l 135 (283)
T PHA02988 67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK-----------TKLDMAIDCCKGL 135 (283)
T ss_pred HHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChh-----------HHHHHHHHHHHHH
Confidence 45677888899999999998766 45789999999999999999865443322 1234567899999
Q ss_pred HHHHH-cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 137 EYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 137 ~ylH~-~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
.|+|+ .+++||||||+|++++.++.+++ .|||+++..... .....||+
T Consensus 136 ~~lH~~~~~~Hrdlkp~nill~~~~~~kl----------------------------~dfg~~~~~~~~---~~~~~~~~ 184 (283)
T PHA02988 136 YNLYKYTNKPYKNLTSVSFLVTENYKLKI----------------------------ICHGLEKILSSP---PFKNVNFM 184 (283)
T ss_pred HHHHhcCCCCCCcCChhhEEECCCCcEEE----------------------------cccchHhhhccc---cccccCcc
Confidence 99998 49999999999999999988888 499988765332 22457899
Q ss_pred CCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|||++|..||+.
T Consensus 185 ~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 185 VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred cccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 9999999976 6789999999999999999999999874
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=207.42 Aligned_cols=151 Identities=28% Similarity=0.465 Sum_probs=126.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++....|++++++++.+.+.+.+|++|||+.||+|.+.+..... ++ ...+..++.|++.||.||
T Consensus 50 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~~~qi~~~l~~l 118 (285)
T cd05605 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----------EERAVFYAAEITCGLEDL 118 (285)
T ss_pred HHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 45677788899999999999999999999999999999988764321 22 233456778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|+++++||||||+||+++..+.+++ .|||.+....... .....+|++.|+|
T Consensus 119 H~~~ivH~dlkp~Nil~~~~~~~~l----------------------------~Dfg~~~~~~~~~-~~~~~~~~~~y~a 169 (285)
T cd05605 119 HRERIVYRDLKPENILLDDYGHIRI----------------------------SDLGLAVEIPEGE-TIRGRVGTVGYMA 169 (285)
T ss_pred HHCCcEecCCCHHHEEECCCCCEEE----------------------------eeCCCceecCCCC-ccccccCCCCccC
Confidence 9999999999999999998888877 5999887653322 2234579999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++|..||.
T Consensus 170 PE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred cHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence 999998889999999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=216.09 Aligned_cols=148 Identities=28% Similarity=0.404 Sum_probs=120.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+.+|++|||+.||+|..... .. ...+..++.|++.||.|||+
T Consensus 122 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~-----------~~~~~~i~~qi~~aL~~LH~ 186 (353)
T PLN00034 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----AD-----------EQFLADVARQILSGIAYLHR 186 (353)
T ss_pred HHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccccc----CC-----------HHHHHHHHHHHHHHHHHHHH
Confidence 4566778889999999999999999999999999999854211 11 12234577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++............+||+.|+|||
T Consensus 187 ~~ivHrDlkp~NIll~~~~~~kL----------------------------~DfG~~~~~~~~~~~~~~~~gt~~y~aPE 238 (353)
T PLN00034 187 RHIVHRDIKPSNLLINSAKNVKI----------------------------ADFGVSRILAQTMDPCNSSVGTIAYMSPE 238 (353)
T ss_pred CCEeecCCCHHHEEEcCCCCEEE----------------------------cccccceecccccccccccccCccccCcc
Confidence 99999999999999999888888 49998876544333334568999999999
Q ss_pred cccC-----CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN-----RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~-----~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.. ...+.++|||||||++|+|++|..||.
T Consensus 239 ~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 9843 234568999999999999999999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=212.44 Aligned_cols=151 Identities=26% Similarity=0.472 Sum_probs=127.2
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++.+...+++ ..+..++.|++.||.|||
T Consensus 52 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~l~~~l~~lH 120 (333)
T cd06650 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----------QILGKVSIAVIKGLTYLR 120 (333)
T ss_pred HHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 356677788899999999999999999999999999999999976554433 234456778999999999
Q ss_pred Hc-CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 TR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~-~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
++ +++||||||+||+++.++.+++ .|||++...... ......||+.|+|
T Consensus 121 ~~~~ivH~dlkp~Nili~~~~~~kL----------------------------~Dfg~~~~~~~~--~~~~~~~~~~y~a 170 (333)
T cd06650 121 EKHKIMHRDVKPSNILVNSRGEIKL----------------------------CDFGVSGQLIDS--MANSFVGTRSYMS 170 (333)
T ss_pred hcCCEEecCCChhhEEEcCCCCEEE----------------------------eeCCcchhhhhh--ccccCCCCccccC
Confidence 75 7999999999999998888887 599988654332 1234579999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++|..||.
T Consensus 171 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred HHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999998889999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=207.01 Aligned_cols=148 Identities=22% Similarity=0.378 Sum_probs=118.8
Q ss_pred ecccccccccccccccc-----CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRKKKTRQTRLYKTFK-----DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~-----~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+....|+|++++++.+. ....+++++|++. ++|.+++....... ...+.+..++.|++.||.|||
T Consensus 58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~lH 127 (290)
T cd07862 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG---------VPTETIKDMMFQLLRGLDFLH 127 (290)
T ss_pred hcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCC---------CCHHHHHHHHHHHHHHHHHHH
Confidence 34457999999998764 3567899999996 58888886432110 112334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++.++.+++ +|||.++..... .......||+.|+||
T Consensus 128 ~~~iiH~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~-~~~~~~~~~~~y~aP 178 (290)
T cd07862 128 SHRVVHRDLKPQNILVTSSGQIKL----------------------------ADFGLARIYSFQ-MALTSVVVTLWYRAP 178 (290)
T ss_pred HCCeeeCCCCHHHEEEcCCCCEEE----------------------------ccccceEeccCC-cccccccccccccCh
Confidence 999999999999999999888888 499988765433 233456799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..++.++|+||+||++|+|++|.+||.
T Consensus 179 E~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred HHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 99998899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=208.97 Aligned_cols=164 Identities=24% Similarity=0.292 Sum_probs=126.2
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccc--------hhhHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA--------ASFITACVIEALDFITACV 132 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~i~~~i 132 (255)
.+++++..+.|+|++++++.+.+.+..|++|||+.+|+|.+++......+... ...........+..++.|+
T Consensus 68 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 147 (304)
T cd05096 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQI 147 (304)
T ss_pred HHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHH
Confidence 35677788899999999999999999999999999999999987543221111 0001111223455678899
Q ss_pred HHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccc
Q psy3182 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWT 210 (255)
Q Consensus 133 l~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~ 210 (255)
+.||.|||++|++||||||+||+++.++.+++ .|||+++....... ....
T Consensus 148 ~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl----------------------------~DfG~~~~~~~~~~~~~~~~ 199 (304)
T cd05096 148 ASGMKYLSSLNFVHRDLATRNCLVGENLTIKI----------------------------ADFGMSRNLYAGDYYRIQGR 199 (304)
T ss_pred HHHHHHHHHCCccccCcchhheEEcCCccEEE----------------------------CCCccceecccCceeEecCc
Confidence 99999999999999999999999999888888 48888765433211 1123
Q ss_pred cccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcC--CCCCc
Q psy3182 211 FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG--MKESN 252 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G--~~~~~ 252 (255)
..+++.|||||++.+..++.++|+||+||++|+|+++ ..||.
T Consensus 200 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 200 AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred CCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 4567889999999888899999999999999999864 45664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=211.22 Aligned_cols=161 Identities=26% Similarity=0.420 Sum_probs=120.6
Q ss_pred Cceeeecccccccccccccccc--CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFK--DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~--~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++++..+.|+|++++++.+. +...+|+++||+.+ ++++.+........... ........+..++.|++.||.|
T Consensus 47 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~ 123 (317)
T cd07867 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKK--PMQLPRSMVKSLLYQILDGIHY 123 (317)
T ss_pred HHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCC--CccCCHHHHHHHHHHHHHHHHH
Confidence 4577788889999999999874 45678999999764 78777754322111100 0011234456788899999999
Q ss_pred HHHcCcccccCCCCceeeC----CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---ccccc
Q psy3182 139 LHTRGIVFRDLKPENLLLD----NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTF 211 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~ 211 (255)
||+++++||||||+||++. ..+.+++ +|||+++....... .....
T Consensus 124 lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~ 175 (317)
T cd07867 124 LHANWVLHRDLKPANILVMGEGPERGRVKI----------------------------ADMGFARLFNSPLKPLADLDPV 175 (317)
T ss_pred HHhCCEEcCCCCHHHEEEccCCCCCCcEEE----------------------------eeccceeccCCCcccccccCcc
Confidence 9999999999999999984 3445666 59998876543221 22345
Q ss_pred ccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 176 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 78999999999976 458899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=204.24 Aligned_cols=152 Identities=27% Similarity=0.494 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+.+..|+++||+.+++|.+++...+.+++ +.+..++.|++.|+.|||+
T Consensus 56 e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~ 124 (267)
T cd06645 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE-----------SQIAYVSRETLQGLYYLHS 124 (267)
T ss_pred HHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34556677899999999999999999999999999999999876654443 2345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++..+.+++ .|||.+..............|++.|+|||
T Consensus 125 ~~i~H~dlkp~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 176 (267)
T cd06645 125 KGKMHRDIKGANILLTDNGHVKL----------------------------ADFGVSAQITATIAKRKSFIGTPYWMAPE 176 (267)
T ss_pred CCeecCCCCHHHEEECCCCCEEE----------------------------CcceeeeEccCcccccccccCcccccChh
Confidence 99999999999999998888887 48888765543333334567999999999
Q ss_pred ccc---CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIK---NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~---~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++. ...++.++|+||+||++|+|++|..||.
T Consensus 177 ~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred hhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 984 4568889999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=213.33 Aligned_cols=155 Identities=24% Similarity=0.403 Sum_probs=124.9
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+++++++.+...+..+||||||+..|+|.++|+.+..-.- ....+-.++.||++|++||.
T Consensus 250 ~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l---------~~~~Ll~~a~qIaeGM~YLe 320 (468)
T KOG0197|consen 250 REAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLL---------NLPQLLDFAAQIAEGMAYLE 320 (468)
T ss_pred HHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCcc---------chHHHHHHHHHHHHHHHHHH
Confidence 357778899999999999999998899999999999999999986221111 11234457889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC-CCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP-EYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~-~y~a 219 (255)
++++|||||...|||++.+..+|++ |||+|+....+......-.-.| .|.|
T Consensus 321 s~~~IHRDLAARNiLV~~~~~vKIs----------------------------DFGLAr~~~d~~Y~~~~~~kfPIkWtA 372 (468)
T KOG0197|consen 321 SKNYIHRDLAARNILVDEDLVVKIS----------------------------DFGLARLIGDDEYTASEGGKFPIKWTA 372 (468)
T ss_pred hCCccchhhhhhheeeccCceEEEc----------------------------ccccccccCCCceeecCCCCCCceecC
Confidence 9999999999999999999999994 9999985444322211111123 7999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+....++.+||+||+||+|||++| |..|+.
T Consensus 373 PEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 373 PEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred HHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 999999999999999999999999986 666654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=219.97 Aligned_cols=155 Identities=28% Similarity=0.441 Sum_probs=121.6
Q ss_pred eeeeccccccccccccccccCcc--------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSK--------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~--------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
+.++....|+++++++..+.... .++++|||+.+|+|.+.+..+...... .....+..++.|++.
T Consensus 82 i~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~-------l~e~~~~~i~~qll~ 154 (496)
T PTZ00283 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT-------FREHEAGLLFIQVLL 154 (496)
T ss_pred HHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCC-------CCHHHHHHHHHHHHH
Confidence 44455667888888776654322 478999999999999998753211100 112234567789999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--Cccccccc
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFC 212 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~ 212 (255)
||.|+|+++|+||||||+||+++.++.+++ .|||+++..... .....+.+
T Consensus 155 aL~~lH~~~IiHrDLKP~NILl~~~~~vkL----------------------------~DFGls~~~~~~~~~~~~~~~~ 206 (496)
T PTZ00283 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKL----------------------------GDFGFSKMYAATVSDDVGRTFC 206 (496)
T ss_pred HHHHHHhCCEecCCCCHHHEEEeCCCCEEE----------------------------EecccCeecccccccccccccc
Confidence 999999999999999999999999888888 599988765332 12234578
Q ss_pred cCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 213 GTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 213 gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||+.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 207 Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred CCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999999999999999999986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=203.56 Aligned_cols=147 Identities=28% Similarity=0.512 Sum_probs=122.4
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ii 145 (255)
+....|++++.++..+.+.+..|++|||+.||+|...+..+..+++ +.+..++.|++.||.|||+++++
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~-----------~~~~~i~~qi~~al~~lH~~~iv 119 (279)
T cd05633 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE-----------KEMRFYATEIILGLEHMHNRFVV 119 (279)
T ss_pred HhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHHCCcC
Confidence 4445689999999999999999999999999999998876554443 33456778999999999999999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccccc-
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK- 224 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~- 224 (255)
||||||+||+++.++.+++ +|||++....... .....||+.|+|||++.
T Consensus 120 H~dikp~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 120 YRDLKPANILLDEHGHVRI----------------------------SDLGLACDFSKKK--PHASVGTHGYMAPEVLQK 169 (279)
T ss_pred CCCCCHHHEEECCCCCEEE----------------------------ccCCcceeccccC--ccCcCCCcCccCHHHhcC
Confidence 9999999999998888877 4899876543322 22357999999999986
Q ss_pred CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 225 NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 225 ~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+..++.++|+||+||++|+|++|..||..
T Consensus 170 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred CCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 46789999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=216.71 Aligned_cols=154 Identities=23% Similarity=0.374 Sum_probs=116.7
Q ss_pred ceeeeccccccccccccccccC--------ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--------SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVI 133 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--------~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il 133 (255)
++.++..+.|+|++++++.|.. ...++++|||+.+ ++.+.+........ ......+..++.|++
T Consensus 109 Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~-------~l~~~~~~~~~~qi~ 180 (440)
T PTZ00036 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNH-------ALPLFLVKLYSYQLC 180 (440)
T ss_pred HHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCC-------CCCHHHHHHHHHHHH
Confidence 4566778899999998776532 2357899999986 56665543111000 011233456778999
Q ss_pred HHHHHHHHcCcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccc
Q psy3182 134 EALEYLHTRGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFC 212 (255)
Q Consensus 134 ~~l~ylH~~~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~ 212 (255)
.||.|||++||+||||||+||+++..+ .+++ +|||+|+...... ...+.+
T Consensus 181 ~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL----------------------------~DFGla~~~~~~~-~~~~~~ 231 (440)
T PTZ00036 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKL----------------------------CDFGSAKNLLAGQ-RSVSYI 231 (440)
T ss_pred HHHHHHHHCCEecCCcCHHHEEEcCCCCceee----------------------------eccccchhccCCC-CcccCC
Confidence 999999999999999999999998654 5777 5999987654322 233567
Q ss_pred cCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 213 GTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 213 gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||+.|+|||++.+ ..|+.++|+||+||++|+|++|.+||.
T Consensus 232 ~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred CCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 8999999999876 468999999999999999999999985
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=215.76 Aligned_cols=146 Identities=28% Similarity=0.512 Sum_probs=121.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcch--hHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGG--EVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg--~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+|+.+..++|||.+.+-+.|-.....|+|||||.|. ||.+..++ ++.+ ..+.-|+.+.+.||.||
T Consensus 76 EVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkK--plqE-----------vEIAAi~~gaL~gLaYL 142 (948)
T KOG0577|consen 76 EVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQE-----------VEIAAITHGALQGLAYL 142 (948)
T ss_pred HHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhc--cchH-----------HHHHHHHHHHHHHHHHH
Confidence 466778889999999999998888999999999874 56665543 2322 23445677899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|+.+.||||||..|||++.+|.+|+ .|||.+... +...+++|||+|||
T Consensus 143 HS~~~IHRDiKAGNILLse~g~VKL----------------------------aDFGSAsi~----~PAnsFvGTPywMA 190 (948)
T KOG0577|consen 143 HSHNRIHRDIKAGNILLSEPGLVKL----------------------------ADFGSASIM----APANSFVGTPYWMA 190 (948)
T ss_pred HHhhHHhhhccccceEecCCCeeee----------------------------ccccchhhc----CchhcccCCccccc
Confidence 9999999999999999999999999 499976543 34557999999999
Q ss_pred cccccC---CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKN---RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~---~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||+|.. ..|+.++||||||+++.||....+|.+
T Consensus 191 PEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 191 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred hhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 999974 469999999999999999999998854
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=200.22 Aligned_cols=153 Identities=31% Similarity=0.482 Sum_probs=126.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.+..|++++++++.+++...+|+++|++.|++|.+.+.+...+++ +.+..++.|++.|+.|||+
T Consensus 54 e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~~l~~~l~~lH~ 122 (263)
T cd06625 54 EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE-----------TVTRKYTRQILEGVEYLHS 122 (263)
T ss_pred HHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 45567778899999999999999999999999999999998876544432 2334567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc---cccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT---WTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~---~~~~gt~~y~ 218 (255)
+|++||||+|+||+++.++.+++ .|||.++......... ....|++.|+
T Consensus 123 ~~i~H~dl~p~nilv~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 174 (263)
T cd06625 123 NMIVHRDIKGANILRDSAGNVKL----------------------------GDFGASKRLQTICSSGTGMKSVTGTPYWM 174 (263)
T ss_pred CCeecCCCCHHHEEEcCCCCEEE----------------------------eecccceeccccccccccccCCCcCcccc
Confidence 99999999999999998888887 4888776543221111 2356888999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|++++|..||+.
T Consensus 175 aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred CcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 99999998899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=205.95 Aligned_cols=151 Identities=22% Similarity=0.365 Sum_probs=123.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+.+..|++|||+.+ ++.+.+..... ++ ...+..++.|++.||.|||
T Consensus 54 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~-----------~~~~~~~~~qi~~aL~~lH 121 (309)
T cd07872 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMS-----------MHNVKIFLYQILRGLAYCH 121 (309)
T ss_pred HHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 46667788999999999999999999999999975 78777764322 22 1234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ .|||.++.............||+.|+||
T Consensus 122 ~~~ivH~dlkp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 173 (309)
T cd07872 122 RRKVLHRDLKPQNLLINERGELKL----------------------------ADFGLARAKSVPTKTYSNEVVTLWYRPP 173 (309)
T ss_pred HCCeecCCCCHHHEEECCCCCEEE----------------------------CccccceecCCCccccccccccccccCC
Confidence 999999999999999999888888 4999886544333233345789999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 174 E~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99865 568899999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=203.43 Aligned_cols=150 Identities=45% Similarity=0.817 Sum_probs=128.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.+..|+|++++++.+.+.+..|++|||+.|++|.+.+.+...+++ ..+..++.|++.||.|||+
T Consensus 51 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~-----------~~~~~~~~qil~~l~~lH~ 119 (290)
T cd05580 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-----------PVARFYAAQVVLALEYLHS 119 (290)
T ss_pred HHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667777899999999999999999999999999999999987654443 2344567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||+|.||+++.++.+++ .|||++...... ....+|++.|+|||
T Consensus 120 ~~i~H~dl~p~nili~~~~~~kl----------------------------~dfg~~~~~~~~---~~~~~~~~~y~aPE 168 (290)
T cd05580 120 LDIVYRDLKPENLLLDSDGYIKI----------------------------TDFGFAKRVKGR---TYTLCGTPEYLAPE 168 (290)
T ss_pred CCEecCCCCHHHEEECCCCCEEE----------------------------eeCCCccccCCC---CCCCCCCccccChh
Confidence 99999999999999999888887 599988765443 33567999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 169 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 169 IILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred hhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99888889999999999999999999999853
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=202.94 Aligned_cols=164 Identities=21% Similarity=0.293 Sum_probs=128.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh-----hHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS-----FITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++....|++++++++.+.+....|+++||+.+|+|.+++.+.....+.... .........+..++.|++.||
T Consensus 58 ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al 137 (283)
T cd05048 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGM 137 (283)
T ss_pred HHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999865433221110 000112234556788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGT 214 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt 214 (255)
.|||+++++||||||+||+++.++.+++ .|||+++...... .......++
T Consensus 138 ~~lH~~~i~H~dlkp~Nil~~~~~~~~L----------------------------~dfg~~~~~~~~~~~~~~~~~~~~ 189 (283)
T cd05048 138 EYLSSHHFVHRDLAARNCLVGEGLTVKI----------------------------SDFGLSRDIYSADYYRVQSKSLLP 189 (283)
T ss_pred HHHHhCCeeccccccceEEEcCCCcEEE----------------------------CCCcceeeccccccccccCCCccc
Confidence 9999999999999999999998888877 4888876543221 112234578
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+.|+|||.+.+..++.++|+||+||++|||++ |..||..
T Consensus 190 ~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred ccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 89999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=203.50 Aligned_cols=153 Identities=27% Similarity=0.428 Sum_probs=125.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|++++.++..+.+.+..|++|||+.||+|.+.+....... .....+..++.|++.||.|||+
T Consensus 50 E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05630 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG---------FEEGRAVFYAAEICCGLEDLHQ 120 (285)
T ss_pred HHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 4566777889999999999999999999999999999998885432111 1122345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||||+||+++..+.+++ .|||++....... ......||+.|+|||
T Consensus 121 ~~iiH~dikp~Nil~~~~~~~~l----------------------------~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE 171 (285)
T cd05630 121 ERIVYRDLKPENILLDDHGHIRI----------------------------SDLGLAVHVPEGQ-TIKGRVGTVGYMAPE 171 (285)
T ss_pred CCEEeCCCCHHHEEECCCCCEEE----------------------------eeccceeecCCCc-cccCCCCCccccChH
Confidence 99999999999999998887777 5999876543222 222357999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 172 ~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~ 202 (285)
T cd05630 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202 (285)
T ss_pred HHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 9999899999999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=200.99 Aligned_cols=152 Identities=28% Similarity=0.493 Sum_probs=125.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+++++++..+.+....|+++||+.+++|.+++.++..+++ ..+..++.|++.|+.|||+
T Consensus 56 e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~qi~~~l~~lH~ 124 (267)
T cd06646 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-----------LQIAYVCRETLQGLAYLHS 124 (267)
T ss_pred HHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778999999999999999999999999999999998876544432 2344577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|||+||+||+++.++.+++ .|||.++.............|++.|+|||
T Consensus 125 ~~i~H~dl~p~nill~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 176 (267)
T cd06646 125 KGKMHRDIKGANILLTDNGDVKL----------------------------ADFGVAAKITATIAKRKSFIGTPYWMAPE 176 (267)
T ss_pred CCccccCCCHHHEEECCCCCEEE----------------------------CcCccceeecccccccCccccCccccCHh
Confidence 99999999999999998888877 48988876543333334567899999999
Q ss_pred ccc---CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIK---NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~---~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+. ...++.++|+||+||++|+|++|..||.
T Consensus 177 ~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred HcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 985 3457789999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=210.37 Aligned_cols=164 Identities=22% Similarity=0.289 Sum_probs=124.4
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCC-------ccchhh-----------------
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFD-------DNAASF----------------- 116 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~-------~~~~~~----------------- 116 (255)
+++++..+ .|+|++++++.+.+....|++||||.||+|.+++++..... ......
T Consensus 88 Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (375)
T cd05104 88 ELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNE 167 (375)
T ss_pred HHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhh
Confidence 45566666 79999999999999999999999999999999997532100 000000
Q ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceee
Q psy3182 117 ----------------------------------------ITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLL 156 (255)
Q Consensus 117 ----------------------------------------~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~ 156 (255)
......+.+..++.|++.||.|||++|++||||||+||++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill 247 (375)
T cd05104 168 YMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247 (375)
T ss_pred hhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE
Confidence 0011233455678899999999999999999999999999
Q ss_pred CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCcccccccCCCCCCcchH
Q psy3182 157 DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYVAPEIIKNRGHDRAVDY 234 (255)
Q Consensus 157 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di 234 (255)
+..+.+++ .|||+++........ ..+..+++.|+|||++.+..++.++|+
T Consensus 248 ~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi 299 (375)
T cd05104 248 THGRITKI----------------------------CDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 299 (375)
T ss_pred ECCCcEEE----------------------------ecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH
Confidence 98877777 489988655332211 112334567999999999999999999
Q ss_pred HHHHHHHHHHhc-CCCCCcC
Q psy3182 235 WALGILMHELLT-GMKESNV 253 (255)
Q Consensus 235 WslGvil~ell~-G~~~~~~ 253 (255)
||+||++|+|++ |..||..
T Consensus 300 ~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 300 WSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred HHHHHHHHHHHhcCCCCCCC
Confidence 999999999997 8888753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=197.87 Aligned_cols=154 Identities=25% Similarity=0.413 Sum_probs=126.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++++...|+|++++++.+.+.+..|+++||+.|++|.+++....... .....+..++.|++.||.|+|+
T Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~i~~~l~~al~~lH~ 119 (256)
T cd08529 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP---------LPEDQVWRFFIQILLGLAHLHS 119 (256)
T ss_pred HHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 3556777889999999999999999999999999999999987631110 0112334567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|+||||+||+++..+..++ .|||.++.............|++.|+|||
T Consensus 120 ~~i~h~dl~~~nili~~~~~~~l----------------------------~df~~~~~~~~~~~~~~~~~~~~~y~aPE 171 (256)
T cd08529 120 KKILHRDIKSLNLFLDAYDNVKI----------------------------GDLGVAKLLSDNTNFANTIVGTPYYLSPE 171 (256)
T ss_pred CCcccCCCCcceEEEeCCCCEEE----------------------------cccccceeccCccchhhccccCccccCHH
Confidence 99999999999999998888887 48888776544433334567899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 172 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred HhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 9999889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=201.26 Aligned_cols=154 Identities=29% Similarity=0.496 Sum_probs=125.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+....|+++||+.+|+|...+.+. ..+++ +.+..++.|++.||.|||
T Consensus 52 e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~-----------~~~~~~~~qi~~~L~~LH 120 (282)
T cd06643 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-----------PQIRVVCKQTLEALNYLH 120 (282)
T ss_pred HHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 455677788999999999999999999999999999998877642 22222 234556788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+.|++||||||+||+++.++.+++ .|||++..............|++.|+||
T Consensus 121 ~~~i~H~dlkp~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aP 172 (282)
T cd06643 121 ENKIIHRDLKAGNILFTLDGDIKL----------------------------ADFGVSAKNTRTIQRRDSFIGTPYWMAP 172 (282)
T ss_pred HCCeeecCCCcccEEEccCCCEEE----------------------------ccccccccccccccccccccccccccCH
Confidence 999999999999999999888888 4888876543333333456789999999
Q ss_pred cccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 221 EIIK-----NRGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 221 E~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
|++. +..++.++|+||+||++|+|++|.+||+.+
T Consensus 173 E~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred hhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 9984 355778999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=209.90 Aligned_cols=151 Identities=24% Similarity=0.383 Sum_probs=122.2
Q ss_pred ceeeeccccccccccccccccCcc-----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK-----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~-----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++....|+|++++++.+.+.+ ..|+++||+. ++|...+.....+++ +.+..++.|++.||
T Consensus 49 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~-----------~~~~~~~~qi~~aL 116 (372)
T cd07853 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSS-----------DHVKVFLYQILRGL 116 (372)
T ss_pred HHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCH-----------HHHHHHHHHHHHHH
Confidence 456677788999999999988776 7899999986 578887765444332 34566788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTP 215 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~ 215 (255)
.|||++|++||||||+||+++.++.+++ .|||+++....... ......||+
T Consensus 117 ~~LH~~~ivH~dlkp~Nili~~~~~~kL----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~ 168 (372)
T cd07853 117 KYLHSAGILHRDIKPGNLLVNSNCVLKI----------------------------CDFGLARVEEPDESKHMTQEVVTQ 168 (372)
T ss_pred HHHHhCCeeCCCCChHHEEECCCCCEEe----------------------------ccccceeecccCccccCCCCCcCC
Confidence 9999999999999999999999988888 48888765433221 122346899
Q ss_pred CCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 169 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred CcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 99999999874 57899999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=198.86 Aligned_cols=140 Identities=29% Similarity=0.522 Sum_probs=120.8
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+.+.+..|++|||+.||+|.+++++...+++ +.+..++.|++.||.|+|+.|++||||
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~qi~~~l~~lH~~~i~H~dl 135 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE-----------AEVKKIIRQLVEALNDLHKHNIIHNDI 135 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 699999999999999999999999999999999987554443 334567788999999999999999999
Q ss_pred CCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 150 KPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 150 kp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
||+||+++..+ .+++ .|||.++..... ....|++.|+|||++.+..+
T Consensus 136 ~p~nil~~~~~~~~~l----------------------------~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~ 183 (267)
T PHA03390 136 KLENVLYDRAKDRIYL----------------------------CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNY 183 (267)
T ss_pred CHHHEEEeCCCCeEEE----------------------------ecCccceecCCC----ccCCCCCcccChhhhcCCCC
Confidence 99999998877 6666 599987665432 23568999999999999889
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 229 DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.++|+||+||++|+|++|..||.
T Consensus 184 ~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 184 DVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999985
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=215.02 Aligned_cols=153 Identities=31% Similarity=0.592 Sum_probs=127.9
Q ss_pred cCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHh--ccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~--~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
++++.|+....||-++.+-..|++.+.+|.|||.+.| |+.+.+-. .+.+.++ +..+++.||+.||.
T Consensus 611 R~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er-----------~TkFlvtQIL~ALr 678 (888)
T KOG4236|consen 611 RNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPER-----------ITKFLVTQILVALR 678 (888)
T ss_pred HHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHH-----------HHHHHHHHHHHHHH
Confidence 4567888899999999999999999999999999865 55555432 2334443 23566778999999
Q ss_pred HHHHcCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|||.++|+|+||||+|+|+.... .+|+ .|||+++..+... .+.+.+||
T Consensus 679 ~LH~knIvHCDLKPENVLLas~~~FPQvKl----------------------------CDFGfARiIgEks-FRrsVVGT 729 (888)
T KOG4236|consen 679 YLHFKNIVHCDLKPENVLLASASPFPQVKL----------------------------CDFGFARIIGEKS-FRRSVVGT 729 (888)
T ss_pred HhhhcceeeccCCchheeeccCCCCCceee----------------------------ccccceeecchhh-hhhhhcCC
Confidence 99999999999999999997643 2343 5999999987754 45578999
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.|+|||+++.++|+.+.|+||+|||+|.-++|-.|||.
T Consensus 730 PAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 730 PAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 999999999999999999999999999999999999984
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=214.84 Aligned_cols=156 Identities=22% Similarity=0.308 Sum_probs=111.9
Q ss_pred ccccccccccccCc-cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH-cCccccc
Q psy3182 71 KTRQTRLYKTFKDS-KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT-RGIVFRD 148 (255)
Q Consensus 71 h~~iv~l~~~~~~~-~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-~~iiHrd 148 (255)
|.++++++++|.+. .+++++||++ |++|.+++.++..+++. .+..++.|++.||.|||+ .||||||
T Consensus 190 ~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~-----------~~~~i~~qi~~aL~yLH~~~gIiHrD 257 (467)
T PTZ00284 190 RFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHR-----------HLAQIIFQTGVALDYFHTELHLMHTD 257 (467)
T ss_pred CcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHhcCCeecCC
Confidence 34566777777654 5788999977 78898888766554432 345677899999999998 5999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
|||+|||++..+..... ..... ...+ ....+..|||.+..... .....+||+.|||||++.+..|
T Consensus 258 lKP~NILl~~~~~~~~~---~~~~~----~~~~-----~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~ 322 (467)
T PTZ00284 258 LKPENILMETSDTVVDP---VTNRA----LPPD-----PCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGW 322 (467)
T ss_pred CCHHHEEEecCCccccc---ccccc----cCCC-----CceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCC
Confidence 99999999875531100 00000 0000 00122359998754322 2335789999999999999999
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 229 DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.++|||||||++|||++|..||..
T Consensus 323 ~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 323 MYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999863
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=200.21 Aligned_cols=147 Identities=30% Similarity=0.529 Sum_probs=122.7
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
++....|+++++++..+.+.+..|++|||+.||+|...+.+...+++ +.+..++.|++.|+.|||++++
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~-----------~~~~~~~~ql~~~l~~lH~~~i 118 (278)
T cd05606 50 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-----------AEMRFYAAEIILGLEHMHNRFV 118 (278)
T ss_pred HHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHHCCE
Confidence 34455789999999999999999999999999999988876544443 3345677889999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~ 224 (255)
+|||+||+||+++.++.+++ +|||.+...... ...+.+|++.|+|||++.
T Consensus 119 ~H~di~p~nili~~~~~~kl----------------------------~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~ 168 (278)
T cd05606 119 VYRDLKPANILLDEHGHVRI----------------------------SDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 168 (278)
T ss_pred EcCCCCHHHEEECCCCCEEE----------------------------ccCcCccccCcc--CCcCcCCCcCCcCcHHhc
Confidence 99999999999998888877 489987655332 223457999999999997
Q ss_pred C-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 225 N-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 225 ~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+ ..++.++|+||+||++|+|++|..||.
T Consensus 169 ~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred CCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 4 468999999999999999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=199.11 Aligned_cols=153 Identities=26% Similarity=0.439 Sum_probs=126.1
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|+|++++++.+.+.+.+|+++||+.+|+|.+.+....... ...+.+..++.|++.||.|||++
T Consensus 49 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~---------~~~~~~~~~~~~i~~al~~lH~~ 119 (255)
T cd08219 49 AVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL---------FPEDTILQWFVQMCLGVQHIHEK 119 (255)
T ss_pred HHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHhhC
Confidence 455667789999999999999999999999999999999886432110 01123445678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++|+||||.||+++.++.+++ +|||.+..............|++.|+|||+
T Consensus 120 ~i~H~dl~p~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~ 171 (255)
T cd08219 120 RVLHRDIKSKNIFLTQNGKVKL----------------------------GDFGSARLLTSPGAYACTYVGTPYYVPPEI 171 (255)
T ss_pred CcccCCCCcceEEECCCCcEEE----------------------------cccCcceeecccccccccccCCccccCHHH
Confidence 9999999999999998888777 488887665443333345679999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+|+++|+|++|..||.
T Consensus 172 ~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred HccCCcCchhhhhhhchhheehhhccCCCC
Confidence 998889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=207.63 Aligned_cols=148 Identities=26% Similarity=0.448 Sum_probs=118.8
Q ss_pred ceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++..+.|+|++++++.+...+ .+|++|||+.+ ++...+.. .+++ +.+..++.|++.|
T Consensus 70 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~-----------~~~~~~~~qi~~~ 135 (359)
T cd07876 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM--ELDH-----------ERMSYLLYQMLCG 135 (359)
T ss_pred HHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc--cCCH-----------HHHHHHHHHHHHH
Confidence 456677788999999998876543 57999999976 45555432 1222 2345677899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ .|||+++...... ......||+
T Consensus 136 L~~LH~~~ivHrDlkp~NIl~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~~t~ 186 (359)
T cd07876 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LDFGLARTACTNF-MMTPYVVTR 186 (359)
T ss_pred HHHHHhCCcccCCCCHHHEEECCCCCEEE----------------------------ecCCCccccccCc-cCCCCcccC
Confidence 99999999999999999999999988888 5999886543321 223457899
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 187 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred CCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=199.45 Aligned_cols=152 Identities=18% Similarity=0.246 Sum_probs=120.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++.+....|+|++++++.+.+.+..|++|||+.+|+|.+++.+.. .++ ...+..++.|++.||.|||
T Consensus 56 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~-----------~~~~~~~~~~i~~al~~lH 124 (266)
T cd05064 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV-----------AGQLMGMLPGLASGMKYLS 124 (266)
T ss_pred HHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4556667789999999999999999999999999999999987532 222 2334567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
+++++||||||+||+++.++..++. |||.+........ ......+++.|+|
T Consensus 125 ~~~iiH~dikp~nili~~~~~~~l~----------------------------dfg~~~~~~~~~~~~~~~~~~~~~y~a 176 (266)
T cd05064 125 EMGYVHKGLAAHKVLVNSDLVCKIS----------------------------GFRRLQEDKSEAIYTTMSGKSPVLWAA 176 (266)
T ss_pred HCCEeeccccHhhEEEcCCCcEEEC----------------------------CCcccccccccchhcccCCCCceeecC
Confidence 9999999999999999988877773 7776543322111 1112345678999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+.+..++.++|+||+||++|++++ |..||.
T Consensus 177 PE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred HHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 999999999999999999999999774 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=200.36 Aligned_cols=163 Identities=21% Similarity=0.279 Sum_probs=126.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccc---hhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA---ASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~---~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++....|++++++++.+.+....|++|||+.||+|.+++.....-.... ...........+..++.|++.|+.|
T Consensus 58 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 137 (280)
T cd05049 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVY 137 (280)
T ss_pred HHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 4566778889999999999999999999999999999999997653211000 0001112233455678899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPE 216 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~ 216 (255)
+|++|++||||||+||+++.++.+++ .|||.++....... ......+++.
T Consensus 138 lH~~~i~h~dlkp~nili~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~ 189 (280)
T cd05049 138 LASQHFVHRDLATRNCLVGYDLVVKI----------------------------GDFGMSRDVYTTDYYRVGGHTMLPIR 189 (280)
T ss_pred HhhCCeeccccccceEEEcCCCeEEE----------------------------CCcccceecccCcceecCCCCcccce
Confidence 99999999999999999999988888 48887754322111 1122346788
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 190 y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred ecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999999999998 999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=200.48 Aligned_cols=152 Identities=27% Similarity=0.459 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++..+.|++++.++..+.+.+..++++||+.||+|...+.... .++ ...+..++.|++.||.||
T Consensus 50 E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~~~ql~~~l~~l 118 (285)
T cd05632 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE-----------EERALFYAAEILCGLEDL 118 (285)
T ss_pred HHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 4567778889999999999999999999999999999988776432 122 233456778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++||+||||||+||+++..+.+++ .|||.+....... ......|++.|+|
T Consensus 119 H~~~iiH~dikp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~g~~~~~a 169 (285)
T cd05632 119 HRENTVYRDLKPENILLDDYGHIRI----------------------------SDLGLAVKIPEGE-SIRGRVGTVGYMA 169 (285)
T ss_pred HhCCeeecCCCHHHEEECCCCCEEE----------------------------ecCCcceecCCCC-cccCCCCCcCccC
Confidence 9999999999999999998888877 5999876543321 2234579999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+..++.++|+||+||++|+|++|..||..
T Consensus 170 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred hHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 9999988899999999999999999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=197.65 Aligned_cols=153 Identities=28% Similarity=0.484 Sum_probs=127.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.+++...|++++++++.+.+...+|++|||+.|++|.+++... ..+++ +.+..++.|++.||.|||
T Consensus 50 e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~-----------~~~~~~~~ql~~~l~~lh 118 (262)
T cd06613 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE-----------LQIAYVCRETLKGLAYLH 118 (262)
T ss_pred HHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 356677889999999999999999999999999999999988764 33332 234557788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++|+||+|+||+++.++.+++ .|||.+..............|++.|+||
T Consensus 119 ~~~i~h~dl~p~ni~i~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~y~~P 170 (262)
T cd06613 119 ETGKIHRDIKGANILLTEDGDVKL----------------------------ADFGVSAQLTATIAKRKSFIGTPYWMAP 170 (262)
T ss_pred hCCceecCCChhhEEECCCCCEEE----------------------------CccccchhhhhhhhccccccCCccccCc
Confidence 999999999999999999888887 4888876654433233356789999999
Q ss_pred ccccCC---CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNR---GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~---~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.+.+. .++.++|+||+||++|+|++|..||..
T Consensus 171 e~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred hhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999876 788999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=213.95 Aligned_cols=151 Identities=22% Similarity=0.351 Sum_probs=123.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++.++.|+|++++++.+......+++||++. ++|..++..+. .++ ...+..++.|++.||.||
T Consensus 209 ~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~-----------~~~~~~i~~qi~~aL~yL 276 (461)
T PHA03211 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLG-----------LAQVTAVARQLLSAIDYI 276 (461)
T ss_pred HHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 35667788899999999999999999999999985 68888876432 122 234556788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y 217 (255)
|++||+||||||+||+++..+.+++ +|||+++....... .....+||+.|
T Consensus 277 H~~gIvHrDLKP~NILl~~~~~vkL----------------------------~DFGla~~~~~~~~~~~~~~~~GT~~Y 328 (461)
T PHA03211 277 HGEGIIHRDIKTENVLVNGPEDICL----------------------------GDFGAACFARGSWSTPFHYGIAGTVDT 328 (461)
T ss_pred HHCCEEECcCCHHHEEECCCCCEEE----------------------------cccCCceecccccccccccccCCCcCC
Confidence 9999999999999999998888887 59998865433211 22346799999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
+|||++.+..++.++|+|||||++|||++|..|+
T Consensus 329 ~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 329 NAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 9999999999999999999999999999987553
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=198.64 Aligned_cols=157 Identities=20% Similarity=0.262 Sum_probs=120.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+|++++++.+.+....|++|||+.+|+|.+++.+........ .....+..++.|++.|+.|||+
T Consensus 45 e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~ 118 (269)
T cd05042 45 EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQM------AQKDVLQRMACEVASGLLWLHQ 118 (269)
T ss_pred HHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhcccccccc------ccHHHHHHHHHHHHHHHHHHHh
Confidence 3455667789999999999999999999999999999999997643221111 0123345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~a 219 (255)
++|+||||||+||+++.++.+++ .|||++........ ......+++.|+|
T Consensus 119 ~~ivH~dlkp~Nill~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 170 (269)
T cd05042 119 ADFIHSDLALRNCQLTADLSVKI----------------------------GDYGLALEQYPEDYYITKDCHAVPLRWLA 170 (269)
T ss_pred cCEecccccHhheEecCCCcEEE----------------------------eccccccccccchheeccCCCCCcccccC
Confidence 99999999999999999888888 48888754322111 1122345678999
Q ss_pred cccccC-------CCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKN-------RGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~-------~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||++.. ..++.++|+||+||++|+|++ |..||.
T Consensus 171 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred HHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 999743 456789999999999999998 677765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=216.69 Aligned_cols=154 Identities=20% Similarity=0.391 Sum_probs=123.3
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++.++..+.|+|++++++.+++.+..|+++|++. ++++.++.... +..... .....+..++.|++.||.|||
T Consensus 212 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~-----~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEA-FDWKDR-----PLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcc-cccccc-----ccHHHHHHHHHHHHHHHHHHH
Confidence 45677888899999999999999999999999884 57777665322 111110 112334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~a 219 (255)
++||+||||||+|||++.++.+++ +|||+++...... ......+||+.|+|
T Consensus 285 ~~gIiHrDLKP~NILl~~~~~vkL----------------------------~DFGla~~~~~~~~~~~~~~~gt~~y~a 336 (501)
T PHA03210 285 DKKLIHRDIKLENIFLNCDGKIVL----------------------------GDFGTAMPFEKEREAFDYGWVGTVATNS 336 (501)
T ss_pred hCCeecCCCCHHHEEECCCCCEEE----------------------------EeCCCceecCcccccccccccCCcCCCC
Confidence 999999999999999999888888 5999987664332 22335689999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMK 249 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~ 249 (255)
||++.+..|+.++||||+||++|||++|..
T Consensus 337 PE~~~~~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 337 PEILAGDGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred chhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999864
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=199.07 Aligned_cols=153 Identities=31% Similarity=0.519 Sum_probs=126.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|++++++++.+.+....|++|||+.|++|.+++.+.. .+++ ..+..++.|++.||.|||
T Consensus 52 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~-----------~~~~~~~~ql~~~l~~lh 120 (280)
T cd06611 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTE-----------PQIRYVCRQMLEALNFLH 120 (280)
T ss_pred HHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4566778889999999999999999999999999999999887532 2332 334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++|+|+||+||+++.++.+++ .|||.+..............|++.|+||
T Consensus 121 ~~~i~h~dl~p~nili~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~y~~P 172 (280)
T cd06611 121 SHKVIHRDLKAGNILLTLDGDVKL----------------------------ADFGVSAKNKSTLQKRDTFIGTPYWMAP 172 (280)
T ss_pred HCCcccCCCChhhEEECCCCCEEE----------------------------ccCccchhhcccccccceeecchhhcCH
Confidence 999999999999999999888888 4888776554433334456799999999
Q ss_pred cccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIK-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++. ..+++.++|+||+||++|+|++|..||+.
T Consensus 173 E~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred HHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 9985 34577899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=199.78 Aligned_cols=162 Identities=17% Similarity=0.256 Sum_probs=123.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+|++++++.+.+....+++|||+.+|+|.+++.+.....+.. ..........+..++.|++.||.|||+
T Consensus 59 e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (277)
T cd05062 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN-PVQAPPSLKKMIQMAGEIADGMAYLNA 137 (277)
T ss_pred HHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456667789999999999999999999999999999999987533211100 000111123345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~a 219 (255)
++++||||||+||+++.++.+++ .|||+++........ .....+++.|||
T Consensus 138 ~~~vH~dlkp~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 189 (277)
T cd05062 138 NKFVHRDLAARNCMVAEDFTVKI----------------------------GDFGMTRDIYETDYYRKGGKGLLPVRWMS 189 (277)
T ss_pred CCcccCCcchheEEEcCCCCEEE----------------------------CCCCCccccCCcceeecCCCCccCHhhcC
Confidence 99999999999999999888887 488887654332111 112345778999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||++.+..++.++|+|||||++|+|++ |..||.
T Consensus 190 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred hhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999998889999999999999999998 677775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=202.31 Aligned_cols=150 Identities=28% Similarity=0.474 Sum_probs=127.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+++.+|+++||+.|++|.+++.+...+++ ..+..++.|++.||.|||+
T Consensus 49 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~ 117 (308)
T cd06615 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----------NILGKISIAVLRGLTYLRE 117 (308)
T ss_pred HHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 56677788999999999999999999999999999999999986554433 2345677889999999997
Q ss_pred -cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 -RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 -~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++++|||+||+||+++.++.+++ .|||.+...... ...+.+|++.|+||
T Consensus 118 ~~~i~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~--~~~~~~~~~~~~aP 167 (308)
T cd06615 118 KHKIMHRDVKPSNILVNSRGEIKL----------------------------CDFGVSGQLIDS--MANSFVGTRSYMSP 167 (308)
T ss_pred hCCEEECCCChHHEEEecCCcEEE----------------------------ccCCCccccccc--ccccCCCCcCccCh
Confidence 69999999999999998888877 488887654332 22356799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+..++.++|+||+||++|+|++|..||.
T Consensus 168 E~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred hHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99988889999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=201.03 Aligned_cols=163 Identities=20% Similarity=0.289 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCc-----cchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDD-----NAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
++.+++...|+|++++++.+.+.+..+++|||+.|++|.+++.....-.. .............+..++.|++.|+
T Consensus 57 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 136 (291)
T cd05094 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 136 (291)
T ss_pred HHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHH
Confidence 35567788899999999999999999999999999999999976432100 0000000112334556788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGT 214 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt 214 (255)
.|||++|++||||||+||+++.++.+++ .|||.+........ ......|+
T Consensus 137 ~~lH~~~i~H~dlkp~Nil~~~~~~~~l----------------------------~dfg~a~~~~~~~~~~~~~~~~~~ 188 (291)
T cd05094 137 VYLASQHFVHRDLATRNCLVGANLLVKI----------------------------GDFGMSRDVYSTDYYRVGGHTMLP 188 (291)
T ss_pred HHHHhCCeeecccCcceEEEccCCcEEE----------------------------CCCCcccccCCCceeecCCCCCcc
Confidence 9999999999999999999999888887 48887765432211 11234567
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+.|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 189 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred eeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 88999999999889999999999999999998 998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=199.48 Aligned_cols=147 Identities=25% Similarity=0.345 Sum_probs=117.5
Q ss_pred ccccccccccccccccC-----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 67 SRKKKTRQTRLYKTFKD-----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 67 ~~~~h~~iv~l~~~~~~-----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
....|+|++++++.+.+ ...+++++|++.+ +|.+++.+..... ...+.+..++.|++.||.|+|+
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~ 126 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG---------LPAETIKDLMRQFLRGLDFLHA 126 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 34479999999987754 3568999999985 8888876532110 1123456678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||+++...... ......||+.|+|||
T Consensus 127 ~~ivH~dikp~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~-~~~~~~~~~~y~aPE 177 (288)
T cd07863 127 NCIVHRDLKPENILVTSGGQVKL----------------------------ADFGLARIYSCQM-ALTPVVVTLWYRAPE 177 (288)
T ss_pred CCeecCCCCHHHEEECCCCCEEE----------------------------CccCccccccCcc-cCCCccccccccCch
Confidence 99999999999999999888888 4999887654322 223457899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|.+||.
T Consensus 178 ~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 178 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred HhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 9998889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=200.05 Aligned_cols=163 Identities=20% Similarity=0.280 Sum_probs=125.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccc--hhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA--ASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++....|++++++++.+.+.+..|+++||+.+|+|.+++.......... ...........+..++.|++.||.||
T Consensus 57 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l 136 (288)
T cd05093 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL 136 (288)
T ss_pred HHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3556677789999999999999999999999999999999997543211100 00000122334566788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y 217 (255)
|++|++||||||+||+++.++.+++ .|||.++....... ......+++.|
T Consensus 137 H~~~i~H~dlkp~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y 188 (288)
T cd05093 137 ASQHFVHRDLATRNCLVGENLLVKI----------------------------GDFGMSRDVYSTDYYRVGGHTMLPIRW 188 (288)
T ss_pred HhCCeeecccCcceEEEccCCcEEe----------------------------ccCCccccccCCceeecCCCCCccccc
Confidence 9999999999999999999888888 48887765432211 11123457789
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 189 ~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred cCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999998889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=205.52 Aligned_cols=148 Identities=25% Similarity=0.436 Sum_probs=119.0
Q ss_pred ceeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++....|+|++++++.+... ...|++|||+.+ ++.+.+.. .++ .+.+..++.|++.|
T Consensus 66 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~-----------~~~~~~~~~qi~~a 131 (355)
T cd07874 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELD-----------HERMSYLLYQMLCG 131 (355)
T ss_pred HHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCC-----------HHHHHHHHHHHHHH
Confidence 34566677899999999877543 357999999976 55555542 122 12345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ .|||+++...... ......||+
T Consensus 132 L~~LH~~givHrDikp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~~t~ 182 (355)
T cd07874 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LDFGLARTAGTSF-MMTPYVVTR 182 (355)
T ss_pred HHHHHhCCcccCCCChHHEEECCCCCEEE----------------------------eeCcccccCCCcc-ccCCccccC
Confidence 99999999999999999999999888888 5999887654322 223467999
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 183 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred CccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=202.08 Aligned_cols=150 Identities=28% Similarity=0.567 Sum_probs=124.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|+|++++++.+.+....|+++||+.|++|.+++.+. .++. ..+..++.|++.||.|||++
T Consensus 68 ~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~-----------~~~~~i~~ql~~aL~~LH~~ 135 (296)
T cd06654 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDE-----------GQIAAVCRECLQALEFLHSN 135 (296)
T ss_pred HHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc-CCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 45566778999999999999999999999999999999988642 2322 22345778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++||||||+||+++.++.+++ .|||.+..............|++.|+|||.
T Consensus 136 gi~H~dLkp~Nill~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 187 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187 (296)
T ss_pred CcccCCCCHHHEEEcCCCCEEE----------------------------CccccchhccccccccCcccCCccccCHHH
Confidence 9999999999999998888877 488887655433223334578999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+||++|+|++|..||.
T Consensus 188 ~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~ 217 (296)
T cd06654 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (296)
T ss_pred HcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 998888999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=196.61 Aligned_cols=158 Identities=18% Similarity=0.235 Sum_probs=122.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++.+..|+|+++++..+.+....|++|||+.+|+|.+++.......... .....+..++.|++.|+.|||+
T Consensus 45 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~ 118 (269)
T cd05087 45 EAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMT------PDPTTLQRMACEIALGLLHLHK 118 (269)
T ss_pred HHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhccccc------ccHHHHHHHHHHHHHHHHHHHH
Confidence 4556777889999999999999999999999999999999997543211100 1112344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~a 219 (255)
++++|||+||+||+++..+.+++ .|||.++....... ......|++.|+|
T Consensus 119 ~~i~H~dlkp~nil~~~~~~~kL----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 170 (269)
T cd05087 119 NNFIHSDLALRNCLLTADLTVKI----------------------------GDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170 (269)
T ss_pred CCEeccccCcceEEEcCCCcEEE----------------------------CCccccccccCcceeecCCCcCCcccccC
Confidence 99999999999999998888887 48887754332211 1123467888999
Q ss_pred cccccCC-------CCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNR-------GHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~-------~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+. .++.++|+||+||++|+|++ |..||..
T Consensus 171 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred HhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 9998642 35789999999999999996 9999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=194.69 Aligned_cols=155 Identities=26% Similarity=0.422 Sum_probs=124.1
Q ss_pred ceeeeccccccccccccccccC-ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD-SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~-~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++++...|++++++++.+.. ...+|+++||+.+++|.+.++...... .....+..++.+++.|+.|+|
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~---------l~~~~~~~~~~~l~~~l~~lH 119 (257)
T cd08223 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---------LPENQVVEWFVQIAMALQYLH 119 (257)
T ss_pred HHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHH
Confidence 3456677789999999888764 446899999999999999887532110 011234456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++..+.+++ .|||.+..............|++.|+||
T Consensus 120 ~~~i~H~di~p~nil~~~~~~~~l----------------------------~df~~~~~~~~~~~~~~~~~~~~~y~aP 171 (257)
T cd08223 120 EKHILHRDLKTQNVFLTRTNIIKV----------------------------GDLGIARVLENQCDMASTLIGTPYYMSP 171 (257)
T ss_pred hCCeeccCCCchhEEEecCCcEEE----------------------------ecccceEEecccCCccccccCCcCccCh
Confidence 999999999999999998888888 4888876554333334456789999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+||+||++|+|++|..||..
T Consensus 172 E~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred hHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999998899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=206.24 Aligned_cols=149 Identities=26% Similarity=0.454 Sum_probs=119.4
Q ss_pred ceeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++....|+|++++++.+... ..+|++|||+.+ ++...+... +++ ..+..++.|++.|
T Consensus 73 E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~-----------~~~~~~~~qi~~a 138 (364)
T cd07875 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDH-----------ERMSYLLYQMLCG 138 (364)
T ss_pred HHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHhc--CCH-----------HHHHHHHHHHHHH
Confidence 34566777899999998876543 357999999975 566655421 221 2345677899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ +|||+++...... ......||+
T Consensus 139 L~~LH~~~ivH~Dlkp~NIll~~~~~~kL----------------------------~DfG~a~~~~~~~-~~~~~~~t~ 189 (364)
T cd07875 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LDFGLARTAGTSF-MMTPYVVTR 189 (364)
T ss_pred HHHHhhCCeecCCCCHHHEEECCCCcEEE----------------------------EeCCCccccCCCC-cccCCcccC
Confidence 99999999999999999999999888888 5999887654322 223467999
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 190 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=202.11 Aligned_cols=150 Identities=29% Similarity=0.559 Sum_probs=125.4
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++....|+|++++++.+.+.+..|+++||+.|++|.+++.. ..+++ +.+..++.|++.|+.|||++
T Consensus 70 ~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~-----------~~~~~~~~qi~~~l~~LH~~ 137 (292)
T cd06658 70 VVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNE-----------EQIATVCLSVLRALSYLHNQ 137 (292)
T ss_pred HHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 4556677899999999999999999999999999999988753 22322 23456778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
+++||||||+||+++.++.+++ .|||++..............|++.|+|||.
T Consensus 138 ~ivH~dlkp~Nill~~~~~~kL----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 189 (292)
T cd06658 138 GVIHRDIKSDSILLTSDGRIKL----------------------------SDFGFCAQVSKEVPKRKSLVGTPYWMAPEV 189 (292)
T ss_pred CEeecCCCHHHEEEcCCCCEEE----------------------------ccCcchhhcccccccCceeecCccccCHHH
Confidence 9999999999999998888887 488887654433333345678999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+||++|+|++|..||.
T Consensus 190 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 998889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=200.86 Aligned_cols=152 Identities=28% Similarity=0.549 Sum_probs=127.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|+++||+.|++|..++.+. .+++ ..+..++.|++.|+.|||+
T Consensus 66 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~-----------~~~~~i~~~l~~al~~LH~ 133 (296)
T cd06655 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDE-----------AQIAAVCRECLQALEFLHA 133 (296)
T ss_pred HHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc-CCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 345567778999999999999999999999999999999988642 2322 3345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ .|||.+..............|++.|+|||
T Consensus 134 ~~i~H~dL~p~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 185 (296)
T cd06655 134 NQVIHRDIKSDNVLLGMDGSVKL----------------------------TDFGFCAQITPEQSKRSTMVGTPYWMAPE 185 (296)
T ss_pred CCcccCCCCHHHEEECCCCCEEE----------------------------ccCccchhcccccccCCCcCCCccccCcc
Confidence 99999999999999999888887 48888766544333334467899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+..++.++|+||+||++|+|++|..||..
T Consensus 186 ~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99988899999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=193.31 Aligned_cols=142 Identities=30% Similarity=0.464 Sum_probs=118.5
Q ss_pred ccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 69 KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
..|+|++++++.+.+.+..|++|||+.||+|.+.+.+...+++ +.+..++.|++.||.|||++|++|||
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~ql~~~l~~lH~~~i~H~d 110 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE-----------ECVKRWAAEMVVALDALHREGIVCRD 110 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCH-----------HHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 3589999999999999999999999999999999876543332 33456778899999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
|||+||+++.++..++ +|||.+...... .....+++.|+|||.+.+..+
T Consensus 111 lkp~Nil~~~~~~~~l----------------------------~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 159 (237)
T cd05576 111 LNPNNILLDDRGHIQL----------------------------TYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEE 159 (237)
T ss_pred CCHHHEEEcCCCCEEE----------------------------ecccchhccccc---cccCCcCccccCCcccCCCCC
Confidence 9999999999888777 488876554332 123456788999999988888
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 229 DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.++|+||+||++|+|++|..||.
T Consensus 160 ~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 160 TEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred CchhhHHHHHHHHHHHHHCcchhh
Confidence 999999999999999999987654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=199.63 Aligned_cols=147 Identities=31% Similarity=0.436 Sum_probs=123.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..++++||+.+|++.... .+++ ..+..++.|++.||.|||+
T Consensus 49 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~-----------~~~~~~~~qi~~~l~~lH~ 113 (279)
T cd06619 49 ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR----KIPE-----------HVLGRIAVAVVKGLTYLWS 113 (279)
T ss_pred HHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh----cCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999885432 1221 2344678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|+||||+||+++.++.+++ .|||++...... .....+||+.|+|||
T Consensus 114 ~~i~H~dlkp~Nill~~~~~~~l----------------------------~dfg~~~~~~~~--~~~~~~~~~~y~aPE 163 (279)
T cd06619 114 LKILHRDVKPSNMLVNTRGQVKL----------------------------CDFGVSTQLVNS--IAKTYVGTNAYMAPE 163 (279)
T ss_pred CCEeeCCCCHHHEEECCCCCEEE----------------------------eeCCcceecccc--cccCCCCChhhcCce
Confidence 99999999999999999888888 499988655332 223468999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 164 ~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred eecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 99998899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=205.55 Aligned_cols=148 Identities=24% Similarity=0.389 Sum_probs=121.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++..+.|+|++++++.+.+....|+++|++. |+|.+++.... .++ ...+..++.|++.||.|||
T Consensus 107 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-----------~~~~~~i~~qi~~aL~~LH 174 (357)
T PHA03209 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLP-----------IDQALIIEKQILEGLRYLH 174 (357)
T ss_pred HHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 3456778899999999999999999999999985 58888776432 222 2334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++..+.+++ +|||.++..... ....+..||+.|+||
T Consensus 175 ~~~ivHrDlkp~Nill~~~~~~kl----------------------------~DfG~a~~~~~~-~~~~~~~gt~~y~aP 225 (357)
T PHA03209 175 AQRIIHRDVKTENIFINDVDQVCI----------------------------GDLGAAQFPVVA-PAFLGLAGTVETNAP 225 (357)
T ss_pred HCCeecCCCCHHHEEECCCCCEEE----------------------------ecCccccccccC-cccccccccccccCC
Confidence 999999999999999999888887 599988643222 223356799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKE 250 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~ 250 (255)
|++.+..++.++|+||+||++|+|+++..|
T Consensus 226 E~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 226 EVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred eecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 999999999999999999999999986544
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=201.34 Aligned_cols=150 Identities=31% Similarity=0.579 Sum_probs=125.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|+|++++++.+..++..|+++||+.+++|..++.. ..+++ +.+..++.|++.||.|||++
T Consensus 69 ~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~-----------~~~~~~~~qi~~~L~~LH~~ 136 (297)
T cd06659 69 VVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNE-----------EQIATVCESVLQALCYLHSQ 136 (297)
T ss_pred HHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCH-----------HHHHHHHHHHHHHHHHHHhC
Confidence 4456677899999999999999999999999999999887754 22322 23455778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
+++||||||+||+++.++.+++ +|||++.............+|++.|+|||+
T Consensus 137 ~ivH~dl~p~Nill~~~~~~kL----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 188 (297)
T cd06659 137 GVIHRDIKSDSILLTLDGRVKL----------------------------SDFGFCAQISKDVPKRKSLVGTPYWMAPEV 188 (297)
T ss_pred CeecCCCCHHHeEEccCCcEEE----------------------------eechhHhhcccccccccceecCccccCHHH
Confidence 9999999999999999888888 599988655443333345679999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+||++|+|++|..||.
T Consensus 189 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 998889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=197.62 Aligned_cols=152 Identities=36% Similarity=0.616 Sum_probs=128.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+....|+++|++.+++|.+.+... .+++ +.+..++.|++.|+.|+|+
T Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~-----------~~~~~~~~ql~~~l~~lh~ 116 (274)
T cd06609 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDE-----------TYIAFILREVLLGLEYLHE 116 (274)
T ss_pred HHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 355566778999999999999999999999999999999998753 2222 3455677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||+|+|++++.++.+++ .|||.++.............|++.|+|||
T Consensus 117 ~~i~h~dl~p~ni~i~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~y~~PE 168 (274)
T cd06609 117 EGKIHRDIKAANILLSEEGDVKL----------------------------ADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168 (274)
T ss_pred CCcccCCCCHHHEEECCCCCEEE----------------------------cccccceeecccccccccccCCccccChh
Confidence 99999999999999999888887 48888876654433344567899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+..++.++|+||+||++|+|++|..||+.
T Consensus 169 ~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=200.71 Aligned_cols=162 Identities=19% Similarity=0.301 Sum_probs=123.5
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch-----hhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-----SFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++.+. .|++++++++.+.+....|+++||+.+|+|.+++.+....+.... ..........+..++.|++.|
T Consensus 52 E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 131 (297)
T cd05089 52 ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATG 131 (297)
T ss_pred HHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHH
Confidence 45555566 699999999999999999999999999999999976543322110 000112234456678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++|++||||||+||+++.++.+++ .|||++....... ......++.
T Consensus 132 l~~lH~~~ivH~dlkp~Nill~~~~~~kl----------------------------~dfg~~~~~~~~~-~~~~~~~~~ 182 (297)
T cd05089 132 MQYLSEKQFIHRDLAARNVLVGENLASKI----------------------------ADFGLSRGEEVYV-KKTMGRLPV 182 (297)
T ss_pred HHHHHHCCcccCcCCcceEEECCCCeEEE----------------------------CCcCCCcccccee-ccCCCCcCc
Confidence 99999999999999999999998888877 4888875432211 111122345
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus 183 ~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred cccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 7999999998889999999999999999997 988874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=196.56 Aligned_cols=153 Identities=30% Similarity=0.524 Sum_probs=126.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.+++.+.|++++++++.+.+....++++||+.|++|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 56 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~-----------~~~~~~~~l~~~l~~lH~ 124 (267)
T cd06628 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEET-----------LVRNFVRQILKGLNYLHN 124 (267)
T ss_pred HHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHH-----------HHHHHHHHHHHHHHHHHh
Confidence 456677888999999999999999999999999999999999765544332 344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC------ccccccccCC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG------CKTWTFCGTP 215 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~------~~~~~~~gt~ 215 (255)
+|++||||+|+||+++.++.+++. |||.++...... .......|++
T Consensus 125 ~~ivH~di~p~nil~~~~~~~~l~----------------------------dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (267)
T cd06628 125 RGIIHRDIKGANILVDNKGGIKIS----------------------------DFGISKKLEANSLSTKTNGARPSLQGSV 176 (267)
T ss_pred cCcccccCCHHHEEEcCCCCEEec----------------------------ccCCCcccccccccCCccccccccCCCc
Confidence 999999999999999988888884 777765543211 1122356889
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||.+.+..++.++|+||+||++|+|++|..||+.
T Consensus 177 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred CccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 99999999988899999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=196.61 Aligned_cols=153 Identities=39% Similarity=0.717 Sum_probs=129.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|++++++++.+.+....+++||++.+++|.+++.....++. ..+..++.|++.||.+||+
T Consensus 48 e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~qi~~~L~~Lh~ 116 (260)
T PF00069_consen 48 EIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSE-----------EEILKIAYQILEALAYLHS 116 (260)
T ss_dssp HHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred hhhccccccccccccccccccccccccccccccccccccccccccccccc-----------ccccccccccccccccccc
Confidence 45667777899999999999999999999999999999999985554443 2345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||||+||+++.++.+++ +|||.+..............||+.|+|||
T Consensus 117 ~~i~H~dikp~NIl~~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 168 (260)
T PF00069_consen 117 KGIVHRDIKPENILLDENGEVKL----------------------------IDFGSSVKLSENNENFNPFVGTPEYMAPE 168 (260)
T ss_dssp TTEEESSBSGGGEEESTTSEEEE----------------------------SSGTTTEESTSTTSEBSSSSSSGGGSCHH
T ss_pred ccccccccccccccccccccccc----------------------------ccccccccccccccccccccccccccccc
Confidence 99999999999999998888877 59998865433333445678999999999
Q ss_pred ccc-CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIK-NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~-~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++. +..++.++|+||+|+++|+|++|..||..
T Consensus 169 ~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 169 VLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp HHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred ccccccccccccccccccccccccccccccccc
Confidence 998 78899999999999999999999998864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=202.82 Aligned_cols=159 Identities=19% Similarity=0.266 Sum_probs=118.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++....|+|++++++.+.+++..|+++||+.+|+|.+++..+. .++ ...+..++.|++.||.||
T Consensus 49 e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~-----------~~~~~~i~~qi~~~L~~L 117 (327)
T cd08227 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMS-----------ELAIAYILQGVLKALDYI 117 (327)
T ss_pred HHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 3456667789999999999999999999999999999999986532 122 233456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|+++++||||||+||+++.++.+++..+...... .++|....... .......++..|+|
T Consensus 118 H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~-------------------~~~~~~~~~~~--~~~~~~~~~~~y~a 176 (327)
T cd08227 118 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM-------------------INHGQRLRVVH--DFPKYSVKVLPWLS 176 (327)
T ss_pred HHCCEecCCCChhhEEEecCCcEEEcccchhhcc-------------------ccccccccccc--cccccccceecccC
Confidence 9999999999999999998887777432211110 01111100000 01112356778999
Q ss_pred cccccC--CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKN--RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 177 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred hHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999976 468999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=199.87 Aligned_cols=163 Identities=23% Similarity=0.296 Sum_probs=125.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|++++++++.+.+.+..|++|||+.+|+|.+++.....................+..++.|++.||.|||+
T Consensus 69 E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 148 (296)
T cd05095 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS 148 (296)
T ss_pred HHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 45667788999999999999999999999999999999999876543222111111112233456678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~a 219 (255)
+|++||||||+||+++.++.+++ .|||.++....... ......+++.|+|
T Consensus 149 ~~i~H~dlkp~Nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (296)
T cd05095 149 LNFVHRDLATRNCLVGKNYTIKI----------------------------ADFGMSRNLYSGDYYRIQGRAVLPIRWMS 200 (296)
T ss_pred CCeecccCChheEEEcCCCCEEe----------------------------ccCcccccccCCcceeccCcCcCccccCC
Confidence 99999999999999998888877 48888765433211 1112344678999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc--CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT--GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~--G~~~~~ 252 (255)
||...+..++.++|+||+||++|||++ |..||.
T Consensus 201 pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 201 WESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred HHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999888889999999999999999998 667775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=197.91 Aligned_cols=163 Identities=20% Similarity=0.292 Sum_probs=125.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh------hHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS------FITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~------~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++..+.|+|++++++.+.+.+..|++|||+.+|+|.+++..+......... .........+..++.|++.|
T Consensus 57 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 136 (283)
T cd05090 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136 (283)
T ss_pred HHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHH
Confidence 456778889999999999999999999999999999999998654321100000 00011223345577899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--cccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~g 213 (255)
|.|||+++++||||||+|++++..+.+++ .|||+++...... .......+
T Consensus 137 l~~lH~~~i~H~dlkp~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~ 188 (283)
T cd05090 137 MEYLSSHFFVHKDLAARNILIGEQLHVKI----------------------------SDLGLSREIYSADYYRVQPKSLL 188 (283)
T ss_pred HHHHHhcCeehhccccceEEEcCCCcEEe----------------------------ccccccccccCCcceecccCCCc
Confidence 99999999999999999999998887877 4888886543321 11223456
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+..|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 189 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred cceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 678999999988889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=198.13 Aligned_cols=162 Identities=20% Similarity=0.322 Sum_probs=124.0
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch-----hhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-----SFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++.+. .|+|++++++.+......|++|||+.+|+|.+++..........+ ........+.+..++.|++.|
T Consensus 45 E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a 124 (270)
T cd05047 45 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 124 (270)
T ss_pred HHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHH
Confidence 45556666 799999999999999999999999999999999976543322110 000112234456678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
+.|||++|++||||||+||+++.++.+++ +|||++....... ......+++
T Consensus 125 l~~lH~~~i~H~dikp~nili~~~~~~kl----------------------------~dfgl~~~~~~~~-~~~~~~~~~ 175 (270)
T cd05047 125 MDYLSQKQFIHRDLAARNILVGENYVAKI----------------------------ADFGLSRGQEVYV-KKTMGRLPV 175 (270)
T ss_pred HHHHHHCCEeecccccceEEEcCCCeEEE----------------------------CCCCCccccchhh-hccCCCCcc
Confidence 99999999999999999999999888887 4888775322111 111123356
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 176 ~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred ccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 7999999988889999999999999999997 888884
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=204.35 Aligned_cols=147 Identities=28% Similarity=0.533 Sum_probs=120.2
Q ss_pred ceeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++....|+|++++++.+.+. ...|+++|++ |++|..+++. ..+++ +.+..++.|++.|
T Consensus 64 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~-----------~~~~~i~~qi~~a 130 (343)
T cd07878 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-QKLSD-----------EHVQFLIYQLLRG 130 (343)
T ss_pred HHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-CCCCH-----------HHHHHHHHHHHHH
Confidence 46677888999999999887543 4578999987 7888877753 22332 3456678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ +|||+++..... ....+||+
T Consensus 131 L~~LH~~~ivHrdikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~---~~~~~~t~ 179 (343)
T cd07878 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRI----------------------------LDFGLARQADDE---MTGYVATR 179 (343)
T ss_pred HHHHHHCCeecccCChhhEEECCCCCEEE----------------------------cCCccceecCCC---cCCccccc
Confidence 99999999999999999999999888888 499988765332 23567999
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred cccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999977 578899999999999999999999885
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=197.92 Aligned_cols=152 Identities=31% Similarity=0.540 Sum_probs=127.3
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++++++...|+|++++++.+.+.+..|+++||+.|++|.+++... .+++ +.+..++.|++.|+.|||
T Consensus 51 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~-----------~~~~~~~~~i~~~l~~lH 118 (277)
T cd06642 51 QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-PLEE-----------TYIATILREILKGLDYLH 118 (277)
T ss_pred HHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC-CCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 3456677888999999999999999999999999999999888642 2222 234556788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++|+||+|+||+++.++.+++ .|||.+..............|+..|+||
T Consensus 119 ~~~ivH~dl~p~ni~i~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aP 170 (277)
T cd06642 119 SERKIHRDIKAANVLLSEQGDVKL----------------------------ADFGVAGQLTDTQIKRNTFVGTPFWMAP 170 (277)
T ss_pred cCCeeccCCChheEEEeCCCCEEE----------------------------ccccccccccCcchhhhcccCcccccCH
Confidence 999999999999999998888877 4888877654433333345788999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+..++.++|+||+||++|+|++|..||+
T Consensus 171 E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred HHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 99998889999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=201.64 Aligned_cols=162 Identities=20% Similarity=0.311 Sum_probs=124.8
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh-----hHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS-----FITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++.+. .|++++++++.+.+.+..|++|||+.||+|.+++.+.....+..+. .........+..++.|++.|
T Consensus 57 Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 136 (303)
T cd05088 57 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 136 (303)
T ss_pred HHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHH
Confidence 45556666 7999999999999999999999999999999999865543322110 00011223455678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
+.|||++|++||||||+|++++.++.+++ .|||++....... ......+++
T Consensus 137 l~~LH~~gi~H~dlkp~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~-~~~~~~~~~ 187 (303)
T cd05088 137 MDYLSQKQFIHRDLAARNILVGENYVAKI----------------------------ADFGLSRGQEVYV-KKTMGRLPV 187 (303)
T ss_pred HHHHHhCCccccccchheEEecCCCcEEe----------------------------CccccCcccchhh-hcccCCCcc
Confidence 99999999999999999999998888887 4888875432111 111123456
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.|+|||.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 188 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred cccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 7999999988889999999999999999998 888885
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=198.83 Aligned_cols=153 Identities=29% Similarity=0.475 Sum_probs=124.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++++...|+|++++++.+..+...|++|||+.|+++..++.+.. .+++ +.+..++.|++.|+.|||
T Consensus 59 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~-----------~~~~~~~~ql~~~l~~lH 127 (292)
T cd06644 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE-----------PQIQVICRQMLEALQYLH 127 (292)
T ss_pred HHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 4556778889999999999999999999999999999988775432 2222 334557788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++||||||+||+++.++.+++ .|||.+..............|++.|+||
T Consensus 128 ~~~i~H~dlkp~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aP 179 (292)
T cd06644 128 SMKIIHRDLKAGNVLLTLDGDIKL----------------------------ADFGVSAKNVKTLQRRDSFIGTPYWMAP 179 (292)
T ss_pred cCCeeecCCCcceEEEcCCCCEEE----------------------------ccCccceeccccccccceecCCccccCc
Confidence 999999999999999998888887 4888776543332333456789999999
Q ss_pred cccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIK-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++. ...++.++|+||+||++|+|++|..||..
T Consensus 180 E~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred eeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 9985 34578899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=196.33 Aligned_cols=154 Identities=28% Similarity=0.485 Sum_probs=121.0
Q ss_pred eeeeccc-cccccccccccccC------ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKD------SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~------~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+.++.+. .|+|++++++.+.+ ....|+++||+.+|+|.+++....... ...+.+..++.|++.|
T Consensus 53 ~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~---------l~~~~~~~~~~qi~~~ 123 (272)
T cd06637 53 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---------LKEEWIAYICREILRG 123 (272)
T ss_pred HHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCC---------CCHHHHHHHHHHHHHH
Confidence 3344444 69999999888764 246899999999999999987532110 1113345577899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
+.|||+++++|||+||+||+++.++.+++ .|||++...........+..|++
T Consensus 124 l~~LH~~~ivh~dl~~~nili~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~g~~ 175 (272)
T cd06637 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKL----------------------------VDFGVSAQLDRTVGRRNTFIGTP 175 (272)
T ss_pred HHHHHHCCCccCCCCHHHEEECCCCCEEE----------------------------ccCCCceecccccccCCcccccc
Confidence 99999999999999999999999888887 49998876543333344578999
Q ss_pred CCccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIK-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++. +..++.++|+||+||++|+|++|..||+.
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred cccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999986 34688899999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=194.81 Aligned_cols=152 Identities=61% Similarity=1.088 Sum_probs=128.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|+++||+.|++|.+.+.+...+++ ..+..++.|++.||.|+|+
T Consensus 43 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~~i~~~l~~lH~ 111 (262)
T cd05572 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-----------YTARFYIACVVLAFEYLHN 111 (262)
T ss_pred HHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCH-----------HHHHHHHHHHHHHHHHHhh
Confidence 35566777899999999999999999999999999999999976544332 2345567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|+||+|.||+++.++.+++ +|||.++...... ......|++.|+|||
T Consensus 112 ~~~~h~dl~~~nilv~~~~~~~l----------------------------~df~~~~~~~~~~-~~~~~~~~~~~~~PE 162 (262)
T cd05572 112 RGIIYRDLKPENLLLDSNGYVKL----------------------------VDFGFAKKLKSGQ-KTWTFCGTPEYVAPE 162 (262)
T ss_pred CCcccCCCCHHHEEEcCCCCEEE----------------------------eeCCcccccCccc-ccccccCCcCccChh
Confidence 99999999999999999888887 5899887664432 233457899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred HhcCCCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 99888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=200.56 Aligned_cols=151 Identities=24% Similarity=0.375 Sum_probs=123.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++..+.|+|++++++.+.+.+..|+++||+. ++|.+.+.... .++ ...+..++.|++.||.|||
T Consensus 54 E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-----------~~~~~~~~~qi~~aL~~lH 121 (301)
T cd07873 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSIN-----------MHNVKLFLFQLLRGLNYCH 121 (301)
T ss_pred HHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4667778899999999999999999999999997 58888776432 222 2335567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++.++.+++ .|||.+..............+++.|+||
T Consensus 122 ~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~~P 173 (301)
T cd07873 122 RRKVLHRDLKPQNLLINERGELKL----------------------------ADFGLARAKSIPTKTYSNEVVTLWYRPP 173 (301)
T ss_pred hCCeeCCCCCHHHEEECCCCcEEE----------------------------CcCcchhccCCCCCcccccceeecccCc
Confidence 999999999999999999888888 4898876544332223345678999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 174 E~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred HHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 99875 457889999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=194.89 Aligned_cols=153 Identities=31% Similarity=0.495 Sum_probs=123.5
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++....|++++++++.+.+. ..+|+++||+.|++|.+.+.+...+++. ....++.|++.||.|+
T Consensus 54 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~l~~~l~~l 122 (265)
T cd06652 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN-----------VTRKYTRQILEGVSYL 122 (265)
T ss_pred HHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHH
Confidence 45667788899999999987763 5688999999999999998765444332 2234677899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC---CccccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS---GCKTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~---~~~~~~~~gt~~ 216 (255)
|+++++|+||||+||+++.++..++ .|||.+...... ........|+..
T Consensus 123 H~~~i~H~dl~p~nil~~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (265)
T cd06652 123 HSNMIVHRDIKGANILRDSVGNVKL----------------------------GDFGASKRLQTICLSGTGMKSVTGTPY 174 (265)
T ss_pred HhCCEecCCCCHHHEEecCCCCEEE----------------------------CcCccccccccccccccccccCCCCcc
Confidence 9999999999999999998888887 488877654321 111223568899
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 175 y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 9999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=197.55 Aligned_cols=162 Identities=19% Similarity=0.292 Sum_probs=125.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+....|++|||+.+|+|.+++.......+.. ..........+..++.|++.||.|||+
T Consensus 59 e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~ 137 (277)
T cd05032 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENN-PGLGPPTLQKFIQMAAEIADGMAYLAA 137 (277)
T ss_pred HHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3455667789999999999999999999999999999999997643221110 000011123345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~a 219 (255)
++++||||||+||+++.++.+++ .|||.++....... ......++..|+|
T Consensus 138 ~~i~H~di~p~nill~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 189 (277)
T cd05032 138 KKFVHRDLAARNCMVAEDLTVKI----------------------------GDFGMTRDIYETDYYRKGGKGLLPVRWMA 189 (277)
T ss_pred CCccccccChheEEEcCCCCEEE----------------------------CCcccchhhccCcccccCCCCCccccccC
Confidence 99999999999999999888887 48887765433221 1223456788999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+.+..++.++|+||+||++|++++ |..||.
T Consensus 190 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred HHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 999988889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=197.70 Aligned_cols=150 Identities=23% Similarity=0.398 Sum_probs=121.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+.+..|+++||+.+ +|.+.+.+. ..++ .+.+..++.|++.||.|||
T Consensus 49 ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~-----------~~~~~~~~~qi~~al~~LH 116 (284)
T cd07839 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDID-----------PEIVKSFMFQLLKGLAFCH 116 (284)
T ss_pred HHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 56677888999999999999999999999999975 777776542 2222 2334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++||||||+||+++.++.+++ .|||.++.............+++.|+||
T Consensus 117 ~~~i~H~dl~~~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aP 168 (284)
T cd07839 117 SHNVLHRDLKPQNLLINKNGELKL----------------------------ADFGLARAFGIPVRCYSAEVVTLWYRPP 168 (284)
T ss_pred HCCEecCCCCHHHEEEcCCCcEEE----------------------------CccchhhccCCCCCCcCCCccccCCcCh
Confidence 999999999999999999888888 4888877554332222345678999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
|++.+ ..++.++|+||+||++|+|++|..||
T Consensus 169 E~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred HHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 99876 45789999999999999999998775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=199.02 Aligned_cols=163 Identities=21% Similarity=0.324 Sum_probs=125.1
Q ss_pred eeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh-----hHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS-----FITACVIEALDFITACVIEAL 136 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~il~~l 136 (255)
+.++.+. .|+|++++++.+.+...+|++|||+.+|+|..++.++....+.... .........+..++.|++.||
T Consensus 66 ~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 145 (293)
T cd05053 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM 145 (293)
T ss_pred HHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 3444455 7999999999999999999999999999999999765432222110 011223345566788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGT 214 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt 214 (255)
.|||+++++||||||+||+++.++.+++ .|||.++........ .....++
T Consensus 146 ~~LH~~~ivH~dlkp~Nil~~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 197 (293)
T cd05053 146 EFLASKKCIHRDLAARNVLVTEDHVMKI----------------------------ADFGLARDIHHIDYYRKTTNGRLP 197 (293)
T ss_pred HHHHHCCccccccceeeEEEcCCCeEEe----------------------------CccccccccccccceeccCCCCCC
Confidence 9999999999999999999999888887 488887765432211 1122345
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+.|+|||++.+..++.++|+||+||++|++++ |..||..
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred ccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 67999999998889999999999999999997 8888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=206.76 Aligned_cols=163 Identities=23% Similarity=0.351 Sum_probs=124.4
Q ss_pred ceeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCC-----c----------------c-------
Q psy3182 62 YVKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFD-----D----------------N------- 112 (255)
Q Consensus 62 ~vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~-----~----------------~------- 112 (255)
+++++.++. |+|++++++.+.+....|++||||.||+|.+++.+..... + .
T Consensus 90 Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (400)
T cd05105 90 ELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVIL 169 (400)
T ss_pred HHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhh
Confidence 456677775 9999999999999999999999999999999886532100 0 0
Q ss_pred ---------------ch-------------------------------------hhH-----HHHHHHHHHHHHHHHHHH
Q psy3182 113 ---------------AA-------------------------------------SFI-----TACVIEALDFITACVIEA 135 (255)
Q Consensus 113 ---------------~~-------------------------------------~~~-----~~~~~~~~~~i~~~il~~ 135 (255)
.+ ... .......+..++.|++.|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~a 249 (400)
T cd05105 170 SFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARG 249 (400)
T ss_pred hhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence 00 000 001223345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--ccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~g 213 (255)
|.|||+++++||||||+||+++.++.+++ .|||+++....... ......|
T Consensus 250 L~~LH~~~ivH~dikp~Nill~~~~~~kL----------------------------~DfGla~~~~~~~~~~~~~~~~~ 301 (400)
T cd05105 250 MEFLASKNCVHRDLAARNVLLAQGKIVKI----------------------------CDFGLARDIMHDSNYVSKGSTFL 301 (400)
T ss_pred HHHHHhCCeeCCCCChHhEEEeCCCEEEE----------------------------EeCCcceeccccccccccCCcCC
Confidence 99999999999999999999998887777 48988765433211 1223457
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
++.|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 302 ~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred CcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 788999999998889999999999999999996 888874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=199.29 Aligned_cols=150 Identities=27% Similarity=0.563 Sum_probs=125.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|++++++++.+.+.+..|+++||+.|++|.+++.+. .+++ ..+..++.|++.||.|||+.
T Consensus 67 ~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~-----------~~~~~~~~~l~~~L~~LH~~ 134 (297)
T cd06656 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDE-----------GQIAAVCRECLQALDFLHSN 134 (297)
T ss_pred HHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC-CCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 44566778999999999999999999999999999999988642 2222 23445778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++||||||+||+++.++.+++ .|||.+..............|++.|+|||.
T Consensus 135 ~i~H~dL~p~Nili~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 186 (297)
T cd06656 135 QVIHRDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186 (297)
T ss_pred CcccCCCCHHHEEECCCCCEEE----------------------------CcCccceEccCCccCcCcccCCccccCHHH
Confidence 9999999999999998888887 488887655443333334678999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+||++|+|++|..||.
T Consensus 187 ~~~~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred HcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=197.54 Aligned_cols=163 Identities=20% Similarity=0.287 Sum_probs=125.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCC----ccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFD----DNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~----~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++....|+|++++++.+.+....|+++||+.+|+|.+++....... ..............+..++.|++.|+.
T Consensus 57 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 136 (280)
T cd05092 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMV 136 (280)
T ss_pred HHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHH
Confidence 3456677789999999999999999999999999999999997643210 000000011223445667889999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~ 215 (255)
|||++|++||||||+||+++.++.+++ .|||.+........ ......+++
T Consensus 137 ~LH~~~i~H~dlkp~nil~~~~~~~kL----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~ 188 (280)
T cd05092 137 YLASLHFVHRDLATRNCLVGQGLVVKI----------------------------GDFGMSRDIYSTDYYRVGGRTMLPI 188 (280)
T ss_pred HHHHCCeecccccHhhEEEcCCCCEEE----------------------------CCCCceeEcCCCceeecCCCccccc
Confidence 999999999999999999998888887 48887754322111 111234567
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.|+|||.+.+..++.++|+|||||++|+|++ |.+||.
T Consensus 189 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred cccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 8999999999889999999999999999998 888885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=194.07 Aligned_cols=155 Identities=16% Similarity=0.250 Sum_probs=119.1
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRG 143 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ 143 (255)
.++....|+|++++++.+.+....|++|||+.+|+|.+++.+....... .....+..++.|++.||.|||+++
T Consensus 47 ~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~~~~~i~~al~~lH~~~ 119 (268)
T cd05086 47 DPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN-------SQLLLLQRMACEIAAGVTHMHKHN 119 (268)
T ss_pred HHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhccccc-------ccHHHHHHHHHHHHHHHHHHHHCC
Confidence 4456678999999999999999999999999999999999764321111 112234556789999999999999
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCcccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYVAPE 221 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~aPE 221 (255)
++||||||+||+++.++.+++ .|||.+....... ......+|++.|+|||
T Consensus 120 i~H~dikp~nil~~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 171 (268)
T cd05086 120 FLHSDLALRNCFLTSDLTVKV----------------------------GDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171 (268)
T ss_pred eeccCCccceEEEcCCccEEe----------------------------cccccccccCcchhhhcccCCcCcccccCch
Confidence 999999999999998888887 4888765322111 1123457889999999
Q ss_pred cccC-------CCCCCcchHHHHHHHHHHHhcC-CCCCcC
Q psy3182 222 IIKN-------RGHDRAVDYWALGILMHELLTG-MKESNV 253 (255)
Q Consensus 222 ~~~~-------~~~~~~~DiWslGvil~ell~G-~~~~~~ 253 (255)
++.. ..++.++|+||+||++|+|+++ ..||..
T Consensus 172 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred hcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 9853 2456789999999999999974 667753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=193.40 Aligned_cols=162 Identities=23% Similarity=0.342 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++++.+...+|++|||+.|++|.+++.....-. ............+..++.|++.||.|||+
T Consensus 46 e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~al~~lH~ 123 (262)
T cd00192 46 EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVF--PSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123 (262)
T ss_pred HHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccc--cccccccCCHHHHHHHHHHHHHHHHHHHc
Confidence 4556677789999999999999999999999999999999997641100 00000001123345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~a 219 (255)
++++||||||+||+++.++.+++ .|||.+....... .......+++.|+|
T Consensus 124 ~~i~H~di~p~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 175 (262)
T cd00192 124 KKFVHRDLAARNCLVGEDLVVKI----------------------------SDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175 (262)
T ss_pred CCcccCccCcceEEECCCCcEEE----------------------------cccccccccccccccccccCCCcCccccC
Confidence 99999999999999999988888 4888876654432 12234567889999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||.+....++.++|+||+||++|+|++ |..||..
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 999998889999999999999999998 5888864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=199.05 Aligned_cols=154 Identities=23% Similarity=0.334 Sum_probs=123.8
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++.+. .|+|++++++.+.+.+..|++|||+.+|+|.+++++..... .....+..++.|++.||.|+|
T Consensus 88 E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~---------l~~~~~~~i~~~i~~~l~~lH 158 (302)
T cd05055 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF---------LTLEDLLSFSYQVAKGMAFLA 158 (302)
T ss_pred HHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCC---------CCHHHHHHHHHHHHHHHHHHH
Confidence 45566677 79999999999999999999999999999999987532100 112334557788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
+++++|+||||+||+++..+.+++ .|||.++....... ......+++.|+
T Consensus 159 ~~~ivH~dlkp~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 210 (302)
T cd05055 159 SKNCIHRDLAARNVLLTHGKIVKI----------------------------CDFGLARDIMNDSNYVVKGNARLPVKWM 210 (302)
T ss_pred HCCeehhhhccceEEEcCCCeEEE----------------------------CCCcccccccCCCceeecCCCCcccccC
Confidence 999999999999999988877777 48888876543221 111234677899
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|||.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 211 aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred CHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence 9999998889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=195.33 Aligned_cols=154 Identities=16% Similarity=0.179 Sum_probs=117.4
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+.++....|+|++++++.+.+....+++|||+.+|+|..++.++. .+++ ..+..++.|++.|+.|||+
T Consensus 55 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH~ 123 (262)
T cd05077 55 ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT-----------PWKFKVAKQLASALSYLED 123 (262)
T ss_pred HHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHhhh
Confidence 456677889999999999999999999999999999988876532 2222 2234577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||||+||+++..+..... . ......|||.+...... ....|++.|+|||
T Consensus 124 ~~ivH~dlkp~Nill~~~~~~~~~---------------~------~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE 178 (262)
T cd05077 124 KDLVHGNVCTKNILLAREGIDGEC---------------G------PFIKLSDPGIPITVLSR----QECVERIPWIAPE 178 (262)
T ss_pred CCeECCCCCcccEEEecCCccCCC---------------C------ceeEeCCCCCCccccCc----ccccccccccChh
Confidence 999999999999999765531100 0 00112488887654322 2346888999999
Q ss_pred ccc-CCCCCCcchHHHHHHHHHHHh-cCCCCCc
Q psy3182 222 IIK-NRGHDRAVDYWALGILMHELL-TGMKESN 252 (255)
Q Consensus 222 ~~~-~~~~~~~~DiWslGvil~ell-~G~~~~~ 252 (255)
.+. +..++.++|+||+||++|+|+ .|..||.
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 179 CVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred hhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 987 467899999999999999997 5777765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=199.09 Aligned_cols=162 Identities=22% Similarity=0.320 Sum_probs=124.2
Q ss_pred eeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch----h-hHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA----S-FITACVIEALDFITACVIEAL 136 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~----~-~~~~~~~~~~~~i~~~il~~l 136 (255)
+.++... .|+|++++++.+.+....|++|||+.+|+|.+++.++........ . .........+..++.|++.||
T Consensus 71 ~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 150 (304)
T cd05101 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGM 150 (304)
T ss_pred HHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHH
Confidence 4555555 799999999999999999999999999999999976532211100 0 001112234556778999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGT 214 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt 214 (255)
.|||++|++||||||+||+++.++.+++ +|||.++........ .....++
T Consensus 151 ~~LH~~givH~dlkp~Nili~~~~~~kl----------------------------~D~g~~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05101 151 EYLASQKCIHRDLAARNVLVTENNVMKI----------------------------ADFGLARDVNNIDYYKKTTNGRLP 202 (304)
T ss_pred HHHHHCCeeecccccceEEEcCCCcEEE----------------------------CCCccceecccccccccccCCCCC
Confidence 9999999999999999999998888877 488888765432211 1223456
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+.|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 203 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 78999999998889999999999999999998 677764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=221.46 Aligned_cols=172 Identities=27% Similarity=0.404 Sum_probs=120.5
Q ss_pred ceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++..+.|++++++++.|.+ ...+|+||||+.+|+|..+|........ ......+..++.||+.||.||
T Consensus 62 EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g-------~L~E~~Il~Ia~QIL~ALaYL 134 (1021)
T PTZ00266 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG-------KIEEHAIVDITRQLLHALAYC 134 (1021)
T ss_pred HHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHH
Confidence 4567778899999999998854 4679999999999999999875211000 011234556788999999999
Q ss_pred HHc-------CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccc
Q psy3182 140 HTR-------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFC 212 (255)
Q Consensus 140 H~~-------~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~ 212 (255)
|+. +||||||||+|||+...... +..... ......+ .....++|||++....... .....+
T Consensus 135 Hs~g~~~~~k~IVHRDLKPeNILL~s~~~~-lg~i~~----~~~n~ng------~~iVKLsDFGlAr~l~~~s-~~~s~v 202 (1021)
T PTZ00266 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRH-IGKITA----QANNLNG------RPIAKIGDFGLSKNIGIES-MAHSCV 202 (1021)
T ss_pred HhcccccccCCceeccCcHHHeEeecCccc-cccccc----cccccCC------CCceEEccCCccccccccc-cccccC
Confidence 984 49999999999999653210 000000 0000000 0112336999987654322 233567
Q ss_pred cCCCCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 213 GTPEYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 213 gt~~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 203 GTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred CCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 9999999999864 458899999999999999999999985
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=193.31 Aligned_cols=152 Identities=30% Similarity=0.504 Sum_probs=126.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++.+..|+|++++++.+.+.+..++++||+.||+|.+.+.+.. .+++ ..+..++.|++.|+.||
T Consensus 49 e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~-----------~~~~~~~~~l~~~l~~l 117 (256)
T cd08221 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE-----------EMVLWYLFQIVSAVSYI 117 (256)
T ss_pred HHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 4556777889999999999999999999999999999999987642 1221 23445678899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++|++|+||+|+||+++..+.+++ .|||.+..............|++.|+|
T Consensus 118 h~~~i~h~dl~p~ni~~~~~~~~kl----------------------------~d~~~~~~~~~~~~~~~~~~~~~~y~a 169 (256)
T cd08221 118 HKAGILHRDIKTLNIFLTKAGLIKL----------------------------GDFGISKILGSEYSMAETVVGTPYYMS 169 (256)
T ss_pred HhCCccccCCChHhEEEeCCCCEEE----------------------------CcCcceEEcccccccccccCCCccccC
Confidence 9999999999999999999888888 488877655443323345678999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++|..||.
T Consensus 170 pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred HhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 999998888999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=193.23 Aligned_cols=151 Identities=23% Similarity=0.341 Sum_probs=120.7
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|++++++++.+++ +..+++|||+.+|+|.+++.+...+++ +.+..++.|++.||.|+|++
T Consensus 47 ~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~al~~lH~~ 114 (257)
T cd05116 47 ANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTE-----------KNITELVHQVSMGMKYLEET 114 (257)
T ss_pred HHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 456667789999999887654 467899999999999999876544443 23345678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCCCCcc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTPEYVA 219 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~~y~a 219 (255)
|++||||||.||+++.++.+++ .|||.++........ .....+++.|+|
T Consensus 115 ~i~H~dlkp~nill~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 166 (257)
T cd05116 115 NFVHRDLAARNVLLVTQHYAKI----------------------------SDFGLSKALGADENYYKAKTHGKWPVKWYA 166 (257)
T ss_pred CEeecccchhhEEEcCCCeEEE----------------------------CCCccccccCCCCCeeeecCCCCCCccccC
Confidence 9999999999999998887777 488887765433221 112234578999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||.+....++.++|+||+||++|||++ |..||..
T Consensus 167 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred HhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=196.42 Aligned_cols=163 Identities=17% Similarity=0.274 Sum_probs=124.8
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccc-----hhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA-----ASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+.+++...|++++++++.+.+....++++||+.+++|.+++..+....... ...........+..++.|++.||.
T Consensus 59 ~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~ 138 (283)
T cd05091 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGME 138 (283)
T ss_pred HHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 445667889999999999999999999999999999999986432211000 000011122345567889999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~ 215 (255)
|+|++|++||||||+||++...+.+++ .|||+++....... ......+++
T Consensus 139 ~lH~~gi~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~ 190 (283)
T cd05091 139 FLSSHHVVHKDLATRNVLVFDKLNVKI----------------------------SDLGLFREVYAADYYKLMGNSLLPI 190 (283)
T ss_pred HHHHcCccccccchhheEecCCCceEe----------------------------cccccccccccchheeeccCccCCc
Confidence 999999999999999999998887887 48998775533211 122345678
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
.|+|||.+.+..++.++|+||+||++|||++ |..||..
T Consensus 191 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred cccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999988889999999999999999998 7788754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=192.50 Aligned_cols=142 Identities=35% Similarity=0.657 Sum_probs=121.4
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
...|+|++++++.+.+.+..|+++||+.|++|.+++.+...+++ +.+..++.|++.||.|||+++++||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~aL~~lH~~~i~H~ 121 (260)
T cd05611 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-----------DWAKQYIAEVVLGVEDLHQRGIIHR 121 (260)
T ss_pred cCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHHCCeecC
Confidence 34789999999999999999999999999999999876544332 3345677899999999999999999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCC
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG 227 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (255)
||+|.||+++.++.+++ .|||+++.... .....|++.|+|||.+.+..
T Consensus 122 dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~ 169 (260)
T cd05611 122 DIKPENLLIDQTGHLKL----------------------------TDFGLSRNGLE----NKKFVGTPDYLAPETILGVG 169 (260)
T ss_pred CCCHHHeEECCCCcEEE----------------------------eecccceeccc----cccCCCCcCccChhhhcCCC
Confidence 99999999998888877 48888765433 22456889999999998888
Q ss_pred CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 228 HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 228 ~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.++|+||+|+++|+|++|..||.
T Consensus 170 ~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 170 DDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred CcchhhhHHHHHHHHHHHHCCCCCC
Confidence 8999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=194.15 Aligned_cols=156 Identities=21% Similarity=0.191 Sum_probs=120.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+.+..+++|||+.+|+|.++++++.. ++ ......++.|++.||.|||
T Consensus 49 e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----------~~~~~~~~~qi~~~l~~lH 117 (258)
T cd05078 49 AASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN-----------ISWKLEVAKQLAWALHFLE 117 (258)
T ss_pred HHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 34566777899999999999999999999999999999999975432 22 1223456789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++..+...++ .....|||.+..... .....|++.|+||
T Consensus 118 ~~~iiH~dlkp~nili~~~~~~~~~~~~--------------------~~~l~d~g~~~~~~~----~~~~~~~~~y~aP 173 (258)
T cd05078 118 DKGLTHGNVCAKNVLLIREEDRKTGNPP--------------------FIKLSDPGISITVLP----KEILLERIPWVPP 173 (258)
T ss_pred HCCeecCCCccceEEEecccccccCCCc--------------------eEEecccccccccCC----chhccccCCccCc
Confidence 9999999999999999877654321110 011248887754432 2345788999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCC-CCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGM-KESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~-~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|. .||.
T Consensus 174 E~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred hhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 99986 45789999999999999999995 5543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=199.44 Aligned_cols=164 Identities=23% Similarity=0.304 Sum_probs=123.9
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhh-----HHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASF-----ITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~i~~~il~~ 135 (255)
+++++... .|+|++++++.+.+....|+++||+.+|+|.+++..+.......... ........+..++.|++.|
T Consensus 67 E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (314)
T cd05099 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARG 146 (314)
T ss_pred HHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHH
Confidence 34555555 59999999999999999999999999999999997643211100000 0011223345577899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--cccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~g 213 (255)
|.|+|++|++||||||+||+++.++.+++ .|||.++........ .....+
T Consensus 147 L~~lH~~gi~H~dlkp~Nill~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~ 198 (314)
T cd05099 147 MEYLESRRCIHRDLAARNVLVTEDNVMKI----------------------------ADFGLARGVHDIDYYKKTSNGRL 198 (314)
T ss_pred HHHHHHCCeeeccccceeEEEcCCCcEEE----------------------------ccccccccccccccccccccCCC
Confidence 99999999999999999999998888887 489988765432211 112234
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
++.|||||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 199 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred CccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 567999999998889999999999999999998 7787753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=199.10 Aligned_cols=178 Identities=33% Similarity=0.595 Sum_probs=122.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++....|++++++++.+.+.+..|+++||+.|++|.+++.+.. .+++ ..+..++.|++.||.||
T Consensus 51 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~-----------~~~~~~~~qi~~~l~~l 119 (316)
T cd05574 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE-----------EVARFYAAEVLLALEYL 119 (316)
T ss_pred HHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCH-----------HHHHHHHHHHHHHHHHH
Confidence 3556667789999999999999999999999999999999987542 2222 23445678899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeee---eeccccccCCCCCccccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK---VDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
|++|++||||||+||+++.++.+++.+++............... ....... ...+................||+.
T Consensus 120 H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 197 (316)
T cd05574 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA--LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEE 197 (316)
T ss_pred HHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccc--cccccccccccccchhhhcccccCCCCCCcCccC
Confidence 99999999999999999999888886443322111000000000 0000000 000000000000111224578999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||++.+..++.++|+||+|+++|+|++|..||.
T Consensus 198 y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 198 YIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred CcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 999999998889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=196.02 Aligned_cols=152 Identities=26% Similarity=0.457 Sum_probs=125.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+++....|+++||+.++.+..++.....+++ +.+..++.|++.||.|||+
T Consensus 50 e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~ql~~~l~~LH~ 118 (286)
T cd07847 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE-----------HLIKKIIWQTLQAVNFCHK 118 (286)
T ss_pred HHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 46677788899999999999999999999999999988877654333332 2345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ .|||.+..............|+..|+|||
T Consensus 119 ~~i~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~aPE 170 (286)
T cd07847 119 HNCIHRDVKPENILITKQGQIKL----------------------------CDFGFARILTGPGDDYTDYVATRWYRAPE 170 (286)
T ss_pred CCceecCCChhhEEEcCCCcEEE----------------------------CccccceecCCCcccccCcccccccCCHH
Confidence 99999999999999999888887 48888876544332333456888999999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred HHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9876 567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=197.95 Aligned_cols=163 Identities=22% Similarity=0.287 Sum_probs=126.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|+++++..+.+.+..++++|++.+++|.+++.+.................+.+..++.|++.||.|||+
T Consensus 69 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~ 148 (296)
T cd05051 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES 148 (296)
T ss_pred HHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667788999999999999999999999999999999999976542211100000112234456678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~a 219 (255)
++++||||||+||+++..+.+++ .|||.++....... ......+++.|+|
T Consensus 149 ~~i~H~dlkp~Nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 200 (296)
T cd05051 149 LNFVHRDLATRNCLVGKNYTIKI----------------------------ADFGMSRNLYSSDYYRVQGRAPLPIRWMA 200 (296)
T ss_pred cCccccccchhceeecCCCceEE----------------------------ccccceeecccCcceeecCcCCCCceecC
Confidence 99999999999999999888887 48888765432211 1223456788999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc--CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT--GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~--G~~~~~ 252 (255)
||.+.+..++.++|+||+||++|+|++ |..||+
T Consensus 201 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 201 WESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred HHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999988889999999999999999998 566765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=195.00 Aligned_cols=156 Identities=22% Similarity=0.375 Sum_probs=125.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+.+..|+++||+.+|+|.+++.....-.. ....+.+..++.|++.||.|||+
T Consensus 52 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08228 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR-------LIPERTVWKYFVQLCSAVEHMHS 124 (267)
T ss_pred HHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccC-------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 45667788899999999999999999999999999999988854211000 00123345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||||+||+++.++.+++ .|||.+..............|++.|+|||
T Consensus 125 ~~i~H~dl~~~nil~~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~aPE 176 (267)
T cd08228 125 RRVMHRDIKPANVFITATGVVKL----------------------------GDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176 (267)
T ss_pred CCeeCCCCCHHHEEEcCCCCEEE----------------------------CccccceeccchhHHHhcCCCCccccChh
Confidence 99999999999999998888777 48888766544332333457899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+.+..++.++|+||+|+++|+|++|..||.
T Consensus 177 ~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred hhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 9998889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=193.01 Aligned_cols=156 Identities=22% Similarity=0.384 Sum_probs=127.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.+..|+++++++..+.+.+..|+++||+.||+|..++........ ....+.+..++.+++.|+.|||+
T Consensus 52 ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~ 124 (267)
T cd08224 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-------LIPERTIWKYFVQLCSALEHMHS 124 (267)
T ss_pred HHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCC-------CcCHHHHHHHHHHHHHHHHHHHh
Confidence 45667788899999999999999999999999999999998864211100 01123445677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||+|+||+++.++..++ .|||.+..............|++.|+|||
T Consensus 125 ~~i~h~dl~p~nil~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~y~apE 176 (267)
T cd08224 125 KRIMHRDIKPANVFITATGVVKL----------------------------GDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176 (267)
T ss_pred CCEecCCcChhhEEECCCCcEEE----------------------------eccceeeeccCCCcccceecCCccccCHH
Confidence 99999999999999998888877 48888765544333334467899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+.+..++.++|+||+||++|+|++|..||.
T Consensus 177 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred HhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 9998889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=193.24 Aligned_cols=154 Identities=25% Similarity=0.411 Sum_probs=123.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|++++++++.+.+.+..|++|||+.+|+|.+++.... .++ ...+..++.|++.||.|||
T Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~-----------~~~~~~~~~~i~~~l~~lH 117 (256)
T cd05113 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ-----------PSQLLEMCKDVCEGMAYLE 117 (256)
T ss_pred HHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4666778889999999999999999999999999999999987532 122 2234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-cccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT-WTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~-~~~~gt~~y~a 219 (255)
++|++|+||||.||+++.++.+++ .|||.++......... ....++..|+|
T Consensus 118 ~~~i~H~dl~p~nili~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~y~~ 169 (256)
T cd05113 118 SKQFIHRDLAARNCLVDDQGCVKV----------------------------SDFGLSRYVLDDEYTSSVGSKFPVRWSP 169 (256)
T ss_pred hCCeeccccCcceEEEcCCCCEEE----------------------------CCCccceecCCCceeecCCCccChhhCC
Confidence 999999999999999998888888 4888766543321111 11234567999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcCC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNVF 254 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~~ 254 (255)
||.+.+..++.++|+||+||++|+|++ |..||+.+
T Consensus 170 pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred HHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 999998889999999999999999998 98888643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=195.61 Aligned_cols=151 Identities=31% Similarity=0.558 Sum_probs=125.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+....|+++||+.||+|.++++.. .+++ ..+..++.|++.|+.|+|+
T Consensus 52 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~l~~-----------~~~~~~~~~l~~~l~~lh~ 119 (277)
T cd06640 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-PFDE-----------FQIATMLKEILKGLDYLHS 119 (277)
T ss_pred HHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC-CCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 456677788999999999999999999999999999999988642 2322 2234567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|+||+|+||+++.++.+++ .|||.+..............|+..|+|||
T Consensus 120 ~~ivH~dl~p~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~apE 171 (277)
T cd06640 120 EKKIHRDIKAANVLLSEQGDVKL----------------------------ADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171 (277)
T ss_pred CCccCcCCChhhEEEcCCCCEEE----------------------------cccccceeccCCccccccccCcccccCHh
Confidence 99999999999999998888777 48888765544332333456888999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||+
T Consensus 172 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred HhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 9998889999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=191.54 Aligned_cols=153 Identities=29% Similarity=0.502 Sum_probs=127.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+....|+++|++.+++|.+++.... .++ ...+..++.|++.|+.|||
T Consensus 48 e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~-----------~~~~~~~~~~l~~~l~~lh 116 (256)
T cd06612 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-----------EEEIAAILYQTLKGLEYLH 116 (256)
T ss_pred HHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4555667799999999999999999999999999999999986532 222 2334557788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++|||++|.||+++.++..++ .|||.+..............|++.|+||
T Consensus 117 ~~~i~H~dl~~~ni~~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~~P 168 (256)
T cd06612 117 SNKKIHRDIKAGNILLNEEGQAKL----------------------------ADFGVSGQLTDTMAKRNTVIGTPFWMAP 168 (256)
T ss_pred HCCcccCCCCcceEEECCCCcEEE----------------------------cccccchhcccCccccccccCCccccCH
Confidence 999999999999999999888877 4898887665443333345688999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+||+||++|+|++|..||+.
T Consensus 169 E~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred HHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999988899999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=197.09 Aligned_cols=164 Identities=20% Similarity=0.266 Sum_probs=126.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch-------------hhHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-------------SFITACVIEALDFI 128 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~i 128 (255)
++.++....|+|++++++.+...+..|+++||+.+|+|.+++.......+... ..........+..+
T Consensus 53 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 132 (290)
T cd05045 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132 (290)
T ss_pred HHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHH
Confidence 45667778899999999999999999999999999999999875332111100 00011223455667
Q ss_pred HHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--
Q psy3182 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-- 206 (255)
Q Consensus 129 ~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-- 206 (255)
+.|++.||.|||+++++||||||+||+++.++.+++ .|||.++.......
T Consensus 133 ~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl----------------------------~dfg~~~~~~~~~~~~ 184 (290)
T cd05045 133 AWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKI----------------------------SDFGLSRDVYEEDSYV 184 (290)
T ss_pred HHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEe----------------------------ccccccccccCccchh
Confidence 889999999999999999999999999998888877 48888765432211
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||..
T Consensus 185 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 1122345678999999988889999999999999999998 8888763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=194.00 Aligned_cols=153 Identities=27% Similarity=0.467 Sum_probs=125.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.+++..+|+|++++++.+.+.+..|+++||+.|++|.+++.+...+++ +.+..++.|++.||.|+|+
T Consensus 52 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~qi~~~l~~lH~ 120 (265)
T cd06631 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-----------PVFCKYTKQILDGVAYLHN 120 (265)
T ss_pred HHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 34556777899999999999999999999999999999999976554433 2344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC------CccccccccCC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS------GCKTWTFCGTP 215 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~------~~~~~~~~gt~ 215 (255)
++++|+||+|+||+++..+.+++ .|||.+...... ........|++
T Consensus 121 ~~i~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (265)
T cd06631 121 NCVVHRDIKGNNVMLMPNGIIKL----------------------------IDFGCARRLAWVGLHGTHSNMLKSMHGTP 172 (265)
T ss_pred CCcccCCcCHHhEEECCCCeEEe----------------------------ccchhhHhhhhccccccccccccccCCCc
Confidence 99999999999999998888887 477766543211 01122356899
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 173 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred cccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 99999999998899999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=194.28 Aligned_cols=156 Identities=23% Similarity=0.404 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|+++++..+.+.+..|+++||+.|++|.+++....... . ....+.+..++.|++.||.|||+
T Consensus 52 e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~-~------~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08229 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-R------LIPEKTVWKYFVQLCSALEHMHS 124 (267)
T ss_pred HHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccC-C------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 4566777889999999999999999999999999999999886421100 0 01122344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|+||||+||+++.++.+++ .|||.+..............|++.|+|||
T Consensus 125 ~~i~H~dl~p~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~ape 176 (267)
T cd08229 125 RRVMHRDIKPANVFITATGVVKL----------------------------GDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176 (267)
T ss_pred CCeecCCCCHHHEEEcCCCCEEE----------------------------CcchhhhccccCCcccccccCCcCccCHH
Confidence 99999999999999998888877 48888765543332233467899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+.+..++.++|+||+|+++|+|++|..||.
T Consensus 177 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred HhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=197.38 Aligned_cols=152 Identities=36% Similarity=0.586 Sum_probs=122.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+|+++++..+.+.+.+|++|||+.|++|.++++....+++ +.+..++.|++.||.|+|+
T Consensus 51 e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~ 119 (305)
T cd05609 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV-----------DMARMYFAETVLALEYLHN 119 (305)
T ss_pred HHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34556677899999999999999999999999999999999976554433 2234466789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC---------------Cc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS---------------GC 206 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~---------------~~ 206 (255)
++++||||||+||+++..+.+++. |||.++..... ..
T Consensus 120 ~~i~H~dl~p~NIll~~~~~~~l~----------------------------dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (305)
T cd05609 120 YGIVHRDLKPDNLLITSMGHIKLT----------------------------DFGLSKIGLMSLTTNLYEGHIEKDTREF 171 (305)
T ss_pred CCccccCCchHHEEECCCCCEEEe----------------------------eCCCccccCcCccccccccccccchhhc
Confidence 999999999999999998888884 66655421000 00
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred cccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1113467889999999998889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=192.90 Aligned_cols=154 Identities=22% Similarity=0.323 Sum_probs=124.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|++++++++.+.+.+..|++|||+.+|+|.+++.+..... ...+.+..++.|++.||.|||+
T Consensus 52 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~~i~~al~~lH~ 122 (261)
T cd05148 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV---------LPVASLIDMACQVAEGMAYLEE 122 (261)
T ss_pred HHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 3456677789999999999999999999999999999999997532111 1123345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ .|||.+..............+++.|+|||
T Consensus 123 ~~i~h~dl~~~nilv~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~~PE 174 (261)
T cd05148 123 QNSIHRDLAARNILVGEDLVCKV----------------------------ADFGLARLIKEDVYLSSDKKIPYKWTAPE 174 (261)
T ss_pred CCeeccccCcceEEEcCCceEEE----------------------------ccccchhhcCCccccccCCCCceEecCHH
Confidence 99999999999999999888887 48888766544322222334567899999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.+....++.++|+||+|+++|+|++ |..||.
T Consensus 175 ~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9998889999999999999999998 788875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=198.57 Aligned_cols=163 Identities=21% Similarity=0.308 Sum_probs=122.8
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCcc-----chhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN-----AASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++... .|++++++++.+.+....|++|||+.+|+|.+++.++...... ............+..++.|++.|
T Consensus 73 e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 152 (307)
T cd05098 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARG 152 (307)
T ss_pred HHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHH
Confidence 34455555 6999999999999999999999999999999999764321100 00000011223455678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc--ccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT--WTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~--~~~~g 213 (255)
|.|||++|++||||||+||+++.++.+++ .|||.++......... ....+
T Consensus 153 L~~lH~~gi~H~dlkp~Nill~~~~~~kL----------------------------~dfg~a~~~~~~~~~~~~~~~~~ 204 (307)
T cd05098 153 MEYLASKKCIHRDLAARNVLVTEDNVMKI----------------------------ADFGLARDIHHIDYYKKTTNGRL 204 (307)
T ss_pred HHHHHHCCcccccccHHheEEcCCCcEEE----------------------------CCCcccccccccchhhccccCCC
Confidence 99999999999999999999998888887 4888876553321111 11234
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
++.|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 205 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred ccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 568999999998889999999999999999998 777775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=196.73 Aligned_cols=162 Identities=17% Similarity=0.274 Sum_probs=124.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+.+..|++|||+.+|+|.+++++.....+.... ........+..++.|++.||.|||+
T Consensus 59 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (288)
T cd05061 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG-RPPPTLQEMIQMAAEIADGMAYLNA 137 (288)
T ss_pred HHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345567778999999999999999999999999999999999764322211110 0111123345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~a 219 (255)
++++||||||+||+++.++.+++ .|||+++........ .....++..|+|
T Consensus 138 ~~i~H~dikp~nili~~~~~~~L----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~ 189 (288)
T cd05061 138 KKFVHRDLAARNCMVAHDFTVKI----------------------------GDFGMTRDIYETDYYRKGGKGLLPVRWMA 189 (288)
T ss_pred CCCcCCCCChheEEEcCCCcEEE----------------------------CcCCccccccccccccccCCCcccccccC
Confidence 99999999999999998888877 488887654332111 112345678999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 190 pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred HHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 999998889999999999999999998 677775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=192.95 Aligned_cols=154 Identities=21% Similarity=0.356 Sum_probs=123.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+|++++++.+.+....|+++||+.||+|.+++.+...... ..+.+..++.|++.||.|||+
T Consensus 51 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~~l~~~l~~LH~ 121 (261)
T cd05072 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKV---------LLPKLIDFSAQIAEGMAYIER 121 (261)
T ss_pred HHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCC---------CHHHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999999875422111 112334567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
++++||||||+||+++..+..++ .|||.+........ ......++..|+||
T Consensus 122 ~~i~H~dl~p~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~aP 173 (261)
T cd05072 122 KNYIHRDLRAANVLVSESLMCKI----------------------------ADFGLARVIEDNEYTAREGAKFPIKWTAP 173 (261)
T ss_pred CCeeccccchhhEEecCCCcEEE----------------------------CCCccceecCCCceeccCCCccceecCCH
Confidence 99999999999999999888777 48888765533211 11123456689999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 174 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred HHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence 99988889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-28 Score=212.21 Aligned_cols=150 Identities=27% Similarity=0.457 Sum_probs=129.3
Q ss_pred CceeeeccccccccccccccccCccc--eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKY--VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~--~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.++.++..+.|+||+++|.++.+... +-+|.|.++.|+|..+.++....+- .++...++|||+||.|
T Consensus 90 ~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~-----------kaik~W~RQILkGL~y 158 (632)
T KOG0584|consen 90 SEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNI-----------KAIKSWCRQILKGLVY 158 (632)
T ss_pred HHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCH-----------HHHHHHHHHHHHHhhh
Confidence 46788999999999999999988765 8999999999999999998765543 3567788999999999
Q ss_pred HHHcC--cccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 139 LHTRG--IVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 139 lH~~~--iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
||++. |||||||.+||+++. .|.+|+ .|+|+|+....+.. ...+|||
T Consensus 159 LHs~~PPIIHRDLKCDNIFinG~~G~VKI----------------------------GDLGLAtl~r~s~a--ksvIGTP 208 (632)
T KOG0584|consen 159 LHSQDPPIIHRDLKCDNIFVNGNLGEVKI----------------------------GDLGLATLLRKSHA--KSVIGTP 208 (632)
T ss_pred hhcCCCCccccccccceEEEcCCcCceee----------------------------cchhHHHHhhcccc--ceeccCc
Confidence 99875 999999999999975 477887 49999987765533 3478999
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|||||+.. ..|+..+||||+|.++.||.|+--|+.
T Consensus 209 EFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 209 EFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred cccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 999999998 779999999999999999999987754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=192.29 Aligned_cols=152 Identities=22% Similarity=0.373 Sum_probs=120.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+....|++|||+.|++|.+++.+.. .+++ ..+..++.|++.||.|||
T Consensus 43 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~~qi~~~L~~lH 111 (252)
T cd05084 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV-----------KELIQMVENAAAGMEYLE 111 (252)
T ss_pred HHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4556777789999999999999999999999999999999987533 1222 234456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc--cccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT--WTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~--~~~~gt~~y~ 218 (255)
++|++||||||+||+++.++.+++ .|||.+.......... ....++..|+
T Consensus 112 ~~~i~H~dl~p~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 163 (252)
T cd05084 112 SKHCIHRDLAARNCLVTEKNVLKI----------------------------SDFGMSREEEDGVYASTGGMKQIPVKWT 163 (252)
T ss_pred hCCccccccchheEEEcCCCcEEE----------------------------CccccCcccccccccccCCCCCCceeec
Confidence 999999999999999998888887 4888776543211000 0112245699
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|||.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 164 aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9999998889999999999999999997 888875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=192.59 Aligned_cols=152 Identities=24% Similarity=0.386 Sum_probs=122.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++.++.|++++++++.+.+....|++|||+.||+|.+.+.... .++ .+.+..++.|++.||.|||
T Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~~i~~~l~~lH 117 (256)
T cd05114 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLS-----------KDMLLSMCQDVCEGMEYLE 117 (256)
T ss_pred HHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4667778899999999999999999999999999999999887532 122 1234557788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-cccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT-WTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~-~~~~gt~~y~a 219 (255)
++|++||||||+|++++.++.+++ .|||.++......... ....++..|+|
T Consensus 118 ~~~i~H~dl~p~ni~i~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~y~a 169 (256)
T cd05114 118 RNSFIHRDLAARNCLVSSTGVVKV----------------------------SDFGMTRYVLDDEYTSSSGAKFPVKWSP 169 (256)
T ss_pred HCCccccccCcceEEEcCCCeEEE----------------------------CCCCCccccCCCceeccCCCCCchhhCC
Confidence 999999999999999998887777 4888776543221111 12234567999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||++.+..++.++|+||+|+++|+|++ |..||.
T Consensus 170 PE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~ 203 (256)
T cd05114 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203 (256)
T ss_pred hhhcccCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence 999998889999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=195.96 Aligned_cols=151 Identities=22% Similarity=0.354 Sum_probs=122.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|+|+||+.+ +|.+++.+... ++ .+.+..++.|+++||.|||
T Consensus 53 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~-----------~~~~~~~~~ql~~al~~lH 120 (291)
T cd07844 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLS-----------MHNVRLFLFQLLRGLAYCH 120 (291)
T ss_pred HHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 56777888999999999999999999999999985 89888765321 22 2344567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++||||||+||+++.++.+++ .|||.++.............+++.|+||
T Consensus 121 ~~~i~H~dl~p~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~aP 172 (291)
T cd07844 121 QRRVLHRDLKPQNLLISERGELKL----------------------------ADFGLARAKSVPSKTYSNEVVTLWYRPP 172 (291)
T ss_pred hCCeecccCCHHHEEEcCCCCEEE----------------------------CccccccccCCCCccccccccccccCCc
Confidence 999999999999999999988888 4888876543222222234578899999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 173 E~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred HHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99875 568899999999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=195.43 Aligned_cols=154 Identities=23% Similarity=0.342 Sum_probs=122.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.++...|+++||+. ++|.+.+....... ......+..++.|++.||.|||+
T Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~ 119 (285)
T cd07861 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQ--------YMDAELVKSYLYQILQGILFCHS 119 (285)
T ss_pred HHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCC--------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 4566777889999999999999999999999997 57887775432100 01123455678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||||+||+++.++.+++ .|||.+..............|++.|+|||
T Consensus 120 ~~i~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 171 (285)
T cd07861 120 RRVLHRDLKPQNLLIDNKGVIKL----------------------------ADFGLARAFGIPVRVYTHEVVTLWYRAPE 171 (285)
T ss_pred CCeeecCCCHHHEEEcCCCcEEE----------------------------CcccceeecCCCcccccCCcccccccChH
Confidence 99999999999999999888888 48888765433322222346789999999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 172 ~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred HhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9875 457889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=194.73 Aligned_cols=151 Identities=28% Similarity=0.471 Sum_probs=119.0
Q ss_pred eccc-ccccccccccccc------CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRK-KKTRQTRLYKTFK------DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 66 ~~~~-~h~~iv~l~~~~~------~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+.+. .|+|++++++.+. +....|++|||+.+|+|.+++........ ..+.+..++.|++.|+.|
T Consensus 66 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~---------~~~~~~~~~~qi~~al~~ 136 (282)
T cd06636 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL---------KEDWIAYICREILRGLAH 136 (282)
T ss_pred HHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCC---------CHHHHHHHHHHHHHHHHH
Confidence 3344 6999999998874 35678999999999999998875322111 112345577899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
||+++++|||+||+||+++.++.+++ .|||.+..............|++.|+
T Consensus 137 LH~~~ivH~dl~~~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~ 188 (282)
T cd06636 137 LHAHKVIHRDIKGQNVLLTENAEVKL----------------------------VDFGVSAQLDRTVGRRNTFIGTPYWM 188 (282)
T ss_pred HHHCCcccCCCCHHHEEECCCCCEEE----------------------------eeCcchhhhhccccCCCccccccccc
Confidence 99999999999999999998888777 58988765543322334567999999
Q ss_pred cccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIK-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++. ...++.++|+||+||++|+|++|..||+.
T Consensus 189 aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred CHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 999986 35688899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=194.57 Aligned_cols=151 Identities=31% Similarity=0.466 Sum_probs=125.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++...+|+++++++..+.+.+..|+++||+.|++|.+.+.+... ++ ...+..++.|++.||.||
T Consensus 43 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~~ql~~~l~~l 111 (277)
T cd05577 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-----------EARAIFYAAQIICGLEHL 111 (277)
T ss_pred HHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999998876442 22 223445677899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++|++||||+|+||+++.++.+++ .|||.+...... .......|++.|+|
T Consensus 112 H~~~i~H~di~p~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~-~~~~~~~~~~~y~~ 162 (277)
T cd05577 112 HQRRIVYRDLKPENVLLDDHGNVRI----------------------------SDLGLAVELKGG-KKIKGRAGTPGYMA 162 (277)
T ss_pred HhCCcccCCCCHHHEEECCCCCEEE----------------------------ccCcchhhhccC-CccccccCCCCcCC
Confidence 9999999999999999999888887 488877655332 12234568889999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++|..||.
T Consensus 163 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred HHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=192.19 Aligned_cols=151 Identities=25% Similarity=0.366 Sum_probs=118.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++..+.|++++++++.++. ...|++|||+.||+|.+++.... .+++ ..+..++.|++.||.|||
T Consensus 45 E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH 112 (257)
T cd05115 45 EAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITV-----------SNVVELMHQVSMGMKYLE 112 (257)
T ss_pred HHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3556677889999999988764 47899999999999999886432 2222 234456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccc---ccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTW---TFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~---~~~gt~~y 217 (255)
++|++||||||+||+++.++.+++ .|||.+........... ...+++.|
T Consensus 113 ~~~i~H~dlkp~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~y 164 (257)
T cd05115 113 GKNFVHRDLAARNVLLVNQHYAKI----------------------------SDFGLSKALGADDSYYKARSAGKWPLKW 164 (257)
T ss_pred hcCeeecccchheEEEcCCCcEEe----------------------------ccCCccccccCCccceeccCCCCCCccc
Confidence 999999999999999998888887 48888765433221111 11235689
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+|||.+.+..++.++|+||+||++|++++ |..||.
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 99999988889999999999999999996 999985
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=192.12 Aligned_cols=153 Identities=24% Similarity=0.393 Sum_probs=122.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+....|++|||+.|++|.+++..... ++ .+.+..++.|++.||.|||
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~i~~qi~~~l~~lH 117 (256)
T cd05059 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-----------TEWLLDMCSDVCEAMEYLE 117 (256)
T ss_pred HHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999999875332 11 2334567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-cccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT-WTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~-~~~~gt~~y~a 219 (255)
++|++|||+||+||+++.++.+++ .|||.++......... ....++..|+|
T Consensus 118 ~~~i~H~dl~p~ni~i~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~~ 169 (256)
T cd05059 118 SNGFIHRDLAARNCLVGEDNVVKV----------------------------SDFGLARYVLDDQYTSSQGTKFPVKWAP 169 (256)
T ss_pred HCCcccccccHhhEEECCCCcEEE----------------------------CCcccceecccccccccCCCCCCccccC
Confidence 999999999999999999888888 4888776543221111 11123347999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||.+.+..++.++|+||+||++|+|++ |..||..
T Consensus 170 Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 999998889999999999999999998 7888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=192.17 Aligned_cols=154 Identities=23% Similarity=0.344 Sum_probs=122.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+...+.+|++|||+.+++|.+++....... .....+..++.|++.||.|||+
T Consensus 52 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------l~~~~~~~~~~ql~~~l~~lH~ 122 (263)
T cd05052 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------VNAVVLLYMATQISSAMEYLEK 122 (263)
T ss_pred HHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 4556677889999999999999999999999999999999886532110 1122345578899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~aP 220 (255)
+|++||||||+||+++.++.+++ .|||.+......... .....+++.|+||
T Consensus 123 ~~i~H~dlkp~nil~~~~~~~kl----------------------------~df~~~~~~~~~~~~~~~~~~~~~~y~aP 174 (263)
T cd05052 123 KNFIHRDLAARNCLVGENHLVKV----------------------------ADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174 (263)
T ss_pred CCEeecccCcceEEEcCCCcEEe----------------------------CCCccccccccceeeccCCCCCccccCCH
Confidence 99999999999999998888888 488877655332111 1112345679999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|.+.+..++.++|+|||||++|+|++ |..||.
T Consensus 175 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99998899999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=195.16 Aligned_cols=150 Identities=28% Similarity=0.555 Sum_probs=124.6
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|++++++++.+...+..|+++||+.|++|.+++.. ..+++ +.+..++.|++.||.|+|++
T Consensus 67 ~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~-----------~~~~~~~~ql~~~l~~lH~~ 134 (285)
T cd06648 67 VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNE-----------EQIATVCLAVLKALSFLHAQ 134 (285)
T ss_pred HHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCH-----------HHHHHHHHHHHHHHHHHHhC
Confidence 3456667899999999999999999999999999999998875 22222 33456778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++||||+|+||+++.++.+++ .|||.+..............|++.|+|||.
T Consensus 135 ~i~H~dl~p~Nil~~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~ 186 (285)
T cd06648 135 GVIHRDIKSDSILLTSDGRVKL----------------------------SDFGFCAQVSKEVPRRKSLVGTPYWMAPEV 186 (285)
T ss_pred CeecCCCChhhEEEcCCCcEEE----------------------------cccccchhhccCCcccccccCCccccCHHH
Confidence 9999999999999999888887 488876654333222334578999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+||++|+|++|..||.
T Consensus 187 ~~~~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred hcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 998889999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=192.16 Aligned_cols=152 Identities=26% Similarity=0.472 Sum_probs=125.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.++.|++++++++.+.+.+..++++||+.|++|.+++.+...+++ ..+..++.|++.||.|||+
T Consensus 53 e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~ql~~al~~LH~ 121 (268)
T cd06630 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----------AVIINYTEQLLRGLSYLHE 121 (268)
T ss_pred HHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 46677788999999999999999999999999999999999876554433 2344567889999999999
Q ss_pred cCcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----cccccccCCC
Q psy3182 142 RGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC----KTWTFCGTPE 216 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~----~~~~~~gt~~ 216 (255)
+|++||||+|+||+++.++ .+++ .|||.+........ ......||..
T Consensus 122 ~~i~H~~i~~~nil~~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 173 (268)
T cd06630 122 NQIIHRDVKGANLLIDSTGQRLRI----------------------------ADFGAAARLAAKGTGAGEFQGQLLGTIA 173 (268)
T ss_pred CCeecCCCCHHHEEEcCCCCEEEE----------------------------cccccccccccccccCCccccccccccc
Confidence 9999999999999997665 3666 48887765543211 1223568899
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 174 ~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred eeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 999999998889999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=211.22 Aligned_cols=152 Identities=27% Similarity=0.329 Sum_probs=116.6
Q ss_pred ceeeecccc-ccccccccccc-c-----C-ccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKK-KTRQTRLYKTF-K-----D-SKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITAC 131 (255)
Q Consensus 62 ~vkl~~~~~-h~~iv~l~~~~-~-----~-~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~ 131 (255)
++.++..+. |+|||.++++. . . ...+++.||||.||.|.+++..+. .++| ..+-.|+.+
T Consensus 84 EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte-----------~eVLkIf~d 152 (738)
T KOG1989|consen 84 EIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTE-----------DEVLKIFYD 152 (738)
T ss_pred HHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCCh-----------HHHHHHHHH
Confidence 455555555 99999999832 1 1 246799999999999999998542 3433 334568889
Q ss_pred HHHHHHHHHHcC--cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-
Q psy3182 132 VIEALEYLHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT- 208 (255)
Q Consensus 132 il~~l~ylH~~~--iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~- 208 (255)
+++|+.+||... |||||||-||+|+..++..||+ |||-+..........
T Consensus 153 v~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC----------------------------DFGSatt~~~~~~~~~ 204 (738)
T KOG1989|consen 153 VCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC----------------------------DFGSATTKILSPTSAQ 204 (738)
T ss_pred HHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC----------------------------cccccccccCCCccHH
Confidence 999999999988 9999999999999999999995 666543222211000
Q ss_pred --------cccccCCCCcccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 209 --------WTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 209 --------~~~~gt~~y~aPE~~---~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
....-||.|+|||+| .+.+.+.|+|||||||+||-|+....||.
T Consensus 205 e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 205 EVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred HHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 012358999999998 46788999999999999999999999986
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=194.22 Aligned_cols=157 Identities=29% Similarity=0.442 Sum_probs=121.6
Q ss_pred ceeeeccc-cccccccccccc-----cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTF-----KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~-----~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+ .|+|++++++.+ +++...|++|||+.||+|.+++......... .....+..++.|++.|
T Consensus 64 e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~~~~~i~~~ 136 (286)
T cd06638 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-------MEEPIIAYILHEALMG 136 (286)
T ss_pred HHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCcc-------ccHHHHHHHHHHHHHH
Confidence 34555565 699999999876 4566799999999999999887642111100 1123345577889999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||+++++||||||+||+++..+.+++ .|||.+..............|++
T Consensus 137 l~~lH~~~i~H~dlkp~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~ 188 (286)
T cd06638 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKL----------------------------VDFGVSAQLTSTRLRRNTSVGTP 188 (286)
T ss_pred HHHHHhCCccccCCCHHhEEECCCCCEEE----------------------------ccCCceeecccCCCccccccCCC
Confidence 99999999999999999999999888877 48998876544333334567999
Q ss_pred CCcccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN-----RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~-----~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.. ..++.++|+||+||++|+|++|..||..
T Consensus 189 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~ 231 (286)
T cd06638 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231 (286)
T ss_pred cccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999853 4578899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=191.92 Aligned_cols=155 Identities=32% Similarity=0.492 Sum_probs=123.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+++..|+++||+.|++|.+++.... .+.. ....+..++.|++.|+.|||
T Consensus 55 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---------~~~~~~~~~~qi~~al~~lH 125 (268)
T cd06624 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD---------NEQTIIFYTKQILEGLKYLH 125 (268)
T ss_pred HHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCC---------cHHHHHHHHHHHHHHHHHHH
Confidence 4566778889999999999999999999999999999999987532 2211 12234556789999999999
Q ss_pred HcCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++. .+.+++ .|||.+..............|++.|+|
T Consensus 126 ~~~i~h~dl~p~nil~~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~a 177 (268)
T cd06624 126 DNQIVHRDIKGDNVLVNTYSGVVKI----------------------------SDFGTSKRLAGINPCTETFTGTLQYMA 177 (268)
T ss_pred HCCEeecCCCHHHEEEcCCCCeEEE----------------------------ecchhheecccCCCccccCCCCccccC
Confidence 999999999999999976 456666 488887655433333334568999999
Q ss_pred cccccCC--CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNR--GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~--~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++... .++.++|+||+|+++|+|++|..||..
T Consensus 178 PE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred hhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 9998653 478899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=196.31 Aligned_cols=155 Identities=19% Similarity=0.281 Sum_probs=121.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++|||+.+|++.+++.+..... .....+..++.|++.||.|||+
T Consensus 49 Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~---------~~~~~~~~~~~~l~~~L~~LH~ 119 (314)
T cd08216 49 EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---------LPELAIAFILKDVLNALDYIHS 119 (314)
T ss_pred HHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 3556677789999999999999999999999999999999987542211 0113345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-------CccccccccC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-------GCKTWTFCGT 214 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-------~~~~~~~~gt 214 (255)
++|+||||||+||+++.++.+++. |||.+...... ........++
T Consensus 120 ~~ivH~dlk~~Nili~~~~~~kl~----------------------------d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 120 KGFIHRSVKASHILLSGDGKVVLS----------------------------GLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred CCeecCCCCcceEEEecCCceEEe----------------------------cCccceeecccccccccccccccccccc
Confidence 999999999999999998888885 44443322110 0112234577
Q ss_pred CCCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..|+|||++.. ..++.++|+||+||++|+|++|..||..
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 88999999976 4688999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=193.66 Aligned_cols=158 Identities=22% Similarity=0.360 Sum_probs=121.2
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|++++++++.+.+....|++|||+.||+|.+++.+.....+... ......+..++.|++.||.|||++
T Consensus 60 ~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~ 135 (277)
T cd05036 60 ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS----SLTMKDLLFCARDVAKGCKYLEEN 135 (277)
T ss_pred HHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCC----CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4456677899999999998888899999999999999999976543222211 112234456778999999999999
Q ss_pred CcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCC
Q psy3182 143 GIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEY 217 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y 217 (255)
+++||||||+||+++..+ .+++ .|||.++........ .....+++.|
T Consensus 136 ~ivH~dlkp~nil~~~~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y 187 (277)
T cd05036 136 HFIHRDIAARNCLLTCKGPGRVAKI----------------------------ADFGMARDIYRASYYRKGGRAMLPIKW 187 (277)
T ss_pred CEeecccchheEEEeccCCCcceEe----------------------------ccCccccccCCccceecCCCCCccHhh
Confidence 999999999999998654 3455 488887765322111 1122335679
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 188 ~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred CCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999998889999999999999999996 888875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=195.39 Aligned_cols=151 Identities=27% Similarity=0.453 Sum_probs=123.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+.+..|+|+||+ +|+|.+++.... .++ .+.+..++.|+++||.|||
T Consensus 52 e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~-----------~~~~~~~~~qi~~al~~lH 119 (298)
T cd07841 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLT-----------PADIKSYMLMTLRGLEYLH 119 (298)
T ss_pred HHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999 999999987543 222 2334557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++|+||||+||+++.++.+++ .|||.+..............+++.|+||
T Consensus 120 ~~~i~H~dl~p~nill~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aP 171 (298)
T cd07841 120 SNWILHRDLKPNNLLIASDGVLKL----------------------------ADFGLARSFGSPNRKMTHQVVTRWYRAP 171 (298)
T ss_pred hCCeeecCCChhhEEEcCCCCEEE----------------------------ccceeeeeccCCCccccccccceeeeCH
Confidence 999999999999999999888887 4888887655433333344678899999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 172 E~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 99865 567889999999999999999977664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=193.47 Aligned_cols=150 Identities=18% Similarity=0.240 Sum_probs=119.1
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
..++...|+|++++++.+.. ...++++||+.+|+|.+++.... .+++ ..+..++.|++.||.|||++
T Consensus 61 ~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH~~ 128 (279)
T cd05111 61 LAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDP-----------QRLLNWCVQIAKGMYYLEEH 128 (279)
T ss_pred HHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 34567789999999987654 56789999999999999997532 2222 23445678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVAP 220 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~aP 220 (255)
+++||||||+||+++.++.+++ .|||.++....... ......|+..|+||
T Consensus 129 ~iiH~dlkp~nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p 180 (279)
T cd05111 129 RMVHRNLAARNILLKSDSIVQI----------------------------ADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180 (279)
T ss_pred CEeccccCcceEEEcCCCcEEE----------------------------cCCccceeccCCCcccccCCCCCcccccCH
Confidence 9999999999999998888887 48888765432211 12234567789999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|.+.+..++.++|+||+||++||+++ |..||..
T Consensus 181 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99998889999999999999999998 9988853
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=198.92 Aligned_cols=163 Identities=21% Similarity=0.348 Sum_probs=122.7
Q ss_pred ceeeeccc-cccccccccccccC-ccceeehhhhhcchhHHHHHHhccCC--C--ccc----------------------
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKD-SKYVYMLLEACLGGEVWTILRERTCF--D--DNA---------------------- 113 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~-~~~~ylv~E~~~gg~l~~~l~~~~~~--~--~~~---------------------- 113 (255)
++.++.+. .|+|++++++.+.. ...+|+++||+.||+|.+.+...... . ...
T Consensus 60 E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (337)
T cd05054 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSS 139 (337)
T ss_pred HHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcc
Confidence 34555555 68999999987654 46789999999999999988653210 0 000
Q ss_pred ------------------------hhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCC
Q psy3182 114 ------------------------ASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPA 169 (255)
Q Consensus 114 ------------------------~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~ 169 (255)
.........+.+..++.|++.||.|||++||+||||||+||+++.++.+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL----- 214 (337)
T cd05054 140 QSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI----- 214 (337)
T ss_pred ccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEE-----
Confidence 000011233456678889999999999999999999999999998888877
Q ss_pred cceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-
Q psy3182 170 GHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT- 246 (255)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~- 246 (255)
.|||++..+..... ...+..+++.|+|||++.+..++.++|+||+||++|+|++
T Consensus 215 -----------------------~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~ 271 (337)
T cd05054 215 -----------------------CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271 (337)
T ss_pred -----------------------eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHc
Confidence 49998876533221 1223456678999999999999999999999999999997
Q ss_pred CCCCCc
Q psy3182 247 GMKESN 252 (255)
Q Consensus 247 G~~~~~ 252 (255)
|..||.
T Consensus 272 g~~p~~ 277 (337)
T cd05054 272 GASPYP 277 (337)
T ss_pred CCCCCC
Confidence 998885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=212.31 Aligned_cols=150 Identities=29% Similarity=0.502 Sum_probs=128.9
Q ss_pred ecccccccccccccccc-----CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRKKKTRQTRLYKTFK-----DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~-----~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.....|+|++.+|..|. .++.+|+|||||.||++.++++.-. +. ....+.+.+|++.++.|+.+||
T Consensus 70 ~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~-------rl~E~~IaYI~re~lrgl~HLH 140 (953)
T KOG0587|consen 70 KKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GN-------RLKEEWIAYILREILRGLAHLH 140 (953)
T ss_pred HhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--cc-------chhhHHHHHHHHHHHHHHHHHh
Confidence 34557999999988764 2467999999999999999997533 21 1234567889999999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
.+.+||||+|-.|||++.++.+|+ +|||+|.++.....++.|.+|||.||||
T Consensus 141 ~nkviHRDikG~NiLLT~e~~VKL----------------------------vDFGvSaQldsT~grRnT~iGtP~WMAP 192 (953)
T KOG0587|consen 141 NNKVIHRDIKGQNVLLTENAEVKL----------------------------VDFGVSAQLDSTVGRRNTFIGTPYWMAP 192 (953)
T ss_pred hcceeeecccCceEEEeccCcEEE----------------------------eeeeeeeeeecccccccCcCCCcccccc
Confidence 999999999999999999999998 7999999988877788899999999999
Q ss_pred ccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-----RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-----~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.. ..|+..+|+||||++..||..|-+|+.
T Consensus 193 EViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 193 EVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred eeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 99964 357889999999999999999999874
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=190.61 Aligned_cols=155 Identities=20% Similarity=0.303 Sum_probs=123.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.+..|+|+++++..+...+..|++||++.|++|.+++....... .....+..++.|++.|+.|||+
T Consensus 51 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~ 121 (261)
T cd05068 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA---------LKLPQLIDMAAQVASGMAYLEA 121 (261)
T ss_pred HHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 4566778889999999999999999999999999999999987543100 1123345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-cccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT-WTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~-~~~~gt~~y~aP 220 (255)
+|++||||||+||+++.++.+++ +|||.++......... ....++..|+||
T Consensus 122 ~~i~H~dl~p~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~aP 173 (261)
T cd05068 122 QNYIHRDLAARNVLVGENNICKV----------------------------ADFGLARVIKEDIYEAREGAKFPIKWTAP 173 (261)
T ss_pred CCeeeccCCcceEEEcCCCCEEE----------------------------CCcceEEEccCCcccccCCCcCceeccCc
Confidence 99999999999999999888887 4888877654321111 111223579999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|.+.+..++.++|+||+||++|+|++ |..||+.
T Consensus 174 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99998889999999999999999999 8888863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=207.42 Aligned_cols=169 Identities=28% Similarity=0.491 Sum_probs=140.8
Q ss_pred CCCcccCCCCcceeec----------ccCceeeecccc---ccccccccccccCccceeehhhhh-cchhHHHHHHhccC
Q psy3182 43 RGIVFRDLKPENLLLD----------NRGYVKLVSRKK---KTRQTRLYKTFKDSKYVYMLLEAC-LGGEVWTILRERTC 108 (255)
Q Consensus 43 ~~i~~rdiK~~nil~~----------~~~~vkl~~~~~---h~~iv~l~~~~~~~~~~ylv~E~~-~gg~l~~~l~~~~~ 108 (255)
.-++.+-|+.+.||++ ..-++.|++.++ |+||+++.+.|+|++++|+.+|.- +|-||++++...+.
T Consensus 587 ~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~ 666 (772)
T KOG1152|consen 587 YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR 666 (772)
T ss_pred eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc
Confidence 3455666777777664 123567777777 999999999999999999999964 46699999999999
Q ss_pred CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeC
Q psy3182 109 FDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISG 188 (255)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 188 (255)
++|..+. .|++||..|+++||+.||||||||-+|+.++.+|.+|+
T Consensus 667 m~E~eAk-----------~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl------------------------ 711 (772)
T KOG1152|consen 667 MDEPEAK-----------LIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL------------------------ 711 (772)
T ss_pred cchHHHH-----------HHHHHHHhccccccccCceecccccccEEEecCCeEEE------------------------
Confidence 9987764 46678999999999999999999999999999999999
Q ss_pred CeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC-CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 189 GQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 189 ~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||.|...... ...+++||..|.|||++.+.+|- ..-|||++|+++|....--+||-
T Consensus 712 ----idfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 ----IDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ----eeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 799977554332 34578999999999999998885 55799999999999998888864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=193.22 Aligned_cols=148 Identities=22% Similarity=0.313 Sum_probs=110.4
Q ss_pred ccccccccccccccccCcc----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 67 SRKKKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 67 ~~~~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
....|+++++++....... ..|+++|++.. ++.+.+......++ ..+..++.|++.||.|||++
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH~~ 145 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNK-----------KLIKNIMKDMLTTLEYIHEH 145 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCH-----------HHHHHHHHHHHHHHHHHHhC
Confidence 3456888888876544332 34788887643 44444443222221 22456788999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-------ccccccccCC
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-------CKTWTFCGTP 215 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-------~~~~~~~gt~ 215 (255)
+++||||||+||+++.++.+++ +|||+|+...... .......||+
T Consensus 146 ~iiHrDiKp~Nill~~~~~~~l----------------------------~DFGla~~~~~~~~~~~~~~~~~~~~~gt~ 197 (294)
T PHA02882 146 GISHGDIKPENIMVDGNNRGYI----------------------------IDYGIASHFIIHGKHIEYSKEQKDLHRGTL 197 (294)
T ss_pred CeecCCCCHHHEEEcCCCcEEE----------------------------EEcCCceeeccCCcccccccccccccCCCc
Confidence 9999999999999998887777 5888876543211 1122357999
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
.|+|||+..+..++.++|+||+||++|+|++|..||..+
T Consensus 198 ~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 198 YYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999999999999999999754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=191.43 Aligned_cols=153 Identities=32% Similarity=0.506 Sum_probs=123.2
Q ss_pred ceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++..+.|+|++++++.+.+ ...+|+++||+.+++|.+.+.....+++ .....++.|++.||.||
T Consensus 54 e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~qi~~~l~~L 122 (266)
T cd06651 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-----------SVTRKYTRQILEGMSYL 122 (266)
T ss_pred HHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 4556777889999999988765 3678999999999999999876544432 22335678899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC---CccccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS---GCKTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~---~~~~~~~~gt~~ 216 (255)
|+++++|||+||+||+++.++.+++ .|||+++..... ........|+..
T Consensus 123 H~~~i~H~~l~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (266)
T cd06651 123 HSNMIVHRDIKGANILRDSAGNVKL----------------------------GDFGASKRLQTICMSGTGIRSVTGTPY 174 (266)
T ss_pred HhCCeeeCCCCHHHEEECCCCCEEE----------------------------ccCCCccccccccccCCccccCCcccc
Confidence 9999999999999999998888887 488877654321 111223568889
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+|||.+.+..++.++|+||+||++|+|++|..||..
T Consensus 175 y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 9999999988899999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=193.22 Aligned_cols=152 Identities=38% Similarity=0.694 Sum_probs=123.8
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++... .|++++.++..++.+...|+++||+.|++|.+.+.....+++ ..+..++.|++.||.|||
T Consensus 54 e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~qi~~al~~lH 122 (290)
T cd05613 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----------QEVQIYSGEIVLALEHLH 122 (290)
T ss_pred HHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 45556555 589999999999999999999999999999999876544432 234556678999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~a 219 (255)
++|++||||+|+||+++.++.+++ .|||.+....... .......|++.|+|
T Consensus 123 ~~~i~H~dl~p~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~a 174 (290)
T cd05613 123 KLGIIYRDIKLENILLDSNGHVVL----------------------------TDFGLSKEFHEDEVERAYSFCGTIEYMA 174 (290)
T ss_pred hCCeeccCCCHHHeEECCCCCEEE----------------------------eeCccceecccccccccccccCCcccCC
Confidence 999999999999999999888887 4888876553322 12234678999999
Q ss_pred cccccC--CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKN--RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||.+.+ ..++.++|+||+|+++|+|++|..||+
T Consensus 175 PE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred hhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 999875 357789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=192.81 Aligned_cols=151 Identities=21% Similarity=0.326 Sum_probs=120.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++..+.|+|++++++.+.+....|+++||+. +++.+.+.... .+. ...+..++.|++.||.|||
T Consensus 53 e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~-----------~~~~~~~~~qi~~~L~~lH 120 (291)
T cd07870 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLH-----------PYNVRLFMFQLLRGLAYIH 120 (291)
T ss_pred HHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4566777889999999999999999999999995 67776665422 111 1234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++.++.+++ .|||.++.............+++.|+||
T Consensus 121 ~~~i~H~dlkp~Nil~~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 172 (291)
T cd07870 121 GQHILHRDLKPQNLLISYLGELKL----------------------------ADFGLARAKSIPSQTYSSEVVTLWYRPP 172 (291)
T ss_pred hCCcccCCCChHHEEEcCCCcEEE----------------------------eccccccccCCCCCCCCCccccccccCC
Confidence 999999999999999998888887 4898876543322223345678999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 173 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred ceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99876 457889999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=189.62 Aligned_cols=147 Identities=20% Similarity=0.247 Sum_probs=118.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+++++++..+.. ...|+++||+.+|+|.+++.+.. .++. ..+..++.|++.||.|||
T Consensus 51 e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~~i~~~l~~LH 118 (259)
T cd05037 51 TASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSL-----------HWKLDVAKQLASALHYLE 118 (259)
T ss_pred HHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 4556777889999999998877 77899999999999999998654 2221 223456789999999999
Q ss_pred HcCcccccCCCCceeeCCCC-------ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRG-------YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG 213 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~-------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g 213 (255)
++|++||||||+||+++..+ .+++ .|||.+..... .....+
T Consensus 119 ~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl----------------------------~Dfg~a~~~~~----~~~~~~ 166 (259)
T cd05037 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKL----------------------------SDPGIPITVLS----REERVE 166 (259)
T ss_pred hCCeecccCccceEEEecCccccCCceeEEe----------------------------CCCCccccccc----cccccc
Confidence 99999999999999998766 3444 49998776533 123457
Q ss_pred CCCCcccccccCC--CCCCcchHHHHHHHHHHHhcC-CCCCc
Q psy3182 214 TPEYVAPEIIKNR--GHDRAVDYWALGILMHELLTG-MKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~--~~~~~~DiWslGvil~ell~G-~~~~~ 252 (255)
++.|+|||++.+. .++.++|+||+||++|+|++| ..||+
T Consensus 167 ~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~ 208 (259)
T cd05037 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208 (259)
T ss_pred CCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence 7889999999876 788999999999999999994 66664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=195.95 Aligned_cols=152 Identities=24% Similarity=0.290 Sum_probs=120.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+. ..++++||+.+|+|.+.+++... ++ ...+..++.|++.||.|||
T Consensus 59 e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~-----------~~~~~~~~~qi~~~L~~LH 126 (316)
T cd05108 59 EAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-----------SQYLLNWCVQIAKGMNYLE 126 (316)
T ss_pred HHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 34567778899999999987765 57899999999999999876431 11 1223446678999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~ 218 (255)
++|++||||||+||+++.++.+++ .|||.++........ .....+++.|+
T Consensus 127 ~~~iiH~dlkp~Nill~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 178 (316)
T cd05108 127 ERRLVHRDLAARNVLVKTPQHVKI----------------------------TDFGLAKLLGADEKEYHAEGGKVPIKWM 178 (316)
T ss_pred hcCeeccccchhheEecCCCcEEE----------------------------ccccccccccCCCcceeccCCccceeec
Confidence 999999999999999999888888 499988765432211 11223456899
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|||++ |..||..
T Consensus 179 apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred ChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999999997 9888864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=190.75 Aligned_cols=152 Identities=32% Similarity=0.628 Sum_probs=127.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++++.+.|+|+++++..+.+....|+++||+.|++|...+.+...+++ +.+..++.|+++||.|||+
T Consensus 50 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~~i~~~l~~lh~ 118 (258)
T cd05578 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----------EQVKFWICEIVLALEYLHS 118 (258)
T ss_pred HHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 35567778899999999999999999999999999999999876544433 2345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|+||+|+||+++.++.+++ +|||.+....... ......|+..|+|||
T Consensus 119 ~~i~h~dl~~~nil~~~~~~~~l----------------------------~d~~~~~~~~~~~-~~~~~~~~~~y~~PE 169 (258)
T cd05578 119 KGIIHRDIKPDNILLDEQGHVHI----------------------------TDFNIATKVTPDT-LTTSTSGTPGYMAPE 169 (258)
T ss_pred CCeeccCCCHHHeEEcCCCCEEE----------------------------eecccccccCCCc-cccccCCChhhcCHH
Confidence 99999999999999999888877 5888876554322 223456888999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 170 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred HHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 99988899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=192.48 Aligned_cols=151 Identities=23% Similarity=0.311 Sum_probs=120.3
Q ss_pred ceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++..+.|+|++++++.+.. ...+|++|||+.+|+|.+++.+. .+++ ..+..++.|++.||.||
T Consensus 56 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~-----------~~~~~i~~~l~~~l~~l 123 (283)
T cd05080 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNL-----------AQLLLFAQQICEGMAYL 123 (283)
T ss_pred HHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCH-----------HHHHHHHHHHHHHHHHH
Confidence 4667778899999999987654 44689999999999999988653 2222 33455778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~~ 216 (255)
|+++++||||||+||+++.++.+++ .|||.++........ .....++..
T Consensus 124 H~~~i~H~dlkp~Nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~ 175 (283)
T cd05080 124 HSQHYIHRDLAARNVLLDNDRLVKI----------------------------GDFGLAKAVPEGHEYYRVREDGDSPVF 175 (283)
T ss_pred HHCCeeccccChheEEEcCCCcEEE----------------------------eecccccccCCcchhhccCCCCCCCce
Confidence 9999999999999999998888887 488887655332111 111235667
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||.+.+..++.++|+||+||++|+|++|..|+.
T Consensus 176 ~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 176 WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred eeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 999999988889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=194.46 Aligned_cols=150 Identities=28% Similarity=0.564 Sum_probs=125.5
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|+|++++++.+.+.+..|+++||+.|++|.+++.+. .+++ ..+..++.|++.|+.|||++
T Consensus 67 ~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~-----------~~~~~i~~~l~~al~~LH~~ 134 (293)
T cd06647 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDE-----------GQIAAVCRECLQALEFLHSN 134 (293)
T ss_pred HHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCH-----------HHHHHHHHHHHHHHHHHHhC
Confidence 44566778999999999999999999999999999999988653 2221 23455778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++||||||+||+++.++..++ .|||++..............|++.|+|||.
T Consensus 135 gi~H~dL~p~Nili~~~~~~kL----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~ 186 (293)
T cd06647 135 QVIHRDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186 (293)
T ss_pred CEeeccCCHHHEEEcCCCCEEE----------------------------ccCcceecccccccccccccCChhhcCchh
Confidence 9999999999999998888877 488877655443333344578999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+....++.++|+||+||++|++++|..||.
T Consensus 187 ~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 988889999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=191.59 Aligned_cols=153 Identities=27% Similarity=0.439 Sum_probs=125.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+.+..|+++||+.++.+....++...+++ +.+..++.|++.||.|||+
T Consensus 50 e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~LH~ 118 (288)
T cd07833 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPP-----------DAVRSYIWQLLQAIAYCHS 118 (288)
T ss_pred HHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999998777666654333332 3345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
++++|||++|+||+++.++.+++ .|||.+........ ......|++.|+||
T Consensus 119 ~~i~H~dl~~~ni~~~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~~~P 170 (288)
T cd07833 119 HNIIHRDIKPENILVSESGVLKL----------------------------CDFGFARALRARPASPLTDYVATRWYRAP 170 (288)
T ss_pred CCeecCCCCHHHeEECCCCCEEE----------------------------EeeecccccCCCccccccCcccccCCcCC
Confidence 99999999999999999888888 58998776544332 23346788999999
Q ss_pred ccccCC-CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNR-GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~-~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+. .++.++|+||+|+++|+|++|.+||..
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred chhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999887 889999999999999999999988863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=200.82 Aligned_cols=156 Identities=26% Similarity=0.329 Sum_probs=126.6
Q ss_pred cCceeeeccccccccccccccccCcc-ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSK-YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~-~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++.++++..|+|+++|.+++.+.+ ...+|+||+..|+|.+++..+... .-. +..--.|+.+++.||+|
T Consensus 119 ~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~------W~~R~kIa~g~A~gL~y 189 (361)
T KOG1187|consen 119 LNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLD------WETRLKIALGAARGLAY 189 (361)
T ss_pred HHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCC------HHHHHHHHHHHHHHHHH
Confidence 34577889999999999999999888 499999999999999999764321 111 22223477889999999
Q ss_pred HHHcC---cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccc-ccC
Q psy3182 139 LHTRG---IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTF-CGT 214 (255)
Q Consensus 139 lH~~~---iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~-~gt 214 (255)
||... ||||||||.|||++.+...|++ |||+|+..........+. .||
T Consensus 190 LH~~~~~~iiHrDiKssNILLD~~~~aKls----------------------------DFGLa~~~~~~~~~~~~~~~gt 241 (361)
T KOG1187|consen 190 LHEGCPPPIIHRDIKSSNILLDEDFNAKLS----------------------------DFGLAKLGPEGDTSVSTTVMGT 241 (361)
T ss_pred HccCCCCCEecCCCCHHHeeECCCCCEEcc----------------------------CccCcccCCccccceeeecCCC
Confidence 99843 9999999999999999988884 999996654312222223 799
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+|+|||.+.....+.++|+||+||++.|+++|.+|.+
T Consensus 242 ~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 242 FGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred CccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 99999999988778999999999999999999997765
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=191.69 Aligned_cols=152 Identities=26% Similarity=0.355 Sum_probs=121.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+++..|++|||+.||+|.+++.+... ++ ...+..++.|++.|+.|||
T Consensus 55 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~i~~~i~~~l~~lH 123 (267)
T cd05066 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT-----------VIQLVGMLRGIASGMKYLS 123 (267)
T ss_pred HHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 34556677899999999999999999999999999999999875421 11 1223456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc---cccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT---FCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~---~~gt~~y 217 (255)
+++++||||||+|++++.++.+++ +|||.+...........+ ..+++.|
T Consensus 124 ~~~i~h~dlkp~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~y 175 (267)
T cd05066 124 DMGYVHRDLAARNILVNSNLVCKV----------------------------SDFGLSRVLEDDPEAAYTTRGGKIPIRW 175 (267)
T ss_pred HCCEeehhhchhcEEECCCCeEEe----------------------------CCCCcccccccccceeeecCCCccceee
Confidence 999999999999999998887777 488887665432221111 2235679
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+|||.+.+..++.++|+||+||++|++++ |..||.
T Consensus 176 ~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred cCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 99999998889999999999999999886 999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=189.22 Aligned_cols=152 Identities=20% Similarity=0.358 Sum_probs=121.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+.+..|++|||+.||+|.+++.... .++ .+.+..++.|++.||.|+|
T Consensus 42 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~~i~~~l~~lH 110 (250)
T cd05085 42 EARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELK-----------TKQLVKFALDAAAGMAYLE 110 (250)
T ss_pred HHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4556777789999999999999999999999999999999886532 122 1233456678999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-cccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT-WTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~-~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ .|||.+.......... ....+++.|+|
T Consensus 111 ~~~~~H~dl~p~nili~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~y~a 162 (250)
T cd05085 111 SKNCIHRDLAARNCLVGENNVLKI----------------------------SDFGMSRQEDDGIYSSSGLKQIPIKWTA 162 (250)
T ss_pred hCCeeecccChheEEEcCCCeEEE----------------------------CCCccceeccccccccCCCCCCcccccC
Confidence 999999999999999998887777 4888776543221111 11234567999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||++.+..++.++|+||+|+++|++++ |..||.
T Consensus 163 PE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 999988888999999999999999998 988885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=190.26 Aligned_cols=152 Identities=26% Similarity=0.361 Sum_probs=123.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|++++++++.+.+.+..|++|||+.+|+|.+++.... .++ ...+..++.|++.|+.|||
T Consensus 55 e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~~l~~~l~~Lh 123 (266)
T cd05033 55 EASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT-----------VGQLVGMLRGIASGMKYLS 123 (266)
T ss_pred HHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4556777889999999999999999999999999999999987532 122 2234456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~ 218 (255)
+++++|||+||+||+++.++..++ +|||.++........ .....+++.|+
T Consensus 124 ~~~i~H~di~p~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 175 (266)
T cd05033 124 EMNYVHRDLAARNILVNSNLVCKV----------------------------SDFGLSRRLEDSEATYTTKGGKIPIRWT 175 (266)
T ss_pred hCCcccCCCCcceEEEcCCCCEEE----------------------------CccchhhcccccccceeccCCCCCcccc
Confidence 999999999999999998888887 488888766422111 11223456899
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|||.+.+..++.++|+||+|+++|+|++ |..||.
T Consensus 176 ~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 9999998889999999999999999997 988875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=189.02 Aligned_cols=153 Identities=31% Similarity=0.549 Sum_probs=126.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+....|+++||+.|++|.+++.+...+++ ..+..++.|++.|+.|||+
T Consensus 52 e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~ 120 (258)
T cd06632 52 EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE-----------PVIRLYTRQILLGLEYLHD 120 (258)
T ss_pred HHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45566777899999999999999999999999999999999876543332 2234467789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|+||+|+||+++.++..++ .|||.+....... ......|++.|+|||
T Consensus 121 ~~i~H~dl~~~ni~~~~~~~~kl----------------------------~d~~~~~~~~~~~-~~~~~~~~~~y~~pe 171 (258)
T cd06632 121 RNTVHRDIKGANILVDTNGVVKL----------------------------ADFGMAKQVVEFS-FAKSFKGSPYWMAPE 171 (258)
T ss_pred CCcccCCCCHHHEEECCCCCEEE----------------------------ccCccceeccccc-cccccCCCcceeCHH
Confidence 99999999999999998888887 4888776553332 223456899999999
Q ss_pred cccCCC-CCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 222 IIKNRG-HDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 222 ~~~~~~-~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
.+.... ++.++|+||+||++|+|++|..||..+
T Consensus 172 ~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred HhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 998766 889999999999999999999998643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=191.16 Aligned_cols=151 Identities=22% Similarity=0.278 Sum_probs=118.3
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+.++....|++++++++.+.+ ...++++|++.+|+|.+.+.+.. .+++ ..+..++.|++.||.|||+
T Consensus 60 ~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~-----------~~~~~~~~qi~~~L~~lH~ 127 (279)
T cd05109 60 AYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGS-----------QDLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred HHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 344566789999998887765 45789999999999999987532 2222 2334467789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~a 219 (255)
++++||||||+||++++.+.+++ .|||.++........ .....+++.|+|
T Consensus 128 ~~iiH~dlkp~Nil~~~~~~~kL----------------------------~dfG~~~~~~~~~~~~~~~~~~~~~~y~~ 179 (279)
T cd05109 128 VRLVHRDLAARNVLVKSPNHVKI----------------------------TDFGLARLLDIDETEYHADGGKVPIKWMA 179 (279)
T ss_pred CCeeccccccceEEEcCCCcEEE----------------------------CCCCceeecccccceeecCCCccchhhCC
Confidence 99999999999999988887877 489988765432211 111234568999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||.+.+..++.++|+||+||++|||++ |..||+.
T Consensus 180 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999998889999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=193.46 Aligned_cols=163 Identities=23% Similarity=0.292 Sum_probs=125.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhh-----------HHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASF-----------ITACVIEALDFITA 130 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~-----------~~~~~~~~~~~i~~ 130 (255)
++++++.+.|++++++++.+.+....|+++||+.+|+|.+++.......+..... ........+..++.
T Consensus 58 ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 137 (288)
T cd05050 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAK 137 (288)
T ss_pred HHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHH
Confidence 4667778899999999999999999999999999999999997654322211100 00112234456788
Q ss_pred HHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cc
Q psy3182 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KT 208 (255)
Q Consensus 131 ~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~ 208 (255)
|++.||.|+|+++++||||||+||+++.++.+++ +|||.+........ ..
T Consensus 138 ~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~ 189 (288)
T cd05050 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI----------------------------ADFGLSRNIYSADYYKAS 189 (288)
T ss_pred HHHHHHHHHHhCCeecccccHhheEecCCCceEE----------------------------CccccceecccCcccccc
Confidence 9999999999999999999999999998888777 48887765432211 11
Q ss_pred cccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 209 WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 209 ~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
....+++.|+|||.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred CCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 12234667999999998889999999999999999997 887874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=191.10 Aligned_cols=154 Identities=19% Similarity=0.152 Sum_probs=115.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+.+++...|+|++++++.+.+....|+||||+.||+|..++++. ..+++ .....++.|++.||.|||+
T Consensus 67 ~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 67 ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPV-----------AWKITVAQQLASALSYLED 135 (274)
T ss_pred HHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHHc
Confidence 44567778999999999999999999999999999999888653 22222 2234567899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||||+||+++..+..... .......|||.+...... ....|++.|+|||
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~---------------------~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe 190 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGT---------------------SPFIKLSDPGVSFTALSR----EERVERIPWIAPE 190 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCc---------------------cceeeecCCccccccccc----cccccCCcccCch
Confidence 999999999999999764321100 000112488876543221 1235788899999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHh-cCCCCCc
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELL-TGMKESN 252 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell-~G~~~~~ 252 (255)
.+.+ ..++.++|+||+||++|+++ +|..||.
T Consensus 191 ~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 191 CVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9875 56899999999999999984 7888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=189.85 Aligned_cols=153 Identities=29% Similarity=0.516 Sum_probs=125.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+.+..|+++||+.||+|.+.+++...+++ +.+..++.|++.||.|+|+
T Consensus 58 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~qi~~~l~~lH~ 126 (272)
T cd06629 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----------QLVRFFTEQVLEGLAYLHS 126 (272)
T ss_pred HHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHHhh
Confidence 35667777899999999999999999999999999999999987544433 2345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--CccccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~gt~~y~a 219 (255)
++++||||+|+||+++.++.+++ .|||.++..... ........|+..|+|
T Consensus 127 ~~i~H~dl~~~nil~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~~~y~~ 178 (272)
T cd06629 127 KGILHRDLKADNLLVDADGICKI----------------------------SDFGISKKSDDIYDNDQNMSMQGSVFWMA 178 (272)
T ss_pred CCeeecCCChhhEEEcCCCeEEE----------------------------eeccccccccccccccccccccCCccccC
Confidence 99999999999999998888887 488877654321 112234568899999
Q ss_pred cccccCCC--CCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRG--HDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~--~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||.+.... ++.++|+||+|+++|++++|..||..
T Consensus 179 PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred HHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 99987654 88999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=190.81 Aligned_cols=151 Identities=24% Similarity=0.351 Sum_probs=120.3
Q ss_pred ceeeecccccccccccccc-ccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKT-FKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~-~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|++++++++. +.+....|+++||+.+|+|.++++++.... .....+..++.|++.||.|||
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH 119 (256)
T cd05082 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---------LGGDCLLKFSLDVCEAMEYLE 119 (256)
T ss_pred HHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCC---------CCHHHHHHHHHHHHHHHHHHH
Confidence 4566778889999999975 456678999999999999999987643211 111233456778999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++.++.+++ .|||.++...... ....++..|+||
T Consensus 120 ~~~i~H~dlkp~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~---~~~~~~~~y~aP 168 (256)
T cd05082 120 ANNFVHRDLAARNVLVSEDNVAKV----------------------------SDFGLTKEASSTQ---DTGKLPVKWTAP 168 (256)
T ss_pred hCCEeccccchheEEEcCCCcEEe----------------------------cCCccceeccccC---CCCccceeecCH
Confidence 999999999999999999988888 4888876543221 233456689999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|++.+..++.++|+||+||++|+|++ |..||.
T Consensus 169 E~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred HHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99998889999999999999999997 888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=189.08 Aligned_cols=152 Identities=24% Similarity=0.336 Sum_probs=120.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.. +..+++|||+.+|+|.+++.+...+++ ..+..++.|++.||.|||+
T Consensus 46 e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~qi~~~l~~lh~ 113 (257)
T cd05060 46 EASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPV-----------SDLKELAHQVAMGMAYLES 113 (257)
T ss_pred HHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCH-----------HHHHHHHHHHHHHHHHHhh
Confidence 4567778889999999987664 467999999999999999986543332 2345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc---cccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT---WTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~---~~~~gt~~y~ 218 (255)
++++||||||+|++++.++.+++. |||.++......... ....++..|+
T Consensus 114 ~~i~H~di~p~nili~~~~~~kl~----------------------------df~~~~~~~~~~~~~~~~~~~~~~~~y~ 165 (257)
T cd05060 114 KHFVHRDLAARNVLLVNRHQAKIS----------------------------DFGMSRALGAGSDYYRATTAGRWPLKWY 165 (257)
T ss_pred cCeeccCcccceEEEcCCCcEEec----------------------------cccccceeecCCcccccccCcccccccc
Confidence 999999999999999999888884 777776543322111 1112345799
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||.+.+..++.++|+||+||++|++++ |..||+.
T Consensus 166 aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred CHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 9999998889999999999999999998 8999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=189.04 Aligned_cols=153 Identities=23% Similarity=0.352 Sum_probs=123.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++++...|+|++++++.+.+ ...++++||+.+|+|.+.+.+... . ......+..++.|++.||.|+|+
T Consensus 46 e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~--------~~~~~~~~~~~~qi~~~L~~lH~ 115 (257)
T cd05040 46 EAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-G--------HFLISTLCDYAVQIANGMRYLES 115 (257)
T ss_pred HHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-c--------cCcHHHHHHHHHHHHHHHHHHHh
Confidence 4667778899999999999888 889999999999999999876432 0 01123345567899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~y~ 218 (255)
++++||||||+||+++.++.+++ .|||.++....... ......++..|+
T Consensus 116 ~~i~H~di~p~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 167 (257)
T cd05040 116 KRFIHRDLAARNILLASDDKVKI----------------------------GDFGLMRALPQNEDHYVMEEHLKVPFAWC 167 (257)
T ss_pred CCccccccCcccEEEecCCEEEe----------------------------ccccccccccccccceecccCCCCCceec
Confidence 99999999999999999888888 48887766533211 111245677899
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|||.+.+..++.++|+||+||++|+|++ |..||+
T Consensus 168 ~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred CHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999998889999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=190.42 Aligned_cols=153 Identities=31% Similarity=0.561 Sum_probs=125.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC---CCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC---FDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~---~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++....|+++++++..+.+.+..|+++|++.|++|.+.++.... +++ ..+..++.|++.||.|
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~-----------~~~~~~~~ql~~al~~ 117 (267)
T cd06610 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDE-----------AIIATVLKEVLKGLEY 117 (267)
T ss_pred HHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCH-----------HHHHHHHHHHHHHHHH
Confidence 34556677899999999999999999999999999999999975422 222 2344567889999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc----ccccccC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK----TWTFCGT 214 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~----~~~~~gt 214 (255)
||++|++||||+|+||+++.++..++ .|||.+......... .....|+
T Consensus 118 lh~~~i~h~~l~p~ni~~~~~~~~~l----------------------------~df~~~~~~~~~~~~~~~~~~~~~~~ 169 (267)
T cd06610 118 LHSNGQIHRDIKAGNILLGEDGSVKI----------------------------ADFGVSASLADGGDRTRKVRKTFVGT 169 (267)
T ss_pred HHhCCeecCCCCHHhEEEcCCCCEEE----------------------------cccchHHHhccCccccccccccccCC
Confidence 99999999999999999998888877 488877655432211 2345789
Q ss_pred CCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||++... .++.++|+||+||++|+|++|..||+.
T Consensus 170 ~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred hhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 999999998876 788999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=189.99 Aligned_cols=153 Identities=29% Similarity=0.483 Sum_probs=123.1
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|++++++++.+.+. ..+++++||+.|++|.+.+.+...+++. .+..++.|++.||.||
T Consensus 54 ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~-----------~~~~~~~~i~~al~~L 122 (264)
T cd06653 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN-----------VTRRYTRQILQGVSYL 122 (264)
T ss_pred HHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHH
Confidence 45567777899999999887664 4689999999999999988765444332 2344678899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC---CccccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS---GCKTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~---~~~~~~~~gt~~ 216 (255)
|++|++||||||+||+++.++..++ .|||+++..... ........|++.
T Consensus 123 H~~~i~H~dl~p~ni~i~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (264)
T cd06653 123 HSNMIVHRDIKGANILRDSAGNVKL----------------------------GDFGASKRIQTICMSGTGIKSVTGTPY 174 (264)
T ss_pred HhCCEecCCCCHHHEEEcCCCCEEE----------------------------CccccccccccccccCccccccCCccc
Confidence 9999999999999999998887777 488887654321 111224568999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+|||.+.+..++.++|+||+||++|+|++|..||..
T Consensus 175 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 9999999988899999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=188.80 Aligned_cols=154 Identities=27% Similarity=0.448 Sum_probs=125.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.+++...|++++++++.+.+.+..|+++||+.|++|.+.+......... ...+..++.|++.|+.|+|+
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08218 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP---------EDQILDWFVQICLALKHVHD 119 (256)
T ss_pred HHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCC---------HHHHHHHHHHHHHHHHHHHh
Confidence 455677778999999999999999999999999999999988753321111 12234456789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|+||+|+||+++.++.+++ .|||.+..............|++.|+|||
T Consensus 120 ~~i~h~~l~~~nil~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~~~~pe 171 (256)
T cd08218 120 RKILHRDIKSQNIFLTKDGTIKL----------------------------GDFGIARVLNSTVELARTCIGTPYYLSPE 171 (256)
T ss_pred CCEecCCCCHHHEEEcCCCCEEE----------------------------eeccceeecCcchhhhhhccCCccccCHH
Confidence 99999999999999998887777 48888765544322233456899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 172 ~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred HhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 9998888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=191.86 Aligned_cols=152 Identities=28% Similarity=0.480 Sum_probs=124.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+.+..|+++||+.++.+..+......++ .+.+..++.|++.||.|||+
T Consensus 50 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-----------~~~~~~~~~~i~~~l~~LH~ 118 (286)
T cd07846 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD-----------ESRVRKYLFQILRGIEFCHS 118 (286)
T ss_pred HHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHHHHH
Confidence 4567778889999999999999999999999999998887765433222 23345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|+|++|+||+++.++.+++ .|||.+..............|++.|+|||
T Consensus 119 ~~i~h~~l~p~ni~~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 170 (286)
T cd07846 119 HNIIHRDIKPENILVSQSGVVKL----------------------------CDFGFARTLAAPGEVYTDYVATRWYRAPE 170 (286)
T ss_pred CCccccCCCHHHEEECCCCcEEE----------------------------EeeeeeeeccCCccccCcccceeeccCcH
Confidence 99999999999999998888877 59998876544333333456889999999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 171 ~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred HhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 9875 457789999999999999999998774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=189.26 Aligned_cols=156 Identities=27% Similarity=0.414 Sum_probs=124.3
Q ss_pred ceeeeccccccccccccccccC-ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD-SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~-~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++..+.|+|++.+...|-+ ...+||++||.+ -|||++|+-+..-. +. ......+..|..||+.|+.|||
T Consensus 77 EiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~---~~---~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 77 EIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASK---AK---QLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred HHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccch---hc---cCCHHHHHHHHHHHHhhhHHHh
Confidence 4667788899999999998877 788999999985 59999997543211 11 2233467888999999999999
Q ss_pred HcCcccccCCCCceeeCCC----CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc---ccccc
Q psy3182 141 TRGIVFRDLKPENLLLDNR----GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT---WTFCG 213 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~---~~~~g 213 (255)
++-|+||||||.||++..+ |.+|+ .|+|+++.....-... ...+-
T Consensus 150 ~NWvlHRDLKPaNIlvmgdgperG~VKI----------------------------aDlGlaR~~~~plkpl~s~d~VVV 201 (438)
T KOG0666|consen 150 SNWVLHRDLKPANILVMGDGPERGRVKI----------------------------ADLGLARLFNNPLKPLASLDPVVV 201 (438)
T ss_pred hhheeeccCCcceEEEeccCCccCeeEe----------------------------ecccHHHHhhccccccccCCceEE
Confidence 9999999999999999766 67777 5999998765533222 23566
Q ss_pred CCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|..|.|||.+.+ ..|+.++|+||+|||..||++-.+-|.
T Consensus 202 TiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 202 TIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred EEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 889999999987 578999999999999999998766553
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=188.99 Aligned_cols=152 Identities=36% Similarity=0.676 Sum_probs=124.6
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++.+..|+|+++++..+.+.+..|+++|++.|++|.+++.+...+++. .+..++.|++.||.|||++
T Consensus 44 ~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~~L~~lH~~ 112 (265)
T cd05579 44 RDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----------VARIYIAEIVLALEYLHSN 112 (265)
T ss_pred HHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHc
Confidence 44566778999999999999999999999999999999999865444332 2345678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--------cccccccC
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--------KTWTFCGT 214 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--------~~~~~~gt 214 (255)
+++|+||+|+||+++.++.+++ .|||++........ ......++
T Consensus 113 ~i~H~di~~~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (265)
T cd05579 113 GIIHRDLKPDNILIDSNGHLKL----------------------------TDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164 (265)
T ss_pred CeecCCCCHHHeEEcCCCCEEE----------------------------EecccchhcccCcccccccccccccCcccC
Confidence 9999999999999999988888 47776654322211 22335688
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||......++.++|+||+|+++|++++|..||..
T Consensus 165 ~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred ccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 899999999888889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=191.96 Aligned_cols=153 Identities=29% Similarity=0.551 Sum_probs=126.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+....|+++||+.|++|.+++.... .++. ..+..++.|++.||.|||
T Consensus 65 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~-----------~~~~~i~~~i~~~L~~lH 133 (286)
T cd06614 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE-----------PQIAYVCREVLQGLEYLH 133 (286)
T ss_pred HHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4556677789999999999999999999999999999999998654 3332 233456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++|+|++|+||+++.++.+++ .|||.+..............|++.|+||
T Consensus 134 ~~gi~H~dl~p~ni~i~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~y~~P 185 (286)
T cd06614 134 SQNVIHRDIKSDNILLSKDGSVKL----------------------------ADFGFAAQLTKEKSKRNSVVGTPYWMAP 185 (286)
T ss_pred hCCeeeCCCChhhEEEcCCCCEEE----------------------------CccchhhhhccchhhhccccCCcccCCH
Confidence 999999999999999998888887 4888765543332233345688999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+||+||++|+|++|..||..
T Consensus 186 E~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred hHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 999988899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=191.51 Aligned_cols=150 Identities=29% Similarity=0.420 Sum_probs=122.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc---CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT---CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~---~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++.+..|+|++++++.+...+..|+++||+.|++|.+++.+.. .++ ...+..++.|++.||.|
T Consensus 49 e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~-----------~~~~~~~~~~i~~~l~~ 117 (286)
T cd06622 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP-----------EDVLRRITYAVVKGLKF 117 (286)
T ss_pred HHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCC-----------HHHHHHHHHHHHHHHHH
Confidence 3556677789999999999999999999999999999988887531 222 23456677899999999
Q ss_pred HHH-cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 139 LHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 139 lH~-~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
||+ ++++||||||+||+++.++.+++ .|||.+...... ...+..|++.|
T Consensus 118 LH~~~~i~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~--~~~~~~~~~~y 167 (286)
T cd06622 118 LKEEHNIIHRDVKPTNVLVNGNGQVKL----------------------------CDFGVSGNLVAS--LAKTNIGCQSY 167 (286)
T ss_pred HHhcCCEeeCCCCHHHEEECCCCCEEE----------------------------eecCCcccccCC--ccccCCCccCc
Confidence 996 59999999999999999888887 499988665332 22345688999
Q ss_pred cccccccCC------CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNR------GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~------~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus 168 ~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred cCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 999998543 35789999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=195.93 Aligned_cols=156 Identities=26% Similarity=0.412 Sum_probs=121.5
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++....|++++++++.+.+. ..+|+|+||+.+ ++.+.+........ .......+..++.|++.||.||
T Consensus 52 e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~l 124 (316)
T cd07842 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKR------VSIPPSMVKSLLWQILNGVHYL 124 (316)
T ss_pred HHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCC------cCcCHHHHHHHHHHHHHHHHHH
Confidence 45677888999999999999988 889999999875 67766653221111 0112234566788999999999
Q ss_pred HHcCcccccCCCCceeeCC----CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccc
Q psy3182 140 HTRGIVFRDLKPENLLLDN----RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFC 212 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~ 212 (255)
|+++++||||||+||+++. .+.+++ +|||+++....... .....+
T Consensus 125 H~~~i~h~dlkp~Nil~~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~ 176 (316)
T cd07842 125 HSNWVLHRDLKPANILVMGEGPERGVVKI----------------------------GDLGLARLFNAPLKPLADLDPVV 176 (316)
T ss_pred HhCCEeeCCCCHHHEEEcCCCCccceEEE----------------------------CCCccccccCCCcccccccCCcc
Confidence 9999999999999999988 667777 48888776533221 122357
Q ss_pred cCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 213 GTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 213 gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred ccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 8899999998876 468899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=192.01 Aligned_cols=151 Identities=31% Similarity=0.460 Sum_probs=125.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+.+..|+++||+.+|+|..++.+.+.++. ..+..++.+++.|+.|||+
T Consensus 53 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~LH~ 121 (284)
T cd06620 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV-----------EILGKIAVAVVEGLTYLYN 121 (284)
T ss_pred HHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999998876544332 2344567789999999997
Q ss_pred -cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 -RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 -~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++++||||||+||+++.++.+++ .|||++...... .....+|+..|+||
T Consensus 122 ~~~i~H~dl~p~nil~~~~~~~~l----------------------------~d~gl~~~~~~~--~~~~~~~~~~~~aP 171 (284)
T cd06620 122 VHRIMHRDIKPSNILVNSRGQIKL----------------------------CDFGVSGELINS--IADTFVGTSTYMSP 171 (284)
T ss_pred hcCeeccCCCHHHEEECCCCcEEE----------------------------ccCCcccchhhh--ccCccccCcccCCH
Confidence 69999999999999998887777 488877554222 12245799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+||+||++|++++|..||..
T Consensus 172 E~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred HHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 999888899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=192.32 Aligned_cols=164 Identities=24% Similarity=0.316 Sum_probs=124.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCcc-chhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN-AASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|++++++++.+.+....|++|||+.|++|.+++......... ............+..++.|++.||.|||
T Consensus 67 ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 146 (295)
T cd05097 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA 146 (295)
T ss_pred HHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH
Confidence 567788889999999999999999999999999999999998653211000 0000001122344567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
++|++||||||+|++++.++.+++ .|||.+........ ......+++.|+
T Consensus 147 ~~~i~H~dlkp~Nill~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 198 (295)
T cd05097 147 SLNFVHRDLATRNCLVGNHYTIKI----------------------------ADFGMSRNLYSGDYYRIQGRAVLPIRWM 198 (295)
T ss_pred hcCeeccccChhhEEEcCCCcEEe----------------------------cccccccccccCcceeccCcCcCceeec
Confidence 999999999999999998888887 48888765432211 111234567899
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT--GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~--G~~~~~~ 253 (255)
|||++.+..++.++|+|||||++|+|++ |..||..
T Consensus 199 aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 199 AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999988889999999999999999988 5567653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=190.06 Aligned_cols=151 Identities=33% Similarity=0.594 Sum_probs=123.3
Q ss_pred eeeecccc---ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK---KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 63 vkl~~~~~---h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++... |++++++++.+.+.+..|++|||+.|++|.++++.. .+++ +.+..++.|++.||.||
T Consensus 50 ~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~-----------~~~~~i~~~i~~~l~~l 117 (277)
T cd06917 50 VALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAE-----------KYISVIIREVLVALKYI 117 (277)
T ss_pred HHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc-CCCH-----------HHHHHHHHHHHHHHHHH
Confidence 34444444 999999999999999999999999999999888643 2222 33445678899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++|++|+||+|+||+++..+.+++ .|||.+..............|++.|+|
T Consensus 118 h~~~i~H~dl~p~ni~i~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~a 169 (277)
T cd06917 118 HKVGVIHRDIKAANILVTNTGNVKL----------------------------CDFGVAALLNQNSSKRSTFVGTPYWMA 169 (277)
T ss_pred HhCCcccCCcCHHHEEEcCCCCEEE----------------------------ccCCceeecCCCccccccccCCcceeC
Confidence 9999999999999999999888877 488887766544333445679999999
Q ss_pred cccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||.+.+ ..++.++|+||+||++|+|++|..||..
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred HHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 999864 5678899999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=190.33 Aligned_cols=162 Identities=21% Similarity=0.281 Sum_probs=123.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++.+..|+++++++..+.+....|++|||+.+|+|.+++.....-..... ........+..++.|++.||.|||
T Consensus 57 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLK--PPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred HHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhccccccccc--ccCCCHHHHHHHHHHHHHHHHHhh
Confidence 346677888899999999999999999999999999999999875431110000 001122345567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~a 219 (255)
+++++||||||+|++++..+..++. |||+++...... .......+++.|+|
T Consensus 135 ~~~i~H~dlkp~Nili~~~~~~~l~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~y~~ 186 (275)
T cd05046 135 NARFVHRDLAARNCLVSSQREVKVS----------------------------LLSLSKDVYNSEYYKLRNALIPLRWLA 186 (275)
T ss_pred hcCcccCcCccceEEEeCCCcEEEc----------------------------ccccccccCcccccccCCceeEEeecC
Confidence 9999999999999999988877773 677665332211 11223356778999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+.+..++.++|+||+||++|++++ |..||.
T Consensus 187 PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 999988888999999999999999998 778875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=188.26 Aligned_cols=153 Identities=20% Similarity=0.319 Sum_probs=119.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+++++++..+.+ ...|++|||+.+|+|.+++.+..... ...+.+..++.|++.||.|+|+
T Consensus 51 E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~~l~~aL~~lH~ 120 (262)
T cd05071 51 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY---------LRLPQLVDMAAQIASGMAYVER 120 (262)
T ss_pred HHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 4566777889999999987754 55799999999999999987532110 0122344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~aP 220 (255)
++++||||||+||+++.++.+++ .|||.++........ .....++..|+||
T Consensus 121 ~~i~H~dl~p~Nill~~~~~~~L----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~~P 172 (262)
T cd05071 121 MNYVHRDLRAANILVGENLVCKV----------------------------ADFGLARLIEDNEYTARQGAKFPIKWTAP 172 (262)
T ss_pred CCccccccCcccEEEcCCCcEEe----------------------------ccCCceeeccccccccccCCcccceecCH
Confidence 99999999999999998888877 488887655432211 1123456789999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|+..+..++.++|+||+||++|+|++ |..||.
T Consensus 173 E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99988889999999999999999999 777774
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=189.44 Aligned_cols=152 Identities=25% Similarity=0.327 Sum_probs=121.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+.+..|++|||+.+++|.+++.... .++. ..+..++.|++.|+.|+|
T Consensus 56 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~~~l~~al~~lH 124 (268)
T cd05063 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS-----------YQLVGMLRGIAAGMKYLS 124 (268)
T ss_pred HHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4566777889999999999999999999999999999999886532 2221 233456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc---cccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT---FCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~---~~gt~~y 217 (255)
++|++|||+||+||+++.++.+++ .|||++...........+ ...++.|
T Consensus 125 ~~~i~H~dlkp~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~y 176 (268)
T cd05063 125 DMNYVHRDLAARNILVNSNLECKV----------------------------SDFGLSRVLEDDPEGTYTTSGGKIPIRW 176 (268)
T ss_pred HCCeeccccchhhEEEcCCCcEEE----------------------------CCCccceecccccccceeccCCCcCcee
Confidence 999999999999999998887777 488877655332211111 1234579
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+|||++.+..++.++|+||+||++|++++ |..||.
T Consensus 177 ~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999998889999999999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=191.87 Aligned_cols=150 Identities=19% Similarity=0.288 Sum_probs=119.4
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++....|+|++++++.+.+. ...|++|||+.|++|.+++.+... ++ .+.+..++.|++.||.|
T Consensus 56 e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~-----------~~~~~~i~~~i~~aL~~ 124 (284)
T cd05079 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN-----------LKQQLKYAVQICKGMDY 124 (284)
T ss_pred HHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHH
Confidence 45667788999999999887765 678999999999999999865321 11 12334567889999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTP 215 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~ 215 (255)
+|++|++||||||+||+++.++..++ .|||.++....... ......|+.
T Consensus 125 lH~~gi~H~dlkp~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~ 176 (284)
T cd05079 125 LGSRQYVHRDLAARNVLVESEHQVKI----------------------------GDFGLTKAIETDKEYYTVKDDLDSPV 176 (284)
T ss_pred HHHCCeeecccchheEEEcCCCCEEE----------------------------CCCccccccccCccceeecCCCCCCc
Confidence 99999999999999999998888877 48888765533221 112345677
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKE 250 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~ 250 (255)
.|+|||++.+..++.++|+||+||++|+|++|..|
T Consensus 177 ~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~ 211 (284)
T cd05079 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211 (284)
T ss_pred cccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence 89999999888899999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=187.00 Aligned_cols=152 Identities=20% Similarity=0.272 Sum_probs=116.2
Q ss_pred eeeecccccccccccccccc-CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFK-DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~-~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+.++....|+|++++++.+. .++..|+++||+.+|+|.+++.+...... ...+..++.|++.||.|||+
T Consensus 47 ~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~----------~~~~~~~~~~i~~~l~~lH~ 116 (262)
T cd05058 47 GIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT----------VKDLIGFGLQVAKGMEYLAS 116 (262)
T ss_pred HHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCC----------HHHHHHHHHHHHHHHHHHHh
Confidence 44566778999999998654 55678999999999999999875432111 11233466789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----cccccccCCCC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC----KTWTFCGTPEY 217 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~----~~~~~~gt~~y 217 (255)
++++||||||+||+++.++.+++ .|||.++....... ......+++.|
T Consensus 117 ~~i~H~dlk~~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~y 168 (262)
T cd05058 117 KKFVHRDLAARNCMLDESFTVKV----------------------------ADFGLARDIYDKEYYSVHNHTGAKLPVKW 168 (262)
T ss_pred CCccccccCcceEEEcCCCcEEE----------------------------CCccccccccCCcceeecccccCcCCccc
Confidence 99999999999999999888887 48887764432111 11123467789
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTG-MKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G-~~~~~ 252 (255)
+|||.+.+..++.++|+||+||++|||++| .+||.
T Consensus 169 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred cChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999888899999999999999999995 55554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=191.31 Aligned_cols=153 Identities=25% Similarity=0.382 Sum_probs=120.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+....|++|||+. +++.+.+......... ...+..++.|++.||.|||+
T Consensus 51 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~---------~~~~~~~~~qi~~aL~~LH~ 120 (294)
T PLN00009 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKN---------PRLIKTYLYQILRGIAYCHS 120 (294)
T ss_pred HHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcC---------HHHHHHHHHHHHHHHHHHHh
Confidence 4667778899999999999999999999999995 5788777654332111 12334567789999999999
Q ss_pred cCcccccCCCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++++||||+|+||+++.. +.+++ .|||.+..............|++.|+||
T Consensus 121 ~~i~H~dl~p~nill~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~~P 172 (294)
T PLN00009 121 HRVLHRDLKPQNLLIDRRTNALKL----------------------------ADFGLARAFGIPVRTFTHEVVTLWYRAP 172 (294)
T ss_pred CCeeCCCCCcceEEEECCCCEEEE----------------------------cccccccccCCCccccccCceeecccCH
Confidence 999999999999999754 45666 4999886554332222345678999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 173 E~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99876 467899999999999999999999884
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=188.16 Aligned_cols=152 Identities=32% Similarity=0.513 Sum_probs=127.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH-
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT- 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~- 141 (255)
++.+....|++++++++.+......|+++||+.|++|.+++.+...+++ +.+..++.|++.|+.|+|+
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~~l~~~l~~lh~~ 118 (264)
T cd06623 50 LKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE-----------PVLAYIARQILKGLDYLHTK 118 (264)
T ss_pred HHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHhcc
Confidence 4556677799999999999999999999999999999999986544433 2334567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||+|+||+++.++.+++ .|||.+..............|+..|+|||
T Consensus 119 ~~~~H~~l~~~ni~~~~~~~~~l----------------------------~df~~~~~~~~~~~~~~~~~~~~~y~~pE 170 (264)
T cd06623 119 RHIIHRDIKPSNLLINSKGEVKI----------------------------ADFGISKVLENTLDQCNTFVGTVTYMSPE 170 (264)
T ss_pred CCCccCCCCHHHEEECCCCCEEE----------------------------ccCccceecccCCCcccceeecccccCHh
Confidence 99999999999999999888887 48888776544433333567889999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+....++.++|+||||+++|+|++|..||..
T Consensus 171 ~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 202 (264)
T cd06623 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLP 202 (264)
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99988899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=188.42 Aligned_cols=159 Identities=25% Similarity=0.348 Sum_probs=122.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+....|++|||+.||+|.+++........... ......+..++.|++.||.|+|+
T Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~ 124 (269)
T cd05044 49 EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPP----LLTLKELLDICLDVAKGCVYLEQ 124 (269)
T ss_pred HHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCc----cccHHHHHHHHHHHHHHHHHHHh
Confidence 45667788999999999999999999999999999999999975322110000 01123345577889999999999
Q ss_pred cCcccccCCCCceeeCCCC-----ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccC
Q psy3182 142 RGIVFRDLKPENLLLDNRG-----YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGT 214 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~-----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt 214 (255)
++++|+||||+||+++..+ .+++ .|||+++....... ......++
T Consensus 125 ~~i~H~dl~p~nil~~~~~~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~ 176 (269)
T cd05044 125 MHFIHRDLAARNCLVSEKGYDADRVVKI----------------------------GDFGLARDIYKSDYYRKEGEGLLP 176 (269)
T ss_pred CCcccCCCChheEEEecCCCCCCcceEE----------------------------CCcccccccccccccccCcccCCC
Confidence 9999999999999998766 5555 48887765432211 11123456
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+.|+|||.+.+..++.++|+|||||++|+|++ |..||.
T Consensus 177 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred ccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 78999999998889999999999999999998 888875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=199.98 Aligned_cols=163 Identities=23% Similarity=0.311 Sum_probs=124.0
Q ss_pred ceeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCC------------------------------
Q psy3182 62 YVKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFD------------------------------ 110 (255)
Q Consensus 62 ~vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~------------------------------ 110 (255)
+++++.++. |+|++++++.+.+.+.+|+++|||.||+|.+++.+.....
T Consensus 90 E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (401)
T cd05107 90 ELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVS 169 (401)
T ss_pred HHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchh
Confidence 456667776 9999999999999999999999999999999997542100
Q ss_pred -------------ccchh--------------------------------------------hHHHHHHHHHHHHHHHHH
Q psy3182 111 -------------DNAAS--------------------------------------------FITACVIEALDFITACVI 133 (255)
Q Consensus 111 -------------~~~~~--------------------------------------------~~~~~~~~~~~~i~~~il 133 (255)
...+. .........+..++.|++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 249 (401)
T cd05107 170 LGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVA 249 (401)
T ss_pred hhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHH
Confidence 00000 000011223445678999
Q ss_pred HHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--ccccc
Q psy3182 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTF 211 (255)
Q Consensus 134 ~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~ 211 (255)
.||.|||+++++||||||+||+++..+.+++ .|||+++....... ...+.
T Consensus 250 ~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL----------------------------~DfGla~~~~~~~~~~~~~~~ 301 (401)
T cd05107 250 NGMEFLASKNCVHRDLAARNVLICEGKLVKI----------------------------CDFGLARDIMRDSNYISKGST 301 (401)
T ss_pred HHHHHHhcCCcCcccCCcceEEEeCCCEEEE----------------------------EecCcceecccccccccCCCc
Confidence 9999999999999999999999998887777 48998865432211 11234
Q ss_pred ccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 212 CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.|++.|||||.+.+..++.++|+||+||++|||++ |..||.
T Consensus 302 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred CCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 57889999999998889999999999999999998 777874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=187.98 Aligned_cols=159 Identities=19% Similarity=0.212 Sum_probs=119.8
Q ss_pred ceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++....|++++++++.+.+.+ ..++++||+.+|+|...+.......... ......+..++.|++.|
T Consensus 51 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~-----~~~~~~~~~~~~~i~~a 125 (273)
T cd05035 51 EAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-----KLPLQTLLKFMVDIALG 125 (273)
T ss_pred HHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcc-----cCCHHHHHHHHHHHHHH
Confidence 355667778999999988665443 4799999999999998886432111100 11123455678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--cccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~g 213 (255)
|.|||+++++||||||+||+++.++.+++ .|||.++........ .....+
T Consensus 126 L~~lH~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~ 177 (273)
T cd05035 126 MEYLSNRNFIHRDLAARNCMLREDMTVCV----------------------------ADFGLSKKIYSGDYYRQGRIAKM 177 (273)
T ss_pred HHHHHhCCeeccccchheEEECCCCeEEE----------------------------CCccceeeccccccccccccccC
Confidence 99999999999999999999998888887 488887654332211 111234
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
++.|+|||.+.+..++.++|+||+||++|||++ |..||..
T Consensus 178 ~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred CccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 668999999988889999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=192.23 Aligned_cols=150 Identities=27% Similarity=0.535 Sum_probs=123.6
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.+++...|++++++++.+.+.+..|++|||+.+++|.+++... .+++ +.+..++.|++.|+.|||++
T Consensus 68 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~-----------~~~~~~~~ql~~~l~~lH~~ 135 (292)
T cd06657 68 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNE-----------EQIAAVCLAVLKALSVLHAQ 135 (292)
T ss_pred HHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC-CCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 44566778999999999999999999999999999999877532 2222 23445678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++|+|++|+||+++.++.+++ .|||.+..............|++.|+|||.
T Consensus 136 givH~dl~p~Nilv~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~ 187 (292)
T cd06657 136 GVIHRDIKSDSILLTHDGRVKL----------------------------SDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187 (292)
T ss_pred CeecCCCCHHHEEECCCCCEEE----------------------------cccccceecccccccccccccCccccCHHH
Confidence 9999999999999998888877 488876654332222234578999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..++.++|+||+|+++|+|++|..||.
T Consensus 188 ~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 988888999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=190.48 Aligned_cols=152 Identities=31% Similarity=0.528 Sum_probs=126.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+++..|+++||+.|++|..++... .++ .+.+..++.|++.|+.|||+
T Consensus 52 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-~~~-----------~~~~~~~~~~l~~~l~~lh~ 119 (277)
T cd06641 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLD-----------ETQIATILREILKGLDYLHS 119 (277)
T ss_pred HHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC-CCC-----------HHHHHHHHHHHHHHHHHHcc
Confidence 355667788999999999999999999999999999999888642 222 23345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|+||+|.||+++.++..++ .|||.+..............|++.|+|||
T Consensus 120 ~~i~h~dl~p~Ni~i~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 171 (277)
T cd06641 120 EKKIHRDIKAANVLLSEHGEVKL----------------------------ADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171 (277)
T ss_pred CCeecCCCCHHhEEECCCCCEEE----------------------------eecccceecccchhhhccccCCccccChh
Confidence 99999999999999998887777 48887765544332333457889999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+..++.++|+||+||++|+|++|..||+.
T Consensus 172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 99888889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=186.17 Aligned_cols=152 Identities=22% Similarity=0.324 Sum_probs=123.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+.+..|++||++.+++|.+++++..... .....+..++.|++.||.|+|+
T Consensus 50 e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lh~ 120 (256)
T cd05039 50 EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV---------ITLAQQLGFALDVCEGMEYLEE 120 (256)
T ss_pred HHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 4556777889999999999999999999999999999999987644100 1123455677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++..++ .|||.++....... ...++..|+|||
T Consensus 121 ~~i~H~di~p~Nili~~~~~~~l----------------------------~d~g~~~~~~~~~~---~~~~~~~~~ape 169 (256)
T cd05039 121 KNFVHRDLAARNVLVSEDLVAKV----------------------------SDFGLAKEASQGQD---SGKLPVKWTAPE 169 (256)
T ss_pred CCccchhcccceEEEeCCCCEEE----------------------------cccccccccccccc---cCCCcccccCch
Confidence 99999999999999998888887 48988876533211 223455799999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
.+....++.++|+||+|+++|++++ |..||..
T Consensus 170 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred hhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 9988889999999999999999997 9888754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=190.47 Aligned_cols=155 Identities=30% Similarity=0.458 Sum_probs=118.7
Q ss_pred eeeccc-cccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRK-KKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 64 kl~~~~-~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
.++.++ .|+|++++++.+... ...|+++||+.||+|.++++........ .....+..++.|++.||.
T Consensus 70 ~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~ 142 (291)
T cd06639 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-------LDEAMISYILYGALLGLQ 142 (291)
T ss_pred HHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCC-------CCHHHHHHHHHHHHHHHH
Confidence 334444 699999999877643 4689999999999999988642110000 112345567888999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
|||+++++||||||+||+++..+.+++ .|||.+..............|++.|
T Consensus 143 ~lH~~~ivH~dlkp~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y 194 (291)
T cd06639 143 HLHNNRIIHRDVKGNNILLTTEGGVKL----------------------------VDFGVSAQLTSTRLRRNTSVGTPFW 194 (291)
T ss_pred HHHhCCeeccCCCHHHEEEcCCCCEEE----------------------------eecccchhcccccccccCccCCccc
Confidence 999999999999999999998887777 5999877654433233345789999
Q ss_pred cccccccCC-----CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNR-----GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~-----~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++... .++.++|+||+||++|+|++|..||..
T Consensus 195 ~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred cChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 999998643 367899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=189.21 Aligned_cols=153 Identities=23% Similarity=0.363 Sum_probs=121.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.+..|+|++++++.+.+.+..|++|||+. ++|..++....... .....+..++.|++.||.|||+
T Consensus 49 E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~---------l~~~~~~~~~~~i~~~l~~lh~ 118 (284)
T cd07860 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSG---------IPLPLIKSYLFQLLQGLAFCHS 118 (284)
T ss_pred HHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5667788899999999999999999999999995 57888776432111 1123345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++||||+|+||+++.++.+++ .|||.+..............+++.|+|||
T Consensus 119 ~~i~H~~l~p~nill~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 170 (284)
T cd07860 119 HRVLHRDLKPQNLLINTEGAIKL----------------------------ADFGLARAFGVPVRTYTHEVVTLWYRAPE 170 (284)
T ss_pred CCeecCCCCHHHEEECCCCCEEE----------------------------eeccchhhcccCccccccccccccccCCe
Confidence 99999999999999999888887 48888765543322223346788999999
Q ss_pred cccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+. .++.++|+||+||++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred EEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 98764 46888999999999999999998873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=186.23 Aligned_cols=152 Identities=21% Similarity=0.357 Sum_probs=120.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+....|+++||+.|++|.+++.+... ++ ...+..++.+++.||.|+|
T Consensus 42 e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~-----------~~~~~~~~~~~~~~l~~lH 110 (251)
T cd05041 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT-----------VKKLLQMSLDAAAGMEYLE 110 (251)
T ss_pred HHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 45567778899999999999999999999999999999999865321 11 1233456678999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
+++++|||+||+||+++.++.+++ +|||.+........ ......++..|+
T Consensus 111 ~~~i~h~di~p~nili~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~y~ 162 (251)
T cd05041 111 SKNCIHRDLAARNCLVGENNVLKI----------------------------SDFGMSREEEGGIYTVSDGLKQIPIKWT 162 (251)
T ss_pred hCCEehhhcCcceEEEcCCCcEEE----------------------------eeccccccccCCcceeccccCcceeccC
Confidence 999999999999999999888888 48887765432111 011122355799
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|||.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 163 ~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred ChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 9999988889999999999999999998 777775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=194.59 Aligned_cols=163 Identities=21% Similarity=0.303 Sum_probs=122.4
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch-----hhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-----SFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++.+. .|+|++++++.+.+...+|+++||+.+|+|.+++.++........ ..........+..++.|++.|
T Consensus 67 E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (334)
T cd05100 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARG 146 (334)
T ss_pred HHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHH
Confidence 34556666 799999999999999999999999999999999976432110000 000011123344577899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--cccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~g 213 (255)
|.|||++|++||||||+||+++.++.+++ .|||.++........ .....+
T Consensus 147 l~~LH~~givH~dlkp~Nill~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~ 198 (334)
T cd05100 147 MEYLASQKCIHRDLAARNVLVTEDNVMKI----------------------------ADFGLARDVHNIDYYKKTTNGRL 198 (334)
T ss_pred HHHHHHCCeeccccccceEEEcCCCcEEE----------------------------CCcccceecccccccccccCCCc
Confidence 99999999999999999999998888887 488877654332111 112234
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
++.|+|||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 199 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred CceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 567999999999899999999999999999998 778775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=189.67 Aligned_cols=150 Identities=33% Similarity=0.519 Sum_probs=125.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+.+..|+++|++.|++|.+++... ..+++ ..+..++.|++.|+.|+|
T Consensus 49 e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~~~l~~~l~~lH 117 (265)
T cd06605 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE-----------RILGKIAVAVLKGLTYLH 117 (265)
T ss_pred HHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCH-----------HHHHHHHHHHHHHHHHHc
Confidence 345566778999999999999999999999999999999998764 22222 233456788999999999
Q ss_pred H-cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 T-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~-~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
+ .|++|+||||+||+++..+.+++ .|||.+....... .....|++.|+|
T Consensus 118 ~~~~i~H~dl~~~ni~~~~~~~~~l----------------------------~d~g~~~~~~~~~--~~~~~~~~~y~~ 167 (265)
T cd06605 118 EKHKIIHRDVKPSNILVNSRGQIKL----------------------------CDFGVSGQLVNSL--AKTFVGTSSYMA 167 (265)
T ss_pred CCCCeecCCCCHHHEEECCCCCEEE----------------------------eecccchhhHHHH--hhcccCChhccC
Confidence 9 99999999999999999888887 5998876553321 112678999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||.+.+..++.++|+||+||++|+|++|..||.
T Consensus 168 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 200 (265)
T cd06605 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200 (265)
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999899999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-26 Score=188.70 Aligned_cols=156 Identities=29% Similarity=0.484 Sum_probs=120.3
Q ss_pred eeeeccc-cccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+.++.+. .|+|++++++.+.+. ...|++|||+.+++|.+++........ ....+.+..++.|++.|
T Consensus 53 ~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~~~~~~~ql~~a 125 (275)
T cd06608 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-------RLKEEWIAYILRETLRG 125 (275)
T ss_pred HHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCC-------CCCHHHHHHHHHHHHHH
Confidence 3445555 699999999988654 458999999999999988864220000 01123455678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||+++++|+||+|+||+++.++.+++ +|||.+..............|++
T Consensus 126 l~~lH~~~i~H~~l~p~ni~~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~ 177 (275)
T cd06608 126 LAYLHENKVIHRDIKGQNILLTKNAEVKL----------------------------VDFGVSAQLDSTLGRRNTFIGTP 177 (275)
T ss_pred HHHHhcCCcccCCCCHHHEEEccCCeEEE----------------------------CCCccceecccchhhhcCccccc
Confidence 99999999999999999999999888887 48887765443333344567899
Q ss_pred CCcccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN-----RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~-----~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.. ..++.++|+||+||++|+|++|..||..
T Consensus 178 ~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 9999999853 3467889999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=187.24 Aligned_cols=158 Identities=20% Similarity=0.224 Sum_probs=117.8
Q ss_pred eeeeccccccccccccccccC------ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKD------SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~------~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
++++....|+|++++++.+.. ....++++||+.+|+|.+++.......... ....+.+..++.|++.||
T Consensus 51 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~l 125 (272)
T cd05075 51 AVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ-----YLPTQMLVKFMTDIASGM 125 (272)
T ss_pred HHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc-----cCCHHHHHHHHHHHHHHH
Confidence 455667789999998875321 235789999999999998875322111000 011233456778999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGT 214 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt 214 (255)
.|||+++|+||||||+||+++.++.+++ .|||.++........ .....++
T Consensus 126 ~~lH~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 177 (272)
T cd05075 126 EYLSSKSFIHRDLAARNCMLNENMNVCV----------------------------ADFGLSKKIYNGDYYRQGRIAKMP 177 (272)
T ss_pred HHHHHCCeeccccchhheEEcCCCCEEE----------------------------CCCCcccccCcccceecCCcccCC
Confidence 9999999999999999999998888877 489988765432211 1123466
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+.|+|||...+..++.++|+||+||++|+|++ |..||..
T Consensus 178 ~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred cccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 78999999999889999999999999999998 7788753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=185.74 Aligned_cols=153 Identities=34% Similarity=0.623 Sum_probs=125.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+.+..++++||+.+++|.+++.+...+++ +.+..++.+++.|+.|||+
T Consensus 49 e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~i~~~i~~~l~~lh~ 117 (264)
T cd06626 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE-----------HVIRVYTLQLLEGLAYLHS 117 (264)
T ss_pred HHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCCh-----------HHHHHHHHHHHHHHHHHHH
Confidence 34567778899999999999999999999999999999999876543332 2334567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc----ccccccCCCC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK----TWTFCGTPEY 217 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~----~~~~~gt~~y 217 (255)
+|++|+||+|+||+++..+.+++ .|||.+......... .....|++.|
T Consensus 118 ~~i~H~dl~~~nil~~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T cd06626 118 HGIVHRDIKPANIFLDHNGVIKL----------------------------GDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169 (264)
T ss_pred CCcccCCCCHHHEEECCCCCEEE----------------------------cccccccccCCCCCcccccccCCcCCcCc
Confidence 99999999999999999888888 488877655332211 1235688899
Q ss_pred cccccccCCC---CCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRG---HDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~---~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++.+.. ++.++|+||+|+++|++++|..||..
T Consensus 170 ~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred cChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 9999998765 88999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=195.39 Aligned_cols=148 Identities=26% Similarity=0.469 Sum_probs=119.8
Q ss_pred ceeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++....|+|++++++.|... ...|+++||+.+ ++.+.+... +++ ..+..++.|++.|
T Consensus 65 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~-----------~~~~~~~~ql~~a 130 (353)
T cd07850 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDH-----------ERMSYLLYQMLCG 130 (353)
T ss_pred HHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCH-----------HHHHHHHHHHHHH
Confidence 45667778899999998877543 357999999965 777766532 222 2345577899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++|++||||||+||+++.++.+++ .|||.++...... ......||+
T Consensus 131 L~~LH~~gi~H~dlkp~Nil~~~~~~~kL----------------------------~Dfg~~~~~~~~~-~~~~~~~~~ 181 (353)
T cd07850 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LDFGLARTAGTSF-MMTPYVVTR 181 (353)
T ss_pred HHHHHhCCeeeCCCCHHHEEECCCCCEEE----------------------------ccCccceeCCCCC-CCCCCcccc
Confidence 99999999999999999999999888888 4899887654322 223456899
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 182 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred cccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999999999999998885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=186.40 Aligned_cols=153 Identities=22% Similarity=0.373 Sum_probs=120.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|++++++++.+. .+..|+++|++.+|+|.+.+........ ....+..++.|++.||.|||+
T Consensus 51 E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~---------~~~~~~~i~~~i~~al~~LH~ 120 (260)
T cd05067 51 EANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKL---------TINKLIDMAAQIAEGMAFIER 120 (260)
T ss_pred HHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCC---------CHHHHHHHHHHHHHHHHHHhc
Confidence 456677888999999998764 4578999999999999998865332111 112344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
+|++||||||+|++++.++.+++ .|||.+........ ......++..|+||
T Consensus 121 ~~i~H~dl~p~ni~i~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~~p 172 (260)
T cd05067 121 KNYIHRDLRAANILVSETLCCKI----------------------------ADFGLARLIEDNEYTAREGAKFPIKWTAP 172 (260)
T ss_pred CCeecccccHHhEEEcCCCCEEE----------------------------ccCcceeecCCCCcccccCCcccccccCH
Confidence 99999999999999999888877 48888765542221 11223456789999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|++.+..++.++|+||+|+++|++++ |..||.
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred HHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99998889999999999999999998 898885
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=189.88 Aligned_cols=151 Identities=25% Similarity=0.387 Sum_probs=121.8
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++....|+|++++++.+.+. ...|+++||+.+ +|.+.+..... ++ .+.+..++.|++.||.|
T Consensus 54 e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~-----------~~~~~~i~~qi~~aL~~ 121 (293)
T cd07843 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFL-----------QSEVKCLMLQLLSGVAH 121 (293)
T ss_pred HHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHH
Confidence 45566777899999999887776 899999999975 88888765332 22 23455678899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
||+++++|+||||+||+++.++.+++ .|||.+..............+++.|+
T Consensus 122 LH~~~i~H~dl~p~nili~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~ 173 (293)
T cd07843 122 LHDNWILHRDLKTSNLLLNNRGILKI----------------------------CDFGLAREYGSPLKPYTQLVVTLWYR 173 (293)
T ss_pred HHHCCeeeccCCHHHEEECCCCcEEE----------------------------eecCceeeccCCcccccccccccccc
Confidence 99999999999999999999888887 48888776554322333456788999
Q ss_pred ccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||.+.+. .++.++|+||+||++|+|++|.+||.
T Consensus 174 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred CchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 99998764 46889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=188.85 Aligned_cols=151 Identities=26% Similarity=0.449 Sum_probs=122.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+....|+++||+ |++|.+.+.... .+++ +.+..++.|++.||.|||
T Consensus 49 e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH 116 (286)
T cd07832 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPE-----------AQVKSYMRMLLKGVAYMH 116 (286)
T ss_pred HHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677778999999999999999999999999 999999886532 1222 334567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
++|++|+||||+||+++.++.+++ .|||.+........ ......|++.|+|
T Consensus 117 ~~~i~H~dl~p~ni~~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~a 168 (286)
T cd07832 117 ANGIMHRDLKPANLLISADGVLKI----------------------------ADFGLARLFSEEEPRLYSHQVATRWYRA 168 (286)
T ss_pred HCCeecCCcCHHHEEEcCCCcEEE----------------------------eeeeecccccCCCCCccccccCcccccC
Confidence 999999999999999998887777 48888766543321 1224578999999
Q ss_pred cccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 169 PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred ceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 999865 456899999999999999999977664
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=193.45 Aligned_cols=154 Identities=18% Similarity=0.251 Sum_probs=115.8
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++....|+|++++++.|++.+..|+++||+.+|++.+++.+..... .....+..++.|++.||.|||++
T Consensus 50 ~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~---------~~~~~~~~~~~qi~~aL~~lH~~ 120 (328)
T cd08226 50 VVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG---------MSEALIGNILFGALRGLNYLHQN 120 (328)
T ss_pred HHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccC---------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 344556789999999999999999999999999999999887642110 11223456778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-------CccccccccCC
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-------GCKTWTFCGTP 215 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-------~~~~~~~~gt~ 215 (255)
|++||||||+||+++..+..++. ||+.+...... ........++.
T Consensus 121 ~ivHrDlkp~Nill~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (328)
T cd08226 121 GYIHRNIKASHILISGDGLVSLS----------------------------GLSHLYSLVRNGQKAKVVYDFPQFSTSVL 172 (328)
T ss_pred CeecCCCCHHHEEEeCCCcEEEe----------------------------chHHHhhhhccCccccccccccccccCcc
Confidence 99999999999999988877774 33211110000 00011123566
Q ss_pred CCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 173 ~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred CccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 7999999976 4578999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=185.18 Aligned_cols=154 Identities=27% Similarity=0.471 Sum_probs=124.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+....|+++||+.+++|.+.+.+...... ..+.+..++.|++.||.|||+
T Consensus 49 E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~---------~~~~~~~~~~~l~~~l~~lh~ 119 (257)
T cd08225 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF---------SEDQILSWFVQISLGLKHIHD 119 (257)
T ss_pred HHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCC---------CHHHHHHHHHHHHHHHHHHHH
Confidence 45567777899999999999999999999999999999998875432110 123345567789999999999
Q ss_pred cCcccccCCCCceeeCCCCc-eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGY-VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++++|+|+||+||+++.++. +++ .|||.+..............|++.|+||
T Consensus 120 ~~i~H~dl~~~nil~~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~~~ap 171 (257)
T cd08225 120 RKILHRDIKSQNIFLSKNGMVAKL----------------------------GDFGIARQLNDSMELAYTCVGTPYYLSP 171 (257)
T ss_pred CCcccccCCHHHEEEcCCCCeEEe----------------------------cccccchhccCCcccccccCCCccccCH
Confidence 99999999999999987653 456 4888776654433333345689999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+..+..++.++|+||+||++|+|++|..||.
T Consensus 172 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99988889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=185.63 Aligned_cols=153 Identities=20% Similarity=0.333 Sum_probs=120.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.+..|+++++++..+.+ +..|++|||+.+|+|.+++.+...... ....+..++.|++.||.|||+
T Consensus 51 E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~---------~~~~~~~~~~~l~~al~~lH~ 120 (260)
T cd05069 51 EAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYL---------KLPQLVDMAAQIADGMAYIER 120 (260)
T ss_pred HHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCC---------CHHHHHHHHHHHHHHHHHHHh
Confidence 5667788899999999887754 568999999999999999875321110 122344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~aP 220 (255)
+|++||||||+||+++.++.+++ .|||.+......... .....++..|+||
T Consensus 121 ~~i~H~dl~~~Nill~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~~P 172 (260)
T cd05069 121 MNYIHRDLRAANILVGDNLVCKI----------------------------ADFGLARLIEDNEYTARQGAKFPIKWTAP 172 (260)
T ss_pred CCEeecccCcceEEEcCCCeEEE----------------------------CCCccceEccCCcccccCCCccchhhCCH
Confidence 99999999999999998888877 488887654332211 1123456789999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|...+..++.++|+||+||++|+|++ |..||.
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred HHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99988889999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=184.93 Aligned_cols=157 Identities=30% Similarity=0.464 Sum_probs=125.2
Q ss_pred ceeeecccccccccccccccc--CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK--DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~--~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++++++...|++++++++.+. +....|+++||+.+++|.+++.+....... ...+.+..++.|++.||.|+
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~-------l~~~~~~~~~~~i~~~l~~l 121 (265)
T cd08217 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-------IEEEFIWRILTQLLLALYEC 121 (265)
T ss_pred HHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccC-------CCHHHHHHHHHHHHHHHHHH
Confidence 345667778999999988664 455789999999999999998753211000 11233455778899999999
Q ss_pred H-----HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 140 H-----TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 140 H-----~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
| +.+++|+||||+||+++.++.+++ .|||.+...........+..|+
T Consensus 122 H~~~~~~~~i~h~dl~p~nili~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~ 173 (265)
T cd08217 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKL----------------------------GDFGLAKILGHDSSFAKTYVGT 173 (265)
T ss_pred hcCccccCcceecCCCHHHEEEecCCCEEE----------------------------ecccccccccCCcccccccccC
Confidence 9 999999999999999999888888 4898887765544323456799
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||++.+..++.++|+||+|+++|+|++|..||..
T Consensus 174 ~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred CCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=186.66 Aligned_cols=151 Identities=26% Similarity=0.393 Sum_probs=119.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+. ..|++|||+.+|+|.+++.+... ++ ...+..++.|++.||.|+|
T Consensus 57 e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~~l~~~l~~lH 124 (270)
T cd05056 57 EAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLD-----------LASLILYSYQLSTALAYLE 124 (270)
T ss_pred HHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 45567777899999999988764 57899999999999999975321 22 2334557788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~a 219 (255)
+++++||||||+||+++.++.+++ .|||.++........ .....+++.|+|
T Consensus 125 ~~~~~H~dl~p~nili~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~y~a 176 (270)
T cd05056 125 SKRFVHRDIAARNVLVSSPDCVKL----------------------------GDFGLSRYLEDESYYKASKGKLPIKWMA 176 (270)
T ss_pred hCCeeccccChheEEEecCCCeEE----------------------------ccCceeeecccccceecCCCCccccccC
Confidence 999999999999999998888887 488877654332111 112234568999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+....++.++|+||+||++|++++ |..||.
T Consensus 177 PE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred hhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 999988889999999999999999985 999985
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=185.76 Aligned_cols=154 Identities=21% Similarity=0.356 Sum_probs=123.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+....|++||++.+++|.+++....... ...+.+..++.|++.|+.|||+
T Consensus 51 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~---------~~~~~~~~~~~~i~~al~~lh~ 121 (261)
T cd05034 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK---------LRLPQLVDMAAQIAEGMAYLES 121 (261)
T ss_pred HHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 4566778889999999999999899999999999999999987532110 1123345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
++++|+|+||+||+++.++.+++ +|||.+........ ......++..|+||
T Consensus 122 ~~i~h~di~p~nili~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~y~~P 173 (261)
T cd05034 122 RNYIHRDLAARNILVGENLVCKI----------------------------ADFGLARLIEDDEYTAREGAKFPIKWTAP 173 (261)
T ss_pred CCcccCCcchheEEEcCCCCEEE----------------------------CccccceeccchhhhhhhccCCCccccCH
Confidence 99999999999999999888887 48888765543211 11122345689999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|.+.+..++.++|+||+||++|++++ |..||.
T Consensus 174 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 206 (261)
T cd05034 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206 (261)
T ss_pred HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99998889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=185.29 Aligned_cols=154 Identities=20% Similarity=0.335 Sum_probs=120.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++.+..|+++++++..+.+ ...|++|||+.+++|.+.+.+..... ...+.+..++.|++.||.|||+
T Consensus 51 E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~~l~~al~~lH~ 120 (260)
T cd05070 51 EAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRA---------LKLPNLVDMAAQVAAGMAYIER 120 (260)
T ss_pred HHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 4566778889999999987754 56899999999999999987532110 1123345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~aP 220 (255)
++++||||||+||+++.++.+++ .|||.+......... .....++..|+||
T Consensus 121 ~~i~H~di~p~Nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~aP 172 (260)
T cd05070 121 MNYIHRDLRSANILVGDGLVCKI----------------------------ADFGLARLIEDNEYTARQGAKFPIKWTAP 172 (260)
T ss_pred CCcccCCCccceEEEeCCceEEe----------------------------CCceeeeeccCcccccccCCCCCccccCh
Confidence 99999999999999998887777 488887655332211 1123355679999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 99988889999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-26 Score=202.77 Aligned_cols=152 Identities=22% Similarity=0.396 Sum_probs=121.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
.+++....|+|++++|+...+...+|++||+|.||+|.++|++.+. .+. .+. ..++.+.+.||+|||+
T Consensus 212 ArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~----------~ek-~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 212 ARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPT----------LEK-LRFCYDAARGLEYLHS 280 (474)
T ss_pred HHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCH----------HHH-HHHHHHHHhHHHHHHH
Confidence 4456678899999999999999999999999999999999987543 221 112 2345678999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccc-cCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFC-GTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~-gt~~y~aP 220 (255)
+++|||||-.+|+|+...+.+|++ |||+|+......... ..+ -...|+||
T Consensus 281 k~~IHRDIAARNcL~~~~~~vKIS----------------------------DFGLs~~~~~~~~~~-~~~klPirWLAP 331 (474)
T KOG0194|consen 281 KNCIHRDIAARNCLYSKKGVVKIS----------------------------DFGLSRAGSQYVMKK-FLKKLPIRWLAP 331 (474)
T ss_pred CCCcchhHhHHHheecCCCeEEeC----------------------------ccccccCCcceeecc-ccccCcceecCh
Confidence 999999999999999998888884 999987654211111 112 23479999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcCC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESNVF 254 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~~ 254 (255)
|.+....|+.++||||+||++||..+ |..|+...
T Consensus 332 Etl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 332 ETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred hhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 99999899999999999999999987 88887643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=187.31 Aligned_cols=151 Identities=24% Similarity=0.390 Sum_probs=121.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++....|++++++++.+.+.+..|+++||+. ++|.+++.... .+++ ..+..++.|++.||.||
T Consensus 48 E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~-----------~~~~~~~~~i~~~L~~l 115 (283)
T cd07835 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDP-----------PLIKSYLYQLLQGIAYC 115 (283)
T ss_pred HHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 4566777889999999999999999999999994 68988886543 2222 33455778899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|+++++|||++|+||+++.++.+++ .|||.+..............+++.|+|
T Consensus 116 H~~~~~H~dl~p~nil~~~~~~~~l----------------------------~df~~~~~~~~~~~~~~~~~~~~~~~a 167 (283)
T cd07835 116 HSHRVLHRDLKPQNLLIDREGALKL----------------------------ADFGLARAFGVPVRTYTHEVVTLWYRA 167 (283)
T ss_pred HHCCeeCCCCCHHHEEEcCCCcEEE----------------------------eecccccccCCCccccCccccccCCCC
Confidence 9999999999999999999888887 488887654332222223457889999
Q ss_pred cccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 168 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred CceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 998866 457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=187.47 Aligned_cols=152 Identities=24% Similarity=0.361 Sum_probs=120.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.++...|++|||+.+|+|.++++.... ++ ...+..++.|++.||.|||
T Consensus 55 e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~i~~~l~~al~~lH 123 (269)
T cd05065 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT-----------VIQLVGMLRGIAAGMKYLS 123 (269)
T ss_pred HHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 35566677899999999999999999999999999999998875321 11 1234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccc--cCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFC--GTP 215 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~--gt~ 215 (255)
++|++||||||+||+++.++.+++ .|||.+......... ..... ++.
T Consensus 124 ~~g~~H~dl~p~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 175 (269)
T cd05065 124 EMNYVHRDLAARNILVNSNLVCKV----------------------------SDFGLSRFLEDDTSDPTYTSSLGGKIPI 175 (269)
T ss_pred HCCEeecccChheEEEcCCCcEEE----------------------------CCCccccccccCccccccccccCCCcce
Confidence 999999999999999998887777 488877654332111 11111 134
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.|+|||.+.+..++.++|+||+||++||+++ |..||.
T Consensus 176 ~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred eecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 7999999998889999999999999999886 998885
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=183.93 Aligned_cols=154 Identities=28% Similarity=0.448 Sum_probs=123.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+...+..++++||+.|++|.+++.+..... .....+..++.+++.|+.|||+
T Consensus 49 e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lh~ 119 (256)
T cd08220 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL---------LDEDTILHFFVQILLALHHVHT 119 (256)
T ss_pred HHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 3556677789999999999999999999999999999999997643110 0112345567889999999999
Q ss_pred cCcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+|++|+||+|+||+++.++ .+++ .|||.+....... ......|++.|+||
T Consensus 120 ~~i~h~dl~~~nil~~~~~~~~~l----------------------------~d~~~~~~~~~~~-~~~~~~~~~~y~aP 170 (256)
T cd08220 120 KLILHRDLKTQNILLDKHKMVVKI----------------------------GDFGISKILSSKS-KAYTVVGTPCYISP 170 (256)
T ss_pred CCeecCCCCHHHEEEcCCCCEEEE----------------------------ccCCCceecCCCc-cccccccCCcccCc
Confidence 9999999999999997654 3455 4888877654332 22346789999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.+.+..++.++|+||+|+++|+|++|..||+.
T Consensus 171 E~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred hhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 999988889999999999999999999988863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=187.70 Aligned_cols=154 Identities=23% Similarity=0.382 Sum_probs=122.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|+++||+.| +|.+++.....-. ....+.+..++.|++.||.|+|+
T Consensus 48 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 118 (284)
T cd07836 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRG--------ALDPNTVKSFTYQLLKGIAFCHE 118 (284)
T ss_pred HHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCC--------CcCHHHHHHHHHHHHHHHHHHHH
Confidence 45677788899999999999999999999999985 8888776533100 01123445677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|||+||+||+++.++.+++ .|||.+..............+++.|+|||
T Consensus 119 ~~i~h~dl~p~ni~~~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~y~~PE 170 (284)
T cd07836 119 NRVLHRDLKPQNLLINKRGELKL----------------------------ADFGLARAFGIPVNTFSNEVVTLWYRAPD 170 (284)
T ss_pred CCeeeCCCCHHHEEECCCCcEEE----------------------------eecchhhhhcCCccccccccccccccChH
Confidence 99999999999999998888887 48887765433222223456788999999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred HhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9866 457889999999999999999998875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=186.99 Aligned_cols=152 Identities=22% Similarity=0.261 Sum_probs=121.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+ ...++++||+.+|+|.+.+.+.. .+++ ..+..++.|++.||.|||
T Consensus 59 e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~~qi~~~l~~LH 126 (279)
T cd05057 59 EAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGS-----------QYLLNWCVQIAKGMSYLE 126 (279)
T ss_pred HHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4556777889999999998877 78899999999999999987532 2221 234456778999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc--cccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT--WTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~--~~~~gt~~y~ 218 (255)
+++++||||||+||+++.++.+++ .|||.++......... ....+++.|+
T Consensus 127 ~~~i~H~di~p~nil~~~~~~~kL----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 178 (279)
T cd05057 127 EKRLVHRDLAARNVLVKTPQHVKI----------------------------TDFGLAKLLDVDEKEYHAEGGKVPIKWM 178 (279)
T ss_pred hCCEEecccCcceEEEcCCCeEEE----------------------------CCCcccccccCcccceecCCCccccccc
Confidence 999999999999999998888887 4888876654322111 1112356799
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||.+....++.++|+||+||++|++++ |..||+.
T Consensus 179 ~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred CHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=185.13 Aligned_cols=152 Identities=21% Similarity=0.348 Sum_probs=122.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+....|+++||+.|++|.+++.... .++ .+.+..++.|++.|+.|||
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~~l~~~l~~lH 117 (256)
T cd05112 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFS-----------QETLLGMCLDVCEGMAYLE 117 (256)
T ss_pred HHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4667778889999999999999999999999999999998886532 222 1334456678999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~a 219 (255)
+++++|||+||+||+++.++.+++ +|||.+......... .....++..|+|
T Consensus 118 ~~~i~h~dl~p~ni~i~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~~a 169 (256)
T cd05112 118 SSNVIHRDLAARNCLVGENQVVKV----------------------------SDFGMTRFVLDDQYTSSTGTKFPVKWSS 169 (256)
T ss_pred HCCccccccccceEEEcCCCeEEE----------------------------CCCcceeecccCcccccCCCccchhhcC
Confidence 999999999999999998887777 488877654332111 112234568999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+.+..++.++|+||+||++|+|++ |..||+
T Consensus 170 Pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred HhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999998889999999999999999998 888885
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=189.68 Aligned_cols=151 Identities=21% Similarity=0.291 Sum_probs=119.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.+.+. ..++++||+.+|+|.+.+..... +++ +.+..++.|++.||.|||
T Consensus 59 e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~-----------~~~~~~~~qi~~~L~~LH 126 (303)
T cd05110 59 EALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGS-----------QLLLNWCVQIAKGMMYLE 126 (303)
T ss_pred HHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 35566778899999999987654 46799999999999998875431 221 223446778999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
+++++||||||+||+++.++.+++ .|||.++....... ......+++.|+
T Consensus 127 ~~~ivH~dikp~Nill~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 178 (303)
T cd05110 127 ERRLVHRDLAARNVLVKSPNHVKI----------------------------TDFGLARLLEGDEKEYNADGGKMPIKWM 178 (303)
T ss_pred hcCeeccccccceeeecCCCceEE----------------------------ccccccccccCcccccccCCCccccccC
Confidence 999999999999999988888887 48888876533221 112234567899
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|||.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 179 ~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred CHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999998889999999999999999997 888875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=184.59 Aligned_cols=153 Identities=20% Similarity=0.330 Sum_probs=120.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+.+ ...|++|||+.+|+|.+++.+...... ....+..++.|++.||.|+|+
T Consensus 51 e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~---------~~~~~~~~~~~l~~aL~~lH~ 120 (260)
T cd05073 51 EANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ---------PLPKLIDFSAQIAEGMAFIEQ 120 (260)
T ss_pred HHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCcccc---------CHHHHHHHHHHHHHHHHHHHh
Confidence 4667788889999999998887 778999999999999999876322111 112344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
+|++||||||+|++++..+.+++. |||.+........ ......++..|+||
T Consensus 121 ~~i~H~dl~p~ni~i~~~~~~~l~----------------------------d~~~~~~~~~~~~~~~~~~~~~~~y~~P 172 (260)
T cd05073 121 RNYIHRDLRAANILVSASLVCKIA----------------------------DFGLARVIEDNEYTAREGAKFPIKWTAP 172 (260)
T ss_pred CCccccccCcceEEEcCCCcEEEC----------------------------CCcceeeccCCCcccccCCcccccccCH
Confidence 999999999999999988888874 7777655432211 11123456679999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|++....++.++|+||+||++|++++ |..||.
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred hHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 99998889999999999999999998 888875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=182.91 Aligned_cols=152 Identities=43% Similarity=0.789 Sum_probs=127.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+++.+..|++||++.+++|.+++.+...+++ ..+..++.|++.|+.|+|+
T Consensus 43 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~-----------~~~~~~~~qi~~~l~~lh~ 111 (250)
T cd05123 43 ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-----------ERARFYAAEIVLALEYLHS 111 (250)
T ss_pred HHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34566777899999999999999999999999999999999976544332 2344567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|+|++|.||+++..+.+++ .|||.+..............|+..|+|||
T Consensus 112 ~~~~H~~l~p~ni~~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe 163 (250)
T cd05123 112 LGIIYRDLKPENILLDADGHIKL----------------------------TDFGLAKELSSEGSRTNTFCGTPEYLAPE 163 (250)
T ss_pred CCceecCCCcceEEEcCCCcEEE----------------------------eecCcceecccCCCcccCCcCCccccChH
Confidence 99999999999999999888777 48887765544322333467889999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
...+..++.++|+||+|+++|++++|..||.
T Consensus 164 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred HhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9998888899999999999999999999985
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-26 Score=196.11 Aligned_cols=174 Identities=29% Similarity=0.434 Sum_probs=136.8
Q ss_pred HHhCCCcccCCCCcceeecccCceeeecccccccccccccccc-CccceeehhhhhcchhHHHHHHhccCCCccchhhHH
Q psy3182 40 LHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFK-DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFIT 118 (255)
Q Consensus 40 lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~-~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~ 118 (255)
+|..+.--||-|.+|-.-..-.+-.|...+.|+.|+++|+.|. |.+.++-|+|||+|+||.-+|+.+..++|.++
T Consensus 495 IHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEA---- 570 (775)
T KOG1151|consen 495 IHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEA---- 570 (775)
T ss_pred eehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHH----
Confidence 4555555677777775444444556788899999999999886 55678899999999999999998887777665
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHc--CcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeee
Q psy3182 119 ACVIEALDFITACVIEALEYLHTR--GIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193 (255)
Q Consensus 119 ~~~~~~~~~i~~~il~~l~ylH~~--~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (255)
+.|+-||+.||.||... -|||-||||.|||+.+ .|.+|+ .
T Consensus 571 -------RSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI----------------------------T 615 (775)
T KOG1151|consen 571 -------RSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI----------------------------T 615 (775)
T ss_pred -------HHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe----------------------------e
Confidence 34556799999999865 5999999999999865 344555 4
Q ss_pred eccccccCCCCCc-------cccccccCCCCcccccccC----CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 194 DFGFSKHLGHSGC-------KTWTFCGTPEYVAPEIIKN----RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 194 dfg~s~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||+|+....... .++...||..|++||.+.- ...+.++|+||+|||+|..+.|.+||-
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 9999887644321 2445689999999999853 246889999999999999999999984
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=192.27 Aligned_cols=163 Identities=21% Similarity=0.344 Sum_probs=119.8
Q ss_pred ceeeeccc-cccccccccccccC-ccceeehhhhhcchhHHHHHHhccCCC---------------------cc------
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKD-SKYVYMLLEACLGGEVWTILRERTCFD---------------------DN------ 112 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~-~~~~ylv~E~~~gg~l~~~l~~~~~~~---------------------~~------ 112 (255)
++.++.++ .|+|++++++.+.. ...+|++||||.+|+|.+++....... +.
T Consensus 60 E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (343)
T cd05103 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLD 139 (343)
T ss_pred HHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcc
Confidence 34555565 57999999987654 457899999999999999987532100 00
Q ss_pred ---------------------------ch--hhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCcee
Q psy3182 113 ---------------------------AA--SFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 163 (255)
Q Consensus 113 ---------------------------~~--~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~ 163 (255)
.. ..........+..++.|++.||.|||+++++||||||+||+++.++.++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~k 219 (343)
T cd05103 140 SITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVK 219 (343)
T ss_pred ccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEE
Confidence 00 0000112334455788999999999999999999999999999888888
Q ss_pred ecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcccccccCCCCCCcchHHHHHHHH
Q psy3182 164 LEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILM 241 (255)
Q Consensus 164 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil 241 (255)
+ .|||++........ ...+..+++.|+|||++.+..++.++|+||+||++
T Consensus 220 l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 271 (343)
T cd05103 220 I----------------------------CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271 (343)
T ss_pred E----------------------------EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHH
Confidence 7 58888765432211 11123456789999999988899999999999999
Q ss_pred HHHhc-CCCCCc
Q psy3182 242 HELLT-GMKESN 252 (255)
Q Consensus 242 ~ell~-G~~~~~ 252 (255)
|+|++ |..||.
T Consensus 272 ~el~~~g~~p~~ 283 (343)
T cd05103 272 WEIFSLGASPYP 283 (343)
T ss_pred HHHHHCCCCCCC
Confidence 99996 888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=186.30 Aligned_cols=151 Identities=36% Similarity=0.666 Sum_probs=122.9
Q ss_pred eeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++.+.. |++++++++.+.+.+..|++||++.+++|.+.+.+...++. ..+..++.|++.||.|||+
T Consensus 52 ~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~-----------~~~~~i~~ql~~~l~~Lh~ 120 (280)
T cd05581 52 KEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE-----------KCTRFYAAEILLALEYLHS 120 (280)
T ss_pred HHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34455555 99999999999999999999999999999999987654433 2345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----------------
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---------------- 205 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---------------- 205 (255)
+|++|+|++|+||+++.++.+++. |||.+.......
T Consensus 121 ~~~~H~dl~~~ni~i~~~~~~~l~----------------------------df~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (280)
T cd05581 121 KGIIHRDLKPENILLDKDMHIKIT----------------------------DFGTAKVLDPNSSPESNKGDATNIDSQI 172 (280)
T ss_pred CCeeecCCCHHHeEECCCCCEEec----------------------------CCccccccCCccccccCCCCCccccccc
Confidence 999999999999999998888885 455443322211
Q ss_pred ----ccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 206 ----CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 206 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.......|++.|+|||+.....++.++|+||+|+++|++++|..||.
T Consensus 173 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred cccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 12234568899999999988888999999999999999999999986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=189.86 Aligned_cols=151 Identities=25% Similarity=0.427 Sum_probs=119.4
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++..+.|++++++++.+.+. +..|+++||+.+ +|.+++.... .++ .+.+..++.|++.||.|
T Consensus 56 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~-----------~~~~~~~~~qi~~~l~~ 123 (309)
T cd07845 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS-----------ESQVKCLMLQLLRGLQY 123 (309)
T ss_pred HHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCC-----------HHHHHHHHHHHHHHHHH
Confidence 56677788999999999988654 568999999975 7777776421 122 23345678899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
||++|++||||||+||+++..+.+++ .|||.+..............+++.|+
T Consensus 124 lH~~~i~H~dl~p~nil~~~~~~~kL----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~ 175 (309)
T cd07845 124 LHENFIIHRDLKVSNLLLTDKGCLKI----------------------------ADFGLARTYGLPAKPMTPKVVTLWYR 175 (309)
T ss_pred HHhCCeecCCCCHHHEEECCCCCEEE----------------------------CccceeeecCCccCCCCccccccccc
Confidence 99999999999999999999888888 48888776543322222334678899
Q ss_pred ccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 176 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred ChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999875 568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=187.07 Aligned_cols=147 Identities=29% Similarity=0.472 Sum_probs=118.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+.+..|+++||+.| ++.+.+... ..++ ...+..++.|++.||.|||
T Consensus 65 Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~-----------~~~~~~~~~ql~~~L~~LH 132 (307)
T cd06607 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQ-----------EVEIAAICHGALQGLAYLH 132 (307)
T ss_pred HHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 45567778999999999999999999999999975 565555432 2222 2234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++||||+|.||+++.++.+++ .|||.+...... .+..|++.|+||
T Consensus 133 ~~~i~H~dl~p~nIl~~~~~~~kL----------------------------~dfg~~~~~~~~----~~~~~~~~y~aP 180 (307)
T cd06607 133 SHERIHRDIKAGNILLTEPGTVKL----------------------------ADFGSASLVSPA----NSFVGTPYWMAP 180 (307)
T ss_pred HCCceecCCCcccEEECCCCCEEE----------------------------eecCcceecCCC----CCccCCccccCc
Confidence 999999999999999999888888 489987654322 245788999999
Q ss_pred cccc---CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIK---NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~---~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++. ...++.++|+||+|+++|+|++|.+||.
T Consensus 181 E~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred eeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 9984 3568889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=183.45 Aligned_cols=150 Identities=23% Similarity=0.373 Sum_probs=118.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++.+..|++++++++.+... ..|++|||+.||+|.+++........ ....+..++.|++.||.|+|+
T Consensus 49 e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~qi~~al~~lH~ 118 (254)
T cd05083 49 ETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALV---------SVIQLLQFSLDVAEGMEYLES 118 (254)
T ss_pred HHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCC---------CHHHHHHHHHHHHHHHHHHHh
Confidence 45567778899999999887664 47999999999999999976432111 112334567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|||+||+||+++.++.+++ .|||.+...... ......++.|+|||
T Consensus 119 ~~~~H~dl~p~nili~~~~~~kl----------------------------~Dfg~~~~~~~~---~~~~~~~~~y~~pe 167 (254)
T cd05083 119 KKLVHRDLAARNILVSEDGVAKV----------------------------SDFGLARVGSMG---VDNSKLPVKWTAPE 167 (254)
T ss_pred CCeeccccCcceEEEcCCCcEEE----------------------------CCCccceecccc---CCCCCCCceecCHH
Confidence 99999999999999998888887 488887654321 11223456799999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.+.+..++.++|+||+||++|+|++ |..||.
T Consensus 168 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred HhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 9988889999999999999999997 888885
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=191.28 Aligned_cols=151 Identities=22% Similarity=0.429 Sum_probs=120.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|++++++++.+.+.+..|++|||+. |+|.+.+.....+++ +.+..++.|++.||.|||+
T Consensus 70 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-----------~~~~~~~~ql~~aL~~LH~ 137 (335)
T PTZ00024 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE-----------SQVKCILLQILNGLNVLHK 137 (335)
T ss_pred HHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 4566778889999999999999999999999997 589888875444332 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCC--------------CCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG--------------HSGCK 207 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~--------------~~~~~ 207 (255)
+|++|+||+|+||+++.++.+++. |||.+.... .....
T Consensus 138 ~~i~H~dl~~~nill~~~~~~kl~----------------------------dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (335)
T PTZ00024 138 WYFMHRDLSPANIFINSKGICKIA----------------------------DFGLARRYGYPPYSDTLSKDETMQRREE 189 (335)
T ss_pred CCeecccccHHHeEECCCCCEEEC----------------------------Cccceeeccccccccccccccccccccc
Confidence 999999999999999999888885 555544332 00111
Q ss_pred ccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 208 TWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 208 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 190 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred ccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 123457889999999876 357899999999999999999999885
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=183.12 Aligned_cols=154 Identities=21% Similarity=0.363 Sum_probs=123.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|++++++++.+.+.+..|++||++.|++|.+++....... .....+..++.|++.||.|||+
T Consensus 51 e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~---------~~~~~~~~~~~ql~~~l~~lh~ 121 (258)
T smart00219 51 EARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKE---------LSLSDLLSFALQIARGMEYLES 121 (258)
T ss_pred HHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhcc---------CCHHHHHHHHHHHHHHHHHHhc
Confidence 3555666789999999999999999999999999999999987543210 1123445677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccc-ccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTW-TFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~-~~~gt~~y~aP 220 (255)
++++|||+||+||+++..+.+++ +|||.++.......... ...+++.|+||
T Consensus 122 ~~~~h~dl~~~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~~P 173 (258)
T smart00219 122 KNFIHRDLAARNCLVGENLVVKI----------------------------SDFGLSRDLYDDDYYKKKGGKLPIRWMAP 173 (258)
T ss_pred CCeeecccccceEEEccCCeEEE----------------------------cccCCceecccccccccccCCCcccccCh
Confidence 99999999999999999888877 48887765543211111 12367899999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|.+.+..++.++|+||+||++|+|++ |.+||.
T Consensus 174 e~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred HHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99988889999999999999999998 778875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-26 Score=206.75 Aligned_cols=172 Identities=23% Similarity=0.309 Sum_probs=135.8
Q ss_pred eeecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHH---HHHHHHHHHHHHH
Q psy3182 55 LLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFIT---ACVIEALDFITAC 131 (255)
Q Consensus 55 il~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~i~~~ 131 (255)
...+-+.++.+++.+.|+|||++++.+...+.++||+||+..|||-++|+.+.+..+..+.... +......-.|+.|
T Consensus 532 ~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~Q 611 (774)
T KOG1026|consen 532 ARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQ 611 (774)
T ss_pred HHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHH
Confidence 4456667788999999999999999999999999999999999999999987765444322111 1122334568899
Q ss_pred HHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-c-
Q psy3182 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT-W- 209 (255)
Q Consensus 132 il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~-~- 209 (255)
|+.|++||-++.++||||..+|+|+...-.+|++ |||+|+..-.++... .
T Consensus 612 IAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIs----------------------------DfGLsRdiYssDYYk~~~ 663 (774)
T KOG1026|consen 612 IAAGMEYLSSHHFVHRDLATRNCLVGENLVVKIS----------------------------DFGLSRDIYSSDYYKVRG 663 (774)
T ss_pred HHHHHHHHHhCcccccchhhhhceeccceEEEec----------------------------ccccchhhhhhhhhcccC
Confidence 9999999999999999999999999999999984 999987543221110 0
Q ss_pred ccccCCCCcccccccCCCCCCcchHHHHHHHHHHHh-cCCCCCcCC
Q psy3182 210 TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL-TGMKESNVF 254 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell-~G~~~~~~~ 254 (255)
...-...|||||.|....|+++|||||+||++||.+ .|..|+..+
T Consensus 664 ~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 664 NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc
Confidence 001124799999999999999999999999999998 588887644
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=211.18 Aligned_cols=165 Identities=16% Similarity=0.160 Sum_probs=119.7
Q ss_pred ccccc-cccccccccc-------cCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 67 SRKKK-TRQTRLYKTF-------KDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 67 ~~~~h-~~iv~l~~~~-------~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
....| .++++++++| .....++.++|++ +++|.+++.... .+++ ..+..+++||+.||.
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~al~ 94 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDA-----------FECFHVFRQIVEIVN 94 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccH-----------HHHHHHHHHHHHHHH
Confidence 34456 5777788877 3345678888865 779999996422 2222 234567889999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-------------
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS------------- 204 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~------------- 204 (255)
|||++||+||||||+|||++..+.+++.++........ +. .+..+..|||+++.....
T Consensus 95 ~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~----~~-----~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~ 165 (793)
T PLN00181 95 AAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS----DE-----DATTKSREIGSSRREEILSERRIEKLEEVKK 165 (793)
T ss_pred HHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc----cc-----cCcccccccccccccccccccchhhhhcccc
Confidence 99999999999999999999888888877655432211 00 112233599988643210
Q ss_pred ---CccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 205 ---GCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 205 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.......+||+.|||||++.+..|+.++||||+||++|||++|.+|+.
T Consensus 166 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 166 QPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred CCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 001123568999999999999999999999999999999999998864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=187.04 Aligned_cols=156 Identities=19% Similarity=0.285 Sum_probs=117.5
Q ss_pred ceeeeccc-cccccccccccccCccc-----eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKY-----VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~-----~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++... .|++++++++.+..... .|++|||+.+ ++.+++......... ....+.+..++.||+.|
T Consensus 50 E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~------~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGR------PLPAKTIKSFMYQLLKG 122 (295)
T ss_pred HHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCC------CCCHHHHHHHHHHHHHH
Confidence 44555555 45999999988877665 8999999986 788877643211000 01123455678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|.|||+++++||||||+||+++. .+.+++ .|||.++.............++
T Consensus 123 L~~LH~~~i~H~dl~~~nil~~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~ 174 (295)
T cd07837 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKI----------------------------ADLGLGRAFSIPVKSYTHEIVT 174 (295)
T ss_pred HHHHHHCCeeecCCChHHEEEecCCCeEEE----------------------------eecccceecCCCccccCCcccc
Confidence 99999999999999999999988 677777 4888876543322222234578
Q ss_pred CCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 175 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred cCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 89999999865 567899999999999999999998874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=186.72 Aligned_cols=152 Identities=38% Similarity=0.654 Sum_probs=122.7
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++... .|+++++++..+.+....|+++||+.||+|.+.+..+..+++ ..+..++.|++.||.|||
T Consensus 54 E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~ql~~~l~~lH 122 (288)
T cd05583 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----------SEVRVYIAEIVLALDHLH 122 (288)
T ss_pred HHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCH-----------HHHHHHHHHHHHHHHHHH
Confidence 34555555 589999999999999999999999999999998876543332 233456678999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
+.+++||||||.||+++.++..++ +|||+++....... ......|++.|+|
T Consensus 123 ~~~~~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~a 174 (288)
T cd05583 123 QLGIIYRDIKLENILLDSEGHVVL----------------------------TDFGLSKEFLAEEEERAYSFCGTIEYMA 174 (288)
T ss_pred HCCeeccCCCHHHeEECCCCCEEE----------------------------EECccccccccccccccccccCCccccC
Confidence 999999999999999998887777 58888765433221 2234568999999
Q ss_pred cccccCCC--CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRG--HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~--~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||.+.+.. .+.++|+||+|+++|+|++|..||.
T Consensus 175 PE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred HHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 99987654 7789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=181.69 Aligned_cols=153 Identities=30% Similarity=0.516 Sum_probs=127.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++.+..|++++++++.+.+....|+++|++.+++|.+.+.+...+++ +.+..++.|++.|+.|+|+
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~-----------~~~~~~~~~i~~~l~~lH~ 117 (254)
T cd06627 49 EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-----------SLVAVYVYQVLQGLAYLHE 117 (254)
T ss_pred HHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCH-----------HHHHHHHHHHHHHHHHHhh
Confidence 45556777899999999999999999999999999999999876543332 2344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|||++|+||+++.++.+++ .|||.+..............|++.|+|||
T Consensus 118 ~~i~H~dl~p~ni~i~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~y~~pe 169 (254)
T cd06627 118 QGVIHRDIKAANILTTKDGVVKL----------------------------ADFGVATKLNDVSKDDASVVGTPYWMAPE 169 (254)
T ss_pred CCcccCCCCHHHEEECCCCCEEE----------------------------eccccceecCCCcccccccccchhhcCHh
Confidence 99999999999999998887777 48888776654433334567899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...+..++.++|+||+|+++|+|++|..||..
T Consensus 170 ~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred hhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99888889999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=196.11 Aligned_cols=153 Identities=24% Similarity=0.361 Sum_probs=121.5
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++|..+.+-+|.||+-+-+++..... -+|.-+|.|.+|+.++.-.. +......+.-|++||+.|+.|||
T Consensus 437 nEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e----------tkfdm~~~idIAqQiaqGM~YLH 505 (678)
T KOG0193|consen 437 NEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE----------TKFDMNTTIDIAQQIAQGMDYLH 505 (678)
T ss_pred HHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh----------hhhhHHHHHHHHHHHHHhhhhhh
Confidence 45556777889999988888888776 88889999999999986422 11112334568999999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCC--CCccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGH--SGCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~--~~~~~~~~~gt~~y~ 218 (255)
.++|||||||..||++.+++.+++. |||++..... .........|...||
T Consensus 506 AK~IIHrDLKSnNIFl~~~~kVkIg----------------------------DFGLatvk~~w~g~~q~~qp~gsilwm 557 (678)
T KOG0193|consen 506 AKNIIHRDLKSNNIFLHEDLKVKIG----------------------------DFGLATVKTRWSGEQQLEQPHGSLLWM 557 (678)
T ss_pred hhhhhhhhccccceEEccCCcEEEe----------------------------cccceeeeeeeccccccCCCccchhhh
Confidence 9999999999999999999888884 8887643221 111223456788999
Q ss_pred ccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKN---RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~---~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||+++. .+|+..+||||+||++|||++|.-|+.
T Consensus 558 APEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 558 APEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 9999974 589999999999999999999998875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=191.22 Aligned_cols=151 Identities=23% Similarity=0.444 Sum_probs=120.2
Q ss_pred ceeeecccccccccccccccc----CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK----DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~----~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
++.++..+.|++++++++.+. +...+|+++||+. |+|.+++.....+++ ..+..++.|++.||.
T Consensus 54 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~-----------~~~~~i~~qi~~aL~ 121 (334)
T cd07855 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTE-----------EHIRYFLYQLLRGLK 121 (334)
T ss_pred HHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCH-----------HHHHHHHHHHHHHHH
Confidence 456677888999999998876 3457899999995 688888865444332 334567788999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----ccccccc
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC----KTWTFCG 213 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~----~~~~~~g 213 (255)
|||+++++||||||+||+++.++..++ .|||.+........ .....+|
T Consensus 122 ~LH~~~ivH~dlkp~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~ 173 (334)
T cd07855 122 YIHSANVIHRDLKPSNLLVNEDCELRI----------------------------GDFGMARGLSSSPTEHKYFMTEYVA 173 (334)
T ss_pred HHHHCCeecCCCCHHHEEEcCCCcEEe----------------------------cccccceeecccCcCCCcccccccc
Confidence 999999999999999999999988888 48887765433211 1124578
Q ss_pred CCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 174 ~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred cccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 999999999865 568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=181.09 Aligned_cols=155 Identities=26% Similarity=0.360 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+....|+++||+.|++|.+++.+...... ....+.+..++.|++.||.|||+
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lh~ 121 (256)
T cd08530 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRK-------LIPEQEIWRIFIQLLRGLQALHE 121 (256)
T ss_pred HHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 35566777899999999999999999999999999999998875321100 01123345567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|+||+|.||+++.++..++ .|||.+...... ......|++.|+|||
T Consensus 122 ~~i~h~~l~~~ni~~~~~~~~kl----------------------------~d~g~~~~~~~~--~~~~~~~~~~~~~Pe 171 (256)
T cd08530 122 QKILHRDLKSANILLVANDLVKI----------------------------GDLGISKVLKKN--MAKTQIGTPHYMAPE 171 (256)
T ss_pred CCcccCCCCcceEEEecCCcEEE----------------------------eeccchhhhccC--CcccccCCccccCHH
Confidence 99999999999999998888877 588887665443 222356889999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 172 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 203 (256)
T cd08530 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203 (256)
T ss_pred HHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99998899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=178.64 Aligned_cols=143 Identities=32% Similarity=0.502 Sum_probs=113.5
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHh-ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH-cCcccc
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALDFITACVIEALEYLHT-RGIVFR 147 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~-~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-~~iiHr 147 (255)
..|.|++-|.+|..+..+++.||.+ +.....++++ .++++|.. +..+...++.||.||-+ +|||||
T Consensus 149 dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~i-----------lGk~tva~v~AL~YLKeKH~viHR 216 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERI-----------LGKMTVAIVKALYYLKEKHGVIHR 216 (391)
T ss_pred CCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHh-----------hhhhHHHHHHHHHHHHHhcceeec
Confidence 3789999999999999999999965 3334344432 23344432 22334457899999974 689999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC--
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-- 225 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 225 (255)
|+||.|||++..|.+|+ .|||.|..+..+...+ ...|.+.|||||-+.-
T Consensus 217 DvKPSNILlDe~GniKl----------------------------CDFGIsGrlvdSkAht-rsAGC~~YMaPERidp~~ 267 (391)
T KOG0983|consen 217 DVKPSNILLDERGNIKL----------------------------CDFGISGRLVDSKAHT-RSAGCAAYMAPERIDPPD 267 (391)
T ss_pred ccCccceEEccCCCEEe----------------------------ecccccceeecccccc-cccCCccccCccccCCCC
Confidence 99999999999999999 5999998887665443 4579999999999853
Q ss_pred -CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 226 -RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 226 -~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..|+.++|+||||+.++||.||..||..
T Consensus 268 ~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 268 KPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred CCccchhhhhhhhccchhhhhcccCCCCC
Confidence 4699999999999999999999999864
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=185.59 Aligned_cols=155 Identities=32% Similarity=0.473 Sum_probs=122.0
Q ss_pred ceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++++++.+.|+|++++++.+.+ ...+|++|||+.|++|.+++.+...... ......+..++.|++.||.|+
T Consensus 49 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG-------RIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred HHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHH
Confidence 4566777889999999987754 4478999999999999887754221000 011233556788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|+.|++|+||+|.||+++.++.+++ .|||++....... .....++..|+|
T Consensus 122 H~~~i~H~dl~~~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~--~~~~~~~~~y~~ 171 (287)
T cd06621 122 HSRKIIHRDIKPSNILLTRKGQVKL----------------------------CDFGVSGELVNSL--AGTFTGTSFYMA 171 (287)
T ss_pred HHCCcccCCCCHHHEEEecCCeEEE----------------------------eeccccccccccc--cccccCCccccC
Confidence 9999999999999999998887777 5888876543321 123567889999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||.+.+..++.++|+||+||++|+|++|..||..
T Consensus 172 pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 9999988899999999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=190.76 Aligned_cols=151 Identities=25% Similarity=0.437 Sum_probs=121.4
Q ss_pred ceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
++.++....|+|++++++.+... ..+|+++||+. ++|.+.+.....+++ +.+..++.|++.||
T Consensus 54 E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~-----------~~~~~i~~qi~~aL 121 (337)
T cd07858 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSD-----------DHCQYFLYQLLRGL 121 (337)
T ss_pred HHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCH-----------HHHHHHHHHHHHHH
Confidence 45566777899999999877644 35899999995 688888876544443 23456778999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
.|||+++++||||||+||+++.++.+++ +|||++..............|+..
T Consensus 122 ~~LH~~~i~H~dlkp~Nil~~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 173 (337)
T cd07858 122 KYIHSANVLHRDLKPSNLLLNANCDLKI----------------------------CDFGLARTTSEKGDFMTEYVVTRW 173 (337)
T ss_pred HHHHhCCEecCCCCHHHEEEcCCCCEEE----------------------------CcCccccccCCCcccccccccccC
Confidence 9999999999999999999998888887 499988765443223334578899
Q ss_pred CcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 174 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred ccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 999999865 568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=186.00 Aligned_cols=151 Identities=21% Similarity=0.318 Sum_probs=116.2
Q ss_pred ceeeecccccccccccccccc--CccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK--DSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~--~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++....|+|++++++.+. +...+|+++||+.||+|.+++.+.. .++ ...+..++.|++.||.|
T Consensus 55 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~-----------~~~~~~~~~~l~~aL~~ 123 (284)
T cd05081 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD-----------HRKLLLYASQICKGMEY 123 (284)
T ss_pred HHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCC-----------HHHHHHHHHHHHHHHHH
Confidence 456677888999999987643 3456899999999999999986532 122 12334567889999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTP 215 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~ 215 (255)
||++|++||||||+||+++.++.+++ .|||.+......... .....++.
T Consensus 124 LH~~~i~H~dlkp~nili~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~ 175 (284)
T cd05081 124 LGSKRYVHRDLATRNILVESENRVKI----------------------------GDFGLTKVLPQDKEYYKVREPGESPI 175 (284)
T ss_pred HHHCCceeccCCHhhEEECCCCeEEE----------------------------CCCcccccccCCCcceeecCCCCCce
Confidence 99999999999999999998888887 488887655332211 01112344
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
.|+|||++.+..++.++|+||+||++|||++|..|+
T Consensus 176 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 176 FWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred EeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 699999999888999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=186.81 Aligned_cols=155 Identities=25% Similarity=0.356 Sum_probs=118.4
Q ss_pred ccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCce
Q psy3182 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENL 154 (255)
Q Consensus 75 v~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~ni 154 (255)
+.+.++|.-.++..+|.|. .|-+++++++..... +...+.++.+..|+++++.|||+++++|.||||+||
T Consensus 154 v~m~~wFdyrghiCivfel-lG~S~~dFlk~N~y~---------~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENI 223 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFEL-LGLSTFDFLKENNYI---------PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENI 223 (415)
T ss_pred EeeehhhhccCceEEEEec-cChhHHHHhccCCcc---------ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheE
Confidence 4567889999999999995 478999999865422 233567888999999999999999999999999999
Q ss_pred eeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCCCcchH
Q psy3182 155 LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDY 234 (255)
Q Consensus 155 l~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 234 (255)
|+.+....+........ .............+|||.|..... ..++.+-|..|.|||++.+.+|+.++|+
T Consensus 224 Lfvss~~~~~~~~k~~~--------~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDv 292 (415)
T KOG0671|consen 224 LFVSSEYFKTYNPKKKV--------CFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDV 292 (415)
T ss_pred EEeccceEEEeccCCcc--------ceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCc
Confidence 99887666553221110 000111122344479998876533 2357788999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCC
Q psy3182 235 WALGILMHELLTGMKE 250 (255)
Q Consensus 235 WslGvil~ell~G~~~ 250 (255)
||+||||+|+.+|..-
T Consensus 293 WSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 293 WSIGCILVELYTGETL 308 (415)
T ss_pred eeeeeEEEEeecccee
Confidence 9999999999999863
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-25 Score=189.80 Aligned_cols=150 Identities=24% Similarity=0.494 Sum_probs=116.5
Q ss_pred ceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
++.++....|+|++++++.+... ..+|+++||+.+ ++...+..+ .+++ +.+..++.|++.||
T Consensus 53 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~l~~-----------~~~~~i~~ql~~aL 119 (336)
T cd07849 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSN-----------DHIQYFLYQILRGL 119 (336)
T ss_pred HHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC-CCCH-----------HHHHHHHHHHHHHH
Confidence 45566777899999998765443 458999999864 787777542 2332 23456778999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---ccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~g 213 (255)
.|||++|++||||||+||+++..+.+++ +|||++........ .....+|
T Consensus 120 ~~LH~~~ivH~dlkp~Nill~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~ 171 (336)
T cd07849 120 KYIHSANVLHRDLKPSNLLLNTNCDLKI----------------------------CDFGLARIADPEHDHTGFLTEYVA 171 (336)
T ss_pred HHHHhCCeeccCCCHHHEEECCCCCEEE----------------------------CcccceeeccccccccCCcCCcCc
Confidence 9999999999999999999999888888 48887765432211 1123578
Q ss_pred CCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 172 ~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred CCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999998754 568899999999999999999999884
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-25 Score=180.62 Aligned_cols=148 Identities=26% Similarity=0.466 Sum_probs=120.5
Q ss_pred CceeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
.+.+++....|+|+++++..|.-. ..+|+|||++.+ +|...+..+ .| =+.++++.-|++.
T Consensus 64 rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e--lD-----------H~tis~i~yq~~~ 129 (369)
T KOG0665|consen 64 RELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILME--LD-----------HETISYILYQMLC 129 (369)
T ss_pred hhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHh--cc-----------hHHHHHHHHHHHH
Confidence 356778888999999999888644 457999998854 565555421 11 1346778889999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|++|+|+.||+||||||+||++..+..+|+ .|||+|+..... ...+..+.|
T Consensus 130 ~ik~lhs~~IihRdLkPsnivv~~~~~lKi----------------------------~dfg~ar~e~~~-~~mtpyVvt 180 (369)
T KOG0665|consen 130 GIKHLHSAGIIHRDLKPSNIVVNSDCTLKI----------------------------LDFGLARTEDTD-FMMTPYVVT 180 (369)
T ss_pred HHHHHHhcceeecccCcccceecchhheee----------------------------ccchhhcccCcc-cccCchhhe
Confidence 999999999999999999999999998888 499998766544 344567889
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
..|.|||++.+.+|...+||||+||++.||++|.--|
T Consensus 181 Ryyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 181 RYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred eeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 9999999999999999999999999999999997544
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-25 Score=188.29 Aligned_cols=151 Identities=23% Similarity=0.447 Sum_probs=122.5
Q ss_pred ceeeeccccccccccccccccCcc-----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK-----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~-----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++....|++++++++.+.+.. .+|++|||+. ++|.+.+.+...+++ +.+..++.|++.||
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~-----------~~~~~i~~~l~~~l 116 (330)
T cd07834 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTD-----------DHIQYFLYQILRGL 116 (330)
T ss_pred HHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCH-----------HHHHHHHHHHHHHH
Confidence 345566778999999999888775 7899999997 588888876443333 23455778899999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC---cccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---CKTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---~~~~~~~g 213 (255)
.|||++|++||||||.||+++.++.+++ +|||.+....... .......|
T Consensus 117 ~~LH~~gi~H~dlkp~nili~~~~~~~L----------------------------~dfg~~~~~~~~~~~~~~~~~~~~ 168 (330)
T cd07834 117 KYLHSANVIHRDLKPSNILVNSNCDLKI----------------------------CDFGLARGVDPDEDEKGFLTEYVV 168 (330)
T ss_pred HHHHhCCeecCCCCHHHEEEcCCCCEEE----------------------------cccCceEeeccccccccccccccc
Confidence 9999999999999999999999988888 4888776654432 12334568
Q ss_pred CCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.|+|||++.+. .++.++|+||+||++|+|++|.+||.
T Consensus 169 ~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 8999999999887 88999999999999999999999885
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=185.21 Aligned_cols=148 Identities=30% Similarity=0.483 Sum_probs=118.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+.+..|++|||+.| ++.+.+.... .++ ...+..++.|++.|+.|||
T Consensus 75 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~-----------~~~~~~i~~~i~~~l~~lH 142 (317)
T cd06635 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQ-----------EVEIAAITHGALQGLAYLH 142 (317)
T ss_pred HHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 34556777899999999999999999999999975 6766664322 122 2234456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++||||+|+||+++.++.+++ .|||.+..... .....|++.|+||
T Consensus 143 ~~~i~H~dL~p~Nil~~~~~~~kl----------------------------~dfg~~~~~~~----~~~~~~~~~y~aP 190 (317)
T cd06635 143 SHNMIHRDIKAGNILLTEPGQVKL----------------------------ADFGSASIASP----ANSFVGTPYWMAP 190 (317)
T ss_pred HCCcccCCCCcccEEECCCCCEEE----------------------------ecCCCccccCC----cccccCCccccCh
Confidence 999999999999999998888887 48887754432 2245789999999
Q ss_pred cccc---CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIK---NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~---~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.+. ...++.++|+||+||++|+|++|..||..
T Consensus 191 E~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred hhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9984 35678899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=182.06 Aligned_cols=147 Identities=22% Similarity=0.353 Sum_probs=116.4
Q ss_pred eeeccc-cccccccccccccCc--cceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRK-KKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 64 kl~~~~-~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
..+.+. .|+|++++++.+.+. +..|+++||+.| ++.+.+..+. .++ ...+..++.|++.||.||
T Consensus 49 ~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~-----------~~~~~~~~~qi~~~L~~L 116 (282)
T cd07831 49 QALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLP-----------EKRVKSYMYQLLKSLDHM 116 (282)
T ss_pred HHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 334444 499999999999887 889999999974 7877776532 222 233456778899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++|++||||||+||+++. +.+++ .|||.++....... .....+++.|+|
T Consensus 117 H~~~i~H~dl~p~ni~l~~-~~~kl----------------------------~dfg~~~~~~~~~~-~~~~~~~~~y~a 166 (282)
T cd07831 117 HRNGIFHRDIKPENILIKD-DILKL----------------------------ADFGSCRGIYSKPP-YTEYISTRWYRA 166 (282)
T ss_pred HHCCceecccCHHHEEEcC-CCeEE----------------------------EecccccccccCCC-cCCCCCCcccCC
Confidence 9999999999999999998 87887 48998876543322 123568899999
Q ss_pred cccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||.+.. ..++.++|+||+||++|+|++|..||.
T Consensus 167 PE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred hhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 998754 556889999999999999999999885
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=179.09 Aligned_cols=152 Identities=30% Similarity=0.620 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|++++++++.+.+....|+++||+.|++|.+++.... .+++ ..+..++.|++.|+.|||
T Consensus 47 e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~i~~~i~~~l~~lh 115 (253)
T cd05122 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTE-----------SQIAYVCKELLKGLEYLH 115 (253)
T ss_pred HHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCH-----------HHHHHHHHHHHHHHHHhh
Confidence 3455666779999999999999999999999999999999887642 2222 334557788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++|+|++|+||+++.++.+++ .|||.+........ .....|+..|+||
T Consensus 116 ~~~i~h~dl~p~ni~i~~~~~~~l----------------------------~d~~~~~~~~~~~~-~~~~~~~~~~~~P 166 (253)
T cd05122 116 SNGIIHRDIKAANILLTSDGEVKL----------------------------IDFGLSAQLSDTKA-RNTMVGTPYWMAP 166 (253)
T ss_pred cCCEecCCCCHHHEEEccCCeEEE----------------------------eecccccccccccc-ccceecCCcccCH
Confidence 999999999999999998888877 58888766544321 3356789999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 167 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 199 (253)
T cd05122 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199 (253)
T ss_pred HHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999888889999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-25 Score=180.35 Aligned_cols=156 Identities=29% Similarity=0.461 Sum_probs=126.6
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++...+|+++++..+.+.+....++++|++.|++|.+.+++...... ......+..++.+++.||.|||++
T Consensus 50 ~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~ 122 (258)
T cd08215 50 VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK-------PFPEEQILDWFVQLCLALKYLHSR 122 (258)
T ss_pred HHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCC-------CcCHHHHHHHHHHHHHHHHHHHhC
Confidence 4556677799999999999999999999999999999999876421000 011233455678899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
|++|+||+|+||+++.++.+++ .|||.+..............|++.|+|||.
T Consensus 123 ~~~H~dl~~~nil~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~ 174 (258)
T cd08215 123 KILHRDIKPQNIFLTSNGLVKL----------------------------GDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174 (258)
T ss_pred CEecccCChHHeEEcCCCcEEE----------------------------CCccceeecccCcceecceeeeecccChhH
Confidence 9999999999999998888877 488877665444333345678999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..+..++.++|+||+|+++|+|++|..||..
T Consensus 175 ~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 205 (258)
T cd08215 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205 (258)
T ss_pred hccCCCCccccHHHHHHHHHHHHcCCCCCCC
Confidence 9988899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=181.43 Aligned_cols=149 Identities=28% Similarity=0.425 Sum_probs=120.5
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH-cCccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT-RGIVF 146 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-~~iiH 146 (255)
...|+|++++++.+.+.+..|++|||+.|++|.+.+......... .....+..++.|++.||.|||+ ++++|
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~-------~~~~~~~~~~~~l~~~l~~lh~~~~i~H 137 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR-------FTEERIWNIFVQMVLALRYLHKEKRIVH 137 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCC-------CCHHHHHHHHHHHHHHHHHhccCCceee
Confidence 467999999999999999999999999999998887531110000 1112345567889999999996 78999
Q ss_pred ccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCC
Q psy3182 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNR 226 (255)
Q Consensus 147 rdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (255)
+||+|+||+++.++..++ .|||.+....... ......|+..|+|||.+.+.
T Consensus 138 ~dl~~~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~ 188 (269)
T cd08528 138 RDLTPNNIMLGEDDKVTI----------------------------TDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNE 188 (269)
T ss_pred cCCCHHHEEECCCCcEEE----------------------------ecccceeeccccc-ccccccCcccCcChhhhcCC
Confidence 999999999999888887 5898887654432 33356789999999999988
Q ss_pred CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 227 GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 227 ~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.++.++|+||+|+++|+|++|..||.
T Consensus 189 ~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 189 PYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred CCchHHHHHHHHHHHHHHHhCCCccc
Confidence 89999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=184.25 Aligned_cols=153 Identities=19% Similarity=0.321 Sum_probs=121.3
Q ss_pred ceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++....|++++++++.+.+ ....|++|||+.+++|.+++.+... ......+..++.|++.||.||
T Consensus 56 ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~----------~~~~~~~~~~~~~l~~aL~~l 125 (284)
T cd05038 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----------QINLKRLLLFSSQICKGMDYL 125 (284)
T ss_pred HHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc----------ccCHHHHHHHHHHHHHHHHHH
Confidence 4566777889999999988777 6689999999999999999875431 011233455778899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~~ 216 (255)
|++|++||||||+||+++.++.+++ .|||.+......... .....++..
T Consensus 126 H~~~i~H~dl~p~nil~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~ 177 (284)
T cd05038 126 GSQRYIHRDLAARNILVESEDLVKI----------------------------SDFGLAKVLPEDKDYYYVKEPGESPIF 177 (284)
T ss_pred HhCCeecCCCCHHhEEEcCCCCEEE----------------------------cccccccccccCCcceeccCCCCCccc
Confidence 9999999999999999999888887 488887665422111 111234557
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||.+.+..++.++|+||+||++|+|++|..||.
T Consensus 178 ~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred ccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 999999988889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=187.97 Aligned_cols=150 Identities=27% Similarity=0.490 Sum_probs=118.4
Q ss_pred ceeeeccc-cccccccccccccCc--cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++..+ .|+|++++++.+... ...|+++||+. ++|...+.+. .+++ .....++.|++.||.|
T Consensus 56 E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~-----------~~~~~i~~qi~~~L~~ 122 (337)
T cd07852 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILED-----------VHKRYIMYQLLKALKY 122 (337)
T ss_pred HHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCH-----------HHHHHHHHHHHHHHHH
Confidence 45566677 899999999987643 46899999997 4888887653 3332 1234467889999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-----cccccccc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-----CKTWTFCG 213 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-----~~~~~~~g 213 (255)
||++|++||||||+||+++.++.+++ .|||.+....... .......|
T Consensus 123 LH~~~i~H~dl~p~nill~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~ 174 (337)
T cd07852 123 IHSGNVIHRDLKPSNILLNSDCRVKL----------------------------ADFGLARSLSELEENPENPVLTDYVA 174 (337)
T ss_pred HHHCCeecCCCCHHHEEEcCCCcEEE----------------------------eeccchhccccccccccCcchhcccc
Confidence 99999999999999999999998888 4888776543221 12234578
Q ss_pred CCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 175 ~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred cccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 999999998865 567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=181.08 Aligned_cols=150 Identities=30% Similarity=0.418 Sum_probs=116.6
Q ss_pred ccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc-Ccc
Q psy3182 67 SRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR-GIV 145 (255)
Q Consensus 67 ~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~-~ii 145 (255)
....|+|++++++.+.+....|+++||+. |+|.+++........ ....+.+..++.|++.||.|||++ +++
T Consensus 55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~~i~ 126 (283)
T cd06617 55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGL-------TIPEDILGKIAVSIVKALEYLHSKLSVI 126 (283)
T ss_pred HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHhhcCCee
Confidence 44578999999999999999999999996 577776654211100 011233456778899999999997 999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN 225 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (255)
||||||+||+++.++.+++ .|||.+........ .....|++.|+|||++.+
T Consensus 127 h~dlkp~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 127 HRDVKPSNVLINRNGQVKL----------------------------CDFGISGYLVDSVA-KTIDAGCKPYMAPERINP 177 (283)
T ss_pred cCCCCHHHEEECCCCCEEE----------------------------eecccccccccccc-cccccCCccccChhhcCC
Confidence 9999999999999888888 48998776543221 123568899999999864
Q ss_pred ----CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 226 ----RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 226 ----~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..++.++|+||+||++|+|++|..||..
T Consensus 178 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 4578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-25 Score=183.25 Aligned_cols=151 Identities=26% Similarity=0.499 Sum_probs=122.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+.+..|+++||+.+ ++.+.+.... .++ ...+..++.|++.||.|||
T Consensus 48 e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~-----------~~~~~~~~~~i~~~l~~LH 115 (283)
T cd05118 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLP-----------ESLIKSYLYQLLQGLAFCH 115 (283)
T ss_pred HHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 45566777899999999999999999999999975 8888776532 222 2334567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++|+||||+||+++.++.+++ .|||.+..............++..|+||
T Consensus 116 ~~~i~H~dl~p~nili~~~~~~~l----------------------------~df~~~~~~~~~~~~~~~~~~~~~~~~P 167 (283)
T cd05118 116 SHGILHRDLKPENLLINTEGVLKL----------------------------ADFGLARSFGSPVRPYTHYVVTRWYRAP 167 (283)
T ss_pred HCCeeecCcCHHHEEECCCCcEEE----------------------------eeeeeeEecCCCcccccCccCcccccCc
Confidence 999999999999999998888877 4888876654433122234678899999
Q ss_pred ccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus 168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999876 78899999999999999999998874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-25 Score=185.33 Aligned_cols=152 Identities=22% Similarity=0.410 Sum_probs=117.1
Q ss_pred ceeeeccccccccccccccccCcc--------ceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK--------YVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACV 132 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~--------~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i 132 (255)
+++++....|++++++++.+.+.. ..|+++||+.+ ++.+.+.+.. .++ .+.+..++.|+
T Consensus 61 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~-----------~~~~~~i~~qi 128 (310)
T cd07865 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFT-----------LSEIKKVMKML 128 (310)
T ss_pred HHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCC-----------HHHHHHHHHHH
Confidence 466777888999999988765543 45999999965 7777775432 122 23455678899
Q ss_pred HHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----cc
Q psy3182 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC----KT 208 (255)
Q Consensus 133 l~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~----~~ 208 (255)
+.||.|||++|++||||||+||+++.++.+++ .|||.+........ ..
T Consensus 129 ~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~ 180 (310)
T cd07865 129 LNGLYYIHRNKILHRDMKAANILITKDGILKL----------------------------ADFGLARAFSLSKNSKPNRY 180 (310)
T ss_pred HHHHHHHHHCCeeccCCCHHHEEECCCCcEEE----------------------------CcCCCcccccCCcccCCCCc
Confidence 99999999999999999999999999888888 48887765432211 11
Q ss_pred cccccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 209 WTFCGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 209 ~~~~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
....+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||..
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 234678899999998664 478899999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=184.90 Aligned_cols=153 Identities=27% Similarity=0.494 Sum_probs=118.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc--cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~--~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++.+...+|+|++++++.+.+.+..++++|||.+|+|.+++... ..++. ..+..++.|++.||.||
T Consensus 51 e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~-----------~~~~~i~~~i~~~l~~L 119 (259)
T PF07714_consen 51 EIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSE-----------QQRLSIAIQIAEALSYL 119 (259)
T ss_dssp HHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBH-----------HHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-----------ccccccccccccccccc
Confidence 456677789999999999999888899999999999999999875 22221 22344678899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y 217 (255)
|+++++|++|++.||+++.++.+|++ |||++........ ......+...|
T Consensus 120 h~~~iiH~~l~~~nill~~~~~~Kl~----------------------------~f~~~~~~~~~~~~~~~~~~~~~~~~ 171 (259)
T PF07714_consen 120 HSNNIIHGNLSPSNILLDSNGQVKLS----------------------------DFGLSRPISEKSKYKNDSSQQLPLRY 171 (259)
T ss_dssp HHTTEEEST-SGGGEEEETTTEEEEE----------------------------STTTGEETTTSSSEEESTTSESGGGG
T ss_pred cccccccccccccccccccccccccc----------------------------cccccccccccccccccccccccccc
Confidence 99999999999999999999999884 8887766522111 11223456789
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+|||.+.+..++.++||||+|+++||+++ |..||..
T Consensus 172 ~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 172 LAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp S-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred ccccccccccccccccccccccccccccccccccccc
Confidence 99999988889999999999999999999 6788764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=168.45 Aligned_cols=144 Identities=30% Similarity=0.450 Sum_probs=114.1
Q ss_pred ccccccccccccccCccceeehhhhhcchhHHHH----HHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc-C
Q psy3182 69 KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTI----LRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR-G 143 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~----l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~-~ 143 (255)
..+|..+++|..+.++..+++.||.+. -+|..+ +.+....+| ..+-.|+..++.||.|||++ .
T Consensus 102 ~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE-----------~vlGkIa~Svv~al~~L~~kL~ 169 (282)
T KOG0984|consen 102 VDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPE-----------DVLGKIAVSVVHALEFLHSKLS 169 (282)
T ss_pred CCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCch-----------HHhhHhHHHHHHHHHHHHHHhh
Confidence 457899999999999999999999764 233222 222222222 23445666789999999975 8
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII 223 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (255)
+||||+||.|||++..|.+|+ +|||.|..+..+...+ .-.|.-.|||||.+
T Consensus 170 vIHRDvKPsNiLIn~~GqVKi----------------------------CDFGIsG~L~dSiAkt-~daGCkpYmaPEri 220 (282)
T KOG0984|consen 170 VIHRDVKPSNILINYDGQVKI----------------------------CDFGISGYLVDSIAKT-MDAGCKPYMAPERI 220 (282)
T ss_pred hhhccCCcceEEEccCCcEEE----------------------------cccccceeehhhhHHH-HhcCCCccCChhhc
Confidence 999999999999999999999 5999998887765443 24688899999998
Q ss_pred c----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 224 K----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 224 ~----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
. ..+|+.++|+||||+.+.||.+|..|+..
T Consensus 221 ~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 221 NPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred CcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 5 35899999999999999999999988763
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=180.17 Aligned_cols=156 Identities=27% Similarity=0.402 Sum_probs=123.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++....|+|++++++.+.+.+..++++||+.+++|.+.+.+..... .....+.+..++.|++.||.|||+
T Consensus 52 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG-------KTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred HHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcc-------cccCHHHHHHHHHHHHHHHHHHHH
Confidence 3456677789999999999999999999999999999998886421100 001123345567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++|+|++|+|++++. +.+++ .|||.++.............|++.|+|||
T Consensus 125 ~~i~h~~l~~~nili~~-~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~~pe 175 (260)
T cd08222 125 RRILHRDLKAKNIFLKN-NLLKI----------------------------GDFGVSRLLMGSCDLATTFTGTPYYMSPE 175 (260)
T ss_pred cCccccCCChhheEeec-CCEee----------------------------cccCceeecCCCcccccCCCCCcCccCHH
Confidence 99999999999999965 44565 48888766544333334567899999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...+..++.++|+||+|+++|+|++|..||+.
T Consensus 176 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99888899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=182.62 Aligned_cols=159 Identities=21% Similarity=0.273 Sum_probs=120.0
Q ss_pred eeeecccccccccccccccc-CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFK-DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~-~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+.++..+.|+|++++++... +....++++||+.+|+|..++......+.... .......+..++.|++.||.|||+
T Consensus 59 ~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~ 135 (280)
T cd05043 59 SCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP---QALSTQQLVHMAIQIACGMSYLHK 135 (280)
T ss_pred HHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44566678999999988644 46788999999999999999875422110000 011123345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--ccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--TWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--~~~~~gt~~y~a 219 (255)
++++||||||+|++++.++.+++ +|||+++........ .....++..|+|
T Consensus 136 ~~i~H~di~p~nil~~~~~~~kl----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~y~a 187 (280)
T cd05043 136 RGVIHKDIAARNCVIDEELQVKI----------------------------TDNALSRDLFPMDYHCLGDNENRPVKWMA 187 (280)
T ss_pred CCEeecccCHhhEEEcCCCcEEE----------------------------CCCCCcccccCCceEEeCCCCCcchhccC
Confidence 99999999999999998888877 488887654322111 112335667999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||++.+..++.++|+||+||++|++++ |..||+
T Consensus 188 pE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred HHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 999998889999999999999999998 999886
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=182.86 Aligned_cols=151 Identities=30% Similarity=0.439 Sum_probs=115.7
Q ss_pred eeeecccc-ccccccccccccCccceeehhhhhcc--hhHHHHHHhc--cCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLG--GEVWTILRER--TCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 63 vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~g--g~l~~~l~~~--~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+.++.+.. |+|++++++.+.+....|++||++.+ +++...+... ..++ ...+..++.|++.||+
T Consensus 53 ~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~-----------~~~~~~i~~~i~~~l~ 121 (288)
T cd06616 53 LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP-----------EEILGKIAVATVKALN 121 (288)
T ss_pred HHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCC-----------HHHHHHHHHHHHHHHH
Confidence 34455554 99999999999999999999999865 2333333211 1122 2334567788999999
Q ss_pred HHHHc-CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 138 YLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 138 ylH~~-~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
|||+. +++||||||+||+++.++.+++ .|||+++....... .....|++.
T Consensus 122 ~lh~~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~-~~~~~~~~~ 172 (288)
T cd06616 122 YLKEELKIIHRDVKPSNILLDRNGNIKL----------------------------CDFGISGQLVDSIA-KTRDAGCRP 172 (288)
T ss_pred HHhhcCCeeccCCCHHHEEEccCCcEEE----------------------------eecchhHHhccCCc-cccccCccC
Confidence 99975 9999999999999998888887 59998866543322 223468899
Q ss_pred CcccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNR---GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~---~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus 173 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred ccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 9999999765 688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-25 Score=205.47 Aligned_cols=156 Identities=26% Similarity=0.374 Sum_probs=122.6
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
+++...|||++++....-+....++++||+.||||..+|++..+-... .+. .....+-.++.+|+.|+.||+++++
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~-~~~---L~~~dLl~~a~dvA~G~~YLe~~~f 823 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQ-PSN---LSMRDLLAFALDVAKGMNYLESKHF 823 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCC-CCC---CCHHHHHHHHHHHhhhhHHHHhCCC
Confidence 467889999999999988899999999999999999999975432222 111 1122344567899999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc--CCCCccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG--TPEYVAPEI 222 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g--t~~y~aPE~ 222 (255)
|||||..+|+|++....+|+ .|||+|+-.-.....+..-.+ ...|||||.
T Consensus 824 vHRDLAaRNCLL~~~r~VKI----------------------------aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEs 875 (1025)
T KOG1095|consen 824 VHRDLAARNCLLDERRVVKI----------------------------ADFGLARDIYDKDYYRKHGEAMLPVKWMPPES 875 (1025)
T ss_pred cCcchhhhheeecccCcEEE----------------------------cccchhHhhhhchheeccCccccceecCCHHH
Confidence 99999999999999988888 499999843222211111112 237999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+....++.++|+||+||++||+++ |..|+.
T Consensus 876 l~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 876 LKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred HhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986 677764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=177.84 Aligned_cols=154 Identities=33% Similarity=0.558 Sum_probs=126.5
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++.+++..|++++++++.+.+. +..|+++|++.+++|.+++.+...+++ ..+..++.|++.||.||
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----------~~~~~~~~~l~~~l~~l 117 (260)
T cd06606 49 EIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-----------PVIRKYTRQILEGLAYL 117 (260)
T ss_pred HHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 45566777899999999998888 899999999999999999876543332 22345677899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y 217 (255)
|+++++|+|++|+||+++..+.+++ .|||.+........ ......+++.|
T Consensus 118 h~~~~~h~dl~p~ni~i~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~~~y 169 (260)
T cd06606 118 HSNGIVHRDIKGANILVDSDGVVKL----------------------------ADFGCAKRLGDIETGEGTGSVRGTPYW 169 (260)
T ss_pred HHCCccccCCCHHHEEEcCCCCEEE----------------------------cccccEEecccccccccccCCCCCccc
Confidence 9999999999999999999888877 47877765544322 12345788999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
+|||.+.+..++.++|+||+|+++|+|++|..||..+
T Consensus 170 ~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred cCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999888999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=211.19 Aligned_cols=143 Identities=22% Similarity=0.385 Sum_probs=115.1
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH--
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH-- 140 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH-- 140 (255)
++.+.+.+|||++++++.+.+.+..|+||||+.||+|.+++++ ++ .+....++.|++.|+.|+|
T Consensus 734 ~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~-----------~~~~~~i~~~ia~~L~yLH~~ 799 (968)
T PLN00113 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LS-----------WERRRKIAIGIAKALRFLHCR 799 (968)
T ss_pred HHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CC-----------HHHHHHHHHHHHHHHHHhccC
Confidence 3445567899999999999999999999999999999999863 21 1223457889999999999
Q ss_pred -HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 -TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 -~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
+.+|+|||+||+||+++..+..++ .+|....... ..+..||+.|||
T Consensus 800 ~~~~iiH~dlkp~Nil~~~~~~~~~-----------------------------~~~~~~~~~~----~~~~~~t~~y~a 846 (968)
T PLN00113 800 CSPAVVVGNLSPEKIIIDGKDEPHL-----------------------------RLSLPGLLCT----DTKCFISSAYVA 846 (968)
T ss_pred CCCCeecCCCCHHhEEECCCCceEE-----------------------------Eecccccccc----CCCccccccccC
Confidence 679999999999999987665544 3333322111 113368899999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++||||+||++|||++|..||+
T Consensus 847 PE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 847 PETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred cccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999999975
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=179.29 Aligned_cols=151 Identities=27% Similarity=0.452 Sum_probs=122.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|++++++++.+.+....|+++|++. ++|.+++.+.. .+++ ..+..++.|++.||.|||
T Consensus 48 e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~-----------~~~~~~~~~i~~~l~~LH 115 (282)
T cd07829 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSP-----------NLIKSIMYQLLRGLAYCH 115 (282)
T ss_pred HHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4556667789999999999999999999999997 48999887642 2222 234456778999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++|||++|+||+++.++.+++ .|||.++.............+++.|+||
T Consensus 116 ~~~i~H~~l~~~ni~~~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~aP 167 (282)
T cd07829 116 SHRILHRDLKPQNILINRDGVLKL----------------------------ADFGLARAFGIPLRTYTHEVVTLWYRAP 167 (282)
T ss_pred HCCcccCCCChheEEEcCCCCEEE----------------------------ecCCcccccCCCccccCccccCcCcCCh
Confidence 999999999999999999888888 4888876654433233334567889999
Q ss_pred ccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+. .++.++|+||+||++|++++|..||.
T Consensus 168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 998765 78899999999999999999988875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=183.27 Aligned_cols=148 Identities=28% Similarity=0.470 Sum_probs=118.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|++++++++.+.+....|+++||+. |++.+.+.... .++ ...+..++.|++.|+.|||
T Consensus 65 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~-----------~~~~~~~~~~l~~~l~~LH 132 (308)
T cd06634 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ-----------EVEIAAVTHGALQGLAYLH 132 (308)
T ss_pred HHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4556777789999999999999999999999997 57776665322 222 1234556788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++||||+|.||+++.++.+++ .|||.+..... .....|++.|+||
T Consensus 133 ~~~i~H~dl~p~nil~~~~~~~kl----------------------------~dfg~~~~~~~----~~~~~~~~~y~aP 180 (308)
T cd06634 133 SHNMIHRDVKAGNILLSEPGLVKL----------------------------GDFGSASIMAP----ANXFVGTPYWMAP 180 (308)
T ss_pred hCCcccCCCCHHhEEECCCCcEEE----------------------------CCcccceeecC----cccccCCccccCH
Confidence 999999999999999998888887 48887765432 2245789999999
Q ss_pred cccc---CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIK---NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~---~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.+. ...++.++|+||+||++|+|++|..||..
T Consensus 181 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred HHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 9985 34578899999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=182.46 Aligned_cols=147 Identities=30% Similarity=0.490 Sum_probs=118.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|++++++++.+.+.+..|+++||+. |++.+.+.... .++ ...+..++.|++.|+.|||
T Consensus 71 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~-----------~~~~~~~~~qi~~al~~LH 138 (313)
T cd06633 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQ-----------EVEIAAITHGALQGLAYLH 138 (313)
T ss_pred HHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 3455677889999999999999999999999996 56777765432 122 1233456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||+|+||+++.++.+++ .|||.+..... .....|++.|+||
T Consensus 139 ~~gi~H~dl~p~nili~~~~~~kL----------------------------~dfg~~~~~~~----~~~~~~~~~y~aP 186 (313)
T cd06633 139 SHNMIHRDIKAGNILLTEPGQVKL----------------------------ADFGSASKSSP----ANSFVGTPYWMAP 186 (313)
T ss_pred HCCeecCCCChhhEEECCCCCEEE----------------------------eecCCCcccCC----CCCccccccccCh
Confidence 999999999999999998888887 48887754322 2246789999999
Q ss_pred cccc---CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIK---NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~---~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++. ...++.++|+||+||++|+|++|..||.
T Consensus 187 E~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9984 3568889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=179.33 Aligned_cols=158 Identities=20% Similarity=0.273 Sum_probs=119.0
Q ss_pred ceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++....|++++++++.+...+ ..++++||+.+|+|..++..... ..... ......+..++.|++.|
T Consensus 51 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~----~l~~~~~~~~~~~i~~~ 125 (273)
T cd05074 51 EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI-GEEPF----TLPLQTLVRFMIDIASG 125 (273)
T ss_pred HHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcc-cCCCC----CCCHHHHHHHHHHHHHH
Confidence 466778889999999998765432 24788899999999887753221 11110 11223456678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--ccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~g 213 (255)
|.|||+++|+||||||+||+++.++.+++ .|||.++....... ......+
T Consensus 126 l~~lH~~~i~H~dikp~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~ 177 (273)
T cd05074 126 MEYLSSKNFIHRDLAARNCMLNENMTVCV----------------------------ADFGLSKKIYSGDYYRQGCASKL 177 (273)
T ss_pred HHHHHhCCEeecccchhhEEEcCCCCEEE----------------------------CcccccccccCCcceecCCCccC
Confidence 99999999999999999999998888877 48888765533211 1122345
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
++.|++||.+.+..++.++|+||+||++|+|++ |.+||.
T Consensus 178 ~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~ 217 (273)
T cd05074 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217 (273)
T ss_pred chhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence 678999999998889999999999999999998 778875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=184.91 Aligned_cols=150 Identities=25% Similarity=0.412 Sum_probs=114.9
Q ss_pred eeeccc-cccccccccccc----cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRK-KKTRQTRLYKTF----KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 64 kl~~~~-~h~~iv~l~~~~----~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.++.+. .|+|++++++.. .....+|+++|++. ++|.+.+.....+++ ..+..++.|++.||.|
T Consensus 53 ~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~-----------~~~~~~~~qi~~aL~~ 120 (332)
T cd07857 53 KLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTD-----------AHFQSFIYQILCGLKY 120 (332)
T ss_pred HHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHH
Confidence 344444 488999888753 23356789999875 688888875544443 3345577889999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----ccccccccC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----CKTWTFCGT 214 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~~~~~~~gt 214 (255)
||++|++||||||+||+++.++.+++ +|||.++...... .......||
T Consensus 121 LH~~givH~dlkp~Nili~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~g~ 172 (332)
T cd07857 121 IHSANVLHRDLKPGNLLVNADCELKI----------------------------CDFGLARGFSENPGENAGFMTEYVAT 172 (332)
T ss_pred HHhCCcccCCCCHHHeEEcCCCCEEe----------------------------CcCCCceecccccccccccccCcccC
Confidence 99999999999999999999888887 4888776543221 112345789
Q ss_pred CCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||.+.+ ..++.++|+||+||++|+|++|..||..
T Consensus 173 ~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 99999998765 5789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=184.92 Aligned_cols=147 Identities=29% Similarity=0.545 Sum_probs=116.9
Q ss_pred ceeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++...+|+|++++++.+... ...|+++|++ |++|.++++.. .+++ +.+..++.|++.|
T Consensus 66 Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~-----------~~~~~i~~qi~~a 132 (345)
T cd07877 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTD-----------DHVQFLIYQILRG 132 (345)
T ss_pred HHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-CCCH-----------HHHHHHHHHHHHH
Confidence 45567778899999998877543 3478888876 78888877542 2322 2345577899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++|++||||||+||+++.++.+++ +|||++..... ......|++
T Consensus 133 L~~LH~~~ivH~dlkp~NIll~~~~~~kl----------------------------~dfg~~~~~~~---~~~~~~~~~ 181 (345)
T cd07877 133 LKYIHSADIIHRDLKPSNLAVNEDCELKI----------------------------LDFGLARHTDD---EMTGYVATR 181 (345)
T ss_pred HHHHHHCCeeecCCChHHEEEcCCCCEEE----------------------------ecccccccccc---cccccccCC
Confidence 99999999999999999999999888887 59998765432 223457899
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 182 ~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred CccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999876 578899999999999999999999885
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-24 Score=183.53 Aligned_cols=147 Identities=27% Similarity=0.502 Sum_probs=118.6
Q ss_pred ceeeeccccccccccccccccC-ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD-SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~-~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.++....|+|++++++.|.. ....|+++||+ +++|..+++.. .+++ +.+..++.|+++||.|||
T Consensus 59 E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~-----------~~~~~~~~ql~~aL~~LH 125 (328)
T cd07856 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR-PLEK-----------QFIQYFLYQILRGLKYVH 125 (328)
T ss_pred HHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC-CCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4566778899999999998865 56789999998 66888777632 2221 234456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++|||++|.|++++..+.+++ +|||.+..... ...+..|++.|+||
T Consensus 126 ~~~iiH~dl~p~Nili~~~~~~~l----------------------------~dfg~~~~~~~---~~~~~~~~~~y~aP 174 (328)
T cd07856 126 SAGVVHRDLKPSNILINENCDLKI----------------------------CDFGLARIQDP---QMTGYVSTRYYRAP 174 (328)
T ss_pred hCCcccCCCCHHHEeECCCCCEEe----------------------------CccccccccCC---CcCCCcccccccCc
Confidence 999999999999999998887777 48988765432 22345688899999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 175 E~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred eeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99865 678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=177.77 Aligned_cols=147 Identities=23% Similarity=0.360 Sum_probs=118.1
Q ss_pred ccccccccccccccccCccc-----eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 67 SRKKKTRQTRLYKTFKDSKY-----VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 67 ~~~~h~~iv~l~~~~~~~~~-----~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
....|++++++++.+.+... .|+++|++.+ +|.+++.+..... ...+.+..++.|++.||.|||+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~ 125 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG---------LPPETIKDLMRQLLRGVDFLHS 125 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 44469999999999888776 9999999975 7888876533210 1123455677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
++++|+|++|+||+++.++.+++ .|||.+....... ......+++.|+|||
T Consensus 126 ~~i~h~~l~~~nili~~~~~~~l----------------------------~dfg~~~~~~~~~-~~~~~~~~~~~~~PE 176 (287)
T cd07838 126 HRIVHRDLKPQNILVTSDGQVKI----------------------------ADFGLARIYSFEM-ALTSVVVTLWYRAPE 176 (287)
T ss_pred CCeeeccCChhhEEEccCCCEEE----------------------------eccCcceeccCCc-ccccccccccccChH
Confidence 99999999999999999988888 4888876654332 222345788999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|.+||.
T Consensus 177 ~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 177 VLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred HhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 9998889999999999999999999988875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=178.00 Aligned_cols=148 Identities=28% Similarity=0.499 Sum_probs=119.5
Q ss_pred eeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 64 kl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
..+.+.. |++++++++.+.+++..|++|||+ +|++.+.+.... .++ ...+..++.|++.||.|||
T Consensus 49 ~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~-----------~~~~~~~~~~l~~~l~~Lh 116 (283)
T cd07830 49 KSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-----------ESVIRSIIYQILQGLAHIH 116 (283)
T ss_pred HHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 3445556 999999999999999999999999 889998887643 122 2234456778999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++|+||+|.||+++..+.+++ .|||.+....... ......|+..|+||
T Consensus 117 ~~~i~H~dl~~~ni~i~~~~~~~l----------------------------~d~~~~~~~~~~~-~~~~~~~~~~~~aP 167 (283)
T cd07830 117 KHGFFHRDLKPENLLVSGPEVVKI----------------------------ADFGLAREIRSRP-PYTDYVSTRWYRAP 167 (283)
T ss_pred HCCcccCCCChhhEEEcCCCCEEE----------------------------eecccceeccCCC-CcCCCCCcccccCc
Confidence 999999999999999999888888 4888876553322 22235688899999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+|+++|+|++|..||.
T Consensus 168 E~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred eeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 98854 567899999999999999999998874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=184.75 Aligned_cols=147 Identities=27% Similarity=0.516 Sum_probs=119.2
Q ss_pred ceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++....|+|++++++.+.... ..++++|++ |++|..++.. ..+++ +.+..++.|++.|
T Consensus 64 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~-----------~~~~~i~~qi~~a 130 (343)
T cd07880 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSE-----------DRIQFLVYQMLKG 130 (343)
T ss_pred HHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCH-----------HHHHHHHHHHHHH
Confidence 456677888999999999887654 358999998 7788877753 22332 3456678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ .|||.+...... .....|++
T Consensus 131 l~~LH~~gi~H~dlkp~Nill~~~~~~kl----------------------------~dfg~~~~~~~~---~~~~~~~~ 179 (343)
T cd07880 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKI----------------------------LDFGLARQTDSE---MTGYVVTR 179 (343)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCCEEE----------------------------eecccccccccC---ccccccCC
Confidence 99999999999999999999998888877 599988765332 22456889
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+ ..++.++|+||+||++|++++|..||.
T Consensus 180 ~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999876 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-24 Score=180.20 Aligned_cols=151 Identities=23% Similarity=0.398 Sum_probs=117.7
Q ss_pred ceeeeccccccccccccccccCcc----------ceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK----------YVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITA 130 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~----------~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~ 130 (255)
+++++...+|+|++++++.+.+.. .+|+++||+.+ ++...+.... .++ .+.+..++.
T Consensus 56 e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~-----------~~~~~~i~~ 123 (302)
T cd07864 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFS-----------EDHIKSFMK 123 (302)
T ss_pred HHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCC-----------HHHHHHHHH
Confidence 456677888999999998877654 89999999986 6666665421 122 234556778
Q ss_pred HHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-cc
Q psy3182 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TW 209 (255)
Q Consensus 131 ~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~ 209 (255)
|++.||.|||++|++||||||+||+++.++.+++ .|||.+......... ..
T Consensus 124 qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~ 175 (302)
T cd07864 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL----------------------------ADFGLARLYNSEESRPYT 175 (302)
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe----------------------------CcccccccccCCcccccc
Confidence 9999999999999999999999999999888888 488887655332211 12
Q ss_pred ccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 210 TFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
...+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 176 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred cceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 2356788999998865 457889999999999999999998885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=181.57 Aligned_cols=152 Identities=24% Similarity=0.395 Sum_probs=115.0
Q ss_pred CceeeeccccccccccccccccC--------ccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD--------SKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITAC 131 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~--------~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~ 131 (255)
++++++..+.|++++++++.+.+ ...+|+++||+.+ ++...+.... .++ ...+..++.|
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~-----------~~~~~~i~~~ 123 (311)
T cd07866 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLT-----------ESQIKCYMLQ 123 (311)
T ss_pred HHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCC-----------HHHHHHHHHH
Confidence 35667788899999999887643 3357999999865 5666554321 222 2345667889
Q ss_pred HHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC------
Q psy3182 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG------ 205 (255)
Q Consensus 132 il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~------ 205 (255)
+++||.|||++|++||||||+||+++.++.+++. |||.++......
T Consensus 124 l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~----------------------------dfg~~~~~~~~~~~~~~~ 175 (311)
T cd07866 124 LLEGINYLHENHILHRDIKAANILIDNQGILKIA----------------------------DFGLARPYDGPPPNPKGG 175 (311)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEC----------------------------cCccchhccCCCcccccC
Confidence 9999999999999999999999999999888885 666554332111
Q ss_pred -----ccccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 206 -----CKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 206 -----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.......|++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 01123467889999999865 458899999999999999999998875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=198.27 Aligned_cols=98 Identities=33% Similarity=0.539 Sum_probs=82.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.++..++|+++++++..+.+...+|+||||+.|++|.+++.....+++ ..+..++.||+.||.|||++
T Consensus 55 ~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~-----------~~~~~i~~qil~aL~yLH~~ 123 (669)
T cd05610 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----------EMAVKYISEVALALDYLHRH 123 (669)
T ss_pred HHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHhC
Confidence 4455667899999999999999999999999999999999976554443 23456778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGH 171 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~ 171 (255)
+|+||||||+|||++.++.+++.+|+.+.
T Consensus 124 gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999988876543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-24 Score=183.99 Aligned_cols=147 Identities=29% Similarity=0.551 Sum_probs=119.2
Q ss_pred ceeeeccccccccccccccccCccc------eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKY------VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~------~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++.++....|++++++++.+...+. .|+++|++ |++|.+++.. ..+++ +.+..++.|++.|
T Consensus 64 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~-----------~~~~~~~~ql~~a 130 (343)
T cd07851 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSD-----------DHIQFLVYQILRG 130 (343)
T ss_pred HHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCH-----------HHHHHHHHHHHHH
Confidence 4566777789999999888776554 89999998 6799888864 23332 2345577889999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++|++||||||+||+++.++.+++ +|||.+...... .....+++
T Consensus 131 L~~LH~~gi~H~dlkp~Nill~~~~~~kL----------------------------~dfg~~~~~~~~---~~~~~~~~ 179 (343)
T cd07851 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKI----------------------------LDFGLARHTDDE---MTGYVATR 179 (343)
T ss_pred HHHHHHCCeecCCCCHHHeEECCCCCEEE----------------------------cccccccccccc---ccCCcccc
Confidence 99999999999999999999999888887 499988765332 23457889
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus 180 ~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred cccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999999865 467889999999999999999999885
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=168.94 Aligned_cols=154 Identities=21% Similarity=0.244 Sum_probs=111.5
Q ss_pred eeeccccccccccccccccC-----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRKKKTRQTRLYKTFKD-----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~-----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
....+..|+|++++++.--. ....|+++.|-..|+|++.+++...-.+.. ....+-+++.++.+||++
T Consensus 70 d~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~-------sE~~iL~if~gic~gL~~ 142 (302)
T KOG2345|consen 70 DNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFV-------SEAQILWIFLGICRGLEA 142 (302)
T ss_pred HHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCcc-------CHHHHHHHHHHHHHHHHH
Confidence 34455667888877665322 345899999999999999987543211110 012344677889999999
Q ss_pred HHHcC--cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---------
Q psy3182 139 LHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--------- 207 (255)
Q Consensus 139 lH~~~--iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--------- 207 (255)
+|+.. .+|||+||.||++..++...+ .|||.+....-....
T Consensus 143 lH~~~~~yAH~DiKP~NILls~~~~~vl----------------------------~D~GS~~~a~i~i~~~~~a~~lQe 194 (302)
T KOG2345|consen 143 LHEKEPPYAHRDIKPANILLSDSGLPVL----------------------------MDLGSATQAPIQIEGSRQALRLQE 194 (302)
T ss_pred HhccCCcccccCCCcceeEecCCCceEE----------------------------EeccCccccceEeechHHHHHHHH
Confidence 99998 999999999999998766655 588876543221100
Q ss_pred ccccccCCCCcccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 208 TWTFCGTPEYVAPEIIKNR---GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 208 ~~~~~gt~~y~aPE~~~~~---~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
-.....|..|.|||.+.-+ ..+.++|||||||++|+|+.|..||+
T Consensus 195 ~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 195 WAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred HHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 0112357889999999754 45689999999999999999999997
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=169.20 Aligned_cols=179 Identities=20% Similarity=0.360 Sum_probs=137.9
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc-ccccccccccccCc--cceeehhhhhcchhHHHHHHhc
Q psy3182 30 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK-KTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRER 106 (255)
Q Consensus 30 ~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~-h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~ 106 (255)
-.+|..|++-....+++.+-+||-.- -....++|++..+. ++|++++++..+|. ...-+++|+..+.|...+-..
T Consensus 51 YSEVFeg~~~~~~eK~ViKiLKPVkk-kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t- 128 (338)
T KOG0668|consen 51 YSEVFEGINITNNEKCVIKILKPVKK-KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT- 128 (338)
T ss_pred HhhHhcccccCCCceEEEeeechHHH-HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-
Confidence 35677788777778888888888532 12234677877766 99999999998875 457899999988776554432
Q ss_pred cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCc-eeecccCCcceeeecCCCCCceee
Q psy3182 107 TCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY-VKLEFYPAGHYIIREGAKGDSFFI 185 (255)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~ 185 (255)
++. -.+++++.+++.||.|||++||+|||+||.|++++.... +++
T Consensus 129 --l~d-----------~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrl--------------------- 174 (338)
T KOG0668|consen 129 --LTD-----------YDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRL--------------------- 174 (338)
T ss_pred --hch-----------hhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeee---------------------
Confidence 111 135778889999999999999999999999999987543 333
Q ss_pred eeCCeeeeeccccccCCCCCccccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 186 ISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 186 ~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|+|+|....... .....+.+..|--||.+.. +.|+.+.|+||+||++..|+.-..||+
T Consensus 175 -------IDWGLAEFYHp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 175 -------IDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred -------eecchHhhcCCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 6999998764432 3334567888999999976 668999999999999999999999985
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=177.15 Aligned_cols=151 Identities=26% Similarity=0.437 Sum_probs=120.1
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++....|++++++++.+.+. +..|+++||+.+ +|.+++.+.. .++ .+.+..++.|++.||.|
T Consensus 48 e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~-----------~~~~~~i~~~i~~al~~ 115 (287)
T cd07840 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFT-----------ESQIKCYMKQLLEGLQY 115 (287)
T ss_pred HHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCC-----------HHHHHHHHHHHHHHHHH
Confidence 45566777899999999998888 899999999974 8888876542 222 23345677889999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEY 217 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y 217 (255)
||++|++|+||||+||+++.++.+++ .|||.+........ ......+++.|
T Consensus 116 LH~~~~~h~dl~p~nil~~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~y 167 (287)
T cd07840 116 LHSNGILHRDIKGSNILINNDGVLKL----------------------------ADFGLARPYTKRNSADYTNRVITLWY 167 (287)
T ss_pred HHHCCceeccCcHHHeEEcCCCCEEE----------------------------ccccceeeccCCCccccccccccccc
Confidence 99999999999999999999988888 48887765544321 11234568889
Q ss_pred cccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||.+.+ ..++.++|+||+|+++|+|++|..||.
T Consensus 168 ~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred CCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99998765 467899999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=176.17 Aligned_cols=143 Identities=33% Similarity=0.486 Sum_probs=113.0
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH-cCcccc
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLHT-RGIVFR 147 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-~~iiHr 147 (255)
.|++++++++.+.+....|+++||+. +++.+++... ..+++ ..+..++.|++.|+.|||+ ++++||
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~-----------~~~~~i~~~i~~~l~~lH~~~~i~H~ 139 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPE-----------DILGKMTVAIVKALHYLKEKHGVIHR 139 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHhhCCEecC
Confidence 58999999999999999999999975 4666655442 11221 2344578899999999997 699999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCC
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG 227 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (255)
||+|+||+++.++.+++ .|||.+......... ....|++.|+|||.+.+..
T Consensus 140 dl~p~nill~~~~~~kL----------------------------~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~ 190 (296)
T cd06618 140 DVKPSNILLDASGNVKL----------------------------CDFGISGRLVDSKAK-TRSAGCAAYMAPERIDPPD 190 (296)
T ss_pred CCcHHHEEEcCCCCEEE----------------------------CccccchhccCCCcc-cCCCCCccccCHhhcCCCC
Confidence 99999999998888887 488887655332222 2335788999999997553
Q ss_pred ----CCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 228 ----HDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 228 ----~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.++|+||+|+++|+|++|..||..
T Consensus 191 ~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 191 PNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 78899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-25 Score=175.63 Aligned_cols=148 Identities=30% Similarity=0.486 Sum_probs=113.6
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHH-----hccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILR-----ERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+.....++|+++|+..-.+.--|+.||.+.- ++..+-+ +.....| +.+..|+...+.||.||-
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE-----------~Ilg~ItvatV~AL~yLK 184 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPE-----------NILGHITVATVDALDYLK 184 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcH-----------hhhhheeeeehhHHHHHH
Confidence 3455789999999988777888999997742 3322211 1112222 233445556789999997
Q ss_pred H-cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 T-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~-~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
. ..|||||+||+|||++..|.+|+ .|||.+.++..+-..+ .-.|...|||
T Consensus 185 ~~lkiIHRDvKPSNILldr~G~vKL----------------------------CDFGIcGqLv~SiAkT-~daGCrpYmA 235 (361)
T KOG1006|consen 185 EELKIIHRDVKPSNILLDRHGDVKL----------------------------CDFGICGQLVDSIAKT-VDAGCRPYMA 235 (361)
T ss_pred HHhhhhhccCChhheEEecCCCEee----------------------------ecccchHhHHHHHHhh-hccCCccccC
Confidence 5 58999999999999999999999 5999998886654443 3478999999
Q ss_pred ccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCcCC
Q psy3182 220 PEIIK--NRGHDRAVDYWALGILMHELLTGMKESNVF 254 (255)
Q Consensus 220 PE~~~--~~~~~~~~DiWslGvil~ell~G~~~~~~~ 254 (255)
||-+. +.+|+.+||+||||+++||..||..|+..|
T Consensus 236 PERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 236 PERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred hhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 99995 457999999999999999999999998643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=181.11 Aligned_cols=146 Identities=26% Similarity=0.496 Sum_probs=115.1
Q ss_pred ceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++....|+|++++++.+.... ..|+++||+.+ ++..... ..+++ +.+..++.|++.|
T Consensus 64 e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~-----------~~~~~~~~qi~~a 129 (342)
T cd07879 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG--HPLSE-----------DKVQYLVYQMLCG 129 (342)
T ss_pred HHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc--CCCCH-----------HHHHHHHHHHHHH
Confidence 456677788999999998876543 45999999854 5655432 12222 3345677889999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||+++++||||||+||+++.++.+++ .|||+++.... ......|++
T Consensus 130 L~~LH~~~i~H~dlkp~NIll~~~~~~kL----------------------------~dfg~~~~~~~---~~~~~~~~~ 178 (342)
T cd07879 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKI----------------------------LDFGLARHADA---EMTGYVVTR 178 (342)
T ss_pred HHHHHHCCcccCCCCHHHEEECCCCCEEE----------------------------eeCCCCcCCCC---CCCCceeee
Confidence 99999999999999999999999888888 59998765432 222457889
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 179 ~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred cccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999876 468899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=181.01 Aligned_cols=150 Identities=23% Similarity=0.409 Sum_probs=113.1
Q ss_pred ceeeeccccccccccccccccCc--------------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--------------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDF 127 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--------------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 127 (255)
++.++....|++++++++.+.+. ...|+++||+. ++|.+.+.. ..+++ ..+..
T Consensus 52 Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~-----------~~~~~ 118 (342)
T cd07854 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSE-----------EHARL 118 (342)
T ss_pred HHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCH-----------HHHHH
Confidence 45566777899999988765543 45899999997 588877753 22322 33456
Q ss_pred HHHHHHHHHHHHHHcCcccccCCCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc
Q psy3182 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC 206 (255)
Q Consensus 128 i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~ 206 (255)
++.|+++||.|||++|++||||||+||+++.. +.+++ .|||.++.......
T Consensus 119 ~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl----------------------------~dfg~~~~~~~~~~ 170 (342)
T cd07854 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI----------------------------GDFGLARIVDPHYS 170 (342)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE----------------------------CCcccceecCCccc
Confidence 77899999999999999999999999999754 34566 48887765432111
Q ss_pred ---cccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 207 ---KTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 207 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
......|++.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1122357889999998754 568889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=158.51 Aligned_cols=149 Identities=23% Similarity=0.386 Sum_probs=119.8
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+-++..++|.|++++++....++.+-+|+|+|.. +|-.+..+- +.++ .+..+.++-|++.||.|||+
T Consensus 52 icllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d-----------~~~~rsfmlqllrgl~fchs 119 (292)
T KOG0662|consen 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLD-----------PEIVRSFMLQLLRGLGFCHS 119 (292)
T ss_pred HHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCC-----------HHHHHHHHHHHHhhhhhhhh
Confidence 4457788999999999999999999999999964 554443321 1122 24456677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+++.|||+||+|+++..+|.+|+ .|||+++..+-.....+..+-|..|.+|.
T Consensus 120 hnvlhrdlkpqnllin~ngelkl----------------------------adfglarafgipvrcysaevvtlwyrppd 171 (292)
T KOG0662|consen 120 HNVLHRDLKPQNLLINRNGELKL----------------------------ADFGLARAFGIPVRCYSAEVVTLWYRPPD 171 (292)
T ss_pred hhhhhccCCcceEEeccCCcEEe----------------------------cccchhhhcCCceEeeeceeeeeeccCcc
Confidence 99999999999999999999999 49999987766544444556788999999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHhc-CCCCC
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELLT-GMKES 251 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell~-G~~~~ 251 (255)
++.+ +-|+++.|+||-||++.|+.. |.+-|
T Consensus 172 vlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred eeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 9977 569999999999999999974 44433
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-23 Score=187.03 Aligned_cols=142 Identities=20% Similarity=0.329 Sum_probs=102.1
Q ss_pred cCccceeehhhhhcchhHHHHHHhccCCCccchhhH----------HHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCC
Q psy3182 82 KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI----------TACVIEALDFITACVIEALEYLHTRGIVFRDLKP 151 (255)
Q Consensus 82 ~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~----------~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp 151 (255)
.+....++++||+.+++|.+++..... ......+. .......+..++.|++.||.|||+++|+||||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~-~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEF-PYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCC-chhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 355678999999999999999875431 10000000 0011234567889999999999999999999999
Q ss_pred CceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-CccccccccCCCCcccccccCC---
Q psy3182 152 ENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-GCKTWTFCGTPEYVAPEIIKNR--- 226 (255)
Q Consensus 152 ~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--- 226 (255)
+|||++. .+.+++ +|||+|+..... .....+.+|||.|||||.+...
T Consensus 284 ~NILl~~~~~~~KL----------------------------~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~ 335 (566)
T PLN03225 284 QNIIFSEGSGSFKI----------------------------IDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQT 335 (566)
T ss_pred HHEEEeCCCCcEEE----------------------------EeCCCccccccccccCCcccccCCCccChHHhhccCCC
Confidence 9999985 466777 599998755322 1223457899999999976422
Q ss_pred -------------------CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 227 -------------------GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 227 -------------------~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.++.++||||+||++|||++|..|++
T Consensus 336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 23446699999999999998765543
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=180.50 Aligned_cols=172 Identities=22% Similarity=0.250 Sum_probs=134.3
Q ss_pred CCCcccCCCCcce---eecccCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHH
Q psy3182 43 RGIVFRDLKPENL---LLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITA 119 (255)
Q Consensus 43 ~~i~~rdiK~~ni---l~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~ 119 (255)
..++|+-++|+.- .-+-..++|++++++|||+++++..+..++.+.|++||++.|||-+++.++..-+ ....
T Consensus 563 lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~---- 637 (807)
T KOG1094|consen 563 LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETA---- 637 (807)
T ss_pred eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccc----
Confidence 4566666776532 1223346899999999999999999999999999999999999999998764322 1111
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccc
Q psy3182 120 CVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSK 199 (255)
Q Consensus 120 ~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~ 199 (255)
....|+.||+.|++||.+.+++|||+.+.|+|++.+..+|+ +|||+|+
T Consensus 638 ----~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKi----------------------------adfgmsR 685 (807)
T KOG1094|consen 638 ----PGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKI----------------------------ADFGMSR 685 (807)
T ss_pred ----hhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEe----------------------------cCccccc
Confidence 11237889999999999999999999999999999999999 4999998
Q ss_pred cCCCCCccc--cccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc--CCCCC
Q psy3182 200 HLGHSGCKT--WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT--GMKES 251 (255)
Q Consensus 200 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~--G~~~~ 251 (255)
.+-...... ...+-...|||||.+.-..+++++|+|++|+++||+++ ...|+
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py 741 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPY 741 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCch
Confidence 663322111 12344568999999999899999999999999999864 34555
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-23 Score=164.59 Aligned_cols=152 Identities=23% Similarity=0.410 Sum_probs=118.3
Q ss_pred cCceeeeccccccccccccccccC--------ccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKD--------SKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITA 130 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~--------~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~ 130 (255)
-.+++++..++|+|++.+.+.+.+ ...+|||+.+|.. ||..++... ..+ ....+..+++
T Consensus 64 lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~-----------sls~Ikk~Mk 131 (376)
T KOG0669|consen 64 LREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRF-----------SLSEIKKVMK 131 (376)
T ss_pred HHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccc-----------cHHHHHHHHH
Confidence 346788888899988877654432 2348999999964 888877543 112 2345667888
Q ss_pred HHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----c
Q psy3182 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----C 206 (255)
Q Consensus 131 ~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~ 206 (255)
+++.||.|+|++.|+|||+||+|+|++.++.+++ +|||+++.+..+. .
T Consensus 132 ~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl----------------------------ADFGlar~fs~~~n~~kp 183 (376)
T KOG0669|consen 132 GLMNGLYYIHRNKILHRDMKAANVLITKDGILKL----------------------------ADFGLARAFSTSKNVVKP 183 (376)
T ss_pred HHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe----------------------------eccccccceecccccCCC
Confidence 9999999999999999999999999999999999 4888886554321 1
Q ss_pred cccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 207 KTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
.....+-|..|.+||.+.+ +.|+++.|+|.-||++.||.+|.+-+
T Consensus 184 rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 184 RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence 1223455889999999987 68999999999999999999998744
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=189.21 Aligned_cols=143 Identities=28% Similarity=0.449 Sum_probs=101.1
Q ss_pred cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceee
Q psy3182 85 KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164 (255)
Q Consensus 85 ~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l 164 (255)
..+|+-||||..-.+.+++++..+... .+..=.++++|++||.|+|++|||||||||.||+++.++.+|+
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~----------~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKI 738 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQ----------RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKI 738 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchh----------hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeee
Confidence 568999999999888888876554421 1223347889999999999999999999999999999999999
Q ss_pred cccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-CccccccccCCCCcccccccCC---CCCCcchHHHHHHH
Q psy3182 165 EFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-GCKTWTFCGTPEYVAPEIIKNR---GHDRAVDYWALGIL 240 (255)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiWslGvi 240 (255)
.+|+.+..........+ .+.+........ .......+||..|+|||++.+. .|+.|+|||||||+
T Consensus 739 GDFGLAt~~~~~~~~~d-----------~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIV 807 (1351)
T KOG1035|consen 739 GDFGLATDLKENLESID-----------QDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIV 807 (1351)
T ss_pred cccccchhhhhhhhhHh-----------hccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHH
Confidence 76555443211000000 000001111111 1123457999999999999874 49999999999999
Q ss_pred HHHHhcCC
Q psy3182 241 MHELLTGM 248 (255)
Q Consensus 241 l~ell~G~ 248 (255)
++||+.-.
T Consensus 808 lFEM~yPF 815 (1351)
T KOG1035|consen 808 LFEMLYPF 815 (1351)
T ss_pred HHHHhccC
Confidence 99998643
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=177.95 Aligned_cols=151 Identities=25% Similarity=0.379 Sum_probs=123.1
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRG 143 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ 143 (255)
-++...+||+|+++.+.+.+. ..|+|||.+.-|+|..+++.+... .....+--++.|+..||.|||+..
T Consensus 443 ~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~s----------L~l~tL~ly~~Qi~talaYLeSkr 511 (974)
T KOG4257|consen 443 SIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDS----------LPLRTLTLYCYQICTALAYLESKR 511 (974)
T ss_pred HHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhcccc----------chHHHHHHHHHHHHHHHHHHHhhc
Confidence 356678999999999987764 689999999999999999864321 011123346789999999999999
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc-CCCCccccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG-TPEYVAPEI 222 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g-t~~y~aPE~ 222 (255)
++||||...|||+..+..+|+ .|||+|+.+........+..- ...|||||.
T Consensus 512 fVHRDIAaRNiLVsSp~CVKL----------------------------aDFGLSR~~ed~~yYkaS~~kLPIKWmaPES 563 (974)
T KOG4257|consen 512 FVHRDIAARNILVSSPQCVKL----------------------------ADFGLSRYLEDDAYYKASRGKLPIKWMAPES 563 (974)
T ss_pred hhhhhhhhhheeecCcceeee----------------------------cccchhhhccccchhhccccccceeecCccc
Confidence 999999999999999999999 499999988765433333211 237999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHh-cCCCCCcC
Q psy3182 223 IKNRGHDRAVDYWALGILMHELL-TGMKESNV 253 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell-~G~~~~~~ 253 (255)
+..+.++.++|+|-+||++||.+ .|++||..
T Consensus 564 INfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 564 INFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred cchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 99999999999999999999976 69999864
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-23 Score=186.14 Aligned_cols=151 Identities=27% Similarity=0.411 Sum_probs=115.5
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
...|+|++|+|++-++..+.|+.+|.|.. +|.+++... ..+..... . .....+..|+.+||++||+.+||||
T Consensus 559 SD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~-~~d~~~~~-----~-i~~~~~l~q~~~GlaHLHsl~iVHR 630 (903)
T KOG1027|consen 559 SDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESS-GLDVEMQS-----D-IDPISVLSQIASGLAHLHSLKIVHR 630 (903)
T ss_pred ccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhcc-ccchhhcc-----c-ccHHHHHHHHHHHHHHHHhcccccc
Confidence 44799999999999999999999999965 787877753 11111000 0 1123456789999999999999999
Q ss_pred cCCCCceeeCCC---CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCCCcccc
Q psy3182 148 DLKPENLLLDNR---GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPEYVAPE 221 (255)
Q Consensus 148 dlkp~nil~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~y~aPE 221 (255)
||||+|||+..+ +.++. .+.|||+|+.+..... +..+..||-+|+|||
T Consensus 631 DLkPQNILI~~~~~~~~~ra--------------------------~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 631 DLKPQNILISVPSADGTLRA--------------------------KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred cCCCceEEEEccCCCcceeE--------------------------EecccccccccCCCcchhhcccCCCCcccccCHH
Confidence 999999999763 22211 1249999998765432 345678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcC-CCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTG-MKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G-~~~~~ 252 (255)
++....-..++||.|+||++|..++| ..||-
T Consensus 685 ~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 685 QLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred HHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99987777899999999999999887 67773
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-23 Score=182.49 Aligned_cols=151 Identities=27% Similarity=0.496 Sum_probs=128.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++-+++..+|+|++.+++.+--.+.+++.||||.||+|.++-.--+.++| ..+.+.++..+.||.|||+
T Consensus 62 ei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgplse-----------lqiayvcRetl~gl~ylhs 130 (829)
T KOG0576|consen 62 EIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSE-----------LQIAYVCRETLQGLKYLHS 130 (829)
T ss_pred ceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchh-----------HHHHHHHhhhhccchhhhc
Confidence 34556778999999999999999999999999999999776543333333 3456677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
.|=+|||+|-.||+++..|.+|+ .|||.+...+-...+...+.|||+|||||
T Consensus 131 ~gk~hRdiKGanilltd~gDvkl----------------------------aDfgvsaqitati~KrksfiGtpywmapE 182 (829)
T KOG0576|consen 131 QGKIHRDIKGANILLTDEGDVKL----------------------------ADFGVSAQITATIAKRKSFIGTPYWMAPE 182 (829)
T ss_pred CCcccccccccceeecccCceee----------------------------cccCchhhhhhhhhhhhcccCCccccchh
Confidence 99999999999999999999999 49999988877767777899999999999
Q ss_pred ccc---CCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 222 IIK---NRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 222 ~~~---~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
+.. ..+|+..+|+|++|+...|+..-.+|-
T Consensus 183 vaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 183 VAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred HHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 973 467999999999999999987766653
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-23 Score=166.25 Aligned_cols=146 Identities=27% Similarity=0.473 Sum_probs=109.3
Q ss_pred ceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
++|++...+|.|+....+..+-. ..+|.+.|.+ ..||-.++.+-..++. +-+..+..||+.||
T Consensus 102 e~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls~-----------DHvKVFlYQILRGL 169 (449)
T KOG0664|consen 102 EIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQALTP-----------DHVKVFVYQILRGL 169 (449)
T ss_pred HHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCCCCCc-----------chhhhhHHHHHhhh
Confidence 35556667788887776655543 2357777755 4577666654333332 33455677899999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc-cccCC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT-FCGTP 215 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~-~~gt~ 215 (255)
.|||+.+|.||||||.|+|++.+-.+|+ .|||+++.-........+ .+-|.
T Consensus 170 KYLHsA~ILHRDIKPGNLLVNSNCvLKI----------------------------CDFGLARvee~d~~~hMTqEVVTQ 221 (449)
T KOG0664|consen 170 KYLHTANILHRDIKPGNLLVNSNCILKI----------------------------CDFGLARTWDQRDRLNMTHEVVTQ 221 (449)
T ss_pred HHHhhcchhhccCCCccEEeccCceEEe----------------------------cccccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999998888888 599998765444333222 35678
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcC
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G 247 (255)
+|.|||++.+ +.|+.++||||+||+..||+..
T Consensus 222 YYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR 254 (449)
T KOG0664|consen 222 YYRAPELLMGARRYTGAVDIWSVGCIFAELLQR 254 (449)
T ss_pred HhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence 9999999987 6799999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-22 Score=161.62 Aligned_cols=152 Identities=41% Similarity=0.792 Sum_probs=124.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++.+....|++++++++.+.+....++++|++.+++|.+++.....++ ...+..++.+++.++.|+|+
T Consensus 37 e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~l~~~l~~lh~ 105 (244)
T smart00220 37 EISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLS-----------EDEARFYARQILSALEYLHS 105 (244)
T ss_pred HHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCC-----------HHHHHHHHHHHHHHHHHHHH
Confidence 3455666789999999999988899999999999999999887543222 12344567789999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
.+++|+|++|.||+++.++..++ .|||.+....... ......|++.|+|||
T Consensus 106 ~~i~h~~i~~~ni~~~~~~~~~l----------------------------~d~~~~~~~~~~~-~~~~~~~~~~~~~pE 156 (244)
T smart00220 106 NGIIHRDLKPENILLDEDGHVKL----------------------------ADFGLARQLDPGG-LLTTFVGTPEYMAPE 156 (244)
T ss_pred cCeecCCcCHHHeEECCCCcEEE----------------------------ccccceeeecccc-ccccccCCcCCCCHH
Confidence 99999999999999998887777 4888876654432 223456889999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...+..++.++|+||+|+++|++++|..||..
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99988889999999999999999999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=157.30 Aligned_cols=151 Identities=39% Similarity=0.715 Sum_probs=121.2
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+.+....|++++++++.+...+..++++|++.+++|.+++..... +++ ..+..++.+++.++.++|++
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~~~l~~~l~~lh~~ 117 (225)
T smart00221 49 RILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSE-----------EEARFYLRQILEALEYLHSL 117 (225)
T ss_pred HHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHHHHhC
Confidence 344555788899999988888999999999999999999876433 221 23345667899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~aPE 221 (255)
+++|+|++|.|++++..+.+++ +|||.+....... .......++..|++||
T Consensus 118 ~i~h~di~~~ni~v~~~~~~~l----------------------------~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe 169 (225)
T smart00221 118 GIVHRDLKPENILLGMDGLVKL----------------------------ADFGLARFIHRDLAALLKTVKGTPFYLAPE 169 (225)
T ss_pred CeecCCCCHHHEEEcCCCCEEE----------------------------eeCceeeEecCcccccccceeccCCcCCHh
Confidence 9999999999999998877777 5888776654431 1223457888999999
Q ss_pred cc-cCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 II-KNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~-~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++ ....++.++|+||+|+++|+|++|..||..
T Consensus 170 ~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 170 VLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred HhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99 667788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-22 Score=177.04 Aligned_cols=152 Identities=26% Similarity=0.403 Sum_probs=123.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++..+-++.|+++++||...-+ ..+.||+|++.+|+|.+.|++.. ...+ ....+..++.||++|+.||.+
T Consensus 161 Eas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~-----~~~l----lv~~Lcdya~QiA~aM~YLes 230 (1039)
T KOG0199|consen 161 EASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAK-----KAIL----LVSRLCDYAMQIAKAMQYLES 230 (1039)
T ss_pred HHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhcc-----ccce----eHHHHHHHHHHHHHHHHHHhh
Confidence 3444567899999999999888 78899999999999999998611 1111 223466788999999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc----CCCC
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG----TPEY 217 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g----t~~y 217 (255)
++.|||||...|+++.....+|+ .|||+.+.++..... +.+.+ ...|
T Consensus 231 krlvHRDLAARNlllasprtVKI----------------------------~DFGLmRaLg~ned~-Yvm~p~rkvPfAW 281 (1039)
T KOG0199|consen 231 KRLVHRDLAARNLLLASPRTVKI----------------------------CDFGLMRALGENEDM-YVMAPQRKVPFAW 281 (1039)
T ss_pred hhhhhhhhhhhhheecccceeee----------------------------ecccceeccCCCCcc-eEecCCCcCcccc
Confidence 99999999999999999888888 499999888764322 22221 2359
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTG-MKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G-~~~~~ 252 (255)
.|||.+....++.++|+|++||++|||+++ ..|+.
T Consensus 282 CaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 282 CAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred cCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 999999999999999999999999999975 56764
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=172.51 Aligned_cols=151 Identities=25% Similarity=0.418 Sum_probs=123.6
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
..++..++|+|.++|..++..+..+|+|.||+..|+|+++|++... +. .. .-.+-+.+.||..|++||..+
T Consensus 314 AAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr--~e----v~---avvLlyMAtQIsSaMeYLEkk 384 (1157)
T KOG4278|consen 314 AAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR--SE----VP---AVVLLYMATQISSAMEYLEKK 384 (1157)
T ss_pred HHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch--hh----cc---hhHHHHHHHHHHHHHHHHHHh
Confidence 3456778999999999999999999999999999999999986321 11 11 112345677999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc-ccc---CCCCc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT-FCG---TPEYV 218 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~-~~g---t~~y~ 218 (255)
++|||||...|+|+..+..+|+ .|||+++.+..+. ++ ..| ...|.
T Consensus 385 nFIHRDLAARNCLVgEnhiVKv----------------------------ADFGLsRlMtgDT---YTAHAGAKFPIKWT 433 (1157)
T KOG4278|consen 385 NFIHRDLAARNCLVGENHIVKV----------------------------ADFGLSRLMTGDT---YTAHAGAKFPIKWT 433 (1157)
T ss_pred hhhhhhhhhhhccccccceEEe----------------------------eccchhhhhcCCc---eecccCccCccccc
Confidence 9999999999999999998988 5999998765432 12 122 23699
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHh-cCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELL-TGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell-~G~~~~~~ 253 (255)
|||-+....++.++|+|++||+|||.. .|+.|+..
T Consensus 434 APEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 434 APESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred CcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999999997 58888764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=149.27 Aligned_cols=104 Identities=27% Similarity=0.313 Sum_probs=82.0
Q ss_pred hhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeee
Q psy3182 97 GEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIR 175 (255)
Q Consensus 97 g~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~ 175 (255)
|+|.++++.+. .+++ +.+..++.|++.||.|||+++ ||+||+++.++.+++
T Consensus 1 GsL~~~l~~~~~~l~~-----------~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~----------- 52 (176)
T smart00750 1 VSLADILEVRGRPLNE-----------EEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL----------- 52 (176)
T ss_pred CcHHHHHHHhCCCCCH-----------HHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee-----------
Confidence 67888887533 2443 335567889999999999998 999999987765442
Q ss_pred cCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 176 EGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||.++..... ...||+.|||||++.+..|+.++||||+||++|||++|..||.
T Consensus 53 -------------------fG~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 105 (176)
T smart00750 53 -------------------DGSVAFKTPE-----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105 (176)
T ss_pred -------------------ccceEeeccc-----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 5655443221 2268999999999999999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-22 Score=175.58 Aligned_cols=171 Identities=35% Similarity=0.516 Sum_probs=135.6
Q ss_pred HHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCC
Q psy3182 32 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFD 110 (255)
Q Consensus 32 ~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~ 110 (255)
..+.+++.+.......|+... ...+-.++.... |+.+++++..|+....+|+++++..||+++..+.....++
T Consensus 22 ~~~yamkvl~k~t~~~~~~~~------t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~ 95 (612)
T KOG0603|consen 22 GHLYAMKVLKKATLKVRDRTH------TKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFD 95 (612)
T ss_pred cchhhhhcccccccccccccc------cccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchH
Confidence 345666666666555555431 111123344444 8999999999999999999999999999999988777666
Q ss_pred ccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCe
Q psy3182 111 DNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190 (255)
Q Consensus 111 ~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (255)
+...+ ++...++.|++++|+.++++||+|++||+++..|.+++.
T Consensus 96 ~~~~~-----------~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~t------------------------- 139 (612)
T KOG0603|consen 96 ELDVA-----------FYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLT------------------------- 139 (612)
T ss_pred HHHHH-----------HHHHHHHHHHhhcchhHHHHhcccccceeecccCccccC-------------------------
Confidence 55443 334457889999999999999999999999999998884
Q ss_pred eeeeccccccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 191 VKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 191 ~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||.++..-.... .|||..|||||++. ++..++|+||+|++.+||++|-.||..
T Consensus 140 ---dfglske~v~~~~----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 140 ---DFGLSKEAVKEKI----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---CchhhhHhHhhhh----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9999876543322 29999999999999 788899999999999999999999864
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.6e-21 Score=174.96 Aligned_cols=157 Identities=24% Similarity=0.390 Sum_probs=119.6
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhcc---CCCccchhhH--HHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT---CFDDNAASFI--TACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~---~~~~~~~~~~--~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
-.+|+|++.+.....+...++++.|||..|+|..+++... ..+....... .......+-.++.||+.|++||++.
T Consensus 358 ~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 358 LGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred hcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 4569999999999888999999999999999999998765 1111100000 0122233445788999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc-cccccC-C-CCcc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT-WTFCGT-P-EYVA 219 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~-~~~~gt-~-~y~a 219 (255)
.+|||||-.+|||+..+..+|+ .|||+++......... ..-.|+ | .|||
T Consensus 438 ~~vHRDLAaRNVLi~~~~~~kI----------------------------aDFGlar~~~~~~~y~~~~~~~~LP~kWmA 489 (609)
T KOG0200|consen 438 PCVHRDLAARNVLITKNKVIKI----------------------------ADFGLARDHYNKDYYRTKSSAGTLPVKWMA 489 (609)
T ss_pred CccchhhhhhhEEecCCCEEEE----------------------------ccccceeccCCCCceEecCCCCccceeecC
Confidence 9999999999999999988888 4999998554433222 111222 2 5999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||.+....|+.++|+||+||++||+++ |..|+.
T Consensus 490 pEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 490 PESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred HHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 999999999999999999999999986 456654
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-22 Score=176.84 Aligned_cols=153 Identities=26% Similarity=0.382 Sum_probs=124.1
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++..|+.+..||||++|-..-...+.+.++.||+++|.|..+|+.+.. .|...+ +-...+.|+.|+.||-
T Consensus 679 ~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG------qftviQ----LVgMLrGIAsGMkYLs 748 (996)
T KOG0196|consen 679 SEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG------QFTVIQ----LVGMLRGIASGMKYLS 748 (996)
T ss_pred hhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC------ceEeeh----HHHHHHHHHHHhHHHh
Confidence 345667888999999999999999999999999999999999987531 122222 2234566889999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccc-cC--CCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFC-GT--PEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~-gt--~~y 217 (255)
+++.+||||...|||++.+-..|++ |||+|+.+.......++.. |. ..|
T Consensus 749 dm~YVHRDLAARNILVNsnLvCKVs----------------------------DFGLSRvledd~~~~ytt~GGKIPiRW 800 (996)
T KOG0196|consen 749 DMNYVHRDLAARNILVNSNLVCKVS----------------------------DFGLSRVLEDDPEAAYTTLGGKIPIRW 800 (996)
T ss_pred hcCchhhhhhhhheeeccceEEEec----------------------------cccceeecccCCCccccccCCccceee
Confidence 9999999999999999998888884 9999998866543333333 32 369
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHh-cCCCCC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELL-TGMKES 251 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell-~G~~~~ 251 (255)
.|||.|..+.++.++|+||+||++||.+ .|-.|+
T Consensus 801 TAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 801 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 9999999999999999999999999965 677664
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-21 Score=168.01 Aligned_cols=143 Identities=26% Similarity=0.393 Sum_probs=115.8
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
...+.++++..|...++++||+|-+ .-+|.++|++-+... ...+.+++.+++|+..||..|-.+||+|.||
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nv--------GL~ikaVRsYaqQLflALklLK~c~vlHaDI 562 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNV--------GLHIKAVRSYAQQLFLALKLLKKCGVLHADI 562 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCccc--------ceeehHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 4556678999999999999999966 457888888654322 2334678889999999999999999999999
Q ss_pred CCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 150 KPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 150 kp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
||.|||+... ..+|+ +|||.|...+..... .+.-+.+|.|||++.|.+|
T Consensus 563 KPDNiLVNE~k~iLKL----------------------------CDfGSA~~~~eneit--PYLVSRFYRaPEIiLG~~y 612 (752)
T KOG0670|consen 563 KPDNILVNESKNILKL----------------------------CDFGSASFASENEIT--PYLVSRFYRAPEIILGLPY 612 (752)
T ss_pred CccceEeccCcceeee----------------------------ccCcccccccccccc--HHHHHHhccCcceeecCcc
Confidence 9999999875 45666 599987766554332 2344678999999999999
Q ss_pred CCcchHHHHHHHHHHHhcCCCCC
Q psy3182 229 DRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~ 251 (255)
+...|+||+||+||||.||.--|
T Consensus 613 d~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 613 DYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cCCccceeeceeeEEeeccceec
Confidence 99999999999999999997444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=165.36 Aligned_cols=141 Identities=23% Similarity=0.306 Sum_probs=98.8
Q ss_pred ccceeehhhhhcchhHHHHHHhcc-CCCccchhhH------------HHHHHHHHHHHHHHHHHHHHHHHHcCcccccCC
Q psy3182 84 SKYVYMLLEACLGGEVWTILRERT-CFDDNAASFI------------TACVIEALDFITACVIEALEYLHTRGIVFRDLK 150 (255)
Q Consensus 84 ~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~------------~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlk 150 (255)
....|+|+||+.+|+|.+++.... .+......+. .......+..++.|++.||.|+|+++|+|||||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK 336 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK 336 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 346799999999999999987532 1111100000 011233456788899999999999999999999
Q ss_pred CCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccccccCCC--
Q psy3182 151 PENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEIIKNRG-- 227 (255)
Q Consensus 151 p~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-- 227 (255)
|+||+++.++.+++ .|||++........ ....-.+||.|+|||++....
T Consensus 337 p~NILl~~~~~~kL----------------------------~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~ 388 (507)
T PLN03224 337 PENLLVTVDGQVKI----------------------------IDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSC 388 (507)
T ss_pred hHhEEECCCCcEEE----------------------------EeCcCccccccCCccCccccCCCcceeChhhhcCCCCC
Confidence 99999998887777 59998865432211 111123479999999985321
Q ss_pred ------------------CC--CcchHHHHHHHHHHHhcCC-CCCc
Q psy3182 228 ------------------HD--RAVDYWALGILMHELLTGM-KESN 252 (255)
Q Consensus 228 ------------------~~--~~~DiWslGvil~ell~G~-~~~~ 252 (255)
|+ .+.|+||+||++|+|++|. .||.
T Consensus 389 ~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 389 PRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred CccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 22 2479999999999999987 3654
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-20 Score=157.45 Aligned_cols=141 Identities=24% Similarity=0.359 Sum_probs=111.5
Q ss_pred cccccccccccccccCcc----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH--
Q psy3182 68 RKKKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT-- 141 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-- 141 (255)
.++|+||+++...-+-.+ .+++|+||-..|+|.++|+.+.. .+..+..++..++.||+|||+
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nti------------sw~~~cria~SmarGLa~LHee~ 327 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTI------------SWNSLCRIAESMARGLAHLHEEL 327 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccc------------cHHHHHHHHHHHHHHHHHhcccC
Confidence 468999999988766655 78999999999999999986431 123345677789999999997
Q ss_pred -------cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccc
Q psy3182 142 -------RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFC 212 (255)
Q Consensus 142 -------~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~ 212 (255)
..|+|||||..|||+.++...-+ .|||+|..+.... ..+...+
T Consensus 328 p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI----------------------------aDFGLAl~~~p~~~~~d~~~qV 379 (534)
T KOG3653|consen 328 PRGDHHKPPIAHRDLKSKNVLVKNDLTCCI----------------------------ADFGLALRLEPGKPQGDTHGQV 379 (534)
T ss_pred CcCCCCCCccccccccccceEEccCCcEEe----------------------------eccceeEEecCCCCCcchhhhh
Confidence 35999999999999999887766 5999987665432 2334478
Q ss_pred cCCCCcccccccCC-CCC-----CcchHHHHHHHHHHHhcCC
Q psy3182 213 GTPEYVAPEIIKNR-GHD-----RAVDYWALGILMHELLTGM 248 (255)
Q Consensus 213 gt~~y~aPE~~~~~-~~~-----~~~DiWslGvil~ell~G~ 248 (255)
||..|||||++.+. .+. .+.||||+|.++||+++--
T Consensus 380 GT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 380 GTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred hhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 99999999999763 222 3689999999999998753
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-20 Score=167.47 Aligned_cols=149 Identities=23% Similarity=0.293 Sum_probs=123.1
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ii 145 (255)
++.++|+|++++......++ +.+|.+|+++|.|.++++.+..-- ....+-.+..||++|+.|||.++++
T Consensus 752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~i----------gsq~lLnw~~QIAkgM~YLe~qrlV 820 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNI----------GSQDLLNWCYQIAKGMKYLEEQRLV 820 (1177)
T ss_pred HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccc----------cHHHHHHHHHHHHHHHHHHHhcchh
Confidence 56789999999999988877 899999999999999998643211 1123344667899999999999999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc--CCCCcccccc
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG--TPEYVAPEII 223 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g--t~~y~aPE~~ 223 (255)
||||..+|+|+.....+|++ |||+++.+........+..| .+.|||-|.+
T Consensus 821 HrdLaaRNVLVksP~hvkit----------------------------dfgla~ll~~d~~ey~~~~gK~pikwmale~i 872 (1177)
T KOG1025|consen 821 HRDLAARNVLVKSPNHVKIT----------------------------DFGLAKLLAPDEKEYSAPGGKVPIKWMALESI 872 (1177)
T ss_pred hhhhhhhheeecCCCeEEEE----------------------------ecchhhccCcccccccccccccCcHHHHHHHh
Confidence 99999999999999999985 99999888776554444333 3479999999
Q ss_pred cCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 224 KNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 224 ~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+...|+.++|+||+||++||++| |.+|...
T Consensus 873 ~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 873 RIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred hccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 99999999999999999999985 7787653
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-20 Score=151.39 Aligned_cols=140 Identities=25% Similarity=0.434 Sum_probs=106.6
Q ss_pred cccccccccc-cccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 70 KKTRQTRLYK-TFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 70 ~h~~iv~l~~-~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
.|.+|+.-|+ .|++.+...+++|||+-|||.+-+...+ ..| ..-..++.|++.|+.|+|+++++|||
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-igE-----------~~~K~v~~ql~SAi~fMHsknlVHRd 146 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGE-----------ANTKKVFAQLLSAIEFMHSKNLVHRD 146 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc-ccH-----------HHHHHHHHHHHHHHHHhhccchhhcc
Confidence 5788888887 5899999999999999999987665322 111 12245678899999999999999999
Q ss_pred CCCCceeeCCCCc--eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCC
Q psy3182 149 LKPENLLLDNRGY--VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNR 226 (255)
Q Consensus 149 lkp~nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (255)
||.+|||+..... +|+ .|||.++..+..-.. .--+..|.|||.+...
T Consensus 147 lK~eNiLif~~df~rvKl----------------------------cDFG~t~k~g~tV~~---~~~~~~y~~pe~~~~~ 195 (378)
T KOG1345|consen 147 LKAENILIFDADFYRVKL----------------------------CDFGLTRKVGTTVKY---LEYVNNYHAPELCDTV 195 (378)
T ss_pred cccceEEEecCCccEEEe----------------------------eecccccccCceehh---hhhhcccCCcHHHhhc
Confidence 9999999876553 444 599988765432211 1234568899987532
Q ss_pred -----CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 227 -----GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 227 -----~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..++.+|+|.+|+++|..++|.+|+.
T Consensus 196 ~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 196 VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred cccceEecccccchheeeeeeeeecCCCcch
Confidence 24678999999999999999999974
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.8e-20 Score=148.47 Aligned_cols=93 Identities=37% Similarity=0.529 Sum_probs=80.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|+.++++.++|+|+.+.||+++|+.|++|+|+++|+.||+||||+|++.+|++|+.+..-...+..- .+
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~ 199 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TW 199 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EE
Confidence 79999999999999999999999999999999999999999999999999999999999999999987655443322 23
Q ss_pred ccCccceeehhhhh
Q psy3182 81 FKDSKYVYMLLEAC 94 (255)
Q Consensus 81 ~~~~~~~ylv~E~~ 94 (255)
--.++.-|+.+|..
T Consensus 200 TlCGTPeYLAPEii 213 (355)
T KOG0616|consen 200 TLCGTPEYLAPEII 213 (355)
T ss_pred EecCCccccChHHh
Confidence 33455668888855
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=150.92 Aligned_cols=210 Identities=20% Similarity=0.246 Sum_probs=128.9
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCcceeec---ccCceee------------------ec-cccccccccccccccCcc
Q psy3182 28 FITACVIEALEYLHTRGIVFRDLKPENLLLD---NRGYVKL------------------VS-RKKKTRQTRLYKTFKDSK 85 (255)
Q Consensus 28 ~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~---~~~~vkl------------------~~-~~~h~~iv~l~~~~~~~~ 85 (255)
..+.++..+....+.-|+-+++.++.+++.. .+..+-+ +. ...+.|++.+...+..++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344444555555555666666666655554 2222221 21 234788889999999999
Q ss_pred ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCC-Cceee
Q psy3182 86 YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKL 164 (255)
Q Consensus 86 ~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~-~~~~l 164 (255)
.+.+||||...-+-.++.+.-. ...++.+.+.++.||.++|.+||||||+||.|+|.+.. +.-.+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~--------------~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLS--------------LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred eeEEEecccCccCHHHHHhcCC--------------HHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceE
Confidence 9999999998877777665321 23467788899999999999999999999999998764 23334
Q ss_pred cccCCcce-eeec-CCCCCc----eeeeeCCeeeee---------ccccc--cCCCCCccccccccCCCCcccccccCC-
Q psy3182 165 EFYPAGHY-IIRE-GAKGDS----FFIISGGQVKVD---------FGFSK--HLGHSGCKTWTFCGTPEYVAPEIIKNR- 226 (255)
Q Consensus 165 ~~~~~~~~-~~~~-~~~~~~----~~~~~~~~~~~d---------fg~s~--~~~~~~~~~~~~~gt~~y~aPE~~~~~- 226 (255)
.+|+.+.. -... +..... -.....+...-. -|..+ ..+ .........|||+|.|||++...
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~-r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDG-RPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCC-ccceecccCCCCCCCchHHHhhcc
Confidence 34433331 0000 000000 000000000000 01100 000 01122345799999999999764
Q ss_pred CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 227 GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 227 ~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.-++++|+||.||++.-++++..||.
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred CcCCccceeeccceeehhhccccccc
Confidence 45789999999999999999999875
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=145.66 Aligned_cols=113 Identities=32% Similarity=0.473 Sum_probs=90.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK- 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~- 79 (255)
||+||+.||+|+.++++.++|+|.++.+|+++++.|+.|||++||+|||+||||||++.+|++++.+..........-+
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 6999999999999999989999999999999999999999999999999999999999999999988655442222111
Q ss_pred -cccCccceeehhhhhc-------------chhHHHHHHhccCCCccc
Q psy3182 80 -TFKDSKYVYMLLEACL-------------GGEVWTILRERTCFDDNA 113 (255)
Q Consensus 80 -~~~~~~~~ylv~E~~~-------------gg~l~~~l~~~~~~~~~~ 113 (255)
..-.++.-||.+|... |--+++.+....+|....
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 1123556799999653 345567777666665443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-19 Score=164.34 Aligned_cols=149 Identities=23% Similarity=0.396 Sum_probs=120.0
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRG 143 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ 143 (255)
.+-..+.|++++......++....+-.||||++ ||+.++.+...+.. ..++.+++|++.|+.|+|+.|
T Consensus 373 ~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~-----------~e~~c~fKqL~~Gv~y~h~~G 440 (601)
T KOG0590|consen 373 CIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTP-----------LEADCFFKQLLRGVKYLHSMG 440 (601)
T ss_pred eecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccch-----------hhhhHHHHHHHHHHHHHHhcC
Confidence 344567888888777777776666667999999 99999987533332 234567789999999999999
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----ccccccccCCCCcc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----CKTWTFCGTPEYVA 219 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~~~~~~~gt~~y~a 219 (255)
+.|||+||+|+++...+.+|+ .|||.+....... ......+|+..|+|
T Consensus 441 iahrdlK~enll~~~~g~lki----------------------------~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~a 492 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKI----------------------------IDFGAASVFRYPWEKNIHESSGIVGSDPYLA 492 (601)
T ss_pred ceeccCccccEEEecCCceEE----------------------------eecCcceeeccCcchhhhhhcCcccCCcCcC
Confidence 999999999999999998888 4888765432211 33456899999999
Q ss_pred cccccCCCCCC-cchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDR-AVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~-~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..|++ .+|+||.|+++..|.+|..||.
T Consensus 493 pE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 493 PEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred cccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 99999999986 5799999999999999998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.9e-19 Score=139.44 Aligned_cols=144 Identities=38% Similarity=0.693 Sum_probs=113.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++.+....|+++++++..+......++++|++.|++|.+++.... ..+ .+.+..++.+++.++.++|
T Consensus 41 e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~~~l~~~l~~lh 109 (215)
T cd00180 41 EIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLS-----------EDEILRILLQILEGLEYLH 109 (215)
T ss_pred HHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 3455666677888899999888899999999999999999987542 111 2334556788999999999
Q ss_pred HcCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
++|++|+|++|.||+++. .+..++ +|||.+..............+.+.|++
T Consensus 110 ~~~~~H~dl~~~ni~~~~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (215)
T cd00180 110 SNGIIHRDLKPENILLDSDNGKVKL----------------------------ADFGLSKLLTSDKSLLKTIVGTPAYMA 161 (215)
T ss_pred hCCeeccCCCHhhEEEeCCCCcEEE----------------------------ecCCceEEccCCcchhhcccCCCCccC
Confidence 999999999999999988 666666 488877654333212233567889999
Q ss_pred cccccCC-CCCCcchHHHHHHHHHHH
Q psy3182 220 PEIIKNR-GHDRAVDYWALGILMHEL 244 (255)
Q Consensus 220 PE~~~~~-~~~~~~DiWslGvil~el 244 (255)
||..... .++.+.|+|++|++++++
T Consensus 162 pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhHhcccCCCCchhhhHHHHHHHHHH
Confidence 9999876 788999999999999886
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.5e-19 Score=147.50 Aligned_cols=96 Identities=28% Similarity=0.368 Sum_probs=87.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~-~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
|+||||.||+|..++++.++++|+....++.+|++|+.|||+ ++|+||||||.|+|++.+|++||+++.-...++.-.+
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 689999999999999999999999999999999999999996 9999999999999999999999999887776666555
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.--.++..||.+|-..|
T Consensus 235 ~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG 251 (364)
T ss_pred ccccccccccChhhhcC
Confidence 55567888999997765
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=149.00 Aligned_cols=76 Identities=30% Similarity=0.512 Sum_probs=59.4
Q ss_pred ccccccccccc----CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH-cCccc
Q psy3182 72 TRQTRLYKTFK----DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT-RGIVF 146 (255)
Q Consensus 72 ~~iv~l~~~~~----~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-~~iiH 146 (255)
..+++|++.|+ ++.++.||+|++ |-+|+.+|++... .......++.|++|||.||.|||+ +||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---------rGlpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---------RGLPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC---------CCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 34566666665 467899999976 7789998886432 223345678899999999999995 79999
Q ss_pred ccCCCCceeeC
Q psy3182 147 RDLKPENLLLD 157 (255)
Q Consensus 147 rdlkp~nil~~ 157 (255)
.||||+|||+.
T Consensus 212 TDlKPENvLl~ 222 (590)
T KOG1290|consen 212 TDLKPENVLLC 222 (590)
T ss_pred cCCCcceeeee
Confidence 99999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=145.45 Aligned_cols=154 Identities=37% Similarity=0.619 Sum_probs=119.4
Q ss_pred eeecccccc-ccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRKKKT-RQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~~h~-~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+++....|+ +++++++.+.+....+++++++.|+++.+.+...... ..........+..|++.++.|+|+.
T Consensus 49 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~H~~ 120 (384)
T COG0515 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK--------GPLSESEALFILAQILSALEYLHSK 120 (384)
T ss_pred HHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc--------cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345555666 6888888887777789999999999999776654310 0111233456778899999999999
Q ss_pred CcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc------cccccccCC
Q psy3182 143 GIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC------KTWTFCGTP 215 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~------~~~~~~gt~ 215 (255)
+++|||+||+|++++..+ ..++ .|||.++....... .....+||+
T Consensus 121 ~~~hrd~kp~nil~~~~~~~~~l----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~t~ 172 (384)
T COG0515 121 GIIHRDIKPENILLDRDGRVVKL----------------------------IDFGLAKLLPDPGSTSSIPALPSTSVGTP 172 (384)
T ss_pred CeeccCCCHHHeeecCCCCeEEE----------------------------eccCcceecCCCCcccccccccccccccc
Confidence 999999999999999877 4666 58888764443321 235678999
Q ss_pred CCcccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN---RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~---~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||.+.+ ..++...|+||+|++++++++|..||..
T Consensus 173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999987 5788899999999999999999998653
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.8e-18 Score=146.94 Aligned_cols=130 Identities=44% Similarity=0.715 Sum_probs=96.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|+||.|.||++|.+++.++.|+++++.||++||+.|.+|||.+||+.||+||||++++.+|++|+++..-...+..=-.+
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 67999999999999999999999999999999999999999999999999999999999999999997655544322222
Q ss_pred c-cCccceeehhhhhc-------------chhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 81 F-KDSKYVYMLLEACL-------------GGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 81 ~-~~~~~~ylv~E~~~-------------gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+ -.++.-|..+|... |-=+++++...++|+....-.. -..|++|+.-+|-
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-----------Yn~ILkGid~i~~ 640 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-----------YNLILKGIDKIEF 640 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-----------HHHHHhhhhhhhc
Confidence 2 12344466666432 2233566666677765432111 1347777777664
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.6e-18 Score=143.22 Aligned_cols=139 Identities=19% Similarity=0.349 Sum_probs=103.0
Q ss_pred cccccccccccccccC----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH--
Q psy3182 68 RKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT-- 141 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-- 141 (255)
.++|+||..+..+=.. -+.+|+|.+|-+.|+|+++|.+. ..+. +..-.++..++.||.+||-
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-tv~~-----------~~ml~LalS~AsGLaHLH~eI 328 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-TVTT-----------EGMLKLALSIASGLAHLHMEI 328 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc-cCCH-----------HHHHHHHHHHhhhHHHHHHHH
Confidence 4689999988765322 24689999999999999999863 2322 2223345568899999995
Q ss_pred ------cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC----Ccccccc
Q psy3182 142 ------RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS----GCKTWTF 211 (255)
Q Consensus 142 ------~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~----~~~~~~~ 211 (255)
-.|.|||||..|||+..++...+ .|+|+|...... .......
T Consensus 329 ~GTqgKPaIAHRDlKSKNILVKkn~~C~I----------------------------ADLGLAv~h~~~t~~idi~~N~r 380 (513)
T KOG2052|consen 329 VGTQGKPAIAHRDLKSKNILVKKNGTCCI----------------------------ADLGLAVRHDSDTDTIDIPPNPR 380 (513)
T ss_pred hcCCCCchhhccccccccEEEccCCcEEE----------------------------eeceeeEEecccCCcccCCCCCc
Confidence 24999999999999999988777 488887543222 1233457
Q ss_pred ccCCCCcccccccCC----CCC--CcchHHHHHHHHHHHhc
Q psy3182 212 CGTPEYVAPEIIKNR----GHD--RAVDYWALGILMHELLT 246 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~----~~~--~~~DiWslGvil~ell~ 246 (255)
+||-.|||||++... .++ ..+||||+|.++||.+.
T Consensus 381 VGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 381 VGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred cceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 899999999998642 121 35899999999999863
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=140.92 Aligned_cols=110 Identities=25% Similarity=0.408 Sum_probs=84.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeeccc------Cceeeecccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR------GYVKLVSRKKKTRQ 74 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~------~~vkl~~~~~h~~i 74 (255)
||||||.||||..+++.++.++|..+.-++.|+..|+++||+++|+||||||+|||+... -.+|+.++.-....
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 699999999999999999999999999999999999999999999999999999999875 24677664432211
Q ss_pred c-cccccccCccceeehhhhh-------------cchhHHHHHHhccCCC
Q psy3182 75 T-RLYKTFKDSKYVYMLLEAC-------------LGGEVWTILRERTCFD 110 (255)
Q Consensus 75 v-~l~~~~~~~~~~ylv~E~~-------------~gg~l~~~l~~~~~~~ 110 (255)
. .-...--.+..+||.+|.+ -|--||+.+.+..+|+
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 1 1112223466789999976 2333455566666665
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-17 Score=143.07 Aligned_cols=96 Identities=30% Similarity=0.448 Sum_probs=80.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeeccc-Cceeeeccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKLVSRKKKTRQT--RL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~-~~vkl~~~~~h~~iv--~l 77 (255)
||||||.||||++.+.+.+++.|..+..+|.|++.|++|+|.+||+||||||||++++.+ +.+|+.+........ .-
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~ 176 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG 176 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC
Confidence 699999999999999999999999999999999999999999999999999999999999 999998876544321 11
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.-....++..|..+|...+
T Consensus 177 ~l~t~cGsp~Y~aPEvl~~ 195 (370)
T KOG0583|consen 177 LLKTFCGSPAYAAPEVLSG 195 (370)
T ss_pred cccCCCCCcccCCHHHhCC
Confidence 1223445678999997654
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-17 Score=139.91 Aligned_cols=96 Identities=27% Similarity=0.435 Sum_probs=79.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeeccc---Cceeeeccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR---GYVKLVSRKKKTRQT-- 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~---~~vkl~~~~~h~~iv-- 75 (255)
|||||+.||||++.+-.++++.|..+..++.|++.|++|||++||+||||||||||+..+ -.+|+.+.....++.
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~ 332 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG 332 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccc
Confidence 799999999999999999999999999999999999999999999999999999999877 347777766554442
Q ss_pred cccccccCccceeehhhhhcch
Q psy3182 76 RLYKTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 76 ~l~~~~~~~~~~ylv~E~~~gg 97 (255)
.+-.+ -.++..|+.+|.+.++
T Consensus 333 sfm~T-lCGTpsYvAPEVl~~k 353 (475)
T KOG0615|consen 333 SFMKT-LCGTPSYVAPEVLASK 353 (475)
T ss_pred eehhh-hcCCccccChhheecC
Confidence 22222 2456789999977543
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-17 Score=143.41 Aligned_cols=70 Identities=40% Similarity=0.750 Sum_probs=66.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
.||||+.+|||.+++++.+.|+|.++++|+++++.|++|||++|||||||||||||++.++.+||.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccc
Confidence 4899999999999999999999999999999999999999999999999999999999999999987653
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.3e-17 Score=151.42 Aligned_cols=107 Identities=38% Similarity=0.674 Sum_probs=77.3
Q ss_pred HHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCC-CCceeeeeCCeeeeeccccccCCCCCccccc
Q psy3182 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAK-GDSFFIISGGQVKVDFGFSKHLGHSGCKTWT 210 (255)
Q Consensus 132 il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~ 210 (255)
.+.+++|+|+.||+|||+||+|.++..-|..|+.+|+......+..+. -.+ +.+.. .++.+ ....
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e------g~I~k---~t~Ef-----~dKq 217 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE------GHIEK---DTHEF-----QDKQ 217 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh------cchHH---HHHHh-----hhcc
Confidence 467999999999999999999999999999999644332221110000 000 00000 00110 1124
Q ss_pred cccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 211 FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.||||.|.|||++..++|+..+|||++|+++||.+.|..||+
T Consensus 218 vcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 218 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred ccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 699999999999999999999999999999999999999986
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-16 Score=131.86 Aligned_cols=154 Identities=22% Similarity=0.320 Sum_probs=103.9
Q ss_pred ccccccccccc-ccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 70 KKTRQTRLYKT-FKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 70 ~h~~iv~l~~~-~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
.|+|+...... .++....+.++-+..-|+|-.+++.-..-+.+.+...... .+-..+.|+..|++|||++|+||.|
T Consensus 345 sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~---qlV~masQla~am~hlh~~~ViHkD 421 (563)
T KOG1024|consen 345 SHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTI---QLVLMASQLAMAMEHLHNHGVIHKD 421 (563)
T ss_pred cCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHH---HHHHHHHHHHHHHHHHHhcCcccch
Confidence 47777665553 3455566666667777899998874433333333333222 2334577999999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
|..+|+++++.-.+|+++....+.+.+ .|+. .++.+. --...||+||.+....|
T Consensus 422 iAaRNCvIdd~LqVkltDsaLSRDLFP-----------------~DYh---cLGDnE------nRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 422 IAARNCVIDDQLQVKLTDSALSRDLFP-----------------GDYH---CLGDNE------NRPVKWMSLEALQNSHY 475 (563)
T ss_pred hhhhcceehhheeEEeccchhccccCc-----------------cccc---ccCCCC------CCcccccCHHHHhhhhh
Confidence 999999999988888864322221111 1111 011111 11337999999999999
Q ss_pred CCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 229 DRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+.++|+||+||++|||+| |..|.-
T Consensus 476 ssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 476 SSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred cchhhhHHHHHHHHHHHhcCCCCcc
Confidence 999999999999999985 666643
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-16 Score=138.67 Aligned_cols=68 Identities=34% Similarity=0.610 Sum_probs=65.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSR 68 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~ 68 (255)
|||||+.|||+.++|.+.+.++|..+++|+++.+.|++.+|..|++||||||+|+|++..|++|+.+.
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccc
Confidence 69999999999999999999999999999999999999999999999999999999999999999553
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-16 Score=134.70 Aligned_cols=68 Identities=43% Similarity=0.750 Sum_probs=63.5
Q ss_pred CeeeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecc
Q psy3182 1 MLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSR 68 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~ 68 (255)
|+||||.||||....++ .++|+|..+.||+++|+.||+|||-.|||.||+||||||+.++|++.+.+.
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeec
Confidence 68999999999999965 568999999999999999999999999999999999999999999988553
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-16 Score=139.54 Aligned_cols=169 Identities=26% Similarity=0.437 Sum_probs=119.5
Q ss_pred CCH-HHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccccccCccceeehhhhhcchhH
Q psy3182 21 FDD-NAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99 (255)
Q Consensus 21 ~~~-~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l 99 (255)
++. ..+...+.++..-..-.|+.+.+.-|+-|.......++.+ ....++|+.|+.|.-++|
T Consensus 282 ~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v------------------~~~~~lyI~Mn~c~~~tl 343 (516)
T KOG1033|consen 282 VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV------------------GKKVYLYIQMNLCEKETL 343 (516)
T ss_pred ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc------------------ccccchhhhhhhhhhhhH
Confidence 444 4445555555555555566655555544432222111111 114468999999999999
Q ss_pred HHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCC
Q psy3182 100 WTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAK 179 (255)
Q Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~ 179 (255)
.++++++....+.... .+..++.|+..|++| ++.+|||+||.||.+..+..+++.
T Consensus 344 edWl~rr~~~e~~s~s--------~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg-------------- 398 (516)
T KOG1033|consen 344 EDWLRRRRTGEERSLS--------LMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG-------------- 398 (516)
T ss_pred HHHhhCCCcccccchh--------HHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh--------------
Confidence 9999876555544332 223456789999999 999999999999999888877774
Q ss_pred CCceeeeeCCeeeeeccccccCCCCC------ccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc
Q psy3182 180 GDSFFIISGGQVKVDFGFSKHLGHSG------CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246 (255)
Q Consensus 180 ~~~~~~~~~~~~~~dfg~s~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~ 246 (255)
|||+........ ......+||..||+||.+.+..|+.++||||||++++|++.
T Consensus 399 --------------DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 399 --------------DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred --------------hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 888765443322 13345689999999999999999999999999999999987
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-16 Score=136.39 Aligned_cols=115 Identities=19% Similarity=0.214 Sum_probs=84.9
Q ss_pred Cceeeecccccccccc-ccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTR-LYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~-l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|++++. ++.. ...|++|||+.|++|... .. . .. ..++.|++.||.||
T Consensus 70 ~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~~---~--~~------------~~~~~~i~~aL~~l 127 (365)
T PRK09188 70 REIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-RP---H--GD------------PAWFRSAHRALRDL 127 (365)
T ss_pred HHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHh-Cc---c--ch------------HHHHHHHHHHHHHH
Confidence 4567788888988874 4442 357999999999999622 10 0 00 12456789999999
Q ss_pred HHcCcccccC-CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc--------ccc
Q psy3182 140 HTRGIVFRDL-KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK--------TWT 210 (255)
Q Consensus 140 H~~~iiHrdl-kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~--------~~~ 210 (255)
|++||+|||| ||+||+++.++.+++ +|||+|+........ ..+
T Consensus 128 H~~gIiHrDL~KP~NILv~~~~~ikL----------------------------iDFGlA~~~~~~~~~~~~~~~~d~~~ 179 (365)
T PRK09188 128 HRAGITHNDLAKPQNWLMGPDGEAAV----------------------------IDFQLASVFRRRGALYRIAAYEDLRH 179 (365)
T ss_pred HHCCCeeCCCCCcceEEEcCCCCEEE----------------------------EECccceecccCcchhhhhhhhhhhh
Confidence 9999999999 999999988777777 599988765443211 125
Q ss_pred cccCCCCcccccccC
Q psy3182 211 FCGTPEYVAPEIIKN 225 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~ 225 (255)
..|++.|+|||.+..
T Consensus 180 ~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 180 LLKHKRTYAPDALTP 194 (365)
T ss_pred hhccCccCCcccCCh
Confidence 678999999999864
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=129.72 Aligned_cols=149 Identities=20% Similarity=0.299 Sum_probs=106.6
Q ss_pred cccccccccc-cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCC
Q psy3182 72 TRQTRLYKTF-KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLK 150 (255)
Q Consensus 72 ~~iv~l~~~~-~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlk 150 (255)
..+.+++..+ ....+-|+||+.+ |-+|.++.+... + ...+ ...+..++.|++.+|+++|+.|++|||+|
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~-~~fs------~~T~l~ia~q~l~~l~~lH~~G~iHRDiK 149 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--P-GRFS------RKTVLRIAIQNLNALEDLHSKGFIHRDIK 149 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--C-CCcC------HhHHHHHHHHHHHHHHHHHhcCcccCCcC
Confidence 3556667777 4777889999954 888888765433 1 1111 12234567789999999999999999999
Q ss_pred CCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccc--cCCCCC------cc--ccccccCCCCccc
Q psy3182 151 PENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSK--HLGHSG------CK--TWTFCGTPEYVAP 220 (255)
Q Consensus 151 p~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~--~~~~~~------~~--~~~~~gt~~y~aP 220 (255)
|+|+.+........ .. ...+|||+++ ...... .+ ...+.||..|+++
T Consensus 150 p~N~~~g~~~~~~~----------------~~-------~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 150 PENFVVGQSSRSEV----------------RT-------LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred HHHeeecCCCCccc----------------ce-------EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence 99999987531000 00 1126999998 321111 11 2345699999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+..+...+.+.|+||++.++.++..|.-|+..
T Consensus 207 ~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~ 239 (322)
T KOG1164|consen 207 NVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA 239 (322)
T ss_pred HHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence 999999999999999999999999999888753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.2e-16 Score=122.77 Aligned_cols=158 Identities=18% Similarity=0.133 Sum_probs=106.7
Q ss_pred CCCcccCCCCcceeec------ccCceeeeccccc-cccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh
Q psy3182 43 RGIVFRDLKPENLLLD------NRGYVKLVSRKKK-TRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS 115 (255)
Q Consensus 43 ~~i~~rdiK~~nil~~------~~~~vkl~~~~~h-~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~ 115 (255)
.+++.||++-.-.+.. ...+++++..+.| +++++++++ ...|++|||+.|.+|...... ..
T Consensus 26 ~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~~-- 93 (218)
T PRK12274 26 RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------GD-- 93 (218)
T ss_pred ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------hh--
Confidence 3455566655444322 2345666666643 567777664 346999999999998654321 00
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC-CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeee
Q psy3182 116 FITACVIEALDFITACVIEALEYLHTRGIVFRDL-KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194 (255)
Q Consensus 116 ~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl-kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 194 (255)
..+..|++.+|.++|++||+|||| ||+||+++.++.+++ +|
T Consensus 94 ----------~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~L----------------------------ID 135 (218)
T PRK12274 94 ----------LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAV----------------------------ID 135 (218)
T ss_pred ----------HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEE----------------------------EE
Confidence 113457889999999999999999 799999988777777 69
Q ss_pred ccccccCCCCCc-----c--------ccccccCCCCcccccccCC-CCC-CcchHHHHHHHHHHHhcCCCC
Q psy3182 195 FGFSKHLGHSGC-----K--------TWTFCGTPEYVAPEIIKNR-GHD-RAVDYWALGILMHELLTGMKE 250 (255)
Q Consensus 195 fg~s~~~~~~~~-----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiWslGvil~ell~G~~~ 250 (255)
||++........ . ..-...+|.|++|+.-.-. ..+ ...+|.+.|+-+|.++|+.-+
T Consensus 136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 998875443321 0 0012368899999876532 233 456777999999999998754
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.3e-16 Score=136.52 Aligned_cols=207 Identities=26% Similarity=0.404 Sum_probs=142.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecc------------
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSR------------ 68 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~------------ 68 (255)
|.||||-||.|.++.+--+.++|-+.++.....+++++|+|+.|.+|||||-.|+++...|++|+.+.
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 57999999999999998899999999999999999999999999999999999999988887666221
Q ss_pred --------------------------------------------------------------------------------
Q psy3182 69 -------------------------------------------------------------------------------- 68 (255)
Q Consensus 69 -------------------------------------------------------------------------------- 68 (255)
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence
Q ss_pred -----------------------------------------ccccc-cccccccccCccceeehhhhhcchhHHHHHHhc
Q psy3182 69 -----------------------------------------KKKTR-QTRLYKTFKDSKYVYMLLEACLGGEVWTILRER 106 (255)
Q Consensus 69 -----------------------------------------~~h~~-iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~ 106 (255)
..||| .++.++.++-+++.++.+++|.+|-
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r-------- 320 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR-------- 320 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc--------
Confidence 12222 2222223333334444444444440
Q ss_pred cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeee
Q psy3182 107 TCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186 (255)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 186 (255)
..-.+..++...... -....+.+.-.++++++|+.-=+||| ||+.... ..+.
T Consensus 321 s~~~~~~~se~~~~~-~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~-~~~~---------------------- 372 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQ-YQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE-EVKL---------------------- 372 (829)
T ss_pred cccccCChhhHhhhh-hhhhhhhhhhcccccccccccccCcc----ccccccc-cccc----------------------
Confidence 000111111111000 01223444556788899988778888 7665542 2222
Q ss_pred eCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCC
Q psy3182 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKE 250 (255)
Q Consensus 187 ~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~ 250 (255)
.+|+....+.... ...++.+|+.++|||+.....+....|.||+|+-..+|.-|.+|
T Consensus 373 ------~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 373 ------LDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ------ccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 3777766665543 45578899999999999999999999999999888888888765
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-15 Score=126.67 Aligned_cols=96 Identities=27% Similarity=0.385 Sum_probs=80.5
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc-cCceeeecccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN-RGYVKLVSRKKKTRQTR-- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~-~~~vkl~~~~~h~~iv~-- 76 (255)
|+|||+.||+|.+++++.+ .++|+.++.++.|++.+++|+|++|++||||||+|+|++. .+.+|+.+.........
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 6899999999999999877 6999999999999999999999999999999999999999 69999988764433331
Q ss_pred cc---ccccCccceeehhhhhcc
Q psy3182 77 LY---KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~---~~~~~~~~~ylv~E~~~g 96 (255)
.. ..-...+..||.+|.+.+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred ccccccccccCCccccCchhhcC
Confidence 11 222345678999999883
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.3e-16 Score=126.91 Aligned_cols=96 Identities=33% Similarity=0.487 Sum_probs=81.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
.||||.+||+|+-++...+.|+|.++.||=+.++.|+.|||+++|+.||+|.||++++++|++|+.+...+...++.-++
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence 38999999999999988888999999999999999999999999999999999999999999999988777666554433
Q ss_pred cc--Cccceeehhhhhcc
Q psy3182 81 FK--DSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~--~~~~~ylv~E~~~g 96 (255)
-+ .++.-|+.+|.+..
T Consensus 325 ~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLED 342 (516)
T ss_pred eccccCChhhcCchhhcc
Confidence 22 23455777776644
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.7e-15 Score=127.07 Aligned_cols=69 Identities=30% Similarity=0.551 Sum_probs=66.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
|||||..||+|++++.+++.++|..+.-+|.|++.|+.|+|+++++|||+|.||||++.++.+||.++.
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccc
Confidence 699999999999999999999999999999999999999999999999999999999999999998754
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.6e-15 Score=137.69 Aligned_cols=94 Identities=29% Similarity=0.438 Sum_probs=78.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc---cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT---RL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv---~l 77 (255)
|||||+.||||..++-+...++|..|.||++.++.|++.+|..|.|||||||+|+|++..|++|+.++..+-..- ..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 699999999999999888899999999999999999999999999999999999999999999998865543221 11
Q ss_pred cccccCccceeehhhhh
Q psy3182 78 YKTFKDSKYVYMLLEAC 94 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~ 94 (255)
...-.-++.-|+.+|.+
T Consensus 232 ~s~~aVGTPDYISPEvL 248 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVL 248 (1317)
T ss_pred EeccccCCCCccCHHHH
Confidence 22233455567777754
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.7e-15 Score=134.10 Aligned_cols=111 Identities=25% Similarity=0.397 Sum_probs=84.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
.||||+.|||++.+. ..+.|+|+++.+|+++|+.||.|||.+|||+||+|.+|+|++.+|++||.+........-. -
T Consensus 446 fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 389999999965555 4578999999999999999999999999999999999999999999999886654432211 1
Q ss_pred ccccCccceeehhhhhcchh-------------HHHHHHhccCCCcc
Q psy3182 79 KTFKDSKYVYMLLEACLGGE-------------VWTILRERTCFDDN 112 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~gg~-------------l~~~l~~~~~~~~~ 112 (255)
.+--.++.-||.+|.+.+.. |++.|..+.+|...
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 11123455688888776542 35666677777644
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=129.75 Aligned_cols=111 Identities=29% Similarity=0.465 Sum_probs=87.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc--ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--RLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--~l~ 78 (255)
+|+||+.||+||+++.+++.++|..+..++.|++.|+.|+|+.+|+|||+||||+|++..+.+||.++....-.+ ++.
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 589999999999999999999999999999999999999999999999999999999999999998876554333 233
Q ss_pred ccccCccceeehhhhhcc-------------h-hHHHHHHhccCCCcc
Q psy3182 79 KTFKDSKYVYMLLEACLG-------------G-EVWTILRERTCFDDN 112 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g-------------g-~l~~~l~~~~~~~~~ 112 (255)
++. .+..-|-.+|...| | =|+.+|...-+|++.
T Consensus 169 eTS-CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 169 ETS-CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred ccc-CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 321 23344777776544 1 245666666666654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-15 Score=122.82 Aligned_cols=121 Identities=17% Similarity=0.211 Sum_probs=83.7
Q ss_pred eeeccccccccccccccccC--------ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRKKKTRQTRLYKTFKD--------SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~--------~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+.++++.|+++......+.+ +...+++|||++|.+|.+... .++ ....+++.+
T Consensus 87 ~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~---------------~~~~~i~~~ 147 (232)
T PRK10359 87 VQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE---------------DVKAKIKAS 147 (232)
T ss_pred HHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH---------------HHHHHHHHH
Confidence 34455556666665554432 346899999999999876531 111 123468899
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
+..+|+.|++|||+||.|++++..+ +++ +|||.+....... .
T Consensus 148 l~~lH~~gi~H~Dikp~Nili~~~g-i~l----------------------------iDfg~~~~~~e~~--a------- 189 (232)
T PRK10359 148 IESLHQHGMVSGDPHKGNFIVSKNG-LRI----------------------------IDLSGKRCTAQRK--A------- 189 (232)
T ss_pred HHHHHHcCCccCCCChHHEEEeCCC-EEE----------------------------EECCCcccccchh--h-------
Confidence 9999999999999999999998777 655 6998765442211 1
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHH
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHEL 244 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~el 244 (255)
....+....|+.++|+||||+.+..+
T Consensus 190 ---~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 190 ---KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ---HHHHHHHhHhcccccccceeEeehHH
Confidence 11244556788899999999887654
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-14 Score=122.38 Aligned_cols=117 Identities=24% Similarity=0.356 Sum_probs=90.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc-cccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK-TRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h-~~iv~l~~ 79 (255)
.|||||+||||..+++..++|.|+.+.+|++++..++=+||++||+.||+|.+|++++.+|++||.+.... .|+..-..
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 38999999999999999999999999999999999999999999999999999999999999999886543 34332111
Q ss_pred c-ccCccceeehhhhh-------------cchhHHHHHHhccCCCccchhhH
Q psy3182 80 T-FKDSKYVYMLLEAC-------------LGGEVWTILRERTCFDDNAASFI 117 (255)
Q Consensus 80 ~-~~~~~~~ylv~E~~-------------~gg~l~~~l~~~~~~~~~~~~~~ 117 (255)
+ --.++.-|+.+|.. .|--|++.+..+.+|+.......
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 1 01234457776632 23345677788888876654433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.7e-14 Score=124.42 Aligned_cols=70 Identities=33% Similarity=0.602 Sum_probs=66.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
||||||.||+|.+++.+.+.+++..+..++.+++.|++|+|++||+||||||+|++++.++.+|+.+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccC
Confidence 6999999999999999888999999999999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.2e-14 Score=123.49 Aligned_cols=95 Identities=24% Similarity=0.371 Sum_probs=78.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
.||||++||.|-+++.+ .+++|.+.+.+..+++.||+|||.+||+|||||.+||++..+|.+|+.+..-+..+..--
T Consensus 347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 48999999999998866 569999999999999999999999999999999999999999999998876555443211
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
..-.-++..||..|....
T Consensus 426 R~TmVGTPYWMAPEVvtr 443 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR 443 (550)
T ss_pred cccccCCCCccchhhhhh
Confidence 122335678999996643
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=7e-14 Score=120.84 Aligned_cols=96 Identities=26% Similarity=0.384 Sum_probs=81.4
Q ss_pred CeeeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCCcceeecccC-ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALEYLHTRG-IVFRDLKPENLLLDNRG-YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--~~~~~~~~~~~~~~~v~~~l~~lh~~~-i~~rdiK~~nil~~~~~-~vkl~~~~~h~~iv~ 76 (255)
|||||+.||.|..++.. .+.++...+..++.++..|++|+|.++ |+|||+||+|+|++.+. .+|+.+.....-...
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 69999999999999987 678999999999999999999999999 99999999999999997 999987654432222
Q ss_pred --ccccccCccceeehhhhhcc
Q psy3182 77 --LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 --l~~~~~~~~~~ylv~E~~~g 96 (255)
.-.+...++..||.+|...+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred ccccccCCCCCccccChhhhcC
Confidence 23334667788999998875
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=109.24 Aligned_cols=96 Identities=27% Similarity=0.372 Sum_probs=75.1
Q ss_pred CeeeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILR--ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~--~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
|++||..+|+++..++ ....|+|.+++.|..|+..|+.|+|.++|+||||||||+|+...|.+|+.+..-.-....--
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence 5899999999999999 56679999999999999999999999999999999999999999999998754211110111
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
..--..+..|+-+|...|
T Consensus 179 R~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred ceeeecccccCCHhhcCC
Confidence 122334556777775543
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-14 Score=122.92 Aligned_cols=96 Identities=32% Similarity=0.500 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccc--------
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKT-------- 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~-------- 72 (255)
||+|||..|++...-....-+++.++..|+.-++.+|+|||.+||+||||||.|+|++..|.+||-++.-..
T Consensus 187 lVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~ 266 (576)
T KOG0585|consen 187 LVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDE 266 (576)
T ss_pred EEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCcc
Confidence 699999999986544332239999999999999999999999999999999999999999999997654322
Q ss_pred -ccccccccccCccceeehhhhhcchh
Q psy3182 73 -RQTRLYKTFKDSKYVYMLLEACLGGE 98 (255)
Q Consensus 73 -~iv~l~~~~~~~~~~ylv~E~~~gg~ 98 (255)
+...|.. .-++..||.+|.|.+|+
T Consensus 267 ~~d~~L~~--tvGTPAF~APE~c~~~~ 291 (576)
T KOG0585|consen 267 GSDDQLSR--TVGTPAFFAPELCSGGN 291 (576)
T ss_pred ccHHHHhh--cCCCccccchHhhcCCC
Confidence 1111111 44678899999998854
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.8e-14 Score=115.32 Aligned_cols=69 Identities=36% Similarity=0.543 Sum_probs=62.2
Q ss_pred CeeeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~--~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~ 69 (255)
||||.++||+|+..+++++. |+|.+++.++.++..|+.|||..+|.|||+||||+|....+ .+|+.+..
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 69999999999999999887 99999999999999999999999999999999999986543 47776643
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-13 Score=115.35 Aligned_cols=100 Identities=31% Similarity=0.459 Sum_probs=70.6
Q ss_pred HHHHHHHHHHHHHHHcCcccccCCCCceeeCCC--CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC
Q psy3182 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNR--GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS 204 (255)
Q Consensus 127 ~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~ 204 (255)
.+..|+++|+.|||++||.|||+|.+|||+.-+ +.-.+ +..|||.+-.....
T Consensus 345 ~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~L--------------------------VvaDFGCcLAd~~h 398 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQL--------------------------VVADFGCCLADDNH 398 (598)
T ss_pred HHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEE--------------------------EEcccceeeecccc
Confidence 367789999999999999999999999998543 21111 11488865322110
Q ss_pred C------ccccccccCCCCcccccccCCCC-----C-CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 205 G------CKTWTFCGTPEYVAPEIIKNRGH-----D-RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 205 ~------~~~~~~~gt~~y~aPE~~~~~~~-----~-~~~DiWslGvil~ell~G~~~~~ 252 (255)
+ +.....-|...-||||+....+- + .++|.|+.|-+.||.+.-.+||-
T Consensus 399 Glqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 399 GLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred ccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 0 11122347778999999865321 1 47899999999999998889984
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-13 Score=118.55 Aligned_cols=96 Identities=24% Similarity=0.335 Sum_probs=76.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc-c-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT-R-LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv-~-l~ 78 (255)
+||||+.||+|...+...+.+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+........ . -.
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 589999999999999988899999999999999999999999999999999999999999999998754322110 0 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred eeeecCCccccChhhhcC
Confidence 011123456888887654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-13 Score=118.60 Aligned_cols=96 Identities=29% Similarity=0.397 Sum_probs=76.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
|||||+.||+|+..+...+.+++.++..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.......... .
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 68999999999999998889999999999999999999999999999999999999999999999876532211100 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05571 152 MKTFCGTPEYLAPEVLED 169 (323)
T ss_pred ccceecCccccChhhhcC
Confidence 011123456788886643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=120.05 Aligned_cols=69 Identities=35% Similarity=0.627 Sum_probs=65.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
||||||.||+|.+++.+.+.+++..+..++.+++.|++|+|++||+||||||+|++++.++.+++.+..
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeecc
Confidence 689999999999999988899999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.7e-13 Score=117.60 Aligned_cols=96 Identities=29% Similarity=0.434 Sum_probs=76.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~-~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
|||||+.||+|...+...+.+++.++..++.+++.|+.|+|+ ++|+||||||+|++++.++.+|+.+.........--.
T Consensus 72 lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 699999999999999888889999999999999999999997 8999999999999999999999988653321111000
Q ss_pred --cccCccceeehhhhhcc
Q psy3182 80 --TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 --~~~~~~~~ylv~E~~~g 96 (255)
....++..|+.+|.+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLED 170 (325)
T ss_pred ccccccCCcccCCHHHHcc
Confidence 11124456888887644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-14 Score=132.57 Aligned_cols=143 Identities=27% Similarity=0.513 Sum_probs=115.9
Q ss_pred ccccccccccccCccceeehhhhhcchhHHHHH-Hhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH-HcCcccc
Q psy3182 71 KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTIL-RERT-CFDDNAASFITACVIEALDFITACVIEALEYLH-TRGIVFR 147 (255)
Q Consensus 71 h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l-~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH-~~~iiHr 147 (255)
|.|++++++...+....++++|+..||+++..+ .... ..++..+ ..+..|+..++.|+| .+++.||
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~-----------~~~~~ql~s~l~~~H~~~~~~h~ 148 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSA-----------SRYLPQLNSGLSYLHPENGVTHR 148 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcch-----------hhhhhhhccCccccCcccccccC
Confidence 999999999999999999999999999999888 4333 3343333 345567899999999 9999999
Q ss_pred cCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCC-CCc--ccccccc-CCCCccccc
Q psy3182 148 DLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGH-SGC--KTWTFCG-TPEYVAPEI 222 (255)
Q Consensus 148 dlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~-~~~--~~~~~~g-t~~y~aPE~ 222 (255)
|+||+|.+++..+ ..+. .|||+|..... .+. .....+| ++.|+|||.
T Consensus 149 ~ikP~n~~l~~s~~~l~~----------------------------~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~ 200 (601)
T KOG0590|consen 149 DIKPSNSLLDESGSALKI----------------------------ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEH 200 (601)
T ss_pred CCCCccchhccCCCcccC----------------------------CCchhhccccccCCcceeeecccCCCCCCCCccc
Confidence 9999999999887 5555 38888876554 222 2334688 999999999
Q ss_pred ccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..+. ......|+||.|+++..+++|..|+.
T Consensus 201 ~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 201 LSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred ccchhhcCCCcccccccccccccccCCCCcc
Confidence 9885 45678899999999999999997764
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-13 Score=117.98 Aligned_cols=95 Identities=32% Similarity=0.417 Sum_probs=75.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
|||||+.||+|...+...+.+++..+..++.|++.|+.|+|+++|+||||||+|++++.++.+++.+.........-.
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred EEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 689999999999999988899999999999999999999999999999999999999999999998765332111100
Q ss_pred ccccCccceeehhhhhc
Q psy3182 79 KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~ 95 (255)
.....++..|+.+|.+.
T Consensus 153 ~~~~~gt~~y~aPE~~~ 169 (330)
T cd05586 153 TNTFCGTTEYLAPEVLL 169 (330)
T ss_pred ccCccCCccccCHHHHc
Confidence 01112344677777654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.6e-13 Score=117.94 Aligned_cols=96 Identities=29% Similarity=0.407 Sum_probs=76.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK- 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~- 79 (255)
|||||+.||+|+..+...+.+++.++..++.+++.|+.|||+++|+||||||+|++++.++.+|+.+............
T Consensus 72 lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 6899999999999998888899999999999999999999999999999999999999999999987653221111000
Q ss_pred -cccCccceeehhhhhcc
Q psy3182 80 -TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 -~~~~~~~~ylv~E~~~g 96 (255)
....++..|+.+|.+.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~ 169 (328)
T cd05593 152 MKTFCGTPEYLAPEVLED 169 (328)
T ss_pred cccccCCcCccChhhhcC
Confidence 11123456888887644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-13 Score=117.61 Aligned_cols=95 Identities=32% Similarity=0.447 Sum_probs=77.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|.+++...+.+++.++..++.+++.|+.|+|.++|+||||||+|++++.++.+|+.+......... ...
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~ 156 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YAN 156 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccC
Confidence 6899999999999999888899999999999999999999999999999999999999999999988654432222 111
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.+
T Consensus 157 ~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 157 SVVGSPDYMAPEVLRG 172 (333)
T ss_pred CcccCccccChhHhcC
Confidence 1223456788886644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-13 Score=118.03 Aligned_cols=96 Identities=31% Similarity=0.431 Sum_probs=76.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|+..+...+.+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........-...
T Consensus 72 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 72 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 68999999999999988888999999999999999999999999999999999999999999999876532211110000
Q ss_pred --ccCccceeehhhhhcc
Q psy3182 81 --FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 --~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05595 152 MKTFCGTPEYLAPEVLED 169 (323)
T ss_pred cccccCCcCcCCcccccC
Confidence 1123456888887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=117.28 Aligned_cols=96 Identities=26% Similarity=0.421 Sum_probs=77.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc--ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--RLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--~l~ 78 (255)
|||||+.||+|...+.+...+++.++..++.+++.|++|+|++||+||||||+|++++.++.+++.+........ .-.
T Consensus 73 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred EEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 689999999999999988889999999999999999999999999999999999999999999998765322110 000
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG 170 (316)
T ss_pred eeccCCCcCccCHHHHcC
Confidence 111223556888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-13 Score=122.91 Aligned_cols=71 Identities=30% Similarity=0.539 Sum_probs=67.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
.||||+.|||+..+|-.-+-|.|.-+.||++++.+|+++.|+.|.|||||||+|||+|.+|++|+.+...+
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence 38999999999999999999999999999999999999999999999999999999999999999876543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-13 Score=117.01 Aligned_cols=96 Identities=32% Similarity=0.462 Sum_probs=76.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
+||||+.||+|...+...+.+++.++..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.......... .
T Consensus 73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 73 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence 58999999999999998888999999999999999999999999999999999999999999999876532211100 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK 170 (325)
T ss_pred cccccCCccccCHHHHcC
Confidence 011123456888886644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-13 Score=120.21 Aligned_cols=96 Identities=23% Similarity=0.299 Sum_probs=77.7
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l- 77 (255)
||||||+||++.+.+.+.+ .|+|.++..|+.|++.|++|||.++|+|||+|+.|+.+.+++.||+=+..........
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 6999999999999997644 5999999999999999999999999999999999999999999988554332222211
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
+..-.-++..||..|.|.|
T Consensus 161 ~~a~tvvGTp~YmcPEil~d 180 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSD 180 (426)
T ss_pred hhhheecCCCcccCHHHhCC
Confidence 2233446678999998865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-13 Score=117.88 Aligned_cols=95 Identities=34% Similarity=0.531 Sum_probs=76.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|.+.+...+.+++..+..++.+++.|++|+|+++|+||||||+|++++.++.+|+.+......... -..
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-~~~ 186 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTY 186 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-Ccc
Confidence 6899999999999999888999999999999999999999999999999999999999999999987654322211 011
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.+
T Consensus 187 ~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 187 TLCGTPEYIAPEILLN 202 (340)
T ss_pred eecCChhhcCHHHHhC
Confidence 1223456888886543
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.8e-14 Score=119.34 Aligned_cols=112 Identities=29% Similarity=0.394 Sum_probs=83.4
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
+||..|+||||.-++.+.+ .|+|.++.||+++++.++++||.++|+.||+||+|||+|..|+++|-+-...-.+..=-
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 5899999999999998877 89999999999999999999999999999999999999999999985432211111000
Q ss_pred -ccccCccceeehhhhhcch-------------hHHHHHHhccCCCcc
Q psy3182 79 -KTFKDSKYVYMLLEACLGG-------------EVWTILRERTCFDDN 112 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~gg-------------~l~~~l~~~~~~~~~ 112 (255)
-...-++.=||.+|.+.++ -|+..|+.+.+|...
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 0112344557777765443 356667766666433
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.4e-13 Score=116.57 Aligned_cols=96 Identities=31% Similarity=0.430 Sum_probs=75.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
+||||+.||+|...+...+.+++.++..++.+++.|++|+|++||+||||||+|++++.++.+|+.+.........-.
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 73 FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred EEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence 689999999999999988889999999999999999999999999999999999999999999998765322111000
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK 170 (323)
T ss_pred cccccCChhhcChhhhcC
Confidence 011123445777776544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.6e-13 Score=116.39 Aligned_cols=96 Identities=25% Similarity=0.357 Sum_probs=76.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc--ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--RLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--~l~ 78 (255)
|||||+.||+|...+...+.+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+........ ...
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 689999999999999988899999999999999999999999999999999999999999999998764322110 000
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|...+
T Consensus 158 ~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY 175 (323)
T ss_pred ccCccCCccccCHHHHcC
Confidence 111123456888887654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.8e-13 Score=115.59 Aligned_cols=96 Identities=33% Similarity=0.426 Sum_probs=76.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
|||||+.||+|.+.+...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+++.+.......... .
T Consensus 70 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc
Confidence 68999999999999988889999999999999999999999999999999999999999999999875432211100 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 150 ~~~~~gt~~y~aPE~~~~ 167 (312)
T cd05585 150 TNTFCGTPEYLAPELLLG 167 (312)
T ss_pred cccccCCcccCCHHHHcC
Confidence 111123456888886644
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.43 E-value=3e-13 Score=116.29 Aligned_cols=95 Identities=34% Similarity=0.429 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--- 77 (255)
+||||+.||+|...+.++..+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........-
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC
Confidence 58999999999999998889999999999999999999999999999999999999999999999876432211000
Q ss_pred cccccCccceeehhhhhc
Q psy3182 78 YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~ 95 (255)
......++..|+.+|.+.
T Consensus 162 ~~~~~~gt~~y~aPE~~~ 179 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIR 179 (332)
T ss_pred ccccccCCccccCHHHhc
Confidence 000112345678888664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.8e-13 Score=116.40 Aligned_cols=96 Identities=28% Similarity=0.396 Sum_probs=76.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
|||||+.||+|...+...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+......... -.
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 6899999999999998888899999999999999999999999999999999999999999999987643221110 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG 170 (327)
T ss_pred eecccCCcccCCHHHHCC
Confidence 111223456888887644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-13 Score=111.83 Aligned_cols=70 Identities=33% Similarity=0.560 Sum_probs=66.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+|+|.|.-|+|++++.+.-.++|+++..++.+++.+++|+|+++|+|||+||||||++.+..+|+.+..-
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 5889999999999999999999999999999999999999999999999999999999999999977543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.8e-13 Score=115.93 Aligned_cols=96 Identities=28% Similarity=0.420 Sum_probs=77.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
+||||+.||+|...+++.+.+++.++..++.|++.|+.|||.++|+||||||+|++++.++.+|+.+......... -.
T Consensus 73 lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 6899999999999999888999999999999999999999999999999999999999999999987653321110 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG 170 (316)
T ss_pred cccccCCccccCHHHHcC
Confidence 111223556888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.7e-13 Score=113.69 Aligned_cols=95 Identities=35% Similarity=0.520 Sum_probs=76.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+.||+|.+++++.+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........- ..
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~ 156 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TW 156 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-cc
Confidence 58999999999999999889999999999999999999999999999999999999999999999876543322110 01
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.+
T Consensus 157 ~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 157 TLCGTPEYLAPEVIQS 172 (291)
T ss_pred cccCChhhcCHHHHcC
Confidence 1123456888886643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-13 Score=112.86 Aligned_cols=68 Identities=35% Similarity=0.633 Sum_probs=63.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc---eeeecc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLVSR 68 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~---vkl~~~ 68 (255)
||||.++||.|...++++.+|+|..++.+++.|..|+++||++||.|||+||||||....+. +||++.
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecc
Confidence 69999999999999999999999999999999999999999999999999999999988775 677653
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.43 E-value=3e-13 Score=116.11 Aligned_cols=96 Identities=33% Similarity=0.434 Sum_probs=75.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK- 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~- 79 (255)
+||||+.||+|...+...+.+++.++..++.|++.|++|+|.+||+||||||+|++++.++.+|+.+............
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 73 FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 6899999999999998888999999999999999999999999999999999999999999999987653221110000
Q ss_pred -cccCccceeehhhhhcc
Q psy3182 80 -TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 -~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK 170 (325)
T ss_pred cccccCChhhCCHHHHcC
Confidence 01123445777776544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.7e-13 Score=118.05 Aligned_cols=69 Identities=35% Similarity=0.633 Sum_probs=65.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
||||||.||+|.+++...+.+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+++.+..
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecc
Confidence 689999999999999988889999999999999999999999999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.9e-13 Score=116.05 Aligned_cols=97 Identities=24% Similarity=0.350 Sum_probs=77.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc--ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--RLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--~l~ 78 (255)
|||||+.||+|...+...+.+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+........ ...
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 689999999999999888899999999999999999999999999999999999999999999998754322110 000
Q ss_pred ccccCccceeehhhhhcch
Q psy3182 79 KTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~gg 97 (255)
.....++..|+.+|.+.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred cccCCCChhhcCHHHhcCC
Confidence 1111234568888876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.4e-13 Score=115.56 Aligned_cols=96 Identities=28% Similarity=0.374 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
|||||+.||+|...+...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+......... ..
T Consensus 73 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 6999999999999998888899999999999999999999999999999999999999999999987543221100 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE 170 (321)
T ss_pred ccccccCccccCHHHHcC
Confidence 111123456788886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.1e-13 Score=116.27 Aligned_cols=94 Identities=38% Similarity=0.551 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+.||+|.+.+.+.+.+++..+..++.+++.|++|+|+++|+||||||+|++++.++.+|+.+.........-. .
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 173 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-F 173 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-c
Confidence 589999999999999998899999999999999999999999999999999999999999999998765432221100 0
Q ss_pred ccCccceeehhhhhc
Q psy3182 81 FKDSKYVYMLLEACL 95 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~ 95 (255)
...++..|+.+|...
T Consensus 174 ~~~gt~~y~aPE~~~ 188 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQ 188 (329)
T ss_pred eecCChhhcCHHHHc
Confidence 112344577777654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.5e-13 Score=115.47 Aligned_cols=96 Identities=28% Similarity=0.386 Sum_probs=76.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
|||||+.||+|...+...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+......... ..
T Consensus 73 iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred EEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 6899999999999999888999999999999999999999999999999999999999999999987543221100 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE 170 (320)
T ss_pred ccccccCccccCHHHHcC
Confidence 111223456888886643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.8e-13 Score=115.72 Aligned_cols=96 Identities=29% Similarity=0.419 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK- 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~- 79 (255)
||||||.||+|...+...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+............
T Consensus 73 lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 6899999999999998888899999999999999999999999999999999999999999999987543221110000
Q ss_pred -cccCccceeehhhhhcc
Q psy3182 80 -TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 -~~~~~~~~ylv~E~~~g 96 (255)
....++..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG 170 (329)
T ss_pred cccccCCccccCHHHHcC
Confidence 01123445788887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=109.43 Aligned_cols=65 Identities=17% Similarity=0.153 Sum_probs=49.2
Q ss_pred eehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH-HHcCcccccCCCCceeeCCCCceee
Q psy3182 88 YMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL-HTRGIVFRDLKPENLLLDNRGYVKL 164 (255)
Q Consensus 88 ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl-H~~~iiHrdlkp~nil~~~~~~~~l 164 (255)
|++|||+.|+++.........++. +.+..++.|++.+|.++ |+.||+||||||+||+++. +.+++
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~~~~~-----------~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~v~L 158 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDAPLSE-----------SKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GKLYI 158 (190)
T ss_pred EEEEEEeCCCCCcchhhhcCCCCH-----------HHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-CcEEE
Confidence 899999999877554333333332 23455778899999999 7999999999999999973 55666
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.4e-13 Score=115.41 Aligned_cols=95 Identities=23% Similarity=0.393 Sum_probs=75.1
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
|||||+.||+|..++.+ ...+++..+..++.+++.|++|+|+++|+||||||+|++++.++.+|+.+.........
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 68999999999999987 46799999999999999999999999999999999999999999999987643221111
Q ss_pred ccccccCccceeehhhhhc
Q psy3182 77 LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~ 95 (255)
.......++..|+.+|.+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQ 176 (331)
T ss_pred eeeccccCCcccCCHHHHh
Confidence 0111122445678888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-13 Score=110.86 Aligned_cols=83 Identities=20% Similarity=0.308 Sum_probs=62.7
Q ss_pred ceeeeccc-----cccccccccccccCcc---cee-ehhhh--hcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-----KKTRQTRLYKTFKDSK---YVY-MLLEA--CLGGEVWTILRERTCFDDNAASFITACVIEALDFITA 130 (255)
Q Consensus 62 ~vkl~~~~-----~h~~iv~l~~~~~~~~---~~y-lv~E~--~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (255)
+++++..+ .|+|++++|++++++. .+| +++|| +.+|+|.+++++. .+++. . .+++
T Consensus 46 Ei~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~------------~-~~~~ 111 (210)
T PRK10345 46 ELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED------------V-AQLR 111 (210)
T ss_pred HHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh------------H-HHHH
Confidence 34444444 5799999999999874 444 78999 6689999999753 33332 1 2345
Q ss_pred HHHHHH-HHHHHcCcccccCCCCceeeCC
Q psy3182 131 CVIEAL-EYLHTRGIVFRDLKPENLLLDN 158 (255)
Q Consensus 131 ~il~~l-~ylH~~~iiHrdlkp~nil~~~ 158 (255)
+++.++ +|||+++|+||||||+||+++.
T Consensus 112 ~~L~~l~~yLh~~~IvhrDlKp~NILl~~ 140 (210)
T PRK10345 112 QLLKKLKRYLLDNRIVTMELKPQNILCQR 140 (210)
T ss_pred HHHHHHHHHHHHCCEeecCCCHHHEEEec
Confidence 677777 8999999999999999999974
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.6e-13 Score=114.71 Aligned_cols=69 Identities=42% Similarity=0.704 Sum_probs=65.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
||||||.||+|...+.....+++.++..++.+++.|+.|+|.++|+||||||+|++++.++.+|+.+..
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCC
Confidence 689999999999999888889999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.2e-13 Score=114.88 Aligned_cols=96 Identities=30% Similarity=0.434 Sum_probs=76.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
|||||+.||+|...+.+.+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........- .
T Consensus 73 lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 68999999999999988888999999999999999999999999999999999999999999999876432211100 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG 170 (329)
T ss_pred cccccCCccccCHHHHcC
Confidence 011123456888887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.7e-13 Score=117.04 Aligned_cols=94 Identities=28% Similarity=0.401 Sum_probs=74.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--c-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--L- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l- 77 (255)
+|||||.||+|.+++... .+++.++..++.+++.|++|+|+++|+||||||+||+++..+.+|+.+......... .
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 689999999999999764 699999999999999999999999999999999999999999999987654322110 0
Q ss_pred cccccCccceeehhhhhc
Q psy3182 78 YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~ 95 (255)
......++..|+.+|.+.
T Consensus 199 ~~~~~~gt~~Y~aPE~~~ 216 (370)
T cd05621 199 RCDTAVGTPDYISPEVLK 216 (370)
T ss_pred ecccCCCCcccCCHHHHh
Confidence 011122455688888653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-13 Score=110.37 Aligned_cols=95 Identities=20% Similarity=0.267 Sum_probs=73.7
Q ss_pred CeeeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CcccCCCCcceeecccCceeeecccccc
Q psy3182 1 MLLEACLGGEVWTILR----ERTCFDDNAASFITACVIEALEYLHT--RG--IVFRDLKPENLLLDNRGYVKLVSRKKKT 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~----~~~~~~~~~~~~~~~~v~~~l~~lh~--~~--i~~rdiK~~nil~~~~~~vkl~~~~~h~ 72 (255)
||||||.+|||.++++ +++.++|+++-.++.|++.|+..+|. .. |+||||||.||.++..|.+|+=+.....
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 6899999999999994 46789999999999999999999999 55 8899999999999999999984432211
Q ss_pred cc--ccccccccCccceeehhhhhc
Q psy3182 73 RQ--TRLYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 73 ~i--v~l~~~~~~~~~~ylv~E~~~ 95 (255)
.. -.-+...--++..||.+|...
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~ 201 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIH 201 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHh
Confidence 10 011222233567788888553
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.40 E-value=7e-13 Score=111.34 Aligned_cols=95 Identities=27% Similarity=0.407 Sum_probs=76.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+.||+|..++...+.+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+++.+.............
T Consensus 74 lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (279)
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence 58999999999999988888999999999999999999999999999999999999999999999876543221111111
Q ss_pred ccCccceeehhhhhc
Q psy3182 81 FKDSKYVYMLLEACL 95 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~ 95 (255)
....+..|+.+|.+.
T Consensus 154 ~~~~~~~y~aPE~~~ 168 (279)
T cd05633 154 ASVGTHGYMAPEVLQ 168 (279)
T ss_pred CcCCCcCccCHHHhc
Confidence 123455678888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.2e-13 Score=117.54 Aligned_cols=69 Identities=32% Similarity=0.591 Sum_probs=65.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
||||||.||+|.+++...+.+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+..
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecc
Confidence 689999999999999988899999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.2e-13 Score=118.07 Aligned_cols=96 Identities=27% Similarity=0.385 Sum_probs=81.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc--ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--RLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--~l~ 78 (255)
+|.|||.| ||+.++...++++|.+++.++.++++|+.|+|+.+|+|||+||.||+++..+.+|+++.....+.. +..
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 48999988 999999999999999999999999999999999999999999999999999999998754333221 112
Q ss_pred ccccCccceeehhhhhcch
Q psy3182 79 KTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~gg 97 (255)
.+--.++.+||.+|.+.|+
T Consensus 157 ltsikGtPlYmAPElv~e~ 175 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQ 175 (808)
T ss_pred eeeccCcccccCHHHHcCC
Confidence 2334577899999988775
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.40 E-value=9e-13 Score=113.48 Aligned_cols=95 Identities=22% Similarity=0.385 Sum_probs=75.5
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
|||||+.||+|.+++.+ ...+++..+..++.+++.|++|+|+++|+||||||+|++++.++.+|+.+.........
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 68999999999999976 46799999999999999999999999999999999999999999999987653322111
Q ss_pred ccccccCccceeehhhhhc
Q psy3182 77 LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~ 95 (255)
.......++..|+.+|++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred ceecccccCccccCHHHHh
Confidence 0111122455688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=8.3e-13 Score=110.79 Aligned_cols=96 Identities=28% Similarity=0.402 Sum_probs=76.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+.||+|..++...+.+++..+..++.+++.|++|+|+++|+||||||+|++++.++.+++.+.............
T Consensus 74 ~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 153 (278)
T cd05606 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (278)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence 58999999999999988888999999999999999999999999999999999999999999999876543222111111
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
.......|+.+|.+.+
T Consensus 154 ~~~~~~~y~aPE~~~~ 169 (278)
T cd05606 154 ASVGTHGYMAPEVLQK 169 (278)
T ss_pred CcCCCcCCcCcHHhcC
Confidence 1234456788887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.6e-13 Score=117.47 Aligned_cols=69 Identities=30% Similarity=0.557 Sum_probs=65.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
||||||.||+|.+.+.+.+.+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+..
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECC
Confidence 699999999999999888889999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.6e-13 Score=113.60 Aligned_cols=96 Identities=30% Similarity=0.425 Sum_probs=76.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc-c-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT-R-LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv-~-l~ 78 (255)
|||||+.||+|...+.....+++.++..++.+++.|++|+|+++|+||||||+|++++.++.+|+.+........ . -.
T Consensus 73 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 689999999999999988889999999999999999999999999999999999999999999998764322110 0 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~ 170 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG 170 (316)
T ss_pred eeeecCCccccCHHHHcC
Confidence 011123456888887644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=1e-12 Score=116.38 Aligned_cols=112 Identities=28% Similarity=0.389 Sum_probs=88.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
||+|+|.-|+|..+++.++.++|+.|+++..|++.|++|||+++|+|||||..|++++.+-.+||-+......+-.-.
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 689999999999999999999999999999999999999999999999999999999999999997765443332111
Q ss_pred ccccCccceeehhhhhcc------hh-------HHHHHHhccCCCcc
Q psy3182 79 KTFKDSKYVYMLLEACLG------GE-------VWTILRERTCFDDN 112 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g------g~-------l~~~l~~~~~~~~~ 112 (255)
..--.++.-|+.+|.+.. -| ++.+|-.+++|...
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 112345667999997642 13 34566667777554
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.1e-13 Score=114.67 Aligned_cols=69 Identities=32% Similarity=0.618 Sum_probs=65.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
+||||+.||+|.+++.+.+.+++..+..++.+++.|+.|+|.+||+||||||+|++++.++.+|+.+..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCC
Confidence 589999999999999988889999999999999999999999999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.6e-13 Score=113.52 Aligned_cols=96 Identities=34% Similarity=0.465 Sum_probs=76.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
+||||+.||+|++.+...+.+++..+..++.+++.|++|+|+++|+||||||+|++++.++.+|+.+.........- .
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred EEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence 58999999999999998888999999999999999999999999999999999999999999999876533211100 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 157 THTFCGTIEYMAPEILMR 174 (323)
T ss_pred ccccCCCccccChhhccC
Confidence 111123456888886543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.7e-13 Score=126.92 Aligned_cols=153 Identities=20% Similarity=0.264 Sum_probs=107.5
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
-.++||...+..+....+..|||=+|... +|++.+..++.+. ...-.+|+-|++.||.-||..||+|+
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~-----------~iEKkWiaFQLL~al~qcH~~gVcHG 144 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLV-----------LIEKKWIAFQLLKALSQCHKLGVCHG 144 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHH-----------HHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 34688888888888888999999999865 6877776543221 22457889999999999999999999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCC-
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNR- 226 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 226 (255)
|||.+|||++.=+.+.+++|....-..-+. .++ .||++-.- |..--..|+|||-+...
T Consensus 145 DIKsENILiTSWNW~~LtDFAsFKPtYLPe----------DNP--adf~fFFD---------TSrRRtCYiAPERFv~~~ 203 (1431)
T KOG1240|consen 145 DIKSENILITSWNWLYLTDFASFKPTYLPE----------DNP--ADFTFFFD---------TSRRRTCYIAPERFVSAL 203 (1431)
T ss_pred ccccceEEEeeechhhhhcccccCCccCCC----------CCc--ccceEEEe---------cCCceeeecChHhhhccc
Confidence 999999999987777776654432111111 111 35553210 00011269999987531
Q ss_pred ---------C-CCCcchHHHHHHHHHHHh-cCCCCCcC
Q psy3182 227 ---------G-HDRAVDYWALGILMHELL-TGMKESNV 253 (255)
Q Consensus 227 ---------~-~~~~~DiWslGvil~ell-~G~~~~~~ 253 (255)
+ ..++-||+|+||++.||+ .|.+||+.
T Consensus 204 ~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 204 GKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred cccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 1 356789999999999996 67898874
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.5e-13 Score=124.09 Aligned_cols=168 Identities=26% Similarity=0.353 Sum_probs=117.5
Q ss_pred ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCC
Q psy3182 71 KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLK 150 (255)
Q Consensus 71 h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlk 150 (255)
+|.+++.+..|-.....+++++|+.|+++...+...+|.++..++-.. ..+..+++|||+..+.|||++
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i-----------~~~vqs~e~L~s~~r~h~~~~ 931 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPI-----------LERVQSLESLHSSLRKHRDLK 931 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchh-----------HHHHhhhhccccchhhccccc
Confidence 355555556666778899999999999999999988877765544332 236778999999999999999
Q ss_pred CCceeeCCCCceeecccCCccee--eecCCCCCceeeeeCCeeeeeccccccCCCCC----ccccccccCCCCccccccc
Q psy3182 151 PENLLLDNRGYVKLEFYPAGHYI--IREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----CKTWTFCGTPEYVAPEIIK 224 (255)
Q Consensus 151 p~nil~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~~~~~~~gt~~y~aPE~~~ 224 (255)
|.|++....+..++..++..... +....... -....+.. -+++.+.....-. .......||+.|.+||...
T Consensus 932 p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s-g~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen 932 PDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS-GPSSSGTP--RRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred ccchhhcccCCcccCccccccccccccCcCCcc-cccccCcc--ccccccccccccccchhhccccccCCCcccCCcccc
Confidence 99999999998888776533322 11111110 00000000 0222111111100 1123467999999999999
Q ss_pred CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 225 NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 225 ~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+..+...+|||+.|++++|.++|.+||+
T Consensus 1009 g~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 1009 GRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred cccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 9999999999999999999999999997
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=113.05 Aligned_cols=77 Identities=18% Similarity=0.183 Sum_probs=56.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccccc----cCccceeehhhhhc
Q psy3182 20 CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTF----KDSKYVYMLLEACL 95 (255)
Q Consensus 20 ~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~~----~~~~~~ylv~E~~~ 95 (255)
.+++.....++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+......+..-.... ......|+.+|.+.
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 249 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhh
Confidence 37778888999999999999999999999999999999999999998765443221110000 11123588888664
Q ss_pred c
Q psy3182 96 G 96 (255)
Q Consensus 96 g 96 (255)
+
T Consensus 250 ~ 250 (338)
T cd05102 250 D 250 (338)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.6e-13 Score=116.23 Aligned_cols=69 Identities=30% Similarity=0.575 Sum_probs=65.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
||||||.||+|.+++...+.+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+..
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 689999999999999988899999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.38 E-value=9e-13 Score=113.47 Aligned_cols=95 Identities=25% Similarity=0.422 Sum_probs=75.5
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
|||||+.||+|.+++.+ ...+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+.........
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 68999999999999976 45799999999999999999999999999999999999999999999987654322111
Q ss_pred ccccccCccceeehhhhhc
Q psy3182 77 LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~ 95 (255)
.......++..|+.+|.+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred ccccceeccccccCHHHHh
Confidence 0111122445688888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.4e-13 Score=116.60 Aligned_cols=69 Identities=30% Similarity=0.535 Sum_probs=65.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
+|||||.||+|.+++...+.+++..+..+++|++.|++|+|.++|+||||||+|++++..+.+|+.+..
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCc
Confidence 689999999999999988889999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=114.74 Aligned_cols=94 Identities=28% Similarity=0.390 Sum_probs=74.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--c-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--L- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l- 77 (255)
||||||.||+|..++.+ ..+++..+..++.+++.|++|||+++|+||||||+|++++.++.+|+.+......... .
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 68999999999999976 4699999999999999999999999999999999999999999999987654322111 0
Q ss_pred cccccCccceeehhhhhc
Q psy3182 78 YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~ 95 (255)
......++..|+.+|.+.
T Consensus 199 ~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 199 RCDTAVGTPDYISPEVLK 216 (370)
T ss_pred cCCCCCCCcCeECHHHhc
Confidence 111122445688888653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.3e-12 Score=107.10 Aligned_cols=95 Identities=26% Similarity=0.397 Sum_probs=75.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|.+.+.+...+++..+..++.+++.|++|+|.++++||||||+|++++.++.+++.+........... .
T Consensus 62 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-~ 140 (237)
T cd05576 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-D 140 (237)
T ss_pred EEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-c
Confidence 689999999999999887789999999999999999999999999999999999999999999987754322211111 1
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
.......|+.+|...+
T Consensus 141 ~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 141 GEAVENMYCAPEVGGI 156 (237)
T ss_pred cCCcCccccCCcccCC
Confidence 1122345788886644
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-12 Score=107.35 Aligned_cols=149 Identities=22% Similarity=0.380 Sum_probs=111.8
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
..+.|...|...+.+.+-.||+|.+ |-+|.++..-.+ .|+ ...+.-++.|++.-++|+|++..|.||
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FS-----------vKTV~miA~Qmi~rie~vH~k~LIYRD 149 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFS-----------VKTVAMIAKQMITRIEYVHEKDLIYRD 149 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCccc-----------HHhHHHHHHHHHHHHHHHHhcceeecc
Confidence 3567777888888898999999966 555554443211 122 122345678899999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-------ccccccCCCCcccc
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-------TWTFCGTPEYVAPE 221 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-------~~~~~gt~~y~aPE 221 (255)
+||+|+|+...+...-. -.-.+|||+++.......+ ...+.||..||+-.
T Consensus 150 IKPdNFLIGrp~~k~~n-----------------------~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSIN 206 (449)
T KOG1165|consen 150 IKPDNFLIGRPGTKDAN-----------------------VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSIN 206 (449)
T ss_pred cCccceeecCCCCCCCc-----------------------eEEEEeccchhhhcCccccccCccccccccccceeeeEee
Confidence 99999999886543210 0112699999877554322 23567999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...++.-+.+-|+=|||=++...+-|.-|+..
T Consensus 207 THlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 207 THLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred ccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 99999899999999999999999999998864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-12 Score=117.82 Aligned_cols=96 Identities=20% Similarity=0.272 Sum_probs=74.5
Q ss_pred CeeeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~----~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~ 76 (255)
|||||+.||+|.+.++. ...+++..+..++.+++.|++|+|+++|+||||||+||+++..+.+|+.+.........
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 69999999999988753 44699999999999999999999999999999999999999999999987654322211
Q ss_pred cc----ccccCccceeehhhhhcc
Q psy3182 77 LY----KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~----~~~~~~~~~ylv~E~~~g 96 (255)
-. .....++..|+.+|.+.+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred ccccccccccCCCccccCHhHhCC
Confidence 00 111123456888886644
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=112.63 Aligned_cols=95 Identities=29% Similarity=0.462 Sum_probs=75.2
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
|||||+.||+|.+++... ..+++..+..++.+++.|++|+|+++|+||||||+|++++..+.+|+.+.........
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 689999999999999875 6799999999999999999999999999999999999999999999987543321110
Q ss_pred ccccccCccceeehhhhhc
Q psy3182 77 LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~ 95 (255)
........+..|+.+|.+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred eeeecccCCccccCHHHhc
Confidence 0111123345677777654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-12 Score=114.43 Aligned_cols=94 Identities=28% Similarity=0.400 Sum_probs=74.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--c-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--L- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l- 77 (255)
+|||||.||+|..++.+ ..+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+......... .
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 58999999999999976 4599999999999999999999999999999999999999999999987654322211 0
Q ss_pred cccccCccceeehhhhhc
Q psy3182 78 YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~ 95 (255)
......++..|+.+|.+.
T Consensus 199 ~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 199 RCDTAVGTPDYISPEVLK 216 (371)
T ss_pred cccCcccCccccCHHHHh
Confidence 011122455688888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.4e-12 Score=111.69 Aligned_cols=96 Identities=27% Similarity=0.403 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
+||||+.||+|...+.+.+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+......... ..
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 5899999999999998888899999999999999999999999999999999999999999999987543211000 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|.+.+
T Consensus 153 ~~~~~g~~~y~aPE~~~~ 170 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY 170 (318)
T ss_pred ccceecCccccCHHHhcC
Confidence 001123456888887654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 255 | ||||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-27 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-27 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-27 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-26 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-26 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-26 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-26 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-26 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-26 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-26 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-26 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-26 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-26 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-26 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-18 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-17 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-16 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-16 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-05 | ||
| 3shr_A | 299 | Crystal Structure Of Cgmp-Dependent Protein Kinase | 4e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-04 |
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3SHR|A Chain A, Crystal Structure Of Cgmp-Dependent Protein Kinase Reveals Novel Site Of Interchain Communication Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-64
Identities = 61/173 (35%), Positives = 96/173 (55%), Gaps = 42/173 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+L +FKD+ +YM++E GGE+++ LR F + A F A ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF--------- 154
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
EYLH+ +++RDLKPENLL+D +GY+++ D
Sbjct: 155 --EYLHSLDLIYRDLKPENLLIDQQGYIQV----------------------------TD 184
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FGF+K + +TWT CGTPE +APEII ++G+++AVD+WALG+L++E+ G
Sbjct: 185 FGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 27/66 (40%), Positives = 44/66 (66%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E GGE+++ LR F + A F A ++ EYLH+ +++RDLKPENLL+D +
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 61 GYVKLV 66
GY+++
Sbjct: 178 GYIQVT 183
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-56
Identities = 57/173 (32%), Positives = 100/173 (57%), Gaps = 42/173 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
R++ TF+D++ ++M+++ GGE++++LR+ F + A F A V AL
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL--------- 119
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
EYLH++ I++RDLKPEN+LLD G++K+ D
Sbjct: 120 --EYLHSKDIIYRDLKPENILLDKNGHIKI----------------------------TD 149
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FGF+K++ T+T CGTP+Y+APE++ + +++++D+W+ GIL++E+L G
Sbjct: 150 FGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 5e-22
Identities = 30/65 (46%), Positives = 47/65 (72%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M+++ GGE++++LR+ F + A F A V ALEYLH++ I++RDLKPEN+LLD
Sbjct: 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 142
Query: 61 GYVKL 65
G++K+
Sbjct: 143 GHIKI 147
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-55
Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 41/175 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+LY TF+D + +Y L GE+ +R+ FD+ F TA E ++
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---E--------IVS 141
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
ALEYLH +GI+ RDLKPEN+LL+ ++++ D
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQI----------------------------TD 173
Query: 195 FGFSKHLGH--SGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG +K L + +F GT +YV+PE++ + ++ D WALG ++++L+ G
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 26/65 (40%), Positives = 40/65 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
L GE+ +R+ FD+ F TA ++ ALEYLH +GI+ RDLKPEN+LL+
Sbjct: 107 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 61 GYVKL 65
++++
Sbjct: 167 MHIQI 171
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-50
Identities = 54/172 (31%), Positives = 81/172 (47%), Gaps = 41/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY F D+ VY++LE G V+ L++ + FD+ + + AL
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS--------- 123
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
Y H++ ++ RD+KPENLLL + G +K+ DF
Sbjct: 124 --YCHSKRVIHRDIKPENLLLGSAGELKI----------------------------ADF 153
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G+S H S + CGT +Y+ PE+I+ R HD VD W+LG+L +E L G
Sbjct: 154 GWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-19
Identities = 22/65 (33%), Positives = 39/65 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE G V+ L++ + FD+ + + AL Y H++ ++ RD+KPENLLL +
Sbjct: 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 145
Query: 61 GYVKL 65
G +K+
Sbjct: 146 GELKI 150
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 9e-50
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 41/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
R+Y F D K +Y++LE GE++ L++ FD+ ++ + +AL
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH--------- 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
Y H R ++ RD+KPENLL+ +G +K+ DF
Sbjct: 129 --YCHERKVIHRDIKPENLLMGYKGELKI----------------------------ADF 158
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G+S H + T CGT +Y+ PE+I+ + HD VD W G+L +E L G
Sbjct: 159 GWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 22/65 (33%), Positives = 40/65 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GE++ L++ FD+ ++ + +AL Y H R ++ RD+KPENLL+ +
Sbjct: 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK 150
Query: 61 GYVKL 65
G +K+
Sbjct: 151 GELKI 155
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-48
Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 45/178 (25%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+L+ F+D +Y+YM++E GG++ ++ + A F TA E V+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA---E--------VVL 179
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
AL+ +H+ G + RD+KP+N+LLD G++KL D
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKL----------------------------AD 211
Query: 195 FGFSKHLGHSGC-KTWTFCGTPEYVAPEIIKNRG----HDRAVDYWALGILMHELLTG 247
FG + G + T GTP+Y++PE++K++G + R D+W++G+ ++E+L G
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 24/65 (36%), Positives = 41/65 (63%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E GG++ ++ + A F TA V+ AL+ +H+ G + RD+KP+N+LLD
Sbjct: 146 MVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
Query: 61 GYVKL 65
G++KL
Sbjct: 205 GHLKL 209
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 43/176 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
L+ +F+D + ++M+++ LGG++ L++ F + ++ AL
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL--------- 128
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+YL + I+ RD+KP+N+LLD G+V + D
Sbjct: 129 --DYLQNQRIIHRDMKPDNILLDEHGHVHI----------------------------TD 158
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNR---GHDRAVDYWALGILMHELLTG 247
F + L + T GT Y+APE+ +R G+ AVD+W+LG+ +ELL G
Sbjct: 159 FNIAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-20
Identities = 21/65 (32%), Positives = 39/65 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M+++ LGG++ L++ F + ++ AL+YL + I+ RD+KP+N+LLD
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH 151
Query: 61 GYVKL 65
G+V +
Sbjct: 152 GHVHI 156
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 58/176 (32%), Positives = 92/176 (52%), Gaps = 42/176 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
L+ F+ ++++L+ GGE++T L +R F ++ ++ AL
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL--------- 172
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
E+LH GI++RD+K EN+LLD+ G+V L D
Sbjct: 173 --EHLHKLGIIYRDIKLENILLDSNGHVVL----------------------------TD 202
Query: 195 FGFSK-HLGHSGCKTWTFCGTPEYVAPEIIK--NRGHDRAVDYWALGILMHELLTG 247
FG SK + + + FCGT EY+AP+I++ + GHD+AVD+W+LG+LM+ELLTG
Sbjct: 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-18
Identities = 26/65 (40%), Positives = 43/65 (66%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GGE++T L +R F ++ ++ ALE+LH GI++RD+K EN+LLD+
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 61 GYVKL 65
G+V L
Sbjct: 196 GHVVL 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-46
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
L+ +F+ + +Y +L+ GGE++ L+ CF + A F A + AL
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL--------- 152
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
YLH+ IV+RDLKPEN+LLD++G++ L D
Sbjct: 153 --GYLHSLNIVYRDLKPENILLDSQGHIVL----------------------------TD 182
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K T TFCGTPEY+APE++ + +DR VD+W LG +++E+L G
Sbjct: 183 FGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-18
Identities = 29/65 (44%), Positives = 43/65 (66%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+L+ GGE++ L+ CF + A F A + AL YLH+ IV+RDLKPEN+LLD++
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 61 GYVKL 65
G++ L
Sbjct: 176 GHIVL 180
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-45
Identities = 63/173 (36%), Positives = 90/173 (52%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
L F+ +Y++LE GGE++ L F ++ A F A + AL
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL--------- 134
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+LH +GI++RDLKPEN++L+++G+VKL D
Sbjct: 135 --GHLHQKGIIYRDLKPENIMLNHQGHVKL----------------------------TD 164
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K H G T TFCGT EY+APEI+ GH+RAVD+W+LG LM+++LTG
Sbjct: 165 FGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 9e-18
Identities = 28/63 (44%), Positives = 43/63 (68%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
LE GGE++ L F ++ A F A + AL +LH +GI++RDLKPEN++L+++G+
Sbjct: 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH 159
Query: 63 VKL 65
VKL
Sbjct: 160 VKL 162
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 57/173 (32%), Positives = 89/173 (51%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+L+ F+ +Y++L+ GG+++T L + F + F A + AL
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL--------- 139
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
++LH+ GI++RDLKPEN+LLD G++KL D
Sbjct: 140 --DHLHSLGIIYRDLKPENILLDEEGHIKL----------------------------TD 169
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG SK K ++FCGT EY+APE++ RGH ++ D+W+ G+LM E+LTG
Sbjct: 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 9e-18
Identities = 27/65 (41%), Positives = 44/65 (67%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GG+++T L + F + F A + AL++LH+ GI++RDLKPEN+LLD
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162
Query: 61 GYVKL 65
G++KL
Sbjct: 163 GHIKL 167
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-45
Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T ++ TF+ + ++ ++E GG++ ++ FD + A+F A +I L
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL--------- 131
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
++LH++GIV+RDLK +N+LLD G++K+ D
Sbjct: 132 --QFLHSKGIVYRDLKLDNILLDKDGHIKI----------------------------AD 161
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K KT TFCGTP+Y+APEI+ + ++ +VD+W+ G+L++E+L G
Sbjct: 162 FGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-18
Identities = 25/65 (38%), Positives = 44/65 (67%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GG++ ++ FD + A+F A +I L++LH++GIV+RDLK +N+LLD
Sbjct: 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 154
Query: 61 GYVKL 65
G++K+
Sbjct: 155 GHIKI 159
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-45
Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 46/180 (25%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALDFITACVI 133
T L+ F+D +Y++++ +GG++ T+L + + A F A E ++
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA---E--------MV 185
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
A++ +H V RD+KP+N+L+D G+++L
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRL----------------------------A 217
Query: 194 DFGFSKHLGHSG-CKTWTFCGTPEYVAPEIIK-----NRGHDRAVDYWALGILMHELLTG 247
DFG L G ++ GTP+Y++PEI++ + D+W+LG+ M+E+L G
Sbjct: 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 19/66 (28%), Positives = 41/66 (62%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++++ +GG++ T+L + + A F A ++ A++ +H V RD+KP+N+L+D
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 210
Query: 60 RGYVKL 65
G+++L
Sbjct: 211 NGHIRL 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-44
Identities = 56/173 (32%), Positives = 90/173 (52%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+L+ F+ ++ ++E GG++ +++ FD+ A F A +I AL
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL--------- 137
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+LH +GI++RDLK +N+LLD+ G+ KL D
Sbjct: 138 --MFLHDKGIIYRDLKLDNVLLDHEGHCKL----------------------------AD 167
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K +G T TFCGTP+Y+APEI++ + AVD+WA+G+L++E+L G
Sbjct: 168 FGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 26/63 (41%), Positives = 42/63 (66%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E GG++ +++ FD+ A F A +I AL +LH +GI++RDLK +N+LLD+ G+
Sbjct: 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH 162
Query: 63 VKL 65
KL
Sbjct: 163 CKL 165
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 48/182 (26%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALDFITACVI 133
T+L+ F+D Y+Y+++E +GG++ T+L + A F A E ++
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA---E--------IV 172
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
A++ +H G V RD+KP+N+LLD G+++L
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRL----------------------------A 204
Query: 194 DFGFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNRG-------HDRAVDYWALGILMHELL 245
DFG L G ++ GTP+Y++PEI++ G + D+WALG+ +E+
Sbjct: 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 246 TG 247
G
Sbjct: 265 YG 266
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-17
Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E +GG++ T+L + A F A ++ A++ +H G V RD+KP+N+LLD
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR 197
Query: 60 RGYVKL 65
G+++L
Sbjct: 198 CGHIRL 203
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-43
Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+L+ F+ +Y ++E GG++ +++ F + A F A + L
Sbjct: 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL--------- 134
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+L ++GI++RDLK +N++LD+ G++K+ D
Sbjct: 135 --FFLQSKGIIYRDLKLDNVMLDSEGHIKI----------------------------AD 164
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K G T TFCGTP+Y+APEII + + ++VD+WA G+L++E+L G
Sbjct: 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 20/63 (31%), Positives = 40/63 (63%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E GG++ +++ F + A F A + L +L ++GI++RDLK +N++LD+ G+
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH 159
Query: 63 VKL 65
+K+
Sbjct: 160 IKI 162
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-43
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
L+ F+ ++ ++E GG++ ++ + + A F +A +
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-----------RFYSAEISL 121
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
AL YLH RGI++RDLK +N+LLD+ G++KL D
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKL----------------------------TD 153
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+G K G T TFCGTP Y+APEI++ + +VD+WALG+LM E++ G
Sbjct: 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-17
Identities = 25/65 (38%), Positives = 42/65 (64%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GG++ ++ + + A F +A + AL YLH RGI++RDLK +N+LLD+
Sbjct: 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 61 GYVKL 65
G++KL
Sbjct: 147 GHIKL 151
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 56/173 (32%), Positives = 85/173 (49%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T L F+ + ++E GGE++ L F + A F A ++ AL
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL--------- 118
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
EYLH+R +V+RD+K ENL+LD G++K+ D
Sbjct: 119 --EYLHSRDVVYRDIKLENLMLDKDGHIKI----------------------------TD 148
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K G TFCGTPEY+APE++++ + RAVD+W LG++M+E++ G
Sbjct: 149 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-17
Identities = 27/63 (42%), Positives = 41/63 (65%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E GGE++ L F + A F A ++ ALEYLH+R +V+RD+K ENL+LD G+
Sbjct: 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 63 VKL 65
+K+
Sbjct: 144 IKI 146
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-43
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
L+ F+ ++ ++E GG++ ++ + + A F +A +
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-----------RFYSAEISL 164
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
AL YLH RGI++RDLK +N+LLD+ G++KL D
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKL----------------------------TD 196
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+G K G T TFCGTP Y+APEI++ + +VD+WALG+LM E++ G
Sbjct: 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 25/65 (38%), Positives = 42/65 (64%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GG++ ++ + + A F +A + AL YLH RGI++RDLK +N+LLD+
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 61 GYVKL 65
G++KL
Sbjct: 190 GHIKL 194
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 40/175 (22%), Positives = 62/175 (35%), Gaps = 36/175 (20%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ VY++ E + D N FI + I V+ +
Sbjct: 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP--IQVIKCII-KSVLNS 163
Query: 136 LEYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
Y+H + I RD+KP N+L+D G VKL D
Sbjct: 164 FSYIHNEKNICHRDVKPSNILMDKNGRVKL----------------------------SD 195
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG--HDRAVDYWALGILMHELLTG 247
FG S+++ K GT E++ PE N + VD W+LGI ++ +
Sbjct: 196 FGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 9/74 (12%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNA--------ASFITACVIEALEYLHT-RGIVFRDLK 51
++ E + D N I V+ + Y+H + I RD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 52 PENLLLDNRGYVKL 65
P N+L+D G VKL
Sbjct: 180 PSNILMDKNGRVKL 193
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-42
Identities = 54/173 (31%), Positives = 73/173 (42%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIE 134
LY F+DS YVY++LE C GE+ L+ R F +N A +I +
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML-------- 126
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
YLH+ GI+ RDL NLLL +K+ D
Sbjct: 127 ---YLHSHGILHRDLTLSNLLLTRNMNIKI----------------------------AD 155
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + L K +T CGTP Y++PEI H D W+LG + + LL G
Sbjct: 156 FGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 24/66 (36%), Positives = 35/66 (53%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++LE C GE+ L+ R F +N A +I + YLH+ GI+ RDL NLLL
Sbjct: 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR 147
Query: 60 RGYVKL 65
+K+
Sbjct: 148 NMNIKI 153
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-42
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 39/172 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ F+D+ +V+++LE C + + + R + A + ++
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ--------- 155
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH ++ RDLK NL L+ VK I DF
Sbjct: 156 --YLHRNRVIHRDLKLGNLFLNEDLEVK----------------------IG------DF 185
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G + + + G + CGTP Y+APE++ +GH VD W++G +M+ LL G
Sbjct: 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 17/65 (26%), Positives = 31/65 (47%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE C + + + R + A + ++ +YLH ++ RDLK NL L+
Sbjct: 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177
Query: 61 GYVKL 65
VK+
Sbjct: 178 LEVKI 182
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 39/172 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ F+D+ +V+++LE C + + + R + A + ++
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ--------- 129
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH ++ RDLK NL L+ VK I DF
Sbjct: 130 --YLHRNRVIHRDLKLGNLFLNEDLEVK----------------------IG------DF 159
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G + + + G + CGTP Y+APE++ +GH VD W++G +M+ LL G
Sbjct: 160 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-16
Identities = 17/65 (26%), Positives = 31/65 (47%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE C + + + R + A + ++ +YLH ++ RDLK NL L+
Sbjct: 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 151
Query: 61 GYVKL 65
VK+
Sbjct: 152 LEVKI 156
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 42/174 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+ F + +L+ GG++ L + F + F A +I L
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL--------- 305
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
E++H R +V+RDLKP N+LLD G+V++ D
Sbjct: 306 --EHMHNRFVVYRDLKPANILLDEHGHVRI----------------------------SD 335
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEII-KNRGHDRAVDYWALGILMHELLTG 247
G + S K GT Y+APE++ K +D + D+++LG ++ +LL G
Sbjct: 336 LGLACDF--SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 24/65 (36%), Positives = 39/65 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+L+ GG++ L + F + F A +I LE++H R +V+RDLKP N+LLD
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 61 GYVKL 65
G+V++
Sbjct: 329 GHVRI 333
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-41
Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 43/177 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGE----VWTILRERTCFDDNAASFITACVIEALDFITA 130
L F+ + +++ GG+ ++ + + F + A F TA ++ L
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL----- 302
Query: 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
E+LH R I++RDLKPEN+LLD+ G V++
Sbjct: 303 ------EHLHQRNIIYRDLKPENVLLDDDGNVRI-------------------------- 330
Query: 191 VKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
D G + L KT + GTP ++APE++ +D +VDY+ALG+ ++E++
Sbjct: 331 --SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 9e-16
Identities = 25/69 (36%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 1 MLLEACLGGE----VWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
+++ GG+ ++ + + F + A F TA ++ LE+LH R I++RDLKPEN+L
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321
Query: 57 LDNRGYVKL 65
LD+ G V++
Sbjct: 322 LDDDGNVRI 330
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 40/174 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T L +F+ + ++E GGE++ L F ++ A F A ++ AL
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL--------- 261
Query: 135 ALEYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+YLH+ + +V+RDLK ENL+LD G++K+
Sbjct: 262 --DYLHSEKNVVYRDLKLENLMLDKDGHIKI----------------------------T 291
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG K G TFCGTPEY+APE++++ + RAVD+W LG++M+E++ G
Sbjct: 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 26/66 (39%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDN 59
++E GGE++ L F ++ A F A ++ AL+YLH+ + +V+RDLK ENL+LD
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 60 RGYVKL 65
G++K+
Sbjct: 285 DGHIKI 290
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 5e-41
Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 39/173 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+L+ F+ +Y ++E GG++ +++ F + A F A + L
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL--------- 455
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+L ++GI++RDLK +N++LD+ G++K+ D
Sbjct: 456 --FFLQSKGIIYRDLKLDNVMLDSEGHIKI----------------------------AD 485
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG K G T TFCGTP+Y+APEII + + ++VD+WA G+L++E+L G
Sbjct: 486 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 20/65 (30%), Positives = 41/65 (63%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GG++ +++ F + A F A + L +L ++GI++RDLK +N++LD+
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 61 GYVKL 65
G++K+
Sbjct: 479 GHIKI 483
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 42/175 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEV-WTILRE-RTCFDDNAASFITACVIEALDFITACV 132
L ++ + ++L GG++ + I + F + A F A + L
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL------- 299
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
E LH IV+RDLKPEN+LLD+ G++++
Sbjct: 300 ----EDLHRERIVYRDLKPENILLDDHGHIRI---------------------------- 327
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
D G + H+ G GT Y+APE++KN + + D+WALG L++E++ G
Sbjct: 328 SDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 25/67 (37%), Positives = 40/67 (59%), Gaps = 2/67 (2%)
Query: 1 MLLEACLGGEV-WTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
++L GG++ + I + F + A F A + LE LH IV+RDLKPEN+LLD
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD 320
Query: 59 NRGYVKL 65
+ G++++
Sbjct: 321 DHGHIRI 327
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-36
Identities = 25/174 (14%), Positives = 56/174 (32%), Gaps = 25/174 (14%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ Y ++ E G + + + ++
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI------SFAMRMLYM 184
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+E +H I+ D+KP+N +L N + + + D + +D
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNG-------------FLEQDDEDDLSAGL----ALIDL 227
Query: 196 GFSKHLGH--SGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G S + G C T + E++ N+ + +DY+ + ++ +L G
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 11/65 (16%), Positives = 23/65 (35%), Gaps = 5/65 (7%)
Query: 1 MLLEACLGGEVWTILRERT-----CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENL 55
++ E G + + ++ +E +H I+ D+KP+N
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203
Query: 56 LLDNR 60
+L N
Sbjct: 204 ILGNG 208
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 38/175 (21%), Positives = 64/175 (36%), Gaps = 41/175 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
RL + +++ +Y+ E C + + AL
Sbjct: 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL--------- 170
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+LH++G+V D+KP N+ L RG KL D
Sbjct: 171 --AHLHSQGLVHLDVKPANIFLGPRGRCKL----------------------------GD 200
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
FG LG +G G P Y+APE+++ + A D ++LG+ + E+ M+
Sbjct: 201 FGLLVELGTAGAGE-VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME 253
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 22/101 (21%), Positives = 35/101 (34%), Gaps = 7/101 (6%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ E C + + AL +LH++G+V D+KP N+ L R
Sbjct: 134 LQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR 193
Query: 61 GYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGG 97
G KL + + T + + YM E G
Sbjct: 194 GRCKLGDFGLLVELGTAGAG--EVQEGDPR-YMAPELLQGS 231
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 43/176 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L + D KYVY++ E GGE+ + + F + AS + + + +
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV---------- 129
Query: 136 LEYLHTRGIVFRDLKPENLLL----DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
EYLH +G+V RDLKP N+L N +++
Sbjct: 130 -EYLHAQGVVHRDLKPSNILYVDESGNPESIRI--------------------------- 161
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFGF+K L T C T +VAPE+++ +G+D A D W+LG+L++ +LTG
Sbjct: 162 -CDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E GGE+ + + F + AS + + + +EYLH +G+V RDLKP N+L +
Sbjct: 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDE 152
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-36
Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 38/173 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L++ F D + ++++E GGE++ ++++ F + AS+I ++ A+
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV---------- 119
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
++H G+V RDLKPENLL + + ++K+ D
Sbjct: 120 -SHMHDVGVVHRDLKPENLLFTDE-------------------NDNL-------EIKIID 152
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FGF++ T C T Y APE++ G+D + D W+LG++++ +L+G
Sbjct: 153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 21/60 (35%), Positives = 39/60 (65%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GGE++ ++++ F + AS+I ++ A+ ++H G+V RDLKPENLL +
Sbjct: 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-34
Identities = 40/185 (21%), Positives = 69/185 (37%), Gaps = 54/185 (29%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY +Y+YM++E C ++ + L+++ D ++EA+
Sbjct: 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV---------- 140
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+H GIV DLKP N L+ + G +KL +DF
Sbjct: 141 -HTIHQHGIVHSDLKPANFLIVD-GMLKL----------------------------IDF 170
Query: 196 GFSKHL--GHSGCKTWTFCGTPEYVAPEIIKNRG-----------HDRAVDYWALGILMH 242
G + + + + GT Y+ PE IK+ D W+LG +++
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230
Query: 243 ELLTG 247
+ G
Sbjct: 231 YMTYG 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-15
Identities = 20/65 (30%), Positives = 35/65 (53%), Gaps = 2/65 (3%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E C ++ + L+++ D ++EA+ +H GIV DLKP N L+ +
Sbjct: 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD- 162
Query: 61 GYVKL 65
G +KL
Sbjct: 163 GMLKL 167
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 39/185 (21%), Positives = 68/185 (36%), Gaps = 54/185 (29%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY +Y+YM++E C ++ + L+++ D ++EA+
Sbjct: 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV---------- 168
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+H GIV DLKP N L+ + G +KL +DF
Sbjct: 169 -HTIHQHGIVHSDLKPANFLIVD-GMLKL----------------------------IDF 198
Query: 196 GFSKHL--GHSGCKTWTFCGTPEYVAPEIIKNRG-----------HDRAVDYWALGILMH 242
G + + + + G Y+ PE IK+ D W+LG +++
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 243 ELLTG 247
+ G
Sbjct: 259 YMTYG 263
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 20/65 (30%), Positives = 35/65 (53%), Gaps = 2/65 (3%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E C ++ + L+++ D ++EA+ +H GIV DLKP N L+ +
Sbjct: 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD- 190
Query: 61 GYVKL 65
G +KL
Sbjct: 191 GMLKL 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-34
Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 39/173 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL+ + ++ + Y++ + GGE++ + R + + AS ++E++
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI---------- 141
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
Y H+ GIV R+LKPENLLL ++ +GA VK+ D
Sbjct: 142 -AYCHSNGIVHRNLKPENLLLASKA---------------KGAA-----------VKLAD 174
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + + F GTP Y++PE++K + + VD WA G++++ LL G
Sbjct: 175 FGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 21/60 (35%), Positives = 37/60 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + GGE++ + R + + AS ++E++ Y H+ GIV R+LKPENLLL ++
Sbjct: 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 164
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 40/185 (21%), Positives = 69/185 (37%), Gaps = 54/185 (29%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY +Y+YM++E C ++ + L+++ D ++EA+
Sbjct: 73 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV---------- 121
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+H GIV DLKP N L+ + G +KL +DF
Sbjct: 122 -HTIHQHGIVHSDLKPANFLIVD-GMLKL----------------------------IDF 151
Query: 196 GFSKHL--GHSGCKTWTFCGTPEYVAPEIIKNRG-----------HDRAVDYWALGILMH 242
G + + + + GT Y+ PE IK+ D W+LG +++
Sbjct: 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211
Query: 243 ELLTG 247
+ G
Sbjct: 212 YMTYG 216
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-15
Identities = 20/65 (30%), Positives = 35/65 (53%), Gaps = 2/65 (3%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E C ++ + L+++ D ++EA+ +H GIV DLKP N L+ +
Sbjct: 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD- 143
Query: 61 GYVKL 65
G +KL
Sbjct: 144 GMLKL 148
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 48/180 (26%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDF-------I 128
L +T+ +YM+ E G ++ + I +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADL---------CFE-----IVKRADAGFVYSEAVASHY 135
Query: 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISG 188
++EAL Y H I+ RD+KP +LL ++ A
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKE---------------NSAP--------- 171
Query: 189 GQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
VK+ FG + LG SG GTP ++APE++K + + VD W G+++ LL+G
Sbjct: 172 --VKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 4/64 (6%)
Query: 1 MLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
M+ E G ++ + +R + + AS ++EAL Y H I+ RD+KP +L
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162
Query: 57 LDNR 60
L ++
Sbjct: 163 LASK 166
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 39/173 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL+ + ++ + Y++ + GGE++ + R + + AS ++E++
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI---------- 118
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
Y H+ GIV R+LKPENLLL ++ G VK+ D
Sbjct: 119 -AYCHSNGIVHRNLKPENLLLASKA--------------------------KGAAVKLAD 151
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + + F GTP Y++PE++K + + VD WA G++++ LL G
Sbjct: 152 FGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-12
Identities = 21/60 (35%), Positives = 37/60 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + GGE++ + R + + AS ++E++ Y H+ GIV R+LKPENLLL ++
Sbjct: 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 141
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 45/173 (26%), Positives = 81/173 (46%), Gaps = 38/173 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL+ + + + Y++ + GGE++ + R + + AS ++EA+
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV---------- 123
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
+ H G+V R+LKPENLLL ++ +GA VK+ D
Sbjct: 124 -LHCHQMGVVHRNLKPENLLLASKL---------------KGAA-----------VKLAD 156
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + + + F GTP Y++PE+++ + + VD WA G++++ LL G
Sbjct: 157 FGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 20/60 (33%), Positives = 36/60 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + GGE++ + R + + AS ++EA+ + H G+V R+LKPENLLL ++
Sbjct: 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK 146
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 46/178 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L T++ + + +++ + GE++ L E+ + I ++E
Sbjct: 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---------MRA--LLEV 136
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ LH IV RDLKPEN+LLD+ +KL DF
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKL----------------------------TDF 168
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIK------NRGHDRAVDYWALGILMHELLTG 247
GFS L G K CGTP Y+APEII+ + G+ + VD W+ G++M+ LL G
Sbjct: 169 GFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 22/65 (33%), Positives = 35/65 (53%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + GE++ L E+ + I ++E + LH IV RDLKPEN+LLD+
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 160
Query: 61 GYVKL 65
+KL
Sbjct: 161 MNIKL 165
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 38/186 (20%), Positives = 76/186 (40%), Gaps = 51/186 (27%)
Query: 76 RLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVI 133
+L+ ++ +++ +++E C G ++T+L E + NA + E L + V+
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS----NAYGLPES---EFLIVLR-DVV 122
Query: 134 EALEYLHTRGIVFRDLKPENLLL----DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG 189
+ +L GIV R++KP N++ D + KL
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL------------------------- 157
Query: 190 QVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK--------NRGHDRAVDYWALGILM 241
DFG ++ L + + GT EY+ P++ + + + VD W++G+
Sbjct: 158 ---TDFGAARELE-DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 242 HELLTG 247
+ TG
Sbjct: 214 YHAATG 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 18/73 (24%), Positives = 35/73 (47%), Gaps = 7/73 (9%)
Query: 1 MLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
+++E C G ++T+L E ++ + V+ + +L GIV R++KP N++
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145
Query: 58 ----DNRGYVKLV 66
D + KL
Sbjct: 146 VIGEDGQSVYKLT 158
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 38/186 (20%), Positives = 75/186 (40%), Gaps = 51/186 (27%)
Query: 76 RLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVI 133
+L+ ++ +++ +++E C G ++T+L E NA + E L + V+
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP----SNAYGLPES---EFLIVLR-DVV 122
Query: 134 EALEYLHTRGIVFRDLKPENLLL----DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG 189
+ +L GIV R++KP N++ D + KL
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL------------------------- 157
Query: 190 QVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK--------NRGHDRAVDYWALGILM 241
DFG ++ L + + GT EY+ P++ + + + VD W++G+
Sbjct: 158 ---TDFGAARELE-DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 242 HELLTG 247
+ TG
Sbjct: 214 YHAATG 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-13
Identities = 18/73 (24%), Positives = 35/73 (47%), Gaps = 7/73 (9%)
Query: 1 MLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
+++E C G ++T+L E ++ + V+ + +L GIV R++KP N++
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145
Query: 58 ----DNRGYVKLV 66
D + KL
Sbjct: 146 VIGEDGQSVYKLT 158
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 39/173 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L + F+ + ++LE GGE++ + E+ + + A+ ++EA+
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAV---------- 161
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
YLH GIV RDLKPENLL D+ +K+ D
Sbjct: 162 -AYLHENGIVHRDLKPENLLYATP-------------------APDA-------PLKIAD 194
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG SK + H T CGTP Y APEI++ + VD W++GI+ + LL G
Sbjct: 195 FGLSKIVEHQVLMK-TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-12
Identities = 24/60 (40%), Positives = 36/60 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ + E+ + + A+ ++EA+ YLH GIV RDLKPENLL
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP 184
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 42/174 (24%), Positives = 83/174 (47%), Gaps = 41/174 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFITACVI 133
+ ++F+++ +Y++++ C GG+++ + + F ++ + LD+ +
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED----------QILDWFVQ-IC 135
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
AL+++H R I+ RD+K +N+ L G V+L G
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQL-----G----------------------- 167
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG ++ L + GTP Y++PEI +N+ ++ D WALG +++EL T
Sbjct: 168 DFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 20/95 (21%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
++++ C GG+++ + + F ++ + AL+++H R I+ RD+K +N+ L
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 159
Query: 59 NRGYVKL----VSRKKKTRQTRLYKTFKDSKYVYM 89
G V+L ++ + L + + Y Y+
Sbjct: 160 KDGTVQLGDFGIA-RVLNSTVELARACIGTPY-YL 192
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-33
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L ++ + + Y++++ GGE++ + ER + + AS + V+ A+
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV---------- 119
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
+YLH GIV RDLKPENLL E +K + + D
Sbjct: 120 -KYLHENGIVHRDLKPENLLYLTPE---------------ENSK-----------IMITD 152
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG SK + T CGTP YVAPE++ + + +AVD W++G++ + LL G
Sbjct: 153 FGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-12
Identities = 24/61 (39%), Positives = 37/61 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++++ GGE++ + ER + + AS + V+ A++YLH GIV RDLKPENLL
Sbjct: 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP 142
Query: 61 G 61
Sbjct: 143 E 143
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 46/181 (25%)
Query: 76 RLYKTFKDSKYV------YMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFIT 129
+ + + + +E C GG++ L + +N +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF----ENCCGLKEG---PIRTLL- 127
Query: 130 ACVIEALEYLHTRGIVFRDLKPENLLLD---NRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+ + AL YLH I+ RDLKPEN++L R K+
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI---------------------- 165
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
+D G++K L G F GT +Y+APE+++ + + VDYW+ G L E +T
Sbjct: 166 ------IDLGYAKEL-DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
Query: 247 G 247
G
Sbjct: 219 G 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 6/72 (8%)
Query: 1 MLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
+ +E C GG++ L + + + + + AL YLH I+ RDLKPEN++L
Sbjct: 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154
Query: 58 D---NRGYVKLV 66
R K++
Sbjct: 155 QPGPQRLIHKII 166
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 46/178 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L +++ S +++++ + GE++ L E+ + I + ++EA
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI---------MRS--LLEA 212
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ +LH IV RDLKPEN+LLD+ ++L DF
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRL----------------------------SDF 244
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIK------NRGHDRAVDYWALGILMHELLTG 247
GFS HL G K CGTP Y+APEI+K + G+ + VD WA G+++ LL G
Sbjct: 245 GFSCHLEP-GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-13
Identities = 22/65 (33%), Positives = 37/65 (56%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + GE++ L E+ + I ++EA+ +LH IV RDLKPEN+LLD+
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN 236
Query: 61 GYVKL 65
++L
Sbjct: 237 MQIRL 241
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 45/179 (25%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
LY ++ +V + +E GG + ++++ C ++ A + +AL E
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG---QAL--------E 161
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
LEYLHTR I+ D+K +N+LL + G L
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAAL----------------------------C 193
Query: 194 DFGFSKHL-----GHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG + L G S GT ++APE++ + D VD W+ +M +L G
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 21/65 (32%), Positives = 36/65 (55%), Gaps = 1/65 (1%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG- 61
+E GG + ++++ C ++ A + +E LEYLHTR I+ D+K +N+LL + G
Sbjct: 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS 188
Query: 62 YVKLV 66
L
Sbjct: 189 RAALC 193
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-32
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 37/173 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L++ ++++ + ++LE GGE + C + A + + I ++E
Sbjct: 93 NLHEVYENTSEIILILEYAAGGE----IFSL-CLPELAEMVSEN---DVIRLIKQ-ILEG 143
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK-VD 194
+ YLH IV DLKP+N+LL + G +K VD
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIY--------------------------PLGDIKIVD 177
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S+ +GH C+ GTPEY+APEI+ A D W +GI+ + LLT
Sbjct: 178 FGMSRKIGH-ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 2/62 (3%)
Query: 1 MLLEACLGGEV--WTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
++LE GGE+ + +N + ++E + YLH IV DLKP+N+LL
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 59 NR 60
+
Sbjct: 166 SI 167
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-32
Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 38/173 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ +++ V ++LE GGE++ L ++ + A+ +++ +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV---------- 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK-VD 194
YLHT+ I DLKPEN++L ++ +K +D
Sbjct: 129 -NYLHTKKIAHFDLKPENIMLLDKNI-------------------------PIPHIKLID 162
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + + G + GTPE+VAPEI+ D W++G++ + LL+G
Sbjct: 163 FGLAHEIED-GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 19/60 (31%), Positives = 36/60 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ L ++ + A+ +++ + YLHT+ I DLKPEN++L ++
Sbjct: 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK 151
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-32
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY+TF+D+ +Y+++E C GGE++ + + F ++ A+ I V+ A+
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV---------- 119
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
Y H + RDLKPEN L DS +K+ D
Sbjct: 120 -AYCHKLNVAHRDLKPENFLFLTD-------------------SPDS-------PLKLID 152
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + G T GTP YV+P++++ + D W+ G++M+ LL G
Sbjct: 153 FGLAARFK-PGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-12
Identities = 20/60 (33%), Positives = 33/60 (55%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E C GGE++ + + F ++ A+ I V+ A+ Y H + RDLKPEN L
Sbjct: 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-32
Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L++ +DS Y++ E GGE++ + +R F ++ A+ I V +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI---------- 134
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
Y+H IV RDLKPEN+LL+++ + D +K+ D
Sbjct: 135 -TYMHKHNIVHRDLKPENILLESK-------------------EKDC-------DIKIID 167
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S K GT Y+APE+++ +D D W+ G++++ LL+G
Sbjct: 168 FGLSTCFQ-QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 22/60 (36%), Positives = 37/60 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E GGE++ + +R F ++ A+ I V + Y+H IV RDLKPEN+LL+++
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-32
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 43/176 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
++ F D++ Y++LE GGE++ + + F ++ A
Sbjct: 204 KIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY---------FYQ--MLLA 251
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
++YLH GI+ RDLKPEN+LL ++ +K+ D
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQE--------------------------EDCLIKITD 285
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN---RGHDRAVDYWALGILMHELLTG 247
FG SK LG T CGTP Y+APE++ + G++RAVD W+LG+++ L+G
Sbjct: 286 FGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ + + ++ A++YLH GI+ RDLKPEN+LL ++
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 43/205 (20%), Positives = 79/205 (38%), Gaps = 57/205 (27%)
Query: 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFIT 129
++ + K +++ +E C G ++ ++ E
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ---------RDEYWRLF- 122
Query: 130 ACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG 189
++EAL Y+H++GI+ RDLKP N+ +D VK+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI------------------------- 157
Query: 190 QVKVDFGFSKHLGHSGCKTW--------------TFCGTPEYVAPEIIKNRGH-DRAVDY 234
DFG +K++ S + GT YVA E++ GH + +D
Sbjct: 158 ---GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214
Query: 235 WALGILMHELL----TGMKESNVFQ 255
++LGI+ E++ TGM+ N+ +
Sbjct: 215 YSLGIIFFEMIYPFSTGMERVNILK 239
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-13
Identities = 19/63 (30%), Positives = 34/63 (53%), Gaps = 1/63 (1%)
Query: 4 EACLGGEVWTILRERTCFDD-NAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
E C G ++ ++ + + ++EAL Y+H++GI+ RDLKP N+ +D
Sbjct: 95 EYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN 154
Query: 63 VKL 65
VK+
Sbjct: 155 VKI 157
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 38/173 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ +++ V ++LE GGE++ L ++ + A+ +++ +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV---------- 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK-VD 194
YLHT+ I DLKPEN++L ++ +K +D
Sbjct: 129 -NYLHTKKIAHFDLKPENIMLLDKNI-------------------------PIPHIKLID 162
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + + G + GTPE+VAPEI+ D W++G++ + LL+G
Sbjct: 163 FGLAHEIED-GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-12
Identities = 19/60 (31%), Positives = 36/60 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ L ++ + A+ +++ + YLHT+ I DLKPEN++L ++
Sbjct: 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK 151
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 43/176 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
++ F D++ Y++LE GGE++ + + F ++ A
Sbjct: 79 KIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY---------FYQ--MLLA 126
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
++YLH GI+ RDLKPEN+LL ++ +K+ D
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQE--------------------------EDCLIKITD 160
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN---RGHDRAVDYWALGILMHELLTG 247
FG SK LG T CGTP Y+APE++ + G++RAVD W+LG+++ L+G
Sbjct: 161 FGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-12
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ + + ++ A++YLH GI+ RDLKPEN+LL ++
Sbjct: 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+ F+D Y Y++ E GGE++ + R F + A+ I V+ +
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI---------- 139
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
Y+H IV RDLKPENLLL+++ +++ D
Sbjct: 140 -TYMHKNKIVHRDLKPENLLLESKS--------------------------KDANIRIID 172
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S H + K GT Y+APE++ +D D W+ G++++ LL+G
Sbjct: 173 FGLSTHF-EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 23/60 (38%), Positives = 36/60 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E GGE++ + R F + A+ I V+ + Y+H IV RDLKPENLLL+++
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 41/173 (23%), Positives = 74/173 (42%), Gaps = 39/173 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY F+ + +++E GGE L +R + + + + + F+ + E
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTEL-----DTILFMKQ-ICEG 199
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
+ ++H I+ DLKPEN+L NR Q+K+ D
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNR---------------------------DAKQIKIID 232
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG ++ K GTPE++APE++ D W++G++ + LL+G
Sbjct: 233 FGLARRYKP-REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 18/62 (29%), Positives = 31/62 (50%), Gaps = 1/62 (1%)
Query: 1 MLLEACLGGEVW-TILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E GGE++ I+ E + + E + ++H I+ DLKPEN+L N
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 60 RG 61
R
Sbjct: 223 RD 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-31
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 38/173 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ F++ V ++LE GGE++ L E+ ++ A+ +++ +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV---------- 121
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK-VD 194
YLH++ I DLKPEN++L ++ ++K +D
Sbjct: 122 -HYLHSKRIAHFDLKPENIMLLDKNV-------------------------PNPRIKLID 155
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + + G + GTPE+VAPEI+ D W++G++ + LL+G
Sbjct: 156 FGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-11
Identities = 19/60 (31%), Positives = 37/60 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ L E+ ++ A+ +++ + YLH++ I DLKPEN++L ++
Sbjct: 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDK 144
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY F+D + Y+++E GGE++ + R F++ A+ I V+ +
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV---------- 149
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
YLH IV RDLKPENLLL+++ +K+ D
Sbjct: 150 -TYLHKHNIVHRDLKPENLLLESKE--------------------------KDALIKIVD 182
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S + K GT Y+APE+++ + +D D W++G+++ LL G
Sbjct: 183 FGLSAVF-ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-13
Identities = 24/60 (40%), Positives = 38/60 (63%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GGE++ + R F++ A+ I V+ + YLH IV RDLKPENLLL+++
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 40/230 (17%), Positives = 65/230 (28%), Gaps = 60/230 (26%)
Query: 35 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEAC 94
E L RGI + +L + +KKK + RL + + L
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 95 ------LGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148
G + + +A +T VI L LH G+V
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA-----------SLHHYGLVHTY 231
Query: 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT 208
L+P +++LD RG V L F G
Sbjct: 232 LRPVDIVLDQRGGVFL----------------------------TGFEHLVRDGARV--- 260
Query: 209 WTFCGTPEYVAPEIIKNRG-----------HDRAVDYWALGILMHELLTG 247
+ + PE+ R + D WALG++++ +
Sbjct: 261 -VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 5e-16
Identities = 18/59 (30%), Positives = 27/59 (45%)
Query: 7 LGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
G + + +A +T VI L LH G+V L+P +++LD RG V L
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 247
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L++ +DS Y++ E GGE++ + +R F ++ A+ I V +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI---------- 134
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
Y+H IV RDLKPEN+LL+++ +K+ D
Sbjct: 135 -TYMHKHNIVHRDLKPENILLESKE--------------------------KDCDIKIID 167
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S K GT Y+APE+++ +D D W+ G++++ LL+G
Sbjct: 168 FGLSTCF-QQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 22/60 (36%), Positives = 37/60 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E GGE++ + +R F ++ A+ I V + Y+H IV RDLKPEN+LL+++
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-31
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 50/185 (27%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L + F++ Y++ E GG + + + +R F++ AS + V ALD
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD--------- 125
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
+LH +GI RDLKPEN+L ++ VK+ D
Sbjct: 126 --FLHNKGIAHRDLKPENILCEHPN--------------------------QVSPVKICD 157
Query: 195 FGFSKHLGHSGCKTW-------TFCGTPEYVAPEIIK-----NRGHDRAVDYWALGILMH 242
F + +G + T CG+ EY+APE+++ +D+ D W+LG++++
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 243 ELLTG 247
LL+G
Sbjct: 218 ILLSG 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-13
Identities = 22/61 (36%), Positives = 37/61 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E GG + + + +R F++ AS + V AL++LH +GI RDLKPEN+L ++
Sbjct: 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP 147
Query: 61 G 61
Sbjct: 148 N 148
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 35/183 (19%), Positives = 73/183 (39%), Gaps = 31/183 (16%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
R Y + +++Y+ LE C + ++ + D+N + + +
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEY---NPISLLRQ-IASG 127
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ +LH+ I+ RDLKP+N+L+ + ++ + +IS DF
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVST---------SSRFTADQQTGAENLRILIS------DF 172
Query: 196 GFSKHLG----HSGCKTWTFCGTPEYVAPEIIKN-------RGHDRAVDYWALGILMHEL 244
G K L GT + APE+++ R R++D +++G + + +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 245 LTG 247
L+
Sbjct: 233 LSK 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 10/29 (34%), Positives = 18/29 (62%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRG 61
+ + +LH+ I+ RDLKP+N+L+
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSS 152
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L+ F+D KY Y++ E GGE++ + R FD+ A+ I ++ +
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI---------- 159
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
YLH IV RD+KPEN+LL+N+ S +K+ D
Sbjct: 160 -CYLHKHNIVHRDIKPENILLENKN--------------------------SLLNIKIVD 192
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S K GT Y+APE++K + ++ D W+ G++M+ LL G
Sbjct: 193 FGLSSFF-SKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 23/60 (38%), Positives = 37/60 (61%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E GGE++ + R FD+ A+ I ++ + YLH IV RD+KPEN+LL+N+
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 60/206 (29%)
Query: 63 VKLVSRKKKTRQ--------------TRLYKTFKDS----KYVYMLLEACLGGEVWT--I 102
+KL+ K RQ + +++ + + +++E GGE+++
Sbjct: 59 LKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118
Query: 103 LRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYV 162
R F + A+ I + A+ ++LH+ I RD+KPENLL ++
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAI-----------QFLHSHNIAHRDVKPENLLYTSK--- 164
Query: 163 KLEFYPAGHYIIREGAKGDSFFIISGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPE 221
+ D+ +K+ DFGF+K + T C TP YVAPE
Sbjct: 165 ----------------EKDA-------VLKLTDFGFAKETTQN--ALQTPCYTPYYVAPE 199
Query: 222 IIKNRGHDRAVDYWALGILMHELLTG 247
++ +D++ D W+LG++M+ LL G
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 20/63 (31%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 1 MLLEACLGGEVWT--ILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+++E GGE+++ R F + A+ I + A+++LH+ I RD+KPENLL
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 59 NRG 61
++
Sbjct: 163 SKE 165
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 43/175 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVW-TILRERTCFD-DNAASFITACVIEALDFITACVI 133
L+ F+D + ++LE GGE++ I E +++
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------------AC 159
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
E L+++H IV D+KPEN++ + + VK+
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETK---------------------------KASSVKI 192
Query: 194 -DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG + L T E+ APEI+ D WA+G+L + LL+G
Sbjct: 193 IDFGLATKLNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 17/62 (27%), Positives = 30/62 (48%), Gaps = 1/62 (1%)
Query: 1 MLLEACLGGEVW-TILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++LE GGE++ I E + E L+++H IV D+KPEN++ +
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184
Query: 60 RG 61
+
Sbjct: 185 KK 186
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 30/168 (17%), Positives = 46/168 (27%), Gaps = 41/168 (24%)
Query: 86 YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145
+ +L + + A +T VI L LH G+V
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLV-------HHARLQLTLQVIRLLASLHHYGLV 233
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG 205
L+P +++LD RG V L F G S
Sbjct: 234 HTYLRPVDIVLDQRGGVFL----------------------------TGFEHLVRDGASA 265
Query: 206 -CKTWTFCGTPEYVAPEIIKNRGHD-----RAVDYWALGILMHELLTG 247
PE A ++ H A D W LG+ ++ +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 18/59 (30%), Positives = 27/59 (45%)
Query: 7 LGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
G + + +A +T VI L LH G+V L+P +++LD RG V L
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-30
Identities = 37/172 (21%), Positives = 68/172 (39%), Gaps = 35/172 (20%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ Y +F + + ++LE G++ +++ F V + + A
Sbjct: 96 KYYASFIEDNELNIVLELADAGDLSRMIKH---FKKQKRLIPERTVWK----YFVQLCSA 148
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LE++H+R ++ RD+KP N+ + G VKL D
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLG----------------------------DL 180
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G + + GTP Y++PE I G++ D W+LG L++E+
Sbjct: 181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 22/100 (22%), Positives = 44/100 (44%), Gaps = 10/100 (10%)
Query: 3 LEACLGGEVWTILRE----RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
LE G++ +++ + + + ALE++H+R ++ RD+KP N+ +
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 170
Query: 59 NRGYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEAC 94
G VKL + + + +T + + Y YM E
Sbjct: 171 ATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPY-YMSPERI 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+++F+ + + M+ E G ++ F+ S E + ++ V EA
Sbjct: 65 HLHESFESMEELVMIFEFISGLDI---------FERINTSAFELNEREIVSYVHQ-VCEA 114
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
L++LH+ I D++PEN++ R +K+ +
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTR---------------------------RSSTIKIIE 147
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG ++ L G PEY APE+ ++ A D W+LG L++ LL+G
Sbjct: 148 FGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-10
Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 1 MLLEACLGGEVW-TILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
M+ E G +++ I ++ V EAL++LH+ I D++PEN++
Sbjct: 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137
Query: 60 R 60
R
Sbjct: 138 R 138
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 41/174 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVW-TILRERTCFD-DNAASFITACVIEALDFITACVI 133
L+ F+D + M+ E GGE++ + E D A ++ V
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------------VC 265
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ L ++H V DLKPEN++ + + + +I
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTK-------------------RSNELKLI------- 299
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG + HL GT E+ APE+ + + D W++G+L + LL+G
Sbjct: 300 DFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 19/69 (27%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 1 MLLEACLGGEVW-TILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
M+ E GGE++ + E ++ A V + L ++H V DLKPEN++
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 60 RG--YVKLV 66
+ +KL+
Sbjct: 291 KRSNELKLI 299
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 59/206 (28%)
Query: 63 VKLVSRKKKTRQ--------------TRLYKTFKDS----KYVYMLLEACLGGEVWT--I 102
+K++ K R+ R+ +++ K + +++E GGE+++
Sbjct: 92 LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 151
Query: 103 LRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYV 162
R F + AS I + EA+ +YLH+ I RD+KPENLL ++
Sbjct: 152 DRGDQAFTEREASEIMKSIGEAI-----------QYLHSINIAHRDVKPENLLYTSK--- 197
Query: 163 KLEFYPAGHYIIREGAKGDSFFIISGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPE 221
+ ++ +K+ DFGF+K S T C TP YVAPE
Sbjct: 198 ----------------RPNA-------ILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPE 233
Query: 222 IIKNRGHDRAVDYWALGILMHELLTG 247
++ +D++ D W+LG++M+ LL G
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-11
Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 2/63 (3%)
Query: 1 MLLEACLGGEVWT--ILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+++E GGE+++ R F + AS I + EA++YLH+ I RD+KPENLL
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 195
Query: 59 NRG 61
++
Sbjct: 196 SKR 198
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-30
Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 42/186 (22%)
Query: 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIE 123
+ + +K +++ +E C G + + +R D
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV----------L 123
Query: 124 ALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSF 183
AL+ + + ++Y+H++ ++ RDLKP N+ L + VK+ G
Sbjct: 124 ALELFEQ-ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI-----G------------- 164
Query: 184 FIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DFG L + G +T GT Y++PE I ++ + + VD +ALG+++ E
Sbjct: 165 ----------DFGLVTSLKNDGKRT-RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
Query: 244 LLTGMK 249
LL
Sbjct: 214 LLHVCD 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-10
Identities = 17/67 (25%), Positives = 35/67 (52%), Gaps = 2/67 (2%)
Query: 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+ +E C G + + +R D A + + + ++Y+H++ ++ RDLKP N+ L
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 59 NRGYVKL 65
+ VK+
Sbjct: 157 DTKQVKI 163
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-30
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 38/173 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L++ +++ V ++LE GGE++ L E+ + A+ +F+ ++
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT----------EFLKQ-ILNG 126
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK-VD 194
+ YLH+ I DLKPEN++L +R ++K +D
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNV-------------------------PKPRIKIID 161
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + + G + GTPE+VAPEI+ D W++G++ + LL+G
Sbjct: 162 FGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 20/60 (33%), Positives = 34/60 (56%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ L E+ + A+ ++ + YLH+ I DLKPEN++L +R
Sbjct: 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 150
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-30
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
++++ F+D +Y+++E C GGE L ER ++ + + ++ A
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEG--YVAELMK-QMMNA 136
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
L Y H++ +V +DLKPEN+L + S +K+ D
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDT-------------------SPHS-------PIKIID 170
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG ++ S + GT Y+APE+ K R D W+ G++M+ LLTG
Sbjct: 171 FGLAELFK-SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-11
Identities = 17/64 (26%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 1 MLLEACLGGE----VWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
+++E C GGE + + + + + ++ AL Y H++ +V +DLKPEN+L
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156
Query: 57 LDNR 60
+
Sbjct: 157 FQDT 160
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 37/174 (21%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 76 RLYKTFKDSKYVYMLLE-ACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
++ F++ + +++E G +++ + D+ AS+I F ++
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI---------FRQ--LVS 141
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
A+ YL + I+ RD+K EN+++ +KL +D
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKL----------------------------ID 173
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
FG + G +TFCGT EY APE++ + ++ W+LG+ ++ L+
Sbjct: 174 FGSAA-YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 17/67 (25%), Positives = 37/67 (55%), Gaps = 1/67 (1%)
Query: 1 MLLE-ACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E G +++ + D+ AS+I ++ A+ YL + I+ RD+K EN+++
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE 165
Query: 60 RGYVKLV 66
+KL+
Sbjct: 166 DFTIKLI 172
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 30/216 (13%), Positives = 61/216 (28%), Gaps = 41/216 (18%)
Query: 35 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFK-DSKYVYMLLEA 93
G + + LL V + S+ + + + + + M +
Sbjct: 112 ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS 171
Query: 94 CLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPEN 153
+++ L F + I AL +TA +I L ++G+V P+N
Sbjct: 172 VDLELLFSTLDFVYVFRGDEG-------ILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224
Query: 154 LLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG 213
L + G + L D +G +
Sbjct: 225 LFIMPDGRLML----------------------------GDVSALWKVGT---RGPASSV 253
Query: 214 TPEYVAPEIIKNRG--HDRAVDYWALGILMHELLTG 247
Y E + A++ W LG+ ++ +
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 14/59 (23%), Positives = 24/59 (40%)
Query: 7 LGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L + + R A +TA +I L ++G+V P+NL + G + L
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLML 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-29
Identities = 47/208 (22%), Positives = 70/208 (33%), Gaps = 63/208 (30%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITAC---- 131
RLY+ ++D +Y+ +++E C GG + L +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 132 -------------------------VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEF 166
+ AL YLH +GI RD+KPEN L
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-------- 203
Query: 167 YPAGHYIIREGAKGDSFFIISGGQVKV-DFGFSKHLGHS----GCKTWTFCGTPEYVAPE 221
++K+ DFG SK T GTP +VAPE
Sbjct: 204 ------------NKSF-------EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 222 IIK--NRGHDRAVDYWALGILMHELLTG 247
++ N + D W+ G+L+H LL G
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-09
Identities = 16/45 (35%), Positives = 20/45 (44%)
Query: 16 RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ S I + AL YLH +GI RD+KPEN L
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 41/175 (23%), Positives = 69/175 (39%), Gaps = 44/175 (25%)
Query: 76 RLYKTFKDSKYVYMLLE-ACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
RL F+ + ++LE +++ + E+ + + F V+
Sbjct: 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF---------FGQ--VVA 150
Query: 135 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
A+++ H+RG+V RD+K EN+L+D RG KL +
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKL----------------------------I 182
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
DFG L F GT Y PE I + W+LGIL+++++ G
Sbjct: 183 DFGSGALLHDEPYT--DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-13
Identities = 20/68 (29%), Positives = 39/68 (57%), Gaps = 2/68 (2%)
Query: 1 MLLE-ACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD- 58
++LE +++ + E+ + + V+ A+++ H+RG+V RD+K EN+L+D
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL 174
Query: 59 NRGYVKLV 66
RG KL+
Sbjct: 175 RRGCAKLI 182
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 40/178 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
R + T KD ++ Y+ +E C + + ++ +E + +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLG---------LEPITLLQQ-TTSG 130
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L +LH+ IV RDLKP N+L+ A G +IS DF
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISM-----------------PNAHGKIKAMIS------DF 167
Query: 196 GFSKHLG---HSGCKTWTFCGTPEYVAPEIIK---NRGHDRAVDYWALGILMHELLTG 247
G K L HS + GT ++APE++ VD ++ G + + +++
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 14/67 (20%), Positives = 24/67 (35%)
Query: 3 LEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+E C + ++ + L +LH+ IV RDLKP N+L+
Sbjct: 97 IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA 156
Query: 63 VKLVSRK 69
+
Sbjct: 157 HGKIKAM 163
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 44/175 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLG-GEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
RL F+ ++LE +++ + ER + A F V+E
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF---------FWQ--VLE 160
Query: 135 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
A+ + H G++ RD+K EN+L+D NRG +KL +
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKL----------------------------I 192
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
DFG L + F GT Y PE I+ + R+ W+LGIL+++++ G
Sbjct: 193 DFGSGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-12
Identities = 22/68 (32%), Positives = 39/68 (57%), Gaps = 2/68 (2%)
Query: 1 MLLEACLG-GEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD- 58
++LE +++ + ER + A V+EA+ + H G++ RD+K EN+L+D
Sbjct: 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184
Query: 59 NRGYVKLV 66
NRG +KL+
Sbjct: 185 NRGELKLI 192
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-28
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 41/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L++ + K +Y+++E GGEV+ L + EA ++ A
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----------EARSKFRQ-IVSA 126
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++Y H + IV RDLK ENLLLD +K+ DF
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKI----------------------------ADF 158
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
GFS G K FCG P Y APE+ + + +D VD W+LG++++ L++G
Sbjct: 159 GFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 23/66 (34%), Positives = 35/66 (53%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GGEV+ L + A ++ A++Y H + IV RDLK ENLLLD
Sbjct: 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD 150
Query: 61 GYVKLV 66
+K+
Sbjct: 151 MNIKIA 156
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-28
Identities = 41/175 (23%), Positives = 65/175 (37%), Gaps = 59/175 (33%)
Query: 84 SKYVYMLLEACLGGEVWTI-----LRERTC---FDDNAASFITACVIEALDFITACVIEA 135
++YM+ E G V + L E F D +I+
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQD--------------------LIKG 149
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+EYLH + I+ RD+KP NLL+ G++K+ DF
Sbjct: 150 IEYLHYQKIIHRDIKPSNLLVGEDGHIKI----------------------------ADF 181
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD---RAVDYWALGILMHELLTG 247
G S S GTP ++APE + +A+D WA+G+ ++ + G
Sbjct: 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-13
Identities = 21/66 (31%), Positives = 35/66 (53%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M+ E G V + ++ A F +I+ +EYLH + I+ RD+KP NLL+
Sbjct: 115 MVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173
Query: 61 GYVKLV 66
G++K+
Sbjct: 174 GHIKIA 179
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 27/176 (15%), Positives = 58/176 (32%), Gaps = 23/176 (13%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
R + + + ++ + E C GG + + E S+ ++ + V
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENY----RIMSYFKEAELKD---LLLQVGR 126
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV- 193
L Y+H+ +V D+KP N+ + + + + K+
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAA----------SEEGDEDDWASNKVMFKIG 176
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK-NRGHDRAVDYWALGILMHELLTGM 248
D G + G ++A E+++ N H D +AL + +
Sbjct: 177 DLGHVTRIS----SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-09
Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 4/82 (4%)
Query: 3 LEACLGGEVWTILRER----TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
E C GG + + E + F + + V L Y+H+ +V D+KP N+ +
Sbjct: 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 59 NRGYVKLVSRKKKTRQTRLYKT 80
S + K
Sbjct: 150 RTSIPNAASEEGDEDDWASNKV 171
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 41/174 (23%)
Query: 78 YKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEAL-DFITACVIEAL 136
+F ++ ++ + +E GG + +LR + + E F T ++E L
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSK---------WGPLKDNEQTIGFYTKQILEGL 135
Query: 137 EYLHTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+YLH IV RD+K +N+L++ G +K+ DF
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKI----------------------------SDF 167
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIK--NRGHDRAVDYWALGILMHELLTG 247
G SK L T TF GT +Y+APEII RG+ +A D W+LG + E+ TG
Sbjct: 168 GTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-10
Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 8/94 (8%)
Query: 3 LEACLGGEVWTILRERT---CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+E GG + +LR + ++ F T ++E L+YLH IV RD+K +N+L++
Sbjct: 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 60 R-GYVKLV---SRKKKTRQTRLYKTFKDSKYVYM 89
G +K+ + K+ +TF + YM
Sbjct: 158 YSGVLKISDFGTSKRLAGINPCTETFTGTLQ-YM 190
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-27
Identities = 47/175 (26%), Positives = 72/175 (41%), Gaps = 42/175 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ Y ++ Y+ LE C GGE++ + + +A F ++
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----------DAQRFFHQ-LMAG 117
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ YLH GI RD+KPENLLLD R +K+ DF
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKI----------------------------SDF 149
Query: 196 GFSKHLGHSGCKTW--TFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
G + ++ + CGT YVAPE++K R VD W+ GI++ +L G
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-11
Identities = 24/65 (36%), Positives = 35/65 (53%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ LE C GGE++ + + A ++ + YLH GI RD+KPENLLLD R
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 61 GYVKL 65
+K+
Sbjct: 142 DNLKI 146
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-27
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 41/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+ +M++E GGE++ + + ++ EA ++ A
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----------EARRLFQQ-ILSA 123
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++Y H +V RDLKPEN+LLD K+ DF
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKI----------------------------ADF 155
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
G S ++ G T CG+P Y APE+I R + VD W+ G++++ LL G
Sbjct: 156 GLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-11
Identities = 21/66 (31%), Positives = 37/66 (56%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E GGE++ + + ++ A + ++ A++Y H +V RDLKPEN+LLD
Sbjct: 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH 147
Query: 61 GYVKLV 66
K+
Sbjct: 148 MNAKIA 153
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 37/184 (20%), Positives = 64/184 (34%), Gaps = 48/184 (26%)
Query: 78 YKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137
+ Y+Y+ ++ C + + R +D I + EA+E
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL--------HIFIQIAEAVE 178
Query: 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGF 197
+LH++G++ RDLKP N+ VK+ G DFG
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDDVVKV-----G-----------------------DFGL 210
Query: 198 SKHLGHSGCKTWTF------------CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
+ + GT Y++PE I + VD ++LG+++ ELL
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Query: 246 TGMK 249
Sbjct: 271 YSFS 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-10
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 3/66 (4%)
Query: 3 LEACLGGEVWTILRER---TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++ C + + R + I + EA+E+LH++G++ RDLKP N+
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199
Query: 60 RGYVKL 65
VK+
Sbjct: 200 DDVVKV 205
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 47/175 (26%), Positives = 72/175 (41%), Gaps = 42/175 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ Y ++ Y+ LE C GGE++ + + +A F ++
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----------DAQRFFHQ-LMAG 117
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ YLH GI RD+KPENLLLD R +K+ DF
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKI----------------------------SDF 149
Query: 196 GFSKHLGHSGCKTW--TFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
G + ++ + CGT YVAPE++K R VD W+ GI++ +L G
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 24/65 (36%), Positives = 35/65 (53%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ LE C GGE++ + + A ++ + YLH GI RD+KPENLLLD R
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 61 GYVKL 65
+K+
Sbjct: 142 DNLKI 146
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 50/183 (27%)
Query: 76 RLYKTF--KDSKYVYMLLEACLGGEVWTIL----RERTCFDDNAASFITACVIEALDFIT 129
R Y + + +Y+++E C GG++ +++ +ER D+ L +T
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE----------FVLRVMT 118
Query: 130 ACVIEALEYLHTRG-----IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFF 184
+ AL+ H R ++ RDLKP N+ LD + VKL
Sbjct: 119 QLTL-ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL-------------------- 157
Query: 185 IISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
DFG ++ L H TF GTP Y++PE + ++ D W+LG L++EL
Sbjct: 158 --------GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209
Query: 245 LTG 247
Sbjct: 210 CAL 212
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-07
Identities = 22/74 (29%), Positives = 39/74 (52%), Gaps = 9/74 (12%)
Query: 1 MLLEACLGGEVWTIL----RERTCFDDNAASFITACVIEALEYLHTRG-----IVFRDLK 51
+++E C GG++ +++ +ER D+ + + AL+ H R ++ RDLK
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 52 PENLLLDNRGYVKL 65
P N+ LD + VKL
Sbjct: 144 PANVFLDGKQNVKL 157
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 39/193 (20%), Positives = 68/193 (35%), Gaps = 52/193 (26%)
Query: 79 KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138
+ Y+Y+ ++ C + + R ++ S L + EA+E+
Sbjct: 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-------LHIFLQ-IAEAVEF 133
Query: 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFS 198
LH++G++ RDLKP N+ VK+ G DFG
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKV-----G-----------------------DFGLV 165
Query: 199 KHLGHSGCKTWTF------------CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL- 245
+ + GT Y++PE I + VD ++LG+++ ELL
Sbjct: 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 246 ---TGMKESNVFQ 255
T M+
Sbjct: 226 PFSTQMERVRTLT 238
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 3/68 (4%)
Query: 1 MLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
+ ++ C + + R + + I + EA+E+LH++G++ RDLKP N+
Sbjct: 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF 151
Query: 58 DNRGYVKL 65
VK+
Sbjct: 152 TMDDVVKV 159
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 41/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY+ ++M++E GGE++ + + D+ E+ ++
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----------ESRRLFQQ-ILSG 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++Y H +V RDLKPEN+LLD K+ DF
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKI----------------------------ADF 160
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
G S ++ G T CG+P Y APE+I R + VD W+ G++++ LL G
Sbjct: 161 GLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 9e-11
Identities = 20/66 (30%), Positives = 36/66 (54%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E GGE++ + + D+ + + ++ ++Y H +V RDLKPEN+LLD
Sbjct: 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH 152
Query: 61 GYVKLV 66
K+
Sbjct: 153 MNAKIA 158
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 40/174 (22%), Positives = 72/174 (41%), Gaps = 41/174 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
R + ++ +++E GGE++ + F ++ EA F ++
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED----------EARFFFQ-QLLSG 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
+ Y H+ I RDLK EN LLD ++K+ D
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPA---------------------------PRLKICD 161
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
FG+SK + + GTP Y+APE++ + +D + D W+ G+ ++ +L G
Sbjct: 162 FGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 20/65 (30%), Positives = 33/65 (50%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GGE++ + F ++ A F ++ + Y H+ I RDLK EN LLD
Sbjct: 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152
Query: 61 GYVKL 65
+L
Sbjct: 153 PAPRL 157
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 42/173 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY + M++E GGE++ + E+ ++ E F +I A
Sbjct: 73 KLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED----------EGRRFFQQ-IICA 120
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+EY H IV RDLKPENLLLD+ VK+ DF
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKI----------------------------ADF 152
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD-RAVDYWALGILMHELLTG 247
G S ++ G T CG+P Y APE+I + + VD W+ GI+++ +L G
Sbjct: 153 GLS-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 20/34 (58%), Positives = 24/34 (70%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66
+I A+EY H IV RDLKPENLLLD+ VK+
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIA 150
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 35/177 (19%), Positives = 59/177 (33%), Gaps = 47/177 (26%)
Query: 83 DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142
++LL G +W + + +F+T + L + + LE +H +
Sbjct: 101 AKHEAWLLLPFFKRGTLWNEIERLK----DKGNFLT--EDQILWLLLG-ICRGLEAIHAK 153
Query: 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG 202
G RDLKP N+LL + G L +D G
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVL----------------------------MDLGSMNQAC 185
Query: 203 HSGCKTW---------TFCGTPEYVAPEIIKNRGH---DRAVDYWALGILMHELLTG 247
+ T Y APE+ + H D D W+LG +++ ++ G
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 18/69 (26%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 1 MLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56
+LL G +W + ++ ++ + LE +H +G RDLKP N+L
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166
Query: 57 LDNRGYVKL 65
L + G L
Sbjct: 167 LGDEGQPVL 175
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-25
Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 40/173 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
T+ Y ++ +++++E GG +L D+ + I E L +
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILR---EIL--------K 130
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L+YLH+ + RD+K N+LL G VKL D
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKL----------------------------AD 162
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG + L + K TF GTP ++APE+IK +D D W+LGI EL G
Sbjct: 163 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 20/66 (30%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG +L D+ + I +++ L+YLH+ + RD+K N+LL
Sbjct: 97 IIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 155
Query: 61 GYVKLV 66
G VKL
Sbjct: 156 GEVKLA 161
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-24
Identities = 40/174 (22%), Positives = 71/174 (40%), Gaps = 42/174 (24%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
Y F + + +E GG + +L++ + + L ++ VI+
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----------QILGKVSIAVIK 142
Query: 135 ALEYLHTRG-IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
L YL + I+ RD+KP N+L+++RG +KL
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGEIKL----------------------------C 174
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG S L S +F GT Y++PE ++ + D W++G+ + E+ G
Sbjct: 175 DFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 20/66 (30%), Positives = 38/66 (57%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG-IVFRDLKPENLLLDN 59
+ +E GG + +L++ + ++ VI+ L YL + I+ RD+KP N+L+++
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 167
Query: 60 RGYVKL 65
RG +KL
Sbjct: 168 RGEIKL 173
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-23
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 40/174 (22%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVI 133
+ Y ++ + +++++E C G V I+R R ++ + I L
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ---STL-------- 135
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ LEYLH + RD+K N+LL+ G+ KL
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKL----------------------------A 167
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG + L + K T GTP ++APE+I+ G++ D W+LGI E+ G
Sbjct: 168 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-09
Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 1/67 (1%)
Query: 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E C G V I+R R ++ + I ++ LEYLH + RD+K N+LL+
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160
Query: 60 RGYVKLV 66
G+ KL
Sbjct: 161 EGHAKLA 167
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-23
Identities = 32/119 (26%), Positives = 48/119 (40%), Gaps = 32/119 (26%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
I+ LEYLH++GIV +D+KP NLLL G +K+
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI---------------------------- 150
Query: 193 VDFGFS--KHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHD-RAVDYWALGILMHELLTG 247
G + H + T G+P + PEI VD W+ G+ ++ + TG
Sbjct: 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
I+ LEYLH++GIV +D+KP NLLL G +K+
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI 150
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-23
Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 40/173 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
++ +++++E GG + ++ E + I A E L +
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECL--------Q 127
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
ALE+LH+ ++ RD+K +N+LL G VKL D
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKL----------------------------TD 159
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FGF + K T GTP ++APE++ + + VD W+LGI+ E++ G
Sbjct: 160 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-10
Identities = 22/65 (33%), Positives = 40/65 (61%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG + ++ E TC D+ + + ++ALE+LH+ ++ RD+K +N+LL
Sbjct: 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 61 GYVKL 65
G VKL
Sbjct: 153 GSVKL 157
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-23
Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 45/171 (26%)
Query: 80 TFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139
T K K + ++ E G + T L+ + L + L++L
Sbjct: 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR---QIL--------KGLQFL 145
Query: 140 HTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-DFG 196
HTR I+ RDLK +N+ + G VK+ D G
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGP----------------------------TGSVKIGDLG 177
Query: 197 FSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ S K GTPE++APE+ + +D +VD +A G+ M E+ T
Sbjct: 178 LATLKRASFAK--AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS 225
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 3/68 (4%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLD 58
++ E G + T L+ +++ L++LHTR I+ RDLK +N+ +
Sbjct: 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165
Query: 59 NR-GYVKL 65
G VK+
Sbjct: 166 GPTGSVKI 173
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 40/173 (23%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+YK++ + +++L+E GG + I+ + ++ A + V++
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA------------TVCEAVLQ 152
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
AL YLH +G++ RD+K +++LL G VKL D
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKL----------------------------SD 184
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FGF + K + GTP ++APE+I + VD W+LGI++ E++ G
Sbjct: 185 FGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 21/65 (32%), Positives = 39/65 (60%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+L+E GG + I+ + ++ + + V++AL YLH +G++ RD+K +++LL
Sbjct: 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 61 GYVKL 65
G VKL
Sbjct: 178 GRVKL 182
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-21
Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 37/179 (20%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
Y +F ++++++ GG V I++ ++ + + I I V+E
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA---TILREVLE 132
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
LEYLH G + RD+K N+LL G V++ D
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQI----------------------------AD 164
Query: 195 FGFSKHLGHSGCKTW-----TFCGTPEYVAPEIIK-NRGHDRAVDYWALGILMHELLTG 247
FG S L G T TF GTP ++APE+++ RG+D D W+ GI EL TG
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 8/70 (11%)
Query: 4 EACLGGEVWTILRERT--------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENL 55
+ GG V I++ D++ + I V+E LEYLH G + RD+K N+
Sbjct: 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNI 152
Query: 56 LLDNRGYVKL 65
LL G V++
Sbjct: 153 LLGEDGSVQI 162
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-21
Identities = 31/115 (26%), Positives = 52/115 (45%), Gaps = 30/115 (26%)
Query: 136 LEYLHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ YLH R IV R+LK NLL+D + VK+
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV----------------------------C 181
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
DFG S+ + + + GTPE++APE++++ + D ++ G+++ EL T
Sbjct: 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-06
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 9/78 (11%)
Query: 4 EACLGGEVWTILRERTC---FDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLD 58
E G ++ +L + D+ + V + + YLH R IV R+LK NLL+D
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173
Query: 59 NRGYVKL----VSRKKKT 72
+ VK+ +SR K +
Sbjct: 174 KKYTVKVCDFGLSRLKAS 191
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 5e-21
Identities = 30/127 (23%), Positives = 50/127 (39%), Gaps = 37/127 (29%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
EA+ ++ AL YLH+ G+V+ DLKPEN++
Sbjct: 183 EAIA-YLLEILPALSYLHSIGLVYNDLKPENIM--------------------------- 214
Query: 183 FFIISGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILM 241
++ Q+K+ D G + G GTP + APEI++ D + +G +
Sbjct: 215 ---LTEEQLKLIDLGAVSRINSFG----YLYGTPGFQAPEIVRTGPTVAT-DIYTVGRTL 266
Query: 242 HELLTGM 248
L +
Sbjct: 267 AALTLDL 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-09
Identities = 16/38 (42%), Positives = 25/38 (65%), Gaps = 1/38 (2%)
Query: 29 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66
++ AL YLH+ G+V+ DLKPEN++L +KL+
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLI 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-21
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 45/179 (25%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVI 133
+L + +++++E C GG V I+ E + + + L
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR---QML-------- 127
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
EAL +LH++ I+ RDLK N+L+ G ++L
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRL----------------------------A 159
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEII-----KNRGHDRAVDYWALGILMHELLTG 247
DFG S + K +F GTP ++APE++ K+ +D D W+LGI + E+
Sbjct: 160 DFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 8/87 (9%)
Query: 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E C GG V I+ E + + ++EAL +LH++ I+ RDLK N+L+
Sbjct: 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152
Query: 60 RGYVKL----VSRK-KKTRQTRLYKTF 81
G ++L VS K KT Q R +F
Sbjct: 153 EGDIRLADFGVSAKNLKTLQKR--DSF 177
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-20
Identities = 42/189 (22%), Positives = 63/189 (33%), Gaps = 59/189 (31%)
Query: 79 KTFKDSKYVYMLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALDFITACVIEA 135
+ + ++LL G++ L R + L A
Sbjct: 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD----------TVLKIFYQ-TCRA 148
Query: 136 LEYLHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
++++H + I+ RDLK ENLLL N+G +KL
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKL----------------------------C 180
Query: 194 DFGFSKHLGHSGCKTW------------TFCGTPEYVAPEII---KNRGHDRAVDYWALG 238
DFG + + H +W T TP Y PEII N D WALG
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240
Query: 239 ILMHELLTG 247
+++ L
Sbjct: 241 CILYLLCFR 249
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-09
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 6/70 (8%)
Query: 1 MLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENL 55
+L E C G++ L R + I A++++H + I+ RDLK ENL
Sbjct: 111 LLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENL 169
Query: 56 LLDNRGYVKL 65
LL N+G +KL
Sbjct: 170 LLSNQGTIKL 179
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 31/126 (24%), Positives = 45/126 (35%), Gaps = 30/126 (23%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
A+ I + AL+ H G RD+KPEN+L+ + L
Sbjct: 135 RAVA-IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYL------------------ 175
Query: 183 FFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILM 241
VDFG + + GT Y+APE D +AL ++
Sbjct: 176 ----------VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVL 225
Query: 242 HELLTG 247
+E LTG
Sbjct: 226 YECLTG 231
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 17/54 (31%), Positives = 25/54 (46%)
Query: 13 TILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66
+LR + A I + AL+ H G RD+KPEN+L+ + LV
Sbjct: 123 AMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLV 176
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-20
Identities = 46/179 (25%), Positives = 67/179 (37%), Gaps = 46/179 (25%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+ + TF + V++ +E R + + L +T +++
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-----------LGKMTVAIVK 135
Query: 135 ALEYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
AL YL G++ RD+KP N+LLD RG +KL
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKL----------------------------C 167
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK-----NRGHDRAVDYWALGILMHELLTG 247
DFG S L K G Y+APE I +D D W+LGI + EL TG
Sbjct: 168 DFGISGRLVDDKAKD-RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 20/66 (30%), Positives = 33/66 (50%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDN 59
+ +E R + + +T +++AL YL G++ RD+KP N+LLD
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160
Query: 60 RGYVKL 65
RG +KL
Sbjct: 161 RGQIKL 166
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-20
Identities = 34/125 (27%), Positives = 51/125 (40%), Gaps = 34/125 (27%)
Query: 128 ITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
I +++ALE+LH+ ++ RD+KP N+L++ G VK+
Sbjct: 114 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKM---------------------- 151
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDY----WALGILMH 242
DFG S +L K G Y+APE I + + W+LGI M
Sbjct: 152 ------CDFGISGYLVDDVAKD-IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204
Query: 243 ELLTG 247
EL
Sbjct: 205 ELAIL 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 15/53 (28%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 14 ILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKL 65
++ + ++ I +++ALE+LH+ ++ RD+KP N+L++ G VK+
Sbjct: 99 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKM 151
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 42/125 (33%), Positives = 55/125 (44%), Gaps = 34/125 (27%)
Query: 128 ITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
IT ++AL +L I+ RD+KP N+LLD G +KL
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL---------------------- 167
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK----NRGHDRAVDYWALGILMH 242
DFG S L S KT G Y+APE I +G+D D W+LGI ++
Sbjct: 168 ------CDFGISGQLVDSIAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 243 ELLTG 247
EL TG
Sbjct: 221 ELATG 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 17/38 (44%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 29 ITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKL 65
IT ++AL +L I+ RD+KP N+LLD G +KL
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-19
Identities = 36/126 (28%), Positives = 53/126 (42%), Gaps = 33/126 (26%)
Query: 127 FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
+I ++ L +LH ++ RD+K +N+LL VKL
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL---------------------- 170
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNR-----GHDRAVDYWALGILM 241
VDFG S L + + TF GTP ++APE+I +D D W+LGI
Sbjct: 171 ------VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 242 HELLTG 247
E+ G
Sbjct: 225 IEMAEG 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 23/88 (26%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 1 MLLEACLGGEVWTILR--ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+++E C G V +++ + + ++I ++ L +LH ++ RD+K +N+LL
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 59 NRGYVKL----VSRK-KKTRQTRLYKTF 81
VKL VS + +T R TF
Sbjct: 164 ENAEVKLVDFGVSAQLDRTVGRR--NTF 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 39/164 (23%)
Query: 88 YMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRG---I 144
+++E GG + +L + D ++ A+ + + YLH I
Sbjct: 82 CLVMEFARGGPLNRVLSGKRIPPDILVNW-------AVQ-----IARGMNYLHDEAIVPI 129
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-DFGFSKHLGH 203
+ RDLK N+L+ + +S +K+ DFG ++
Sbjct: 130 IHRDLKSSNILILQKVENGD---------------------LSNKILKITDFGLAREWHR 168
Query: 204 SGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ + G ++APE+I+ + D W+ G+L+ ELLTG
Sbjct: 169 TTKMS--AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 4 EACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG---IVFRDLKPENLLLDNR 60
E GG + +L + + + + YLH I+ RDLK N+L+ +
Sbjct: 86 EFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 61 GYVKLVSRK 69
+S K
Sbjct: 145 VENGDLSNK 153
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-19
Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 32/128 (25%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
A++ + A +AL + H GI+ RD+KP N+++ VK+
Sbjct: 117 RAIE-VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV------------------ 157
Query: 183 FFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGI 239
+DFG ++ + SG +T GT +Y++PE + D D ++LG
Sbjct: 158 ----------MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 240 LMHELLTG 247
+++E+LTG
Sbjct: 208 VLYEVLTG 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 15/52 (28%), Positives = 25/52 (48%)
Query: 14 ILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
I+ A + A +AL + H GI+ RD+KP N+++ VK+
Sbjct: 106 IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 157
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-18
Identities = 32/126 (25%), Positives = 59/126 (46%), Gaps = 30/126 (23%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
A++ T +++ +++ H IV RD+KP+N+L+D+ +K+
Sbjct: 112 TAIN-FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKI------------------ 152
Query: 183 FFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILM 241
DFG +K L + +T GT +Y +PE K D D +++GI++
Sbjct: 153 ----------FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVL 202
Query: 242 HELLTG 247
+E+L G
Sbjct: 203 YEMLVG 208
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 13/52 (25%), Positives = 28/52 (53%)
Query: 14 ILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ + A T +++ +++ H IV RD+KP+N+L+D+ +K+
Sbjct: 101 YIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKI 152
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 37/177 (20%), Positives = 64/177 (36%), Gaps = 57/177 (32%)
Query: 88 YMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLHTRGIVF 146
++ C G +++++R+ D N I A + +++ + YLH +GI+
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQI------AQE-----IVKGMGYLHAKGILH 153
Query: 147 RDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-DFGFSK-----H 200
+DLK +N+ DN G+V + DFG
Sbjct: 154 KDLKSKNVFYDN------------------------------GKVVITDFGLFSISGVLQ 183
Query: 201 LGHSGCKTWTFCGTPEYVAPEIIKNRG---------HDRAVDYWALGILMHELLTGM 248
G K G ++APEII+ + D +ALG + +EL
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 20/76 (26%), Positives = 37/76 (48%), Gaps = 6/76 (7%)
Query: 4 EACLGGEVWTILRERTC-FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
C G +++++R+ D N I +++ + YLH +GI+ +DLK +N+ DN G
Sbjct: 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GK 167
Query: 63 VKL----VSRKKKTRQ 74
V + + Q
Sbjct: 168 VVITDFGLFSISGVLQ 183
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-18
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 35/117 (29%)
Query: 135 ALEYLHTR---GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ YLH+ ++ RDLKP NLLL G V +
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTV----------------------------L 145
Query: 192 KV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K+ DFG + + T G+ ++APE+ + + D ++ GI++ E++T
Sbjct: 146 KICDFGTACDIQTH--MT-NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR 199
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-06
Identities = 17/49 (34%), Positives = 24/49 (48%), Gaps = 8/49 (16%)
Query: 36 ALEYLHTR---GIVFRDLKPENLLLDNRGYV-KL----VSRKKKTRQTR 76
+ YLH+ ++ RDLKP NLLL G V K+ + +T T
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN 162
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 29/118 (24%), Positives = 48/118 (40%), Gaps = 33/118 (27%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++YLH + I+ RDLK N+ L VK+ DF
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKI----------------------------GDF 164
Query: 196 GFS--KHLGHSGCKTWTFCGTPEYVAPEIIKNRGH---DRAVDYWALGILMHELLTGM 248
G + K + G+ ++APE+I+ + D +A GI+++EL+TG
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 20/92 (21%), Positives = 38/92 (41%), Gaps = 7/92 (7%)
Query: 4 EACLGGEVWTILRERTC-FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62
+ C G ++ L F+ I ++YLH + I+ RDLK N+ L
Sbjct: 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT 158
Query: 63 VKL----VSR-KKKTRQTRLYKTFKDSKYVYM 89
VK+ ++ K + + ++ S ++M
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGS-ILWM 189
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-18
Identities = 41/176 (23%), Positives = 66/176 (37%), Gaps = 46/176 (26%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+ + ++++E CLG + + + + +T AL +
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GAL--------Q 165
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L YLH+ ++ RD+K N+LL G VKL D
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKL----------------------------GD 197
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHELLTG 247
FG + + +F GTP ++APE+I +D VD W+LGI EL
Sbjct: 198 FGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 19/79 (24%), Positives = 36/79 (45%), Gaps = 4/79 (5%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E CLG + + + + +T ++ L YLH+ ++ RD+K N+LL
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190
Query: 61 GYVKL----VSRKKKTRQT 75
G VKL + +
Sbjct: 191 GLVKLGDFGSASIMAPANS 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 41/179 (22%), Positives = 72/179 (40%), Gaps = 66/179 (36%)
Query: 76 RLYKTFKDS----KYVYMLLEACLGGEVWT--ILRERTCFDDNAASFITACVIEALDFIT 129
R+ +++ K + +++E GGE+++ R F + AS I + EA+
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI---- 130
Query: 130 ACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG 189
+YLH+ I RD+KPENLL ++ + ++
Sbjct: 131 -------QYLHSINIAHRDVKPENLLYTSK-------------------RPNA------- 157
Query: 190 QVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+K+ DFGF A E +D++ D W+LG++M+ LL G
Sbjct: 158 ILKLTDFGF---------------------AKETTG-EKYDKSCDMWSLGVIMYILLCG 194
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 2/63 (3%)
Query: 1 MLLEACLGGEVWT--ILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+++E GGE+++ R F + AS I + EA++YLH+ I RD+KPENLL
Sbjct: 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 59 NRG 61
++
Sbjct: 152 SKR 154
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 30/183 (16%), Positives = 59/183 (32%), Gaps = 48/183 (26%)
Query: 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI-EALDFITACVI 133
TF ++++ G ++ F D A ++ L
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVL-------- 138
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+AL+Y+H G V R +K ++L+ G V L
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYL----------------------------S 170
Query: 194 DFGFSKHLGHSGCKTWT-------FCGTPEYVAPEIIK--NRGHDRAVDYWALGILMHEL 244
+ + G + +++PE+++ +G+D D +++GI EL
Sbjct: 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
Query: 245 LTG 247
G
Sbjct: 231 ANG 233
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-08
Identities = 16/66 (24%), Positives = 30/66 (45%), Gaps = 2/66 (3%)
Query: 3 LEACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
G ++ ++ A ++I V++AL+Y+H G V R +K ++L+
Sbjct: 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 164
Query: 61 GYVKLV 66
G V L
Sbjct: 165 GKVYLS 170
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-17
Identities = 34/176 (19%), Positives = 64/176 (36%), Gaps = 54/176 (30%)
Query: 87 VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIE-ALDFITACVIEALEYLHTRGIV 145
+ + E GG + I++ + + + + A D + + YLH+ I+
Sbjct: 82 LNFITEYIKGGTLRGIIK------SMDSQYPWSQRVSFAKD-----IASGMAYLHSMNII 130
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHL---- 201
RDL N L+ V ++ DFG ++ +
Sbjct: 131 HRDLNSHNCLVRENKNVV----------------------VA------DFGLARLMVDEK 162
Query: 202 ----------GHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K +T G P ++APE+I R +D VD ++ GI++ E++
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 4/69 (5%)
Query: 37 LEYLHTRGIVFRDLKPENLLLDNRGYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLE 92
+ YLH+ I+ RDL N L+ V + ++R +T+ K
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 93 ACLGGEVWT 101
+G W
Sbjct: 181 TVVGNPYWM 189
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 32/118 (27%)
Query: 135 ALEYLHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+EY+ + IV RDL+ N+ L + + K
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDEN------------------------APVCAK 169
Query: 193 V-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG--HDRAVDYWALGILMHELLTG 247
V DFG S+ HS G +++APE I + D ++ ++++ +LTG
Sbjct: 170 VADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-05
Identities = 15/72 (20%), Positives = 31/72 (43%), Gaps = 3/72 (4%)
Query: 1 MLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLL 57
M++E G+++ L ++ + + + +EY+ + IV RDL+ N+ L
Sbjct: 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL 157
Query: 58 DNRGYVKLVSRK 69
+ V K
Sbjct: 158 QSLDENAPVCAK 169
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-16
Identities = 20/117 (17%), Positives = 37/117 (31%), Gaps = 38/117 (32%)
Query: 136 LEYLHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ +LHT I L ++++D ++
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARI----------------------------S 155
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD---RAVDYWALGILMHELLTG 247
G P +VAPE ++ + D R+ D W+ +L+ EL+T
Sbjct: 156 MADVKFSFQSPGR-----MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-05
Identities = 12/66 (18%), Positives = 25/66 (37%), Gaps = 4/66 (6%)
Query: 4 EACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLDN 59
G ++ +L E T D + A + + +LHT I L ++++D
Sbjct: 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE 148
Query: 60 RGYVKL 65
++
Sbjct: 149 DMTARI 154
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 9e-13
Identities = 30/119 (25%), Positives = 51/119 (42%), Gaps = 41/119 (34%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+++LH+ GI+ RDLKP N+++ + +K+ +D
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LD 207
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGHDRAVDYWALGILMHELLTG 247
FG ++ G S T YV APE+I G+ VD W++G +M E++
Sbjct: 208 FGLARTAGTSFMMT-------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 11/30 (36%), Positives = 22/30 (73%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+++LH+ GI+ RDLKP N+++ + +K+
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 32/187 (17%), Positives = 58/187 (31%), Gaps = 58/187 (31%)
Query: 79 KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138
+ S ++++ G ++ L+ T ++ I L + L +
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTTL------DTVSCLRI-VLS-----IASGLAH 120
Query: 139 LHTR--------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
LH I RDLK +N+L+ G +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI-------------------------- 154
Query: 191 VKVDFGFSKHLGHSGCKTWTF----CGTPEYVAPEIIKNR------GHDRAVDYWALGIL 240
D G + S + GT Y+APE++ + VD WA G++
Sbjct: 155 --ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212
Query: 241 MHELLTG 247
+ E+
Sbjct: 213 LWEVARR 219
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 13/82 (15%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR--------GIVFRDLKP 52
++ G ++ L+ T D + I + L +LH I RDLK
Sbjct: 83 LITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141
Query: 53 ENLLLDNRGYVKL----VSRKK 70
+N+L+ G + ++
Sbjct: 142 KNILVKKNGQCCIADLGLAVMH 163
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-12
Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 41/123 (33%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
++A+ + H + RD+KPEN+L+ +KL
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENILITKHSVIKL--------------------------- 143
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYV------APEII-KNRGHDRAVDYWALGILMHEL 244
DFGF++ L + + V +PE++ + + VD WA+G + EL
Sbjct: 144 -CDFGFARLLTGPS-DYYD-----DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196
Query: 245 LTG 247
L+G
Sbjct: 197 LSG 199
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 11/33 (33%), Positives = 20/33 (60%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++A+ + H + RD+KPEN+L+ +KL
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENILITKHSVIKL 143
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 41/122 (33%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
I + + H+ I+ RD+KPEN+L+ G VKL
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKL---------------------------- 165
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPEYV------APEII-KNRGHDRAVDYWALGILMHELL 245
DFGF++ L + + + + V APE++ + + +AVD WA+G L+ E+
Sbjct: 166 CDFGFARTLA-APGEVYD-----DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
Query: 246 TG 247
G
Sbjct: 220 MG 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 14/32 (43%), Positives = 21/32 (65%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
I + + H+ I+ RD+KPEN+L+ G VKL
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKL 165
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 31/119 (26%), Positives = 52/119 (43%), Gaps = 41/119 (34%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+++LH+ GI+ RDLKP N+++ + +K+ +D
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LD 170
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGHDRAVDYWALGILMHELLTG 247
FG ++ G S T YV APE+I G+ VD W++G +M E++ G
Sbjct: 171 FGLARTAGTSFMMT-------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 11/30 (36%), Positives = 22/30 (73%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+++LH+ GI+ RDLKP N+++ + +K+
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-12
Identities = 23/130 (17%), Positives = 40/130 (30%), Gaps = 46/130 (35%)
Query: 136 LEYLHTR--------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
L +LHT I RDLK +N+L+ G +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI----------------------- 183
Query: 188 GGQVKVDFGFSKHLGHSGCKTW----TFCGTPEYVAPEII------KNRGHDRAVDYWAL 237
D G + + T GT Y+ PE++ + D ++
Sbjct: 184 -----ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238
Query: 238 GILMHELLTG 247
G+++ E+
Sbjct: 239 GLILWEVARR 248
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 12/37 (32%), Positives = 17/37 (45%), Gaps = 8/37 (21%)
Query: 37 LEYLHTR--------GIVFRDLKPENLLLDNRGYVKL 65
L +LHT I RDLK +N+L+ G +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-11
Identities = 23/130 (17%), Positives = 40/130 (30%), Gaps = 46/130 (35%)
Query: 136 LEYLHTR--------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
L +LH I RDLK +N+L+ G +
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI----------------------- 188
Query: 188 GGQVKVDFGFSKHLGHSGCKTWTF----CGTPEYVAPEIIKNRG------HDRAVDYWAL 237
D G + + GT Y+APE++ + + D +A+
Sbjct: 189 -----ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243
Query: 238 GILMHELLTG 247
G++ E+
Sbjct: 244 GLVFWEIARR 253
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-11
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 39/120 (32%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ L++LH+ +V RDLKP+N+L+ + G +KL
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL---------------------------- 161
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG ++ T Y APE++ + VD W++G + E+
Sbjct: 162 ADFGLARIYSFQM----AL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-09
Identities = 14/32 (43%), Positives = 24/32 (75%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ L++LH+ +V RDLKP+N+L+ + G +KL
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-11
Identities = 33/152 (21%), Positives = 52/152 (34%), Gaps = 50/152 (32%)
Query: 123 EALDFITACVI-----EALEYLHTR----------GIVFRDLKPENLLLDNRGYVKLEFY 167
+ + C I L YLH I RD+K +N+LL N
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC---- 171
Query: 168 PAGHYIIREGAKGDSFFIISGGQVKVDFGFSK--HLGHSGCKTWTFCGTPEYVAPEII-- 223
I+ DFG + G S T GT Y+APE++
Sbjct: 172 ------------------IA------DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 224 ---KNRGHDRAVDYWALGILMHELLTGMKESN 252
R +D +A+G+++ EL + ++
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 4e-11
Identities = 31/120 (25%), Positives = 47/120 (39%), Gaps = 39/120 (32%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ L++LH IV RDLKPEN+L+ + G VKL
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKL---------------------------- 161
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG ++ + TP Y APE++ + VD W++G + E+
Sbjct: 162 ADFGLARIYSYQM----AL--TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 8e-09
Identities = 17/32 (53%), Positives = 23/32 (71%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ L++LH IV RDLKPEN+L+ + G VKL
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 40/120 (33%), Positives = 53/120 (44%), Gaps = 39/120 (32%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ LEYLH I+ RDLKP NLLLD G +KL A
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKL----A------------------------ 154
Query: 194 DFGFSKHLGHSGCKTWTFCGTPE-----YVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
DFG +K G S + + T + Y APE++ R + VD WA+G ++ ELL
Sbjct: 155 DFGLAKSFG-SPNRAY----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 19/31 (61%), Positives = 22/31 (70%)
Query: 35 EALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ LEYLH I+ RDLKP NLLLD G +KL
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKL 153
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-11
Identities = 33/121 (27%), Positives = 49/121 (40%), Gaps = 43/121 (35%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+L Y+H+ GI RD+KP+NLLLD + +KL
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKL----------------------------C 199
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKN-RGHDRAVDYWALGILMHELLT 246
DFG +K L Y+ APE+I + ++D W+ G ++ ELL
Sbjct: 200 DFGSAKQLVRGEPNV-------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
Query: 247 G 247
G
Sbjct: 253 G 253
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 16/31 (51%), Positives = 23/31 (74%), Gaps = 1/31 (3%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKL 65
+L Y+H+ GI RD+KP+NLLLD + +KL
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 198
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-11
Identities = 35/121 (28%), Positives = 52/121 (42%), Gaps = 16/121 (13%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+++AL YL + DLKPEN+LLD+ + K K + +
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR----VTDGKKIQIYRTKSTGI 201
Query: 192 KV-DFGFSKHLGHSGC----KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
K+ DFG + T +Y APE+I N G D + D W+ G ++ EL T
Sbjct: 202 KLIDFG-------CATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 247 G 247
G
Sbjct: 255 G 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 14/53 (26%), Positives = 28/53 (52%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSK 85
+++AL YL + DLKPEN+LLD+ + K + ++ + + ++
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-11
Identities = 29/121 (23%), Positives = 55/121 (45%), Gaps = 39/121 (32%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ + + H I+ RDLKP+NLL+++ G +KL
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKL---------------------------- 160
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELLT 246
DFG ++ G +++ T E Y AP+++ ++ + +VD W++G + E++T
Sbjct: 161 ADFGLARAFG-IPVRSY----THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
Query: 247 G 247
G
Sbjct: 216 G 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 13/32 (40%), Positives = 22/32 (68%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ + + H I+ RDLKP+NLL+++ G +KL
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 8e-09
Identities = 13/32 (40%), Positives = 23/32 (71%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L + H+ ++ RDLKP+NLL++ G +KL
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKL 144
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 26/121 (21%), Positives = 43/121 (35%), Gaps = 35/121 (28%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ L Y+H I+ RD+K N+L+ G +KL
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKL---------------------------- 165
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELLT 246
DFG ++ + + T Y PE++ R + +D W G +M E+ T
Sbjct: 166 ADFGLARAFSLAK-NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
Query: 247 G 247
Sbjct: 225 R 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ L Y+H I+ RD+K N+L+ G +KL
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKL 165
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 30/121 (24%), Positives = 50/121 (41%), Gaps = 39/121 (32%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ L Y H + ++ RDLKP+NLL++ RG +KL
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKL---------------------------- 141
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELLT 246
DFG ++ KT+ E Y P+I+ + + +D W +G + +E+ T
Sbjct: 142 ADFGLARAKS-IPTKTY----DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
Query: 247 G 247
G
Sbjct: 197 G 197
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 15/32 (46%), Positives = 23/32 (71%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ L Y H + ++ RDLKP+NLL++ RG +KL
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKL 141
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 27/120 (22%), Positives = 40/120 (33%), Gaps = 42/120 (35%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L LH G+V RDL P N+LL + + + D
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITI----------------------------CD 177
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELLTG 247
F ++ KT YV APE++ + VD W+ G +M E+
Sbjct: 178 FNLAREDTADANKT-------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 12/30 (40%), Positives = 17/30 (56%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L LH G+V RDL P N+LL + + +
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITI 175
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-10
Identities = 13/125 (10%), Positives = 24/125 (19%), Gaps = 56/125 (44%)
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
A+ + A + H G+ P + + G V L
Sbjct: 130 GAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL------------------ 170
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
P + + D +G ++
Sbjct: 171 ------------------------------AYPATMPDA-------NPQDDIRGIGASLY 193
Query: 243 ELLTG 247
LL
Sbjct: 194 ALLVN 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-08
Identities = 8/41 (19%), Positives = 13/41 (31%)
Query: 25 AASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
A + A + H G+ P + + G V L
Sbjct: 130 GAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL 170
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 29/136 (21%), Positives = 48/136 (35%), Gaps = 36/136 (26%)
Query: 136 LEYLHT---------RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFII 186
L YLHT I RDL N+L+ N G + D F +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI---------------SD--FGL 166
Query: 187 SGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-------RGHDRAVDYWALGI 239
S +++ G + GT Y+APE+++ + VD +ALG+
Sbjct: 167 S---MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 240 LMHELLTGMKESNVFQ 255
+ E+ + +
Sbjct: 224 IYWEIFMRCTDLFPGE 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-10
Identities = 27/121 (22%), Positives = 52/121 (42%), Gaps = 39/121 (32%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ + Y H R ++ RDLKP+NLL++ G +K+
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKI---------------------------- 141
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELLT 246
DFG ++ G + + T E Y AP+++ ++ + +D W++G + E++
Sbjct: 142 ADFGLARAFG-IPVRKY----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 247 G 247
G
Sbjct: 197 G 197
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 1e-08
Identities = 13/32 (40%), Positives = 22/32 (68%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
+ + Y H R ++ RDLKP+NLL++ G +K+
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 3e-10
Identities = 25/123 (20%), Positives = 51/123 (41%), Gaps = 39/123 (31%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ L + H+R ++ RDLKP+NLL++ G +KL
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKL---------------------------- 142
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELLT 246
+FG ++ G + + + E Y P+++ + + ++D W+ G + EL
Sbjct: 143 ANFGLARAFG-IPVRCY----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 247 GMK 249
+
Sbjct: 198 AGR 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 14/32 (43%), Positives = 24/32 (75%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L + H+R ++ RDLKP+NLL++ G +KL
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 30/148 (20%), Positives = 56/148 (37%), Gaps = 25/148 (16%)
Query: 122 IEALDFITACVIEALEYLHTR-GIVFRDLKPENLLL------DNRGYVKLEFYPAGHYII 174
+ + I V++ L+YLHT+ I+ D+KPEN+LL R + +
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 175 REGAKGDSFFIISGGQVK---------------VDFGFSKHLGHSGCKTWTFCGTPEYVA 219
G+ + +G + D G + + + T +Y +
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRS 261
Query: 220 PEIIKNRGHDRAVDYWALGILMHELLTG 247
E++ G++ D W+ + EL TG
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATG 289
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 39/121 (32%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ L + H I+ RDLKP+NLL++ RG +KL
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKL---------------------------- 149
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELLT 246
DFG ++ G T+ + E Y AP+++ +R + ++D W+ G ++ E++T
Sbjct: 150 GDFGLARAFG-IPVNTF----SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
Query: 247 G 247
G
Sbjct: 205 G 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 15/32 (46%), Positives = 23/32 (71%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++ L + H I+ RDLKP+NLL++ RG +KL
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKL 149
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-10
Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 44/120 (36%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L+Y+H+ G+V RDLKP NL ++ +K+ +D
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKI----------------------------LD 169
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELLTG 247
FG ++H T YV APE+I + H ++ VD W++G +M E+LTG
Sbjct: 170 FGLARHADA----EMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 13/30 (43%), Positives = 21/30 (70%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L+Y+H+ G+V RDLKP NL ++ +K+
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKI 167
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 34/122 (27%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ + YLH ++ RDLKP N+L+ G + G+VK
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPER-------------------------GRVK 172
Query: 193 V-DFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELL 245
+ D GF++ S K P Y APE++ R + +A+D WA+G + ELL
Sbjct: 173 IADMGFARLFN-SPLKPLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
Query: 246 TG 247
T
Sbjct: 231 TS 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 4/36 (11%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLL----DNRGYVKL 65
++ + YLH ++ RDLKP N+L+ RG VK+
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 32/120 (26%), Positives = 48/120 (40%), Gaps = 44/120 (36%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L Y+H GI+ RDLKP NL ++ +K+ +D
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKI----------------------------LD 171
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELLTG 247
FG ++ T YV APE+I N + VD W++G +M E++TG
Sbjct: 172 FGLARQADSE----MT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 13/30 (43%), Positives = 19/30 (63%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L Y+H GI+ RDLKP NL ++ +K+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKI 169
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 35/120 (29%), Positives = 52/120 (43%), Gaps = 44/120 (36%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L+Y+H+ I+ RDLKP NL ++ +K+ +D
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKI----------------------------LD 175
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELLTG 247
FG ++H T YV APEI+ N H ++ VD W++G +M ELLTG
Sbjct: 176 FGLARHTAD----EMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 12/30 (40%), Positives = 20/30 (66%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L+Y+H+ I+ RDLKP NL ++ +K+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKI 173
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 31/125 (24%), Positives = 54/125 (43%), Gaps = 16/125 (12%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPAGHYIIREGAKGDSFFIISGGQVKV 193
++Y+H+ GI+ RDLKP N L++ VK+ +F A E + +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELLT 246
+ + T +V APE+I + + A+D W++G + ELL
Sbjct: 228 VTFPHT---KNLKRQLT-----GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 247 GMKES 251
+KE+
Sbjct: 280 MIKEN 284
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 13/30 (43%), Positives = 21/30 (70%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++Y+H+ GI+ RDLKP N L++ VK+
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKV 197
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 29/124 (23%), Positives = 48/124 (38%), Gaps = 39/124 (31%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
A++ LH ++ RDLKP NLL+++ +K+ D
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKV----------------------------CD 155
Query: 195 FGFSKHLGHSGCKTWTFCGTP----EYV------APEIIKNRGH-DRAVDYWALGILMHE 243
FG ++ + S G E+V APE++ RA+D W+ G ++ E
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215
Query: 244 LLTG 247
L
Sbjct: 216 LFLR 219
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 6e-04
Identities = 12/30 (40%), Positives = 21/30 (70%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
A++ LH ++ RDLKP NLL+++ +K+
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKV 153
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 29/122 (23%), Positives = 54/122 (44%), Gaps = 24/122 (19%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPAGHYIIREG-AKGDSFFIISGGQVK 192
++YLH+ G++ RD+KP N+LL+ +VK+ +F G ++ +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADF----------GLSRSFVNIRRVTNNIP 170
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKN-RGHDRAVDYWALGILMHELL 245
+ + T +YV APEI+ + + +D W+LG ++ E+L
Sbjct: 171 LSINENTENFDDDQPILT-----DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 246 TG 247
G
Sbjct: 226 CG 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 13/30 (43%), Positives = 23/30 (76%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++YLH+ G++ RD+KP N+LL+ +VK+
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKV 150
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 29/121 (23%), Positives = 46/121 (38%), Gaps = 22/121 (18%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ +++ +LH+ + DLKPEN+L Y + + +
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP----------KIKRDERTLINPDI 176
Query: 192 KV-DFGFSKHLGHSGC----KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
KV DFG S T T Y APE+I G + D W++G ++ E
Sbjct: 177 KVVDFG-------SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 247 G 247
G
Sbjct: 230 G 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-05
Identities = 13/48 (27%), Positives = 24/48 (50%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80
+ +++ +LH+ + DLKPEN+L Y + + K K + L
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 42/122 (34%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
L+Y+H+ ++ RDLKP NLLL+ +K+ D
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKI----------------------------CD 171
Query: 195 FGFSKHL--GHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELL 245
FG ++ H T EYV APEI+ N +++D W++G ++ E+L
Sbjct: 172 FGLARVADPDHDHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 246 TG 247
+
Sbjct: 227 SN 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 13/30 (43%), Positives = 21/30 (70%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
L+Y+H+ ++ RDLKP NLLL+ +K+
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 34/121 (28%), Positives = 49/121 (40%), Gaps = 43/121 (35%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+L Y+H+ GI RD+KP+NLLLD G +KL +
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKL----------------------------I 184
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKN-RGHDRAVDYWALGILMHELLT 246
DFG +K L Y+ APE+I + +D W+ G +M EL+
Sbjct: 185 DFGSAKILIAGEPNV-------SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 247 G 247
G
Sbjct: 238 G 238
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 17/31 (54%), Positives = 23/31 (74%), Gaps = 1/31 (3%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKL 65
+L Y+H+ GI RD+KP+NLLLD G +KL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKL 183
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 30/123 (24%), Positives = 44/123 (35%), Gaps = 26/123 (21%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ AL +LH + DLKPEN+L N + L K + +
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE----------HKSCEEKSVKNTSI 181
Query: 192 KV-DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGHDRAVDYWALGILMHEL 244
+V DFG S T V PE+I G + D W++G ++ E
Sbjct: 182 RVADFG-------SATFDHEHHTT--IVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 245 LTG 247
G
Sbjct: 233 YRG 235
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 15/48 (31%), Positives = 23/48 (47%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80
+ AL +LH + DLKPEN+L N + L + K + + T
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 29/121 (23%), Positives = 48/121 (39%), Gaps = 43/121 (35%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
A+ ++H+ GI RD+KP+NLL++ +KL
Sbjct: 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKL----------------------------C 184
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELLT 246
DFG +K L S Y+ APE++ ++D W++G + EL+
Sbjct: 185 DFGSAKKLIPSEPSV-------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 247 G 247
G
Sbjct: 238 G 238
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 13/31 (41%), Positives = 22/31 (70%), Gaps = 1/31 (3%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKL 65
A+ ++H+ GI RD+KP+NLL++ +KL
Sbjct: 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 25/123 (20%), Positives = 48/123 (39%), Gaps = 43/123 (34%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV- 193
L+Y+H+ ++ RDLKP NL ++ +K+
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDL----------------------------VLKIG 163
Query: 194 DFGFSKHLGHSGCKT--WTFCGTPEYV------APEIIKN-RGHDRAVDYWALGILMHEL 244
DFG ++ + + E + +P ++ + + +A+D WA G + E+
Sbjct: 164 DFGLARIMDPHYSHKGHLS-----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
Query: 245 LTG 247
LTG
Sbjct: 219 LTG 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 10/23 (43%), Positives = 17/23 (73%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLD 58
L+Y+H+ ++ RDLKP NL ++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFIN 154
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 29/122 (23%), Positives = 49/122 (40%), Gaps = 36/122 (29%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
I + + H+R + RDLKP+NLLL + +K
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASET------------------------PVLK 177
Query: 193 V-DFGFSKHLGHSGCKTWTFCGTPE-----YVAPEII-KNRGHDRAVDYWALGILMHELL 245
+ DFG ++ G + +T E Y PEI+ +R + +VD W++ + E+L
Sbjct: 178 IGDFGLARAFG-IPIRQFT----HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 246 TG 247
Sbjct: 233 MK 234
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 13/37 (35%), Positives = 20/37 (54%), Gaps = 5/37 (13%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLD-----NRGYVKL 65
I + + H+R + RDLKP+NLLL +K+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-09
Identities = 29/125 (23%), Positives = 50/125 (40%), Gaps = 21/125 (16%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL-EFYPAGHYIIREGAKGDSFFIISGGQVKV 193
++H GI+ RDLKP N LL+ VK+ +F A + + +
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKNRGH-DRAVDYWALGILMHELLT 246
+ K L T +V APE+I + + +++D W+ G + ELL
Sbjct: 201 NKNLKKQL------T-------SHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 247 GMKES 251
++
Sbjct: 248 MLQSH 252
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 13/30 (43%), Positives = 18/30 (60%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
++H GI+ RDLKP N LL+ VK+
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKV 170
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 29/128 (22%), Positives = 51/128 (39%), Gaps = 28/128 (21%)
Query: 122 IEALDFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKG 180
+ + I+ ++ L+Y+H R GI+ D+KPEN+L++ +
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI-------------- 175
Query: 181 DSFFIISGGQVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGI 239
Q+K+ D G + T EY +PE++ D W+
Sbjct: 176 ---------QIKIADLGNACWYDEHYT---NSIQTREYRSPEVLLGAPWGCGADIWSTAC 223
Query: 240 LMHELLTG 247
L+ EL+TG
Sbjct: 224 LIFELITG 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 33/122 (27%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLL--DNRGYVKLEFYPAGHYIIREGAKGDSFFI 185
+++ L+ LH I+ DLKPEN+LL R +K+
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKV--------------------- 243
Query: 186 ISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
+DFG S + + +T+ + Y APE+I + +D W+LG ++ ELL
Sbjct: 244 -------IDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 246 TG 247
TG
Sbjct: 294 TG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 35/124 (28%)
Query: 128 ITACVIEALEYLHTR--GIVFRDLKPENLLLDN--RGYVKLEFYPAGHYIIREGAKGDSF 183
+ AL +L T I+ DLKPEN+LL N R +K+
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI------------------- 202
Query: 184 FIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
VDFG S LG + + + + Y +PE++ +D A+D W+LG ++ E
Sbjct: 203 ---------VDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
Query: 244 LLTG 247
+ TG
Sbjct: 251 MHTG 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 45/123 (36%)
Query: 135 ALEYLH--TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ LH + + RD+KP N+L++ + G +K
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNE----------------------------ADGTLK 172
Query: 193 V-DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKN-RGHDRAVDYWALGILMHEL 244
+ DFG +K L S Y+ APE+I + + AVD W++G + E+
Sbjct: 173 LCDFGSAKKLSPSEPNV-------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225
Query: 245 LTG 247
+ G
Sbjct: 226 MLG 228
|
| >1vp6_A CNBD, cyclic-nucleotide binding domain of mesorhizobium LOTI CNG potassium channel; dimer helical bundle beta barrel core with cyclic AMP bound; HET: CMP; 1.70A {Mesorhizobium loti} SCOP: b.82.3.2 PDB: 3cl1_A* 2k0g_A* 2kxl_A 3clp_A* 1u12_A 3co2_A Length = 138 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-08
Identities = 17/57 (29%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG 202
F+ L +L++ ++ PAG I R G GD F + G V V LG
Sbjct: 19 FQKL-GPAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPNPVELG 74
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 8e-08
Identities = 28/120 (23%), Positives = 49/120 (40%), Gaps = 39/120 (32%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
+ +LH + RD+K N+LLD F K+ D
Sbjct: 146 INFLHENHHIHRDIKSANILLDE------AFTA-----------------------KISD 176
Query: 195 FGFSKHLGHSGCKTWT---FCGTPEYVAPEIIKNRGH--DRAVDYWALGILMHELLTGMK 249
FG ++ +T GT Y+APE + RG ++ D ++ G+++ E++TG+
Sbjct: 177 FGLAR-ASEKFAQTVMTSRIVGTTAYMAPEAL--RGEITPKS-DIYSFGVVLLEIITGLP 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 23/122 (18%), Positives = 44/122 (36%), Gaps = 33/122 (27%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ALE+LH V ++ EN+ +D ++ +
Sbjct: 169 LDALEFLHENEYVHGNVTAENIFVDPEDQSQV-------TLA------------------ 203
Query: 193 VDFGFSK-------HLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
+GF+ H+ + G E+++ ++ K G R D +LG M + L
Sbjct: 204 -GYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262
Query: 246 TG 247
G
Sbjct: 263 YG 264
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 9/25 (36%), Positives = 16/25 (64%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLD 58
++ALE+LH V ++ EN+ +D
Sbjct: 169 LDALEFLHENEYVHGNVTAENIFVD 193
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 34/120 (28%), Positives = 50/120 (41%), Gaps = 38/120 (31%)
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
L YLHTR I+ RD+K N+LLD F P K+ D
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDE------NFVP-----------------------KITD 182
Query: 195 FGFSKHLGHSGCKTW---TFCGTPEYVAPEIIKNRGH--DRAVDYWALGILMHELLTGMK 249
FG SK G +T GT Y+ PE +G +++ D ++ G+++ E+L
Sbjct: 183 FGISK-KGTELDQTHLSTVVKGTLGYIDPEYF-IKGRLTEKS-DVYSFGVVLFEVLCARS 239
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 14/23 (60%), Positives = 17/23 (73%)
Query: 37 LEYLHTRGIVFRDLKPENLLLDN 59
L YLHTR I+ RD+K N+LLD
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDE 174
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 24/121 (19%), Positives = 53/121 (43%), Gaps = 43/121 (35%)
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV- 193
AL+Y H+ GI+ RD+KP N+++D+ ++++
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDH----------------------------EHRKLRLI 173
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYV------APEIIKN-RGHDRAVDYWALGILMHELLT 246
D+G ++ H G + + V PE++ + + +D ++D W+LG ++ ++
Sbjct: 174 DWGLAE-FYHPG-QEYN-----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 247 G 247
Sbjct: 227 R 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 12/23 (52%), Positives = 19/23 (82%)
Query: 36 ALEYLHTRGIVFRDLKPENLLLD 58
AL+Y H+ GI+ RD+KP N+++D
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMID 164
|
| >3gyd_A CNMP-BD protein, cyclic nucleotide-binding domain; nucleotide binding protein, structural genomics; HET: MSE CMP; 1.79A {Methylobacillus flagellatus KT} Length = 187 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 14/49 (28%), Positives = 21/49 (42%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F D E + L Y++ P ++ EG GD +I G+V V
Sbjct: 47 FGDFSNEEVRYL--CSYMQCYAAPRDCQLLTEGDPGDYLLLILTGEVNV 93
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 33/122 (27%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ LEY+H V D+K NLLL+ + ++ Y++
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLLNYKNPDQV-------YLV------------------ 196
Query: 193 VDFGFSKHLGHSGCKT-------WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
D+G + G GT E+ + + R D LG M + L
Sbjct: 197 -DYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255
Query: 246 TG 247
TG
Sbjct: 256 TG 257
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 11/27 (40%), Positives = 17/27 (62%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNR 60
++ LEY+H V D+K NLLL+ +
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLLNYK 188
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 27/122 (22%), Positives = 40/122 (32%), Gaps = 33/122 (27%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
++ LEY+H V D+K NLLL + ++ Y+
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYKNPDQV-------YLA------------------ 195
Query: 193 VDFGFSKHLGHSG-------CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
D+G S +G GT E+ + + K R D LG M L
Sbjct: 196 -DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
Query: 246 TG 247
G
Sbjct: 255 CG 256
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 11/27 (40%), Positives = 16/27 (59%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNR 60
++ LEY+H V D+K NLLL +
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYK 187
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} Length = 299 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 18/31 (58%), Positives = 23/31 (74%)
Query: 163 KLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ Y G YIIR+GA+GD+FFIIS G+V V
Sbjct: 181 EETHYENGEYIIRQGARGDTFFIISKGKVNV 211
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} Length = 299 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 10/49 (20%), Positives = 22/49 (44%), Gaps = 1/49 (2%)
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
++L + + + + Y II+EG G +++ G+V+V
Sbjct: 46 FMKNL-ELSQIQEIVDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKVEV 93
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 Length = 469 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-06
Identities = 10/51 (19%), Positives = 18/51 (35%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F P L + E G + R+G G +++ + G + V
Sbjct: 49 AFEKFHPNLLRQICL---CGYYENLEKGITLFRQGDIGTNWYAVLAGSLDV 96
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 Length = 469 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 4e-05
Identities = 10/49 (20%), Positives = 16/49 (32%)
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
L + G + +G +G S++II G V V
Sbjct: 344 ALSHLSTTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNV 392
|
| >1wgp_A Probable cyclic nucleotide-gated ION channel 6; cyclic nucleotide monophosphate, CNMP, CNMP-binding, structural genomics; NMR {Arabidopsis thaliana} SCOP: b.82.3.2 Length = 137 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 2e-06
Identities = 11/48 (22%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F ++ E LL +K + Y++REG + I G+++
Sbjct: 14 FENM-DERLLDAICERLKPCLFTEKSYLVREGDPVNEMLFIIRGRLES 60
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* Length = 416 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 3e-06
Identities = 21/99 (21%), Positives = 35/99 (35%), Gaps = 19/99 (19%)
Query: 97 GEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENL-- 154
G +W + +R F FI + + L+
Sbjct: 240 GALWGL--DRVTFRRIIVKNNAKKRKMYESFIESLPF------------LKSLEVSERLK 285
Query: 155 LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
++D + + Y G II +G DSFFI+ G+VK+
Sbjct: 286 VVDV---IGTKVYNDGEQIIAQGDLADSFFIVESGEVKI 321
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* Length = 416 | Back alignment and structure |
|---|
Score = 40.1 bits (93), Expect = 4e-04
Identities = 14/51 (27%), Positives = 28/51 (54%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+F++L PE + +LD + + G ++I +G GD+F++I G +
Sbjct: 152 LFKNLDPEQMSQVLD---AMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDI 199
|
| >3mdp_A Cyclic nucleotide-binding domain (CNMP-BD) protei; structural genomics, joint center for structural genomics; HET: MSE; 1.90A {Geobacter metallireducens} Length = 142 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-06
Identities = 12/49 (24%), Positives = 23/49 (46%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F L E L + + + +P G I +E +K D+ ++ G V++
Sbjct: 14 FASLTDEQLKDI--ALISEEKSFPTGSVIFKENSKADNLMLLLEGGVEL 60
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 4e-06
Identities = 21/125 (16%), Positives = 44/125 (35%), Gaps = 11/125 (8%)
Query: 78 YKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDF------ITAC 131
+ + ++V + E GE+ I A + + I+ + T
Sbjct: 182 VDVYVNGEWVTNISEGGSFGELALIYGTPRAATVKAKTDLKLWGIDRDSYRRILMGSTLR 241
Query: 132 VIEALEYLHTRGIVFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG 189
+ E ++ + L+ + D ++ + G I+ +G GD F+II+ G
Sbjct: 242 KRKMYEEFLSKVSILESLEKWERLTVADA---LEPVQFEDGEKIVVQGEPGDDFYIITEG 298
Query: 190 QVKVD 194
V
Sbjct: 299 TASVL 303
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} Length = 381 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 14/61 (22%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ AL ++ ++F L + + AG +I++G +GD+F+++ G+V
Sbjct: 125 MTALAKAISKNVLFAHLDDNERSDIFD-AMFPVTHIAGETVIQQGNEGDNFYVVDQGEVD 183
Query: 193 V 193
V
Sbjct: 184 V 184
|
| >3idb_B CAMP-dependent protein kinase type II-beta regulatory subunit, CAMP-dependent protein kinase catalytic subunit alpha; PKA, SPR, affinity; HET: TPO SEP ANP; 1.62A {Rattus norvegicus} PDB: 3idc_B* Length = 161 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-06
Identities = 14/51 (27%), Positives = 28/51 (54%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+F++L PE + +LD + + G ++I +G GD+F++I G +
Sbjct: 45 LFKNLDPEQMSQVLD---AMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDI 92
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 27/124 (21%), Positives = 46/124 (37%), Gaps = 36/124 (29%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
I +E++H++ + RD+KP+N L + G + + +II
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFL------------------MGLGRRANQVYII------ 148
Query: 193 VDFGFSK---------HLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DFG +K H+ + K GT Y + R D +LG ++
Sbjct: 149 -DFGLAKKYRDTSTHQHIPYRENK--NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMY 205
Query: 244 LLTG 247
L G
Sbjct: 206 FLRG 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 15/60 (25%), Positives = 26/60 (43%), Gaps = 10/60 (16%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVS----------RKKKTRQTRLYKTFKD 83
I +E++H++ + RD+KP+N L+ V R T Q Y+ K+
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} Length = 246 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 6e-06
Identities = 17/51 (33%), Positives = 26/51 (50%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
V + L + L D + + Y G IIREG +G++F++I G V V
Sbjct: 132 VLKSLTTYDRAKLADA---LDTKIYQPGETIIREGDQGENFYLIEYGAVDV 179
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} Length = 246 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 12/51 (23%), Positives = 27/51 (52%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+F L ++ +++ ++ + P G II++G +GD F+++ G V
Sbjct: 14 LFNKLDSDSKRLVIN---CLEEKSVPKGATIIKQGDQGDYFYVVEKGTVDF 61
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 47/124 (37%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ +EYL T+ + RDL N+L++N VK I
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVK----------------------IG------ 156
Query: 194 DFGFSKHLGHS--------GCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG +K L ++ W APE + A D W+ G++++
Sbjct: 157 DFGLTKVLPQDKEFFKVKEPGESPIFWY--------APESLTESKFSVASDVWSFGVVLY 208
Query: 243 ELLT 246
EL T
Sbjct: 209 ELFT 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 24/122 (19%), Positives = 41/122 (33%), Gaps = 30/122 (24%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
+ ++ +H + +V+RD+KP+N L+ + +++
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIG----------------RPNSKNANMIYVV------ 153
Query: 193 VDFGFSKHLGHSGCKT-------WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
DFG K K GT Y++ R R D ALG + L
Sbjct: 154 -DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 212
Query: 246 TG 247
G
Sbjct: 213 RG 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 8/24 (33%), Positives = 18/24 (75%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLL 57
+ ++ +H + +V+RD+KP+N L+
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLI 139
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-06
Identities = 29/140 (20%), Positives = 42/140 (30%), Gaps = 52/140 (37%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ + Y+ V RDL+ N+L+ K ++
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCK----------------------VA---- 405
Query: 192 KVDFGFSKHL------GHSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG ++ + G K WT APE D W+ GIL+
Sbjct: 406 --DFGLARLIEDNEYTARQGAKFPIKWT--------APEAALYGRFTIKSDVWSFGILLT 455
Query: 243 ELLT-------GMKESNVFQ 255
EL T GM V
Sbjct: 456 ELTTKGRVPYPGMVNREVLD 475
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 47/124 (37%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ +EYL T+ + RDL N+L++N VK I
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVK----------------------IG------ 187
Query: 194 DFGFSKHLGHS--------GCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG +K L ++ W APE + A D W+ G++++
Sbjct: 188 DFGLTKVLPQDKEYYKVKEPGESPIFWY--------APESLTESKFSVASDVWSFGVVLY 239
Query: 243 ELLT 246
EL T
Sbjct: 240 ELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 29/121 (23%), Positives = 46/121 (38%), Gaps = 47/121 (38%)
Query: 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFG 196
EYL +R V RDL N+L+++ +VK I+ DFG
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVK----------------------IA------DFG 172
Query: 197 FSKHLG--------HSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
+K L ++ W APE + + R D W+ G++++EL
Sbjct: 173 LAKLLPLDKDYYVVREPGQSPIFWY--------APESLSDNIFSRQSDVWSFGVVLYELF 224
Query: 246 T 246
T
Sbjct: 225 T 225
|
| >2pqq_A Putative transcriptional regulator; APC7345, streptomyces coelicolor structural genomics, PSI-2, protein structure initiative; 2.00A {Streptomyces coelicolor A3} Length = 149 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-05
Identities = 12/50 (24%), Positives = 20/50 (40%), Gaps = 3/50 (6%)
Query: 145 VFRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+F L E L G + EG GD ++++ G+VK+
Sbjct: 12 LFAALDDEQSAELRASMSEV--TLARGDTLFHEGDPGDRLYVVTEGKVKL 59
|
| >3pna_A CAMP-dependent protein kinase type I-alpha regula subunit; beta-barrel, CAMP-binding, catalytic subunit, transferase; HET: CMP; 1.50A {Bos taurus} PDB: 3fhi_B* 3iia_A 3plq_A* 1u7e_B* 3pvb_B* Length = 154 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-05
Identities = 13/51 (25%), Positives = 26/51 (50%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+F L + D + + AG +I++G +GD+F++I G++ V
Sbjct: 45 LFSHLDDNERSDIFD---AMFPVSFIAGETVIQQGDEGDNFYVIDQGEMDV 92
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 32/122 (26%), Positives = 50/122 (40%), Gaps = 40/122 (32%)
Query: 136 LEYLH---TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
L YLH I+ RD+K N+LLD EF
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDE------EFEA-----------------------V 174
Query: 193 V-DFGFSKHL--GHSGCKTWTFCGTPEYVAPEIIKNRGH--DRAVDYWALGILMHELLTG 247
V DFG +K + + T GT ++APE + + G ++ D + G+++ EL+TG
Sbjct: 175 VGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL-STGKSSEKT-DVFGYGVMLLELITG 231
Query: 248 MK 249
+
Sbjct: 232 QR 233
|
| >3ocp_A PRKG1 protein; serine/threonine kinase, TF2I and IRAG, transferase; HET: CMP; 2.49A {Homo sapiens} PDB: 3od0_A* 3ogj_A* Length = 139 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-05
Identities = 10/49 (20%), Positives = 22/49 (44%), Gaps = 1/49 (2%)
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
++L + + + + Y II+EG G +++ G+V+V
Sbjct: 30 FMKNL-ELSQIQEIVDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKVEV 77
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 31/136 (22%), Positives = 45/136 (33%), Gaps = 48/136 (35%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
V EA+EYL V RDL N+L+ K +S
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK----------------------VS---- 331
Query: 192 KVDFGFSKHL--GHSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG +K K WT APE ++ + D W+ GIL+ E+ +
Sbjct: 332 --DFGLTKEASSTQDTGKLPVKWT--------APEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 247 -------GMKESNVFQ 255
+ +V
Sbjct: 382 FGRVPYPRIPLKDVVP 397
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 32/124 (25%), Positives = 44/124 (35%), Gaps = 47/124 (37%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
E + YLH + + RDL N+LLDN VK I
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVK----------------------IG------ 176
Query: 194 DFGFSKHLGH--------SGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG +K + + W APE +K A D W+ G+ ++
Sbjct: 177 DFGLAKAVPEGHEYYRVREDGDSPVFWY--------APECLKEYKFYYASDVWSFGVTLY 228
Query: 243 ELLT 246
ELLT
Sbjct: 229 ELLT 232
|
| >2z69_A DNR protein; beta barrel, dimerization helix, transcription regulator; 2.10A {Pseudomonas aeruginosa} Length = 154 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-05
Identities = 13/49 (26%), Positives = 20/49 (40%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F L P L L + G Y+ R+G +F+ + G VK+
Sbjct: 20 FEPLSPVQLQELLASSDLV--NLDKGAYVFRQGEPAHAFYYLISGCVKI 66
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 29/124 (23%), Positives = 44/124 (35%), Gaps = 47/124 (37%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ ++YL +R V RDL N+L+++ VK I
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVK----------------------IG------ 168
Query: 194 DFGFSKHLG--------HSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG +K + + W APE + A D W+ G+ +H
Sbjct: 169 DFGLTKAIETDKEYYTVKDDRDSPVFWY--------APECLMQSKFYIASDVWSFGVTLH 220
Query: 243 ELLT 246
ELLT
Sbjct: 221 ELLT 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 29/140 (20%), Positives = 42/140 (30%), Gaps = 52/140 (37%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ + Y+ V RDL+ N+L+ K ++
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCK----------------------VA---- 322
Query: 192 KVDFGFSKHL------GHSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG ++ + G K WT APE D W+ GIL+
Sbjct: 323 --DFGLARLIEDNEYTARQGAKFPIKWT--------APEAALYGRFTIKSDVWSFGILLT 372
Query: 243 ELLT-------GMKESNVFQ 255
EL T GM V
Sbjct: 373 ELTTKGRVPYPGMVNREVLD 392
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 33/139 (23%), Positives = 49/139 (35%), Gaps = 53/139 (38%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ + YL R +V RDL N+L+ +VK I+
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVK----------------------IT------ 159
Query: 194 DFGFSKHLGH-------SGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DFG +K LG G K W A E I +R + D W+ G+ + E
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWM--------ALESILHRIYTHQSDVWSYGVTVWE 211
Query: 244 LLT-------GMKESNVFQ 255
L+T G+ S +
Sbjct: 212 LMTFGSKPYDGIPASEISS 230
|
| >4ava_A Lysine acetyltransferase; allosteric regulation, domain coupling; HET: ACO; 1.70A {Mycobacterium tuberculosis} PDB: 4avb_A* 4avc_A* Length = 333 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 4e-05
Identities = 16/51 (31%), Positives = 24/51 (47%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
VF+ E L L + V+ AG ++R+G SF +IS G +V
Sbjct: 20 VFQGCPAEGLVSLAAS---VQPLRAAAGQVLLRQGEPAVSFLLISSGSAEV 67
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 32/140 (22%), Positives = 50/140 (35%), Gaps = 52/140 (37%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ A+EYL + + R+L N L+ VK ++
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVK----------------------VA---- 360
Query: 192 KVDFGFSKHL------GHSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG S+ + H+G K WT APE + D WA G+L+
Sbjct: 361 --DFGLSRLMTGDTYTAHAGAKFPIKWT--------APESLAYNKFSIKSDVWAFGVLLW 410
Query: 243 ELLT-------GMKESNVFQ 255
E+ T G+ S V++
Sbjct: 411 EIATYGMSPYPGIDLSQVYE 430
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-05
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 22/118 (18%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+I +EY+H++ + RD+KP+N L + G KG+ +II G
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFL------------------MGLGKKGNLVYIIDFGLA 155
Query: 192 K--VDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
K D +H+ + K GT Y + R D +LG ++ G
Sbjct: 156 KKYRDARTHQHIPYRENK--NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 7e-04
Identities = 10/25 (40%), Positives = 19/25 (76%)
Query: 33 VIEALEYLHTRGIVFRDLKPENLLL 57
+I +EY+H++ + RD+KP+N L+
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLM 138
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-05
Identities = 28/124 (22%), Positives = 45/124 (36%), Gaps = 34/124 (27%)
Query: 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK 192
I +EY+H++ +++RD+KPEN L+ II
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIG----------------RPGNKTQQVIHII------ 152
Query: 193 VDFGFSK---------HLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DF +K H+ + K + GT Y++ + R D ALG +
Sbjct: 153 -DFALAKEYIDPETKKHIPYREHK--SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY 209
Query: 244 LLTG 247
L G
Sbjct: 210 FLRG 213
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 11/24 (45%), Positives = 20/24 (83%)
Query: 34 IEALEYLHTRGIVFRDLKPENLLL 57
I +EY+H++ +++RD+KPEN L+
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLI 138
|
| >3iwz_A CAP-like, catabolite activation-like protein; XCC, pathogenicity, CRP, CLP, C-DI-GMP receptor, quorum SENS binding, transcription; 2.30A {Xanthomonas campestris PV} Length = 230 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-05
Identities = 9/66 (13%), Positives = 18/66 (27%), Gaps = 7/66 (10%)
Query: 129 TACVIEALEYLHTRGIVFRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
T V + L + + + YP + R G + + +
Sbjct: 6 TTVVTTTVRNAT----PSLTLDAGTIERFLAHSHRR--RYPTRTDVFRPGDPAGTLYYVI 59
Query: 188 GGQVKV 193
G V +
Sbjct: 60 SGSVSI 65
|
| >2d93_A RAP guanine nucleotide exchange factor 6; CNMP_binding domain, PDZ domain containing guanine nucleotide exchange factor 2, PDZ-GEF2, RA-GEF-2; NMR {Homo sapiens} Length = 134 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-05
Identities = 11/49 (22%), Positives = 25/49 (51%), Gaps = 2/49 (4%)
Query: 146 FRDLKPENLLLDNRGYVKLEFYP-AGHYIIREGAKGDSFFIISGGQVKV 193
F ++ ++ + + E AG I+ +G + DS+++I G V++
Sbjct: 24 FANM-TMSVRRELCSVMIFEVVEQAGAIILEDGQELDSWYVILNGTVEI 71
|
| >3ryp_A Catabolite gene activator; CAMP receptor protein (CRP), allostery, DNA binding cyclic A transcription regulator; HET: CMP; 1.60A {Escherichia coli} PDB: 2cgp_A* 3hif_A 1g6n_A* 3ryr_A* 1i5z_A* 1j59_A* 1lb2_A* 1run_A* 1zrc_A* 1zrd_A* 1zre_A* 1zrf_A* 2gzw_A* 2wc2_A 3iyd_G* 3n4m_A* 3qop_A* 3rdi_A* 3rou_A* 3rpq_A* ... Length = 210 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-05
Identities = 10/49 (20%), Positives = 20/49 (40%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ L + ++ YP+ +I +G K ++ + I G V V
Sbjct: 4 GKPQTDPTLEWFLSHCHIH--KYPSKSTLIHQGEKAETLYYIVKGSVAV 50
|
| >2qcs_B CAMP-dependent protein kinase type I-alpha regula subunit, CAMP-dependent protein kinase, alpha-catalytic SU; cyclic adenosine monophosphate; HET: SEP TPO ANP TAM; 2.20A {Bos taurus} PDB: 1rl3_A* 1rgs_A* 1ne6_A* 1ne4_A* Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 7e-05
Identities = 13/52 (25%), Positives = 20/52 (38%), Gaps = 5/52 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
+ L + D ++ + G I+ +G GD FFII G V
Sbjct: 164 ILESLDKWERLTVADA---LEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVL 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 8e-05
Identities = 33/139 (23%), Positives = 49/139 (35%), Gaps = 53/139 (38%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ + YL R +V RDL N+L+ +VK I+
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVK----------------------IT------ 159
Query: 194 DFGFSKHLG-------HSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DFG +K LG G K W A E I +R + D W+ G+ + E
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWM--------ALESILHRIYTHQSDVWSYGVTVWE 211
Query: 244 LLT-------GMKESNVFQ 255
L+T G+ S +
Sbjct: 212 LMTFGSKPYDGIPASEISS 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-05
Identities = 29/139 (20%), Positives = 48/139 (34%), Gaps = 53/139 (38%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ + YL G+V R+L N+LL + V+ ++
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQ----------------------VA------ 157
Query: 194 DFGFSKHLG-------HSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DFG + L +S KT W A E I + D W+ G+ + E
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWM--------ALESIHFGKYTHQSDVWSYGVTVWE 209
Query: 244 LLT-------GMKESNVFQ 255
L+T G++ + V
Sbjct: 210 LMTFGAEPYAGLRLAEVPD 228
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 31/144 (21%), Positives = 49/144 (34%), Gaps = 52/144 (36%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIIS 187
+A + E + ++ R + RDL+ N+L+ K I+
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK----------------------IA 326
Query: 188 GGQVKVDFGFSKHLG------HSGCK---TWTFCGTPEYVAPEIIKNRGHDRAVDYWALG 238
DFG ++ + G K WT APE I D W+ G
Sbjct: 327 ------DFGLARVIEDNEYTAREGAKFPIKWT--------APEAINFGSFTIKSDVWSFG 372
Query: 239 ILMHELLT-------GMKESNVFQ 255
IL+ E++T GM V +
Sbjct: 373 ILLMEIVTYGRIPYPGMSNPEVIR 396
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 39/142 (27%), Positives = 47/142 (33%), Gaps = 54/142 (38%)
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
V ++YL + V R+L N+LL NR Y K IS
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK----------------------IS---- 478
Query: 192 KVDFGFSKHLG--------HSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGIL 240
DFG SK LG S K W APE I R D W+ G+
Sbjct: 479 --DFGLSKALGADDSYYTARSAGKWPLKWY--------APECINFRKFSSRSDVWSYGVT 528
Query: 241 MHELLT-------GMKESNVFQ 255
M E L+ MK V
Sbjct: 529 MWEALSYGQKPYKKMKGPEVMA 550
|
| >3e97_A Transcriptional regulator, CRP/FNR family; YP_604437.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE; 1.86A {Deinococcus geothermalis dsm 11300} Length = 231 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 8/62 (12%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 133 IEALEYLHTRGIVFRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ L+ L + F+++ + + + + ++ + A+G++ +++ G V
Sbjct: 2 VGRLDDLKRSPL-FQNVPEDAMREALKVVTER--NFQPDELVVEQDAEGEALHLVTTGVV 58
Query: 192 KV 193
+V
Sbjct: 59 RV 60
|
| >3kcc_A Catabolite gene activator; helix-turn-helix, CAMP, CAMP-binding, DNA-binding nucleotide-binding, transcription, transcription regulation; HET: CMP; 1.66A {Escherichia coli} Length = 260 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 10/49 (20%), Positives = 20/49 (40%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ L + ++ YP+ +I +G K ++ + I G V V
Sbjct: 54 GKPQTDPTLEWFLSHCHIH--KYPSKSTLIHQGEKAETLYYIVKGSVAV 100
|
| >1o5l_A Transcriptional regulator, CRP family; TM1171, structural GE JCSG, PSI, protein structure initiative, joint center for S genomics; 2.30A {Thermotoga maritima} SCOP: b.82.3.2 Length = 213 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 1e-04
Identities = 8/51 (15%), Positives = 17/51 (33%), Gaps = 5/51 (9%)
Query: 145 VFRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ +L LL K+ + G + + + I+ G +K
Sbjct: 6 IHHHHHHMDLKKLLPC---GKVIVFRKGEIVKHQDDPIEDVLILLEGTLKT 53
|
| >3d0s_A Transcriptional regulatory protein; CAMP receptor protein (CRP), dimer, inactive(APO, unliganded allostery, DNA binding, cyclic AMP; 2.00A {Mycobacterium tuberculosis} PDB: 3i54_A* 3i59_A* 3mzh_A* 3h3u_A* 3r6s_A* Length = 227 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 15/49 (30%), Positives = 25/49 (51%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F+ ++P + L + +P GH + EG GD +II G+VK+
Sbjct: 14 FQGVEPSAIAALTKQLQPV--DFPRGHTVFAEGEPGDRLYIIISGKVKI 60
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 31/124 (25%), Positives = 40/124 (32%), Gaps = 47/124 (37%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
E + YL ++ + RDL NLLL R VK I
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVK----------------------IG------ 163
Query: 194 DFGFSKHLG--------HSGCKT---WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
DFG + L K W APE +K R A D W G+ +
Sbjct: 164 DFGLMRALPQNDDHYVMQEHRKVPFAWC--------APESLKTRTFSHASDTWMFGVTLW 215
Query: 243 ELLT 246
E+ T
Sbjct: 216 EMFT 219
|
| >2gau_A Transcriptional regulator, CRP/FNR family; structural genomics, porphyromona gingivalis, PSI, protein structure initiative; 1.90A {Porphyromonas gingivalis} SCOP: a.4.5.4 b.82.3.2 Length = 232 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 11/50 (22%), Positives = 19/50 (38%), Gaps = 3/50 (6%)
Query: 145 VFRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
V+ L E LLD + EG ++ F + G++K+
Sbjct: 17 VWSLLNEEERELLDKEIQPF--PCKKASTVFSEGDIPNNLFYLYEGKIKI 64
|
| >1zyb_A Transcription regulator, CRP family; NP_813211.1, structural genomics, joint center for structura genomics, JCSG; 2.15A {Bacteroides thetaiotaomicron} SCOP: a.4.5.4 b.82.3.2 Length = 232 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 2e-04
Identities = 11/50 (22%), Positives = 22/50 (44%), Gaps = 3/50 (6%)
Query: 146 FRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F+ L E+ +LD ++ + AG II+ G + G++ +
Sbjct: 26 FQGLCHEDFTSILDKVKLHFIK-HKAGETIIKSGNPCTQLCFLLKGEISI 74
|
| >4ev0_A Transcription regulator, CRP family; CAMP binding, winged helix-turn-helix motif, DNA binding, transcription activator; HET: CMP; 2.40A {Thermus thermophilus} Length = 216 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 3e-04
Identities = 14/50 (28%), Positives = 25/50 (50%), Gaps = 5/50 (10%)
Query: 146 FRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F L PE + L Y + YP G I +G G + ++++ G+V++
Sbjct: 7 FHGLAPEEVDLALS---YFQRRLYPQGKPIFYQGDLGQALYLVASGKVRL 53
|
| >3e6c_C CPRK, cyclic nucleotide-binding protein; CPRK, halorespiration; HET: DNA 3C4; 1.80A {Desulfitobacterium hafniense} SCOP: a.4.5.4 b.82.3.2 PDB: 3e6b_A* 3e5u_C* 3e6d_A 3e5x_A* 3e5q_A 2h6b_A* 2h6c_A Length = 250 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 10/51 (19%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 144 IVFRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
I E L G ++ + G +I G + S + G++K+
Sbjct: 15 IPDNFFPIEKLRNYTQMGLIR--DFAKGSAVIMPGEEITSMIFLVEGKIKL 63
|
| >2fmy_A COOA, carbon monoxide oxidation system transcription RE COOA-1; DNA transcription regulator, DNA binding protein; HET: HEM; 2.20A {Carboxydothermus hydrogenoformans} PDB: 2hkx_A* Length = 220 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 3e-04
Identities = 7/49 (14%), Positives = 16/49 (32%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
L E + + Y + + + F++ G+V+V
Sbjct: 12 LEVLNSEEYSGVLKEFREQ--RYSKKAILYTPNTERNLVFLVKSGRVRV 58
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 27/139 (19%), Positives = 43/139 (30%), Gaps = 53/139 (38%)
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+EYL ++ + RDL N L+ + +K IS
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLK----------------------IS------ 255
Query: 194 DFGFSKHLG------HSGCKT----WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHE 243
DFG S+ G + WT APE + + D W+ GIL+ E
Sbjct: 256 DFGMSREEADGVYAASGGLRQVPVKWT--------APEALNYGRYSSESDVWSFGILLWE 307
Query: 244 LLT-------GMKESNVFQ 255
+ + +
Sbjct: 308 TFSLGASPYPNLSNQQTRE 326
|
| >3fx3_A Cyclic nucleotide-binding protein; helix_TURN_helix, CAMP regulatory protein, structural genomi 2, protein structure initiative; 2.20A {Ruegeria pomeroyi} PDB: 3h3z_A* Length = 237 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 9/49 (18%), Positives = 21/49 (42%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
R L +++ L ++ + Y G + + K + ++ G VK+
Sbjct: 19 IRSLPEQHVDALLSQAVWR--SYDRGETLFLQEEKAQAIHVVIDGWVKL 65
|
| >3dkw_A DNR protein; CRP-FNR, HTH, beta barrel, dimerization helix, homodimer, transcription regulator; 3.60A {Pseudomonas aeruginosa} Length = 227 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 4e-04
Identities = 15/50 (30%), Positives = 21/50 (42%), Gaps = 5/50 (10%)
Query: 146 FRDLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
F L P L LL L G Y+ R+G +F+ + G VK+
Sbjct: 17 FEPLSPVQLQELLA---SSDLVNLDKGAYVFRQGEPAHAFYYLISGCVKI 63
|
| >2bgc_A PRFA; bacterial infection, human pathogen, transcriptional regulat transcription; HET: PR3; 2.3A {Listeria monocytogenes} SCOP: a.4.5.4 b.82.3.3 PDB: 2beo_A* 1omi_A Length = 238 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 6/48 (12%), Positives = 15/48 (31%), Gaps = 3/48 (6%)
Query: 148 DLKPENL--LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ + E L+ G + + I + + + G K+
Sbjct: 3 NAQAEEFKKYLETNGIKPKQ-FHKKELIFNQWDPQEYCIFLYDGITKL 49
|
| >3dv8_A Transcriptional regulator, CRP/FNR family; cyclic nucleotide-binding domain, structural genomics, joint for structural genomics; 2.55A {Eubacterium rectale atcc 33656} Length = 220 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 4e-04
Identities = 7/49 (14%), Positives = 15/49 (30%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ DL L+ + + G I ++ GQ++
Sbjct: 11 WNDLNTAQKKLISDNLITQ--HVKKGTIIHNGNMDCTGLLLVKSGQLRT 57
|
| >4f8a_A Potassium voltage-gated channel subfamily H membe; probable regulatory domain of potassium channel, membrane PR transport protein; 2.20A {Mus musculus} Length = 160 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 5e-04
Identities = 10/48 (20%), Positives = 15/48 (31%), Gaps = 1/48 (2%)
Query: 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
FR + L + G I G DS + G ++V
Sbjct: 35 FRLA-SDGCLRALAMEFQTVHCAPGDLIYHAGESVDSLCFVVSGSLEV 81
|
| >3la7_A Global nitrogen regulator; activator, DNA-binding, transcription, transcription regulation; HET: BOG; 1.90A {Anabaena} PDB: 3la2_A* 3la3_A* 2xko_A* 2xgx_A* 2xhk_A* 2xkp_A* Length = 243 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 7e-04
Identities = 9/49 (18%), Positives = 16/49 (32%), Gaps = 6/49 (12%)
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
VFR + +E + I G + + + G VK+
Sbjct: 32 VFRQMATGAFP------PVVETFERNKTIFFPGDPAERVYFLLKGAVKL 74
|
| >1ft9_A Carbon monoxide oxidation system transcription regulator; heme sensor, catabolite gene activator protein; HET: HEM; 2.60A {Rhodospirillum rubrum} SCOP: a.4.5.4 b.82.3.1 Length = 222 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 7e-04
Identities = 6/49 (12%), Positives = 15/49 (30%), Gaps = 3/49 (6%)
Query: 146 FRDLKPENL-LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
L + K + G + + F++ G+++V
Sbjct: 8 ANVLLSPDGETFFRGFRSK--IHAKGSLVCTGEGDENGVFVVVDGRLRV 54
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 255 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.98 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.98 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.98 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.98 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.98 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.94 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.94 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.8 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.79 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.77 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.77 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.76 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.75 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.75 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.74 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.74 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.71 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.71 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.67 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.66 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.66 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.65 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.64 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.64 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.63 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.63 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.61 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.59 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.57 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.56 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.55 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.55 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.55 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.54 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.54 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.54 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.53 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.52 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.52 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.52 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.51 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.51 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.48 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.48 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.48 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.48 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.47 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.46 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.45 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.45 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.45 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.45 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.45 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.45 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.45 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.45 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.45 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.44 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.44 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.44 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.42 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.42 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.41 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.41 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.41 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.4 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.4 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.4 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.4 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.4 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.4 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.39 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.39 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.39 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.39 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.39 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.39 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.39 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.38 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.38 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.38 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.37 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.37 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.37 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.37 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.37 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.36 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.36 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.36 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.36 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.36 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.36 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.36 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.35 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.35 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.35 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.35 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.35 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.35 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.34 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.34 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.34 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.34 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.34 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.34 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.34 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.34 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.34 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.34 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.33 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.33 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.33 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.33 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.33 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.33 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.33 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.33 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.32 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.32 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.32 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.32 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.32 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.32 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.32 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.32 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.32 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.32 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.32 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.32 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.31 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.31 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.31 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.31 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.31 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.31 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.31 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.31 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.3 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.3 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.3 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.3 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.3 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.3 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.3 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.3 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.3 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.3 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.3 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.3 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.3 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.3 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.3 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.3 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.29 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.29 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.29 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.29 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.29 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.29 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.29 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.29 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.29 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.29 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.29 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.29 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.29 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.29 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.28 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.28 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.28 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.28 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.28 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.28 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.28 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.28 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.28 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.28 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.28 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.28 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.28 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.27 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.27 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.27 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.27 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.27 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.27 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.27 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.26 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.26 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.26 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.26 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.26 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.25 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.25 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.25 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.25 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.25 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.25 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.25 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.25 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.24 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.24 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.24 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.24 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.23 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.23 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.23 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.23 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.23 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.22 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.21 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.21 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.21 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.2 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.2 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.2 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.19 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.19 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.19 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.19 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.19 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.18 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.18 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.18 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.17 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.17 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.17 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.16 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.15 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.15 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.14 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.14 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.13 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.12 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.1 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.1 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.1 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=309.89 Aligned_cols=154 Identities=34% Similarity=0.622 Sum_probs=137.8
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||+++++++|++.+.+|+|||||.||||++++++.+.+++.. +..+++||+.||+|||
T Consensus 81 ~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~-----------~~~~~~qi~~al~ylH 149 (311)
T 4aw0_A 81 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----------TRFYTAEIVSALEYLH 149 (311)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHH-----------HHHHHHHHHHHHHHHH
Confidence 35667788899999999999999999999999999999999999888777654 4567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--CccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~gt~~y~ 218 (255)
++||+||||||+|||++.++.+|+ +|||+|+.+... .....+.||||.||
T Consensus 150 ~~~IiHRDlKPeNILl~~~g~vKl----------------------------~DFGla~~~~~~~~~~~~~~~~GTp~Ym 201 (311)
T 4aw0_A 150 GKGIIHRDLKPENILLNEDMHIQI----------------------------TDFGTAKVLSPESKQARANSFVGTAQYV 201 (311)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCTTTTCCCBCCCCSCGGGC
T ss_pred HCCCccCCCCHHHeEEcCCCCEEE----------------------------EEcCCceecCCCCCcccccCcccCcccC
Confidence 999999999999999999999998 599999876432 23456789999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+.+|+.++||||+||++|+|++|..||..
T Consensus 202 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp CHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999999963
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=307.04 Aligned_cols=155 Identities=37% Similarity=0.683 Sum_probs=134.9
Q ss_pred cCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
..+++++..+.|||+++++++|++.+.+|+|||||.||+|.+++.+...+++.. +..+++|++.||.||
T Consensus 74 ~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~-----------~~~~~~qi~~aL~yl 142 (304)
T 3ubd_A 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----------VKFYLAELALALDHL 142 (304)
T ss_dssp ----CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHH-----------HHHHHHHHHHHHHHH
Confidence 346788899999999999999999999999999999999999999877776643 456778899999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++||+||||||+|||++.++.+|+ +|||+|+..........+.+|||.|||
T Consensus 143 H~~~IiHRDlKp~NILl~~~g~vKl----------------------------~DFGla~~~~~~~~~~~~~~GT~~YmA 194 (304)
T 3ubd_A 143 HSLGIIYRDLKPENILLDEEGHIKL----------------------------TDFGLSKESIDHEKKAYSFCGTVEYMA 194 (304)
T ss_dssp HHTTCCCSSCCGGGEEECTTSCEEE----------------------------ESSEEEEC-----CCCCSCCCCGGGCC
T ss_pred HHCCCcCCCCCHHHeEEcCCCCEEe----------------------------cccccceeccCCCccccccccCcccCC
Confidence 9999999999999999999999998 599999876555555667899999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+.+|+.++||||+||++|||++|..||..
T Consensus 195 PE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=305.36 Aligned_cols=152 Identities=27% Similarity=0.519 Sum_probs=136.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.||||++++++|++.+.+|+|||||.||+|.+++.+ ..+++. .+..++.||+.||.|||+
T Consensus 121 Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~-----------~~~~~~~qi~~aL~ylH~ 188 (346)
T 4fih_A 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEE-----------QIAAVCLAVLQALSVLHA 188 (346)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 46667788999999999999999999999999999999999875 445543 345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|||||||||+|||++.++.+|+ +|||+|+..........+.+|||.|||||
T Consensus 189 ~~IiHRDlKp~NILl~~~g~vKl----------------------------~DFGla~~~~~~~~~~~~~~GTp~YmAPE 240 (346)
T 4fih_A 189 QGVIHRDIKSDSILLTHDGRVKL----------------------------SDFGFCAQVSKEVPRRKSLVGTPYWMAPE 240 (346)
T ss_dssp TTEECCCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCSSSCCBCCCCSCGGGCCHH
T ss_pred CCcccccCCHHHEEECCCCCEEE----------------------------ecCcCceecCCCCCcccccccCcCcCCHH
Confidence 99999999999999999999998 59999988766656667889999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+.+|+.++||||+||++|||++|..||..
T Consensus 241 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 241 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=305.97 Aligned_cols=154 Identities=27% Similarity=0.480 Sum_probs=135.3
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++++..+.||||++++++|++.+.+|+|||||.||+|.+++..+.. +++. .+..++.||+.||.|
T Consensus 72 ~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~-----------~~~~~~~qi~~aL~y 140 (350)
T 4b9d_A 72 REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED-----------QILDWFVQICLALKH 140 (350)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHH-----------HHHHHHHHHHHHHHH
Confidence 467788889999999999999999999999999999999999975432 3332 345678899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
||++|||||||||+|||++.++.+|+ +|||+|+..........+.+|||.||
T Consensus 141 lH~~~IiHRDlKp~NILl~~~g~vKl----------------------------~DFGla~~~~~~~~~~~~~~GT~~Ym 192 (350)
T 4b9d_A 141 VHDRKILHRDIKSQNIFLTKDGTVQL----------------------------GDFGIARVLNSTVELARACIGTPYYL 192 (350)
T ss_dssp HHHTTCEETTCCGGGEEECTTCCEEE----------------------------CSTTEESCCCHHHHHHHHHHSCCTTC
T ss_pred HHHCCeeeccCCHHHEEECCCCCEEE----------------------------cccccceeecCCcccccccCCCcccc
Confidence 99999999999999999999999998 59999987754433455689999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+.+|+.++|||||||++|||++|..||..
T Consensus 193 APE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999999999963
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=300.07 Aligned_cols=154 Identities=27% Similarity=0.455 Sum_probs=132.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.||||++++++|++.+.+|+|||||.||+|.+++++.+.+++.. +..++.||+.||.|||
T Consensus 99 ~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~-----------~~~~~~qi~~aL~ylH 167 (336)
T 4g3f_A 99 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-----------ALYYLGQALEGLEYLH 167 (336)
T ss_dssp HHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHH-----------HHHHHHHHHHHHHHHH
Confidence 35777888999999999999999999999999999999999999877777643 4567788999999999
Q ss_pred HcCcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-----cccccccC
Q psy3182 141 TRGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-----KTWTFCGT 214 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-----~~~~~~gt 214 (255)
++|||||||||+|||++.++ .+|+ +|||+|+....... ...+.+||
T Consensus 168 ~~~IiHRDlKp~NILl~~~g~~vKl----------------------------~DFGla~~~~~~~~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 168 TRRILHGDVKADNVLLSSDGSRAAL----------------------------CDFGHALCLQPDGLGKSLLTGDYIPGT 219 (336)
T ss_dssp TTTEECSCCCGGGEEECTTSCCEEE----------------------------CCCTTCEEC------------CCCCCC
T ss_pred HCCceecccCHHHEEEeCCCCEEEE----------------------------eeCCCCeEccCCCcccceecCCccccC
Confidence 99999999999999999887 5888 59999987644321 22346899
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|.|||||++.+.+|+.++||||+||++|||++|..||..
T Consensus 220 ~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 999999999999999999999999999999999999963
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=306.65 Aligned_cols=152 Identities=27% Similarity=0.519 Sum_probs=136.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+||++++++|++.+.+|+|||||.||+|.++++. ..+++. .+..++.||+.||.|||+
T Consensus 198 Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~-----------~~~~~~~qil~aL~ylH~ 265 (423)
T 4fie_A 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEE-----------QIAAVCLAVLQALSVLHA 265 (423)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 56677888999999999999999999999999999999999875 345543 345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|||||||||+|||++.++.+|+ +|||+|+..........+.||||.|||||
T Consensus 266 ~~IiHRDiKp~NILl~~~g~vKl----------------------------~DFGla~~~~~~~~~~~~~~GTp~YmAPE 317 (423)
T 4fie_A 266 QGVIHRDIKSDSILLTHDGRVKL----------------------------SDFGFCAQVSKEVPRRKSLVGTPYWMAPE 317 (423)
T ss_dssp TTEECCCCSTTTEEECTTCCEEE----------------------------CCCTTCEECCSSCCCBCCCEECTTTCCHH
T ss_pred CCeecccCCHHHEEEcCCCCEEE----------------------------ecCccceECCCCCccccccccCcCcCCHH
Confidence 99999999999999999999998 59999988766666667889999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..|+.++|||||||++|||++|..||..
T Consensus 318 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 318 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=287.48 Aligned_cols=151 Identities=30% Similarity=0.517 Sum_probs=123.9
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||+++++++|++.+.+|+||||| +|+|++.+.+++.+++.. +..+++|++.||+|||
T Consensus 62 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~-----------~~~~~~qi~~al~ylH 129 (275)
T 3hyh_A 62 REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQE-----------ARRFFQQIISAVEYCH 129 (275)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHH-----------HHHHHHHHHHHHHHHH
Confidence 4577788899999999999999999999999999 789999998877776543 4567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+|||++.++.+|+ +|||+|+...... ...+.+|||.||||
T Consensus 130 ~~~IiHRDiKP~NILl~~~~~vkl----------------------------~DFGla~~~~~~~-~~~~~~GT~~Y~AP 180 (275)
T 3hyh_A 130 RHKIVHRDLKPENLLLDEHLNVKI----------------------------ADFGLSNIMTDGN-FLKTSCGSPNYAAP 180 (275)
T ss_dssp HTTCCCCCCCTTTEEECTTCCEEE----------------------------CCSSCC----------------CTTSCH
T ss_pred HCCcccccCChHHeEECCCCCEEE----------------------------eecCCCeecCCCC-ccCCeeECcccCCh
Confidence 999999999999999999999988 5999998764432 34468999999999
Q ss_pred ccccCCCC-CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGH-DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~-~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..| +.++||||+||++|+|++|..||.
T Consensus 181 E~~~~~~y~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 181 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp HHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence 99999876 579999999999999999999996
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=285.63 Aligned_cols=150 Identities=26% Similarity=0.436 Sum_probs=129.4
Q ss_pred CceeeeccccccccccccccccC----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
.++++++.+.||||++++++|++ ...+|+|||||.||+|.+++++...+++. .+..++.||+.||
T Consensus 74 ~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL 142 (290)
T 3fpq_A 74 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK-----------VLRSWCRQILKGL 142 (290)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHH
Confidence 45778888999999999998865 46789999999999999999887766653 3456778999999
Q ss_pred HHHHHcC--cccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc
Q psy3182 137 EYLHTRG--IVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~--iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g 213 (255)
.|||+++ ||||||||+|||++. ++.+|+ +|||+|+.... ....+.+|
T Consensus 143 ~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl----------------------------~DFGla~~~~~--~~~~~~~G 192 (290)
T 3fpq_A 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKI----------------------------GDLGLATLKRA--SFAKAVIG 192 (290)
T ss_dssp HHHHTSSSCCCCCCCCGGGEEESSTTSCEEE----------------------------CCTTGGGGCCT--TSBEESCS
T ss_pred HHHHHCCCCEEecccChhheeEECCCCCEEE----------------------------EeCcCCEeCCC--CccCCccc
Confidence 9999999 999999999999975 678888 59999976433 24457899
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||.|||||++.+ .|+.++||||+||++|||++|..||.
T Consensus 193 Tp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 193 TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp SCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999876 59999999999999999999999995
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=308.91 Aligned_cols=148 Identities=30% Similarity=0.523 Sum_probs=132.2
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRG 143 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ 143 (255)
+++....|||+++++++|++.+.+|+|||||.||||++++.+.+.+++.. ++++++||+.||+|||++|
T Consensus 244 ~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~-----------a~~y~~qIl~aL~yLH~~g 312 (689)
T 3v5w_A 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-----------MRFYAAEIILGLEHMHNRF 312 (689)
T ss_dssp HHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHH-----------HHHHHHHHHHHHHHHHTTT
T ss_pred HHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHH-----------HHHHHHHHHHHHHHHHHCC
Confidence 34456689999999999999999999999999999999999888777654 4567788999999999999
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII 223 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (255)
||||||||+|||++.+|.+|+ +|||+|+..... ...+.||||.|||||++
T Consensus 313 IiHRDLKPeNILld~~G~vKL----------------------------~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl 362 (689)
T 3v5w_A 313 VVYRDLKPANILLDEHGHVRI----------------------------SDLGLACDFSKK--KPHASVGTHGYMAPEVL 362 (689)
T ss_dssp EECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECSSC--CCCSCCSCGGGCCHHHH
T ss_pred ccccCCchHHeEEeCCCCEEe----------------------------cccceeeecCCC--CCCCccCCcCccCHHHH
Confidence 999999999999999999999 499999876543 35578999999999999
Q ss_pred c-CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 224 K-NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 224 ~-~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
. +.+|+.++|||||||++|||++|.+||.
T Consensus 363 ~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp STTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6 4689999999999999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=276.76 Aligned_cols=150 Identities=25% Similarity=0.492 Sum_probs=119.5
Q ss_pred CceeeeccccccccccccccccCcc------------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSK------------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFI 128 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~------------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i 128 (255)
.+++++..+.|||+++++++|.+.+ ++|++||||.||+|.+++.++..+.+... ..+..+
T Consensus 52 ~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~--------~~~~~i 123 (299)
T 4g31_A 52 REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER--------SVCLHI 123 (299)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCH--------HHHHHH
T ss_pred HHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHH--------HHHHHH
Confidence 4677888999999999999887544 47999999999999999987665544331 224567
Q ss_pred HHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC---
Q psy3182 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--- 205 (255)
Q Consensus 129 ~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--- 205 (255)
+.|++.||.|||++|||||||||+|||++.++.+|+ +|||+|+......
T Consensus 124 ~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl----------------------------~DFGla~~~~~~~~~~ 175 (299)
T 4g31_A 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV----------------------------GDFGLVTAMDQDEEEQ 175 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE----------------------------CCCCCC----------
T ss_pred HHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE----------------------------ccCccceecCCCcccc
Confidence 889999999999999999999999999999999998 4888887654321
Q ss_pred ---------ccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc
Q psy3182 206 ---------CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246 (255)
Q Consensus 206 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~ 246 (255)
....+.+|||.|||||++.+.+|+.++||||+||++|||++
T Consensus 176 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp ----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 12345689999999999999999999999999999999997
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=275.96 Aligned_cols=153 Identities=22% Similarity=0.338 Sum_probs=123.5
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.++++++.++|||++++++++.+ +.+|+|||||.||+|.+++.... .+++ ..+..++.|++.||.||
T Consensus 81 ~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~-----------~~~~~i~~qia~gL~yL 148 (307)
T 3omv_A 81 NEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQM-----------FQLIDIARQTAQGMDYL 148 (307)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 35777889999999999997654 56899999999999999997542 3332 23345788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--CccccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~gt~~y 217 (255)
|+++||||||||+|||++.++.+|+ .|||+|+..... .....+.+||+.|
T Consensus 149 H~~~IiHRDlKp~NILl~~~~~~Ki----------------------------~DFGla~~~~~~~~~~~~~~~~GT~~y 200 (307)
T 3omv_A 149 HAKNIIHRDMKSNNIFLHEGLTVKI----------------------------GDFGLATVKSRWSGSQQVEQPTGSVLW 200 (307)
T ss_dssp HHTTCBCSCCCSSSEEEETTEEEEE----------------------------CCCSSCBC------------CCCCTTS
T ss_pred HHCCccCCccCHHHEEECCCCcEEE----------------------------eeccCceecccCCcceeecccccCCCc
Confidence 9999999999999999999998988 499999865432 2234467899999
Q ss_pred cccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKN---RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~---~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||||++.+ .+|+.++||||+||++|||+||..||..
T Consensus 201 mAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp CCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 99999964 3589999999999999999999999964
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=276.47 Aligned_cols=165 Identities=21% Similarity=0.274 Sum_probs=132.8
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccc--hhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA--ASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~--~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++++++++|||++++++.+.+.+.+|+|||||.||+|.+++++........ ...........+..++.|++.||.|
T Consensus 64 ~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 143 (299)
T 4asz_A 64 REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY 143 (299)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 46788889999999999999999999999999999999999998643110000 0000011223455688999999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPE 216 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~ 216 (255)
||+++||||||||+|||++.++.+|+ .|||+|+....... .....+||+.
T Consensus 144 LH~~~iiHRDlKp~NILl~~~~~~Ki----------------------------~DFGla~~~~~~~~~~~~~~~~gt~~ 195 (299)
T 4asz_A 144 LASQHFVHRDLATRNCLVGENLLVKI----------------------------GDFGMSRDVYSTDYYRVGGHTMLPIR 195 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCSCHHHHTGGGCEEETTTEEECGG
T ss_pred HHhCCcccCccCHhhEEECCCCcEEE----------------------------CCcccceecCCCCceeecCceecChh
Confidence 99999999999999999999999998 49999976543322 1223579999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||||++.+..|+.++||||+||++|||+| |..||..
T Consensus 196 ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999999999998 8999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=274.88 Aligned_cols=164 Identities=21% Similarity=0.263 Sum_probs=125.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch----hhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA----SFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~----~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
++++++.++|||++++++++.+.+.+|+|||||.||+|.+++++......... ..........+..++.|++.||.
T Consensus 93 E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~ 172 (329)
T 4aoj_A 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMV 172 (329)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHH
Confidence 45667788999999999999999999999999999999999986542211100 00011223345568899999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~ 215 (255)
|||+++||||||||+|||++.++.+|+ .|||+|+....... ...+.+||+
T Consensus 173 yLH~~~iiHRDLKp~NILl~~~~~~Ki----------------------------~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 173 YLAGLHFVHRDLATRNCLVGQGLVVKI----------------------------GDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp HHHHTTCCCSCCCGGGEEEETTTEEEE----------------------------CCCC----------------CCCCG
T ss_pred HHhcCCeecccccHhhEEECCCCcEEE----------------------------cccccceeccCCCcceecCcccccc
Confidence 999999999999999999999999998 49999986644322 223468999
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
.|||||++.+..|+.++||||+||++|||+| |..||..
T Consensus 225 ~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp GGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred cccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999999999998 8999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=278.48 Aligned_cols=149 Identities=23% Similarity=0.367 Sum_probs=120.4
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++... .|+|+++++++|++.+++|+|||||.||+|.+++++ +++ +.++.+++|++.||.|||
T Consensus 69 E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~---l~~-----------~~~~~~~~qll~al~ylH 134 (361)
T 4f9c_A 69 ELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS---LSF-----------QEVREYMLNLFKALKRIH 134 (361)
T ss_dssp HHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT---CCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC---CCH-----------HHHHHHHHHHHHHHHHHH
Confidence 45555555 699999999999999999999999999999998842 333 345678899999999999
Q ss_pred HcCcccccCCCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC---------------
Q psy3182 141 TRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--------------- 204 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--------------- 204 (255)
++||+||||||+|||++.+ +.+|+. |||+|+.....
T Consensus 135 ~~gIiHRDiKPeNiLl~~~~~~~kl~----------------------------DFGla~~~~~~~~~~~~~~~~~~~~~ 186 (361)
T 4f9c_A 135 QFGIVHRDVKPSNFLYNRRLKKYALV----------------------------DFGLAQGTHDTKIELLKFVQSEAQQE 186 (361)
T ss_dssp HTTEECSCCSGGGEEEETTTTEEEEC----------------------------CCTTCEECTTCSCGGGGGC-------
T ss_pred HCCeEeCcCCHHHeEEeCCCCeEEEC----------------------------cCCCCcccCCcccccccccccccccc
Confidence 9999999999999999876 688885 56655433211
Q ss_pred -------------CccccccccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 205 -------------GCKTWTFCGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 205 -------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.....+.+|||.|||||++.+. .|+.++||||+||++|||++|..||.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 187 RCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp -------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 1123456899999999999875 58999999999999999999999984
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=271.75 Aligned_cols=165 Identities=19% Similarity=0.288 Sum_probs=133.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh-----hHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS-----FITACVIEALDFITACVIEA 135 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~il~~ 135 (255)
.+++++++++|||++++++.+.+.+.+|+|||||.||+|.++|..+......... .........+..++.||+.|
T Consensus 78 ~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 157 (308)
T 4gt4_A 78 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 157 (308)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHH
Confidence 4577888999999999999999999999999999999999999765432211000 00111223345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--cccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~g 213 (255)
|.|||+++||||||||+|||++.++.+|+ .|||+|+...... ....+.+|
T Consensus 158 l~yLH~~~iiHRDLK~~NILl~~~~~~Ki----------------------------~DFGlar~~~~~~~~~~~~~~~g 209 (308)
T 4gt4_A 158 MEYLSSHHVVHKDLATRNVLVYDKLNVKI----------------------------SDLGLFREVYAADYYKLLGNSLL 209 (308)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEE----------------------------CCSCCBCGGGGGGCBCSSSSSCB
T ss_pred HHHHHhCCCCCCCccccceEECCCCCEEE----------------------------CCcccceeccCCCceeEeccccc
Confidence 99999999999999999999999999998 4999987653322 22345689
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|+.|||||++.+..|+.++||||+||++|||+| |..||..
T Consensus 210 t~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999999999998 8999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=277.69 Aligned_cols=151 Identities=23% Similarity=0.420 Sum_probs=127.1
Q ss_pred ceeeecccccccccccccccc------CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK------DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~------~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+.|+|++++++.++ +.+.+|+|||||. |+|++++.+...+++. .+..+++||+.|
T Consensus 103 Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~-----------~~~~~~~qil~a 170 (398)
T 4b99_A 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLE-----------HVRYFLYQLLRG 170 (398)
T ss_dssp HHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHH-----------HHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHH-----------HHHHHHHHHHHH
Confidence 566777889999999998765 4468999999995 6899999877666653 356778899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC----Ccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS----GCKTWTF 211 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~----~~~~~~~ 211 (255)
|.|||++|||||||||+|||++.++.+|+ +|||+|+.+... .....+.
T Consensus 171 l~ylH~~~iiHRDlKP~NIl~~~~~~~Ki----------------------------~DFGla~~~~~~~~~~~~~~~~~ 222 (398)
T 4b99_A 171 LKYMHSAQVIHRDLKPSNLLVNENCELKI----------------------------GDFGMARGLCTSPAEHQYFMTEY 222 (398)
T ss_dssp HHHHHHTTCBCCCCCGGGEEECTTCCEEE----------------------------CCCTTCBCC-------CCCCCSS
T ss_pred HHHHHHCcCcCCCcCccccccCCCCCEEE----------------------------eecceeeecccCccccccccccc
Confidence 99999999999999999999999999988 599998765432 2234568
Q ss_pred ccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+||+.|||||++.+. .|+.++||||+||++|||++|.+||.
T Consensus 223 ~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred eeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 999999999998874 57999999999999999999999995
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=271.58 Aligned_cols=164 Identities=22% Similarity=0.320 Sum_probs=128.9
Q ss_pred ceeeeccccc-cccccccccccC-ccceeehhhhhcchhHHHHHHhccCCC-ccc----hhhHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKK-TRQTRLYKTFKD-SKYVYMLLEACLGGEVWTILRERTCFD-DNA----ASFITACVIEALDFITACVIE 134 (255)
Q Consensus 62 ~vkl~~~~~h-~~iv~l~~~~~~-~~~~ylv~E~~~gg~l~~~l~~~~~~~-~~~----~~~~~~~~~~~~~~i~~~il~ 134 (255)
+++++.++.| +|++++++.+.+ ++.+|+|||||.||+|.++|++..... ... .........+.+..++.||+.
T Consensus 117 E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~ 196 (353)
T 4ase_A 117 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 196 (353)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHH
Confidence 3445556655 899999998755 567999999999999999997643210 000 000011123445567889999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccc
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFC 212 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~ 212 (255)
||.|||+++||||||||+|||++.++.+|+ .|||+|+....... ...+.+
T Consensus 197 gl~yLH~~~iiHRDLK~~NILl~~~~~vKi----------------------------~DFGlar~~~~~~~~~~~~~~~ 248 (353)
T 4ase_A 197 GMEFLASRKCIHRDLAARNILLSEKNVVKI----------------------------CDFGLARDIYKDPDYVRKGDAR 248 (353)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCGGGSCTTTCTTSEEETTEE
T ss_pred HHHhHhhCCeecCccCccceeeCCCCCEEE----------------------------CcchhhhhcccCCCceeecccc
Confidence 999999999999999999999999999998 49999987654332 334578
Q ss_pred cCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 213 GTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 213 gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||+.|||||++.+..|+.++||||+||++|||+| |..||..
T Consensus 249 gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999999998 8999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=285.29 Aligned_cols=152 Identities=26% Similarity=0.430 Sum_probs=131.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..++|||++++++.|++.+.+|++||||.||+|++++..+ ..+++. .+..+++||+.||.|||
T Consensus 204 Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~-----------~~~~~~~qi~~al~ylH 272 (573)
T 3uto_A 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-----------EAVEYMRQVCKGLCHMH 272 (573)
T ss_dssp HHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 466778889999999999999999999999999999999998643 344443 34567889999999999
Q ss_pred HcCcccccCCCCceeeCCC--CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNR--GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
++||+||||||+|||++.+ +.+|+ +|||+|+.+.... ...+.+||+.||
T Consensus 273 ~~~iiHRDlKp~Nill~~~~~~~vKl----------------------------~DFG~a~~~~~~~-~~~~~~GT~~y~ 323 (573)
T 3uto_A 273 ENNYVHLDLKPENIMFTTKRSNELKL----------------------------IDFGLTAHLDPKQ-SVKVTTGTAEFA 323 (573)
T ss_dssp HTTEECCCCCGGGEEESSSSCCCEEE----------------------------CCCSSCEECCTTS-EEEEECSSGGGC
T ss_pred HCCeeeccCChhhccccCCCCCCEEE----------------------------eeccceeEccCCC-ceeeeEECcccc
Confidence 9999999999999999864 66777 5999998875433 445679999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+.+|+.++||||+||++|+|++|..||..
T Consensus 324 APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999999999963
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=258.13 Aligned_cols=150 Identities=18% Similarity=0.285 Sum_probs=118.4
Q ss_pred ceeeeccccccccccccccccCcc----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
++..+..++|||++++++.+.+.+ .+|+|||||.||+|.+++++.. ++. +....++.|++.||.
T Consensus 47 Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-l~~-----------~~~~~i~~~ia~gl~ 114 (303)
T 3hmm_A 47 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTV-----------EGMIKLALSTASGLA 114 (303)
T ss_dssp HHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BCH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC-CCH-----------HHHHHHHHHHHHHHH
Confidence 345566788999999999887653 5899999999999999997643 222 223456778999999
Q ss_pred HHHHc--------CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---
Q psy3182 138 YLHTR--------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--- 206 (255)
Q Consensus 138 ylH~~--------~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--- 206 (255)
|||++ +||||||||+|||++.++.+|+ .|||+|+.......
T Consensus 115 ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki----------------------------~DFGla~~~~~~~~~~~ 166 (303)
T 3hmm_A 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI----------------------------ADLGLAVRHDSATDTID 166 (303)
T ss_dssp HHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE----------------------------CCCTTCEEEETTTTEES
T ss_pred HHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE----------------------------EeCCCCccccCCCCcee
Confidence 99987 9999999999999999999998 49999876543221
Q ss_pred -cccccccCCCCcccccccCC------CCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 207 -KTWTFCGTPEYVAPEIIKNR------GHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 207 -~~~~~~gt~~y~aPE~~~~~------~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
...+.+||+.|||||++.+. .|+.++||||+||++|||+||.+||
T Consensus 167 ~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 22346899999999999764 3567899999999999999997765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=250.68 Aligned_cols=152 Identities=36% Similarity=0.667 Sum_probs=133.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+++++++..+++.+.+|++|||+.||+|...+.+...+++. .+..++.|++.||.|||+
T Consensus 55 E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~ 123 (337)
T 1o6l_A 55 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----------RARFYGAEIVSALEYLHS 123 (337)
T ss_dssp HHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 345566778999999999999999999999999999999999876666543 345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++..........+.+||+.|+|||
T Consensus 124 ~~ivHrDlkp~NIll~~~g~vkL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aPE 175 (337)
T 1o6l_A 124 RDVVYRDIKLENLMLDKDGHIKI----------------------------TDFGLCKEGISDGATMKTFCGTPEYLAPE 175 (337)
T ss_dssp TTCBCCCCCGGGEEECTTSCEEE----------------------------CCCTTCBCSCCTTCCBCCCEECGGGCCGG
T ss_pred CCeecCcCCHHHEEECCCCCEEE----------------------------eeccchhhcccCCCcccccccChhhCChh
Confidence 99999999999999999998888 59999886544444566789999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..|+.++|+|||||++|+|++|..||.
T Consensus 176 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence 9999999999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=256.32 Aligned_cols=144 Identities=36% Similarity=0.670 Sum_probs=129.8
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+|+++++.+|++.+.+|+|||||.||+|..++.+...+++. .+..++.|++.||.|||++||+||||
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL~~LH~~givHrDL 179 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----------HARFYSAEISLALNYLHERGIIYRDL 179 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCEEeccC
Confidence 7999999999999999999999999999999999877666553 34567788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+|||++.++.+++ +|||+++..........+.+||+.|+|||++.+..|+
T Consensus 180 Kp~NILl~~~g~ikL----------------------------~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~ 231 (396)
T 4dc2_A 180 KLDNVLLDSEGHIKL----------------------------TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231 (396)
T ss_dssp CGGGEEECTTSCEEE----------------------------CCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBC
T ss_pred CHHHEEECCCCCEEE----------------------------eecceeeecccCCCccccccCCcccCCchhhcCCCCC
Confidence 999999999999988 5999998654445556678999999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 230 RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~ 252 (255)
.++|||||||++|+|++|..||.
T Consensus 232 ~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 232 FSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp THHHHHHHHHHHHHHHHSSCSST
T ss_pred hHHHHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999995
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=254.07 Aligned_cols=145 Identities=38% Similarity=0.693 Sum_probs=123.8
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+++.+.+|+|||||.||+|..++.+...+++.. +..++.|++.||.|||++||+||||
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~-----------~~~~~~qi~~aL~~LH~~givHrDl 150 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-----------ARFYAAEIISALMFLHDKGIIYRDL 150 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH-----------HHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH-----------HHHHHHHHHHHHHHHHHCCCcccCC
Confidence 69999999999999999999999999999999998776666533 4567788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+..|+
T Consensus 151 kp~NILl~~~g~ikL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 202 (353)
T 3txo_A 151 KLDNVLLDHEGHCKL----------------------------ADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202 (353)
T ss_dssp CGGGEEECTTSCEEE----------------------------CCCTTCBCSCC---------CCGGGCCHHHHHHHHCT
T ss_pred CHHHEEECCCCCEEE----------------------------ccccceeecccCCccccccCCCcCeEChhhcCCCCcC
Confidence 999999999999888 5999988655555556678999999999999998999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|||||||++|+|++|..||..
T Consensus 203 ~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 203 PAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCCCcchHHHHHHHhCCCCCCC
Confidence 999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=250.74 Aligned_cols=148 Identities=39% Similarity=0.698 Sum_probs=131.4
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ii 145 (255)
+....|+++++++..+++.+.+|+||||+.||+|.+++.+...+++.. +..++.|++.||.|||++||+
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~-----------~~~~~~qi~~aL~~LH~~giv 161 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-----------ARFYAAEIASALGYLHSLNIV 161 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH-----------HHHHHHHHHHHHHHHHHTTCC
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH-----------HHHHHHHHHHHHHHHHHCCce
Confidence 456789999999999999999999999999999999998776665433 455778899999999999999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN 225 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (255)
||||||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+
T Consensus 162 HrDlkp~NIll~~~g~ikL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 162 YRDLKPENILLDSQGHIVL----------------------------TDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp CCCCCGGGEEECTTSCEEE----------------------------CCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT
T ss_pred ecCCCHHHEEECCCCCEEE----------------------------eeCccccccccCCCccccccCCccccCHHHhCC
Confidence 9999999999999998888 599998765444445667899999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 226 RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 226 ~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..|+.++|||||||++|||++|..||.
T Consensus 214 ~~~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 214 QPYDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.15 Aligned_cols=145 Identities=36% Similarity=0.678 Sum_probs=129.1
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|++++++++.+++.+.+|+||||+.||+|.+++.+...+++. .+..++.|++.||.|||++||+||||
T Consensus 76 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~~~ivHrDl 144 (345)
T 1xjd_A 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----------RATFYAAEIILGLQFLHSKGIVYRDL 144 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred CCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 7999999999999999999999999999999999876666543 34557788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+..|+
T Consensus 145 kp~NIll~~~g~vkL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (345)
T 1xjd_A 145 KLDNILLDKDGHIKI----------------------------ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196 (345)
T ss_dssp CGGGEEECTTSCEEE----------------------------CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred ChhhEEECCCCCEEE----------------------------eEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCC
Confidence 999999999998888 5999988654444456678999999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|+||+||++|+|++|..||..
T Consensus 197 ~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 197 HSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChhhhHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=248.92 Aligned_cols=145 Identities=35% Similarity=0.643 Sum_probs=129.3
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+++++++..+++.+.+|+||||+.||+|.+++.+...+++. .+..++.|++.||.|||++||+||||
T Consensus 79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~~givHrDl 147 (353)
T 2i0e_A 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----------HAVFYAAEIAIGLFFLQSKGIIYRDL 147 (353)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCEEeccC
Confidence 7999999999999999999999999999999999876666543 34567788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+||+++.++.+++ +|||+++..........+.+||+.|+|||++.+..|+
T Consensus 148 kp~NIll~~~g~vkL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 199 (353)
T 2i0e_A 148 KLDNVMLDSEGHIKI----------------------------ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 199 (353)
T ss_dssp CGGGEEECTTSCEEE----------------------------CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBS
T ss_pred CHHHEEEcCCCcEEE----------------------------EeCCcccccccCCcccccccCCccccChhhhcCCCcC
Confidence 999999999998888 5999988654444456678999999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|||||||++|||++|..||..
T Consensus 200 ~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 200 KSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcccccchHHHHHHHHcCCCCCCC
Confidence 999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=247.86 Aligned_cols=150 Identities=35% Similarity=0.652 Sum_probs=131.3
Q ss_pred eeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+++... .|++++++++.+++.+.+|+||||+.||+|.+++.+...+++. .+..++.|++.||.|||++
T Consensus 61 ~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL~~LH~~ 129 (345)
T 3a8x_A 61 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----------HARFYSAEISLALNYLHER 129 (345)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHC
Confidence 344444 7999999999999999999999999999999999876655543 3456778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
||+||||||+||+++.++.+++ +|||+++..........+.+||+.|+|||+
T Consensus 130 ~ivHrDlkp~NIll~~~g~~kL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~ 181 (345)
T 3a8x_A 130 GIIYRDLKLDNVLLDSEGHIKL----------------------------TDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181 (345)
T ss_dssp TCBCCCCCGGGEEECTTSCEEE----------------------------CCGGGCBCSCCTTCCBCCCCSCGGGCCHHH
T ss_pred CceecCCCHHHEEECCCCCEEE----------------------------EeccccccccCCCCcccccCCCccccCccc
Confidence 9999999999999999998888 599999865444445667899999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.+..|+.++|+||+||++|+|++|..||.
T Consensus 182 ~~~~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 999999999999999999999999999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=243.20 Aligned_cols=149 Identities=38% Similarity=0.776 Sum_probs=130.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+..++....|+|++++++.+++.+.+|++|||+.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 56 E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~ 124 (318)
T 1fot_A 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----------VAKFYAAEVCLALEYLHS 124 (318)
T ss_dssp HHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHH-----------HHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 345566778999999999999999999999999999999999876655543 345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++.... ...+.+||+.|+|||
T Consensus 125 ~~ivHrDlkp~NIll~~~g~~kL----------------------------~Dfg~a~~~~~---~~~~~~gt~~y~aPE 173 (318)
T 1fot_A 125 KDIIYRDLKPENILLDKNGHIKI----------------------------TDFGFAKYVPD---VTYTLCGTPDYIAPE 173 (318)
T ss_dssp TTEECCCCCGGGEEECTTSCEEE----------------------------CCCSSCEECSS---CBCCCCSCTTTCCHH
T ss_pred CCccccCCChheEEEcCCCCEEE----------------------------eecCcceecCC---ccccccCCccccCHh
Confidence 99999999999999999998888 59999876543 344678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..|+.++|+|||||++|+|++|..||.
T Consensus 174 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred HhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=251.41 Aligned_cols=148 Identities=32% Similarity=0.663 Sum_probs=127.3
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
++....|+++++++..+++.+.+|+|||||.||+|.+++.+. .+++ ..+..++.|++.||.|||++||
T Consensus 122 il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~e-----------~~~~~~~~qi~~aL~~LH~~gi 189 (410)
T 3v8s_A 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPE-----------KWARFYTAEVVLALDAIHSMGF 189 (410)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC-CCCH-----------HHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-CCCH-----------HHHHHHHHHHHHHHHHHHHCCe
Confidence 445668999999999999999999999999999999998753 3443 2345677889999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEII 223 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE~~ 223 (255)
+||||||+||+++.++.+++ +|||+++....... ...+.+||+.|+|||++
T Consensus 190 vHrDLKp~NILl~~~g~ikL----------------------------~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l 241 (410)
T 3v8s_A 190 IHRDVKPDNMLLDKSGHLKL----------------------------ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241 (410)
T ss_dssp ECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCTTSEEECCSCCSCGGGCCHHHH
T ss_pred EeccCCHHHeeECCCCCEEE----------------------------eccceeEeeccCCcccccCCcCCccccCHHHh
Confidence 99999999999999999988 59999877654332 34468999999999999
Q ss_pred cCCC----CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 224 KNRG----HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 224 ~~~~----~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+.+ |+.++|||||||++|+|++|..||.
T Consensus 242 ~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp HTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 8765 7899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=251.58 Aligned_cols=148 Identities=30% Similarity=0.565 Sum_probs=126.8
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHh-ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~-~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
+....|+++++++..+++.+.+|+|||||.||+|.+++.+ ...+++ +.+..++.|++.||.|||++||
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e-----------~~~~~~~~qi~~aL~~LH~~gi 196 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE-----------EMARFYLAEMVIAIDSVHQLHY 196 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCH-----------HHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCH-----------HHHHHHHHHHHHHHHHHHhCCe
Confidence 4456799999999999999999999999999999999976 334443 3345678899999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEII 223 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE~~ 223 (255)
+||||||+|||++.++.+|+ +|||+++....... .....+||+.|+|||++
T Consensus 197 iHrDLKp~NILl~~~g~vkL----------------------------~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l 248 (437)
T 4aw2_A 197 VHRDIKPDNILMDMNGHIRL----------------------------ADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248 (437)
T ss_dssp ECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCTTSCEECCSCCSCGGGCCHHHH
T ss_pred EecccCHHHeeEcCCCCEEE----------------------------cchhhhhhcccCCCcccccccCCcCeeChHHH
Confidence 99999999999999999988 59999876644332 23347899999999999
Q ss_pred c-----CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 224 K-----NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 224 ~-----~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
. ...|+.++||||+||++|||++|..||.
T Consensus 249 ~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp HHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 7 4568999999999999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=249.29 Aligned_cols=153 Identities=28% Similarity=0.505 Sum_probs=132.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||++++++.+.+.+..|++||||.||+|.+.+..+..+++.. +..++.|++.||.|||
T Consensus 59 ~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~-----------~~~i~~qil~aL~~lH 127 (444)
T 3soa_A 59 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD-----------ASHCIQQILEAVLHCH 127 (444)
T ss_dssp HHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHH-----------HHHHHHHHHHHHHHHH
Confidence 34667778899999999999999999999999999999999998876665433 3456788999999999
Q ss_pred HcCcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
++||+||||||+||+++. .+.+++ +|||++.............+||+.|
T Consensus 128 ~~givHrDlKp~NIll~~~~~~~~vkL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~Y 179 (444)
T 3soa_A 128 QMGVVHRNLKPENLLLASKLKGAAVKL----------------------------ADFGLAIEVEGEQQAWFGFAGTPGY 179 (444)
T ss_dssp HTTCBCCCCSSTTEEESBSSTTCCEEE----------------------------CCCSSCBCCCTTCCBCCCSCSCGGG
T ss_pred HCCccccCCCHHHEEEeccCCCCcEEE----------------------------ccCceeEEecCCCceeecccCCccc
Confidence 999999999999999984 355666 5999998776554445567899999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||++.+..|+.++|+||+||++|+|++|.+||.
T Consensus 180 ~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=243.75 Aligned_cols=149 Identities=40% Similarity=0.783 Sum_probs=130.5
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++....|+++++++..+++.+.+|+||||+.||+|.+++.+...+++. .+..++.|++.||.|||++
T Consensus 92 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~~ 160 (350)
T 1rdq_E 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----------HARFYAAQIVLTFEYLHSL 160 (350)
T ss_dssp HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHH-----------HHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHC
Confidence 34456678999999999999999999999999999999999876665543 3456778899999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
||+||||||+||+++.++.+++ +|||+++.... ...+.+||+.|+|||+
T Consensus 161 ~ivHrDlkp~NIll~~~g~~kL----------------------------~DFg~a~~~~~---~~~~~~gt~~y~aPE~ 209 (350)
T 1rdq_E 161 DLIYRDLKPENLLIDQQGYIQV----------------------------TDFGFAKRVKG---RTWTLCGTPEALAPEI 209 (350)
T ss_dssp TEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECSS---CBCCCEECGGGCCHHH
T ss_pred CcccccCccceEEECCCCCEEE----------------------------cccccceeccC---CcccccCCccccCHHH
Confidence 9999999999999999998888 59999876543 2346789999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.+..++.++|+|||||++|+|++|..||..
T Consensus 210 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 9999999999999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=244.73 Aligned_cols=151 Identities=30% Similarity=0.599 Sum_probs=131.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|+++++..|++.+.+|+||||+.||+|..++.+...+++. .+..++.|++.||.|||+
T Consensus 65 E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~-----------~~~~~~~qi~~aL~~LH~ 133 (384)
T 4fr4_A 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----------TVKLFICELVMALDYLQN 133 (384)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999876665543 345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++..... ....+.+||+.|+|||
T Consensus 134 ~givHrDlkp~NIll~~~g~vkL----------------------------~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE 184 (384)
T 4fr4_A 134 QRIIHRDMKPDNILLDEHGHVHI----------------------------TDFNIAAMLPRE-TQITTMAGTKPYMAPE 184 (384)
T ss_dssp TTEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCTT-CCBCCCCSCGGGCCGG
T ss_pred CCceeccCcHHHeEECCCCCEEE----------------------------eccceeeeccCC-CceeccCCCccccCCe
Confidence 99999999999999999998888 599998766443 3445689999999999
Q ss_pred cccC---CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN---RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~---~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+ .+|+.++|||||||++|+|++|..||.
T Consensus 185 ~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp GTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 9974 468999999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=248.95 Aligned_cols=149 Identities=32% Similarity=0.603 Sum_probs=127.0
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~i 144 (255)
+....|+++++++..|++.+.+|+||||+.||+|.+++.+.. .+++ +.+..++.|++.||.|||++||
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~-----------~~~~~~~~qi~~aL~~LH~~gi 183 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA-----------EMARFYLAEIVMAIDSVHRLGY 183 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCH-----------HHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHHHCCe
Confidence 345679999999999999999999999999999999998643 3443 2345677889999999999999
Q ss_pred ccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccccc
Q psy3182 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEII 223 (255)
Q Consensus 145 iHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE~~ 223 (255)
+||||||+||+++.++.+++ +|||+++....... ...+.+||+.|+|||++
T Consensus 184 iHrDLKp~NILld~~g~vkL----------------------------~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l 235 (412)
T 2vd5_A 184 VHRDIKPDNILLDRCGHIRL----------------------------ADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235 (412)
T ss_dssp ECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCTTSCEECSSCCSCGGGCCHHHH
T ss_pred eecccCHHHeeecCCCCEEE----------------------------eechhheeccCCCccccceeccccCcCCHHHH
Confidence 99999999999999999988 59999877654332 23457899999999999
Q ss_pred c-------CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 224 K-------NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 224 ~-------~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
. ...|+.++||||+||++|||++|..||..
T Consensus 236 ~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp HHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 7 35689999999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=239.71 Aligned_cols=154 Identities=41% Similarity=0.686 Sum_probs=128.0
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+++.+.+|++|||+.||+|.+++.+...+++. .+..++.|++.||.|||
T Consensus 70 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~al~~lH 138 (327)
T 3a62_A 70 AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----------TACFYLAEISMALGHLH 138 (327)
T ss_dssp -HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3456677888999999999999999999999999999999999876655543 34456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ +|||+++............+||+.|+||
T Consensus 139 ~~~ivH~Dlkp~Nill~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 190 (327)
T 3a62_A 139 QKGIIYRDLKPENIMLNHQGHVKL----------------------------TDFGLCKESIHDGTVTHTFCGTIEYMAP 190 (327)
T ss_dssp HTTCCCCCCCTTTEEECTTSCEEE----------------------------CCCSCC----------CTTSSCCTTSCH
T ss_pred hCCEEcccCCHHHeEECCCCcEEE----------------------------EeCCcccccccCCccccccCCCcCccCH
Confidence 999999999999999999988888 5999887654444445567899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+|||||++|+|++|..||..
T Consensus 191 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp HHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=239.87 Aligned_cols=152 Identities=32% Similarity=0.580 Sum_probs=131.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+.+|+||||+.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 64 E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~-----------~~~~~~~qi~~al~~lH~ 132 (328)
T 3fe3_A 64 EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----------EARSKFRQIVSAVQYCHQ 132 (328)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 466677788999999999999999999999999999999999877666543 344577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++..... ....+.+||+.|+|||
T Consensus 133 ~~ivHrDlkp~NIll~~~~~~kl----------------------------~DFG~a~~~~~~-~~~~~~~gt~~y~aPE 183 (328)
T 3fe3_A 133 KRIVHRDLKAENLLLDADMNIKI----------------------------ADFGFSNEFTVG-GKLDAFCGAPPYAAPE 183 (328)
T ss_dssp TTCCCSCCCGGGEEECTTSCEEE----------------------------CSTTCCGGGSSS-CGGGTTSSSGGGCCHH
T ss_pred CCEeccCCCHHHEEEcCCCCEEE----------------------------eeccCceecCCC-CccccccCCcceeCcc
Confidence 99999999999999999988888 599998765443 2345678999999999
Q ss_pred cccCCCCC-CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHD-RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~-~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..+. .++|+||+||++|+|++|..||..
T Consensus 184 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp HHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99988775 689999999999999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=242.21 Aligned_cols=152 Identities=27% Similarity=0.517 Sum_probs=130.9
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++.++..+.|||++++++.+++.+.+|+||||+.||+|.+++.....+++. .+..++.|++.||.|||
T Consensus 64 ~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~-----------~~~~i~~qi~~aL~~LH 132 (361)
T 2yab_A 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-----------EATSFIKQILDGVNYLH 132 (361)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3566778888999999999999999999999999999999999876555543 34557789999999999
Q ss_pred HcCcccccCCCCceeeCCCC----ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRG----YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
++||+||||||+||+++..+ .+++ +|||+++...... ...+.+||+.
T Consensus 133 ~~givHrDlkp~NIll~~~~~~~~~vkl----------------------------~DFG~a~~~~~~~-~~~~~~gt~~ 183 (361)
T 2yab_A 133 TKKIAHFDLKPENIMLLDKNIPIPHIKL----------------------------IDFGLAHEIEDGV-EFKNIFGTPE 183 (361)
T ss_dssp HTTEECCCCSGGGEEESCTTSSSCCEEE----------------------------CCCSSCEECCTTC-CCCCCCSCGG
T ss_pred HCCcccCCCCHHHEEEeCCCCCccCEEE----------------------------EecCCceEcCCCC-ccccCCCCcc
Confidence 99999999999999998765 4666 5999987765432 3346789999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||++.+..|+.++|+||+||++|+|++|..||.
T Consensus 184 y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred EECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=257.85 Aligned_cols=145 Identities=35% Similarity=0.643 Sum_probs=129.9
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+++++++..|++.+.+|+||||+.||+|..++.+...+++.. +..++.||+.||.|||++||+||||
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~-----------~~~~~~qi~~aL~~LH~~gIiHrDL 468 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-----------AVFYAAEIAIGLFFLQSKGIIYRDL 468 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHH-----------HHHHHHHHHHHHHHHHHTSEECCCC
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHH-----------HHHHHHHHHHHHHHHHhCCeEeccC
Confidence 68999999999999999999999999999999998877666543 4557788999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHD 229 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (255)
||+|||++.++.+++ +|||+++..........+.+||+.|+|||++.+..|+
T Consensus 469 Kp~NILl~~~g~ikL----------------------------~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 520 (674)
T 3pfq_A 469 KLDNVMLDSEGHIKI----------------------------ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 520 (674)
T ss_dssp CSTTEEECSSSCEEE----------------------------CCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBS
T ss_pred ChhhEEEcCCCcEEE----------------------------eecceeeccccCCcccccccCCCcccCHhhhcCCCCC
Confidence 999999999999988 5999998655545556678999999999999999999
Q ss_pred CcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 230 RAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 230 ~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++|||||||++|||++|..||..
T Consensus 521 ~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 521 KSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccceEechHHHHHHHHcCCCCCCC
Confidence 999999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=252.53 Aligned_cols=151 Identities=30% Similarity=0.536 Sum_probs=130.5
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc----CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT----CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~----~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++....|+++++++..+++.+.+|+||||+.||+|.+++.... .+++ ..+..++.||+.||.||
T Consensus 237 ~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e-----------~~~~~~~~qi~~aL~~L 305 (543)
T 3c4z_A 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-----------PRAIFYTAQIVSGLEHL 305 (543)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccH-----------HHHHHHHHHHHHHHHHH
Confidence 34556789999999999999999999999999999999987543 2332 23456778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++||+||||||+||+++.++.+++ +|||+++..........+.+||+.|+|
T Consensus 306 H~~gIvHrDLKP~NILl~~~g~vkL----------------------------~DFGla~~~~~~~~~~~~~~GT~~Y~A 357 (543)
T 3c4z_A 306 HQRNIIYRDLKPENVLLDDDGNVRI----------------------------SDLGLAVELKAGQTKTKGYAGTPGFMA 357 (543)
T ss_dssp HHTTEECCCCCGGGEEECTTSCEEE----------------------------CCCTTCEECCTTCCCBCCCCSCTTTSC
T ss_pred HHcCCcccCCChHHEEEeCCCCEEE----------------------------eecceeeeccCCCcccccccCCccccC
Confidence 9999999999999999999999888 599999876555444556799999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+..|+.++|||||||++|||++|..||..
T Consensus 358 PE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=246.77 Aligned_cols=152 Identities=36% Similarity=0.669 Sum_probs=129.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+.+|+||||+.||+|...+.+...+++. .+..++.|++.||.|||+
T Consensus 198 e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH~ 266 (446)
T 4ejn_A 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----------RARFYGAEIVSALDYLHS 266 (446)
T ss_dssp ---CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHhh
Confidence 345567788999999999999999999999999999999999876655543 345577889999999998
Q ss_pred -cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 -RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 -~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+||+||||||+||+++.++.+++ +|||+++..........+.+||+.|+||
T Consensus 267 ~~giiHrDlkp~NIll~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aP 318 (446)
T 4ejn_A 267 EKNVVYRDLKLENLMLDKDGHIKI----------------------------TDFGLCKEGIKDGATMKTFCGTPEYLAP 318 (446)
T ss_dssp HTCCCCCCCCGGGEEECSSSCEEE----------------------------CCCCCCCTTCC-----CCSSSCGGGCCH
T ss_pred cCCEEECCCCHHHEEECCCCCEEE----------------------------ccCCCceeccCCCcccccccCCccccCH
Confidence 99999999999999999988888 5999988655444455678999999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..|+.++|+||+||++|+|++|..||.
T Consensus 319 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 99999999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=235.58 Aligned_cols=152 Identities=28% Similarity=0.549 Sum_probs=132.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++|||+.||+|.+++.+. .+++ ..+..++.|++.||.|||+
T Consensus 67 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~-----------~~~~~~~~qi~~~l~~lH~ 134 (297)
T 3fxz_A 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDE-----------GQIAAVCRECLQALEFLHS 134 (297)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 345567788999999999999999999999999999999998764 3333 2345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||++...........+.+||+.|+|||
T Consensus 135 ~~i~H~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 186 (297)
T 3fxz_A 135 NQVIHRDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQSKRSTMVGTPYWMAPE 186 (297)
T ss_dssp TTEECCCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCSTTCCBCCCCSCGGGCCHH
T ss_pred CCceeCCCCHHHEEECCCCCEEE----------------------------eeCCCceecCCcccccCCccCCcCccChh
Confidence 99999999999999999988888 59999877665555556678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 187 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp HHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=238.83 Aligned_cols=151 Identities=30% Similarity=0.593 Sum_probs=128.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++||||.||+|.+.+..+..+++. .+..++.|++.||.|||+
T Consensus 78 E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~-----------~~~~~~~qi~~al~~lH~ 146 (362)
T 2bdw_A 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----------DASHCIQQILESIAYCHS 146 (362)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999776555443 344567889999999999
Q ss_pred cCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+||+||||||+||+++..+ .+++ +|||++....... .....+||+.|+
T Consensus 147 ~~ivH~Dlkp~NIll~~~~~~~~~kl----------------------------~DfG~a~~~~~~~-~~~~~~gt~~y~ 197 (362)
T 2bdw_A 147 NGIVHRNLKPENLLLASKAKGAAVKL----------------------------ADFGLAIEVNDSE-AWHGFAGTPGYL 197 (362)
T ss_dssp TTCBCCCCSGGGEEESCSSTTCCEEE----------------------------CCCTTCBCCTTCC-SCCCSCSCTTTC
T ss_pred CCeEeccCchHHEEEecCCCCCCEEE----------------------------eecCcceEecCCc-ccccCCCCcccc
Confidence 9999999999999998653 3666 5999987765432 234578999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+..|+.++|+||+||++|+|++|..||.
T Consensus 198 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 198 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-33 Score=239.02 Aligned_cols=152 Identities=28% Similarity=0.494 Sum_probs=128.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC----CCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC----FDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~----~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++..+.|+|++++++.+.+.+.+|+|||||.||+|.+.+.++.. +++ ..+..++.|++.||.
T Consensus 76 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~-----------~~~~~i~~qi~~al~ 144 (351)
T 3c0i_A 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE-----------AVASHYMRQILEALR 144 (351)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCH-----------HHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999888765321 222 234567789999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCc---eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGY---VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|||++||+||||||+||+++..+. +++ +|||++.............+||
T Consensus 145 ~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl----------------------------~Dfg~a~~~~~~~~~~~~~~gt 196 (351)
T 3c0i_A 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKL----------------------------GGFGVAIQLGESGLVAGGRVGT 196 (351)
T ss_dssp HHHHTTEECSCCSGGGEEECSSSTTCCEEE----------------------------CCCTTCEECCTTSCBCCCCCSC
T ss_pred HHHHCCceeccCChHHeEEecCCCCCcEEE----------------------------ecCcceeEecCCCeeecCCcCC
Confidence 999999999999999999976543 566 5999988776554445567899
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.|+|||++.+..|+.++|+||+||++|+|++|..||.
T Consensus 197 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=231.36 Aligned_cols=153 Identities=24% Similarity=0.392 Sum_probs=126.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 61 e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~ 129 (294)
T 4eqm_A 61 EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD-----------TAINFTNQILDGIKHAHD 129 (294)
T ss_dssp HHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 455677788999999999999999999999999999999999876655443 344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~aP 220 (255)
+||+||||||+||+++.++.+++ +|||.++...... ......+||+.|+||
T Consensus 130 ~~i~H~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP 181 (294)
T 4eqm_A 130 MRIVHRDIKPQNILIDSNKTLKI----------------------------FDFGIAKALSETSLTQTNHVLGTVQYFSP 181 (294)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEE----------------------------CCCSSSTTC-------------CCSSCCH
T ss_pred CCcccCCCCHHHEEECCCCCEEE----------------------------EeCCCccccccccccccCccccCccccCH
Confidence 99999999999999999988888 5999987654332 223346799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+||+||++|+|++|..||..
T Consensus 182 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp HHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred hHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=237.91 Aligned_cols=151 Identities=17% Similarity=0.220 Sum_probs=123.3
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
...|++++++++.+.+.+..|+|||||.||+|.+++.......... .....+..++.|++.||.|||++||+||
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~------l~~~~~~~i~~qi~~~L~~lH~~~ivHr 196 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV------MPQGLVISFAMRMLYMIEQVHDCEIIHG 196 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCS------CCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccC------CCHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence 4448999999999999999999999999999999997533221111 1123455678899999999999999999
Q ss_pred cCCCCceeeCC-----------CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCC--CCCccccccccC
Q psy3182 148 DLKPENLLLDN-----------RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG--HSGCKTWTFCGT 214 (255)
Q Consensus 148 dlkp~nil~~~-----------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~--~~~~~~~~~~gt 214 (255)
||||+||+++. .+.+++ +|||+|+... .........+||
T Consensus 197 DiKp~NIll~~~~~~~~~~~~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~gt 248 (365)
T 3e7e_A 197 DIKPDNFILGNGFLEQDDEDDLSAGLAL----------------------------IDLGQSIDMKLFPKGTIFTAKCET 248 (365)
T ss_dssp CCSGGGEEECGGGTCC------CTTEEE----------------------------CCCTTCEEGGGSCTTEEECCSSCT
T ss_pred CCCHHHEEecccccCccccccccCCEEE----------------------------eeCchhhhhhccCCCceeeeecCC
Confidence 99999999987 566666 5999986443 222334457899
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.|||||++.+..|+.++|+|||||++|+|++|..||.
T Consensus 249 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp TSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred CCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 99999999999999999999999999999999998874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-33 Score=239.87 Aligned_cols=150 Identities=33% Similarity=0.637 Sum_probs=126.8
Q ss_pred eeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
.++.+. .|+|++++++.+++.+.+|+|||||.||+|.+.+.+...+++. .+..++.|++.||.|||++
T Consensus 67 ~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~-----------~~~~~~~qi~~al~~lH~~ 135 (342)
T 2qr7_A 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----------EASAVLFTITKTVEYLHAQ 135 (342)
T ss_dssp HHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHH-----------HHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHC
Confidence 334444 6999999999999999999999999999999999876655543 3455778899999999999
Q ss_pred CcccccCCCCceeeCCC-C---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 143 GIVFRDLKPENLLLDNR-G---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~-~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
||+||||||+||++... + .+++ +|||+++..........+.+||+.|+
T Consensus 136 givHrDlkp~NIl~~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~gt~~y~ 187 (342)
T 2qr7_A 136 GVVHRDLKPSNILYVDESGNPESIRI----------------------------CDFGFAKQLRAENGLLMTPCYTANFV 187 (342)
T ss_dssp TEECSCCCGGGEEESSSSCSGGGEEE----------------------------CCCTTCEECBCTTCCBCCSSCCSSCC
T ss_pred CcEeccCCHHHEEEecCCCCcCeEEE----------------------------EECCCcccCcCCCCceeccCCCcccc
Confidence 99999999999998543 2 3555 59999887655444556789999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+..|+.++|+||+||++|+|++|..||.
T Consensus 188 aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 9999998889999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=233.44 Aligned_cols=150 Identities=32% Similarity=0.536 Sum_probs=129.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+ +|+|++.+.+...+++. .+..++.|++.||.|||+
T Consensus 59 E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~-----------~~~~i~~qi~~aL~~LH~ 126 (336)
T 3h4j_B 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----------EGRRFFQQIICAIEYCHR 126 (336)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999 78999998876665543 345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||++...... ....+.+||+.|+|||
T Consensus 127 ~givH~Dlkp~NIll~~~~~~kl----------------------------~DFG~s~~~~~~-~~~~~~~gt~~y~aPE 177 (336)
T 3h4j_B 127 HKIVHRDLKPENLLLDDNLNVKI----------------------------ADFGLSNIMTDG-NFLKTSCGSPNYAAPE 177 (336)
T ss_dssp HTCCCCCCSTTTEEECTTCCEEE----------------------------CCSSCTBTTTTS-BTTCCCTTSTTTSCGG
T ss_pred CCeEecCCchhhEEEcCCCCEEE----------------------------EEeccceeccCC-cccccccCCcCcCCHH
Confidence 99999999999999999988888 599998765443 2345678999999999
Q ss_pred cccCCCC-CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGH-DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~-~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..+ +.++|+||+||++|+|++|..||.
T Consensus 178 ~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp GSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred HHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 9998776 678999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=234.73 Aligned_cols=151 Identities=28% Similarity=0.563 Sum_probs=109.6
Q ss_pred eeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++.... |+|++++++.+.+....|+||||+.||+|.+.+.+...+++. .+..++.|++.||.|||+
T Consensus 56 ~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~~l~~LH~ 124 (325)
T 3kn6_A 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-----------EASYIMRKLVSAVSHMHD 124 (325)
T ss_dssp HHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 34444444 999999999999999999999999999999999877665543 344577889999999999
Q ss_pred cCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+||+||||||+||+++..+ .+++ +|||.++..........+.+||+.|+
T Consensus 125 ~~ivH~Dlkp~NIll~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~t~~y~ 176 (325)
T 3kn6_A 125 VGVVHRDLKPENLLFTDENDNLEIKI----------------------------IDFGFARLKPPDNQPLKTPCFTLHYA 176 (325)
T ss_dssp TTEECCCCCGGGEEEEC----CEEEE----------------------------CCCTTCEECCC---------------
T ss_pred CCCeecCCCHHHEEEecCCCcccEEE----------------------------eccccceecCCCCCcccccCCCcCcc
Confidence 9999999999999997654 4566 59999876655444455678999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+..|+.++|+||+||++|+|++|..||.
T Consensus 177 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=249.41 Aligned_cols=149 Identities=29% Similarity=0.482 Sum_probs=128.4
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++....|+++++++..+++.+.+|+||||+.||+|.+++..... +++ ..+..++.||+.||.|||++
T Consensus 237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e-----------~~~~~i~~qIl~aL~yLH~~ 305 (576)
T 2acx_A 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-----------ARAVFYAAEICCGLEDLHRE 305 (576)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCH-----------HHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 34556899999999999999999999999999999999876432 332 23456778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
||+||||||+||+++.++.+++ +|||+++...... ...+.+||+.|+|||+
T Consensus 306 gIvHrDLKPeNILld~~g~vKL----------------------------~DFGla~~~~~~~-~~~~~~GT~~Y~APEv 356 (576)
T 2acx_A 306 RIVYRDLKPENILLDDHGHIRI----------------------------SDLGLAVHVPEGQ-TIKGRVGTVGYMAPEV 356 (576)
T ss_dssp TEECCCCCGGGEEECTTSCEEE----------------------------CCCTTCEECCTTC-CEECCCSCGGGCCHHH
T ss_pred CEeccCCchheEEEeCCCCeEE----------------------------EecccceecccCc-cccccCCCccccCHHH
Confidence 9999999999999999998888 5999987764432 3345689999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.+..|+.++||||+||++|+|++|..||..
T Consensus 357 l~~~~~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp HTTCEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred HcCCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=231.23 Aligned_cols=152 Identities=27% Similarity=0.514 Sum_probs=129.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++.....+++. .+..++.|++.||.|||
T Consensus 63 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~al~~lH 131 (326)
T 2y0a_A 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-----------EATEFLKQILNGVYYLH 131 (326)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3466777888999999999999999999999999999999999765554432 34557789999999999
Q ss_pred HcCcccccCCCCceeeCCCC----ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRG----YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
++||+||||||+||+++..+ .+++ +|||+++...... .....+||+.
T Consensus 132 ~~~ivH~Dlkp~NIll~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~ 182 (326)
T 2y0a_A 132 SLQIAHFDLKPENIMLLDRNVPKPRIKI----------------------------IDFGLAHKIDFGN-EFKNIFGTPE 182 (326)
T ss_dssp HTTEECCCCCGGGEEESCSSSSSCCEEE----------------------------CCCTTCEECCTTS-CCCCCCSCTT
T ss_pred HCCeEcCCCCHHHEEEecCCCCCCCEEE----------------------------EECCCCeECCCCC-ccccccCCcC
Confidence 99999999999999998776 5666 5999987664332 2335689999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 183 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp TCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 999999999999999999999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=233.33 Aligned_cols=151 Identities=23% Similarity=0.438 Sum_probs=128.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+++.+.+|++||||.||+|.+.+.... .+++ ..+..++.|++.||.|||
T Consensus 51 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~al~~lH 119 (321)
T 1tki_A 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE-----------REIVSYVHQVCEALQFLH 119 (321)
T ss_dssp HHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4566777889999999999999999999999999999999986543 2332 234557789999999999
Q ss_pred HcCcccccCCCCceeeCC--CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDN--RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++. ++.+++ +|||.++...... .....+|||.|+
T Consensus 120 ~~givH~Dlkp~NIl~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y~ 170 (321)
T 1tki_A 120 SHNIGHFDIRPENIIYQTRRSSTIKI----------------------------IEFGQARQLKPGD-NFRLLFTAPEYY 170 (321)
T ss_dssp HTTEECCCCCGGGEEESSSSCCCEEE----------------------------CCCTTCEECCTTC-EEEEEESCGGGS
T ss_pred HCCCCcCCCCHHHEEEccCCCCCEEE----------------------------EECCCCeECCCCC-ccccccCChhhc
Confidence 999999999999999987 566666 5999987765432 334568999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 171 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999889999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=228.58 Aligned_cols=156 Identities=24% Similarity=0.368 Sum_probs=120.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+....|++|||+.||+|.+++.+.... .......+..++.|++.||.|||+
T Consensus 84 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~ 155 (309)
T 3p86_A 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR--------EQLDERRRLSMAYDVAKGMNYLHN 155 (309)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHH--------HHSCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHc
Confidence 456677788999999999999999999999999999999999754320 011123345577899999999999
Q ss_pred cC--cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 142 RG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~--iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
+| |+||||||+||+++.++.+++ +|||.++............+||+.|+|
T Consensus 156 ~~~~ivH~Dikp~NIll~~~~~~kL----------------------------~Dfg~a~~~~~~~~~~~~~~gt~~y~a 207 (309)
T 3p86_A 156 RNPPIVHRNLKSPNLLVDKKYTVKV----------------------------CDFGLSRLKASTFLSSKSAAGTPEWMA 207 (309)
T ss_dssp SSSCCCCTTCCGGGEEECTTCCEEE----------------------------CCCC-----------------CCTTSC
T ss_pred CCCCEECCCCChhhEEEeCCCcEEE----------------------------CCCCCCccccccccccccCCCCccccC
Confidence 99 999999999999999988888 599988765444334456789999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+..++.++|+||+||++|+|++|..||..
T Consensus 208 PE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=226.94 Aligned_cols=152 Identities=22% Similarity=0.340 Sum_probs=125.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.+.+|++|||+.|+.+..+......+++ ..+..++.|++.||.|||
T Consensus 50 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~-----------~~~~~~~~ql~~~l~~lH 118 (292)
T 3o0g_A 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-----------EIVKSFLFQLLKGLGFCH 118 (292)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 356677888999999999999999999999999987544444333344433 334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ +|||.++............+||+.|+||
T Consensus 119 ~~~ivH~dikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~t~~y~aP 170 (292)
T 3o0g_A 119 SRNVLHRDLKPQNLLINRNGELKL----------------------------ANFGLARAFGIPVRCYSAEVVTLWYRPP 170 (292)
T ss_dssp HTTEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCSCCSCCCSCCSCGGGCCH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEE----------------------------eecccceecCCccccccCCccccCCcCh
Confidence 999999999999999999988888 5999987765544445567899999999
Q ss_pred ccccCCC-CCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 221 EIIKNRG-HDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 221 E~~~~~~-~~~~~DiWslGvil~ell~G~~~~ 251 (255)
|++.+.. ++.++|+||+||++|+|++|..||
T Consensus 171 E~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred HHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 9998755 899999999999999999998775
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=234.43 Aligned_cols=144 Identities=33% Similarity=0.587 Sum_probs=115.1
Q ss_pred ccccccccccccccC----ccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 69 KKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
..|+|++++++.+++ ...+|+|||||.||+|.+++..+.. +++ ..+..++.|++.||.|||++
T Consensus 112 ~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~-----------~~~~~i~~qi~~aL~~LH~~ 180 (400)
T 1nxk_A 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-----------REASEIMKSIGEAIQYLHSI 180 (400)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBH-----------HHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 468999999998765 6789999999999999999976432 332 33456788999999999999
Q ss_pred CcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 143 GIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
||+||||||+||+++. ++.+++ +|||+++...... ...+.+||+.|+|
T Consensus 181 ~ivHrDlkp~Nill~~~~~~~~~kl----------------------------~DFG~a~~~~~~~-~~~~~~gt~~y~a 231 (400)
T 1nxk_A 181 NIAHRDVKPENLLYTSKRPNAILKL----------------------------TDFGFAKETTSHN-SLTTPCYTPYYVA 231 (400)
T ss_dssp TEECCCCCGGGEEESSSSTTCCEEE----------------------------CCCTTCEECC------------CTTCC
T ss_pred CccccCcCcceEEEecCCCCccEEE----------------------------EecccccccCCCC-ccccCCCCCCccC
Confidence 9999999999999987 566777 5999987654322 3346789999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..|+.++||||+||++|+|++|..||.
T Consensus 232 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp GGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=225.82 Aligned_cols=153 Identities=23% Similarity=0.403 Sum_probs=126.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|+||||+.||+|.++++.. ..+++ ..+..++.|++.||.|||
T Consensus 57 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~al~~lH 125 (310)
T 3s95_A 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW-----------SQRVSFAKDIASGMAYLH 125 (310)
T ss_dssp HHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999863 22222 234457789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--------------
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-------------- 206 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-------------- 206 (255)
++||+||||||+||+++.++.+++. |||.++.......
T Consensus 126 ~~~ivH~dlkp~Nil~~~~~~~kl~----------------------------Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 177 (310)
T 3s95_A 126 SMNIIHRDLNSHNCLVRENKNVVVA----------------------------DFGLARLMVDEKTQPEGLRSLKKPDRK 177 (310)
T ss_dssp HTTEECSCCSTTSEEECTTSCEEEC----------------------------CCTTCEECC------------------
T ss_pred hCCccCCCCCcCeEEECCCCCEEEe----------------------------ecccceecccccccccccccccccccc
Confidence 9999999999999999999888884 7777654432211
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...+.+||+.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp --CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred cccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 12256899999999999999999999999999999999999988753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=226.07 Aligned_cols=157 Identities=24% Similarity=0.418 Sum_probs=128.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+.+|++|||+. |+|.+++.......... ......+..++.|++.||.|||+
T Consensus 53 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~ 126 (317)
T 2pmi_A 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPR-----GLELNLVKYFQWQLLQGLAFCHE 126 (317)
T ss_dssp HHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCC-----CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcccccccc-----CCCHHHHHHHHHHHHHHHHHHHH
Confidence 4667788899999999999999999999999998 58998887543211110 01123456678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||.++............+||+.|+|||
T Consensus 127 ~~ivH~Dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE 178 (317)
T 2pmi_A 127 NKILHRDLKPQNLLINKRGQLKL----------------------------GDFGLARAFGIPVNTFSSEVVTLWYRAPD 178 (317)
T ss_dssp TTEECCCCCGGGEEECTTCCEEE----------------------------CCCSSCEETTSCCCCCCCCCSCCTTCCHH
T ss_pred CCeeeCCCChHHeEEcCCCCEEE----------------------------CcCccceecCCCcccCCCCcccccccCch
Confidence 99999999999999999988888 59998876654333344568999999999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9986 468999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=236.87 Aligned_cols=149 Identities=24% Similarity=0.442 Sum_probs=115.6
Q ss_pred ceeeeccccccccccccccc-----cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTF-----KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~-----~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++..+.|+|++++++.+ ++...+|+|||++ +|+|..+++....+++. .+..++.||+.||
T Consensus 102 E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~-----------~~~~~~~qi~~aL 169 (458)
T 3rp9_A 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTEL-----------HIKTLLYNLLVGV 169 (458)
T ss_dssp HHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHH-----------HHHHHHHHHHHHH
Confidence 45667778999999999988 4446799999987 67999999876555543 3456788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-----------
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----------- 205 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----------- 205 (255)
.|||++||+||||||+|||++.++.+|+. |||+++......
T Consensus 170 ~~LH~~~iiHrDlKp~NILl~~~~~~kl~----------------------------DFGla~~~~~~~~~~~~~~~~~~ 221 (458)
T 3rp9_A 170 KYVHSAGILHRDLKPANCLVNQDCSVKVC----------------------------DFGLARTVDYPENGNSQLPISPR 221 (458)
T ss_dssp HHHHHTTCBCCCCCGGGEEECTTCCEEEC----------------------------CCTTCBCTTSCTTCCCCCC----
T ss_pred HHHHhCCcCCCCCChhhEEECCCCCEeec----------------------------ccccchhccCccccccccccCcc
Confidence 99999999999999999999999999995 566554432110
Q ss_pred ----------------ccccccccCCCCcccccc-cCCCCCCcchHHHHHHHHHHHhcCCCC
Q psy3182 206 ----------------CKTWTFCGTPEYVAPEII-KNRGHDRAVDYWALGILMHELLTGMKE 250 (255)
Q Consensus 206 ----------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiWslGvil~ell~G~~~ 250 (255)
......+||+.|+|||++ .+..|+.++||||+||++|||++|..|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp -----------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred ccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 123456899999999986 456799999999999999999995443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=226.04 Aligned_cols=152 Identities=22% Similarity=0.389 Sum_probs=126.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+.+|+||||+.| ++.+.+..... +++ ..+..++.|++.||.|||
T Consensus 69 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~-----------~~~~~~~~qi~~~l~~LH 136 (311)
T 3niz_A 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD-----------SQIKIYLYQLLRGVAHCH 136 (311)
T ss_dssp HHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 46677788999999999999999999999999985 77777765332 322 334567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ +|||.++............+||+.|+||
T Consensus 137 ~~~ivH~Dikp~NIl~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~t~~y~aP 188 (311)
T 3niz_A 137 QHRILHRDLKPQNLLINSDGALKL----------------------------ADFGLARAFGIPVRSYTHEVVTLWYRAP 188 (311)
T ss_dssp HTTEECCCCCGGGEEECTTCCEEE----------------------------CCCTTCEETTSCCC---CCCCCCTTCCH
T ss_pred HCCcccCCCchHhEEECCCCCEEE----------------------------ccCcCceecCCCcccccCCcccCCcCCH
Confidence 999999999999999999988888 5999987765444444456899999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 99976 5689999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=239.67 Aligned_cols=151 Identities=28% Similarity=0.531 Sum_probs=130.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+.+|+|||||.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 66 Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~-----------~~~~i~~qi~~aL~~LH~ 134 (476)
T 2y94_A 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----------ESRRLFQQILSGVDYCHR 134 (476)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHH-----------HHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999866555443 345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||+++..... ....+.+||+.|+|||
T Consensus 135 ~givHrDLkp~NIll~~~~~vkL----------------------------~DFG~a~~~~~~-~~~~~~~gt~~y~aPE 185 (476)
T 2y94_A 135 HMVVHRDLKPENVLLDAHMNAKI----------------------------ADFGLSNMMSDG-EFLRTSCGSPNYAAPE 185 (476)
T ss_dssp TTEECSCCSGGGEEECTTCCEEE----------------------------CCCSSCEECCTT-CCBCCCCSCSTTCCHH
T ss_pred CCCCcccccHHHEEEecCCCeEE----------------------------Eeccchhhcccc-ccccccCCCcCeEChh
Confidence 99999999999999999988888 599998766443 2344678999999999
Q ss_pred cccCCCC-CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGH-DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~-~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..+ +.++|+||+||++|+|++|..||.
T Consensus 186 ~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 9998776 678999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=227.20 Aligned_cols=153 Identities=25% Similarity=0.404 Sum_probs=121.4
Q ss_pred CceeeeccccccccccccccccCccce----eehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYV----YMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~----ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
.+++++..+.|+|++++++.+.+.... |+||||+.||+|.+++.....+++. .+..++.|++.||
T Consensus 61 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l 129 (311)
T 3ork_A 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-----------RAIEVIADACQAL 129 (311)
T ss_dssp HHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHH
Confidence 346667788999999999998876644 9999999999999999876655433 3345678899999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC---cccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---CKTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---~~~~~~~g 213 (255)
.|||++||+||||||+||+++.++.+++ +|||.++...... ......+|
T Consensus 130 ~~lH~~~ivH~dlkp~Nil~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~g 181 (311)
T 3ork_A 130 NFSHQNGIIHRDVKPANIMISATNAVKV----------------------------MDFGIARAIADSGNSVTQTAAVIG 181 (311)
T ss_dssp HHHHHTTCCCCCCCGGGEEEETTSCEEE----------------------------CCCSCC------------------
T ss_pred HHHHHCCCCcCCCCHHHEEEcCCCCEEE----------------------------eeccCcccccccccccccccccCc
Confidence 9999999999999999999999888888 5999887654322 12334679
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 182 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=231.84 Aligned_cols=160 Identities=23% Similarity=0.326 Sum_probs=125.7
Q ss_pred eccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhH-----HHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI-----TACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 66 ~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~i~~~il~~l~yl 139 (255)
+..+ .|+|++++++.+.+.+.+|+||||+.||+|.+++.............. .......+..++.|++.||.||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4445 799999999999999999999999999999999986542111000000 0012234556788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y 217 (255)
|++||+||||||+||+++.++.+++ +|||+++....... ......||+.|
T Consensus 220 H~~~ivHrDlkp~NIll~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~~t~~y 271 (370)
T 2psq_A 220 ASQKCIHRDLAARNVLVTENNVMKI----------------------------ADFGLARDINNIDYYKKTTNGRLPVKW 271 (370)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEE----------------------------CCCSSCEETTCCCTTCTTTTTTSCGGG
T ss_pred HhCCeeccccchhhEEECCCCCEEE----------------------------ccccCCcccCcccceecccCCCcccce
Confidence 9999999999999999999998888 59998876543321 22334678899
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+|||++.+..++.++|+|||||++|||++ |..||..
T Consensus 272 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 272 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999999999 8888863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=227.17 Aligned_cols=151 Identities=30% Similarity=0.553 Sum_probs=129.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++|||+.||+|.+++.+. .+++ ..+..++.|++.||.|||+
T Consensus 92 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~l~~-----------~~~~~i~~qi~~~L~~LH~ 159 (321)
T 2c30_A 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNE-----------EQIATVCEAVLQALAYLHA 159 (321)
T ss_dssp HHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-CCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-CCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 345567788999999999999999999999999999999988642 2332 3345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||++.............+||+.|+|||
T Consensus 160 ~~ivH~Dlkp~NIll~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 211 (321)
T 2c30_A 160 QGVIHRDIKSDSILLTLDGRVKL----------------------------SDFGFCAQISKDVPKRKSLVGTPYWMAPE 211 (321)
T ss_dssp TTEECCCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCSSSCCBCCCCSCGGGCCHH
T ss_pred CCeecCCCCHHHEEECCCCcEEE----------------------------eeeeeeeecccCccccccccCCccccCHh
Confidence 99999999999999999888888 59998877655444445678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 212 ~~~~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=230.12 Aligned_cols=152 Identities=34% Similarity=0.571 Sum_probs=119.1
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+.+.....+++. .+..++.|++.||.|||
T Consensus 97 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~~L~~LH 165 (349)
T 2w4o_A 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSER-----------DAADAVKQILEAVAYLH 165 (349)
T ss_dssp --CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3566677888999999999999999999999999999999999766554432 34557789999999999
Q ss_pred HcCcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
++||+||||||+||+++. ++.+++ +|||+++...... .....+||+.|
T Consensus 166 ~~~ivH~Dikp~NIll~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y 216 (349)
T 2w4o_A 166 ENGIVHRDLKPENLLYATPAPDAPLKI----------------------------ADFGLSKIVEHQV-LMKTVCGTPGY 216 (349)
T ss_dssp HTTCCCCCCCGGGEEESSSSTTCCEEE----------------------------CCCC-----------------CGGG
T ss_pred HCCeEecCCCcccEEEecCCCCCCEEE----------------------------ccCccccccCccc-ccccccCCCCc
Confidence 999999999999999975 566666 5999887654322 23456899999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 217 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp SCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=222.60 Aligned_cols=153 Identities=22% Similarity=0.395 Sum_probs=123.5
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|+|++++++.+.+.+..|++||++.+ +|.+.+... ..+++ ..+..++.|++.||.||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~-----------~~~~~~~~qi~~~l~~l 116 (288)
T 1ob3_A 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES-----------VTAKSFLLQLLNGIAYC 116 (288)
T ss_dssp HHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 356778888999999999999999999999999986 888888653 22222 23456778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++||+||||||+||+++.++.+++ +|||.++............+||+.|+|
T Consensus 117 H~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~t~~y~a 168 (288)
T 1ob3_A 117 HDRRVLHRDLKPQNLLINREGELKI----------------------------ADFGLARAFGIPVRKYTHEIVTLWYRA 168 (288)
T ss_dssp HHTTCCCSCCCGGGEEECTTSCEEE----------------------------CCTTHHHHHCC---------CCCTTCC
T ss_pred HHCCeecCCCCHHHEEEcCCCCEEE----------------------------eECccccccCccccccccccccccccC
Confidence 9999999999999999999988888 599998765443333445689999999
Q ss_pred cccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 169 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred chheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999976 4689999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=231.02 Aligned_cols=152 Identities=25% Similarity=0.418 Sum_probs=119.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|+|++++++.+.+.+.+|+||||+.||+|.+.+.....+++. .+..++.|++.||.|||+
T Consensus 66 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~ql~~~L~~LH~ 134 (361)
T 3uc3_A 66 EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED-----------EARFFFQQLLSGVSYCHS 134 (361)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 455667788999999999999999999999999999999999876655543 345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCc--eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGY--VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
+||+||||||+||+++.++. +++ +|||+++..... ......+||+.|+|
T Consensus 135 ~~ivH~Dlkp~Nill~~~~~~~~kl----------------------------~Dfg~a~~~~~~-~~~~~~~gt~~y~a 185 (361)
T 3uc3_A 135 MQICHRDLKLENTLLDGSPAPRLKI----------------------------CDFGYSKSSVLH-SQPKSTVGTPAYIA 185 (361)
T ss_dssp TTCCSCCCCGGGEEECSSSSCCEEE----------------------------CCCCCC----------------CTTSC
T ss_pred CCcccCCCCHHHEEEcCCCCceEEE----------------------------eecCcccccccc-CCCCCCcCCCCcCC
Confidence 99999999999999987654 666 599988744322 22345689999999
Q ss_pred cccccCCCCCCc-chHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRA-VDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~-~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+..++.+ +|+||+||++|+|++|..||..
T Consensus 186 PE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp HHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred hhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 999988887665 8999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=232.72 Aligned_cols=152 Identities=25% Similarity=0.424 Sum_probs=127.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+...+|++|||+.||+|.+.+.... .+++ ..+..++.|++.||.|||
T Consensus 98 E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~-----------~~~~~i~~qi~~aL~~LH 166 (387)
T 1kob_A 98 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-----------AEVINYMRQACEGLKHMH 166 (387)
T ss_dssp HHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4556777889999999999999999999999999999999887533 2332 234567789999999999
Q ss_pred HcCcccccCCCCceeeCCC--CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNR--GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++.. +.+++ +|||+++...... .....+||+.|+
T Consensus 167 ~~givHrDlkp~NIll~~~~~~~vkL----------------------------~DFG~a~~~~~~~-~~~~~~gt~~y~ 217 (387)
T 1kob_A 167 EHSIVHLDIKPENIMCETKKASSVKI----------------------------IDFGLATKLNPDE-IVKVTTATAEFA 217 (387)
T ss_dssp HTTEECCCCCGGGEEESSTTCCCEEE----------------------------CCCTTCEECCTTS-CEEEECSSGGGC
T ss_pred hCCeeecccchHHeEEecCCCCceEE----------------------------EecccceecCCCc-ceeeeccCCCcc
Confidence 9999999999999999753 45666 5999988765433 233468999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 218 aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-33 Score=254.04 Aligned_cols=145 Identities=14% Similarity=0.171 Sum_probs=109.5
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++.+. .|+|+++++++++++..+|||||||.|++|.+.+++.+.+++. .|++||+.||.|+|
T Consensus 291 E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~--------------~I~~QIl~AL~ylH 356 (569)
T 4azs_A 291 EIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE--------------KILGSLLRSLAALE 356 (569)
T ss_dssp HHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH--------------HHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH--------------HHHHHHHHHHHHHH
Confidence 46666666 6999999999999999999999999999999999987766531 26789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|||||||||+|||++.++.+|+ +|||+|+..........+.+|||.||||
T Consensus 357 ~~GIIHRDIKPeNILL~~dg~vKL----------------------------~DFGlAr~~~~~~~~~~t~vGTp~YmAP 408 (569)
T 4azs_A 357 KQGFWHDDVRPWNVMVDARQHARL----------------------------IDFGSIVTTPQDCSWPTNLVQSFFVFVN 408 (569)
T ss_dssp HTTCEESCCCGGGEEECTTSCEEE----------------------------CCCTTEESCC---CCSHHHHHHHHHHHH
T ss_pred HCCceeccCchHhEEECCCCCEEE----------------------------eecccCeeCCCCCccccCceechhhccH
Confidence 999999999999999999999998 5999998876665666778999999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMK 249 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~ 249 (255)
|++.+. +..++|+||+|+++|++.+|..
T Consensus 409 E~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 409 ELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHC------------------CCCCTTHH
T ss_pred HHhCCC-CCCcccccccccchhhhccccc
Confidence 999875 5678999999999888766643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=227.19 Aligned_cols=152 Identities=22% Similarity=0.356 Sum_probs=126.8
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+ .|++++++++.+.+.+..|++|||+ |++|.+++... ..+++ ..+..++.|++.||.||
T Consensus 54 E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~-----------~~~~~i~~qi~~~l~~L 121 (330)
T 2izr_A 54 EYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL-----------KTVLMIAIQLISRMEYV 121 (330)
T ss_dssp HHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 45556666 8999999999999999999999999 99999998753 23332 33456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCc-----eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-------c
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGY-----VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-------K 207 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-------~ 207 (255)
|++||+||||||+||+++.++. +++ +|||+++....... .
T Consensus 122 H~~~iiHrDlkp~Nill~~~~~~~~~~~kl----------------------------~DFg~a~~~~~~~~~~~~~~~~ 173 (330)
T 2izr_A 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHI----------------------------IDFALAKEYIDPETKKHIPYRE 173 (330)
T ss_dssp HHTTEECCCCCGGGEEECCGGGTCTTSEEE----------------------------CCCTTCEESBCTTTCCBCCCCC
T ss_pred HhCCeeccCCCHHHeeeccCCCCCCceEEE----------------------------EEcccceeeecCCCCccccccc
Confidence 9999999999999999988765 666 59998876533221 1
Q ss_pred ccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 208 TWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 208 ~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 2457899999999999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=225.47 Aligned_cols=131 Identities=27% Similarity=0.511 Sum_probs=106.2
Q ss_pred ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeec
Q psy3182 86 YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLE 165 (255)
Q Consensus 86 ~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~ 165 (255)
..|++||||.||+|.+++.++....+.. ...+..++.|++.||.|||++||+||||||+||+++.++.+++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~--------~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL- 205 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDRE--------HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV- 205 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSC--------HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE-
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchh--------hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEE-
Confidence 3899999999999999998765433322 1224457889999999999999999999999999999988888
Q ss_pred ccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC------------ccccccccCCCCcccccccCCCCCCcch
Q psy3182 166 FYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG------------CKTWTFCGTPEYVAPEIIKNRGHDRAVD 233 (255)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 233 (255)
+|||.++...... ......+||+.|+|||++.+..++.++|
T Consensus 206 ---------------------------~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 258 (332)
T 3qd2_B 206 ---------------------------GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258 (332)
T ss_dssp ---------------------------CCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHH
T ss_pred ---------------------------eecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhh
Confidence 4888876654431 1223467999999999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCCc
Q psy3182 234 YWALGILMHELLTGMKESN 252 (255)
Q Consensus 234 iWslGvil~ell~G~~~~~ 252 (255)
+||+||++|+|++|..|+.
T Consensus 259 i~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 259 IFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp HHHHHHHHHHHHSCCCCHH
T ss_pred HHHHHHHHHHHHHcCCChh
Confidence 9999999999999987753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=232.09 Aligned_cols=153 Identities=18% Similarity=0.263 Sum_probs=125.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc--cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~--~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++.+.+.+.+|+|||||.||+|.+++... ..+++ ..+..++.|++.||.||
T Consensus 76 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-----------~~~~~~~~qi~~~l~~L 144 (389)
T 3gni_B 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE-----------LAIAYILQGVLKALDYI 144 (389)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999999764 22222 33556788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-------Cccccccc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-------GCKTWTFC 212 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-------~~~~~~~~ 212 (255)
|++||+||||||+||+++.++.+++. |||.+...... .......+
T Consensus 145 H~~~ivHrDlkp~NIll~~~~~~kl~----------------------------dfg~~~~~~~~~~~~~~~~~~~~~~~ 196 (389)
T 3gni_B 145 HHMGYVHRSVKASHILISVDGKVYLS----------------------------GLRSNLSMISHGQRQRVVHDFPKYSV 196 (389)
T ss_dssp HHTTEECCCCSGGGEEECTTCCEEEC----------------------------CGGGCEECEETTEECSCBCCCCTTCT
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEc----------------------------ccccceeecccccccccccccccccc
Confidence 99999999999999999999988884 66655332111 11122357
Q ss_pred cCCCCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 213 GTPEYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 213 gt~~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||+.|+|||++.+ ..|+.++|+||+||++|+|++|..||..
T Consensus 197 gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp TTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999987 6799999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=227.47 Aligned_cols=152 Identities=21% Similarity=0.294 Sum_probs=120.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.+.+|+||||+.| +|.+++.....+++ ..+..++.|++.||.|||
T Consensus 82 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~-----------~~~~~i~~ql~~~l~~LH 149 (329)
T 3gbz_A 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM-----------RVIKSFLYQLINGVNFCH 149 (329)
T ss_dssp HHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 356778888999999999999999999999999985 99999987655443 234567889999999999
Q ss_pred HcCcccccCCCCceeeCCC-----CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 141 TRGIVFRDLKPENLLLDNR-----GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~-----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
++||+||||||+||+++.+ +.+++ +|||.++............+||+
T Consensus 150 ~~~ivH~Dlkp~NIll~~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~t~ 201 (329)
T 3gbz_A 150 SRRCLHRDLKPQNLLLSVSDASETPVLKI----------------------------GDFGLARAFGIPIRQFTHEIITL 201 (329)
T ss_dssp HTTCCCSCCCGGGEEEEC-----CCEEEE----------------------------CCTTHHHHHC-----------CC
T ss_pred hCCEECCCCCHHHEEEecCCCCccceEEE----------------------------CcCCCccccCCcccccCCCcCCc
Confidence 9999999999999999543 33565 59999876654434444568999
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 202 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9999999987 458999999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=230.31 Aligned_cols=153 Identities=29% Similarity=0.539 Sum_probs=128.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++||||.||+|.+.+.....+++ ..+..++.|++.||.|||+
T Consensus 55 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~aL~~LH~ 123 (323)
T 3tki_A 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVVYLHG 123 (323)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999998876544443 2345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~a 219 (255)
+||+||||||+||+++.++.+++ +|||.++...... ......+||+.|+|
T Consensus 124 ~givH~Dlkp~NIll~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 175 (323)
T 3tki_A 124 IGITHRDIKPENLLLDERDNLKI----------------------------SDFGLATVFRYNNRERLLNKMCGTLPYVA 175 (323)
T ss_dssp TTEECSCCSGGGEEECTTCCEEE----------------------------CCCTTCEECEETTEECCBCSCCSCGGGSC
T ss_pred CCccccccchHHEEEeCCCCEEE----------------------------EEeeccceeccCCcccccCCCccCcCccC
Confidence 99999999999999999988888 5899886543221 12335689999999
Q ss_pred cccccCCCC-CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGH-DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~-~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+..+ +.++|+||+||++|+|++|..||..
T Consensus 176 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp HHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 999987765 6789999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=226.11 Aligned_cols=152 Identities=24% Similarity=0.491 Sum_probs=130.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcch-hHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGG-EVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++||++.+| +|.+++.+...+++. .+..++.|++.||.|||
T Consensus 79 E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~-----------~~~~i~~qi~~~L~~LH 147 (335)
T 3dls_A 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP-----------LASYIFRQLVSAVGYLR 147 (335)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 456677889999999999999999999999998776 999999876655543 34457788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ +|||.++...... ...+.+||+.|+||
T Consensus 148 ~~~ivH~Dlkp~NIll~~~~~~kL----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y~aP 198 (335)
T 3dls_A 148 LKDIIHRDIKDENIVIAEDFTIKL----------------------------IDFGSAAYLERGK-LFYTFCGTIEYCAP 198 (335)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCTTC-CBCEECSCGGGCCH
T ss_pred hCCeEEeccCHHHEEEcCCCcEEE----------------------------eecccceECCCCC-ceeccCCCccccCh
Confidence 999999999999999999988888 5999987665432 33457899999999
Q ss_pred ccccCCCC-CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGH-DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~-~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..+ +.++|+||+||++|+|++|..||..
T Consensus 199 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp HHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred hhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99998776 7789999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=229.24 Aligned_cols=147 Identities=24% Similarity=0.350 Sum_probs=120.7
Q ss_pred eccccccccccccccccCc----cceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRKKKTRQTRLYKTFKDS----KYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~----~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+..+.|+|++++++.+.+. ...|++|||+ ||+|.+++... ..+++ ..+..++.|++.||.|||
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~-----------~~~~~i~~qi~~~l~~lH 169 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR-----------KTVLQLSLRILDILEYIH 169 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3456799999999988765 5689999999 99999999764 23332 234567889999999999
Q ss_pred HcCcccccCCCCceeeC--CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-------cccccc
Q psy3182 141 TRGIVFRDLKPENLLLD--NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-------CKTWTF 211 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-------~~~~~~ 211 (255)
++||+||||||+||+++ ..+.+++ +|||+++...... ......
T Consensus 170 ~~~iiHrDlkp~Nill~~~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~~~~~ 221 (364)
T 3op5_A 170 EHEYVHGDIKASNLLLNYKNPDQVYL----------------------------VDYGLAYRYCPEGVHKAYAADPKRCH 221 (364)
T ss_dssp HTTEECCCCCGGGEEEESSCTTCEEE----------------------------CCCTTCEESSGGGCCCCSSCCSSCCC
T ss_pred HCCeEEecCCHHHEEEecCCCCeEEE----------------------------EECCcceecccCCcccccccCccccc
Confidence 99999999999999998 6777777 4888886543221 112345
Q ss_pred ccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 222 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 222 DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp CCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred CCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 69999999999999999999999999999999999999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=237.07 Aligned_cols=151 Identities=34% Similarity=0.597 Sum_probs=128.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|||++++++.+.+.+..|++||||.||+|.+.+..+..+++. .+..++.|++.||.|||+
T Consensus 76 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~i~~qi~~~l~~lH~ 144 (484)
T 3nyv_A 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----------DAARIIRQVLSGITYMHK 144 (484)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677889999999999999999999999999999999999876655543 234577899999999999
Q ss_pred cCcccccCCCCceeeC---CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLD---NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+||+||||||+||+++ ..+.+++ +|||+++...... .....+||+.|+
T Consensus 145 ~~ivH~Dlkp~Nil~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y~ 195 (484)
T 3nyv_A 145 NKIVHRDLKPENLLLESKSKDANIRI----------------------------IDFGLSTHFEASK-KMKDKIGTAYYI 195 (484)
T ss_dssp TTCCCSCCCGGGEEESSSSTTCCEEE----------------------------CCTTHHHHBCCCC-SHHHHTTGGGTC
T ss_pred CCeeeCCCCHHHEEEecCCCCCcEEE----------------------------EeeeeeEEccccc-ccccCCCCcccc
Confidence 9999999999999994 4556666 5999987765433 334568999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+ .|+.++|+||+||++|+|++|.+||..
T Consensus 196 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp CHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 9999987 689999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=226.76 Aligned_cols=152 Identities=38% Similarity=0.683 Sum_probs=125.7
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+ .|+++++++..+.+.+..|+||||+.||+|.+++.....+++. .+..++.|++.||.|||
T Consensus 108 E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~aL~~LH 176 (355)
T 1vzo_A 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----------EVQIYVGEIVLALEHLH 176 (355)
T ss_dssp HHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 44555566 5999999999999999999999999999999999876655432 34556788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~a 219 (255)
++||+||||||+||+++.++.+++ +|||+++...... ......+||+.|+|
T Consensus 177 ~~~ivH~Dlkp~NIll~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~gt~~y~a 228 (355)
T 1vzo_A 177 KLGIIYRDIKLENILLDSNGHVVL----------------------------TDFGLSKEFVADETERAYDFCGTIEYMA 228 (355)
T ss_dssp HTTCCCCCCCGGGEEECTTSCEEE----------------------------SCSSEEEECCGGGGGGGCGGGSCCTTCC
T ss_pred HCCcccCCCCHHHEEECCCCcEEE----------------------------eeCCCCeecccCCCCcccCcccCcCccC
Confidence 999999999999999999988888 5999887653322 22345689999999
Q ss_pred cccccC--CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKN--RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+ ..++.++|+|||||++|+|++|..||.
T Consensus 229 PE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp HHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred hhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 999985 457899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=223.83 Aligned_cols=153 Identities=27% Similarity=0.551 Sum_probs=131.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|+|++++++.+.+.+..|++|||+.|++|.+++..+..+++. .+..++.|++.||.|||+
T Consensus 91 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-----------~~~~i~~qi~~aL~~LH~ 159 (335)
T 2owb_A 91 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----------EARYYLRQIVLGCQYLHR 159 (335)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 345566778999999999999999999999999999999998876555432 345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||.+.............+||+.|+|||
T Consensus 160 ~~ivH~dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 211 (335)
T 2owb_A 160 NRVIHRDLKLGNLFLNEDLEVKI----------------------------GDFGLATKVEYDGERKKVLCGTPNYIAPE 211 (335)
T ss_dssp TTEECSCCCGGGEEECTTCCEEE----------------------------CCCTTCEECCSTTCCBCCCCSCCSSCCHH
T ss_pred CCCEecCCCchhEEEcCCCCEEE----------------------------eeccCceecccCcccccccCCCccccCHH
Confidence 99999999999999999888888 59998876654444445578999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+|||||++|+|++|..||..
T Consensus 212 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp HHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 99999999999999999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=230.69 Aligned_cols=159 Identities=21% Similarity=0.315 Sum_probs=125.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++..+.|+|++++++.+.+....|+|||||.||+|.+++............. ....+..++.|++.||.|||++
T Consensus 125 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~----~~~~~~~i~~qi~~aL~~LH~~ 200 (367)
T 3l9p_A 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL----AMLDLLHVARDIACGCQYLEEN 200 (367)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccc----cHHHHHHHHHHHHHHHHHHHhC
Confidence 344556789999999999999999999999999999999998755332221111 1223456788999999999999
Q ss_pred CcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--CccccccccCCCC
Q psy3182 143 GIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCGTPEY 217 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~gt~~y 217 (255)
||+||||||+||+++.++ .+++ +|||+++..... ........||+.|
T Consensus 201 ~ivHrDlkp~NIll~~~~~~~~~kL----------------------------~DFG~a~~~~~~~~~~~~~~~~~t~~y 252 (367)
T 3l9p_A 201 HFIHRDIAARNCLLTCPGPGRVAKI----------------------------GDFGMARDIYRAGYYRKGGCAMLPVKW 252 (367)
T ss_dssp TCCCSCCCGGGEEESCSSTTCCEEE----------------------------CCCHHHHHHHHHSSCTTCCGGGSCGGG
T ss_pred CeeCCCCChhhEEEecCCCCceEEE----------------------------CCCccccccccccccccCCCcCCcccE
Confidence 999999999999998554 3666 599998643211 1123346789999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+|||++.+..++.++|+|||||++|+|++ |..||..
T Consensus 253 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998899999999999999999998 9898863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=229.61 Aligned_cols=150 Identities=23% Similarity=0.476 Sum_probs=117.7
Q ss_pred eeeecccc-ccccccccccccCc--cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK-KTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 63 vkl~~~~~-h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++++.... |+|++++++.+.+. ..+|+||||+. |+|...++.. .+++ ..+..++.|++.||.||
T Consensus 59 ~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~-----------~~~~~i~~qi~~~L~~L 125 (388)
T 3oz6_A 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN-ILEP-----------VHKQYVVYQLIKVIKYL 125 (388)
T ss_dssp HHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT-CCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC-CCCH-----------HHHHHHHHHHHHHHHHH
Confidence 44555555 99999999998754 47899999997 5898888753 3332 23455778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCC----------------
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGH---------------- 203 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~---------------- 203 (255)
|++||+||||||+||+++.++.+++. |||+|+....
T Consensus 126 H~~~ivHrDlkp~NIll~~~~~~kl~----------------------------DFG~a~~~~~~~~~~~~~~~~~~~~~ 177 (388)
T 3oz6_A 126 HSGGLLHRDMKPSNILLNAECHVKVA----------------------------DFGLSRSFVNIRRVTNNIPLSINENT 177 (388)
T ss_dssp HHTTEECCCCCGGGEEECTTCCEEEC----------------------------CCTTCEESSSCCCCCCCGGGCCC---
T ss_pred HhCCEEeCCCCHHHeEEcCCCCEEec----------------------------CCcccccccccccccccccccccccc
Confidence 99999999999999999999999985 6666654321
Q ss_pred -----CCccccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 204 -----SGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 204 -----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
........+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||..
T Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp ------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 1112335689999999999987 6799999999999999999999999853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=235.19 Aligned_cols=150 Identities=31% Similarity=0.559 Sum_probs=125.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|||++++++.+.+...+|++||||.||+|.+.+.....+++. .+..++.|++.||.|||+
T Consensus 71 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~i~~qi~~al~~lH~ 139 (486)
T 3mwu_A 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----------DAARIIKQVFSGITYMHK 139 (486)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 466677889999999999999999999999999999999999876665543 345577899999999999
Q ss_pred cCcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+||+||||||+||+++. .+.+++ +|||+++...... .....+||+.|+
T Consensus 140 ~~ivH~Dlkp~Nil~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y~ 190 (486)
T 3mwu_A 140 HNIVHRDLKPENILLESKEKDCDIKI----------------------------IDFGLSTCFQQNT-KMKDRIGTAYYI 190 (486)
T ss_dssp TTCCCSCCSGGGEEESSSSTTCCEEE----------------------------CSCSCTTTBCCC-----CCTTGGGGC
T ss_pred CCeEeccCchHHEEEecCCCCCCEEE----------------------------EECCcCeECCCCC-ccCCCcCCCCCC
Confidence 99999999999999964 345666 5999987664432 334568999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+ .|+.++|+||+||++|+|++|..||.
T Consensus 191 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 191 APEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp CGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999986 48999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=235.57 Aligned_cols=151 Identities=32% Similarity=0.593 Sum_probs=127.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|||++++++.+++....|+|||||.||+|.+.+..+..+++. .+..++.|++.||.|||+
T Consensus 86 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~-----------~~~~i~~qi~~~l~~lH~ 154 (494)
T 3lij_A 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV-----------DAAVIIKQVLSGVTYLHK 154 (494)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 466778889999999999999999999999999999999998876655543 234577889999999999
Q ss_pred cCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+||+||||||+||+++..+ .+++ +|||+++...... .....+||+.|+
T Consensus 155 ~~ivH~Dlkp~Nil~~~~~~~~~~kl----------------------------~DfG~a~~~~~~~-~~~~~~gt~~y~ 205 (494)
T 3lij_A 155 HNIVHRDLKPENLLLESKEKDALIKI----------------------------VDFGLSAVFENQK-KMKERLGTAYYI 205 (494)
T ss_dssp TTEECSCCSGGGEEESCSSTTCCEEE----------------------------CCCTTCEECBTTB-CBCCCCSCTTTC
T ss_pred CCceeccCChhhEEEeCCCCCCcEEE----------------------------EECCCCeECCCCc-cccccCCCcCee
Confidence 9999999999999997643 3666 5999987664432 334578999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+ .|+.++|+||+||++|+|++|..||..
T Consensus 206 aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 206 APEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp CHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999874 689999999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=229.05 Aligned_cols=151 Identities=23% Similarity=0.446 Sum_probs=125.5
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++..+.|+|++++++.+.+.+..|+||||+.||+|.+.+.... .+++ ..+..++.|++.||.|||+
T Consensus 137 ~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~-----------~~~~~i~~qi~~aL~~LH~ 205 (373)
T 2x4f_A 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE-----------LDTILFMKQICEGIRHMHQ 205 (373)
T ss_dssp HHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 445667789999999999999999999999999999998886532 2222 2344577899999999999
Q ss_pred cCcccccCCCCceee--CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLL--DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
+||+||||||+||++ +..+.+++ +|||+++...... .....+||+.|+|
T Consensus 206 ~~ivH~Dlkp~NIll~~~~~~~~kl----------------------------~DFG~a~~~~~~~-~~~~~~gt~~y~a 256 (373)
T 2x4f_A 206 MYILHLDLKPENILCVNRDAKQIKI----------------------------IDFGLARRYKPRE-KLKVNFGTPEFLA 256 (373)
T ss_dssp TTEECCCCCGGGEEEEETTTTEEEE----------------------------CCCSSCEECCTTC-BCCCCCSSCTTCC
T ss_pred CCcccccCCHHHEEEecCCCCcEEE----------------------------EeCCCceecCCcc-ccccccCCCcEeC
Confidence 999999999999998 44556777 5999987765433 2335679999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+..++.++|+|||||++|+|++|..||..
T Consensus 257 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp HHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999988899999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=218.24 Aligned_cols=152 Identities=36% Similarity=0.656 Sum_probs=107.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.+++|.+++.... .+++ +.+..++.|++.||.|||
T Consensus 61 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~qi~~~l~~lH 129 (278)
T 3cok_A 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE-----------NEARHFMHQIITGMLYLH 129 (278)
T ss_dssp HHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4556677789999999999999999999999999999999987642 2322 334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++.++.+++ +|||.+.............+||+.|+||
T Consensus 130 ~~~i~H~dl~p~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aP 181 (278)
T 3cok_A 130 SHGILHRDLTLSNLLLTRNMNIKI----------------------------ADFGLATQLKMPHEKHYTLCGTPNYISP 181 (278)
T ss_dssp HTTEECSSCCGGGEEECTTCCEEE----------------------------CCCTTCEECC------------------
T ss_pred HCCeecCCCCHHHEEEcCCCCEEE----------------------------EeecceeeccCCCCcceeccCCCCcCCc
Confidence 999999999999999999888888 5999887665443344457899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..++.++|+||+||++|+|++|..||.
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp ----------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred chhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999889999999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=223.20 Aligned_cols=155 Identities=22% Similarity=0.419 Sum_probs=125.0
Q ss_pred ceeeeccccccccccccccccCcc--ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK--YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~--~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++.+.+.+ ..|++|||+.||+|.+++........ .....+..++.|++.||.||
T Consensus 57 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--------~~~~~~~~i~~qi~~~L~~L 128 (319)
T 4euu_A 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG--------LPESEFLIVLRDVVGGMNHL 128 (319)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTC--------CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccC--------CCHHHHHHHHHHHHHHHHHH
Confidence 456677888999999999887655 78999999999999999976432100 11233456788999999999
Q ss_pred HHcCcccccCCCCceee----CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 140 HTRGIVFRDLKPENLLL----DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|++||+||||||+||++ +..+.+++ +|||.++...... ...+.+||+
T Consensus 129 H~~~ivH~Dlkp~NIll~~~~~~~~~~kL----------------------------~Dfg~a~~~~~~~-~~~~~~gt~ 179 (319)
T 4euu_A 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKL----------------------------TDFGAARELEDDE-QFVSLYGTE 179 (319)
T ss_dssp HHTTEECSCCSGGGEEEEECTTSCEEEEE----------------------------CCCTTCEECCTTC-CBCCCCSCG
T ss_pred HHCCEecCCCCHHHEEEeccCCCCceEEE----------------------------ccCCCceecCCCC-ceeecccCC
Confidence 99999999999999998 55555666 5999987765433 334567999
Q ss_pred CCccccccc--------CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIK--------NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~--------~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++. +..++.++|+||+||++|+|++|..||..
T Consensus 180 ~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp GGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999986 56789999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=233.91 Aligned_cols=148 Identities=25% Similarity=0.439 Sum_probs=116.2
Q ss_pred eeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
++++..+.|+|++++++.+.+. ..+|+||||+.++ +.+.+.. .+++ ..+..++.|++.||
T Consensus 112 ~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~~--~l~~-----------~~~~~~~~qil~aL 177 (464)
T 3ttj_A 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQM--ELDH-----------ERMSYLLYQMLCGI 177 (464)
T ss_dssp HHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTS--CCCH-----------HHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHhh--cCCH-----------HHHHHHHHHHHHHH
Confidence 4455667899999999998655 4579999999875 5555542 2322 33456788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
.|||++||+||||||+||+++.++.+++ +|||+++...... .....+||+.
T Consensus 178 ~~lH~~~iiHrDlkp~NIll~~~~~~kl----------------------------~DFG~a~~~~~~~-~~~~~~gt~~ 228 (464)
T 3ttj_A 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LDFGLARTAGTSF-MMTPYVVTRY 228 (464)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTTSCEEE----------------------------CCCCCC-----CC-CC----CCCT
T ss_pred HHHHHCCcccCCCChHhEEEeCCCCEEE----------------------------EEEEeeeecCCCc-ccCCCccccc
Confidence 9999999999999999999999998888 5999987664432 3345789999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+|||++.+..|+.++||||+||++|+|++|..||..
T Consensus 229 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-31 Score=229.52 Aligned_cols=152 Identities=23% Similarity=0.281 Sum_probs=122.3
Q ss_pred eeecccccccccccc-------ccccCcc-----------------ceeehhhhhcchhHHHHHHhccCCCccchhhHHH
Q psy3182 64 KLVSRKKKTRQTRLY-------KTFKDSK-----------------YVYMLLEACLGGEVWTILRERTCFDDNAASFITA 119 (255)
Q Consensus 64 kl~~~~~h~~iv~l~-------~~~~~~~-----------------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~ 119 (255)
++++...|+|+++++ +.+++.+ ..|++|||+ +|+|.+++.....+++... .
T Consensus 128 ~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~----~ 202 (377)
T 3byv_A 128 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHK----S 202 (377)
T ss_dssp GGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTH----H
T ss_pred HhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccc----c
Confidence 556666899999998 4444432 389999999 7899999987655554321 1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccc
Q psy3182 120 CVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSK 199 (255)
Q Consensus 120 ~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~ 199 (255)
.....+..++.|++.||.|||++||+||||||+||+++.++.+++ +|||+++
T Consensus 203 l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL----------------------------~DFG~a~ 254 (377)
T 3byv_A 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL----------------------------TGFEHLV 254 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE----------------------------CCGGGCE
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE----------------------------Eechhhe
Confidence 122344557889999999999999999999999999999988888 5999987
Q ss_pred cCCCCCccccccccCCCCcccccccCC-----------CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 200 HLGHSGCKTWTFCGTPEYVAPEIIKNR-----------GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 200 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.... ...+.+| +.|+|||++.+. .|+.++|+|||||++|+|++|..||.
T Consensus 255 ~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~ 314 (377)
T 3byv_A 255 RDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314 (377)
T ss_dssp ETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence 6433 3446678 999999999887 89999999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=217.72 Aligned_cols=153 Identities=27% Similarity=0.551 Sum_probs=131.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++|||+.|++|.+++.....+++. .+..++.|++.||.|||+
T Consensus 65 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~i~~qi~~~l~~lH~ 133 (294)
T 2rku_A 65 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----------EARYYLRQIVLGCQYLHR 133 (294)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 355566778999999999999999999999999999999998876555432 345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ .|||.+..............||+.|+|||
T Consensus 134 ~~i~H~dl~p~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 185 (294)
T 2rku_A 134 NRVIHRDLKLGNLFLNEDLEVKI----------------------------GDFGLATKVEYDGERKKVLCGTPNYIAPE 185 (294)
T ss_dssp TTEECCCCCGGGEEECTTCCEEE----------------------------CCCTTCEECCSTTCCBCCCCSCCSSCCHH
T ss_pred CCccccCCChHhEEEcCCCCEEE----------------------------EeccCceecccCccccccccCCCCcCCcc
Confidence 99999999999999999888888 49998876654443444568999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+|+++|+|++|..||..
T Consensus 186 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp HHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99998899999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=234.66 Aligned_cols=151 Identities=33% Similarity=0.593 Sum_probs=128.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|||++++++.+++...+|+|||||.||+|.+.+.....+++. .+..++.|++.||.|||+
T Consensus 96 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~-----------~~~~i~~qi~~~l~~lH~ 164 (504)
T 3q5i_A 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC-----------DAANIMKQILSGICYLHK 164 (504)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 466777889999999999999999999999999999999999876665543 234577889999999999
Q ss_pred cCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+||+||||||+||+++..+ .+++ +|||+++...... .....+||+.|+
T Consensus 165 ~~ivH~Dlkp~Nil~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y~ 215 (504)
T 3q5i_A 165 HNIVHRDIKPENILLENKNSLLNIKI----------------------------VDFGLSSFFSKDY-KLRDRLGTAYYI 215 (504)
T ss_dssp TTEECSCCSGGGEEESSTTCCSSEEE----------------------------CCCTTCEECCTTS-CBCCCCSCTTTC
T ss_pred CCeEeCCCcHHHEEEecCCCCccEEE----------------------------EECCCCEEcCCCC-ccccccCCcCCC
Confidence 9999999999999998765 3555 5999987665432 334568999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+ .|+.++|+||+||++|+|++|..||..
T Consensus 216 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 216 APEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp CHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999874 589999999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=224.46 Aligned_cols=165 Identities=26% Similarity=0.410 Sum_probs=122.4
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+|++++++.+.+.+..|++||++ |++|.+++.+..... .....+..++.|++.||.|||++||+||||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 163 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG---------FHIEDIKLYCIEILKALNYLRKMSLTHTDL 163 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCC---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 4999999999999999999999999 999999998654211 112335567889999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCcee---eeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCC
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFF---IISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNR 226 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (255)
||+||+++.....+.. ........+.... ...+..+.+|||.++..... ....+||+.|+|||++.+.
T Consensus 164 kp~NIll~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 234 (360)
T 3llt_A 164 KPENILLDDPYFEKSL------ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNL 234 (360)
T ss_dssp SGGGEEESCTTCCEEE------EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTC
T ss_pred CcccEEEccccccccc------cchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCC
Confidence 9999999864321110 0000001111111 11223344699998765432 2356899999999999999
Q ss_pred CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 227 GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 227 ~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.++.++|+||+||++|+|++|..||..
T Consensus 235 ~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 235 GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=221.70 Aligned_cols=152 Identities=28% Similarity=0.517 Sum_probs=129.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.|++|.+++.....+++ +.+..++.|++.||.|||+
T Consensus 65 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~aL~~lH~ 133 (321)
T 2a2a_A 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-----------EEATSFIKQILDGVNYLHT 133 (321)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 45667788899999999999999999999999999999999986544432 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCC----ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 142 RGIVFRDLKPENLLLDNRG----YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
+|++||||||+||+++.++ .+++ +|||.+....... ......||+.|
T Consensus 134 ~~ivH~dikp~NIl~~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~gt~~y 184 (321)
T 2a2a_A 134 KKIAHFDLKPENIMLLDKNIPIPHIKL----------------------------IDFGLAHEIEDGV-EFKNIFGTPEF 184 (321)
T ss_dssp TTEECCCCSGGGEEESCTTSSSCCEEE----------------------------CCCTTCEECCTTC-CCCCCCSCGGG
T ss_pred CCeecCCCChHHEEEecCCCCcCCEEE----------------------------ccCccceecCccc-cccccCCCCCc
Confidence 9999999999999998776 4666 5999887664432 23356799999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999999999999853
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=221.77 Aligned_cols=153 Identities=23% Similarity=0.334 Sum_probs=122.3
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|+|++++++.+.+.+..|++|||+. |+|.+.+..... +++ ..+..++.|++.||.||
T Consensus 49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~-----------~~~~~~~~qi~~aL~~L 116 (324)
T 3mtl_A 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINM-----------HNVKLFLFQLLRGLAYC 116 (324)
T ss_dssp CCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 45777888899999999999999999999999997 488888875432 222 33456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++||+||||||+||+++.++.+++ +|||.++............+||+.|+|
T Consensus 117 H~~~ivH~Dikp~NIl~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~t~~y~a 168 (324)
T 3mtl_A 117 HRQKVLHRDLKPQNLLINERGELKL----------------------------ADFGLARAKSIPTKTYDNEVVTLWYRP 168 (324)
T ss_dssp HHTTEEESSCCGGGEEECTTCCEEE----------------------------CSSSEEECC------------CGGGCC
T ss_pred HHCCccCCCcCHHHEEECCCCCEEE----------------------------ccCcccccccCCccccccccCcccccC
Confidence 9999999999999999999988888 599998766544444445689999999
Q ss_pred cccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 169 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999976 6789999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-31 Score=221.48 Aligned_cols=153 Identities=24% Similarity=0.405 Sum_probs=123.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.|++|..++.....+++ ..+..++.|++.||.|||+
T Consensus 52 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~-----------~~~~~i~~~l~~~l~~lH~ 120 (311)
T 4agu_A 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPE-----------HLVKSITWQTLQAVNFCHK 120 (311)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999998876555443 2345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+.............+||+.|+|||
T Consensus 121 ~~ivH~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 172 (311)
T 4agu_A 121 HNCIHRDVKPENILITKHSVIKL----------------------------CDFGFARLLTGPSDYYDDEVATRWYRSPE 172 (311)
T ss_dssp TTEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECC------------GGGCCHH
T ss_pred CCCcCCCCChhhEEEcCCCCEEE----------------------------eeCCCchhccCcccccCCCcCCccccChH
Confidence 99999999999999999888888 59998876654443444568999999999
Q ss_pred cccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 173 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp HHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9976 6789999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-31 Score=224.19 Aligned_cols=152 Identities=26% Similarity=0.482 Sum_probs=125.4
Q ss_pred CceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++++..+.|+|++++++.+.+ ...+|++|||+.+|+|.+++.. ..+++ ..+..++.|++.||.|
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~-----------~~~~~~~~qi~~~l~~ 152 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSE-----------DQARFYFQDLIKGIEY 152 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCH-----------HHHHHHHHHHHHHHHH
Confidence 45677888899999999999886 5689999999999998765432 22222 3345678899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
||++||+||||||+||+++.++.+++ +|||+++............+||+.|+
T Consensus 153 lH~~~ivH~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~gt~~y~ 204 (298)
T 2zv2_A 153 LHYQKIIHRDIKPSNLLVGEDGHIKI----------------------------ADFGVSNEFKGSDALLSNTVGTPAFM 204 (298)
T ss_dssp HHHTTEECCCCCGGGEEECTTSCEEE----------------------------CCCTTCEECSSSSCEECCCCSCGGGC
T ss_pred HHHCCeeccCCCHHHEEECCCCCEEE----------------------------ecCCCccccccccccccCCcCCcccc
Confidence 99999999999999999999888888 59999877655444445678999999
Q ss_pred ccccccCCC---CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRG---HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~---~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+.. ++.++|+||+||++|+|++|..||.
T Consensus 205 aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999998755 3678999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=230.54 Aligned_cols=150 Identities=25% Similarity=0.451 Sum_probs=119.0
Q ss_pred ceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++..+.|+|++++++.+.+. ..+|+|||++. |+|.++++....+++ ..+..++.|++.||
T Consensus 75 E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~-----------~~~~~i~~qil~aL 142 (432)
T 3n9x_A 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTE-----------EHIKTILYNLLLGE 142 (432)
T ss_dssp HHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCH-----------HHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCH-----------HHHHHHHHHHHHHH
Confidence 46667788899999999988776 57999999876 599999986554543 33556788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-----------
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----------- 205 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----------- 205 (255)
.|||++||+||||||+||+++.++.+++. |||+++......
T Consensus 143 ~~LH~~givHrDlkp~NILl~~~~~~kL~----------------------------DFGla~~~~~~~~~~~~~~~~~~ 194 (432)
T 3n9x_A 143 NFIHESGIIHRDLKPANCLLNQDCSVKVC----------------------------DFGLARTINSEKDTNIVNDLEEN 194 (432)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCCEEEC----------------------------CCTTCEEC---------------
T ss_pred HHHHHCCCCCCCCCHHHeEECCCCCEEEc----------------------------cCCCccccccccccccccccccc
Confidence 99999999999999999999999999885 677665443221
Q ss_pred -----------ccccccccCCCCcccccc-cCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 206 -----------CKTWTFCGTPEYVAPEII-KNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 206 -----------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
....+.+||+.|+|||++ .+..|+.++||||+||++|||++|..||
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 123467899999999996 5567999999999999999999866554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=215.45 Aligned_cols=151 Identities=37% Similarity=0.645 Sum_probs=126.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+.+.....+++. .+..++.|++.||.|||+
T Consensus 59 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~LH~ 127 (279)
T 3fdn_A 59 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ-----------RTATYITELANALSYCHS 127 (279)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 455667778999999999999999999999999999999999876555432 344567889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+...... ......||+.|+|||
T Consensus 128 ~~i~H~dlkp~Nili~~~~~~~l----------------------------~Dfg~~~~~~~~--~~~~~~~~~~y~aPE 177 (279)
T 3fdn_A 128 KRVIHRDIKPENLLLGSAGELKI----------------------------ADFGWSVHAPSS--RRTDLCGTLDYLPPE 177 (279)
T ss_dssp TTCEECCCCGGGEEECTTSCEEE----------------------------CSCCEESCC----------CCCCTTCCHH
T ss_pred CCEecccCChHhEEEcCCCCEEE----------------------------EeccccccCCcc--cccccCCCCCccCHh
Confidence 99999999999999999988888 599988654332 233568999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+|+++|+|++|..||..
T Consensus 178 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=214.60 Aligned_cols=151 Identities=30% Similarity=0.573 Sum_probs=127.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.|++|.+.+.....+++. .+..++.|++.||.|||+
T Consensus 56 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~i~~~i~~~l~~lH~ 124 (277)
T 3f3z_A 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-----------DAARIMKDVLSAVAYCHK 124 (277)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999998876655432 345577889999999999
Q ss_pred cCcccccCCCCceee---CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLL---DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+|++||||||+||++ +..+.+++ +|||.+....... ......||+.|+
T Consensus 125 ~~i~H~dlkp~Nil~~~~~~~~~~~l----------------------------~Dfg~~~~~~~~~-~~~~~~~t~~y~ 175 (277)
T 3f3z_A 125 LNVAHRDLKPENFLFLTDSPDSPLKL----------------------------IDFGLAARFKPGK-MMRTKVGTPYYV 175 (277)
T ss_dssp TTEECCCCSGGGEEESSSSTTCCEEE----------------------------CCCTTCEECCTTS-CBCCCCSCTTTC
T ss_pred CCccCCCCCHHHEEEecCCCCCcEEE----------------------------EecccceeccCcc-chhccCCCCCcc
Confidence 999999999999999 56666776 5999887654432 334567999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+. ++.++|+||+||++|+|++|..||..
T Consensus 176 aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 176 SPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp CHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 99998765 89999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-31 Score=224.97 Aligned_cols=148 Identities=23% Similarity=0.274 Sum_probs=122.7
Q ss_pred eeccccccccccccccccC----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 65 LVSRKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+....|+|++++++.+.+ ....|++|||+ |++|.+++.....+++ ..+..++.|++.||.|||
T Consensus 101 ~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~aL~~LH 168 (345)
T 2v62_A 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK-----------STVLQLGIRMLDVLEYIH 168 (345)
T ss_dssp HHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred hhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3455689999999998877 78999999999 9999999876554443 234567889999999999
Q ss_pred HcCcccccCCCCceeeCCCC--ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-------Ccccccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRG--YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-------GCKTWTF 211 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-------~~~~~~~ 211 (255)
++||+||||||+||+++.++ .+++ +|||+++..... .......
T Consensus 169 ~~~ivH~Dlkp~NIll~~~~~~~~kL----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~~~ 220 (345)
T 2v62_A 169 ENEYVHGDIKAANLLLGYKNPDQVYL----------------------------ADYGLSYRYCPNGNHKQYQENPRKGH 220 (345)
T ss_dssp HTTEECSCCSGGGEEEESSSTTSEEE----------------------------CCCTTCEESSGGGCCCCCCCCGGGCS
T ss_pred hCCeeCCCcCHHHEEEccCCCCcEEE----------------------------EeCCCceecccccccccchhcccccc
Confidence 99999999999999998776 7777 488888654321 1122456
Q ss_pred ccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 221 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 221 NGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp CSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred CCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 89999999999999999999999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=217.71 Aligned_cols=143 Identities=27% Similarity=0.390 Sum_probs=120.7
Q ss_pred ccccccccccccccCcc-----ceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 69 KKKTRQTRLYKTFKDSK-----YVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~-----~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
..|+|++++++.+.+.. .+|++||++. |+|.+++..... +++ ..+..++.|++.||.|||+
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~-----------~~~~~i~~qi~~al~~lH~ 138 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPA-----------ETIKDLMRQFLRGLDFLHA 138 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34999999999887654 5899999997 599999876543 222 3345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+||+++.++.+++ +|||.++...... .....+||+.|+|||
T Consensus 139 ~~ivH~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE 189 (308)
T 3g33_A 139 NCIVHRDLKPENILVTSGGTVKL----------------------------ADFGLARIYSYQM-ALTPVVVTLWYRAPE 189 (308)
T ss_dssp TTCCCSCCCTTTEEECTTSCEEE----------------------------CSCSCTTTSTTCC-CSGGGGCCCSSCCHH
T ss_pred CCcccCCCCHHHEEEcCCCCEEE----------------------------eeCccccccCCCc-ccCCccccccccCch
Confidence 99999999999999999988888 5999987664432 334578999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 190 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 190 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp HHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred HHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=220.88 Aligned_cols=153 Identities=27% Similarity=0.400 Sum_probs=123.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.|+++..++.....+++ ..+..++.|++.||.|||+
T Consensus 74 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~qi~~~l~~LH~ 142 (331)
T 4aaa_A 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY-----------QVVQKYLFQIINGIGFCHS 142 (331)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999888765444433 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.++............+||+.|+|||
T Consensus 143 ~~ivH~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE 194 (331)
T 4aaa_A 143 HNIIHRDIKPENILVSQSGVVKL----------------------------CDFGFARTLAAPGEVYDDEVATRWYRAPE 194 (331)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEE----------------------------CCCTTC------------CCCCCTTCCHH
T ss_pred CCEEccCcChheEEEcCCCcEEE----------------------------EeCCCceeecCCccccCCCcCCccccCcc
Confidence 99999999999999999888888 59998876655444445568999999999
Q ss_pred cccCC-CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNR-GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~-~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+. .++.++|+||+||++|+|++|..||..
T Consensus 195 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99875 789999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-31 Score=221.87 Aligned_cols=152 Identities=30% Similarity=0.578 Sum_probs=119.6
Q ss_pred eeeecc-ccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSR-KKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~-~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++.. ..|+|++++++.+.+.+.+|+||||+.||+|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 61 ~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~~l~~lH~ 129 (316)
T 2ac3_A 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----------EASVVVQDVASALDFLHN 129 (316)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 444444 47999999999999999999999999999999999876655432 344577899999999999
Q ss_pred cCcccccCCCCceeeCCCCc---eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-------cccccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGY---VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-------CKTWTF 211 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-------~~~~~~ 211 (255)
+||+||||||+||+++.++. +++ .|||++....... ......
T Consensus 130 ~~ivH~dlkp~Nil~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~ 181 (316)
T 2ac3_A 130 KGIAHRDLKPENILCEHPNQVSPVKI----------------------------CDFDLGSGIKLNGDCSPISTPELLTP 181 (316)
T ss_dssp TTCCCCCCCGGGEEESCSSSSCSEEE----------------------------CCTTCCC-------------------
T ss_pred CCceeCCCCHHHEEEccCCCcCceEE----------------------------EEccCccccccCCccccccccccccc
Confidence 99999999999999987664 566 4888776543211 122345
Q ss_pred ccCCCCcccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 212 CGTPEYVAPEIIKN-----RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 212 ~gt~~y~aPE~~~~-----~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 182 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 79999999999975 4588999999999999999999999853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=222.74 Aligned_cols=153 Identities=26% Similarity=0.309 Sum_probs=123.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|+||||+.||+|.++++... .+++ ..+..++.|++.||.|||
T Consensus 100 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~~L~~LH 168 (325)
T 3kul_A 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI-----------MQLVGMLRGVGAGMRYLS 168 (325)
T ss_dssp HHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3455667789999999999999999999999999999999996542 2222 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~~y 217 (255)
++||+||||||+||+++.++.+++ +|||.++........ .....||+.|
T Consensus 169 ~~~ivH~Dlkp~NIll~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~t~~y 220 (325)
T 3kul_A 169 DLGYVHRDLAARNVLVDSNLVCKV----------------------------SDFGLSRVLEDDPDAAYTTTGGKIPIRW 220 (325)
T ss_dssp HTTEECSCCSGGGEEECTTCCEEE----------------------------CCCSSCEECC----CCEECC---CCGGG
T ss_pred HCCeeCCCCCcceEEECCCCCEEE----------------------------CCCCcccccccCccceeeccCCCCcccc
Confidence 999999999999999999888888 599988765443221 1223467789
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 221 ~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp SCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 99999998889999999999999999998 9999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=223.57 Aligned_cols=164 Identities=32% Similarity=0.519 Sum_probs=124.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCcc-----------------------------
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDN----------------------------- 112 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~----------------------------- 112 (255)
+++++..+.|+|++++++.+.+.+..|+|||||.||+|.+.+.........
T Consensus 78 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (345)
T 3hko_A 78 EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF 157 (345)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--C
T ss_pred HHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccc
Confidence 466677788999999999999999999999999999999988531110000
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCC--ceeecccCCcceeeecCCCCCceeeeeCCe
Q psy3182 113 AASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG--YVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190 (255)
Q Consensus 113 ~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (255)
............+..++.|++.||.|||++||+||||||+||+++.++ .+++
T Consensus 158 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl-------------------------- 211 (345)
T 3hko_A 158 RESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL-------------------------- 211 (345)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEE--------------------------
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEE--------------------------
Confidence 000011122345667889999999999999999999999999998765 5666
Q ss_pred eeeeccccccCCCCC----ccccccccCCCCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 191 VKVDFGFSKHLGHSG----CKTWTFCGTPEYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 191 ~~~dfg~s~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||.++...... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 212 --~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 212 --VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp --CCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --eeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 5999886542211 12345679999999999975 6789999999999999999999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=220.71 Aligned_cols=156 Identities=25% Similarity=0.305 Sum_probs=129.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++|||+.||+|.+++..+...... .....+..++.|++.||.|||+
T Consensus 77 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~i~~~i~~~l~~lH~ 149 (326)
T 3uim_A 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP-------LDWPKRQRIALGSARGLAYLHD 149 (326)
T ss_dssp HHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCC-------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCC-------CCHHHHHHHHHHHHHHHHHHHh
Confidence 456778888999999999999999999999999999999999864321111 1122345678899999999999
Q ss_pred c---CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCC
Q psy3182 142 R---GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEY 217 (255)
Q Consensus 142 ~---~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y 217 (255)
+ |++||||||+||+++.++.+++ +|||.++....... ......||+.|
T Consensus 150 ~~~~~ivH~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~gt~~y 201 (326)
T 3uim_A 150 HCDPKIIHRDVKAANILLDEEFEAVV----------------------------GDFGLAKLMDYKDTHVTTAVRGTIGH 201 (326)
T ss_dssp SSSSCEECCCCSGGGEEECTTCCEEE----------------------------CCCSSCEECCSSSSCEECCCCSCGGG
T ss_pred CCCCCeEeCCCchhhEEECCCCCEEe----------------------------ccCccccccCcccccccccccCCcCc
Confidence 9 9999999999999999888888 59998876543322 23345699999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 202 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999988889999999999999999999999984
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=214.85 Aligned_cols=151 Identities=30% Similarity=0.593 Sum_probs=127.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+.+..+..+++. .+..++.|++.||.|||+
T Consensus 55 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~-----------~~~~~~~~i~~~l~~lH~ 123 (284)
T 3kk8_A 55 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----------DASHCIQQILESIAYCHS 123 (284)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677778999999999999999999999999999999988876655543 234567889999999999
Q ss_pred cCcccccCCCCceeeCCCCc---eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRGY---VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+|++||||||+||+++.++. +++ +|||.+....... ......||+.|+
T Consensus 124 ~~i~H~dikp~Nil~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~~~~~y~ 174 (284)
T 3kk8_A 124 NGIVHRNLKPENLLLASKAKGAAVKL----------------------------ADFGLAIEVNDSE-AWHGFAGTPGYL 174 (284)
T ss_dssp TTEECSCCCGGGEEESSSSTTCCEEE----------------------------CCCTTCEECCSSC-BCCCSCSCGGGC
T ss_pred CCcCcCCCCHHHEEEecCCCCCcEEE----------------------------eeceeeEEcccCc-cccCCCCCcCCc
Confidence 99999999999999976554 566 5999887654432 233567999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 175 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=215.25 Aligned_cols=151 Identities=35% Similarity=0.670 Sum_probs=129.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++.++..+.|+|++++++.+.+.+..|++|||+.||+|.+.+.+...+++. .+..++.|++.||.|||+
T Consensus 64 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~ 132 (284)
T 2vgo_A 64 EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ-----------RSATFMEELADALHYCHE 132 (284)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 355666778999999999999999999999999999999999876555432 344577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+...... .....+||+.|+|||
T Consensus 133 ~~i~H~dl~p~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~--~~~~~~~~~~y~aPE 182 (284)
T 2vgo_A 133 RKVIHRDIKPENLLMGYKGELKI----------------------------ADFGWSVHAPSL--RRRTMCGTLDYLPPE 182 (284)
T ss_dssp TTEECCCCSGGGEEECTTCCEEE----------------------------CCCTTCEECSSS--CBCCCCSCGGGCCHH
T ss_pred CCceecCCCHHHEEEcCCCCEEE----------------------------ecccccccCccc--ccccccCCCCcCCHH
Confidence 99999999999999999888888 599987654332 233568999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+|+++|+|++|..||..
T Consensus 183 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-31 Score=229.67 Aligned_cols=161 Identities=26% Similarity=0.429 Sum_probs=117.8
Q ss_pred Cceeeeccccccccccccccc--cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTF--KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~--~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++++..+.|+|++++++.+ .+...+|++|||+.| +|.+.+.......... .........+..++.|++.||.|
T Consensus 67 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~al~~ 143 (405)
T 3rgf_A 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANK--KPVQLPRGMVKSLLYQILDGIHY 143 (405)
T ss_dssp HHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC---------CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccc--cccCCCHHHHHHHHHHHHHHHHH
Confidence 356778888999999999998 567889999999864 7887776432111000 00012234456788999999999
Q ss_pred HHHcCcccccCCCCceee----CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC---cccccc
Q psy3182 139 LHTRGIVFRDLKPENLLL----DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---CKTWTF 211 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---~~~~~~ 211 (255)
||++||+||||||+||++ +..+.+++ +|||+++...... ......
T Consensus 144 LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~ 195 (405)
T 3rgf_A 144 LHANWVLHRDLKPANILVMGEGPERGRVKI----------------------------ADMGFARLFNSPLKPLADLDPV 195 (405)
T ss_dssp HHHTTCCCCCCCGGGEEECCSSTTTTCEEE----------------------------CCTTCCC---------------
T ss_pred HHhCCEeCCCcCHHHeEEecCCCCCCcEEE----------------------------EECCCceecCCCCcccccCCCc
Confidence 999999999999999999 55567777 5999887654321 223457
Q ss_pred ccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 196 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp -CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 89999999999987 458999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=219.64 Aligned_cols=152 Identities=19% Similarity=0.245 Sum_probs=123.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+. .+..|+++||+.||+|.+++... ..+++. .+..++.|++.||.|||
T Consensus 65 e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~-----------~~~~~~~qi~~~l~~lH 132 (325)
T 3kex_A 65 HMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQ-----------LLLNWGVQIAKGMYYLE 132 (325)
T ss_dssp HHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTT-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 455667779999999999886 45689999999999999998753 233332 23456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++.++.+++ +|||.++....... ......||+.|+
T Consensus 133 ~~~ivH~Dikp~Nil~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~~~y~ 184 (325)
T 3kex_A 133 EHGMVHRNLAARNVLLKSPSQVQV----------------------------ADFGVADLLPPDDKQLLYSEAKTPIKWM 184 (325)
T ss_dssp HTTCCCSCCSSTTEEESSSSCEEE----------------------------CSCSGGGGSCCCTTCCC-----CCTTTS
T ss_pred hCCCCCCccchheEEECCCCeEEE----------------------------CCCCcccccCcccccccccCCCCccccc
Confidence 999999999999999999888888 59999987644322 223456888999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 185 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 9999998889999999999999999999 9999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=221.08 Aligned_cols=151 Identities=28% Similarity=0.449 Sum_probs=127.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.+ +|...+.... .+++. .+..++.|++.||.|||
T Consensus 62 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~-----------~~~~~~~qi~~~l~~lH 129 (346)
T 1ua2_A 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS-----------HIKAYMLMTLQGLEYLH 129 (346)
T ss_dssp HHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSS-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 56677788899999999999999999999999986 7888776543 23332 23456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ +|||+++............+||+.|+||
T Consensus 130 ~~~ivH~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~t~~y~aP 181 (346)
T 1ua2_A 130 QHWILHRDLKPNNLLLDENGVLKL----------------------------ADFGLAKSFGSPNRAYTHQVVTRWYRAP 181 (346)
T ss_dssp HTTCCCCCCCGGGEEECTTCCEEE----------------------------CCCGGGSTTTSCCCCCCCSCCCCTTCCH
T ss_pred HCCEECCCCCHHHEEEcCCCCEEE----------------------------EecccceeccCCcccCCcccccccccCc
Confidence 999999999999999999988888 5999998765544444567899999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 182 E~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99976 458899999999999999999998875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=224.39 Aligned_cols=161 Identities=22% Similarity=0.302 Sum_probs=126.8
Q ss_pred eeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch-----hhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 65 LVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-----SFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 65 l~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++..+ .|+|++++++.+.+.+..|+||||+.||+|.+++........... ..........+..++.|++.||.|
T Consensus 127 ~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 206 (382)
T 3tt0_A 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206 (382)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 34444 899999999999999999999999999999999987542110000 000011123455678899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPE 216 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~ 216 (255)
||++||+||||||+||+++.++.+++ +|||.++...... .......||+.
T Consensus 207 LH~~~ivH~Dlkp~NIll~~~~~~kL----------------------------~DFG~a~~~~~~~~~~~~~~~~~t~~ 258 (382)
T 3tt0_A 207 LASKKCIHRDLAARNVLVTEDNVMKI----------------------------ADFGLARDIHHIDYYKKTTNGRLPVK 258 (382)
T ss_dssp HHHTTCCCSCCCGGGEEECTTCCEEE----------------------------CSCSCCCCSSCCCTTCCCTTCCCGGG
T ss_pred HHhCCEecCCCCcceEEEcCCCcEEE----------------------------cccCcccccccccccccccCCCCCcc
Confidence 99999999999999999999988888 5999987664432 12234567889
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 259 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999999999 9888863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=222.83 Aligned_cols=151 Identities=26% Similarity=0.467 Sum_probs=118.8
Q ss_pred ceeeeccccc--cccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKK--TRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h--~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.| +|++++++.+.+...+|++|| +.+|+|.+++.....+++. .+..++.|++.||.||
T Consensus 57 E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~al~~l 124 (343)
T 3dbq_A 57 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW-----------ERKSYWKNMLEAVHTI 124 (343)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCCHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHH
Confidence 4555666655 899999999999999999999 6789999999876655543 2345778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y 217 (255)
|++||+||||||+||+++ ++.+++ +|||+++....... .....+||+.|
T Consensus 125 H~~~iiHrDikp~NIll~-~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~gt~~y 175 (343)
T 3dbq_A 125 HQHGIVHSDLKPANFLIV-DGMLKL----------------------------IDFGIANQMQPDTTSVVKDSQVGTVNY 175 (343)
T ss_dssp HHTTCCCCCCCGGGEEEE-TTEEEE----------------------------CCCSSSCCC------------CCCCSS
T ss_pred HhCCeecCCCCcceEEEE-CCcEEE----------------------------eecccccccCcccccccCCCCcCCcCc
Confidence 999999999999999996 456676 59999876643322 23356899999
Q ss_pred cccccccC-----------CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKN-----------RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~-----------~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 176 ~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp CCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 99999864 6688899999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=226.33 Aligned_cols=150 Identities=26% Similarity=0.469 Sum_probs=118.7
Q ss_pred eeeecccc--ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK--KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~--h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++..+. |+|++++++.+.+.+.+|++|| +.+++|.+++.+...+++. .+..++.|++.||.|||
T Consensus 105 i~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~aL~~lH 172 (390)
T 2zmd_A 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW-----------ERKSYWKNMLEAVHTIH 172 (390)
T ss_dssp HHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 34444554 5999999999999999999999 7899999999876554432 23456789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++ ++.+++ +|||+++....... ...+.+||+.|+
T Consensus 173 ~~~ivHrDlkp~NIll~-~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 223 (390)
T 2zmd_A 173 QHGIVHSDLKPANFLIV-DGMLKL----------------------------IDFGIANQMQPDTTSVVKDSQVGAVNYM 223 (390)
T ss_dssp TTTCCCCCCCGGGEEES-SSCEEE----------------------------CCCSSSCCC---------CCSCCCGGGC
T ss_pred HCCeeecCCCHHHEEEE-CCeEEE----------------------------EecCccccccCCCccccCCCCCcCCCcc
Confidence 99999999999999995 466777 59999876643321 234568999999
Q ss_pred ccccccC-----------CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKN-----------RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~-----------~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 224 aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp CHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 9999975 3688899999999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=224.03 Aligned_cols=164 Identities=23% Similarity=0.351 Sum_probs=125.7
Q ss_pred ceeeeccc-cccccccccccccCcc-ceeehhhhhcchhHHHHHHhccCCC----ccchhh-------------------
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSK-YVYMLLEACLGGEVWTILRERTCFD----DNAASF------------------- 116 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~-~~ylv~E~~~gg~l~~~l~~~~~~~----~~~~~~------------------- 116 (255)
+++++..+ .|+|++++++.+.+.+ .+|++||||.||+|.+++....... +..+.+
T Consensus 75 E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (359)
T 3vhe_A 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLD 154 (359)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------
T ss_pred HHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhcccc
Confidence 34555555 6899999999987754 4899999999999999997643210 000000
Q ss_pred --------------------------------HHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceee
Q psy3182 117 --------------------------------ITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164 (255)
Q Consensus 117 --------------------------------~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l 164 (255)
-.......+..++.|++.||.|||++||+||||||+||+++.++.+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl 234 (359)
T 3vhe_A 155 SITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 234 (359)
T ss_dssp -----------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEE
Confidence 000223445668889999999999999999999999999998888887
Q ss_pred cccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCcccccccCCCCCCcchHHHHHHHHH
Q psy3182 165 EFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242 (255)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ 242 (255)
+|||.++...... .......||+.|+|||++.+..++.++|+||+||++|
T Consensus 235 ----------------------------~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 286 (359)
T 3vhe_A 235 ----------------------------CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286 (359)
T ss_dssp ----------------------------CCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ----------------------------EeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHH
Confidence 5999987653322 2233467899999999999989999999999999999
Q ss_pred HHhc-CCCCCcC
Q psy3182 243 ELLT-GMKESNV 253 (255)
Q Consensus 243 ell~-G~~~~~~ 253 (255)
+|++ |..||..
T Consensus 287 ellt~g~~p~~~ 298 (359)
T 3vhe_A 287 EIFSLGASPYPG 298 (359)
T ss_dssp HHTTTSCCSSTT
T ss_pred HHHhcCCCCCCc
Confidence 9998 9999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=220.20 Aligned_cols=156 Identities=22% Similarity=0.256 Sum_probs=126.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++......... .....+..++.|++.||.|||+
T Consensus 85 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~i~~~i~~~l~~lH~ 157 (321)
T 2qkw_B 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-------MSWEQRLEICIGAARGLHYLHT 157 (321)
T ss_dssp HHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCC-------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccc-------cCHHHHHHHHHHHHHHHHHhcC
Confidence 456677788999999999999999999999999999998888643211100 1123345578899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~a 219 (255)
+|++||||||+||+++.++.+++ +|||.++...... .......||+.|+|
T Consensus 158 ~~ivH~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 209 (321)
T 2qkw_B 158 RAIIHRDVKSINILLDENFVPKI----------------------------TDFGISKKGTELDQTHLSTVVKGTLGYID 209 (321)
T ss_dssp TTEECSCCCSTTEEECTTCCEEE----------------------------CCCTTCEECSSSSCCCCBCCCEEETTTCC
T ss_pred CCeecCCCCHHHEEECCCCCEEE----------------------------eecccccccccccccccccccCCCccccC
Confidence 99999999999999999888888 5999886543221 12234569999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++|..||.
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp HHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred HHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 999988889999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=229.45 Aligned_cols=152 Identities=32% Similarity=0.621 Sum_probs=117.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.. .|++|||+.||+|.+.+.....+++. .+..++.|++.||.|||
T Consensus 189 ~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~-----------~~~~i~~qi~~~l~~LH 256 (419)
T 3i6u_A 189 TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEA-----------TCKLYFYQMLLAVQYLH 256 (419)
T ss_dssp HHHHHHHHCCCTTBCCCCEEEESSE-EEEEEECCTTCBGGGGTSSSCCCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCc-eEEEEEcCCCCcHHHHHhccCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3566778889999999999886654 79999999999999888765554432 34457788999999999
Q ss_pred HcCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
++||+||||||+||+++..+ .+++ +|||+++..... ....+.+||+.|
T Consensus 257 ~~~ivHrDlkp~NIll~~~~~~~~~kl----------------------------~DFG~a~~~~~~-~~~~~~~gt~~y 307 (419)
T 3i6u_A 257 ENGIIHRDLKPENVLLSSQEEDCLIKI----------------------------TDFGHSKILGET-SLMRTLCGTPTY 307 (419)
T ss_dssp HTTCCCSCCCGGGEEESSSSSSCCEEE----------------------------CCSSTTTSCC------------CTT
T ss_pred HCCccccCCChHhEEEecCCCcceEEE----------------------------eecccceecCCC-ccccccCCCCCc
Confidence 99999999999999997654 3666 599999876543 233467899999
Q ss_pred cccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKN---RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~---~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++.+ ..|+.++|+||+||++|+|++|..||..
T Consensus 308 ~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp CCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999864 5678899999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=216.10 Aligned_cols=150 Identities=32% Similarity=0.609 Sum_probs=127.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+.+.....+++. .+..++.|++.||.|||+
T Consensus 56 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~ 124 (304)
T 2jam_A 56 EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK-----------DASLVIQQVLSAVKYLHE 124 (304)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677788999999999999999999999999999999998776555432 344577889999999999
Q ss_pred cCcccccCCCCceee---CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLL---DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+|++||||||+||++ +..+.+++ .|||.++..... .....+||+.|+
T Consensus 125 ~~i~H~dikp~NIl~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~--~~~~~~~~~~y~ 174 (304)
T 2jam_A 125 NGIVHRDLKPENLLYLTPEENSKIMI----------------------------TDFGLSKMEQNG--IMSTACGTPGYV 174 (304)
T ss_dssp TTCCCCSCCGGGCEESSSSTTCCEEB----------------------------CSCSTTCCCCCB--TTHHHHSCCCBC
T ss_pred CCccccCCCHHHEEEecCCCCCCEEE----------------------------ccCCcceecCCC--ccccccCCCCcc
Confidence 999999999999998 55666666 599988654332 233567999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 175 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=221.63 Aligned_cols=149 Identities=25% Similarity=0.505 Sum_probs=125.0
Q ss_pred CceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
.+++++..+.|+|++++++.+.... .+|++|||+ |++|.++++. ..+++ +.+..++.|++.
T Consensus 73 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~-----------~~~~~~~~qi~~ 139 (367)
T 1cm8_A 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGE-----------DRIQFLVYQMLK 139 (367)
T ss_dssp HHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCH-----------HHHHHHHHHHHH
T ss_pred HHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCH-----------HHHHHHHHHHHH
Confidence 3566777888999999999987763 469999999 8999998875 33332 234567889999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
||.|||++||+||||||+||+++.++.+++ +|||+++.... .....+||
T Consensus 140 ~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl----------------------------~Dfg~a~~~~~---~~~~~~~t 188 (367)
T 1cm8_A 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKI----------------------------LDFGLARQADS---EMTGYVVT 188 (367)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTCCEEE----------------------------CCCTTCEECCS---SCCSSCSC
T ss_pred HHHHHHHCCccccCcCHHHEEEcCCCCEEE----------------------------Eeeeccccccc---ccCcCcCC
Confidence 999999999999999999999999988888 59998876543 23356899
Q ss_pred CCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 189 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp GGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999987 7899999999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=222.67 Aligned_cols=151 Identities=23% Similarity=0.348 Sum_probs=123.2
Q ss_pred ceeeeccccccccccccccccCcc----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++..+.|+|++++++.+.+.. .+|++||||.||+|.++++... +++ ..+..++.|++.||.
T Consensus 68 E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~-----------~~~~~i~~qi~~al~ 135 (322)
T 3soc_A 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSW-----------NELCHIAETMARGLA 135 (322)
T ss_dssp HHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BCH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC-CCH-----------HHHHHHHHHHHHHHH
Confidence 455677788999999999988754 3699999999999999997632 322 234567889999999
Q ss_pred HHHHc----------CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-
Q psy3182 138 YLHTR----------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC- 206 (255)
Q Consensus 138 ylH~~----------~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~- 206 (255)
|||++ ||+||||||+||+++..+.+++ +|||.++.......
T Consensus 136 ~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL----------------------------~DFg~a~~~~~~~~~ 187 (322)
T 3soc_A 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI----------------------------ADFGLALKFEAGKSA 187 (322)
T ss_dssp HHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE----------------------------CCCTTCEEECTTSCC
T ss_pred HHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE----------------------------ccCCcccccccccCc
Confidence 99999 9999999999999999988888 49998866543222
Q ss_pred -cccccccCCCCcccccccCC-----CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 207 -KTWTFCGTPEYVAPEIIKNR-----GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 207 -~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 23346899999999999873 45567899999999999999998885
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=215.98 Aligned_cols=153 Identities=23% Similarity=0.274 Sum_probs=118.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|+++|++.|++|.+++.....+++. .+..++.|++.||.|||+
T Consensus 84 e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~~l~~lH~ 152 (309)
T 2h34_A 84 EARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP-----------RAVAIVRQIGSALDAAHA 152 (309)
T ss_dssp HHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 355566778999999999999999999999999999999999876554432 344577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~aP 220 (255)
+||+||||||+||+++.++.+++ +|||.+....... .......||+.|+||
T Consensus 153 ~~i~H~dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 204 (309)
T 2h34_A 153 AGATHRDVKPENILVSADDFAYL----------------------------VDFGIASATTDEKLTQLGNTVGTLYYMAP 204 (309)
T ss_dssp TTCCCSCCCGGGEEECTTSCEEE----------------------------CSCCC----------------CCGGGCCG
T ss_pred CcCCcCCCChHHEEEcCCCCEEE----------------------------ecCccCccccccccccccccCCCcCccCH
Confidence 99999999999999999888888 4888876554322 122345799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+||||+++|+|++|..||..
T Consensus 205 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp GGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred HHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=222.30 Aligned_cols=150 Identities=27% Similarity=0.479 Sum_probs=125.8
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++.+...+++. .+..++.|++.||.|||+.
T Consensus 82 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~i~~~i~~~l~~lh~~ 150 (360)
T 3eqc_A 82 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ-----------ILGKVSIAVIKGLTYLREK 150 (360)
T ss_dssp HGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHH-----------HHHHHHHHHHHHHHHHHHh
Confidence 45566778999999999999999999999999999999999876554432 3455778899999999995
Q ss_pred -CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 143 -GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 -~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
||+||||||+||+++.++.+++ +|||.+...... .....+||+.|+|||
T Consensus 151 ~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~--~~~~~~gt~~y~aPE 200 (360)
T 3eqc_A 151 HKIMHRDVKPSNILVNSRGEIKL----------------------------CDFGVSGQLIDS--MANSFVGTRSYMSPE 200 (360)
T ss_dssp HCCCCSCCSGGGEEECTTCCEEE----------------------------CCCCCCHHHHHH--C----CCCCTTCCHH
T ss_pred CCEEcCCccHHHEEECCCCCEEE----------------------------EECCCCcccccc--cccCCCCCCCeECHH
Confidence 9999999999999999988888 599987544221 223468999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 201 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp HHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=214.78 Aligned_cols=151 Identities=19% Similarity=0.281 Sum_probs=123.7
Q ss_pred eeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++..+ .|+++++++..+.+....|++|||+ |++|.+++..... +++ ..+..++.|++.||.|||
T Consensus 56 ~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH 123 (298)
T 1csn_A 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV-----------KTVAMAAKQMLARVQSIH 123 (298)
T ss_dssp HHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3444444 6899999999999999999999999 9999999976432 322 334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCc-----eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-------cc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGY-----VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-------KT 208 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-------~~ 208 (255)
++||+||||||+||+++.++. +++ +|||.++....... ..
T Consensus 124 ~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~ 175 (298)
T 1csn_A 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYV----------------------------VDFGMVKFYRDPVTKQHIPYREK 175 (298)
T ss_dssp TTTEECCCCCGGGEEECCSSSTTTTCEEE----------------------------CCCTTCEESBCTTTCCBCCCCCC
T ss_pred hCCEecCCCCHHHEEeccCCCCCCCeEEE----------------------------EECccccccccccccccccccCc
Confidence 999999999999999987654 666 58888865543221 23
Q ss_pred cccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 209 WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 209 ~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...+||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 176 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 456799999999999999999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=221.54 Aligned_cols=164 Identities=21% Similarity=0.252 Sum_probs=126.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh-------------hHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS-------------FITACVIEALDFI 128 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~-------------~~~~~~~~~~~~i 128 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++............ .........+..+
T Consensus 100 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 179 (343)
T 1luf_A 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179 (343)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHH
T ss_pred HHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHH
Confidence 345566778999999999999999999999999999999999864321100000 0001122345567
Q ss_pred HHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--c
Q psy3182 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--C 206 (255)
Q Consensus 129 ~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~ 206 (255)
+.|++.||.|||++||+||||||+||+++.++.+++ +|||.++...... .
T Consensus 180 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~ 231 (343)
T 1luf_A 180 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI----------------------------ADFGLSRNIYSADYYK 231 (343)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCSCHHHHTGGGCBC
T ss_pred HHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEE----------------------------eecCCCcccccCcccc
Confidence 889999999999999999999999999998888888 5999876543221 1
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
......||+.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 2234568899999999998889999999999999999999 9988864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=221.60 Aligned_cols=164 Identities=22% Similarity=0.378 Sum_probs=128.4
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhh-----------HHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASF-----------ITACVIEALDFI 128 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~-----------~~~~~~~~~~~i 128 (255)
+++++..+ .|+|++++++.+.+.+..|++|||+.||+|.+++..... +++..... ........+..+
T Consensus 98 E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 177 (344)
T 1rjb_A 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177 (344)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHH
T ss_pred HHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHH
Confidence 34556666 899999999999999999999999999999999976432 11111100 011223445668
Q ss_pred HHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--
Q psy3182 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-- 206 (255)
Q Consensus 129 ~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-- 206 (255)
+.|++.||.|||++||+||||||+||+++.++.+++ +|||.+........
T Consensus 178 ~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~ 229 (344)
T 1rjb_A 178 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI----------------------------CDFGLARDIMSDSNYV 229 (344)
T ss_dssp HHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEE----------------------------CCCGGGSCGGGCTTSE
T ss_pred HHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEe----------------------------CCCccCcccccCccce
Confidence 889999999999999999999999999999888888 59998876533221
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
......||+.|+|||++.+..++.++|+|||||++|+|++ |..||..
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 2234567889999999998889999999999999999998 9999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=217.88 Aligned_cols=164 Identities=20% Similarity=0.260 Sum_probs=129.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch-------------hhHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-------------SFITACVIEALDFI 128 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~i 128 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++........... ..........+..+
T Consensus 76 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 155 (314)
T 2ivs_A 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155 (314)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHH
T ss_pred HHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHH
Confidence 45667778899999999999999999999999999999999986543211000 00001123345667
Q ss_pred HHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--
Q psy3182 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-- 206 (255)
Q Consensus 129 ~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-- 206 (255)
+.|++.||.|||++|++||||||+||+++.++.+++ +|||.++.......
T Consensus 156 ~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~ 207 (314)
T 2ivs_A 156 AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKI----------------------------SDFGLSRDVYEEDSYV 207 (314)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEE----------------------------CCCTTCEECTTTSCEE
T ss_pred HHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEE----------------------------ccccccccccccccce
Confidence 889999999999999999999999999999888888 49998876543322
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
......||+.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 208 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2233467889999999998889999999999999999999 9888853
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=220.87 Aligned_cols=143 Identities=36% Similarity=0.680 Sum_probs=123.0
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccC
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDL 149 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdl 149 (255)
.|+|++++++.+.+.+..|++|||+.||+|.+++.....+++ ..+..++.|++.||.|||++|++||||
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~-----------~~~~~i~~qi~~~L~~LH~~gi~H~Dl 226 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE-----------KETRSIMRSLLEAVSFLHANNIVHRDL 226 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCH-----------HHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 799999999999999999999999999999999986554443 234567789999999999999999999
Q ss_pred CCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC----
Q psy3182 150 KPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN---- 225 (255)
Q Consensus 150 kp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~---- 225 (255)
||+||+++.++.+++ +|||++....... .....+||+.|+|||++.+
T Consensus 227 kp~NIl~~~~~~ikl----------------------------~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 277 (365)
T 2y7j_A 227 KPENILLDDNMQIRL----------------------------SDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDE 277 (365)
T ss_dssp SGGGEEECTTCCEEE----------------------------CCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCT
T ss_pred CHHHEEECCCCCEEE----------------------------EecCcccccCCCc-ccccCCCCCCccChhhccccccc
Confidence 999999999988888 5999887665432 3345789999999999863
Q ss_pred --CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 226 --RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 226 --~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..++.++|+|||||++|+|++|..||.
T Consensus 278 ~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 278 THPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp TSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 368899999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=216.06 Aligned_cols=156 Identities=17% Similarity=0.133 Sum_probs=122.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++.+... +++ ..+..++.|++.||.|||
T Consensus 62 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~~L~~LH 130 (289)
T 4fvq_A 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI-----------LWKLEVAKQLAAAMHFLE 130 (289)
T ss_dssp HHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 35567778899999999999999999999999999999999976432 222 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++..+...+ ...+..|||.+..... .....||+.|+||
T Consensus 131 ~~~ivH~Dlkp~NIll~~~~~~~~~~~--------------------~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aP 186 (289)
T 4fvq_A 131 ENTLIHGNVCAKNILLIREEDRKTGNP--------------------PFIKLSDPGISITVLP----KDILQERIPWVPP 186 (289)
T ss_dssp HTTCCCCCCCGGGEEEEECCBGGGTBC--------------------CEEEECCCCSCTTTSC----HHHHHHTTTTSCH
T ss_pred hCCeECCCcCcceEEEecCCccccccc--------------------ceeeeccCcccccccC----ccccCCcCcccCH
Confidence 999999999999999988776222100 0011259998865432 2345689999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCC-CCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGM-KESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~-~~~~ 252 (255)
|++.+ ..++.++|+||+||++|+|++|. +|+.
T Consensus 187 E~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp HHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 99987 77899999999999999999965 4443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=223.51 Aligned_cols=152 Identities=24% Similarity=0.324 Sum_probs=115.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|+||||+.||+|.+++.+.. .+++ ..+..++.|++.||.|||
T Consensus 96 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~-----------~~~~~i~~qi~~aL~~LH 164 (373)
T 2qol_A 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----------IQLVGMLRGIASGMKYLS 164 (373)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3455667789999999999999999999999999999999997543 2221 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc---cccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT---WTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~---~~~~gt~~y 217 (255)
++||+||||||+||+++.++.+++ +|||+++......... ....+|+.|
T Consensus 165 ~~~ivH~Dlkp~NIll~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~~~~y 216 (373)
T 2qol_A 165 DMGYVHRDLAARNILINSNLVCKV----------------------------SDFGLGRVLEDDPEAAYTTRGGKIPIRW 216 (373)
T ss_dssp HTTCCCSCCCGGGEEECTTCCEEE----------------------------CCC----------------------CTT
T ss_pred HCCeeCCCCCcceEEEcCCCCEEE----------------------------CcCccccccccCCccceeccCCCcCCCc
Confidence 999999999999999999888888 4999887654432211 122357789
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
+|||++.+..++.++|+||+||++|||++ |..||.
T Consensus 217 ~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred cChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 99999998899999999999999999997 999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=216.80 Aligned_cols=153 Identities=29% Similarity=0.518 Sum_probs=129.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++... ..+++ ..+..++.|++.||.|||
T Consensus 74 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~i~~~i~~~l~~lH 142 (314)
T 3com_A 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-----------DEIATILQSTLKGLEYLH 142 (314)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 455667788999999999999999999999999999999998742 23332 234567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++.++.+++ +|||.+..............||+.|+||
T Consensus 143 ~~~i~H~dl~p~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~y~aP 194 (314)
T 3com_A 143 FMRKIHRDIKAGNILLNTEGHAKL----------------------------ADFGVAGQLTDTMAKRNTVIGTPFWMAP 194 (314)
T ss_dssp HTTEECCCCSGGGEEECTTCCEEE----------------------------CCCTTCEECBTTBSCBCCCCSCGGGCCH
T ss_pred hCCCcCCCcCHHHEEECCCCCEEE----------------------------eecccchhhhhhccccCccCCCCCccCh
Confidence 999999999999999999888888 5999887655443344456899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+..++.++|+||+||++|+|++|..||..
T Consensus 195 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp HHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=211.79 Aligned_cols=153 Identities=22% Similarity=0.331 Sum_probs=127.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+....|++|||+.||+|.+++..... +++ ..+..++.|++.||.|||
T Consensus 53 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH 121 (268)
T 3sxs_A 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-----------SQLLEMCYDVCEGMAFLE 121 (268)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 45666777899999999999999999999999999999999976432 322 234567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ +|||.+........ ......||+.|+|
T Consensus 122 ~~~i~H~dikp~Nil~~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 173 (268)
T 3sxs_A 122 SHQFIHRDLAARNCLVDRDLCVKV----------------------------SDFGMTRYVLDDQYVSSVGTKFPVKWSA 173 (268)
T ss_dssp HTTEEESSCSGGGEEECTTCCEEE----------------------------CCTTCEEECCTTCEEECCSCCCCGGGCC
T ss_pred HCCeecCCcCcceEEECCCCCEEE----------------------------ccCccceecchhhhhcccCCCcCcccCC
Confidence 999999999999999999988888 48988876544321 1223456778999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+|+++|+|++ |..||..
T Consensus 174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp HHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred HHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 999998889999999999999999999 9999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=213.32 Aligned_cols=154 Identities=25% Similarity=0.417 Sum_probs=127.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++... ..+++ ..+..++.|++.||.|||
T Consensus 69 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH 137 (283)
T 3gen_A 69 EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLE 137 (283)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677778999999999999999999999999999999999752 22332 234567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ +|||.++....... ......||+.|+|
T Consensus 138 ~~~i~H~dikp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 189 (283)
T 3gen_A 138 SKQFLHRDLAARNCLVNDQGVVKV----------------------------SDFGLSRYVLDDEYTSSVGSKFPVRWSP 189 (283)
T ss_dssp HTTCCCSSCSGGGEEECTTSCEEE----------------------------CSTTGGGGBCCHHHHSTTSTTSCGGGCC
T ss_pred HCCccCCCCccceEEEcCCCCEEE----------------------------ccccccccccccccccccCCccCcccCC
Confidence 999999999999999999888888 59998876543211 1223457788999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcCC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNVF 254 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~~ 254 (255)
||++.+..++.++|+||+||++|+|++ |..||..+
T Consensus 190 PE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999998889999999999999999998 99998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=211.73 Aligned_cols=152 Identities=28% Similarity=0.531 Sum_probs=125.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.|++|.+++.+...+++ +.+..++.|++.||.|||+
T Consensus 58 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~ 126 (283)
T 3bhy_A 58 EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-----------DEATQFLKQILDGVHYLHS 126 (283)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 45667778899999999999999999999999999999999987655543 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCC----ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 142 RGIVFRDLKPENLLLDNRG----YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
+|++||||||+||+++..+ .+++ .|||.+....... ......||+.|
T Consensus 127 ~~i~H~dl~p~Nil~~~~~~~~~~~kl----------------------------~dfg~~~~~~~~~-~~~~~~~~~~y 177 (283)
T 3bhy_A 127 KRIAHFDLKPENIMLLDKNVPNPRIKL----------------------------IDFGIAHKIEAGN-EFKNIFGTPEF 177 (283)
T ss_dssp TTEECSCCSGGGEEESCSSSSSCCEEE----------------------------CCCTTCEECC---------CCCGGG
T ss_pred CCccCCCCChHHEEEecCCCCCCceEE----------------------------EecccceeccCCC-cccccCCCcCc
Confidence 9999999999999998765 4555 5999887654332 22345799999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++.+..++.++|+||+|+++|+|++|..||..
T Consensus 178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=224.59 Aligned_cols=152 Identities=22% Similarity=0.394 Sum_probs=123.9
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++..+.|+|++++++.+.+.+.+|+||||+.||+|.++++.... ++ ...+..++.|++.||.|||+
T Consensus 163 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----------~~~~~~~~~qi~~~l~~LH~ 231 (377)
T 3cbl_A 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR-----------VKTLLQMVGDAAAGMEYLES 231 (377)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCC-----------HHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCC-----------HHHHHHHHHHHHHHHHHHHH
Confidence 3445567899999999999999999999999999999999975431 22 23345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccc--cccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKT--WTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~--~~~~gt~~y~a 219 (255)
+|++||||||+||+++.++.+++ +|||+++......... ....+++.|+|
T Consensus 232 ~~ivHrDlkp~Nil~~~~~~~kl----------------------------~DfG~s~~~~~~~~~~~~~~~~~~~~y~a 283 (377)
T 3cbl_A 232 KCCIHRDLAARNCLVTEKNVLKI----------------------------SDFGMSREEADGVYAASGGLRQVPVKWTA 283 (377)
T ss_dssp TTEECSCCSGGGEEECTTCCEEE----------------------------CCGGGCEECTTSEEECCSSCCEEEGGGSC
T ss_pred CCcCCcccCHHHEEEcCCCcEEE----------------------------CcCCCceecCCCceeecCCCCCCCcCcCC
Confidence 99999999999999999988888 4999887643321111 11235678999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+||++|||++ |..||..
T Consensus 284 PE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred HhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999998889999999999999999998 8898864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=222.22 Aligned_cols=152 Identities=26% Similarity=0.391 Sum_probs=120.2
Q ss_pred ceeeecccccccccccccccc------CccceeehhhhhcchhHHHHHHh---ccCCCccchhhHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK------DSKYVYMLLEACLGGEVWTILRE---RTCFDDNAASFITACVIEALDFITACV 132 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~------~~~~~ylv~E~~~gg~l~~~l~~---~~~~~~~~~~~~~~~~~~~~~~i~~~i 132 (255)
+++++..+.|+|++++++.+. +..++|++|||+.++.+...... ...+++ ..+..++.|+
T Consensus 82 E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~-----------~~~~~~~~qi 150 (394)
T 4e7w_A 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM-----------LLIKLYMYQL 150 (394)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCH-----------HHHHHHHHHH
T ss_pred HHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCH-----------HHHHHHHHHH
Confidence 567778889999999999884 44458999999988654333221 222222 3355678899
Q ss_pred HHHHHHHHHcCcccccCCCCceeeC-CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccc
Q psy3182 133 IEALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTF 211 (255)
Q Consensus 133 l~~l~ylH~~~iiHrdlkp~nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~ 211 (255)
+.||.|||++||+||||||+||+++ ..+.+++ +|||.++...... .....
T Consensus 151 ~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL----------------------------~DFG~a~~~~~~~-~~~~~ 201 (394)
T 4e7w_A 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL----------------------------IDFGSAKILIAGE-PNVSY 201 (394)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE----------------------------CCCTTCEECCTTC-CCCSS
T ss_pred HHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE----------------------------eeCCCcccccCCC-CCccc
Confidence 9999999999999999999999998 6777887 5999987664432 23356
Q ss_pred ccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 212 CGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+||+.|+|||++.+. .|+.++||||+||++|+|++|..||..
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp CSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 899999999999764 589999999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=219.14 Aligned_cols=148 Identities=28% Similarity=0.493 Sum_probs=122.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|+||||+. |++.+.+... ..+++ ..+..++.|++.||.|||
T Consensus 104 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~-----------~~~~~i~~qi~~aL~~LH 171 (348)
T 1u5q_A 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE-----------VEIAAVTHGALQGLAYLH 171 (348)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3555677789999999999999999999999997 5777776532 33332 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+++ +|||.++.... ....+||+.|+||
T Consensus 172 ~~~ivH~Dlkp~NIll~~~~~~kL----------------------------~DfG~a~~~~~----~~~~~gt~~y~aP 219 (348)
T 1u5q_A 172 SHNMIHRDVKAGNILLSEPGLVKL----------------------------GDFGSASIMAP----ANSFVGTPYWMAP 219 (348)
T ss_dssp HTTCBCCCCSGGGEEEETTTEEEE----------------------------CCCTTCBSSSS----BCCCCSCGGGCCH
T ss_pred hCCeeeCCCCHHHEEECCCCCEEE----------------------------eeccCceecCC----CCcccCCcceeCH
Confidence 999999999999999999888888 59998876543 2356899999999
Q ss_pred cccc---CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIK---NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~---~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++. ...++.++|+||+||++|+|++|..||..
T Consensus 220 E~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp HHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9985 46789999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=212.59 Aligned_cols=151 Identities=26% Similarity=0.544 Sum_probs=119.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc----cCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~----~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+.+... ..+++ ..+..++.|++.||.
T Consensus 70 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~-----------~~~~~i~~qi~~~L~ 138 (285)
T 3is5_A 70 EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE-----------GYVAELMKQMMNALA 138 (285)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCH-----------HHHHHHHHHHHHHHH
Confidence 456677889999999999999999999999999999999988643 22222 334567889999999
Q ss_pred HHHHcCcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|||++||+||||||+||+++. .+.+++ +|||.+....... .....+||
T Consensus 139 ~LH~~~ivH~dikp~NIl~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~~t 189 (285)
T 3is5_A 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKI----------------------------IDFGLAELFKSDE-HSTNAAGT 189 (285)
T ss_dssp HHHHTTCCCCCCSGGGEEESSSSTTCCEEE----------------------------CCCCCCCC-----------CTT
T ss_pred HHHhCCEEECCCCHHHEEEecCCCCCCEEE----------------------------EeeecceecCCcc-cCcCcccc
Confidence 999999999999999999954 455666 5999887654332 23456799
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||++. ..++.++|+||+||++|+|++|..||..
T Consensus 190 ~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 190 ALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp GGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 9999999986 4688999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=214.14 Aligned_cols=141 Identities=28% Similarity=0.455 Sum_probs=116.3
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
.|+|++++++.+.+.+.+|++|||+ +|+|.+.+..... +++ ..+..++.|++.||.|||+++|+|||
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~-----------~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE-----------AQVWGYLRDTLLALAHLHSQGLVHLD 182 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCH-----------HHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred CCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHHHCCEecCC
Confidence 7999999999999999999999999 7788888865432 332 33456788999999999999999999
Q ss_pred CCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCC
Q psy3182 149 LKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH 228 (255)
Q Consensus 149 lkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 228 (255)
|||+||+++.++.+++ +|||++....... ......||+.|+|||++.+ .+
T Consensus 183 ikp~NIll~~~~~~kl----------------------------~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~ 232 (311)
T 3p1a_A 183 VKPANIFLGPRGRCKL----------------------------GDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG-SY 232 (311)
T ss_dssp CSGGGEEECGGGCEEE----------------------------CCCTTCEECC-------CCCCCGGGCCGGGGGT-CC
T ss_pred CCHHHEEECCCCCEEE----------------------------ccceeeeecccCC-CCcccCCCccccCHhHhcC-CC
Confidence 9999999999888888 5999887664432 2335679999999999986 68
Q ss_pred CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 229 DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 229 ~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.++|+||+||++|+|++|..||.
T Consensus 233 ~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 233 GTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp STHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999976653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=212.01 Aligned_cols=153 Identities=20% Similarity=0.326 Sum_probs=126.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++..... +++ +.+..++.|++.||.|||
T Consensus 55 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~~i~~~l~~lH 123 (269)
T 4hcu_A 55 EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLE 123 (269)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCH-----------HHHHHHHHHHHHHHHHHH
Confidence 46667788899999999999999999999999999999999975432 222 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-ccccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-~~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ +|||.++...... .......||+.|+|
T Consensus 124 ~~~i~H~dikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 175 (269)
T 4hcu_A 124 EACVIHRDLAARNCLVGENQVIKV----------------------------SDFGMTRFVLDDQYTSSTGTKFPVKWAS 175 (269)
T ss_dssp HTTCCCSCCCGGGEEECGGGCEEE----------------------------CCTTGGGGBCCHHHHSTTSTTCCGGGCC
T ss_pred hCCeecCCcchheEEEcCCCCEEe----------------------------ccccccccccccccccccCcccccccCC
Confidence 999999999999999998888887 5999887654321 11223457788999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 176 PE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 176 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred HHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 999998899999999999999999999 8888863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=215.43 Aligned_cols=164 Identities=22% Similarity=0.271 Sum_probs=128.5
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCc-cchh------hHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDD-NAAS------FITACVIEALDFITACVI 133 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~-~~~~------~~~~~~~~~~~~i~~~il 133 (255)
+++++..+ .|+|++++++.+.+.+..|++|||+.||+|.+++........ .... .........+..++.|++
T Consensus 76 E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~ 155 (313)
T 1t46_A 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155 (313)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHH
T ss_pred HHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHH
Confidence 34556666 899999999999999999999999999999999976432100 0000 000112344566788999
Q ss_pred HHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--ccccc
Q psy3182 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTF 211 (255)
Q Consensus 134 ~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~ 211 (255)
.||.|||++|++||||||+||+++.++.+++ +|||.+........ .....
T Consensus 156 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~ 207 (313)
T 1t46_A 156 KGMAFLASKNCIHRDLAARNILLTHGRITKI----------------------------CDFGLARDIKNDSNYVVKGNA 207 (313)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEEETTTEEEE----------------------------CCCGGGSCTTSCTTSEECSSS
T ss_pred HHHHHHHHCCeecCCCccceEEEcCCCCEEE----------------------------ccccccccccccccceeccCC
Confidence 9999999999999999999999998888888 59999876654322 12345
Q ss_pred ccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 212 CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
.||+.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 208 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 67889999999998899999999999999999998 8888863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=221.23 Aligned_cols=164 Identities=21% Similarity=0.351 Sum_probs=127.6
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhH---HHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI---TACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++..+ .|+|++++++.+.+.+..|++|||+.||+|.+++.......+....+. .......+..++.|++.||.
T Consensus 99 E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 178 (333)
T 2i1m_A 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178 (333)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 34556666 799999999999999999999999999999999976432111111000 01122345567889999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~ 215 (255)
|||++||+||||||+||+++.++.+++ +|||.++....... ......||+
T Consensus 179 ~lH~~~ivH~Dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T 2i1m_A 179 FLASKNCIHRDVAARNVLLTNGHVAKI----------------------------GDFGLARDIMNDSNYIVKGNARLPV 230 (333)
T ss_dssp HHHHTTEECSCCSGGGCEEEGGGEEEB----------------------------CCCGGGCCGGGCTTSEECSSCEECG
T ss_pred HHhcCCcccCCcccceEEECCCCeEEE----------------------------CccccccccccccceeecCCCCCCc
Confidence 999999999999999999998888887 59998875533221 123356788
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
.|+|||++.+..++.++|+|||||++|+|++ |..||..
T Consensus 231 ~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999998889999999999999999998 8888863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=219.40 Aligned_cols=152 Identities=22% Similarity=0.390 Sum_probs=121.9
Q ss_pred ceeeeccccccccccccccccC--------ccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--------SKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACV 132 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--------~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~i 132 (255)
+++++..+.|+|++++++.+.+ .+.+|+||||+.| ++.+.+... ..+++ ..+..++.|+
T Consensus 66 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~-----------~~~~~i~~qi 133 (351)
T 3mi9_A 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL-----------SEIKRVMQML 133 (351)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCH-----------HHHHHHHHHH
T ss_pred HHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCH-----------HHHHHHHHHH
Confidence 5667778889999999998876 4468999999986 666666543 22322 3355678899
Q ss_pred HHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC----Cccc
Q psy3182 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS----GCKT 208 (255)
Q Consensus 133 l~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~----~~~~ 208 (255)
+.||.|||++||+||||||+||+++.++.+++ +|||.++..... ....
T Consensus 134 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~ 185 (351)
T 3mi9_A 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKL----------------------------ADFGLARAFSLAKNSQPNRY 185 (351)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECCCCSSSSCCCC
T ss_pred HHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEE----------------------------ccchhccccccccccccccc
Confidence 99999999999999999999999999988888 589988655321 1223
Q ss_pred cccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 209 WTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 209 ~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp CSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 45679999999999976 5689999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=219.94 Aligned_cols=149 Identities=26% Similarity=0.450 Sum_probs=114.2
Q ss_pred ceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+.|+|++++++.+.+.+ .+|+||||+.| +|.+.+.. .+++ ..+..++.|++.|
T Consensus 74 E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~-----------~~~~~i~~qi~~a 139 (371)
T 2xrw_A 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDH-----------ERMSYLLYQMLCG 139 (371)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS--CCCH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh--ccCH-----------HHHHHHHHHHHHH
Confidence 456677778999999999887665 78999999975 67777752 2222 2345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ +|||.++...... .....+||+
T Consensus 140 l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~gt~ 190 (371)
T 2xrw_A 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LDFGLARTAGTSF-MMTPYVVTR 190 (371)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTSCEEE----------------------------CCCCC-----------------C
T ss_pred HHHHHHCCeecccCCHHHEEEcCCCCEEE----------------------------EEeeccccccccc-ccCCceecC
Confidence 99999999999999999999999988888 5999887654322 233568999
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 191 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp TTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=220.15 Aligned_cols=151 Identities=20% Similarity=0.298 Sum_probs=113.8
Q ss_pred eeeeccccccccccccccc-cCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTF-KDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~-~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++..+.|+|++++++.+ .+.+..|++|||+.||+|.++++.... ++ ...+..++.|++.||.|||
T Consensus 141 ~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----------~~~~~~i~~qi~~aL~~LH 209 (373)
T 3c1x_A 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT-----------VKDLIGFGLQVAKGMKFLA 209 (373)
T ss_dssp HTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCB-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4456677899999999974 556788999999999999999975432 21 1234456789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----cccccccCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC----KTWTFCGTPE 216 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~----~~~~~~gt~~ 216 (255)
++||+||||||+||+++.++.+++ +|||+++....... ......||+.
T Consensus 210 ~~~ivHrDlkp~NIll~~~~~~kL----------------------------~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 261 (373)
T 3c1x_A 210 SKKFVHRDLAARNCMLDEKFTVKV----------------------------ADFGLARDMYDKEFDSVHNKTGAKLPVK 261 (373)
T ss_dssp HTTCCCSCCCGGGEEECTTCCEEE----------------------------CCC---------------------CCGG
T ss_pred HCCEecCccchheEEECCCCCEEE----------------------------eeccccccccccccccccccCCCCCccc
Confidence 999999999999999999988888 48998875533211 1223467889
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|+|||++.+..++.++|+||+||++|+|++ |.+||.
T Consensus 262 y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 999999999999999999999999999999 567765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=226.74 Aligned_cols=155 Identities=22% Similarity=0.418 Sum_probs=124.0
Q ss_pred ceeeeccccccccccccccccCcc--ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK--YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~--~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++.+.+.+ ..|++||||.||+|.+++........ .....+..++.|++.||.||
T Consensus 57 E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------l~~~~~~~i~~qi~~aL~~L 128 (396)
T 4eut_A 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG--------LPESEFLIVLRDVVGGMNHL 128 (396)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTC--------CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccC--------CCHHHHHHHHHHHHHHHHHH
Confidence 456677888999999999887655 78999999999999999875432100 11233456788999999999
Q ss_pred HHcCcccccCCCCceee----CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 140 HTRGIVFRDLKPENLLL----DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|++||+||||||+||++ +..+.+++ +|||.++...... ...+.+||+
T Consensus 129 H~~~ivH~Dlkp~NIll~~~~~~~~~~kL----------------------------~DFG~a~~~~~~~-~~~~~~gt~ 179 (396)
T 4eut_A 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKL----------------------------TDFGAARELEDDE-QFVSLYGTE 179 (396)
T ss_dssp HHTTEECCCCCGGGEEEEECTTSCEEEEE----------------------------CCGGGCEECCCGG-GSSCSSSCC
T ss_pred HHCCEEECCcCHHHEEEeecCCCceeEEE----------------------------ecCCCceEccCCC-ccccccCCc
Confidence 99999999999999998 55555666 5999997765432 334568999
Q ss_pred CCcccccccC--------CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN--------RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~--------~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 180 ~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp TTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred cccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999865 4677899999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=213.24 Aligned_cols=152 Identities=28% Similarity=0.408 Sum_probs=114.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+. .+..|++|||+.||+|.+++.... .+++ ..+..++.|++.||.|||
T Consensus 66 e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~qi~~~l~~lH 133 (281)
T 1mp8_A 66 EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDL-----------ASLILYAYQLSTALAYLE 133 (281)
T ss_dssp HHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 345566778999999999875 457899999999999999997543 2222 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ +|||.++....... ......||+.|+|
T Consensus 134 ~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 185 (281)
T 1mp8_A 134 SKRFVHRDIAARNVLVSSNDCVKL----------------------------GDFGLSRYMEDSTYYKASKGKLPIKWMA 185 (281)
T ss_dssp HTTCCCSCCSGGGEEEEETTEEEE----------------------------CC-------------------CCGGGCC
T ss_pred hCCeecccccHHHEEECCCCCEEE----------------------------CccccccccCcccccccccCCCcccccC
Confidence 999999999999999998888888 59998876543321 1223457789999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 186 PE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 999998889999999999999999996 8889863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=221.61 Aligned_cols=132 Identities=16% Similarity=0.188 Sum_probs=105.3
Q ss_pred cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHH-HHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCcee
Q psy3182 85 KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEAL-DFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 163 (255)
Q Consensus 85 ~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~-~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~ 163 (255)
..+|+||||+. |+|.+++.......+..+.. ...+ ..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~-----~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 234 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDE-----GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLM 234 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHH-----HHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEE
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhh-----hhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEE
Confidence 45899999999 89999998653322222110 0111 34558999999999999999999999999999999888
Q ss_pred ecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC--CCCCCcchHHHHHHHH
Q psy3182 164 LEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN--RGHDRAVDYWALGILM 241 (255)
Q Consensus 164 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiWslGvil 241 (255)
+ +|||+++.... ......||+.|+|||++.+ ..|+.++|+||+||++
T Consensus 235 L----------------------------~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 235 L----------------------------GDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp E----------------------------CCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred E----------------------------EecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 8 59999986643 2224567799999999987 7899999999999999
Q ss_pred HHHhcCCCCCcC
Q psy3182 242 HELLTGMKESNV 253 (255)
Q Consensus 242 ~ell~G~~~~~~ 253 (255)
|+|++|..||..
T Consensus 284 ~elltg~~Pf~~ 295 (371)
T 3q60_A 284 YRVWCLFLPFGL 295 (371)
T ss_dssp HHHHHSSCSTTB
T ss_pred HHHHhCCCCCCC
Confidence 999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=208.98 Aligned_cols=150 Identities=27% Similarity=0.436 Sum_probs=123.9
Q ss_pred ceeeeccccccccccccccccC----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++..+.|+|++++++.+.+ ...+|++|||+.||+|.+++.+...+++ ..+..++.|++.||.
T Consensus 75 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~qi~~~l~ 143 (290)
T 1t4h_A 75 EAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI-----------KVLRSWCRQILKGLQ 143 (290)
T ss_dssp HHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCH-----------HHHHHHHHHHHHHHH
Confidence 4556677789999999987764 5678999999999999999987655443 234557788999999
Q ss_pred HHHHcC--cccccCCCCceeeC-CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 138 YLHTRG--IVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 138 ylH~~~--iiHrdlkp~nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|||+++ ++||||||+||+++ ..+.+++ +|||.+...... ......||
T Consensus 144 ~lH~~~~~i~H~dikp~Nil~~~~~~~~kl----------------------------~Dfg~~~~~~~~--~~~~~~~t 193 (290)
T 1t4h_A 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKI----------------------------GDLGLATLKRAS--FAKAVIGT 193 (290)
T ss_dssp HHHTSSSCCCCSCCCGGGEEESSTTSCEEE----------------------------CCTTGGGGCCTT--SBEESCSS
T ss_pred HHHcCCCCEEECCCCHHHEEEECCCCCEEE----------------------------eeCCCccccccc--ccccccCC
Confidence 999999 99999999999997 6677777 599998654433 23356799
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||++.+ .++.++|+||+||++|+|++|..||..
T Consensus 194 ~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 99999998875 489999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=219.46 Aligned_cols=152 Identities=23% Similarity=0.416 Sum_probs=121.1
Q ss_pred Cceeeeccccccccccccccc--------------------------------------cCccceeehhhhhcchhHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTF--------------------------------------KDSKYVYMLLEACLGGEVWTI 102 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~--------------------------------------~~~~~~ylv~E~~~gg~l~~~ 102 (255)
.+++++..+.|+|++++++.+ .+..++|+||||+.| +|.+.
T Consensus 49 ~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~ 127 (383)
T 3eb0_A 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127 (383)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHH
T ss_pred HHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHH
Confidence 457778888999999999987 344568999999985 76666
Q ss_pred HHh----ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeC-CCCceeecccCCcceeeecC
Q psy3182 103 LRE----RTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREG 177 (255)
Q Consensus 103 l~~----~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~-~~~~~~l~~~~~~~~~~~~~ 177 (255)
+.. ...+++ ..+..++.|++.||.|||++||+||||||+||+++ ..+.+++
T Consensus 128 l~~~~~~~~~l~~-----------~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl------------- 183 (383)
T 3eb0_A 128 LKSFIRSGRSIPM-----------NLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL------------- 183 (383)
T ss_dssp HHHHHHTTCCCCH-----------HHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEE-------------
T ss_pred HHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEE-------------
Confidence 543 222322 33556788999999999999999999999999997 5677777
Q ss_pred CCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 178 AKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 178 ~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||.++...... .....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus 184 ---------------~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 184 ---------------CDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp ---------------CCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------EECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 5999987664433 23356899999999999874 589999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=211.88 Aligned_cols=162 Identities=30% Similarity=0.508 Sum_probs=122.2
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++........... .......+..++.|++.||.|||
T Consensus 62 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH 138 (303)
T 2vwi_A 62 KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS---GVLDESTIATILREVLEGLEYLH 138 (303)
T ss_dssp ----CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTT---CSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhcccccc---CCCCHHHHHHHHHHHHHHHHHHH
Confidence 456777888999999999999999999999999999999998874211000000 00112345567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-----ccccccccCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-----CKTWTFCGTP 215 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-----~~~~~~~gt~ 215 (255)
++|++||||||+||+++.++.+++ .|||.+....... .......||+
T Consensus 139 ~~~i~H~dl~p~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 190 (303)
T 2vwi_A 139 KNGQIHRDVKAGNILLGEDGSVQI----------------------------ADFGVSAFLATGGDITRNKVRKTFVGTP 190 (303)
T ss_dssp HTTCCCCCCSGGGEEECTTCCEEE----------------------------CCCHHHHHCC---------------CCC
T ss_pred hCCCCCCCCChhhEEEcCCCCEEE----------------------------EeccchheeccCCCccchhhhcccCCCc
Confidence 999999999999999999888888 4999876543321 1223467999
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 191 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp TTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999976 5789999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=226.53 Aligned_cols=152 Identities=24% Similarity=0.343 Sum_probs=122.6
Q ss_pred ceeeeccccccccccccccccCcc-ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK-YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~-~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.. .+|+||||+.||+|.+++++.....- ....+..++.|++.||.|||
T Consensus 236 E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~~~~~qi~~~l~~LH 306 (450)
T 1k9a_A 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---------GGDCLLKFSLDVCEAMEYLE 306 (450)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTC---------CHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCC---------CHHHHHHHHHHHHHHHHHHH
Confidence 345566788999999999865554 79999999999999999986542110 11234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++++||||||+||+++.++.+++ +|||+++..... .....+|+.|+||
T Consensus 307 ~~~ivHrDlkp~Nill~~~~~~kl----------------------------~DfG~a~~~~~~---~~~~~~~~~y~aP 355 (450)
T 1k9a_A 307 GNNFVHRDLAARNVLVSEDNVAKV----------------------------SDFGLTKEASST---QDTGKLPVKWTAP 355 (450)
T ss_dssp HTTEECSCCCGGGEEECTTSCEEE----------------------------CCCTTCEECC---------CCCTTTSCH
T ss_pred hCCeeCCCCCHhhEEECCCCCEEE----------------------------eeCCCccccccc---ccCCCCCcceeCH
Confidence 999999999999999999988888 499988754332 2234678899999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|++.+..++.++|+||+||++|||++ |..||..
T Consensus 356 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp HHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999998 9998863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=222.13 Aligned_cols=150 Identities=27% Similarity=0.469 Sum_probs=118.1
Q ss_pred ceeeecccccccccccccccc------CccceeehhhhhcchhHHHHHHh----ccCCCccchhhHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK------DSKYVYMLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALDFITAC 131 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~------~~~~~ylv~E~~~gg~l~~~l~~----~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (255)
+++++..+.|+|++++++.+. +..+++++|||+.+ ++.+.+.. ...++ ...+..++.|
T Consensus 97 E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~-----------~~~~~~~~~q 164 (420)
T 1j1b_A 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-----------VIYVKLYMYQ 164 (420)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCC-----------HHHHHHHHHH
T ss_pred HHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCC-----------HHHHHHHHHH
Confidence 566777889999999988773 33457899999986 55555542 12222 2334567889
Q ss_pred HHHHHHHHHHcCcccccCCCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc
Q psy3182 132 VIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT 210 (255)
Q Consensus 132 il~~l~ylH~~~iiHrdlkp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~ 210 (255)
++.||.|||++||+||||||+|||++.+ +.+|+ +|||+++...... ....
T Consensus 165 i~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl----------------------------~DFG~a~~~~~~~-~~~~ 215 (420)
T 1j1b_A 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL----------------------------CDFGSAKQLVRGE-PNVS 215 (420)
T ss_dssp HHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEE----------------------------CCCTTCEECCTTC-CCCS
T ss_pred HHHHHHHHHHCCccccCCChhhEEEeCCCCeEEe----------------------------ccchhhhhcccCC-Ccee
Confidence 9999999999999999999999999865 45677 5999998654432 2335
Q ss_pred cccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 211 FCGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+||+.|+|||++.+. .|+.++||||+||++|||++|..||.
T Consensus 216 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 6899999999999764 79999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=212.43 Aligned_cols=152 Identities=31% Similarity=0.539 Sum_probs=129.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|++++++++.+.+....|++|||+.|++|.+++.. ..+++ ..+..++.|++.||.|||+
T Consensus 70 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~-----------~~~~~~~~qi~~~l~~lH~ 137 (303)
T 3a7i_A 70 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDE-----------TQIATILREILKGLDYLHS 137 (303)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34556677899999999999999999999999999999998864 22332 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+..............||+.|+|||
T Consensus 138 ~~i~H~dl~p~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 189 (303)
T 3a7i_A 138 EKKIHRDIKAANVLLSEHGEVKL----------------------------ADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189 (303)
T ss_dssp TTEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECBTTBCCBCCCCSCGGGCCHH
T ss_pred CCCccCCCChheEEECCCCCEEE----------------------------eecccceecCccccccCccCCCcCccCHH
Confidence 99999999999999999888888 59998876655444445678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..++.++|+||+||++|+|++|..||..
T Consensus 190 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 99999999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=219.37 Aligned_cols=152 Identities=23% Similarity=0.348 Sum_probs=121.3
Q ss_pred ceeeeccccccccccccc---------------cccC-ccceeehhhhhcchhHHHHHHhc--cCCCccchhhHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYK---------------TFKD-SKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIE 123 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~---------------~~~~-~~~~ylv~E~~~gg~l~~~l~~~--~~~~~~~~~~~~~~~~~ 123 (255)
+++++..+.|+|+++++. .+.. ....|++|||+ |++|.+++... ..+++ .
T Consensus 92 E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~-----------~ 159 (352)
T 2jii_A 92 EQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE-----------R 159 (352)
T ss_dssp HHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCH-----------H
T ss_pred HHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCH-----------H
Confidence 455667778888887443 3332 67889999999 99999999864 33332 3
Q ss_pred HHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCC--ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccC
Q psy3182 124 ALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG--YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHL 201 (255)
Q Consensus 124 ~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~ 201 (255)
.+..++.|++.||.|||++||+||||||+||+++.++ .+++ +|||.++..
T Consensus 160 ~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl----------------------------~Dfg~a~~~ 211 (352)
T 2jii_A 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTL----------------------------AGYGFAFRY 211 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEE----------------------------CCGGGCBCS
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEE----------------------------ecCcceeec
Confidence 3456788999999999999999999999999999877 6666 599988765
Q ss_pred CCCCc-------cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 202 GHSGC-------KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 202 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 212 CPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp SGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 43211 12345899999999999999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=215.32 Aligned_cols=159 Identities=19% Similarity=0.237 Sum_probs=117.3
Q ss_pred ceeeeccccccccccccccccCccce------eehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYV------YMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~------ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+.|+|++++++.+.+.... |++|||+.||+|.+++.......... ......+..++.|++.|
T Consensus 75 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~~~i~~qi~~a 149 (323)
T 3qup_A 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF-----NLPLQTLVRFMVDIACG 149 (323)
T ss_dssp HHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC-----CCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc-----ccCHHHHHHHHHHHHHH
Confidence 45667778899999999998877665 99999999999999987543111000 01123345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--ccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~g 213 (255)
|.|||++||+||||||+||+++.++.+++ +|||.++....... ......|
T Consensus 150 l~~LH~~~ivH~Dikp~NIli~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~ 201 (323)
T 3qup_A 150 MEYLSSRNFIHRDLAARNCMLAEDMTVCV----------------------------ADFGLSRKIYSGDYYRQGCASKL 201 (323)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECTTSCEEE----------------------------CCCCC-----------------C
T ss_pred HHHHHcCCcccCCCCcceEEEcCCCCEEE----------------------------eeccccccccccccccccccccC
Confidence 99999999999999999999999888888 59998876533221 1223457
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|+.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 202 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 789999999999999999999999999999999 8888864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=215.23 Aligned_cols=151 Identities=24% Similarity=0.400 Sum_probs=116.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+ ..|++|||+.||+|.+++.......... ...+..++.|++.||.|||+
T Consensus 51 E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~--------~~~~~~~~~qi~~~l~~LH~ 120 (307)
T 2eva_A 51 ELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYT--------AAHAMSWCLQCSQGVAYLHS 120 (307)
T ss_dssp HHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCC--------HHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccC--------HHHHHHHHHHHHHHHHHHHh
Confidence 4666778889999999998875 4899999999999999998654321111 12234467789999999999
Q ss_pred ---cCcccccCCCCceeeCCCCc-eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 142 ---RGIVFRDLKPENLLLDNRGY-VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 142 ---~~iiHrdlkp~nil~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
+||+||||||+||+++.++. +++ +|||.+...... .....||+.|
T Consensus 121 ~~~~~ivH~dlkp~NIll~~~~~~~kl----------------------------~Dfg~~~~~~~~---~~~~~gt~~y 169 (307)
T 2eva_A 121 MQPKALIHRDLKPPNLLLVAGGTVLKI----------------------------CDFGTACDIQTH---MTNNKGSAAW 169 (307)
T ss_dssp CSSSCCCCCCCSGGGEEEETTTTEEEE----------------------------CCCCC---------------CCTTS
T ss_pred CCCCCeecCCCChhHEEEeCCCCEEEE----------------------------cccccccccccc---cccCCCCCce
Confidence 89999999999999987765 577 599988654332 2245699999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 170 ~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp SCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred EChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 999999999999999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=214.61 Aligned_cols=152 Identities=22% Similarity=0.329 Sum_probs=120.2
Q ss_pred ceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++..+.|+|++++++.+.+ ...+|++|||+.||+|.+++..... +++ ..+..++.|++.||.|
T Consensus 61 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~qi~~~l~~ 129 (295)
T 3ugc_A 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----------IKLLQYTSQICKGMEY 129 (295)
T ss_dssp HHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCH-----------HHHHHHHHHHHHHHHH
Confidence 4566777889999999998754 3568999999999999999976432 222 2344577899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTP 215 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~ 215 (255)
||++||+||||||+||+++.++.+++ +|||.++....... ......||+
T Consensus 130 lH~~~ivH~Dikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~ 181 (295)
T 3ugc_A 130 LGTKRYIHRDLATRNILVENENRVKI----------------------------GDFGLTKVLPQDKEFFKVKEPGESPI 181 (295)
T ss_dssp HHHTTCCCSCCSGGGEEEEETTEEEE----------------------------CCCCSCC-------------CTTCGG
T ss_pred HhcCCcccCCCCHhhEEEcCCCeEEE----------------------------ccCcccccccCCcceeeeccCCCCcc
Confidence 99999999999999999999888888 59998876543221 122345777
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 182 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred ceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 8999999999999999999999999999999988764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=216.93 Aligned_cols=152 Identities=24% Similarity=0.300 Sum_probs=123.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.. .++++|++.+|+|.+++.+.. .+++ ..+..++.|++.||.|||
T Consensus 67 E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~~qi~~~l~~LH 134 (327)
T 3poz_A 67 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-----------QYLLNWCVQIAKGMNYLE 134 (327)
T ss_dssp HHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 456677889999999999988765 788999999999999997643 2222 234457789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++.++.+++ +|||+++....... ......||+.|+
T Consensus 135 ~~~ivH~Dikp~NIll~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 186 (327)
T 3poz_A 135 DRRLVHRDLAARNVLVKTPQHVKI----------------------------TDFGLAKLLGAEEKEYHAEGGKVPIKWM 186 (327)
T ss_dssp HTTCCCSCCCGGGEEEEETTEEEE----------------------------CCTTHHHHHTTTCC-------CCCGGGS
T ss_pred hCCeeCCCCChheEEECCCCCEEE----------------------------ccCcceeEccCCcccccccCCCcccccc
Confidence 999999999999999999888888 59999876543322 122345788999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 9999999999999999999999999999 9999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=225.29 Aligned_cols=158 Identities=23% Similarity=0.400 Sum_probs=114.5
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++... .|+|++++++.+++.+.+|++||||. |+|.+++.......+.... .....+..++.|++.||.|||
T Consensus 58 E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~----~~~~~~~~i~~qi~~aL~~LH 132 (434)
T 2rio_A 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL----QKEYNPISLLRQIASGVAHLH 132 (434)
T ss_dssp HHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC----------------CCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhh----ccchhHHHHHHHHHHHHHHHH
Confidence 34555544 79999999999999999999999995 6999999865433221110 000112347789999999999
Q ss_pred HcCcccccCCCCceeeCCCC-------------ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-
Q psy3182 141 TRGIVFRDLKPENLLLDNRG-------------YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC- 206 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~-------------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~- 206 (255)
++||+||||||+||+++..+ .+++ +|||+++.......
T Consensus 133 ~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL----------------------------~DFG~a~~~~~~~~~ 184 (434)
T 2rio_A 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI----------------------------SDFGLCKKLDSGQSS 184 (434)
T ss_dssp HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE----------------------------CCCTTCEECCC----
T ss_pred HCCccccCCChHhEEEecCcccccccccCCCceEEEE----------------------------cccccceecCCCCcc
Confidence 99999999999999997643 3344 59999877654322
Q ss_pred ---cccccccCCCCcccccccC-------CCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 207 ---KTWTFCGTPEYVAPEIIKN-------RGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 207 ---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.....+||+.|+|||++.+ ..++.++||||+||++|+|++ |..||.
T Consensus 185 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp ----------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 1234689999999999976 568899999999999999998 888885
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=212.73 Aligned_cols=157 Identities=31% Similarity=0.487 Sum_probs=124.5
Q ss_pred ceeeeccccccccccccccc--cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTF--KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~--~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++.+ .+....|++|||+.||+|.+++......... ...+.+..++.|++.||.||
T Consensus 55 e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~i~~~i~~~l~~l 127 (279)
T 2w5a_A 55 EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-------LDEEFVLRVMTQLTLALKEC 127 (279)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCC-------CCHHHHHHHHHHHHHHHHHH
Confidence 45566777899999999977 4567899999999999999998754321000 11233456788999999999
Q ss_pred HHcC-----cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 140 HTRG-----IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 140 H~~~-----iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
|+++ ++||||||+||+++.++.+++ +|||.++.............||
T Consensus 128 H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~ 179 (279)
T 2w5a_A 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKL----------------------------GDFGLARILNHDTSFAKTFVGT 179 (279)
T ss_dssp HHHC------CCCCCSGGGEEECSSSCEEE----------------------------CCCCHHHHC---CHHHHHHHSC
T ss_pred hcccCCCCeeEEeccchhhEEEcCCCCEEE----------------------------ecCchheeeccccccccccCCC
Confidence 9999 999999999999999888888 5999987665443334456799
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 180 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp CTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 999999999998899999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=207.24 Aligned_cols=148 Identities=16% Similarity=0.201 Sum_probs=120.7
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++..+.|+|++++++.+.+. ...|++|||+.||+|.+++.+... +++ ..+..++.|++.||.
T Consensus 57 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-----------~~~~~i~~qi~~~l~ 125 (271)
T 3kmu_A 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ-----------SQAVKFALDMARGMA 125 (271)
T ss_dssp HGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCH-----------HHHHHHHHHHHHHHH
Confidence 46667778899999999998887 789999999999999999986542 222 234557789999999
Q ss_pred HHHHcC--cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 138 YLHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~--iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|||+++ ++||||||+||+++.++..++. |||++.... .....||+
T Consensus 126 ~lH~~~~~i~H~dikp~Nil~~~~~~~~l~----------------------------~~~~~~~~~-----~~~~~~t~ 172 (271)
T 3kmu_A 126 FLHTLEPLIPRHALNSRSVMIDEDMTARIS----------------------------MADVKFSFQ-----SPGRMYAP 172 (271)
T ss_dssp HHTTSSSCCTTCCCSGGGEEECTTSCEEEE----------------------------GGGSCCTTS-----CTTCBSCG
T ss_pred HHhcCCCceecCCCccceEEEcCCcceeEE----------------------------eccceeeec-----ccCccCCc
Confidence 999999 9999999999999988877773 444433221 12357899
Q ss_pred CCcccccccCCCCCC---cchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDR---AVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~---~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+..++. ++|+||+||++|+|++|..||..
T Consensus 173 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp GGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred cccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999998766554 79999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=208.75 Aligned_cols=152 Identities=28% Similarity=0.513 Sum_probs=119.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++||++.|++|.+++.+...+++ ..+..++.|++.||.|||+
T Consensus 61 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~qi~~~l~~lH~ 129 (276)
T 2h6d_A 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----------MEARRLFQQILSAVDYCHR 129 (276)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 34556677899999999999999999999999999999999987655443 2344577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+....... .....+||+.|+|||
T Consensus 130 ~~i~H~dl~p~Nil~~~~~~~~l----------------------------~dfg~~~~~~~~~-~~~~~~~~~~y~aPE 180 (276)
T 2h6d_A 130 HMVVHRDLKPENVLLDAHMNAKI----------------------------ADFGLSNMMSDGE-FLRTSCGSPNYAAPE 180 (276)
T ss_dssp HCSSCCCCCGGGEEECTTSCEEE----------------------------CCCCGGGCCCC--------------CCTG
T ss_pred CCCccCCCChhhEEECCCCCEEE----------------------------eecccccccCCCc-ceecccCCccccCHH
Confidence 99999999999999999888887 5999887654432 233567999999999
Q ss_pred cccCCCC-CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGH-DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~-~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+..+ +.++|+||+|+++|+|++|..||..
T Consensus 181 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp GGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9988766 5789999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=211.52 Aligned_cols=155 Identities=23% Similarity=0.330 Sum_probs=128.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++........ ....+..++.|++.||.|||+
T Consensus 59 E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~---------~~~~~~~i~~~i~~~l~~lH~ 129 (288)
T 3kfa_A 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---------SAVVLLYMATQISSAMEYLEK 129 (288)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTS---------CHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCc---------cHhHHHHHHHHHHHHHHHHHH
Confidence 45667778899999999999999999999999999999999976432111 112345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aP 220 (255)
+|++||||||+||+++.++.+++ +|||.+........ ......||+.|+||
T Consensus 130 ~~i~H~dikp~Nil~~~~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 181 (288)
T 3kfa_A 130 KNFIHRDLAARNCLVGENHLVKV----------------------------ADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181 (288)
T ss_dssp HTCCCSCCSGGGEEECGGGCEEE----------------------------CCCCGGGTSCSSSSEEETTEEECGGGCCH
T ss_pred CCccCCCCCcceEEEcCCCCEEE----------------------------ccCccceeccCCccccccCCccccCcCCh
Confidence 99999999999999998888887 59999876654322 22334678899999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|++.+..++.++|+||+|+++|+|++ |..||..
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99998899999999999999999999 8888863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=228.60 Aligned_cols=154 Identities=23% Similarity=0.332 Sum_probs=125.4
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++..+.|+|++++++.+.+...+|+||||+.||+|.++++....... ....+..++.|++.||.|||++
T Consensus 267 ~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~---------~~~~~~~i~~qi~~~L~~LH~~ 337 (495)
T 1opk_A 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---------SAVVLLYMATQISSAMEYLEKK 337 (495)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTS---------CHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCC---------CHHHHHHHHHHHHHHHHHHHhC
Confidence 3445667899999999999999999999999999999999976432111 1123455778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE 221 (255)
||+||||||+||+++.++.+|+ +|||+++....... ......+|+.|+|||
T Consensus 338 ~ivHrDlkp~NIll~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE 389 (495)
T 1opk_A 338 NFIHRNLAARNCLVGENHLVKV----------------------------ADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389 (495)
T ss_dssp TEECSCCSGGGEEECGGGCEEE----------------------------CCTTCEECCTTCCEECCTTCCCCGGGCCHH
T ss_pred CcccCCCChhhEEECCCCcEEE----------------------------eecccceeccCCceeecCCCcCCcceeCHh
Confidence 9999999999999998888888 59999876543221 122345677899999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
++.+..++.++|+|||||++|||++ |..||..
T Consensus 390 ~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred HHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 9998889999999999999999999 8888853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=216.52 Aligned_cols=144 Identities=32% Similarity=0.565 Sum_probs=117.6
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhc--cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~--~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
.|++++++++.+++.+..|++|||+.||+|.+++... ..+++ ..+..++.|++.||.|||++||+||
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-----------~~~~~i~~ql~~~L~~LH~~givH~ 155 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-----------NDVIRLIKQILEGVYYLHQNNIVHL 155 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCH-----------HHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHHHHHCCeecC
Confidence 4699999999999999999999999999999887542 22222 2345678899999999999999999
Q ss_pred cCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccccc
Q psy3182 148 DLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224 (255)
Q Consensus 148 dlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~ 224 (255)
||||+||+++. .+.+++ +|||.++...... .....+||+.|+|||++.
T Consensus 156 Dikp~NIl~~~~~~~~~~kL----------------------------~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 206 (327)
T 3lm5_A 156 DLKPQNILLSSIYPLGDIKI----------------------------VDFGMSRKIGHAC-ELREIMGTPEYLAPEILN 206 (327)
T ss_dssp CCCGGGEEESCBTTBCCEEE----------------------------CCGGGCEEC----------CCCGGGCCHHHHT
T ss_pred cCChHHEEEecCCCCCcEEE----------------------------eeCccccccCCcc-ccccccCCcCccCCeeec
Confidence 99999999987 566666 5999987664432 234568999999999999
Q ss_pred CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 225 NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 225 ~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+..++.++|+|||||++|+|++|..||..
T Consensus 207 ~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 207 YDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=220.63 Aligned_cols=141 Identities=26% Similarity=0.475 Sum_probs=119.6
Q ss_pred cccccccccccccCccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
.|+|++++++.+...+.++++||++. ++|.+++..... ++ ...+..++.|++.||.|||++||+||
T Consensus 157 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~-----------~~~~~~i~~qi~~aL~~LH~~~ivHr 224 (429)
T 3kvw_A 157 NTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFS-----------LPLVRKFAHSILQCLDALHKNRIIHC 224 (429)
T ss_dssp SCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCC-----------HHHHHHHHHHHHHHHHHHHHHTEECS
T ss_pred CCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCC-----------HHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 57799999999999999999999996 589988876432 22 22345678899999999999999999
Q ss_pred cCCCCceeeCCCCc--eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC
Q psy3182 148 DLKPENLLLDNRGY--VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN 225 (255)
Q Consensus 148 dlkp~nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (255)
||||+||+++.++. +++ +|||++..... ...+.+||+.|+|||++.+
T Consensus 225 DlKp~NILl~~~~~~~vkL----------------------------~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 225 DLKPENILLKQQGRSGIKV----------------------------IDFGSSCYEHQ---RVYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp CCSGGGEEESSTTSCCEEE----------------------------CCCTTCEETTC---CCCSSCSCGGGCCHHHHHT
T ss_pred CCCHHHeEEccCCCcceEE----------------------------eecccceecCC---cccccCCCCCccChHHHhC
Confidence 99999999998876 666 59999865433 2345789999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 226 RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 226 ~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..|+.++||||+||++|+|++|.+||..
T Consensus 274 ~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 274 ARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp BCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999853
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=216.56 Aligned_cols=163 Identities=20% Similarity=0.312 Sum_probs=125.3
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhH-----HHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI-----TACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+ .|+|++++++.+.+.+..|++|||+.||+|.+++.............. .......+..++.|++.|
T Consensus 75 E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~a 154 (327)
T 1fvr_A 75 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154 (327)
T ss_dssp HHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHH
Confidence 34556666 899999999999999999999999999999999976531111000000 011234456678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ +|||+++...... ......+|+
T Consensus 155 L~~LH~~~ivH~dlkp~NIl~~~~~~~kL----------------------------~Dfg~~~~~~~~~-~~~~~~~~~ 205 (327)
T 1fvr_A 155 MDYLSQKQFIHRDLAARNILVGENYVAKI----------------------------ADFGLSRGQEVYV-KKTMGRLPV 205 (327)
T ss_dssp HHHHHHTTEECSCCSGGGEEECGGGCEEE----------------------------CCTTCEESSCEEC-CC----CCT
T ss_pred HHHHHhCCccCCCCccceEEEcCCCeEEE----------------------------cccCcCccccccc-cccCCCCCc
Confidence 99999999999999999999998888888 5999876433211 122345788
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 206 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp TTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 9999999998889999999999999999998 9999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=211.30 Aligned_cols=152 Identities=23% Similarity=0.397 Sum_probs=114.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++. ......+++|||+.|++|.+.+.... .++ ...+..++.|++.||.|||
T Consensus 70 E~~~l~~l~h~~iv~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~i~~qi~~~L~~lH 137 (289)
T 3og7_A 70 EVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFE-----------MKKLIDIARQTARGMDYLH 137 (289)
T ss_dssp HHHHHTTCCCTTBCCEEEE-ECSSSCEEEEECCCEEEHHHHHTTC---CC-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCcEEEEEee-ccCCccEEEEEecCCCcHHHHHhhccCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 4566778889999999984 45667899999999999999986432 222 1234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--CccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~gt~~y~ 218 (255)
++|++||||||+||+++.++.+++ +|||.+...... ........||+.|+
T Consensus 138 ~~~i~H~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 189 (289)
T 3og7_A 138 AKSIIHRDLKSNNIFLHEDNTVKI----------------------------GDFGLATEKSRWSGSHQFEQLSGSILWM 189 (289)
T ss_dssp HTTCCCSCCCGGGEEEETTTEEEE----------------------------CCCC------------------CCCTTC
T ss_pred hCCcccccCccceEEECCCCCEEE----------------------------ccceeccccccccccccccccCCCcccc
Confidence 999999999999999999888888 599988654321 11233467999999
Q ss_pred cccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIK---NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~---~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++. +..++.++|+||+||++|+|++|..||..
T Consensus 190 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp CHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 999997 56788899999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=209.03 Aligned_cols=152 Identities=26% Similarity=0.435 Sum_probs=125.3
Q ss_pred CceeeeccccccccccccccccC----------------ccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD----------------SKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVI 122 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~----------------~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~ 122 (255)
.+++++..+.|+|++++++.+.+ ...+|++|||+.||+|.+++.+.. .+++
T Consensus 53 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----------- 121 (284)
T 2a19_B 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK----------- 121 (284)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCH-----------
T ss_pred HHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCH-----------
Confidence 34666777889999999987754 556899999999999999997542 2222
Q ss_pred HHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCC
Q psy3182 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLG 202 (255)
Q Consensus 123 ~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~ 202 (255)
..+..++.|++.||.|||++|++||||||+||+++.++.+++ +|||.+....
T Consensus 122 ~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~ 173 (284)
T 2a19_B 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI----------------------------GDFGLVTSLK 173 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE----------------------------CCCTTCEESS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE----------------------------Ccchhheecc
Confidence 234457789999999999999999999999999998888887 5999887665
Q ss_pred CCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 203 HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
... ......||+.|+|||++.+..++.++|+||+||++|+|++|..|+.
T Consensus 174 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 174 NDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred ccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 432 2334679999999999999999999999999999999999998763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=221.14 Aligned_cols=152 Identities=24% Similarity=0.388 Sum_probs=115.6
Q ss_pred Cceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 61 ~~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+++++... .|+|++++++.+++.+..|++||+|. |+|.+++..... ..+.. +..++.|++.||.|
T Consensus 66 ~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~-----------~~~i~~qi~~aL~~ 133 (432)
T 3p23_A 66 REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE-----------PITLLQQTTSGLAH 133 (432)
T ss_dssp HHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSC-----------HHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchh-----------HHHHHHHHHHHHHH
Confidence 355666666 79999999999999999999999996 599999876432 22211 12467889999999
Q ss_pred HHHcCcccccCCCCceeeCCC---Cc--eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC---ccccc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNR---GY--VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---CKTWT 210 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~---~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---~~~~~ 210 (255)
||++||+||||||+||+++.+ +. +++ +|||+++...... .....
T Consensus 134 LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL----------------------------~DFG~a~~~~~~~~~~~~~~~ 185 (432)
T 3p23_A 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMI----------------------------SDFGLCKKLAVGRHSFSRRSG 185 (432)
T ss_dssp HHHTTCCCCCCSTTSEEECCCBTTTBCCEEE----------------------------CCTTEEECC------------
T ss_pred HHHCcCEeCCCCHHHEEEecCCCCCceeEEE----------------------------ecccceeeccCCCcceeeccc
Confidence 999999999999999999643 22 334 5999987664322 23345
Q ss_pred cccCCCCccccccc---CCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 211 FCGTPEYVAPEIIK---NRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 211 ~~gt~~y~aPE~~~---~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
.+||+.|+|||++. ...++.++||||+||++|+|++ |..||.
T Consensus 186 ~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred cCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 78999999999997 4567789999999999999999 888875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=213.13 Aligned_cols=152 Identities=28% Similarity=0.514 Sum_probs=116.0
Q ss_pred eeeeccc-cccccccccccccC------ccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKD------SKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVI 133 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~------~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il 133 (255)
++++... .|+|++++++.+.+ ....|++|||+.||+|.+++.... .++ ...+..++.|++
T Consensus 71 ~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~i~~qi~ 139 (326)
T 2x7f_A 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-----------EEWIAYICREIL 139 (326)
T ss_dssp HHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCC-----------HHHHHHHHHHHH
T ss_pred HHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCC-----------HHHHHHHHHHHH
Confidence 3344444 79999999998876 567899999999999999997642 222 233456788999
Q ss_pred HHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc
Q psy3182 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG 213 (255)
Q Consensus 134 ~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g 213 (255)
.||.|||++|++||||||+||+++.++.+++ +|||.+..............|
T Consensus 140 ~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~ 191 (326)
T 2x7f_A 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKL----------------------------VDFGVSAQLDRTVGRRNTFIG 191 (326)
T ss_dssp HHHHHHHHTTCCCCCCSGGGEEECTTCCEEE----------------------------CCCTTTC-------------C
T ss_pred HHHHHHHHCCccccCCcHHHEEEcCCCCEEE----------------------------eeCcCceecCcCccccccccC
Confidence 9999999999999999999999999888888 599988765443333445689
Q ss_pred CCCCccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 214 TPEYVAPEIIK-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+.|+|||++. +..++.++|+|||||++|+|++|..||..
T Consensus 192 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99999999997 56788999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-30 Score=211.59 Aligned_cols=153 Identities=29% Similarity=0.539 Sum_probs=125.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|+++|++.|++|.+.+.....+++ ..+..++.|++.||.|||+
T Consensus 55 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~ 123 (276)
T 2yex_A 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVVYLHG 123 (276)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 35556677899999999999999999999999999999988865444432 2345677899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~a 219 (255)
+|++||||||+||+++.++.+++ +|||.+....... ......+||+.|+|
T Consensus 124 ~~i~H~dl~p~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 175 (276)
T 2yex_A 124 IGITHRDIKPENLLLDERDNLKI----------------------------SDFGLATVFRYNNRERLLNKMCGTLPYVA 175 (276)
T ss_dssp TTEECSCCSGGGEEECTTCCEEE----------------------------CCCTTCEECEETTEECCBCCCCSCGGGCC
T ss_pred CCeeccCCChHHEEEccCCCEEE----------------------------eeCCCccccCCCcchhcccCCccccCccC
Confidence 99999999999999999888888 4888776543211 12335679999999
Q ss_pred cccccCCCC-CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGH-DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~-~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+..+ +.++|+||+||++|+|++|..||..
T Consensus 176 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 210 (276)
T 2yex_A 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (276)
T ss_dssp GGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred hHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 999987665 6789999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-29 Score=213.05 Aligned_cols=159 Identities=22% Similarity=0.371 Sum_probs=118.4
Q ss_pred ccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCC
Q psy3182 73 RQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPE 152 (255)
Q Consensus 73 ~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~ 152 (255)
+++++++.+.+.+..|++|||+ +++|.+++.......- ....+..++.|++.||.|||++||+||||||+
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~---------~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 147 (339)
T 1z57_A 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPF---------RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE 147 (339)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCC---------CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred eeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCC---------cHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 4788899999999999999999 8999999876542111 12334567889999999999999999999999
Q ss_pred ceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCCCcc
Q psy3182 153 NLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAV 232 (255)
Q Consensus 153 nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 232 (255)
||+++..+...... ............+..+.+|||.++.... .....+||+.|+|||++.+..++.++
T Consensus 148 Nil~~~~~~~~~~~---------~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~ 215 (339)
T 1z57_A 148 NILFVQSDYTEAYN---------PKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPC 215 (339)
T ss_dssp GEEESCCCEEEEEC-------------CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHH
T ss_pred HEEEeccccccccC---------CccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcch
Confidence 99998754322110 0000001111122233469999876433 23356899999999999999999999
Q ss_pred hHHHHHHHHHHHhcCCCCCcC
Q psy3182 233 DYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 233 DiWslGvil~ell~G~~~~~~ 253 (255)
|+||+||++|+|++|..||..
T Consensus 216 Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 216 DVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp HHHHHHHHHHHHHHSSCSCCC
T ss_pred hhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=210.58 Aligned_cols=155 Identities=20% Similarity=0.304 Sum_probs=125.6
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++........ .....+..++.|++.||.|||+
T Consensus 80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--------~~~~~~~~i~~~i~~~l~~lH~ 151 (307)
T 2nru_A 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--------LSWHMRCKIAQGAANGINFLHE 151 (307)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCC--------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCC--------CCHHHHHHHHHHHHHHHHHHhc
Confidence 45567778899999999999999999999999999999999874321100 1123345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~a 219 (255)
+|++||||||+||+++.++.+++ +|||.++....... ......||+.|+|
T Consensus 152 ~~i~H~dlkp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 203 (307)
T 2nru_A 152 NHHIHRDIKSANILLDEAFTAKI----------------------------SDFGLARASEKFAQTVMTSRIVGTTAYMA 203 (307)
T ss_dssp TTEECSCCCGGGEEECTTCCEEE----------------------------CCCTTCEECCSCSSCEECSSCCSCGGGCC
T ss_pred CCeecCCCCHHHEEEcCCCcEEE----------------------------eecccccccccccccccccccCCCcCcCC
Confidence 99999999999999999888888 48988765543221 2234579999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++.+. ++.++|+|||||++|+|++|..||..
T Consensus 204 PE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 204 PEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp HHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred hHHhcCC-CCccchhHHHHHHHHHHHHCCCCccc
Confidence 9998764 78999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=211.69 Aligned_cols=155 Identities=32% Similarity=0.516 Sum_probs=124.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.|++|.+++........ .....+..++.|++.||.|||+
T Consensus 69 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~ 140 (295)
T 2clq_A 69 EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK--------DNEQTIGFYTKQILEGLKYLHD 140 (295)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCT--------TCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCC--------ccHHHHHHHHHHHHHHHHHHHh
Confidence 45566778899999999999999999999999999999999976421110 0113345577899999999999
Q ss_pred cCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+|++||||||+||+++. ++.+++ +|||.+..............||+.|+||
T Consensus 141 ~~i~H~dl~p~Nil~~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 192 (295)
T 2clq_A 141 NQIVHRDIKGDNVLINTYSGVLKI----------------------------SDFGTSKRLAGINPCTETFTGTLQYMAP 192 (295)
T ss_dssp TTEECCCCSGGGEEEETTTCCEEE----------------------------CCTTTCEESCC-----CCCCCCGGGCCH
T ss_pred CCEEccCCChhhEEEECCCCCEEE----------------------------eecccccccCCCCCcccccCCCccccCh
Confidence 99999999999999987 677777 5999887665443334466899999999
Q ss_pred ccccCC--CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNR--GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~--~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+. .++.++|+||+||++|+|++|..||.
T Consensus 193 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp HHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred hhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 999764 38889999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=209.16 Aligned_cols=150 Identities=25% Similarity=0.411 Sum_probs=115.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++....|+|++++++.+.+.+..|++|||+.|++|.+++.. ..+++ ..+..++.|++.||.|||+
T Consensus 56 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~-----------~~~~~i~~~l~~~l~~lH~ 123 (271)
T 3dtc_A 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPP-----------DILVNWAVQIARGMNYLHD 123 (271)
T ss_dssp HHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-SCCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-CCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 45566777899999999999999999999999999999998853 23332 2345577899999999999
Q ss_pred cC---cccccCCCCceeeCC--------CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc
Q psy3182 142 RG---IVFRDLKPENLLLDN--------RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT 210 (255)
Q Consensus 142 ~~---iiHrdlkp~nil~~~--------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~ 210 (255)
+| ++||||||+||+++. .+.+++ +|||.++...... ...
T Consensus 124 ~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~--~~~ 173 (271)
T 3dtc_A 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKI----------------------------TDFGLAREWHRTT--KMS 173 (271)
T ss_dssp SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE----------------------------CCCCC-------------
T ss_pred CCCCceeecCCchHHEEEecccccccccCcceEE----------------------------ccCCccccccccc--ccC
Confidence 99 899999999999986 334444 5999887654332 224
Q ss_pred cccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 211 FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..||+.|+|||++.+..++.++|+||+|+++|+|++|..||..
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp --CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5799999999999998899999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=213.05 Aligned_cols=163 Identities=17% Similarity=0.263 Sum_probs=127.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++........... .........+..++.|++.||.|||+
T Consensus 78 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~ 156 (322)
T 1p4o_A 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP-VLAPPSLSKMIQMAGEIADGMAYLNA 156 (322)
T ss_dssp HHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCT-TCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCC-CCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 45667788899999999999999999999999999999999875321100000 00001123445678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCcc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVA 219 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~a 219 (255)
+||+||||||+||+++.++.+++ +|||.++....... ......||+.|+|
T Consensus 157 ~~i~H~dikp~NIli~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 208 (322)
T 1p4o_A 157 NKFVHRDLAARNCMVAEDFTVKI----------------------------GDFGMTRDIYETDYYRKGGKGLLPVRWMS 208 (322)
T ss_dssp TTCBCSCCSGGGEEECTTCCEEE----------------------------CCTTCCCGGGGGGCEEGGGSSEECGGGCC
T ss_pred CCCccCCCccceEEEcCCCeEEE----------------------------CcCccccccccccccccccCCCCCCCccC
Confidence 99999999999999999888888 48988765433221 1223467899999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 209 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 999998889999999999999999999 7888864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=234.32 Aligned_cols=148 Identities=24% Similarity=0.322 Sum_probs=119.8
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcc
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIV 145 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ii 145 (255)
+..+.|+|++++++.+++. ..|+||||+.||+|.+++.....+++. .+..++.||+.||.|||++||+
T Consensus 424 l~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~l~~~-----------~~~~i~~qi~~~L~yLH~~~ii 491 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDK-----------NIIELVHQVSMGMKYLEESNFV 491 (635)
T ss_dssp HHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHH-----------HHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHhCCCCCEeeEEEEEecC-CEEEEEEccCCCCHHHHHhhCCCCCHH-----------HHHHHHHHHHHHHHHHHHCCEe
Confidence 4456799999999988754 589999999999999999876555432 3455778999999999999999
Q ss_pred cccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCCCccccc
Q psy3182 146 FRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPEYVAPEI 222 (255)
Q Consensus 146 Hrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~y~aPE~ 222 (255)
||||||+||+++.++.+++ +|||+++....... ......||+.|+|||+
T Consensus 492 HrDLkp~NILl~~~~~~kL----------------------------~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~ 543 (635)
T 4fl3_A 492 HRDLAARNVLLVTQHYAKI----------------------------SDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 543 (635)
T ss_dssp CSCCSGGGEEEEETTEEEE----------------------------CCTTHHHHTTC-------------CGGGSCHHH
T ss_pred CCCCChHhEEEeCCCCEEE----------------------------EEcCCccccccCccccccccCCCCceeeeChhh
Confidence 9999999999999888888 59999876644321 1223457789999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+.+..++.++||||+||++|||++ |..||..
T Consensus 544 ~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999899999999999999999998 9999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=214.43 Aligned_cols=152 Identities=24% Similarity=0.300 Sum_probs=119.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.. .++++|++.+|+|.+++.... .+++ ..+..++.|++.||.|||
T Consensus 67 E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~aL~~LH 134 (327)
T 3lzb_A 67 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-----------QYLLNWCVQIAKGMNYLE 134 (327)
T ss_dssp HHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 456677889999999999988765 788999999999999997643 2322 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++.++.+++ +|||.++....... ......||+.|+
T Consensus 135 ~~~ivH~Dikp~NIl~~~~~~~kL----------------------------~DfG~a~~~~~~~~~~~~~~~~~t~~y~ 186 (327)
T 3lzb_A 135 DRRLVHRDLAARNVLVKTPQHVKI----------------------------TDFGLAKLLGAEEKEYHAEGGKVPIKWM 186 (327)
T ss_dssp HTTCCCSCCCGGGEEEEETTEEEE----------------------------CCTTC----------------CCCGGGS
T ss_pred hCCCcCCCCCHHHEEEcCCCCEEE----------------------------ccCcceeEccCccccccccCCCcccccc
Confidence 999999999999999998888888 59998876543221 122345788999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999999999 9999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-29 Score=207.42 Aligned_cols=148 Identities=22% Similarity=0.357 Sum_probs=120.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.. +++|||+.||+|.+.+.... .+++ ..+..++.|++.||.|||
T Consensus 73 E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~~l~~~l~~lH 139 (287)
T 4f0f_A 73 EVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKW-----------SVKLRLMLDIALGIEYMQ 139 (287)
T ss_dssp HHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccH-----------HHHHHHHHHHHHHHHHHH
Confidence 455677788999999999988765 79999999999998886543 2222 234457789999999999
Q ss_pred HcC--cccccCCCCceeeCCCCc-----eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc
Q psy3182 141 TRG--IVFRDLKPENLLLDNRGY-----VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG 213 (255)
Q Consensus 141 ~~~--iiHrdlkp~nil~~~~~~-----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g 213 (255)
++| ++||||||+||+++..+. +++ +|||.++.... ......|
T Consensus 140 ~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl----------------------------~Dfg~~~~~~~---~~~~~~g 188 (287)
T 4f0f_A 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV----------------------------ADFGLSQQSVH---SVSGLLG 188 (287)
T ss_dssp TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE----------------------------CCCTTCBCCSS---CEECCCC
T ss_pred hCCCCeecCCCCcceEEEeccCCCCceeEEe----------------------------CCCCccccccc---cccccCC
Confidence 999 999999999999987664 555 59998875433 2345689
Q ss_pred CCCCccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 214 TPEYVAPEIIK--NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~--~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+.|+|||++. ...++.++|+||+||++|+|++|..||..
T Consensus 189 ~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp CCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999994 45678899999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=214.42 Aligned_cols=152 Identities=32% Similarity=0.614 Sum_probs=124.3
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+.+ .|++|||+.||+|.+.+.....+++. .+..++.|++.||.|||
T Consensus 64 ~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~qi~~~l~~lH 131 (322)
T 2ycf_A 64 TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEA-----------TCKLYFYQMLLAVQYLH 131 (322)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3566777889999999999987765 89999999999999988765544432 33456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCc---eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGY---VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
++|++||||||+||+++..+. +++ +|||.++...... .....+||+.|
T Consensus 132 ~~~ivH~dlkp~NIl~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~gt~~y 182 (322)
T 2ycf_A 132 ENGIIHRDLKPENVLLSSQEEDCLIKI----------------------------TDFGHSKILGETS-LMRTLCGTPTY 182 (322)
T ss_dssp HTTEECCCCSGGGEEESSSSSSCCEEE----------------------------CCCTTCEECCCCH-HHHHHHSCCTT
T ss_pred HCCeeccCCCHHHEEEecCCCCCeEEE----------------------------ccCccceeccccc-ccccccCCcCc
Confidence 999999999999999987653 666 5999987664432 23356799999
Q ss_pred ccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIK---NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~---~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++. ...++.++|+|||||++|+|++|..||..
T Consensus 183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999974 46788999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=209.21 Aligned_cols=163 Identities=17% Similarity=0.253 Sum_probs=116.4
Q ss_pred eccc-cccccccccccccCccceeehhhhhcchhHHHHHHhc----cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 66 ~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~----~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+... .|+|++++++.+.+.+..|++|||+.||+|.+++.+. ..+++ ..+..++.|++.||.|||
T Consensus 64 ~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~-----------~~~~~i~~qi~~al~~lH 132 (289)
T 1x8b_A 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE-----------AELKDLLLQVGRGLRYIH 132 (289)
T ss_dssp HHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3344 7999999999999999999999999999999999764 22222 334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++..+........ .............+..|||.+....... ...||+.|+||
T Consensus 133 ~~~ivH~Dikp~NIl~~~~~~~~~~~~~---------~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aP 199 (289)
T 1x8b_A 133 SMSLVHMDIKPSNIFISRTSIPNAASEE---------GDEDDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLAN 199 (289)
T ss_dssp HTTEECSCCSGGGEEEC-----------------------------CCCEEECCCTTCEETTCSC----CCCCCGGGCCH
T ss_pred hCCEeecCCCHHHEEEcCCCCCcccccc---------cccccccCCceEEEEcccccccccCCcc----ccCCCccccCh
Confidence 9999999999999999866532221000 0000000011122336999887664432 34699999999
Q ss_pred ccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+. .++.++|+||+||++|+|++|.+|+.
T Consensus 200 E~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 200 EVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp HHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred hHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 999875 56679999999999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=216.72 Aligned_cols=147 Identities=27% Similarity=0.374 Sum_probs=115.3
Q ss_pred eccccccccccccc-----cccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRKKKTRQTRLYK-----TFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 66 ~~~~~h~~iv~l~~-----~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+....|+|+++++. .+.+...+|++||||.||+|.+++..... +. ..+..++.|++.||.|||
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~-----------~~~~~i~~qi~~~L~~LH 128 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-DW-----------VSSCRLAHSVTRGLAYLH 128 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCB-CH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhccc-ch-----------hHHHHHHHHHHHHHHHHH
Confidence 34568999999986 34455678999999999999999976432 11 223457789999999999
Q ss_pred Hc---------CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-------
Q psy3182 141 TR---------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS------- 204 (255)
Q Consensus 141 ~~---------~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~------- 204 (255)
++ ||+||||||+||+++.++.+++ +|||+++.....
T Consensus 129 ~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL----------------------------~DFG~a~~~~~~~~~~~~~ 180 (336)
T 3g2f_A 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI----------------------------SDFGLSMRLTGNRLVRPGE 180 (336)
T ss_dssp CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE----------------------------CCCTTCEECSSSSCC----
T ss_pred hhhccccccccceeecccccceEEEcCCCcEEE----------------------------eeccceeecccccccCccc
Confidence 99 9999999999999999888888 488888654321
Q ss_pred -CccccccccCCCCcccccccC-------CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 205 -GCKTWTFCGTPEYVAPEIIKN-------RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 205 -~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.......+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp -----CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred cccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 112234579999999999987 456678999999999999999976653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-29 Score=218.00 Aligned_cols=168 Identities=21% Similarity=0.293 Sum_probs=116.1
Q ss_pred cccccccccccc----CccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc-C
Q psy3182 71 KTRQTRLYKTFK----DSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLHTR-G 143 (255)
Q Consensus 71 h~~iv~l~~~~~----~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~-~ 143 (255)
|++++++++.+. +...+|++|||+ +|++.+.+.+.. .+++ ..+..++.|++.||.|||++ |
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~-----------~~~~~i~~qi~~aL~~lH~~~g 167 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPL-----------PCVKKIIQQVLQGLDYLHTKCR 167 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCH-----------HHHHHHHHHHHHHHHHHHHTTC
T ss_pred cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCH-----------HHHHHHHHHHHHHHHHHHHhCC
Confidence 788999999887 677899999999 666666665432 2222 33556788999999999998 9
Q ss_pred cccccCCCCceeeCCCCceeeccc-------------CCcceeee-cCCCCC-------ceeeeeCCeeeeeccccccCC
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFY-------------PAGHYIIR-EGAKGD-------SFFIISGGQVKVDFGFSKHLG 202 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~-------------~~~~~~~~-~~~~~~-------~~~~~~~~~~~~dfg~s~~~~ 202 (255)
|+||||||+||+++.++....... +.+..... ....+. .........+.+|||.+....
T Consensus 168 ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~ 247 (397)
T 1wak_A 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247 (397)
T ss_dssp EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT
T ss_pred EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc
Confidence 999999999999987652100000 00000000 000000 000000123446999987654
Q ss_pred CCCccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 203 HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 248 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 248 KH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp BC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 32 3346899999999999999999999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-29 Score=211.22 Aligned_cols=156 Identities=23% Similarity=0.397 Sum_probs=117.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++||++.||+|.+++......... .....+..++.|++.||.|||+
T Consensus 82 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~i~~qi~~~l~~LH~ 154 (310)
T 2wqm_A 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-------IPERTVWKYFVQLCSALEHMHS 154 (310)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccC-------CCHHHHHHHHHHHHHHHHHHhh
Confidence 455667778999999999999999999999999999999988642110000 0112345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+..............||+.|+|||
T Consensus 155 ~~i~H~dl~p~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 206 (310)
T 2wqm_A 155 RRVMHRDIKPANVFITATGVVKL----------------------------GDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206 (310)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEE----------------------------CCC------------------CCSSCCHH
T ss_pred CCeeCCCCcHHHEEEcCCCCEEE----------------------------EeccceeeecCCCccccccCCCeeEeChH
Confidence 99999999999999999888888 59998876554433344567999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+|||||++|+|++|..||.
T Consensus 207 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=214.17 Aligned_cols=153 Identities=25% Similarity=0.312 Sum_probs=120.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++.... .+++ ..+..++.|++.||.|||
T Consensus 96 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~aL~~LH 164 (333)
T 1mqb_A 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV-----------LQLVGMLRGIAAGMKYLA 164 (333)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3445667789999999999999999999999999999999997542 2322 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~~y 217 (255)
++|++||||||+||+++.++.+++ +|||.++........ .....||+.|
T Consensus 165 ~~~ivH~Dikp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 216 (333)
T 1mqb_A 165 NMNYVHRDLAARNILVNSNLVCKV----------------------------SDFGLSRVLEDDPEATYTTSGGKIPIRW 216 (333)
T ss_dssp HTTCCCSCCCGGGEEECTTCCEEE----------------------------CCCCC-----------------CCCGGG
T ss_pred hCCeeCCCCChheEEECCCCcEEE----------------------------CCCCcchhhccccccccccCCCCccccc
Confidence 999999999999999999888888 589888765432211 1223467889
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 217 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp SCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 99999999899999999999999999998 9999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-29 Score=209.11 Aligned_cols=152 Identities=20% Similarity=0.284 Sum_probs=121.6
Q ss_pred ceeeecccccccccccccc-ccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKT-FKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~-~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++. +.+.+..|++|||+.||+|.++++.... ++ ...+..++.|++.||.||
T Consensus 76 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~i~~ql~~~l~~l 144 (298)
T 3f66_A 76 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT-----------VKDLIGFGLQVAKGMKYL 144 (298)
T ss_dssp HHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCC-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 4556777889999999997 5667789999999999999999975332 22 123445678999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----ccccccccCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----CKTWTFCGTP 215 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~~~~~~~gt~ 215 (255)
|++|++||||||+||+++.++.+++ +|||.++...... .......||+
T Consensus 145 H~~~i~H~dikp~Nil~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 196 (298)
T 3f66_A 145 ASKKFVHRDLAARNCMLDEKFTVKV----------------------------ADFGLARDMYDKEYYSVHNKTGAKLPV 196 (298)
T ss_dssp HHTTCCCSCCSGGGEEECTTCCEEE----------------------------CSCGGGCCCSCGGGCBC-----CCBCG
T ss_pred HhCCccCCCCchheEEECCCCCEEE----------------------------CcccccccccccchhccccccCCCCCc
Confidence 9999999999999999999888888 5999887654322 1223456788
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTG-MKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G-~~~~~ 252 (255)
.|+|||++.+..++.++|+||+||++|+|++| .+||.
T Consensus 197 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999998999999999999999999995 45554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=225.25 Aligned_cols=153 Identities=20% Similarity=0.321 Sum_probs=122.6
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++++..+.|+|++++++.+. .+.+|+||||+.+|+|.++++...... .....+..++.|++.||.|||++
T Consensus 234 ~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~ 303 (454)
T 1qcf_A 234 ANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK---------QPLPKLIDFSAQIAEGMAFIEQR 303 (454)
T ss_dssp HHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHT---------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 34456678999999999876 567899999999999999997532100 11123445778999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPE 221 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE 221 (255)
+|+||||||+||+++.++.+|+ +|||+++....... ......+|+.|+|||
T Consensus 304 ~ivHrDlkp~Nill~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE 355 (454)
T 1qcf_A 304 NYIHRDLRAANILVSASLVCKI----------------------------ADFGLARVIEDNEYTAREGAKFPIKWTAPE 355 (454)
T ss_dssp TCCCSSCSGGGEEECTTCCEEE----------------------------CSTTGGGGBCCHHHHTTCSSSSCGGGSCHH
T ss_pred CccCCCCCHHHEEECCCCcEEE----------------------------eeCCCceEcCCCceeccCCCcccccccCHH
Confidence 9999999999999999988888 59999876543211 112334677899999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
++....++.++|+||+||++|||++ |..||..
T Consensus 356 ~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred HhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9998889999999999999999999 9999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-29 Score=217.93 Aligned_cols=148 Identities=29% Similarity=0.529 Sum_probs=110.3
Q ss_pred ceeeeccccccccccccccccCc------cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS------KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~------~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+.|+|++++++.+... ..+|+++|++ |++|.++++. ..+++ ..+..++.|++.|
T Consensus 78 E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~-----------~~~~~i~~qi~~a 144 (367)
T 2fst_X 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTD-----------DHVQFLIYQILRG 144 (367)
T ss_dssp HHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCH-----------HHHHHHHHHHHHH
Confidence 46667778899999999987654 5689999998 7899888764 23332 3345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ +|||+++..... ....+||+
T Consensus 145 L~~LH~~givH~Dlkp~NIll~~~~~~kL----------------------------~DFG~a~~~~~~---~~~~~~t~ 193 (367)
T 2fst_X 145 LKYIHSADIIHRDLKPSNLAVNEDCELKI----------------------------LDFGLARHTADE---MTGYVATR 193 (367)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCCEEE----------------------------CC------------------CCC
T ss_pred HHHHHHCCeeeCCCCHhhEEECCCCCEEE----------------------------eecccccccccc---CCCcCcCc
Confidence 99999999999999999999999988888 599998765332 33568999
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 194 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp TTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999987 6789999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=215.27 Aligned_cols=163 Identities=22% Similarity=0.319 Sum_probs=127.1
Q ss_pred eeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchh-----hHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAAS-----FITACVIEALDFITACVIEAL 136 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~il~~l 136 (255)
++++..+ .|+|++++++.+.+.+.+|+||||+.||+|.+++............ .........+..++.|++.||
T Consensus 91 ~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 170 (334)
T 2pvf_A 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170 (334)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 4455555 8999999999999999999999999999999999865421100000 000112234556788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGT 214 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt 214 (255)
.|||++|++||||||+||+++.++.+++ +|||.++....... ......||
T Consensus 171 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 222 (334)
T 2pvf_A 171 EYLASQKCIHRDLAARNVLVTENNVMKI----------------------------ADFGLARDINNIDYYKKTTNGRLP 222 (334)
T ss_dssp HHHHHTTEECSCCSGGGEEECTTCCEEE----------------------------CCCTTCEECTTTSSEECCSCCCCC
T ss_pred HHHHhCCeeCCCCccceEEEcCCCCEEE----------------------------ccccccccccccccccccCCCCcc
Confidence 9999999999999999999999888888 48998876544321 12234578
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 223 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 89999999988889999999999999999999 9888863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=208.41 Aligned_cols=151 Identities=22% Similarity=0.254 Sum_probs=122.1
Q ss_pred ceeeeccccccccccccccccCccce-eehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYV-YMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~-ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++.+.+.+.. |+++||+.+|+|.+++.... .+++ ..+..++.|++.||.||
T Consensus 72 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~i~~qi~~~l~~L 140 (298)
T 3pls_A 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV-----------KDLISFGLQVARGMEYL 140 (298)
T ss_dssp HHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 35566777899999999999876665 99999999999999997532 1221 23445778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----ccccccccCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----CKTWTFCGTP 215 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~~~~~~~gt~ 215 (255)
|++|++||||||+||+++.++.+++ +|||.++...... .......||+
T Consensus 141 H~~~i~H~dikp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 192 (298)
T 3pls_A 141 AEQKFVHRDLAARNCMLDESFTVKV----------------------------ADFGLARDILDREYYSVQQHRHARLPV 192 (298)
T ss_dssp HHTTCCCSCCSGGGEEECTTCCEEE----------------------------CCTTSSCTTTTGGGGCSCCSSCTTCGG
T ss_pred HhCCcccCCCCcceEEEcCCCcEEe----------------------------CcCCCcccccCCcccccccCcCCCCCc
Confidence 9999999999999999999988888 5999887543321 1223456888
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
.|+|||.+.+..++.++|+||+||++|+|++|..|+
T Consensus 193 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 999999999999999999999999999999965443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-29 Score=209.56 Aligned_cols=154 Identities=23% Similarity=0.347 Sum_probs=122.0
Q ss_pred cCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
..+++++..+.|+|++++++.+.+.+..|++|||+.|++|.+++.... .+++ ..+..++.|++.||.|
T Consensus 77 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~al~~ 145 (319)
T 2y4i_B 77 KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDV-----------NKTRQIAQEIVKGMGY 145 (319)
T ss_dssp CTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCS-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHH
Confidence 356777888899999999999999999999999999999999997543 2332 2344577889999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-----Ccccccccc
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-----GCKTWTFCG 213 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-----~~~~~~~~g 213 (255)
||++|++||||||+||+++ ++.+++ .|||.+...... ........|
T Consensus 146 lH~~~i~H~dlkp~NIl~~-~~~~~l----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~g 196 (319)
T 2y4i_B 146 LHAKGILHKDLKSKNVFYD-NGKVVI----------------------------TDFGLFSISGVLQAGRREDKLRIQNG 196 (319)
T ss_dssp HHHTTCCCCCCCSTTEEEC---CCEE----------------------------CCCSCCC----------CCSCBCCSG
T ss_pred HHhCCccccCCChhhEEEe-CCCEEE----------------------------eecCCccccccccccccccccccCCC
Confidence 9999999999999999997 556666 488876543221 112234569
Q ss_pred CCCCcccccccC---------CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 214 TPEYVAPEIIKN---------RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~---------~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 197 ~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp GGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred cccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999975 3578899999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=213.13 Aligned_cols=151 Identities=20% Similarity=0.280 Sum_probs=124.0
Q ss_pred ceeeeccccccccccccccccCc--cceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++..+.|+|++++++.+.+. ..+|++|||+.||+|.+++.+.. .+++ ..+..++.|++.||.|
T Consensus 73 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~~i~~~l~~ 141 (302)
T 4e5w_A 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL-----------KQQLKYAVQICKGMDY 141 (302)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCH-----------HHHHHHHHHHHHHHHH
Confidence 45667778899999999998876 67899999999999999996532 2322 2344577899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTP 215 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~ 215 (255)
||++|++||||||+||+++.++.+++ +|||.+........ ......||+
T Consensus 142 lH~~~i~H~dikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~ 193 (302)
T 4e5w_A 142 LGSRQYVHRDLAARNVLVESEHQVKI----------------------------GDFGLTKAIETDKEYYTVKDDRDSPV 193 (302)
T ss_dssp HHHTTEECSCCSGGGEEEEETTEEEE----------------------------CCCTTCEECCTTCCEEECCCCTTCCG
T ss_pred hhcCCcccCCCchheEEEcCCCCEEE----------------------------CcccccccccCCCcceeccCCCCCCc
Confidence 99999999999999999998888887 59998876544321 223456888
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
.|+|||++.+..++.++|+||+||++|+|++|..|+
T Consensus 194 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred cccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 999999999888999999999999999999998875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-29 Score=211.84 Aligned_cols=139 Identities=22% Similarity=0.374 Sum_probs=111.8
Q ss_pred ccccccccccccc----cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH----
Q psy3182 69 KKKTRQTRLYKTF----KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH---- 140 (255)
Q Consensus 69 ~~h~~iv~l~~~~----~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH---- 140 (255)
..|+|++++++.+ .+...+|++|||+.||+|.++++.. .+++ ..+..++.|++.||.|||
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~-----------~~~~~i~~~i~~~l~~lH~~~~ 126 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDT-----------VSCLRIVLSIASGLAHLHIEIF 126 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-CBCH-----------HHHHHHHHHHHHHHHHHHSCBC
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-ccCH-----------HHHHHHHHHHHHHHHHHHHhhh
Confidence 6799999998874 3456789999999999999999642 2332 223457789999999999
Q ss_pred ----HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc----ccccc
Q psy3182 141 ----TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK----TWTFC 212 (255)
Q Consensus 141 ----~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~----~~~~~ 212 (255)
+++|+||||||+||+++.++.+++ +|||.++........ ....+
T Consensus 127 ~~~~~~~ivH~Dlkp~Nill~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~ 178 (301)
T 3q4u_A 127 GTQGKPAIAHRDLKSKNILVKKNGQCCI----------------------------ADLGLAVMHSQSTNQLDVGNNPRV 178 (301)
T ss_dssp STTCBCEEECSCCCGGGEEECTTSCEEE----------------------------CCCTTCEEEETTTTEEECCCCCCC
T ss_pred hccCCCCeecCCCChHhEEEcCCCCEEE----------------------------eeCCCeeecccccccccccccccc
Confidence 999999999999999999988888 488887654332211 22358
Q ss_pred cCCCCcccccccCC------CCCCcchHHHHHHHHHHHhcC
Q psy3182 213 GTPEYVAPEIIKNR------GHDRAVDYWALGILMHELLTG 247 (255)
Q Consensus 213 gt~~y~aPE~~~~~------~~~~~~DiWslGvil~ell~G 247 (255)
||+.|+|||++.+. .++.++|+||+||++|+|++|
T Consensus 179 gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp CCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 99999999999876 344689999999999999999
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-29 Score=208.57 Aligned_cols=150 Identities=34% Similarity=0.621 Sum_probs=125.4
Q ss_pred eeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++..+ .|+|++++++.+.+.+..|++|||+.|++|.+++..+..+++. .+..++.|++.||.|||+
T Consensus 74 ~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~ 142 (298)
T 1phk_A 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----------ETRKIMRALLEVICALHK 142 (298)
T ss_dssp HHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 3444455 4999999999999999999999999999999999876554432 345577889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.+....... .....+||+.|+|||
T Consensus 143 ~~i~H~dl~p~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~-~~~~~~~~~~y~aPE 193 (298)
T 1phk_A 143 LNIVHRDLKPENILLDDDMNIKL----------------------------TDFGFSCQLDPGE-KLREVCGTPSYLAPE 193 (298)
T ss_dssp TTEECSCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCTTC-CBCCCCSCGGGCCHH
T ss_pred CCcccCCCCcceEEEcCCCcEEE----------------------------ecccchhhcCCCc-ccccccCCccccCHH
Confidence 99999999999999999888888 5999887654332 334567999999999
Q ss_pred ccc------CCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIK------NRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~------~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++. ...++.++|+||+||++|+|++|..||.
T Consensus 194 ~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp HHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 985 4568899999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=212.22 Aligned_cols=153 Identities=27% Similarity=0.489 Sum_probs=121.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++....|+|++++++.+.+.+..|++|||+.|++|.+++.+. ..+++ ..+..++.|++.||.|||
T Consensus 66 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH 134 (302)
T 2j7t_A 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-----------PQIQVVCRQMLEALNFLH 134 (302)
T ss_dssp HHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 355567778999999999999999999999999999999988653 22332 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++|++||||||+||+++.++.+++ .|||.+..............||+.|+||
T Consensus 135 ~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 186 (302)
T 2j7t_A 135 SKRIIHRDLKAGNVLMTLEGDIRL----------------------------ADFGVSAKNLKTLQKRDSFIGTPYWMAP 186 (302)
T ss_dssp HTTCCCCCCSGGGEEECTTSCEEE----------------------------CCCHHHHHHHHHHHC-----CCGGGCCH
T ss_pred cCCcccCCCCHHHEEECCCCCEEE----------------------------EECCCCccccccccccccccCChhhcCC
Confidence 999999999999999998888888 5999864322111122346799999999
Q ss_pred ccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EII-----KNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~-----~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++ .+..++.++|+||+||++|+|++|..||..
T Consensus 187 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp HHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 998 467789999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=210.72 Aligned_cols=139 Identities=19% Similarity=0.365 Sum_probs=113.7
Q ss_pred ccccccccccccccCc----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc--
Q psy3182 69 KKKTRQTRLYKTFKDS----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR-- 142 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~-- 142 (255)
..|+|++++++.+.+. ..+|++|||+.||+|.++++.. .+++ ..+..++.|++.||.|||++
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~-----------~~~~~i~~~i~~~l~~lH~~~~ 155 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDA-----------KSMLKLAYSSVSGLCHLHTEIF 155 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCH-----------HHHHHHHHHHHHHHHHHHSCBC
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCH-----------HHHHHHHHHHHHHHHHHHHhhh
Confidence 4799999999988776 7899999999999999999753 2332 23445778899999999999
Q ss_pred ------CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc----ccccc
Q psy3182 143 ------GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK----TWTFC 212 (255)
Q Consensus 143 ------~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~----~~~~~ 212 (255)
||+||||||+||+++.++.+++ +|||.++........ ..+.+
T Consensus 156 ~~~~~~~ivH~Dikp~Nill~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~ 207 (337)
T 3mdy_A 156 STQGKPAIAHRDLKSKNILVKKNGTCCI----------------------------ADLGLAVKFISDTNEVDIPPNTRV 207 (337)
T ss_dssp STTCBCCEECSCCCGGGEEECTTSCEEE----------------------------CCCTTCEECC---------CCSSC
T ss_pred hhccCCCEEecccchHHEEECCCCCEEE----------------------------EeCCCceeeccccccccCCCCCCc
Confidence 9999999999999999988888 589988655332211 22568
Q ss_pred cCCCCcccccccCCCCCCc------chHHHHHHHHHHHhcC
Q psy3182 213 GTPEYVAPEIIKNRGHDRA------VDYWALGILMHELLTG 247 (255)
Q Consensus 213 gt~~y~aPE~~~~~~~~~~------~DiWslGvil~ell~G 247 (255)
||+.|+|||++.+..++.+ +|+||+||++|+|++|
T Consensus 208 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp SCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999999999988776665 9999999999999999
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=212.22 Aligned_cols=148 Identities=20% Similarity=0.404 Sum_probs=121.9
Q ss_pred ceeeecccc-ccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKK-KTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~-h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++..+. |+|++++++.+.+ ....+++|||+.+++|.+++.. +++ ..+..++.|++.||.|
T Consensus 80 E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~-----------~~~~~~~~qi~~~l~~ 145 (330)
T 3nsz_A 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTD-----------YDIRFYMYEILKALDY 145 (330)
T ss_dssp HHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---CCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---CCH-----------HHHHHHHHHHHHHHHH
Confidence 345555665 9999999999987 6788999999999999888753 222 2345678899999999
Q ss_pred HHHcCcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
||++||+||||||+||+++.++ .+++ +|||.++...... .....+||+.|
T Consensus 146 lH~~~ivH~Dikp~Nil~~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~~~~~~~y 196 (330)
T 3nsz_A 146 CHSMGIMHRDVKPHNVMIDHEHRKLRL----------------------------IDWGLAEFYHPGQ-EYNVRVASRYF 196 (330)
T ss_dssp HHHTTEECCCCSGGGEEEETTTTEEEE----------------------------CCCTTCEECCTTC-CCCSCCSCGGG
T ss_pred HHhCCeeeCCCCHHHEEEcCCCCEEEE----------------------------EeCCCceEcCCCC-ccccccccccc
Confidence 9999999999999999998766 6777 5999987654432 23456899999
Q ss_pred cccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 197 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999987 678999999999999999999999983
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=211.79 Aligned_cols=163 Identities=22% Similarity=0.325 Sum_probs=125.0
Q ss_pred eeeeccc-cccccccccccccCcc-ceeehhhhhcchhHHHHHHhccCCCccc-h----hhHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSK-YVYMLLEACLGGEVWTILRERTCFDDNA-A----SFITACVIEALDFITACVIEA 135 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~-~~ylv~E~~~gg~l~~~l~~~~~~~~~~-~----~~~~~~~~~~~~~i~~~il~~ 135 (255)
++++..+ .|+|++++++.+.+.+ .+|++|||+.||+|.+++.....-.... . ..........+..++.|++.|
T Consensus 81 ~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 160 (316)
T 2xir_A 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160 (316)
T ss_dssp HHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHH
Confidence 4445555 6899999999877654 5999999999999999997643210000 0 000001233455678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--ccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCG 213 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~g 213 (255)
|.|||++|++||||||+||+++.++.+++ +|||.++....... ......|
T Consensus 161 l~~lH~~~i~H~dikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~ 212 (316)
T 2xir_A 161 MEFLASRKCIHRDLAARNILLSEKNVVKI----------------------------CDFGLARDIYKDPDYVRKGDARL 212 (316)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCGGGSCTTTCTTSEEETTEEE
T ss_pred HHHHHhCCcccccCccceEEECCCCCEEE----------------------------CCCccccccccCccceeccCCCc
Confidence 99999999999999999999998888887 59999876543322 2334568
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|+.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 213 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 899999999999899999999999999999998 9999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-29 Score=206.21 Aligned_cols=153 Identities=20% Similarity=0.320 Sum_probs=126.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.+..|++||++.||+|.+++.... .+++ +.+..++.|++.||.|||
T Consensus 53 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH 121 (267)
T 3t9t_A 53 EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLE 121 (267)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 4566777789999999999999999999999999999999997643 2222 234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ .|||.+........ ......||+.|+|
T Consensus 122 ~~~i~H~dl~p~Nili~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~y~a 173 (267)
T 3t9t_A 122 EACVIHRDLAARNCLVGENQVIKV----------------------------SDFGMTRFVLDDQYTSSTGTKFPVKWAS 173 (267)
T ss_dssp HTTCCCSSCCGGGEEECGGGCEEE----------------------------CCTTGGGGBCCHHHHSTTSTTCCGGGCC
T ss_pred hCCcccCCCchheEEECCCCCEEE----------------------------cccccccccccccccccccccccccccC
Confidence 999999999999999998888887 59998876533211 1123457889999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+|+++|+|++ |..||..
T Consensus 174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 999998889999999999999999999 8888863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=230.55 Aligned_cols=150 Identities=26% Similarity=0.388 Sum_probs=119.1
Q ss_pred eeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
+++..+.|+|++++++.+++ +.+|+|||||.||+|.+++.... .+++ ..+..++.|++.||.|||++
T Consensus 388 ~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~-----------~~~~~i~~qi~~~L~~LH~~ 455 (613)
T 2ozo_A 388 QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPV-----------SNVAELLHQVSMGMKYLEEK 455 (613)
T ss_dssp HHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCH-----------HHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCH-----------HHHHHHHHHHHHHHHHHHHC
Confidence 34556789999999999877 56899999999999999986432 1222 23456788999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCCCcc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPEYVA 219 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~y~a 219 (255)
||+||||||+||+++.++.+|+ +|||+++....... ......||+.|+|
T Consensus 456 ~iiHrDlkp~NILl~~~~~vkL----------------------------~DFGla~~~~~~~~~~~~~~~~~~~~~y~A 507 (613)
T 2ozo_A 456 NFVHRNLAARNVLLVNRHYAKI----------------------------SDFGLSKALGADDSYYTARSAGKWPLKWYA 507 (613)
T ss_dssp TCCCSCCSGGGEEEEETTEEEE----------------------------CCCSTTTTCC--------------CCTTSC
T ss_pred CEEcCcCCHHHEEEcCCCcEEE----------------------------eeccCcccccCCCceeeeccCCCCccceeC
Confidence 9999999999999999888888 59999876643221 1112346689999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++||||+||++|||++ |..||..
T Consensus 508 PE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred HhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999998899999999999999999998 9999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-29 Score=207.81 Aligned_cols=151 Identities=19% Similarity=0.306 Sum_probs=118.8
Q ss_pred eeeeccccccccccccc-cccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYK-TFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~-~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++....|++.+..+. .+.+.+..|++||++ ||+|.+++... ..+++ ..+..++.|++.||.|||
T Consensus 55 ~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~-----------~~~~~i~~qi~~~l~~LH 122 (296)
T 4hgt_A 55 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL-----------KTVLLLADQMISRIEYIH 122 (296)
T ss_dssp HHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 44555666666555544 446777889999999 99999998743 22322 334567889999999999
Q ss_pred HcCcccccCCCCceee---CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-------cccc
Q psy3182 141 TRGIVFRDLKPENLLL---DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-------KTWT 210 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-------~~~~ 210 (255)
++||+||||||+||++ +..+.+++ +|||.++....... ....
T Consensus 123 ~~~ivH~Dlkp~NIl~~~~~~~~~~kL----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~~ 174 (296)
T 4hgt_A 123 SKNFIHRDVKPDNFLMGLGKKGNLVYI----------------------------IDFGLAKKYRDARTHQHIPYRENKN 174 (296)
T ss_dssp HTTEECSCCSGGGEEECCGGGTTCEEE----------------------------CCCTTCEECBCTTTCCBCCCCCSCC
T ss_pred HCCeecCCCCHHHeeeeccCCCCeEEE----------------------------ecCccceeccCcccCccCCCCcccc
Confidence 9999999999999999 66777777 48888765533221 2235
Q ss_pred cccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 211 FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
..||+.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 4hgt_A 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp CCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence 6899999999999999999999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=208.08 Aligned_cols=153 Identities=24% Similarity=0.353 Sum_probs=118.0
Q ss_pred Cceeeecccccccccccccccc-CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFK-DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~-~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|+|++++++.+. +.+..|++|||+.||+|.+++.+... .....+.+..++.|++.||.||
T Consensus 63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~l 133 (278)
T 1byg_A 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---------SVLGGDCLLKFSLDVCEAMEYL 133 (278)
T ss_dssp HTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH---------HHCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc---------ccCCHHHHHHHHHHHHHHHHHH
Confidence 3566777889999999999854 44589999999999999999875431 0011233456778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++|++||||||+||+++.++.+++ +|||.+...... .....||+.|+|
T Consensus 134 H~~~i~H~dlkp~Nil~~~~~~~~l----------------------------~Dfg~~~~~~~~---~~~~~~~~~y~a 182 (278)
T 1byg_A 134 EGNNFVHRDLAARNVLVSEDNVAKV----------------------------SDFGLTKEASST---QDTGKLPVKWTA 182 (278)
T ss_dssp HHTTCCCSCCSGGGEEECTTSCEEE----------------------------CCCCC---------------CCTTTSC
T ss_pred HhCCccccCCCcceEEEeCCCcEEE----------------------------eecccccccccc---ccCCCccccccC
Confidence 9999999999999999999888888 599987654332 223467899999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+|+++|+|++ |..||..
T Consensus 183 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred HHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 999998889999999999999999998 9988863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-29 Score=213.04 Aligned_cols=159 Identities=21% Similarity=0.311 Sum_probs=124.3
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+....|++|||+.||+|.+++............ .....+..++.|++.||.|||+
T Consensus 83 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~~~~~i~~qi~~al~~LH~ 158 (327)
T 2yfx_A 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS----LAMLDLLHVARDIACGCQYLEE 158 (327)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTS----CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhccccccccc----ccHHHHHHHHHHHHHHHHHHhh
Confidence 455666778999999999999999999999999999999999875432211111 1123345577899999999999
Q ss_pred cCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCC
Q psy3182 142 RGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPE 216 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~ 216 (255)
+|++||||||+||+++..+ .+++ +|||.+....... .......||+.
T Consensus 159 ~~i~H~dlkp~NIli~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~ 210 (327)
T 2yfx_A 159 NHFIHRDIAARNCLLTCPGPGRVAKI----------------------------GDFGMARDIYRASYYRKGGCAMLPVK 210 (327)
T ss_dssp TTCCCSCCCGGGEEESCSSTTCCEEE----------------------------CCCHHHHHHHC------CCGGGSCGG
T ss_pred CCeecCcCCHhHEEEecCCCcceEEE----------------------------CccccccccccccccccCCCcCCCcc
Confidence 9999999999999998543 3555 5999876432221 12234568999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus 211 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999998889999999999999999998 888885
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-29 Score=213.08 Aligned_cols=151 Identities=24% Similarity=0.325 Sum_probs=124.6
Q ss_pred ceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++.+.+ ...+|++|||+.+|+|.+++.+.. +++ ..+..++.|++.||.||
T Consensus 83 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~-----------~~~~~i~~~l~~~l~~L 150 (318)
T 3lxp_A 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGL-----------AQLLLFAQQICEGMAYL 150 (318)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC-CCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC-CCH-----------HHHHHHHHHHHHHHHHH
Confidence 4566777889999999999877 467899999999999999987543 322 23455778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~ 216 (255)
|++|++||||||+||+++.++.+++ +|||.+........ ......||+.
T Consensus 151 H~~~ivH~Dikp~Nil~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 202 (318)
T 3lxp_A 151 HAQHYIHRDLAARNVLLDNDRLVKI----------------------------GDFGLAKAVPEGHEYYRVREDGDSPVF 202 (318)
T ss_dssp HHTTEECSCCSGGGEEECTTCCEEE----------------------------CCGGGCEECCTTCSEEEC---CCCCGG
T ss_pred HhCCccCCCCchheEEEcCCCCEEE----------------------------CCccccccccccccccccccCCCCCce
Confidence 9999999999999999999888888 59998876644321 1234568889
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 203 y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred eeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 999999998889999999999999999999998875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=207.01 Aligned_cols=151 Identities=22% Similarity=0.325 Sum_probs=121.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.++ ..|++||++.|++|.+++.+... +++ ..+..++.|++.||.|||
T Consensus 63 E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH 130 (281)
T 3cc6_A 63 EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKV-----------LTLVLYSLQICKAMAYLE 130 (281)
T ss_dssp HHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 45566777899999999988765 56899999999999999976432 222 234457789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ +|||.+........ ......||+.|+|
T Consensus 131 ~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 182 (281)
T 3cc6_A 131 SINCVHRDIAVRNILVASPECVKL----------------------------GDFGLSRYIEDEDYYKASVTRLPIKWMS 182 (281)
T ss_dssp HTTCCCCCCSGGGEEEEETTEEEE----------------------------CCCCGGGCC---------CCCCCGGGCC
T ss_pred HCCcccCCCccceEEECCCCcEEe----------------------------CccCCCcccccccccccccCCCCcceeC
Confidence 999999999999999998888887 59998876544321 1223457889999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||++.+..++.++|+||+||++|+|++ |..||.
T Consensus 183 PE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred chhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 999998889999999999999999998 999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=206.40 Aligned_cols=152 Identities=19% Similarity=0.301 Sum_probs=118.6
Q ss_pred ceeeeccccccccccccc-cccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYK-TFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~-~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|++.+..+. .+.+.+..|++|||+ |++|.+++.... .+++ ..+..++.|++.||.||
T Consensus 54 e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~-----------~~~~~i~~qi~~~l~~l 121 (296)
T 3uzp_A 54 ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL-----------KTVLLLADQMISRIEYI 121 (296)
T ss_dssp HHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 345556666766554444 446677889999999 999999987432 2322 33456788999999999
Q ss_pred HHcCcccccCCCCceeeC---CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-------ccc
Q psy3182 140 HTRGIVFRDLKPENLLLD---NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-------KTW 209 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-------~~~ 209 (255)
|++|++||||||+||+++ ..+.+++ +|||.++....... ...
T Consensus 122 H~~~ivH~dlkp~NIl~~~~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 173 (296)
T 3uzp_A 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYI----------------------------IDFGLAKKYRDARTHQHIPYRENK 173 (296)
T ss_dssp HHTTEECSCCCGGGEEECCGGGTTCEEE----------------------------CCCTTCEECBCTTTCCBCCCCCSC
T ss_pred HhCCeeeCCCCHHHeEEecCCCCCeEEE----------------------------eeCCCccccccccccccccccccc
Confidence 999999999999999994 6667777 48888765543221 124
Q ss_pred ccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 210 TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
...||+.|+|||++.+..++.++|+||+||++|+|++|..||..
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 3uzp_A 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 56899999999999999999999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=213.79 Aligned_cols=150 Identities=23% Similarity=0.480 Sum_probs=121.8
Q ss_pred ceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++..+.|+|++++++.+.+. ...|++||++.| +|.++++.. .+++ ..+..++.|++.||
T Consensus 75 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~-~~~~-----------~~~~~i~~qi~~aL 141 (364)
T 3qyz_A 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-HLSN-----------DHICYFLYQILRGL 141 (364)
T ss_dssp HHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHC-CCCH-----------HHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhC-CCCH-----------HHHHHHHHHHHHHH
Confidence 45667778899999999988655 468999999974 899888753 2332 23456788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---ccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~g 213 (255)
.|||++||+||||||+||+++.++.+++ +|||.++....... .....+|
T Consensus 142 ~~LH~~~ivH~Dikp~NIl~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~g 193 (364)
T 3qyz_A 142 KYIHSANVLHRDLKPSNLLLNTTCDLKI----------------------------CDFGLARVADPDHDHTGFLTEYVA 193 (364)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCCEEE----------------------------CCCTTCEECCGGGCBCCTTCCCCS
T ss_pred HHHHHCCeecCCCChHhEEECCCCCEEE----------------------------EeCcceEecCCCCCcccccccccc
Confidence 9999999999999999999999988888 58998865543211 1234689
Q ss_pred CCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 194 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp CGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 999999998754 568999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=209.12 Aligned_cols=143 Identities=23% Similarity=0.393 Sum_probs=120.4
Q ss_pred cccccccccccccc-----CccceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 69 KKKTRQTRLYKTFK-----DSKYVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 69 ~~h~~iv~l~~~~~-----~~~~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
..|+|++++++.+. +....|++||++. |+|.+++..... ++ .+.+..++.|++.||.|||+
T Consensus 71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~-----------~~~~~~~~~qi~~~l~~lH~ 138 (326)
T 1blx_A 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVP-----------TETIKDMMFQLLRGLDFLHS 138 (326)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSC-----------HHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCC-----------HHHHHHHHHHHHHHHHHHHH
Confidence 37999999999886 6778999999998 599998876432 22 23345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|++||||||+||+++.++.+++ +|||.++...... ......||+.|+|||
T Consensus 139 ~gi~H~dlkp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE 189 (326)
T 1blx_A 139 HRVVHRDLKPQNILVTSSGQIKL----------------------------ADFGLARIYSFQM-ALTSVVVTLWYRAPE 189 (326)
T ss_dssp TTCCCCCCCGGGEEECTTCCEEE----------------------------CSCCSCCCCCGGG-GGCCCCCCCTTCCHH
T ss_pred CCceeccCCHHHeEEcCCCCEEE----------------------------ecCcccccccCCC-CccccccccceeCHH
Confidence 99999999999999999888888 5999887654322 233567999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
++.+..++.++|+||+||++|+|++|..||.
T Consensus 190 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 9999899999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-29 Score=212.50 Aligned_cols=152 Identities=22% Similarity=0.315 Sum_probs=124.6
Q ss_pred ceeeecccccccccccccccc--CccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK--DSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~--~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++..+.|+|++++++.+. +...+|++|||+.||+|.+++.... .+++ ..+..++.|++.||.|
T Consensus 74 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~al~~ 142 (327)
T 3lxl_A 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA-----------SRLLLYSSQICKGMEY 142 (327)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHH
Confidence 455667778999999988765 5667999999999999999997532 2322 3345677899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTP 215 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~ 215 (255)
||++|++||||||+||+++.++.+++ +|||.+........ ......||+
T Consensus 143 lH~~~ivH~Dikp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~ 194 (327)
T 3lxl_A 143 LGSRRCVHRDLAARNILVESEAHVKI----------------------------ADFGLAKLLPLDKDYYVVREPGQSPI 194 (327)
T ss_dssp HHHTTEECSCCSGGGEEEEETTEEEE----------------------------CCGGGCEECCTTCSEEECSSCCCSCG
T ss_pred HHhCCccCCCCChhhEEECCCCCEEE----------------------------cccccceecccCCccceeeccCCccc
Confidence 99999999999999999998888888 59998876543322 222346888
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 195 ~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp GGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 8999999998889999999999999999999998874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=209.14 Aligned_cols=152 Identities=23% Similarity=0.320 Sum_probs=123.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+ +.+..|++||++.|++|.+++.....+++ ..+..++.|++.||.|||+
T Consensus 68 e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~~l~~LH~ 135 (291)
T 1xbb_A 68 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD-----------KNIIELVHQVSMGMKYLEE 135 (291)
T ss_dssp HHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCH-----------HHHHHHHHHHHHHHHHHHh
Confidence 45556677899999999988 55678999999999999999987554443 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~~y~ 218 (255)
+|++||||||+||+++.++.+++ +|||.+......... .....||+.|+
T Consensus 136 ~~i~H~dikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 187 (291)
T 1xbb_A 136 SNFVHRDLAARNVLLVTQHYAKI----------------------------SDFGLSKALRADENYYKAQTHGKWPVKWY 187 (291)
T ss_dssp TTEECSCCSGGGEEEEETTEEEE----------------------------CCCTTCEECCTTCSEEEC----CCCGGGC
T ss_pred CCeEcCCCCcceEEEeCCCcEEE----------------------------ccCCcceeeccCCCcccccccCCCCceee
Confidence 99999999999999998888887 488888765433221 12234678999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 188 aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 9999988889999999999999999999 9999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=204.16 Aligned_cols=147 Identities=27% Similarity=0.393 Sum_probs=110.8
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHh----ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~----~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+....|+|++++++.+.+.+..|++|||+.| +|.+++.. ...+++ ..+..++.|++.||.|||+
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH~ 127 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPE-----------DILGKIAVSIVKALEHLHS 127 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCH-----------HHHHHHHHHHHHHHHHHhh
Confidence 4556899999999999999999999999975 77666653 222322 3345678899999999999
Q ss_pred c-CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 R-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~-~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+ |++||||||+||+++..+.+++ +|||.++...... ......||+.|+||
T Consensus 128 ~~~i~H~dlkp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~~t~~y~aP 178 (290)
T 3fme_A 128 KLSVIHRDVKPSNVLINALGQVKM----------------------------CDFGISGYLVDDV-AKDIDAGCKPYMAP 178 (290)
T ss_dssp HSCCCCCCCSGGGCEECTTCCEEB----------------------------CCC----------------CCCCCCSCH
T ss_pred cCCeecCCCCHHHEEECCCCCEEE----------------------------eecCCcccccccc-cccccCCCccccCh
Confidence 8 9999999999999999888888 5999887654432 22345799999999
Q ss_pred ccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EII----KNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~----~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++ .+..++.++|+||+||++|+|++|..||..
T Consensus 179 E~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp HHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred hhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 996 456788999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=211.21 Aligned_cols=156 Identities=21% Similarity=0.313 Sum_probs=114.2
Q ss_pred cccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCC
Q psy3182 74 QTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKP 151 (255)
Q Consensus 74 iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp 151 (255)
++.+++.+...+..|++||++ ++++.+.+.... .+++ ..+..++.|++.||.|||++||+||||||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~-----------~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp 151 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPL-----------PHVRHMAYQLCHALRFLHENQLTHTDLKP 151 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCH-----------HHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred EEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCH-----------HHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 677788888889999999999 667777776543 2222 33456788999999999999999999999
Q ss_pred CceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCCCCCc
Q psy3182 152 ENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRA 231 (255)
Q Consensus 152 ~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 231 (255)
+||++...+...+... ...........+..+.+|||.++..... ....+||+.|+|||++.+..++.+
T Consensus 152 ~NIll~~~~~~~~~~~---------~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~ 219 (355)
T 2eu9_A 152 ENILFVNSEFETLYNE---------HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQP 219 (355)
T ss_dssp GGEEESCCCEEEEECC---------C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred HHEEEecccccccccc---------cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCc
Confidence 9999965543222100 0000001111122333699998764332 235689999999999999999999
Q ss_pred chHHHHHHHHHHHhcCCCCCcC
Q psy3182 232 VDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 232 ~DiWslGvil~ell~G~~~~~~ 253 (255)
+|+|||||++|+|++|..||..
T Consensus 220 ~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 220 CDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCC
T ss_pred cchHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=211.96 Aligned_cols=151 Identities=20% Similarity=0.409 Sum_probs=115.0
Q ss_pred ceeeeccccccccccccccc-----cCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTF-----KDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~-----~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+.|+|++++++.+ .+...+|++|||+. |+|.+.+.... .+++ ..+..++.|++.|
T Consensus 79 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~-----------~~~~~~~~qi~~~ 146 (362)
T 3pg1_A 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISP-----------QHIQYFMYHILLG 146 (362)
T ss_dssp HHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCH-----------HHHHHHHHHHHHH
Confidence 45667778899999999988 44557899999998 57877776432 2222 3345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ +|||.++...... .....+||+
T Consensus 147 l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~~t~ 197 (362)
T 3pg1_A 147 LHVLHEAGVVHRDLHPGNILLADNNDITI----------------------------CDFNLAREDTADA-NKTHYVTHR 197 (362)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCCEEE----------------------------CCTTC----------------CG
T ss_pred HHHHHHCcCEecCCChHHEEEcCCCCEEE----------------------------EecCccccccccc-ccceecccc
Confidence 99999999999999999999999888888 5999887543322 233467999
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 198 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp GGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 9999999987 6789999999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=208.14 Aligned_cols=159 Identities=21% Similarity=0.233 Sum_probs=117.7
Q ss_pred ceeeeccccccccccccccccCcc-----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK-----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~-----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++..+.|+|++++++.+.+.+ ..|++|||+.+|+|.+++.......... ......+..++.|++.||
T Consensus 86 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~~~i~~qi~~aL 160 (313)
T 3brb_A 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK-----HIPLQTLLKFMVDIALGM 160 (313)
T ss_dssp HHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCC-----CCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCc-----cCCHHHHHHHHHHHHHHH
Confidence 355567778999999999887654 4599999999999999986432111110 011234556788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGT 214 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt 214 (255)
.|||++||+||||||+||+++.++.+++ +|||.++...... .......|+
T Consensus 161 ~~LH~~~ivH~dikp~NIli~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (313)
T 3brb_A 161 EYLSNRNFLHRDLAARNCMLRDDMTVCV----------------------------ADFGLSKKIYSGDYYRQGRIAKMP 212 (313)
T ss_dssp HHHHTTTCCCCCCSGGGEEECTTSCEEE----------------------------CSCSCC----------------CC
T ss_pred HHHHhCCcccCCCCcceEEEcCCCcEEE----------------------------eecCcceecccccccCcccccCCC
Confidence 9999999999999999999999888888 4888886553321 112234578
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+.|+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 213 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 252 (313)
T 3brb_A 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252 (313)
T ss_dssp GGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 89999999999999999999999999999999 8888763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-29 Score=221.06 Aligned_cols=151 Identities=21% Similarity=0.356 Sum_probs=118.0
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++..+.|+|++++++.+.+ +..|+||||+.||+|.++++... .++ ...+..++.|++.||.|||
T Consensus 230 ~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~i~~qi~~~l~~LH 297 (452)
T 1fmk_A 230 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLR-----------LPQLVDMAAQIASGMAYVE 297 (452)
T ss_dssp HHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCC-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 344566789999999998876 67899999999999999996432 122 2234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
++|++||||||+||+++.++.+++ +|||+++....... ......||+.|+|
T Consensus 298 ~~~ivHrDlkp~Nill~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~~~~y~a 349 (452)
T 1fmk_A 298 RMNYVHRDLRAANILVGENLVCKV----------------------------ADFGLARLIEDNEYTARQGAKFPIKWTA 349 (452)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCCTTC--------------CCGGGSC
T ss_pred hCCeeCCCCChhhEEECCCCCEEE----------------------------CCCccceecCCCceecccCCcccccccC
Confidence 999999999999999998888888 59998876543221 1223457788999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|+||+||++|||++ |..||..
T Consensus 350 PE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred HhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 999998889999999999999999999 8888863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-29 Score=211.82 Aligned_cols=145 Identities=31% Similarity=0.576 Sum_probs=102.4
Q ss_pred ccccccccccccccccC----ccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 67 SRKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 67 ~~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
....|+|++++++.+.+ ...+|++|||+.||+|.+++.++. .+++ ..+..++.|++.||.|||
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~-----------~~~~~i~~ql~~~l~~LH 145 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE-----------REAAEIMRDIGTAIQFLH 145 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 44578999999998876 566899999999999999998653 2332 234567889999999999
Q ss_pred HcCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
++||+||||||+||+++.++ .+++ +|||.++..... .....+||+.|
T Consensus 146 ~~~ivH~dlkp~NIll~~~~~~~~~kl----------------------------~Dfg~~~~~~~~--~~~~~~~t~~y 195 (336)
T 3fhr_A 146 SHNIAHRDVKPENLLYTSKEKDAVLKL----------------------------TDFGFAKETTQN--ALQTPCYTPYY 195 (336)
T ss_dssp HTTEECSCCSGGGEEESCSSTTCCEEE----------------------------CCCTTCEEC----------------
T ss_pred hCCeecCCCCHHHEEEEecCCCceEEE----------------------------eccccceecccc--ccccCCCCcCc
Confidence 99999999999999997643 3566 599988765432 23356899999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 196 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp --------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999988889999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=210.27 Aligned_cols=150 Identities=23% Similarity=0.338 Sum_probs=115.9
Q ss_pred eeeccccccccccccccccCcc-------ceeehhhhhcchhHHHHH---HhccCCCccchhhHHHHHHHHHHHHHHHHH
Q psy3182 64 KLVSRKKKTRQTRLYKTFKDSK-------YVYMLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALDFITACVI 133 (255)
Q Consensus 64 kl~~~~~h~~iv~l~~~~~~~~-------~~ylv~E~~~gg~l~~~l---~~~~~~~~~~~~~~~~~~~~~~~~i~~~il 133 (255)
+.+..+.|+|++++++.+.+.. .+|++|||+.|+.+.... .....++ ...+..++.|++
T Consensus 71 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~-----------~~~~~~~~~qi~ 139 (360)
T 3e3p_A 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP-----------PILIKVFLFQLI 139 (360)
T ss_dssp HHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCC-----------HHHHHHHHHHHH
T ss_pred HHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCC-----------HHHHHHHHHHHH
Confidence 3345668999999999885533 389999999875333222 2222222 123455778999
Q ss_pred HHHHHHH--HcCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc
Q psy3182 134 EALEYLH--TRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT 210 (255)
Q Consensus 134 ~~l~ylH--~~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~ 210 (255)
.||.||| ++||+||||||+||+++. ++.+++ +|||.++...... ....
T Consensus 140 ~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl----------------------------~Dfg~a~~~~~~~-~~~~ 190 (360)
T 3e3p_A 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL----------------------------CDFGSAKKLSPSE-PNVA 190 (360)
T ss_dssp HHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE----------------------------CCCTTCBCCCTTS-CCCS
T ss_pred HHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE----------------------------eeCCCceecCCCC-Cccc
Confidence 9999999 999999999999999986 777777 5999988765433 2335
Q ss_pred cccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 211 FCGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+||+.|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus 191 ~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp TTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 6799999999999764 489999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-29 Score=207.47 Aligned_cols=152 Identities=26% Similarity=0.386 Sum_probs=123.5
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.++ .+..|++||++.||+|.+++.... .+++ ..+..++.|++.||.|||
T Consensus 60 E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~qi~~~l~~lH 127 (287)
T 1u59_A 60 EAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPV-----------SNVAELLHQVSMGMKYLE 127 (287)
T ss_dssp HHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTTCTTTSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHHhCCccCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 456677778999999999984 456899999999999999986432 2222 334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~y 217 (255)
++|++||||||+||+++.++.+++ +|||.+........ ......||+.|
T Consensus 128 ~~~i~H~dlkp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 179 (287)
T 1u59_A 128 EKNFVHRDLAARNVLLVNRHYAKI----------------------------SDFGLSKALGADDSYYTARSAGKWPLKW 179 (287)
T ss_dssp HTTEECCCCSGGGEEEEETTEEEE----------------------------CCCTTCEECTTCSCEECCCCSSCCCGGG
T ss_pred HCCEeeCCCchheEEEcCCCCEEE----------------------------CcccceeeeccCcceeeccccccccccc
Confidence 999999999999999998888888 48888876543321 12234578899
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 180 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999988889999999999999999998 9999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=211.62 Aligned_cols=147 Identities=27% Similarity=0.501 Sum_probs=118.2
Q ss_pred ceeeeccccccccccccccccCccce------eehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYV------YMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~------ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+.|+|++++++.+.+.+.. |++|||+. |+|.+.+.. .+++ ..+..++.|++.|
T Consensus 91 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~-----------~~~~~i~~qi~~a 156 (371)
T 4exu_A 91 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM--EFSE-----------EKIQYLVYQMLKG 156 (371)
T ss_dssp HHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS--CCCH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc--CCCH-----------HHHHHHHHHHHHH
Confidence 34556677899999999999887765 99999997 588777642 2322 3345678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+||+++.++.+++ +|||.++.... .....+||+
T Consensus 157 L~~LH~~~ivH~Dikp~NIll~~~~~~kL----------------------------~Dfg~a~~~~~---~~~~~~~t~ 205 (371)
T 4exu_A 157 LKYIHSAGVVHRDLKPGNLAVNEDCELKI----------------------------LDFGLARHADA---EMTGYVVTR 205 (371)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTCCEEE----------------------------CSTTCC-----------CTTCCC
T ss_pred HHHHHHCCCcCCCcCHHHeEECCCCCEEE----------------------------EecCccccccc---CcCCcccCc
Confidence 99999999999999999999999988888 59998875533 233568999
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp TTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999987 7899999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=203.31 Aligned_cols=151 Identities=30% Similarity=0.557 Sum_probs=125.0
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|+++|++.|++|.+.+.....+++ ..+..++.|++.||.|||+
T Consensus 71 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~i~~qi~~~l~~LH~ 139 (287)
T 2wei_A 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----------HDAARIIKQVFSGITYMHK 139 (287)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCH-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCH-----------HHHHHHHHHHHHHHHHHHH
Confidence 45567778899999999999999999999999999999998876655443 2345577899999999999
Q ss_pred cCcccccCCCCceeeCCCC---ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRG---YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
+|++||||||+||+++..+ .+++ +|||.+....... ......||+.|+
T Consensus 140 ~~i~H~dl~p~NIlv~~~~~~~~~kL----------------------------~Dfg~~~~~~~~~-~~~~~~~~~~y~ 190 (287)
T 2wei_A 140 HNIVHRDLKPENILLESKEKDCDIKI----------------------------IDFGLSTCFQQNT-KMKDRIGTAYYI 190 (287)
T ss_dssp TTCCCSCCCGGGEEESCSSTTCCEEE----------------------------CSTTGGGTBCCCS-SCSCHHHHHTTC
T ss_pred CCeeccCCChhhEEEecCCCcccEEE----------------------------eccCcceeecCCC-ccccccCccccc
Confidence 9999999999999997643 4555 5999887654432 223456899999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+. ++.++|+||+|+++|+|++|..||..
T Consensus 191 aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 191 APEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp CHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 99998764 88999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=207.36 Aligned_cols=152 Identities=22% Similarity=0.326 Sum_probs=121.0
Q ss_pred ceeeecccccccccccccccc----CccceeehhhhhcchhHHHHHHhc----cCCCccchhhHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK----DSKYVYMLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALDFITACVI 133 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~----~~~~~ylv~E~~~gg~l~~~l~~~----~~~~~~~~~~~~~~~~~~~~~i~~~il 133 (255)
+++++..+.|+|++++++.+. .....|+++||+.+|+|.+++... ..++ ...+..++.|++
T Consensus 76 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~-----------~~~~~~i~~qi~ 144 (317)
T 2buj_A 76 EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-----------EDQILWLLLGIC 144 (317)
T ss_dssp HHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCC-----------HHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCC-----------HHHHHHHHHHHH
Confidence 455666778999999999886 456889999999999999998753 2222 233456788999
Q ss_pred HHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-------
Q psy3182 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC------- 206 (255)
Q Consensus 134 ~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~------- 206 (255)
.||.|||++|++||||||+||+++.++.+++ +|||.+........
T Consensus 145 ~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~ 196 (317)
T 2buj_A 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVL----------------------------MDLGSMNQACIHVEGSRQALT 196 (317)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEECTTSCEEE----------------------------CCCSSCEESCEEEESHHHHHH
T ss_pred HHHHHHHhCCcccCCCCHHHEEEcCCCCEEE----------------------------EecCcchhccccccccccccc
Confidence 9999999999999999999999999888888 48887654422110
Q ss_pred --cccccccCCCCcccccccCCC---CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 207 --KTWTFCGTPEYVAPEIIKNRG---HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 207 --~~~~~~gt~~y~aPE~~~~~~---~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp HHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred ccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 012346899999999997654 6889999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-29 Score=212.69 Aligned_cols=159 Identities=25% Similarity=0.397 Sum_probs=125.4
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|+|++++++.+.+.+..|++|||+.||+|.+++............ ......+..++.|++.||.|||+
T Consensus 93 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC---FIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp HHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCC---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcccc---CCCHHHHHHHHHHHHHHHHHHhc
Confidence 456677788999999999999999999999999999998873211111110000 01123445678899999999999
Q ss_pred -cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 -RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 -~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+|++||||||+||+++.++.+++ +|||.+...... ......||+.|+||
T Consensus 170 ~~~i~H~dl~p~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~--~~~~~~~~~~y~aP 219 (348)
T 2pml_X 170 EKNICHRDVKPSNILMDKNGRVKL----------------------------SDFGESEYMVDK--KIKGSRGTYEFMPP 219 (348)
T ss_dssp TSCEECCCCCGGGEEECTTSCEEE----------------------------CCCTTCEECBTT--EECSSCSCGGGCCG
T ss_pred cCCEeecCCChHhEEEcCCCcEEE----------------------------eccccccccccc--cccCCCCCcCccCc
Confidence 99999999999999999888888 499988765332 33456799999999
Q ss_pred ccccCC-CCCC-cchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNR-GHDR-AVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~-~~~~-~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+. .++. ++|+||+||++|+|++|..||..
T Consensus 220 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp GGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999887 6666 89999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=204.33 Aligned_cols=152 Identities=23% Similarity=0.385 Sum_probs=123.2
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++..+.|+|++++++.+.+ +..|++|||+.|++|.+++.... .++ ...+..++.|++.||.||
T Consensus 58 E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~i~~qi~~~l~~l 125 (279)
T 1qpc_A 58 EANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLT-----------INKLLDMAAQIAEGMAFI 125 (279)
T ss_dssp HHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCC-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCC-----------HHHHHHHHHHHHHHHHHH
Confidence 4566777889999999998765 46899999999999999986432 122 233456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYV 218 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~ 218 (255)
|++|++||||||+||+++.++.+++ +|||.+........ ......||+.|+
T Consensus 126 H~~~i~H~dikp~Nil~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~y~ 177 (279)
T 1qpc_A 126 EERNYIHRDLRAANILVSDTLSCKI----------------------------ADFGLARLIEDNEYTAREGAKFPIKWT 177 (279)
T ss_dssp HHTTEECSCCSGGGEEECTTSCEEE----------------------------CCCTTCEECSSSCEECCTTCCCCTTTS
T ss_pred HHCCeeccCCCHhhEEEcCCCCEEE----------------------------CCCcccccccCcccccccCCCCccCcc
Confidence 9999999999999999999888888 48988876543321 122345788999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..++.++|+||+||++|+|++ |..||..
T Consensus 178 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 9999988889999999999999999999 8888853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=202.38 Aligned_cols=149 Identities=26% Similarity=0.494 Sum_probs=111.9
Q ss_pred ceeeecccccccccccccccc-------------CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFK-------------DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFI 128 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~-------------~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i 128 (255)
+++++..+.|+|++++++.+. +.+..|++|||+.||+|.+++...... ...+.+..+
T Consensus 52 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~i 121 (303)
T 1zy4_A 52 EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN----------QQRDEYWRL 121 (303)
T ss_dssp HHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGG----------GCHHHHHHH
T ss_pred HHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccc----------cchHHHHHH
Confidence 455666778999999887664 357789999999999999999753311 111234557
Q ss_pred HHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC----
Q psy3182 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS---- 204 (255)
Q Consensus 129 ~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~---- 204 (255)
+.|++.||.|||++|++||||||+||+++.++.+++. |||.+......
T Consensus 122 ~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~----------------------------dfg~~~~~~~~~~~~ 173 (303)
T 1zy4_A 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG----------------------------DFGLAKNVHRSLDIL 173 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC----------------------------CCCCCSCTTC-----
T ss_pred HHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe----------------------------eCcchhhcccccchh
Confidence 7899999999999999999999999999998888884 77776654321
Q ss_pred ----------CccccccccCCCCcccccccCC-CCCCcchHHHHHHHHHHHhcCC
Q psy3182 205 ----------GCKTWTFCGTPEYVAPEIIKNR-GHDRAVDYWALGILMHELLTGM 248 (255)
Q Consensus 205 ----------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~ 248 (255)
........||+.|+|||++.+. .++.++|+||+||++|+|+++.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~ 228 (303)
T 1zy4_A 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228 (303)
T ss_dssp --------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCC
T ss_pred ccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhcc
Confidence 1123356799999999999864 6899999999999999999843
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=208.59 Aligned_cols=147 Identities=29% Similarity=0.463 Sum_probs=121.9
Q ss_pred eecccc--ccccccccccccCccceeehhhhhcc-hhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 65 LVSRKK--KTRQTRLYKTFKDSKYVYMLLEACLG-GEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 65 l~~~~~--h~~iv~l~~~~~~~~~~ylv~E~~~g-g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++..+. |++++++++.+.+.+..|+++|++.+ ++|.+++.+...+++. .+..++.|++.||.|||+
T Consensus 99 ~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~-----------~~~~i~~qi~~~L~~LH~ 167 (320)
T 3a99_A 99 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE-----------LARSFFWQVLEAVRHCHN 167 (320)
T ss_dssp HHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 344443 69999999999999999999999986 8999999876555432 344577889999999999
Q ss_pred cCcccccCCCCceeeC-CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 142 RGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+||+||||||+||+++ ..+.+++ +|||.++..... ......||+.|+||
T Consensus 168 ~~ivH~Dlkp~NIll~~~~~~~kL----------------------------~Dfg~~~~~~~~--~~~~~~gt~~y~aP 217 (320)
T 3a99_A 168 CGVLHRDIKDENILIDLNRGELKL----------------------------IDFGSGALLKDT--VYTDFDGTRVYSPP 217 (320)
T ss_dssp TTEECCCCSGGGEEEETTTTEEEE----------------------------CCCTTCEECCSS--CBCCCCSCGGGSCH
T ss_pred CCcEeCCCCHHHEEEeCCCCCEEE----------------------------eeCccccccccc--cccCCCCCccCCCh
Confidence 9999999999999998 6677777 599988766432 23346799999999
Q ss_pred ccccCCCC-CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGH-DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~-~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+..+ +.++|+|||||++|+|++|..||.
T Consensus 218 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 99987665 678899999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=206.33 Aligned_cols=150 Identities=28% Similarity=0.379 Sum_probs=104.2
Q ss_pred eeeecccc-ccccccccccc--------cCccceeehhhhhcchhHHHHHHhc---cCCCccchhhHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK-KTRQTRLYKTF--------KDSKYVYMLLEACLGGEVWTILRER---TCFDDNAASFITACVIEALDFITA 130 (255)
Q Consensus 63 vkl~~~~~-h~~iv~l~~~~--------~~~~~~ylv~E~~~gg~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~i~~ 130 (255)
++++.... |+|++++++.+ .+...+|++|||+. |+|.+++... ..+++ ..+..++.
T Consensus 76 ~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~-----------~~~~~i~~ 143 (337)
T 3ll6_A 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSC-----------DTVLKIFY 143 (337)
T ss_dssp HHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCH-----------HHHHHHHH
T ss_pred HHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCH-----------HHHHHHHH
Confidence 33444554 99999998877 55667899999996 6888887642 22222 23456778
Q ss_pred HHHHHHHHHHHcC--cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--
Q psy3182 131 CVIEALEYLHTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-- 206 (255)
Q Consensus 131 ~il~~l~ylH~~~--iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-- 206 (255)
|++.||.|||++| |+||||||+||+++.++.+++ +|||.++.......
T Consensus 144 qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~ 195 (337)
T 3ll6_A 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL----------------------------CDFGSATTISHYPDYS 195 (337)
T ss_dssp HHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB----------------------------CCCTTCBCCSSCC---
T ss_pred HHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE----------------------------ecCccceeccccCccc
Confidence 9999999999999 999999999999999888888 48888766543221
Q ss_pred ----------cccccccCCCCcccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 207 ----------KTWTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 207 ----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.....+||+.|+|||++ .+..++.++|+|||||++|+|++|..||.
T Consensus 196 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp ----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 11245699999999999 56678899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=209.12 Aligned_cols=141 Identities=28% Similarity=0.412 Sum_probs=115.3
Q ss_pred cccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH--HcCcccccC
Q psy3182 72 TRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH--TRGIVFRDL 149 (255)
Q Consensus 72 ~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH--~~~iiHrdl 149 (255)
++++++++.+.+.+..|+|||++. |+|.+++.....-. .....+..++.|++.||.||| +.||+||||
T Consensus 116 ~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl 185 (382)
T 2vx3_A 116 YYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRG---------VSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185 (382)
T ss_dssp GGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSC---------CCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred eeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCC---------CCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence 358888899999999999999996 49999987643111 112345567889999999999 579999999
Q ss_pred CCCceeeCC--CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCC
Q psy3182 150 KPENLLLDN--RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG 227 (255)
Q Consensus 150 kp~nil~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (255)
||+||++.. .+.+++ +|||.++..... ....+||+.|+|||++.+..
T Consensus 186 kp~NIll~~~~~~~~kL----------------------------~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~ 234 (382)
T 2vx3_A 186 KPENILLCNPKRSAIKI----------------------------VDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMP 234 (382)
T ss_dssp SGGGEEESSTTSCCEEE----------------------------CCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCC
T ss_pred CcccEEEecCCCCcEEE----------------------------EeccCceecccc---cccccCCccccChHHHcCCC
Confidence 999999954 556676 599998776432 33568999999999999999
Q ss_pred CCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 228 HDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 228 ~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.++|+||+||++|+|++|..||..
T Consensus 235 ~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 235 YDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-29 Score=212.82 Aligned_cols=157 Identities=16% Similarity=0.166 Sum_probs=114.5
Q ss_pred cccccccccccccccC-------------ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 68 RKKKTRQTRLYKTFKD-------------SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~-------------~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
...|+|++++++.|++ .+.+|+|||||.||++.+.+.+ ..++ ...+..++.|++.
T Consensus 105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~-----------~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSS-----------LATAKSILHQLTA 172 (336)
T ss_dssp SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCC-----------HHHHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCC-----------HHHHHHHHHHHHH
Confidence 3449999999999886 7899999999999987766643 2232 2345678899999
Q ss_pred HHHHHH-HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeC--CeeeeeccccccCCCCCcccccc
Q psy3182 135 ALEYLH-TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISG--GQVKVDFGFSKHLGHSGCKTWTF 211 (255)
Q Consensus 135 ~l~ylH-~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~dfg~s~~~~~~~~~~~~~ 211 (255)
||.||| ++||+||||||+|||++..+........ .+........ ..+.+|||+|+..... +.
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~----------~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~ 237 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL----------NGKSSTIPSCGLQVSIIDYTLSRLERDG-----IV 237 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEE----------TTEEEEEECTTEEEEECCCTTCBEEETT-----EE
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeec----------cCccccccCCCceEEEeeccccEecCCC-----cE
Confidence 999999 9999999999999999877621110000 0000000000 1223699999865432 45
Q ss_pred ccCCCCcccccccCCCCCCcchHHHHHHH-HHHHhcCCCCCc
Q psy3182 212 CGTPEYVAPEIIKNRGHDRAVDYWALGIL-MHELLTGMKESN 252 (255)
Q Consensus 212 ~gt~~y~aPE~~~~~~~~~~~DiWslGvi-l~ell~G~~~~~ 252 (255)
+||+.|||||++.+.. +.++||||++++ .+++++|..||.
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 8999999999999876 889999998777 778889999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-28 Score=216.57 Aligned_cols=151 Identities=18% Similarity=0.290 Sum_probs=118.1
Q ss_pred eeeeccccc-cccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKK-TRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~h-~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++..+.| +++..+...+.+.+..|++|||+ |++|.+++... ..+++ ..+..++.||+.||.|||
T Consensus 53 ~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~-----------~~~~~i~~qi~~aL~yLH 120 (483)
T 3sv0_A 53 SKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL-----------KTVLMLADQMINRVEFVH 120 (483)
T ss_dssp HHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 344555555 34444555566778889999999 99999999742 22332 334567889999999999
Q ss_pred HcCcccccCCCCceee---CCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-------cccc
Q psy3182 141 TRGIVFRDLKPENLLL---DNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-------KTWT 210 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-------~~~~ 210 (255)
++||+||||||+|||+ +..+.+++ +|||+++....... ....
T Consensus 121 ~~gIvHrDIKP~NILl~~~~~~~~vkL----------------------------~DFGla~~~~~~~~~~~~~~~~~~~ 172 (483)
T 3sv0_A 121 SKSFLHRDIKPDNFLMGLGRRANQVYI----------------------------IDFGLAKKYRDTSTHQHIPYRENKN 172 (483)
T ss_dssp HTTEECCCCCGGGEEECCGGGTTCEEE----------------------------CCCTTCEECBCTTTCCBCCCCCCCC
T ss_pred HCCEeecccCcceEEEecCCCCCeEEE----------------------------EeCCcceeccCCccccccccccccc
Confidence 9999999999999999 46677777 58998876543221 1225
Q ss_pred cccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 211 FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 173 ~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 6899999999999999999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-28 Score=205.47 Aligned_cols=152 Identities=27% Similarity=0.355 Sum_probs=122.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..+.|+|++++++.+.+.. .++++|++.+|+|.+.+.... .+++ ..+..++.|++.||.|||
T Consensus 71 e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH 138 (291)
T 1u46_A 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-----------GTLSRYAVQVAEGMGYLE 138 (291)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCH-----------HHHHHHHHHHHHHHHHHH
Confidence 455667778999999999988765 899999999999999987642 2222 334557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~y 217 (255)
++|++||||||+||+++.++.+++ +|||.+........ ......||+.|
T Consensus 139 ~~~i~H~dikp~Nili~~~~~~kl----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 190 (291)
T 1u46_A 139 SKRFIHRDLAARNLLLATRDLVKI----------------------------GDFGLMRALPQNDDHYVMQEHRKVPFAW 190 (291)
T ss_dssp HTTEECSCCCGGGEEEEETTEEEE----------------------------CCCTTCEECCC-CCEEEC-----CCGGG
T ss_pred hCCcccCCCchheEEEcCCCCEEE----------------------------ccccccccccccccchhhhccCCCCcee
Confidence 999999999999999998888887 48888876544322 12234678899
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+|||++.+..++.++|+||+|+++|+|++ |..||..
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999998889999999999999999999 9999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-28 Score=202.92 Aligned_cols=152 Identities=28% Similarity=0.487 Sum_probs=118.3
Q ss_pred ceeeeccccccccccccccc--cCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTF--KDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALE 137 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~--~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ 137 (255)
+++++..+.|+|++++++.+ .+....|++|||+.+| +.+.+.... .++ ...+..++.|++.||.
T Consensus 56 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~-----------~~~~~~~~~qi~~al~ 123 (305)
T 2wtk_C 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFP-----------VCQAHGYFCQLIDGLE 123 (305)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCC-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccC-----------HHHHHHHHHHHHHHHH
Confidence 45667778899999999988 5567899999999988 666665422 122 2234557789999999
Q ss_pred HHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--CccccccccCC
Q psy3182 138 YLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCGTP 215 (255)
Q Consensus 138 ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~gt~ 215 (255)
|||++|++||||||+||+++.++.+++ .|||.+...... ........||+
T Consensus 124 ~LH~~~i~H~dlkp~NIl~~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~ 175 (305)
T 2wtk_C 124 YLHSQGIVHKDIKPGNLLLTTGGTLKI----------------------------SALGVAEALHPFAADDTCRTSQGSP 175 (305)
T ss_dssp HHHHTTEECSCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCTTCSSCEECCCCSCG
T ss_pred HHHHCCeeecCCCcccEEEcCCCcEEe----------------------------eccccccccCccccccccccCCCCC
Confidence 999999999999999999999888888 488887655322 12223567999
Q ss_pred CCcccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKNRG--HDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~--~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+.. ++.++|+||+||++|+|++|..||..
T Consensus 176 ~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp GGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998644 36789999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-28 Score=208.01 Aligned_cols=151 Identities=23% Similarity=0.430 Sum_probs=119.5
Q ss_pred ceeeeccccccccccccccccC-----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD-----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~-----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++..+.|+|++++++.+.+ ....|++||++. |+|.+.+... .+++ ..+..++.|++.||
T Consensus 59 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~-----------~~~~~~~~qi~~~L 125 (353)
T 2b9h_A 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ-MLSD-----------DHIQYFIYQTLRAV 125 (353)
T ss_dssp HHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC-CCCH-----------HHHHHHHHHHHHHH
T ss_pred HHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc-CCCH-----------HHHHHHHHHHHHHH
Confidence 4566777889999999976654 378899999997 5898888753 2332 23456788999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----------
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---------- 206 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---------- 206 (255)
.|||++|++||||||+||+++.++.+++ +|||.++.......
T Consensus 126 ~~LH~~~ivH~Dlkp~Nil~~~~~~~kl----------------------------~Dfg~a~~~~~~~~~~~~~~~~~~ 177 (353)
T 2b9h_A 126 KVLHGSNVIHRDLKPSNLLINSNCDLKV----------------------------CDFGLARIIDESAADNSEPTGQQS 177 (353)
T ss_dssp HHHHHTTEECSCCCGGGEEECTTCCEEE----------------------------CCCTTCEECC--------------
T ss_pred HHHHHCCeecCCCCHHHeEEcCCCcEEE----------------------------EecccccccccccccccCcccccc
Confidence 9999999999999999999999988888 48887765432211
Q ss_pred cccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 207 KTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp --CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred chhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1224579999999998764 6789999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-28 Score=222.92 Aligned_cols=151 Identities=21% Similarity=0.356 Sum_probs=122.2
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++..+.|+|++++++.+.+ ..+|+||||+.||+|.++++... .++ ...+..++.|++.||.|||
T Consensus 313 ~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~-----------~~~~~~i~~qi~~~L~~LH 380 (535)
T 2h8h_A 313 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLR-----------LPQLVDMAAQIASGMAYVE 380 (535)
T ss_dssp HHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCC-----------HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCC-----------HHHHHHHHHHHHHHHHHHH
Confidence 344556789999999998876 67899999999999999997432 122 2234557789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
+++|+||||||+|||++.++.+++ +|||+++....... ......+|+.|+|
T Consensus 381 ~~~ivHrDlkp~NIll~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~~~~y~a 432 (535)
T 2h8h_A 381 RMNYVHRDLRAANILVGENLVCKV----------------------------ADFGLARLIEDNEYTARQGAKFPIKWTA 432 (535)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEE----------------------------CCTTSTTTCCCHHHHTTCSTTSCGGGSC
T ss_pred hCCeeCCCCCHhhEEEcCCCcEEE----------------------------cccccceecCCCceecccCCcCcccccC
Confidence 999999999999999998888888 59999876543211 1123456788999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||++.+..++.++|||||||++|||++ |..||..
T Consensus 433 PE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999998889999999999999999999 8888863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=226.25 Aligned_cols=149 Identities=28% Similarity=0.447 Sum_probs=118.7
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcC
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLHTRG 143 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~ 143 (255)
++..+.|+|++++++.+.+ +..|+||||+.||+|.+++..+. .++ ...+..++.|++.||.|||++|
T Consensus 444 ~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~-----------~~~~~~i~~qi~~aL~~LH~~g 511 (656)
T 2j0j_A 444 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLD-----------LASLILYAYQLSTALAYLESKR 511 (656)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCC-----------HHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCC-----------HHHHHHHHHHHHHHHHHHHhCC
Confidence 3455689999999998854 56899999999999999997543 122 1234457789999999999999
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCccccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVAPEI 222 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~aPE~ 222 (255)
|+||||||+||+++.++.+++ +|||+++....... ......||+.|+|||+
T Consensus 512 ivHrDikp~NILl~~~~~vkL----------------------------~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~ 563 (656)
T 2j0j_A 512 FVHRDIAARNVLVSSNDCVKL----------------------------GDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563 (656)
T ss_dssp CCCSCCSGGGEEEEETTEEEE----------------------------CCCCCCCSCCC----------CCGGGCCHHH
T ss_pred ccccccchHhEEEeCCCCEEE----------------------------EecCCCeecCCCcceeccCCCCCcceeCHHH
Confidence 999999999999999888888 59999876644321 1223457789999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
+.+..++.++|+||+||++|||++ |..||..
T Consensus 564 ~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 998899999999999999999997 8999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=219.16 Aligned_cols=151 Identities=26% Similarity=0.517 Sum_probs=125.3
Q ss_pred ceeeeccccccccccccccccC------ccceeehhhhhcchhHHHHHHhcc---CCCccchhhHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKD------SKYVYMLLEACLGGEVWTILRERT---CFDDNAASFITACVIEALDFITACV 132 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~------~~~~ylv~E~~~gg~l~~~l~~~~---~~~~~~~~~~~~~~~~~~~~i~~~i 132 (255)
+++++..+.|+|++++++.+.+ .+..|++||||.||+|.+++.... .+++. .+..++.|+
T Consensus 62 Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~-----------~i~~I~~QL 130 (676)
T 3qa8_A 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-----------PIRTLLSDI 130 (676)
T ss_dssp HHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSS-----------HHHHHHHHH
T ss_pred HHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHH-----------HHHHHHHHH
Confidence 4667778899999999888765 778899999999999999998643 23332 234567889
Q ss_pred HHHHHHHHHcCcccccCCCCceeeCCCCc---eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccc
Q psy3182 133 IEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTW 209 (255)
Q Consensus 133 l~~l~ylH~~~iiHrdlkp~nil~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~ 209 (255)
+.||.|||++||+||||||+||+++.++. +++ +|||.+....... ...
T Consensus 131 l~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL----------------------------~DFG~a~~~~~~~-~~~ 181 (676)
T 3qa8_A 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI----------------------------IDLGYAKELDQGE-LCT 181 (676)
T ss_dssp HHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE----------------------------CSCCCCCBTTSCC-CCC
T ss_pred HHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE----------------------------ccccccccccccc-ccc
Confidence 99999999999999999999999986653 455 5999987765432 234
Q ss_pred ccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 210 TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
..+||+.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 182 ~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 5689999999999999999999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-28 Score=204.43 Aligned_cols=150 Identities=27% Similarity=0.479 Sum_probs=115.9
Q ss_pred eeeecccc--ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKK--KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~--h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++++..+. |++++++++.+.+.+..|++|| +.+++|.+++.+...+++. .+..++.|++.||.|||
T Consensus 77 ~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~-----------~~~~i~~qi~~aL~~LH 144 (313)
T 3cek_A 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW-----------ERKSYWKNMLEAVHTIH 144 (313)
T ss_dssp HHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 44455555 5899999999999999999999 7789999999876554432 23456788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
++|++||||||+||+++. +.+++ +|||.++....... .....+||+.|+
T Consensus 145 ~~~ivH~dlkp~NIl~~~-~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 195 (313)
T 3cek_A 145 QHGIVHSDLKPANFLIVD-GMLKL----------------------------IDFGIANQMQPDTTSVVKDSQVGTVNYM 195 (313)
T ss_dssp HTTCCCCCCCGGGEEEET-TEEEE----------------------------CCCSSSCC--------------CCGGGC
T ss_pred HCCceecCCCcccEEEEC-CeEEE----------------------------eeccccccccCccccccccCCCCCCCcC
Confidence 999999999999999954 66777 59998876543221 223457999999
Q ss_pred ccccccC-----------CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKN-----------RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~-----------~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 196 aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 9999975 4678899999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-28 Score=205.04 Aligned_cols=142 Identities=28% Similarity=0.462 Sum_probs=115.8
Q ss_pred cccccccccccccCccceeehhhh-hcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCccccc
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEA-CLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRD 148 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~-~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrd 148 (255)
.|+|++++++.+.+.+..|+++|+ +.|++|.+++.++..+++. .+..++.|++.||.|||++|++|||
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~-----------~~~~~~~qi~~~l~~lH~~~i~H~d 164 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-----------PSRCFFGQVVAAIQHCHSRGVVHRD 164 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHHHTEECCC
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHH-----------HHHHHHHHHHHHHHHHHHCCeeecC
Confidence 799999999999999999999999 7899999999876555432 3445778899999999999999999
Q ss_pred CCCCceeeC-CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCC
Q psy3182 149 LKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG 227 (255)
Q Consensus 149 lkp~nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (255)
|||+||+++ .++.+++ +|||.+...... ......||+.|+|||++.+..
T Consensus 165 lkp~Nil~~~~~~~~kl----------------------------~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 214 (312)
T 2iwi_A 165 IKDENILIDLRRGCAKL----------------------------IDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQ 214 (312)
T ss_dssp CSGGGEEEETTTTEEEE----------------------------CCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSC
T ss_pred CChhhEEEeCCCCeEEE----------------------------EEcchhhhcccC--cccccCCcccccCceeeecCC
Confidence 999999998 6777777 599988765443 233567999999999998766
Q ss_pred CC-CcchHHHHHHHHHHHhcCCCCCc
Q psy3182 228 HD-RAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 228 ~~-~~~DiWslGvil~ell~G~~~~~ 252 (255)
+. .++|+||+||++|+|++|..||.
T Consensus 215 ~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 215 YHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCccchHHHHHHHHHHHHHCCCCCC
Confidence 64 58999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-28 Score=207.89 Aligned_cols=140 Identities=24% Similarity=0.402 Sum_probs=114.3
Q ss_pred cccccccccccccCcc----ceeehhhhhcchhHHHHHHhccC--CCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc-
Q psy3182 70 KKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALDFITACVIEALEYLHTR- 142 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~--~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~- 142 (255)
.|+|++++++.+.+.. .++++||++ |++|.+++..... ++ ...+..++.|++.||.|||++
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~-----------~~~~~~i~~qi~~aL~~lH~~~ 151 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIP-----------LIYVKQISKQLLLGLDYMHRRC 151 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCC-----------HHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCc-----------HHHHHHHHHHHHHHHHHHHhcC
Confidence 4889999999887654 799999999 9999999876332 22 123456788999999999998
Q ss_pred CcccccCCCCceeeCCC------CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 143 GIVFRDLKPENLLLDNR------GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
||+||||||+||+++.. +.+++ +|||.+...... ....+||+.
T Consensus 152 ~ivH~Dikp~NIll~~~~~~~~~~~~kl----------------------------~Dfg~a~~~~~~---~~~~~~t~~ 200 (373)
T 1q8y_A 152 GIIHTDIKPENVLMEIVDSPENLIQIKI----------------------------ADLGNACWYDEH---YTNSIQTRE 200 (373)
T ss_dssp CEECSCCSGGGEEEEEEETTTTEEEEEE----------------------------CCCTTCEETTBC---CCSCCSCGG
T ss_pred CEEecCCChHHeEEeccCCCcCcceEEE----------------------------cccccccccCCC---CCCCCCCcc
Confidence 99999999999999532 24455 599998765432 234579999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 201 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 201 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp GCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=207.40 Aligned_cols=147 Identities=27% Similarity=0.496 Sum_probs=116.9
Q ss_pred ceeeeccccccccccccccccCccc------eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKY------VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~------~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
+++++..+.|+|++++++.+.+... .|++|||+. |+|.+.+.. .+++ +.+..++.|++.|
T Consensus 73 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~-----------~~~~~i~~qi~~a 138 (353)
T 3coi_A 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSE-----------EKIQYLVYQMLKG 138 (353)
T ss_dssp HHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS--CCCH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC--CCCH-----------HHHHHHHHHHHHH
Confidence 4556677789999999999887654 499999997 577665532 1222 3355678899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++|++||||||+||+++.++.+++ +|||.++.... .....+||+
T Consensus 139 l~~LH~~~ivH~dlkp~NIl~~~~~~~kl----------------------------~Dfg~~~~~~~---~~~~~~~t~ 187 (353)
T 3coi_A 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKI----------------------------LDFGLARHADA---EMTGYVVTR 187 (353)
T ss_dssp HHHHHHTTCCCSSCCGGGEEECTTCCEEE----------------------------CSTTCTTC-----------CCSB
T ss_pred HHHHHHCCcccCCCCHHHEeECCCCcEEE----------------------------eecccccCCCC---CccccccCc
Confidence 99999999999999999999999888888 59998876533 233568999
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 216 EYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 188 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp CCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999987 6789999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=202.94 Aligned_cols=148 Identities=30% Similarity=0.401 Sum_probs=102.5
Q ss_pred eeccccccccccccccccCccceeehhhhhcchhHHHHHHh-----ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 65 LVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE-----RTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++....|+|++++++.+.+.+..|++|||+.| +|.+++.. ...++ .+.+..++.|++.||.||
T Consensus 74 ~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~-----------~~~~~~i~~~i~~~l~~l 141 (327)
T 3aln_A 74 VMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIP-----------EEILGKITLATVKALNHL 141 (327)
T ss_dssp HHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCC-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCc-----------HHHHHHHHHHHHHHHHHH
Confidence 34556899999999999999999999999986 67666653 12222 233456778999999999
Q ss_pred HHc-CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 140 HTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 140 H~~-~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
|++ |++||||||+||+++.++.+++ +|||.++...... ......||+.|+
T Consensus 142 H~~~~ivH~dlkp~NIll~~~~~~kl----------------------------~Dfg~~~~~~~~~-~~~~~~gt~~y~ 192 (327)
T 3aln_A 142 KENLKIIHRDIKPSNILLDRSGNIKL----------------------------CDFGISGQLVDSI-AKTRDAGCRPYM 192 (327)
T ss_dssp HHHHSCCCSCCCGGGEEEETTTEEEE----------------------------CCCSSSCC------------------
T ss_pred hccCCEeECCCCHHHEEEcCCCCEEE----------------------------ccCCCceeccccc-ccccCCCCcccc
Confidence 999 9999999999999999888888 5999887654432 222347999999
Q ss_pred ccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEII----KNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~----~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++ .+..++.++|+||+||++|+|++|..||..
T Consensus 193 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp -------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred CceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999 456789999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-28 Score=206.65 Aligned_cols=152 Identities=22% Similarity=0.323 Sum_probs=121.6
Q ss_pred ceeeeccccccccccccccccCcc--ceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSK--YVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~--~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+++++..+.|+|++++++.+.+.+ .+|++|||+.||+|.+++..... +++ ..+..++.|++.||.|
T Consensus 92 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~aL~~ 160 (326)
T 2w1i_A 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----------IKLLQYTSQICKGMEY 160 (326)
T ss_dssp HHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCH-----------HHHHHHHHHHHHHHHH
Confidence 345566778999999999876644 78999999999999999976432 222 2344577899999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTP 215 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~ 215 (255)
||++|++||||||+||+++.++.+++ +|||.+......... .....||+
T Consensus 161 LH~~~ivH~dikp~NIli~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~ 212 (326)
T 2w1i_A 161 LGTKRYIHRDLATRNILVENENRVKI----------------------------GDFGLTKVLPQDKEYYKVKEPGESPI 212 (326)
T ss_dssp HHHTTEECSCCCGGGEEEEETTEEEE----------------------------CCCTTCEECCSSCSEEECSSCCSCCG
T ss_pred HHhCCEeccCCCcceEEEcCCCcEEE----------------------------ecCcchhhccccccccccccCCCCce
Confidence 99999999999999999998888888 488888765443211 12345777
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 213 ~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred eEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 8999999998889999999999999999999988764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-28 Score=225.16 Aligned_cols=144 Identities=23% Similarity=0.382 Sum_probs=116.5
Q ss_pred ceeeeccccccccccccccccCccc-----eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKY-----VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~-----~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
+++++..+.|+|++++++.+.+.+. .|+||||+.|++|.+.+.. .+++ ..+..++.|++.||
T Consensus 129 E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~-----------~~~~~~~~qi~~aL 195 (681)
T 2pzi_A 129 ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPV-----------AEAIAYLLEILPAL 195 (681)
T ss_dssp HHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCH-----------HHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCH-----------HHHHHHHHHHHHHH
Confidence 4566778889999999999887665 7999999999999876653 2222 33455778999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
.|||++||+||||||+||+++.. .+++ +|||.++..... ...+||+.
T Consensus 196 ~~lH~~giiHrDlkp~NIll~~~-~~kl----------------------------~DFG~a~~~~~~----~~~~gt~~ 242 (681)
T 2pzi_A 196 SYLHSIGLVYNDLKPENIMLTEE-QLKL----------------------------IDLGAVSRINSF----GYLYGTPG 242 (681)
T ss_dssp HHHHHTTEECCCCSGGGEEECSS-CEEE----------------------------CCCTTCEETTCC----SCCCCCTT
T ss_pred HHHHHCCCeecccChHHeEEeCC-cEEE----------------------------EecccchhcccC----CccCCCcc
Confidence 99999999999999999999874 6666 599998776443 35679999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+|||++.+. ++.++||||+||++|+|++|.+||.
T Consensus 243 y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 243 FQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp TSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred ccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCc
Confidence 9999999765 4889999999999999999998875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=201.42 Aligned_cols=151 Identities=22% Similarity=0.397 Sum_probs=117.6
Q ss_pred ceeeeccccccccccccccc--------------cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTF--------------KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDF 127 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~--------------~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 127 (255)
+++++..+.|+|++++++.+ .+....|++|||+. |+|.+++.+ ..+++ +.+..
T Consensus 58 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~-----------~~~~~ 124 (320)
T 2i6l_A 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLE-----------EHARL 124 (320)
T ss_dssp HHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCH-----------HHHHH
T ss_pred HHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccH-----------HHHHH
Confidence 45667777899999998766 44578899999998 599988864 23332 23455
Q ss_pred HHHHHHHHHHHHHHcCcccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--
Q psy3182 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-- 204 (255)
Q Consensus 128 i~~~il~~l~ylH~~~iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-- 204 (255)
++.|++.||.|||++|++||||||+||+++. .+.+++ +|||.++.....
T Consensus 125 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl----------------------------~Dfg~~~~~~~~~~ 176 (320)
T 2i6l_A 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI----------------------------GDFGLARIMDPHYS 176 (320)
T ss_dssp HHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE----------------------------CCCTTCBCC-----
T ss_pred HHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE----------------------------ccCccccccCCCcc
Confidence 7789999999999999999999999999974 456777 489988765322
Q ss_pred -CccccccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 205 -GCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 205 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp ---CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence 112234568999999999865 6789999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=204.87 Aligned_cols=139 Identities=19% Similarity=0.312 Sum_probs=113.4
Q ss_pred ccccccccccccccCcc----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH----
Q psy3182 69 KKKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH---- 140 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH---- 140 (255)
..|+|++++++.+.+.. ..|++|||+.+|+|.+++.+. .+++ +.+..++.|++.||.|||
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~-----------~~~~~i~~~i~~~l~~lH~~~~ 160 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTV-----------EGMIKLALSTASGLAHLHMEIV 160 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCH-----------HHHHHHHHHHHHHHHHHHCCBC
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccH-----------HHHHHHHHHHHHHHHHHHHHHh
Confidence 68999999999988776 899999999999999999753 2222 234457788999999999
Q ss_pred ----HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----cccccc
Q psy3182 141 ----TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC----KTWTFC 212 (255)
Q Consensus 141 ----~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~----~~~~~~ 212 (255)
+++++||||||+||+++.++.+++ +|||.+........ ......
T Consensus 161 ~~~~~~~ivH~Dlkp~NIll~~~~~~kL----------------------------~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (342)
T 1b6c_B 161 GTQGKPAIAHRDLKSKNILVKKNGTCCI----------------------------ADLGLAVRHDSATDTIDIAPNHRV 212 (342)
T ss_dssp STTCBCEEECSCCSGGGEEECTTSCEEE----------------------------CCCTTCEEEETTTTEEEECCCSCC
T ss_pred hhcccCCeeeCCCCHHHEEECCCCCEEE----------------------------EECCCceeccccccccccccccCC
Confidence 899999999999999999888888 48888765433221 123457
Q ss_pred cCCCCcccccccCCC------CCCcchHHHHHHHHHHHhcC
Q psy3182 213 GTPEYVAPEIIKNRG------HDRAVDYWALGILMHELLTG 247 (255)
Q Consensus 213 gt~~y~aPE~~~~~~------~~~~~DiWslGvil~ell~G 247 (255)
||+.|+|||++.+.. ++.++|+||+||++|+|++|
T Consensus 213 gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999999999998752 23689999999999999999
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=197.49 Aligned_cols=147 Identities=31% Similarity=0.486 Sum_probs=109.6
Q ss_pred eccccccccccccccccCccceeehhhhhcchhHHHHHHh-ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc-C
Q psy3182 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALDFITACVIEALEYLHTR-G 143 (255)
Q Consensus 66 ~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~-~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~-~ 143 (255)
+....|+|++++++.+.+.+..|++|||+ ++.+..+... ...+++ ..+..++.|++.||.|||++ |
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~-----------~~~~~~~~~i~~~l~~lH~~~~ 145 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE-----------RILGKMTVAIVKALYYLKEKHG 145 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCH-----------HHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCH-----------HHHHHHHHHHHHHHHHHHhhCC
Confidence 45568999999999999999999999999 5556555543 222322 23456778999999999995 9
Q ss_pred cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccc
Q psy3182 144 IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII 223 (255)
Q Consensus 144 iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (255)
++||||||+||+++.++.+++ .|||.+....... ......||+.|+|||++
T Consensus 146 i~H~dlkp~Nil~~~~~~~kl----------------------------~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~ 196 (318)
T 2dyl_A 146 VIHRDVKPSNILLDERGQIKL----------------------------CDFGISGRLVDDK-AKDRSAGCAAYMAPERI 196 (318)
T ss_dssp CCCCCCCGGGEEECTTSCEEE----------------------------CCCTTC---------------CCTTCCHHHH
T ss_pred EEeCCCCHHHEEECCCCCEEE----------------------------EECCCchhccCCc-cccccCCCccccChhhc
Confidence 999999999999999888888 5999886654332 22345799999999999
Q ss_pred c-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 224 K-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 224 ~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
. ...++.++|+||+||++|+|++|..||..
T Consensus 197 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp C--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 5 45688999999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-26 Score=190.67 Aligned_cols=123 Identities=15% Similarity=0.110 Sum_probs=101.8
Q ss_pred eeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
++.+....|+|++++++.+.+.+..|+||||+.|++|.+++++. . .. ..+..++.|++.||.|||++
T Consensus 82 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~-~~-----------~~~~~i~~ql~~aL~~lH~~ 148 (286)
T 3uqc_A 82 TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-P-SP-----------VGAIRAMQSLAAAADAAHRA 148 (286)
T ss_dssp HHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-C-CH-----------HHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-C-Ch-----------HHHHHHHHHHHHHHHHHHHC
Confidence 45567778999999999999999999999999999999998542 1 11 11334678999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEI 222 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~ 222 (255)
||+||||||+||+++.++.+++ . ++.|++|
T Consensus 149 givH~Dikp~NIll~~~g~~kl-----------------------------~-------------------~~~~~~~-- 178 (286)
T 3uqc_A 149 GVALSIDHPSRVRVSIDGDVVL-----------------------------A-------------------YPATMPD-- 178 (286)
T ss_dssp TCCCCCCSGGGEEEETTSCEEE-----------------------------C-------------------SCCCCTT--
T ss_pred CCccCCCCcccEEEcCCCCEEE-----------------------------E-------------------eccccCC--
Confidence 9999999999999988876665 1 2345554
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 223 IKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.++|+|||||++|+|++|..||..
T Consensus 179 -----~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 179 -----ANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp -----CCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred -----CCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 78899999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-25 Score=194.94 Aligned_cols=131 Identities=24% Similarity=0.260 Sum_probs=99.9
Q ss_pred ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeec
Q psy3182 86 YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLE 165 (255)
Q Consensus 86 ~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~ 165 (255)
..+++|+. .+++|.+++.......... ..........++.|++.||.|||++||+||||||+|||++.++.+|+
T Consensus 179 ~~~~~~~~-~~~~L~~ll~~l~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL- 252 (413)
T 3dzo_A 179 SRFFLYPR-MQSNLQTFGEVLLSHSSTH----KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL- 252 (413)
T ss_dssp SEEEEEEC-CSEEHHHHHHHHHHHTTTS----HHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE-
T ss_pred ceEEEeeh-hcCCHHHHHHHhhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEE-
Confidence 34666664 5678888775321101111 11223345567789999999999999999999999999999998888
Q ss_pred ccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccc----------cCCCCCCcchHH
Q psy3182 166 FYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII----------KNRGHDRAVDYW 235 (255)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiW 235 (255)
+|||+++..... ..+.+| +.|+|||++ .+..++.++|+|
T Consensus 253 ---------------------------~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 253 ---------------------------TGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp ---------------------------CCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred ---------------------------EeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 599998765432 445788 999999999 556688899999
Q ss_pred HHHHHHHHHhcCCCCCcC
Q psy3182 236 ALGILMHELLTGMKESNV 253 (255)
Q Consensus 236 slGvil~ell~G~~~~~~ 253 (255)
||||++|+|++|..||..
T Consensus 302 SlGvil~elltg~~Pf~~ 319 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTD 319 (413)
T ss_dssp HHHHHHHHHHHSSCCCCT
T ss_pred HHHHHHHHHHHCCCCCCC
Confidence 999999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=182.94 Aligned_cols=125 Identities=31% Similarity=0.584 Sum_probs=103.2
Q ss_pred ccccccccccccccccC----ccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 67 SRKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 67 ~~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
....|+|++++++.+.+ ...+|++|||+.||+|.+++.... .+++ ..+..++.|++.||.|||
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-----------~~~~~i~~qi~~~l~~lH 134 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-----------REASEIMKSIGEAIQYLH 134 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 44579999999998876 788999999999999999998653 2322 334567889999999999
Q ss_pred HcCcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
++|++||||||+||+++. .+.+++ +|||.+....
T Consensus 135 ~~~i~H~dlkp~Nil~~~~~~~~~~kl----------------------------~Dfg~a~~~~--------------- 171 (299)
T 3m2w_A 135 SINIAHRDVKPENLLYTSKRPNAILKL----------------------------TDFGFAKETT--------------- 171 (299)
T ss_dssp HTTEECCCCSGGGEEESSSSTTCCEEE----------------------------CCCTTCEECT---------------
T ss_pred hCCcccCCCCHHHEEEecCCCCCcEEE----------------------------eccccccccc---------------
Confidence 999999999999999987 556666 5999875432
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+..++.++|+||+||++|+|++|..||.
T Consensus 172 -------~~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 172 -------GEKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp -------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 2346789999999999999999999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.1e-24 Score=191.59 Aligned_cols=142 Identities=16% Similarity=0.152 Sum_probs=114.0
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++.....+.+..|++|||+.||+|.+++.+ ...++.|++.||.|||
T Consensus 388 ~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-------------------~~~i~~qi~~aL~~LH 448 (540)
T 3en9_A 388 REARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-------------------NLDIAYKIGEIVGKLH 448 (540)
T ss_dssp HHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-------------------CTHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-------------------HHHHHHHHHHHHHHHH
Confidence 345667778999999444444466677999999999999998864 1236788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-------cccccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-------TWTFCG 213 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-------~~~~~g 213 (255)
++||+||||||+||+++. .+++ +|||+++........ ..+.+|
T Consensus 449 ~~gIiHrDiKp~NILl~~--~~kL----------------------------~DFGla~~~~~~~~~~~~~~~~~~~~~G 498 (540)
T 3en9_A 449 KNDVIHNDLTTSNFIFDK--DLYI----------------------------IDFGLGKISNLDEDKAVDLIVFKKAVLS 498 (540)
T ss_dssp HTTEECTTCCTTSEEESS--SEEE----------------------------CCCTTCEECCCHHHHHHHHHHHHHHHHH
T ss_pred HCcCccCCCCHHHEEECC--eEEE----------------------------EECccCEECCCccccccchhhhhhhhcC
Confidence 999999999999999988 7777 599999877553221 236789
Q ss_pred CCCCcccccccC--CCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 214 TPEYVAPEIIKN--RGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 214 t~~y~aPE~~~~--~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
|+.|||||++.. ..|+..+|+||..+-..+...+..++
T Consensus 499 T~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 499 THHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999999999987 67888899999998888877666554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=153.03 Aligned_cols=96 Identities=29% Similarity=0.412 Sum_probs=80.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc----c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT----R 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv----~ 76 (255)
||||||.||+|++++++.+.++|.++..++.|++.|++|+|++||+||||||+||+++.++.+|+.+........ .
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 699999999999999998999999999999999999999999999999999999999999999998876543221 0
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
....-..++..||.+|.+.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH
T ss_pred ccccCcccCcccCCHHHHcC
Confidence 11111236778999997744
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=149.89 Aligned_cols=96 Identities=31% Similarity=0.444 Sum_probs=79.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
||||||.||+|++++++.+.++|.++..++.|++.|++|+|++||+||||||+|+|++.+|.+|+.+.........- .
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 69999999999999999899999999999999999999999999999999999999999999999887654322111 1
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..||.+|.+.+
T Consensus 183 ~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp CCSCCCCGGGCCHHHHHT
T ss_pred ccccccCcccCCHHHhcc
Confidence 112346778999997644
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=5.2e-19 Score=150.72 Aligned_cols=96 Identities=26% Similarity=0.427 Sum_probs=78.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC-ceeeecccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG-YVKLVSRKKKTRQTR--L 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~-~vkl~~~~~h~~iv~--l 77 (255)
||||||.||+|.+++++.+.++|.++..++.|++.|++|+|+++|+||||||+|||++.+| .+|+.++........ .
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 6999999999999999989999999999999999999999999999999999999999987 599988764332110 0
Q ss_pred c-----ccccCccceeehhhhhcc
Q psy3182 78 Y-----KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~-----~~~~~~~~~ylv~E~~~g 96 (255)
. .....++..||.+|.+.|
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTT
T ss_pred ccceecCCccccCccccCHHHHCC
Confidence 0 111235678999997754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.7e-19 Score=150.18 Aligned_cols=95 Identities=23% Similarity=0.342 Sum_probs=79.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
||||||.||+|++++++ +.++|.++..++.|++.|++|||++||+||||||+|||++.+|.+|+.++.....+..-.
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 69999999999999976 569999999999999999999999999999999999999999999999876543322111
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
..-..++..||.+|.+.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISR 244 (346)
T ss_dssp BCCCCSCGGGCCHHHHTT
T ss_pred ccccccCcCcCCHHHHCC
Confidence 112235678999997754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5.8e-19 Score=161.86 Aligned_cols=111 Identities=28% Similarity=0.443 Sum_probs=89.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
||||||.||+|+.++.+.+.|+|..+.+|++|++.|++|||++||+||||||+|||++.+|.+||.+.........-...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~ 348 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCCC
Confidence 69999999999999999899999999999999999999999999999999999999999999999887654332211112
Q ss_pred ccCccceeehhhhhcch-------h-------HHHHHHhccCCCc
Q psy3182 81 FKDSKYVYMLLEACLGG-------E-------VWTILRERTCFDD 111 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~gg-------~-------l~~~l~~~~~~~~ 111 (255)
-..++..||.+|.+.+| | |+..+..+.+|..
T Consensus 349 t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 23467789999987532 3 3455666667754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=144.54 Aligned_cols=96 Identities=22% Similarity=0.262 Sum_probs=78.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCcceeecc-cCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLDN-RGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~--i~~rdiK~~nil~~~-~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+++++.+.+++..+..++.|++.|++|+|+++ |+||||||+|||++. ++.+|+.+.........-
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 69999999999999999889999999999999999999999999 999999999999974 789999887654311111
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
...-..++..||.+|.+.+
T Consensus 186 ~~~~~~GTp~YmAPE~~~~ 204 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT
T ss_pred ccCCcccCccccCHHHcCC
Confidence 1112245778999997643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.3e-18 Score=147.44 Aligned_cols=96 Identities=21% Similarity=0.323 Sum_probs=78.0
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
||||||.||+|++++... ..++|.++..++.|++.|++|+|++||+||||||+|||++.+|.+||.++........-.
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 699999999999999754 357999999999999999999999999999999999999999999998876543221110
Q ss_pred --ccccCccceeehhhhhcc
Q psy3182 79 --KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 --~~~~~~~~~ylv~E~~~g 96 (255)
.....++..||.+|.+.|
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTT
T ss_pred ccccccCCCccccCHHHHCC
Confidence 111235678999997755
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.5e-18 Score=150.59 Aligned_cols=95 Identities=23% Similarity=0.342 Sum_probs=78.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
||||||.||+|+++++. +.++|.++..++.|++.||+|||++||+||||||+|||++.+|.+||.++.....+..-.
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 69999999999999976 569999999999999999999999999999999999999999999999876543322111
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
..-..++..||.+|.+.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~ 321 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISR 321 (423)
T ss_dssp BCCCEECTTTCCHHHHTT
T ss_pred ccccccCcCcCCHHHHCC
Confidence 111235677999997754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.74 E-value=3.1e-18 Score=142.27 Aligned_cols=95 Identities=32% Similarity=0.392 Sum_probs=75.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
|||||| ||+|.+.+.+++.++|..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.........- ..
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 699999 8999999999999999999999999999999999999999999999999999999999887644321110 01
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
....++..||.+|.+.|
T Consensus 169 ~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISG 185 (275)
T ss_dssp ------CTTSCHHHHSS
T ss_pred CCeeECcccCChhhhcC
Confidence 11235678999997644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=139.71 Aligned_cols=95 Identities=22% Similarity=0.305 Sum_probs=76.5
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
||||||.||+|.++++.. ..+++.++..++.|++.|++|||+++|+||||||+|||++.++.+|+.++...........
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 699999999999999754 5799999999999999999999999999999999999999999999988764432211111
Q ss_pred ----cccCccceeehhhhhc
Q psy3182 80 ----TFKDSKYVYMLLEACL 95 (255)
Q Consensus 80 ----~~~~~~~~ylv~E~~~ 95 (255)
....++..||.+|.+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~ 207 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIR 207 (307)
T ss_dssp ------CCCCTTSCCHHHHH
T ss_pred ceeecccccCCCccCHHHhh
Confidence 1123567799999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=139.66 Aligned_cols=96 Identities=24% Similarity=0.338 Sum_probs=73.5
Q ss_pred CeeeccCCCchHHHHHhCCCCC---HHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFD---DNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~---~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.++++.+..++ +..+..++.|++.|++|+|++||+||||||+||+++.++.+|+.+.........-
T Consensus 92 ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~ 171 (299)
T 4g31_A 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171 (299)
T ss_dssp EEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCC
Confidence 5899999999999998876544 4567889999999999999999999999999999999999999876543211100
Q ss_pred --------------cccccCccceeehhhhhcc
Q psy3182 78 --------------YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 --------------~~~~~~~~~~ylv~E~~~g 96 (255)
..+...++..||.+|.+.|
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 204 (299)
T 4g31_A 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204 (299)
T ss_dssp --------------------CCCTTSCHHHHTT
T ss_pred ccccccccccccccccCCcccCccccCHHHHcC
Confidence 0011235678999997755
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7.4e-17 Score=135.67 Aligned_cols=96 Identities=21% Similarity=0.243 Sum_probs=76.6
Q ss_pred CeeeccCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeec
Q psy3182 1 MLLEACLGGEVWTILRER-------------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVS 67 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-------------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~ 67 (255)
||||||.||+|.+++++. ..+++.++..++.|++.|+.|||+++|+||||||+|+|++.++.+|+.+
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 699999999999999764 3699999999999999999999999999999999999999999999988
Q ss_pred ccccccccc--cccc--ccCccceeehhhhhcc
Q psy3182 68 RKKKTRQTR--LYKT--FKDSKYVYMLLEACLG 96 (255)
Q Consensus 68 ~~~h~~iv~--l~~~--~~~~~~~ylv~E~~~g 96 (255)
......... .+.. ....+..||.+|.+.+
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 204 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 204 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcC
Confidence 764432111 1111 1113456999997654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=137.18 Aligned_cols=67 Identities=25% Similarity=0.293 Sum_probs=61.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeeccc-Cceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~-~~vkl~~~~~ 70 (255)
||||||.||+|.++++ .+++.++..++.|++.|++|+|++||+||||||+|+|++.+ +.+|+.+...
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 6999999999999983 59999999999999999999999999999999999999877 7899987653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=139.16 Aligned_cols=95 Identities=19% Similarity=0.289 Sum_probs=77.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR---- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~---- 76 (255)
|||||| +|+|++++.+.+.+++..+..++.|++.|++|||++||+||||||+||+++.++.+|+.+.........
T Consensus 136 ivmE~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~ 214 (398)
T 4b99_A 136 VVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214 (398)
T ss_dssp EEEECC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC------
T ss_pred EEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccc
Confidence 699999 578999999989999999999999999999999999999999999999999999999988664432211
Q ss_pred --ccccccCccceeehhhhhcc
Q psy3182 77 --LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 --l~~~~~~~~~~ylv~E~~~g 96 (255)
....-..++..|+.+|.+.|
T Consensus 215 ~~~~~~~~~GT~~Y~APEv~~~ 236 (398)
T 4b99_A 215 HQYFMTEYVATRWYRAPELMLS 236 (398)
T ss_dssp -CCCCCSSCCCCTTCCHHHHTT
T ss_pred cccccccceeChHhcCHHHhcC
Confidence 01111235677999997644
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=133.14 Aligned_cols=95 Identities=18% Similarity=0.215 Sum_probs=76.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCcceeecccCceeeecccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR--------GIVFRDLKPENLLLDNRGYVKLVSRKKKT 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~--------~i~~rdiK~~nil~~~~~~vkl~~~~~h~ 72 (255)
||||||.||+|.++++. ..+++.....++.+++.|+.|+|++ +|+||||||+|||++.++.+|+.+.....
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 69999999999999987 4599999999999999999999987 99999999999999999999998876432
Q ss_pred ccccccc------cccCccceeehhhhhcc
Q psy3182 73 RQTRLYK------TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 73 ~iv~l~~------~~~~~~~~ylv~E~~~g 96 (255)
....--. .....+..||.+|++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred cccCCCCceeeecccccccccccCHHHhcc
Confidence 2211111 11235677999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=9e-17 Score=146.51 Aligned_cols=94 Identities=17% Similarity=0.238 Sum_probs=72.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK- 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~- 79 (255)
||||||.||+|.+.+++.+.+++.+ ++.|++.||+|+|++||+||||||+|||++.+|.+|++++.-......--.
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEEecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 6999999999999999999998764 789999999999999999999999999999999999998764322111000
Q ss_pred -cccCccceeehhhhhcch
Q psy3182 80 -TFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 80 -~~~~~~~~ylv~E~~~gg 97 (255)
.-.-.+..||.+|.+.|.
T Consensus 396 ~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp SHHHHHHHHHHHHHHC---
T ss_pred ccCceechhhccHHHhCCC
Confidence 001134568888877653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=136.64 Aligned_cols=96 Identities=21% Similarity=0.267 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRER----------------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----------------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
||||||.||+|.+++++. ..+++..+..++.|++.|++|+|+++|+||||||+||+++.++.+|
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEE
Confidence 689999999999999753 3489999999999999999999999999999999999999999999
Q ss_pred eeccccccccccccccc----cCccceeehhhhhcc
Q psy3182 65 LVSRKKKTRQTRLYKTF----KDSKYVYMLLEACLG 96 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~~----~~~~~~ylv~E~~~g 96 (255)
+.+......+..--... ...+..||.+|.+.+
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 261 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 261 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence 98876543322111111 112345999996643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.3e-16 Score=132.73 Aligned_cols=96 Identities=21% Similarity=0.162 Sum_probs=74.4
Q ss_pred CeeeccCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceee
Q psy3182 1 MLLEACLGGEVWTILRER---------------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~---------------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl 65 (255)
||||||.||+|.+++++. +.+++.++..++.|++.|+.|||+++|+||||||+|+|++.++.+|+
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 699999999999999763 35899999999999999999999999999999999999999999999
Q ss_pred ecccccccccc--ccc--cccCccceeehhhhhcc
Q psy3182 66 VSRKKKTRQTR--LYK--TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 66 ~~~~~h~~iv~--l~~--~~~~~~~~ylv~E~~~g 96 (255)
.+......... ... .-...+..||.+|.+.+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTT
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcC
Confidence 88764432211 011 11123456999997755
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-16 Score=130.88 Aligned_cols=96 Identities=22% Similarity=0.296 Sum_probs=76.3
Q ss_pred CeeeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRER----------------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----------------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
||||||.||+|.+++..+ ..+++.+...++.++..|++|||+++|+||||||+|+|++.++.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 699999999999999653 3589999999999999999999999999999999999999999999
Q ss_pred eecccccccccc--ccc--cccCccceeehhhhhcc
Q psy3182 65 LVSRKKKTRQTR--LYK--TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 65 l~~~~~h~~iv~--l~~--~~~~~~~~ylv~E~~~g 96 (255)
+.+......... .+. .....+..||.+|.+.+
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 221 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 221 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence 988764332211 011 11123456999997654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-17 Score=136.16 Aligned_cols=102 Identities=23% Similarity=0.231 Sum_probs=78.7
Q ss_pred ccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccccCCCCce
Q psy3182 75 TRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENL 154 (255)
Q Consensus 75 v~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHrdlkp~ni 154 (255)
+++++.+. .+..|++|||+.||+|.+ +.. + . ...++.|++.||.|||++||+||||||+||
T Consensus 164 ~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----~--~-----------~~~i~~qi~~~l~~lH~~giiHrDlkp~NI 224 (282)
T 1zar_A 164 LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----E--N-----------PDEVLDMILEEVAKFYHRGIVHGDLSQYNV 224 (282)
T ss_dssp SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----S--C-----------HHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred CCcCeEEe-ccceEEEEEecCCCcHHH-cch----h--h-----------HHHHHHHHHHHHHHHHHCCCEeCCCCHHHE
Confidence 55666543 466799999999999977 321 1 1 124678899999999999999999999999
Q ss_pred eeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccC---------
Q psy3182 155 LLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN--------- 225 (255)
Q Consensus 155 l~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~--------- 225 (255)
+++ ++.+++ +|||+|+ ++..++|||.+..
T Consensus 225 Ll~-~~~vkl----------------------------~DFG~a~-------------~~~~~~a~e~l~rdv~~i~~~f 262 (282)
T 1zar_A 225 LVS-EEGIWI----------------------------IDFPQSV-------------EVGEEGWREILERDVRNIITYF 262 (282)
T ss_dssp EEE-TTEEEE----------------------------CCCTTCE-------------ETTSTTHHHHHHHHHHHHHHHH
T ss_pred EEE-CCcEEE----------------------------EECCCCe-------------ECCCCCHHHHHHHHHHHHHHHH
Confidence 999 888888 5999874 3456789999853
Q ss_pred -CCCCCcchHHHH
Q psy3182 226 -RGHDRAVDYWAL 237 (255)
Q Consensus 226 -~~~~~~~DiWsl 237 (255)
..|+..+|+|++
T Consensus 263 ~~~~~~~~~~~~~ 275 (282)
T 1zar_A 263 SRTYRTEKDINSA 275 (282)
T ss_dssp HHHHCCCCCHHHH
T ss_pred HHhcCCCCChHHH
Confidence 456777788765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=136.49 Aligned_cols=96 Identities=21% Similarity=0.282 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeeccc--Cceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR--GYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~--~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|++++.+ .+.++|.++..++.|++.|++|||+++|+||||||+|++++.+ +.+|+.+......+..-
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 69999999999999964 4679999999999999999999999999999999999999865 78999886543322110
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
......++..||.+|.+.|
T Consensus 311 ~~~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTT
T ss_pred CceeeeEECccccCHHHhCC
Confidence 0011235667999997755
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.5e-15 Score=125.99 Aligned_cols=96 Identities=29% Similarity=0.416 Sum_probs=76.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
||||||.||+|..++++.+.+++.++..++.+++.|++|||++||+||||||+||+++.++.+|+.+......... ..
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 6999999999999999888999999999999999999999999999999999999999999999988654322110 01
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|...+
T Consensus 181 ~~~~~gt~~y~aPE~~~~ 198 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQE 198 (353)
T ss_dssp -----CCGGGCCHHHHHH
T ss_pred ccccCCCcCeEChhhcCC
Confidence 111224556888886543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.8e-15 Score=128.43 Aligned_cols=96 Identities=30% Similarity=0.434 Sum_probs=78.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
||||||.||+|..++.+.+.+++..+.+++.+++.|++|||++||+||||||+||+++.++.+|+.+.......... .
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 69999999999999998889999999999999999999999999999999999999999999999886543321111 1
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 210 ~~~~~gt~~Y~aPE~l~~ 227 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRG 227 (396)
T ss_dssp BCCCCBCGGGCCHHHHTT
T ss_pred cccccCCcccCCchhhcC
Confidence 111234566888887654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=9.1e-15 Score=125.81 Aligned_cols=96 Identities=23% Similarity=0.337 Sum_probs=78.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
||||||.||+|.++++..+.+++..+..++.+++.|++|||++||+||||||+|++++.++.+|+.+......... ..
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 6999999999999999888899999999999999999999999999999999999999999999987654322110 01
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 178 ~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp BCCCCSCGGGCCHHHHTT
T ss_pred cccccCCccccChhhhcC
Confidence 111234566888887654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=124.55 Aligned_cols=96 Identities=30% Similarity=0.419 Sum_probs=77.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
|||||+.||+|+.++...+.+++.++..++.+++.|++|||++||+||||||+|++++.++.+|+.+.........--
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 689999999999999988899999999999999999999999999999999999999999999998765432211100
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 162 ~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp BCCCEECGGGCCGGGGSS
T ss_pred ccccccChhhCChhhhcC
Confidence 011123556888887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1e-14 Score=125.08 Aligned_cols=96 Identities=30% Similarity=0.434 Sum_probs=78.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
||||||.||+|.+++++.+.+++.++..++.+++.|++|||++||+||||||+|++++.++.+|+.+......... -.
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 6999999999999999888999999999999999999999999999999999999999999999987654321110 01
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|...+
T Consensus 175 ~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp BCCCCSCGGGCCHHHHTT
T ss_pred ccCCCCCcccCChhhhcC
Confidence 111234566888887654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=128.72 Aligned_cols=95 Identities=22% Similarity=0.381 Sum_probs=78.0
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
||||||.||+|.+++.+ .+.+++..+..++.+++.|++|+|+++|+||||||+||+++.++.+|+.+.........
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 69999999999999987 57899999999999999999999999999999999999999999999988664322111
Q ss_pred ccccccCccceeehhhhhc
Q psy3182 77 LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~ 95 (255)
.......++..|+.+|.+.
T Consensus 231 ~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp EECCSCCSCGGGCCHHHHH
T ss_pred cccccccCCcCeeChHHHh
Confidence 1111123566799999775
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=124.95 Aligned_cols=97 Identities=15% Similarity=0.171 Sum_probs=77.5
Q ss_pred CeeeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc-----------cCcee
Q psy3182 1 MLLEACLGGEVWTILRE-----RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN-----------RGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-----~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~-----------~~~vk 64 (255)
||||||.||+|.+++.. ...+++..+..++.+++.|++|+|+++|+||||||+||+++. .+.+|
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEE
Confidence 69999999999999973 567999999999999999999999999999999999999998 78999
Q ss_pred eeccccccccccc----cccccCccceeehhhhhcch
Q psy3182 65 LVSRKKKTRQTRL----YKTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 65 l~~~~~h~~iv~l----~~~~~~~~~~ylv~E~~~gg 97 (255)
+.+.......... .......+..|+.+|...+.
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 260 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC
Confidence 9886544221100 11112346679999977553
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=125.66 Aligned_cols=96 Identities=32% Similarity=0.462 Sum_probs=78.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
||||||.||+|++++++.+.+++.++.+++.+++.|++|||++||+||||||+||+++.++.+|+.+.........- .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 69999999999999998889999999999999999999999999999999999999999999999876543221110 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 196 ~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp CCSBSCCCCCCCHHHHTT
T ss_pred cccccCCccccCHHHhCC
Confidence 111224556888887654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.5e-14 Score=124.54 Aligned_cols=94 Identities=28% Similarity=0.400 Sum_probs=76.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--c-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--L- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l- 77 (255)
||||||.||+|++++++ ..+++..+.+++++++.|++|||++||+||||||+||+++.++.+|+.+......... .
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 69999999999999977 4699999999999999999999999999999999999999999999988654322111 0
Q ss_pred cccccCccceeehhhhhc
Q psy3182 78 YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~ 95 (255)
......++..|+.+|.+.
T Consensus 225 ~~~~~~gt~~Y~APE~l~ 242 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLK 242 (410)
T ss_dssp ECCSCCSCGGGCCHHHHH
T ss_pred cccCCcCCccccCHHHhh
Confidence 111223556788888764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.3e-14 Score=122.85 Aligned_cols=96 Identities=30% Similarity=0.434 Sum_probs=78.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
|||||+.||+|..++.+.+.+++..+..++.+++.|++|||++||+||||||+|++++.++.+|+.+.........- .
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 69999999999999998888999999999999999999999999999999999999999999999876543321110 1
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 167 ~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp BCCCCSCGGGCCHHHHTT
T ss_pred ccccCCCccccCccccCC
Confidence 111234566888887654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-14 Score=121.97 Aligned_cols=95 Identities=34% Similarity=0.513 Sum_probs=77.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|.+++++.+.+++..+..++.+++.|++|||++||+||||||+|++++.++.+|+.+.......... ..
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-~~ 161 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY 161 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BC
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-cc
Confidence 58999999999999999889999999999999999999999999999999999999999999999876543322111 11
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|...+
T Consensus 162 ~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 162 TLCGTPDYIAPEVVST 177 (318)
T ss_dssp CCCSCTTTCCHHHHTT
T ss_pred cccCCccccCHhHhcC
Confidence 1224456888886644
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.9e-14 Score=124.29 Aligned_cols=95 Identities=25% Similarity=0.385 Sum_probs=77.2
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
||||||.||+|.+++.+. ..+++..+.+++++++.|++|+|+++|+||||||+||+++.++.+|+.+.........
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 699999999999999874 4799999999999999999999999999999999999999999999987654322211
Q ss_pred ccccccCccceeehhhhhc
Q psy3182 77 LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~ 95 (255)
.......++..|+.+|.+.
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp EECSSCCSCGGGCCHHHHH
T ss_pred cccceeccccCcCCHHHHh
Confidence 0111223566789988765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=133.48 Aligned_cols=96 Identities=23% Similarity=0.337 Sum_probs=78.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
|||||+.||+|+.++++.+.+++..+.+++++++.|++|||+++|+||||||+||+++.++.+||.+......... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 6999999999999999888999999999999999999999999999999999999999999999988654332110 01
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 499 ~~~~~GT~~Y~APE~l~~ 516 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAY 516 (674)
T ss_dssp BCCCCSCSSSCCHHHHTC
T ss_pred cccccCCCcccCHhhhcC
Confidence 111224567899997754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-14 Score=122.95 Aligned_cols=95 Identities=32% Similarity=0.491 Sum_probs=77.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|.+++.+.+.+++..+..++.+++.|++|||++||+||||||+||+++.++.+|+.+.........- ..
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~~ 196 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW 196 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-cc
Confidence 69999999999999998888999999999999999999999999999999999999999999999876543322110 11
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|...+
T Consensus 197 ~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 197 TLCGTPEALAPEIILS 212 (350)
T ss_dssp CCEECGGGCCHHHHTT
T ss_pred cccCCccccCHHHhcC
Confidence 1123456888886643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.1e-14 Score=121.94 Aligned_cols=95 Identities=27% Similarity=0.448 Sum_probs=77.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
+|||||.||+|..+++..+.+++..+..++.+++.|+.|||++||+||||||+||+++.++.+|+.+.........- ..
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 58999999999999999889999999999999999999999999999999999999999999999876543221110 01
Q ss_pred cccCccceeehhhhhc
Q psy3182 80 TFKDSKYVYMLLEACL 95 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~ 95 (255)
....++..|+.+|.+.
T Consensus 172 ~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFS 187 (384)
T ss_dssp CCCCSCGGGCCGGGTC
T ss_pred eccCCCccccCCeeec
Confidence 1123455688888764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=120.34 Aligned_cols=96 Identities=18% Similarity=0.281 Sum_probs=76.2
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--- 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--- 75 (255)
||||||.||+|.+++... ..+++..+..++.+++.|++|||+++|+||||||+||+++.++.+|+.+........
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 689999999999999875 679999999999999999999999999999999999999999999998754322111
Q ss_pred ------cccccccCccceeehhhhhcc
Q psy3182 76 ------RLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ------~l~~~~~~~~~~ylv~E~~~g 96 (255)
.-.......+..|+.+|.+.+
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred ccccccccccccccccccccCHHHHhc
Confidence 011111233455888887755
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.48 E-value=7.8e-14 Score=118.74 Aligned_cols=95 Identities=27% Similarity=0.281 Sum_probs=76.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
+||||+.||+|.+++.+.+.+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.........- ..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 58999999999999988889999999999999999999999999999999999999999999999876533211100 01
Q ss_pred cccCccceeehhhhhc
Q psy3182 80 TFKDSKYVYMLLEACL 95 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~ 95 (255)
.....+..|+.+|...
T Consensus 171 ~~~~gt~~y~aPE~~~ 186 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQ 186 (328)
T ss_dssp GTTSSSGGGCCHHHHH
T ss_pred ccccCCcceeCccccc
Confidence 1122455688888654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=8.5e-14 Score=118.30 Aligned_cols=96 Identities=32% Similarity=0.450 Sum_probs=76.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
||||||.||+|.+++...+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........- .
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 177 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCcc
Confidence 68999999999999998888999999999999999999999999999999999999999999999876533211100 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|.+.+
T Consensus 178 ~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 178 THTFCGTIEYMAPEILMR 195 (327)
T ss_dssp -CTTSSCCTTSCHHHHTT
T ss_pred ccccCCCcCccCHhhCcC
Confidence 111224556888886644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-13 Score=120.80 Aligned_cols=96 Identities=26% Similarity=0.311 Sum_probs=76.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc---cCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN---RGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~---~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+.+.+++.+++..+..++.+++.|+.|+|++||+||||||+||+++. .+.+|+.+.........-
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 68999999999999999999999999999999999999999999999999999999984 567898876543222111
Q ss_pred cc--cccCccceeehhhhhcc
Q psy3182 78 YK--TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~--~~~~~~~~ylv~E~~~g 96 (255)
.. ....++..|+.+|.+.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTT
T ss_pred CceeecccCCcccCCHHHhcC
Confidence 00 11234567888887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=125.42 Aligned_cols=96 Identities=28% Similarity=0.351 Sum_probs=77.4
Q ss_pred CeeeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~--~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
||||||.||+|..++...+. +++..+..++.+++.|++|||++||+||||||+||+++.++.+|+.+.........-.
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 69999999999999987544 9999999999999999999999999999999999999999999998765433221100
Q ss_pred -ccccCccceeehhhhhcc
Q psy3182 79 -KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 341 ~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp CEECCCSCGGGCCHHHHTT
T ss_pred cccccCCCccccCHHHHcC
Confidence 011234567899987755
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=124.15 Aligned_cols=96 Identities=30% Similarity=0.431 Sum_probs=77.1
Q ss_pred CeeeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~ 76 (255)
|||||+.||+|..++.+. ..+++..+..++.+++.|++|||++||+||||||+||+++.+|.+|+.+.........
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 689999999999999764 3699999999999999999999999999999999999999999999987654332211
Q ss_pred c--cccccCccceeehhhhhcc
Q psy3182 77 L--YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l--~~~~~~~~~~ylv~E~~~g 96 (255)
- ......++..|+.+|.+.+
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTT
T ss_pred CCcccccccCCccccChhhhcC
Confidence 1 0111234567899987755
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=116.98 Aligned_cols=96 Identities=25% Similarity=0.389 Sum_probs=64.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+.+.+.+.+++..+..++.+++.|+.|+|+++|+||||||+|++++..+ .+|+.+.........-
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 6899999999999999989999999999999999999999999999999999999998766 6888775433211100
Q ss_pred cc--cccCccceeehhhhhcc
Q psy3182 78 YK--TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~--~~~~~~~~ylv~E~~~g 96 (255)
.. .....+..|+.+|.+.+
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQ 183 (325)
T ss_dssp ---------------------
T ss_pred CCcccccCCCcCccCHHHhcC
Confidence 00 01112455778876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=116.99 Aligned_cols=96 Identities=22% Similarity=0.308 Sum_probs=74.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeeccc----Cceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR----GYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~----~~vkl~~~~~h~~iv~ 76 (255)
||||||.||+|.+.+.+.+.+++..+..++.+++.|++|+|++||+||||||+|+++... +.+|+.+.........
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 699999999999999998899999999999999999999999999999999999997443 2488877653322111
Q ss_pred cc--ccccCccceeehhhhhcc
Q psy3182 77 LY--KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~--~~~~~~~~~ylv~E~~~g 96 (255)
-. ......+..|+.+|.+.+
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~ 194 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLER 194 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHH
T ss_pred CCCceeccCCCccccCHHHhcC
Confidence 00 011223556888886654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=122.28 Aligned_cols=96 Identities=29% Similarity=0.437 Sum_probs=77.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCcceeecccCceeeeccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~-~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-- 77 (255)
||||||.||+|..++...+.+++..+..++.+++.|++|||+ +||+||||||+||+++.++.+|+.+.........-
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 699999999999999988899999999999999999999998 99999999999999999999999886543221110
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
......++..|+.+|.+.+
T Consensus 305 ~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp --CCSSSCGGGCCHHHHHT
T ss_pred ccccccCCccccCHhhcCC
Confidence 0111234567888887644
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.45 E-value=5.4e-14 Score=121.79 Aligned_cols=94 Identities=23% Similarity=0.166 Sum_probs=74.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDD-------NAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~-------~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~ 73 (255)
|||||+ +|+|.+++...+.+++ ..+..++.|++.|++|||++||+||||||+||+++.++.+|+.+......
T Consensus 177 lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 177 FLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp EEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhhee
Confidence 589999 7899999987666776 67778999999999999999999999999999999999999988764432
Q ss_pred cccccccccCccceeehhhhhcch
Q psy3182 74 QTRLYKTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 74 iv~l~~~~~~~~~~ylv~E~~~gg 97 (255)
...... ...+ ..|+.+|...++
T Consensus 256 ~~~~~~-~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 256 DGARVV-SSVS-RGFEPPELEARR 277 (377)
T ss_dssp TTCEEE-CCCC-TTCCCHHHHHHH
T ss_pred cCCccc-CCCC-cCccChhhhccc
Confidence 222111 1223 678888876543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.45 E-value=4.7e-14 Score=120.14 Aligned_cols=93 Identities=19% Similarity=0.123 Sum_probs=74.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCcceeecccC------------------
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLH-TRGIVFRDLKPENLLLDNRG------------------ 61 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh-~~~i~~rdiK~~nil~~~~~------------------ 61 (255)
||||||.||++.+.+.+ +.+++..+..++.|++.|+.|+| +++|+||||||+||+++..+
T Consensus 139 lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~ 217 (336)
T 2vuw_A 139 IVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217 (336)
T ss_dssp EEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECT
T ss_pred EEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCC
Confidence 69999999987777755 67999999999999999999999 99999999999999999887
Q ss_pred --ceeeeccccccccccccccccCccceeehhhhhcch
Q psy3182 62 --YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 62 --~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg 97 (255)
.+|+.+........ ......+..|+.+|.+.|.
T Consensus 218 ~~~vkL~DFG~a~~~~---~~~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 218 GLQVSIIDYTLSRLER---DGIVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp TEEEEECCCTTCBEEE---TTEEECCCCTTCSGGGCCC
T ss_pred CceEEEeeccccEecC---CCcEEEeecccChhhhcCC
Confidence 78888765433221 1122345678999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.4e-13 Score=113.87 Aligned_cols=95 Identities=25% Similarity=0.395 Sum_probs=75.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
+|||||.||+|.+++.+. .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........- .
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 589999999999999874 6999999999999999999999999999999999999999999999876533221110 1
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 173 ~~~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR 190 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC
T ss_pred cCCccCCcCccChhhhcC
Confidence 112234556888886643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-13 Score=117.55 Aligned_cols=96 Identities=23% Similarity=0.337 Sum_probs=76.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC----ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG----YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~----~vkl~~~~~h~~iv~ 76 (255)
||||||.||+|++++.+.+.+++..+..++.+++.|+.|||++||+||||||+|++++..+ .+|+.+.........
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 6899999999999999888999999999999999999999999999999999999998777 688877654322111
Q ss_pred cc-ccccCccceeehhhhhcc
Q psy3182 77 LY-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~-~~~~~~~~~ylv~E~~~g 96 (255)
-. .....++..|+.+|...+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~ 192 (361)
T 2yab_A 172 GVEFKNIFGTPEFVAPEIVNY 192 (361)
T ss_dssp TCCCCCCCSCGGGCCHHHHTT
T ss_pred CCccccCCCCccEECchHHcC
Confidence 00 011224556888887654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.5e-13 Score=118.41 Aligned_cols=96 Identities=25% Similarity=0.364 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec--ccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD--NRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~--~~~~vkl~~~~~h~~iv~l 77 (255)
|||||| ||+|.+++... +.+++..+..++.+++.|+.|||+++|+||||||+||+++ ..+.+|+.+.........-
T Consensus 129 lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 129 MIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp EEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGG
T ss_pred EEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccC
Confidence 689999 99999999876 6799999999999999999999999999999999999999 8888999876543221110
Q ss_pred --cc-------cccCccceeehhhhhcch
Q psy3182 78 --YK-------TFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 78 --~~-------~~~~~~~~ylv~E~~~gg 97 (255)
.. .....+..|+.+|...+.
T Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp GCCCCSSCCSSCCCCCCTTTCCHHHHTTC
T ss_pred CcccccccCcccccCCCCCccCHHHhCCC
Confidence 00 111255678999977654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=117.64 Aligned_cols=96 Identities=30% Similarity=0.403 Sum_probs=77.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--- 77 (255)
|||||+.||+|.+++...+.+++..+..++.+++.|+.|||+++|+||||||+||+++.++.+|+.+.........-
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 215 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC
Confidence 68999999999999998889999999999999999999999999999999999999999999999876533211100
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|.+.+
T Consensus 216 ~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 216 RAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp GGCGGGSCCTTCCHHHHTT
T ss_pred cccCcccCcCccChhhhcC
Confidence 0011123456888887764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=114.78 Aligned_cols=96 Identities=19% Similarity=0.257 Sum_probs=75.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
+||||+.||+|.+++.+.+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........- .
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 58999999999999998888999999999999999999999999999999999999999999999876533221110 0
Q ss_pred -ccccCccceeehhhhhcc
Q psy3182 79 -KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp -------CCSSCCHHHHHT
T ss_pred ccCccccCccccCHhHhcC
Confidence 011123456888886543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.42 E-value=1.7e-13 Score=119.72 Aligned_cols=96 Identities=30% Similarity=0.391 Sum_probs=72.7
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc---cCceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN---RGYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~---~~~vkl~~~~~h~~iv 75 (255)
||||||.||+|.+++.+.+ .+++..+..++.+++.|++|||++||+||||||+||+++. ++.+|+.+........
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 5999999999999998754 5999999999999999999999999999999999999998 6789998765432211
Q ss_pred ccc-ccccCccceeehhhhhcc
Q psy3182 76 RLY-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ~l~-~~~~~~~~~ylv~E~~~g 96 (255)
.-. ......+..|+.+|.+.+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp -----------CTTCCGGGSCC
T ss_pred CCCccccCCCCCCccCHhhcCC
Confidence 100 011123456888887644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-13 Score=115.69 Aligned_cols=96 Identities=21% Similarity=0.256 Sum_probs=74.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK- 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~- 79 (255)
|||||+.||+|.++++..+.+++..+..++.+++.|+.|+|+++|+||||||+||+++.++.+|+.+.........-..
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc
Confidence 5899999999999999888899999999999999999999999999999999999999999999987654322111000
Q ss_pred ----cccCccceeehhhhhcc
Q psy3182 80 ----TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ----~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|...+
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp ---------CCTTCCHHHHHT
T ss_pred cccccccCcCcccCCHHHhcC
Confidence 01113456888886644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=3.5e-13 Score=112.53 Aligned_cols=96 Identities=20% Similarity=0.220 Sum_probs=76.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCcceeecccCceeeecccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLH--------TRGIVFRDLKPENLLLDNRGYVKLVSRKKKT 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh--------~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~ 72 (255)
+||||+.||+|.++++. ..+++..+..++.+++.|+.|+| +++|+||||||+|++++.++.+|+.+.....
T Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 58999999999999965 57999999999999999999999 9999999999999999999999998765432
Q ss_pred cccccc------ccccCccceeehhhhhcch
Q psy3182 73 RQTRLY------KTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 73 ~iv~l~------~~~~~~~~~ylv~E~~~gg 97 (255)
....-. ......+..|+.+|...++
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred ecccccccccccccccccccceeChhhhcCc
Confidence 111100 1112345678888876553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.8e-13 Score=113.08 Aligned_cols=96 Identities=23% Similarity=0.410 Sum_probs=75.5
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc-----eeeecccccccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY-----VKLVSRKKKTRQ 74 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~-----vkl~~~~~h~~i 74 (255)
|||||+ ||+|.+++.. .+.+++..+..++.+++.|++|+|+++|+||||||+||+++.++. +|+.+.......
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 689999 9999999986 467999999999999999999999999999999999999999887 899876543221
Q ss_pred cccc---------ccccCccceeehhhhhcch
Q psy3182 75 TRLY---------KTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 75 v~l~---------~~~~~~~~~ylv~E~~~gg 97 (255)
..-. .....++..|+.+|...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGK 192 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCC
Confidence 1100 0122345668888876553
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=5.3e-13 Score=112.21 Aligned_cols=70 Identities=20% Similarity=0.313 Sum_probs=65.2
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.++++. ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence 58999999999999987 56799999999999999999999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=116.63 Aligned_cols=95 Identities=24% Similarity=0.338 Sum_probs=72.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc--eeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY--VKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~--vkl~~~~~h~~iv~l- 77 (255)
||||||.||+|.+++.+.+.+++..+..++.+++.|+.|||++||+||||||+|++++..+. +|+.+.........-
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 68999999999999988889999999999999999999999999999999999999987766 888776532211100
Q ss_pred cccccCccceeehhhhhc
Q psy3182 78 YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~ 95 (255)
.......+..|+.+|.+.
T Consensus 173 ~~~~~~gt~~y~aPE~~~ 190 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLL 190 (361)
T ss_dssp --------CTTSCHHHHH
T ss_pred CCCCCcCCCCcCChhhhc
Confidence 011122455688888653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.8e-13 Score=116.12 Aligned_cols=96 Identities=28% Similarity=0.372 Sum_probs=76.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc----c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT----R 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv----~ 76 (255)
||||||.||+|.+.+.....+++..+..++.+++.|++|||++||+||||||+|++++.++.+|+.+........ .
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 589999999999999988889999999999999999999999999999999999999999999998765332110 0
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
........+..|+.+|...+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHC
T ss_pred cccCCCccCcCccCcHHhcc
Confidence 00111234556888886643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.40 E-value=5e-13 Score=115.56 Aligned_cols=96 Identities=22% Similarity=0.274 Sum_probs=74.6
Q ss_pred CeeeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRERT----------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~----------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
|||||+.||+|.++++..+ .+++..+..++.+++.|+.|||++||+||||||+||+++.++.+|
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 243 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEE
Confidence 5899999999999998753 488999999999999999999999999999999999999999999
Q ss_pred eeccccccccccc--cc--cccCccceeehhhhhcc
Q psy3182 65 LVSRKKKTRQTRL--YK--TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 65 l~~~~~h~~iv~l--~~--~~~~~~~~ylv~E~~~g 96 (255)
+.+.......... +. .....+..|+.+|.+.+
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 9886543322111 11 11112235888886543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.8e-13 Score=120.88 Aligned_cols=96 Identities=24% Similarity=0.358 Sum_probs=77.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc-ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR-LYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~-l~~ 79 (255)
||||||.||+|.+++.+.+.+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+......... -..
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 6899999999999999888999999999999999999999999999999999999999999999987653322110 001
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|.+.+
T Consensus 173 ~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISG 189 (476)
T ss_dssp CCCCSCSTTCCHHHHTT
T ss_pred cccCCCcCeEChhhccC
Confidence 11224456888886644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.40 E-value=6e-13 Score=114.72 Aligned_cols=96 Identities=27% Similarity=0.371 Sum_probs=75.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|++.+...+.+++..+..++.+++.|+.|+|++||+||||||+||+++.++ .+|+.+.........-
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 5899999999999999888999999999999999999999999999999999999998764 4888776543221110
Q ss_pred c-ccccCccceeehhhhhcc
Q psy3182 78 Y-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~-~~~~~~~~~ylv~E~~~g 96 (255)
. ......+..|+.+|...+
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~ 204 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKK 204 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTT
T ss_pred cccccCCCCccccCHHHHcc
Confidence 0 011234556888887654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.40 E-value=3.5e-13 Score=111.60 Aligned_cols=96 Identities=27% Similarity=0.376 Sum_probs=75.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+.||+|.+.+.+...+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+++.+.........-...
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 165 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccccc
Confidence 58999999999999998888999999999999999999999999999999999999999999999876532211111111
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
....+..|+.+|...+
T Consensus 166 ~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEG 181 (279)
T ss_dssp --CCCCTTCCHHHHTT
T ss_pred ccCCCCCccCHhHhcc
Confidence 1223455777776543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=7.2e-13 Score=112.41 Aligned_cols=95 Identities=20% Similarity=0.242 Sum_probs=75.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCcceeecccCceeeecccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR--------GIVFRDLKPENLLLDNRGYVKLVSRKKKT 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~--------~i~~rdiK~~nil~~~~~~vkl~~~~~h~ 72 (255)
|||||+.||+|.++++. ..+++..+..++.+++.|+.|+|.+ +|+||||||+|++++.++.+|+.+.....
T Consensus 112 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 58999999999999977 4699999999999999999999999 99999999999999999999998765432
Q ss_pred cccccc------ccccCccceeehhhhhcc
Q psy3182 73 RQTRLY------KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 73 ~iv~l~------~~~~~~~~~ylv~E~~~g 96 (255)
....-. ......+..|+.+|...+
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTT
T ss_pred eeccccccccCCCCCCccCcceeChhhccc
Confidence 211100 011234567888887644
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=7.6e-13 Score=112.35 Aligned_cols=95 Identities=26% Similarity=0.281 Sum_probs=75.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR---------GIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~---------~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
||||||.||+|.++++... .++..+..++.+++.|+.|||++ +|+||||||+|++++.++.+|+.+....
T Consensus 89 lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 5899999999999997744 69999999999999999999999 9999999999999999999999876543
Q ss_pred ccccc----------ccccccCccceeehhhhhcc
Q psy3182 72 TRQTR----------LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 72 ~~iv~----------l~~~~~~~~~~ylv~E~~~g 96 (255)
..... ........+..|+.+|...+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcC
Confidence 22110 00111234567888887765
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.39 E-value=4.8e-13 Score=111.00 Aligned_cols=96 Identities=27% Similarity=0.433 Sum_probs=77.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+.||+|.+.+...+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.............
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBC
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccccc
Confidence 58999999999999998888999999999999999999999999999999999999999999999876533222111112
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
....+..|+.+|...+
T Consensus 171 ~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEG 186 (284)
T ss_dssp CCCSCGGGCCHHHHTT
T ss_pred cccCCCCcCCHHHhcc
Confidence 2234556888886654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.2e-13 Score=112.92 Aligned_cols=96 Identities=23% Similarity=0.302 Sum_probs=75.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC----ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG----YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~----~vkl~~~~~h~~iv~ 76 (255)
+|||||.||+|.+++.+.+.+++..+..++.+++.|+.|||+++|+||||||+|++++.++ .+|+.+.........
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 5899999999999999888999999999999999999999999999999999999998887 688877553322110
Q ss_pred cc-ccccCccceeehhhhhcc
Q psy3182 77 LY-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~-~~~~~~~~~ylv~E~~~g 96 (255)
-. ......+..|+.+|.+.+
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~ 191 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVNY 191 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHTT
T ss_pred CCccccccCCcCcCCceeecC
Confidence 00 011124456888886644
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=5.8e-13 Score=112.93 Aligned_cols=96 Identities=18% Similarity=0.240 Sum_probs=73.6
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc--cCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN--RGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~--~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+.+.... .+++..+..++.+++.|+.|+|++||+||||||+|++++. .+.+|+.+.........-
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 5899999999999997654 6999999999999999999999999999999999999987 678888775533221100
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|...+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~ 177 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT
T ss_pred CccccccCChhhcCcHHhcC
Confidence 0011123345778886644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.39 E-value=4.2e-13 Score=111.97 Aligned_cols=70 Identities=24% Similarity=0.333 Sum_probs=64.7
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5899999999999998755 499999999999999999999999999999999999999999999987643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=5.4e-13 Score=114.31 Aligned_cols=51 Identities=24% Similarity=0.336 Sum_probs=47.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 21 FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 21 ~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+++..+..++.+++.|+.|+|+++|+||||||+||+++.++.+|+.+....
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 240 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccce
Confidence 899999999999999999999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=7.4e-13 Score=112.13 Aligned_cols=95 Identities=21% Similarity=0.202 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR----------GIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~----------~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
||||||.||+|.+++++ ..+++..+..++.+++.|+.|+|++ +|+||||||+|++++..+.+|+.+...
T Consensus 99 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 58999999999999987 4599999999999999999999999 999999999999999999999987654
Q ss_pred ccccccc----cccccCccceeehhhhhcc
Q psy3182 71 KTRQTRL----YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 71 h~~iv~l----~~~~~~~~~~ylv~E~~~g 96 (255)
......- .......+..|+.+|...+
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred ccccccccCccccccCccCccccCHhhccc
Confidence 3221110 0111234567888887765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.38 E-value=7.7e-13 Score=111.36 Aligned_cols=69 Identities=35% Similarity=0.626 Sum_probs=64.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc---eeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~---vkl~~~~ 69 (255)
|||||+.||+|.+++...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++. +|+.+..
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 68999999999999998888999999999999999999999999999999999999988776 7887653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=7.4e-13 Score=109.99 Aligned_cols=94 Identities=13% Similarity=0.100 Sum_probs=72.5
Q ss_pred CeeeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc--------eeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY--------VKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~-~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~--------vkl~~~~~h 71 (255)
|||||+.||+|.+++..... +++..+..++.+++.|+.|||+++|+||||||+|++++..+. +|+.+....
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~ 168 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence 58999999999999987665 999999999999999999999999999999999999988876 777665432
Q ss_pred cccccccccccCccceeehhhhhcc
Q psy3182 72 TRQTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 72 ~~iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.....- .....+..|+.+|...+
T Consensus 169 ~~~~~~--~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 169 ITVLPK--DILQERIPWVPPECIEN 191 (289)
T ss_dssp TTTSCH--HHHHHTTTTSCHHHHHC
T ss_pred ccccCc--cccCCcCcccCHHHhCC
Confidence 211100 01112334777776543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=113.70 Aligned_cols=71 Identities=20% Similarity=0.307 Sum_probs=65.4
Q ss_pred CeeeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRERT----------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~----------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
|||||+.||+|.+++.... .+++..+..++.+++.|+.|||+++|+||||||+||+++.++.+|
T Consensus 152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 231 (382)
T 3tt0_A 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231 (382)
T ss_dssp EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEE
Confidence 6899999999999998754 499999999999999999999999999999999999999999999
Q ss_pred eeccccc
Q psy3182 65 LVSRKKK 71 (255)
Q Consensus 65 l~~~~~h 71 (255)
+.+....
T Consensus 232 L~DFG~a 238 (382)
T 3tt0_A 232 IADFGLA 238 (382)
T ss_dssp ECSCSCC
T ss_pred EcccCcc
Confidence 9876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=7e-13 Score=112.54 Aligned_cols=70 Identities=26% Similarity=0.242 Sum_probs=65.0
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
|||||+.||+|.++++.. +.+++..+..++.+++.|+.|+|+++|+||||||+||+++.++.+|+.+...
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 689999999999999754 5799999999999999999999999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.3e-13 Score=113.14 Aligned_cols=95 Identities=32% Similarity=0.411 Sum_probs=75.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc-ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR-LYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~-l~~ 79 (255)
|||||+ +|+|.+.+.+.+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+......... -..
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 589999 899999998888999999999999999999999999999999999999999999999987653321110 001
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
....++..|+.+|...+
T Consensus 165 ~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVING 181 (336)
T ss_dssp CCCTTSTTTSCGGGSCC
T ss_pred ccccCCcCcCCHHHHcC
Confidence 11224456888887654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=109.69 Aligned_cols=70 Identities=20% Similarity=0.289 Sum_probs=64.5
Q ss_pred CeeeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~-~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++. ....+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 5899999999999994 456799999999999999999999999999999999999999999999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=108.22 Aligned_cols=95 Identities=22% Similarity=0.263 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCcceeec-ccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLD-NRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~--i~~rdiK~~nil~~-~~~~vkl~~~~~h~~iv~l 77 (255)
+||||+.||+|.+++...+.+++..+..++.+++.|+.|+|+++ |+||||||+|++++ ..+.+|+.+.........-
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 58999999999999998888999999999999999999999999 99999999999997 7888999876543221111
Q ss_pred cccccCccceeehhhhhc
Q psy3182 78 YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~ 95 (255)
.......+..|+.+|...
T Consensus 186 ~~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp SBEESCSSCCCCCGGGGG
T ss_pred ccccccCCcCcCCHHHHh
Confidence 111222445688888654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=110.61 Aligned_cols=96 Identities=23% Similarity=0.300 Sum_probs=72.6
Q ss_pred CeeeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCcceeecccCceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTC---FDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLDNRGYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~---~~~~~~~~~~~~v~~~l~~lh~~~--i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv 75 (255)
+||||+.||+|.+++..... +++..+..++.+++.|+.|+|++| |+||||||+|++++.++.+|+.+........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 58999999999999987654 999999999999999999999999 9999999999999999999998765332111
Q ss_pred cc--cccccCccceeehhhhhcc
Q psy3182 76 RL--YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ~l--~~~~~~~~~~ylv~E~~~g 96 (255)
.- .......+..|+.+|...+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp -----------CCTTSCHHHHTT
T ss_pred ccccccccCCCCccccChhhhcC
Confidence 10 0111223456888886644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=5.2e-13 Score=123.24 Aligned_cols=70 Identities=23% Similarity=0.311 Sum_probs=66.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
||||||.||+|.+++++.+.+++..+..++.+++.|++|||+++|+||||||+||+++.++.+|+.+...
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 6899999999999999988999999999999999999999999999999999999999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=8.7e-13 Score=112.46 Aligned_cols=96 Identities=27% Similarity=0.369 Sum_probs=63.2
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~~h~~iv 75 (255)
||||||.||+|.+++.+.. .+++.++..++.+++.|+.|||++||+||||||+|++++.++ .+|+.+........
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 5899999999999998764 699999999999999999999999999999999999998644 48887754332211
Q ss_pred cccccccCccceeehhhhhcc
Q psy3182 76 RLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ~l~~~~~~~~~~ylv~E~~~g 96 (255)
.-.......+..|+.+|...+
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp ---------------------
T ss_pred ccccccCCCCcCccChhhhCC
Confidence 111111223455777876644
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=111.69 Aligned_cols=70 Identities=26% Similarity=0.294 Sum_probs=64.9
Q ss_pred CeeeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCccee
Q psy3182 1 MLLEACLGGEVWTILRER------------------------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~------------------------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil 56 (255)
|||||+.||+|.++++.. ..+++.++..++.+++.|+.|+|+++|+||||||+||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 206 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence 589999999999999874 56999999999999999999999999999999999999
Q ss_pred ecccCceeeecccc
Q psy3182 57 LDNRGYVKLVSRKK 70 (255)
Q Consensus 57 ~~~~~~vkl~~~~~ 70 (255)
++.++.+|+.+...
T Consensus 207 ~~~~~~~kl~Dfg~ 220 (343)
T 1luf_A 207 VGENMVVKIADFGL 220 (343)
T ss_dssp ECGGGCEEECCCSC
T ss_pred ECCCCeEEEeecCC
Confidence 99999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=108.67 Aligned_cols=70 Identities=30% Similarity=0.429 Sum_probs=65.2
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.+ ...+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 58999999999999986 56799999999999999999999999999999999999999999999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=6.9e-13 Score=113.90 Aligned_cols=96 Identities=25% Similarity=0.363 Sum_probs=76.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~-~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
|||||+.||+|.+++.+.+.+++..+..++.+++.|+.|+|++ +|+||||||+|++++.++.+|+.+.........-..
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 187 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence 6899999999999999888999999999999999999999996 999999999999999999999987653322111111
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|...+
T Consensus 188 ~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQG 204 (360)
T ss_dssp ---CCCCTTCCHHHHTT
T ss_pred cCCCCCCCeECHHHHcC
Confidence 11234556888886654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-12 Score=112.55 Aligned_cols=96 Identities=25% Similarity=0.309 Sum_probs=73.2
Q ss_pred CeeeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc---eeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~---vkl~~~~~h~~ 73 (255)
||||||.||+|.+.+.+. ..+++..+..++.+++.|+.|+|+++|+||||||+|++++.++. +|+.+......
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 699999999999887542 35999999999999999999999999999999999999987665 88877543322
Q ss_pred ccc--ccccccCccceeehhhhhcc
Q psy3182 74 QTR--LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 74 iv~--l~~~~~~~~~~ylv~E~~~g 96 (255)
... ........+..|+.+|.+.+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKR 207 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred ecCCCeeecCCcCCcCccCHHHHcC
Confidence 111 11112234567888887654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=107.68 Aligned_cols=94 Identities=20% Similarity=0.334 Sum_probs=70.6
Q ss_pred CeeeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---------------
Q psy3182 1 MLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG--------------- 61 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~--------------- 61 (255)
+||||+.||+|.+++.+. ..+++..+..++.+++.|+.|+|+++|+||||||+|++++..+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 589999999999999764 6799999999999999999999999999999999999998554
Q ss_pred ----ceeeeccccccccccccccccCccceeehhhhhcc
Q psy3182 62 ----YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 62 ----~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.+|+.+......... ......+..|+.+|...+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~--~~~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISS--PQVEEGDSRFLANEVLQE 204 (289)
T ss_dssp --CCCEEECCCTTCEETTC--SCCCCCCGGGCCHHHHTT
T ss_pred CCceEEEEcccccccccCC--ccccCCCccccChhHhcC
Confidence 566665442221111 111234556888886643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=8.1e-13 Score=112.00 Aligned_cols=71 Identities=17% Similarity=0.245 Sum_probs=65.4
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+||||+.||+|.+++... +.+++..+..++.+++.|++|+|++||+||||||+|++++.++.+|+.+....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 589999999999999874 57999999999999999999999999999999999999999999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.9e-12 Score=105.10 Aligned_cols=93 Identities=16% Similarity=0.180 Sum_probs=72.6
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCcceeecccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~--i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~ 76 (255)
+||||+.||+|.+++.+.. .+++..+..++.+++.|+.|+|+++ |+||||||+|++++.++.+++........
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~--- 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS--- 162 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT---
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee---
Confidence 5899999999999998765 4999999999999999999999999 99999999999999998888754321111
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
........+..|+.+|...+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 163 FQSPGRMYAPAWVAPEALQK 182 (271)
T ss_dssp TSCTTCBSCGGGSCHHHHHS
T ss_pred ecccCccCCccccChhhhcc
Confidence 00111223456888886644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=109.76 Aligned_cols=70 Identities=20% Similarity=0.257 Sum_probs=64.5
Q ss_pred CeeeccCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCccee
Q psy3182 1 MLLEACLGGEVWTILRERTC------------------------FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~------------------------~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil 56 (255)
+||||+.||+|.+++.+... +++..+..++.+++.|+.|+|+++|+||||||+||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 58999999999999987544 899999999999999999999999999999999999
Q ss_pred ecccCceeeecccc
Q psy3182 57 LDNRGYVKLVSRKK 70 (255)
Q Consensus 57 ~~~~~~vkl~~~~~ 70 (255)
++.++.+|+.+...
T Consensus 183 i~~~~~~kl~Dfg~ 196 (314)
T 2ivs_A 183 VAEGRKMKISDFGL 196 (314)
T ss_dssp EETTTEEEECCCTT
T ss_pred EcCCCCEEEccccc
Confidence 99999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=111.03 Aligned_cols=71 Identities=23% Similarity=0.363 Sum_probs=64.2
Q ss_pred CeeeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee
Q psy3182 1 MLLEACLGGEVWTILRERT-----------------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-----------------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~ 57 (255)
|||||+.||+|.+++.... .+++..+..++.+++.|+.|||++||+||||||+||++
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 205 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 205 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE
Confidence 5899999999999998653 37999999999999999999999999999999999999
Q ss_pred cccCceeeeccccc
Q psy3182 58 DNRGYVKLVSRKKK 71 (255)
Q Consensus 58 ~~~~~vkl~~~~~h 71 (255)
+.++.+|+.+....
T Consensus 206 ~~~~~~kL~Dfg~~ 219 (344)
T 1rjb_A 206 THGKVVKICDFGLA 219 (344)
T ss_dssp ETTTEEEECCCGGG
T ss_pred cCCCcEEeCCCccC
Confidence 99999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=111.35 Aligned_cols=96 Identities=29% Similarity=0.394 Sum_probs=73.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc---cCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN---RGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~---~~~vkl~~~~~h~~iv~l 77 (255)
|||||+.||+|.+.+.+.+.+++..+..++.+++.|+.|+|+++|+||||||+|++++. ++.+|+.+.........-
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 68999999999999998888999999999999999999999999999999999999975 778898776533211110
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|...+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp --------CGGGSCHHHHTT
T ss_pred cccccccCCCCccCHHHhcC
Confidence 0111224556888887654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=108.19 Aligned_cols=70 Identities=23% Similarity=0.311 Sum_probs=66.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.++++..+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 5899999999999999988899999999999999999999999999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=109.37 Aligned_cols=94 Identities=20% Similarity=0.325 Sum_probs=72.1
Q ss_pred CeeeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee----cccCceeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTC---FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL----DNRGYVKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~---~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~----~~~~~vkl~~~~~h~~ 73 (255)
|||||+.||+|.++++.... +++..+..++.+++.|+.|+|+++|+||||||+||++ +..+.+|+.+......
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 58999999999999976443 9999999999999999999999999999999999998 7777788877643322
Q ss_pred cccccc-cccCccceeehhhhh
Q psy3182 74 QTRLYK-TFKDSKYVYMLLEAC 94 (255)
Q Consensus 74 iv~l~~-~~~~~~~~ylv~E~~ 94 (255)
...-.. .....+..|+.+|..
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~ 187 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMY 187 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHH
T ss_pred cCCCCceeecccCCCccCHHHh
Confidence 111000 011234567777755
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2.1e-12 Score=111.38 Aligned_cols=95 Identities=25% Similarity=0.344 Sum_probs=76.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-K 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-~ 79 (255)
|||||+.||+|.+++.....+++..+..++.+++.|+.|+|++||+||||||+||+++.++.+++.+......+..-. .
T Consensus 177 lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~ 256 (365)
T 2y7j_A 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256 (365)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCccc
Confidence 689999999999999988889999999999999999999999999999999999999999999998765332211100 0
Q ss_pred cccCccceeehhhhhc
Q psy3182 80 TFKDSKYVYMLLEACL 95 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~ 95 (255)
.....+..|+.+|...
T Consensus 257 ~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 257 RELCGTPGYLAPEILK 272 (365)
T ss_dssp CCCCSCGGGCCHHHHH
T ss_pred ccCCCCCCccChhhcc
Confidence 1122455688888664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=8.1e-13 Score=114.07 Aligned_cols=94 Identities=16% Similarity=0.160 Sum_probs=70.3
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAA------SFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~------~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~ 73 (255)
||||||. |+|.+++...+ .+++... ..++.+++.|+.|||++||+||||||+|++++.++.+|+.+......
T Consensus 165 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~ 243 (371)
T 3q60_A 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243 (371)
T ss_dssp EEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEE
T ss_pred EEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeee
Confidence 6899998 89999998643 3444444 46669999999999999999999999999999999999988765432
Q ss_pred cccccccccCccceeehhhhhcc
Q psy3182 74 QTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 74 iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
..... .....+..|+.+|.+.+
T Consensus 244 ~~~~~-~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 244 VGTRG-PASSVPVTYAPREFLNA 265 (371)
T ss_dssp TTCEE-EGGGSCGGGCCHHHHTC
T ss_pred cCCCc-cCccCCcCCcChhhccC
Confidence 22111 01222367888887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=108.66 Aligned_cols=70 Identities=27% Similarity=0.421 Sum_probs=63.3
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++...+ .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccc
Confidence 5899999999999998655 699999999999999999999999999999999999999999999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.34 E-value=3e-12 Score=106.58 Aligned_cols=95 Identities=19% Similarity=0.352 Sum_probs=73.3
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee---cccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL---DNRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~---~~~~~vkl~~~~~h~~iv~ 76 (255)
+||||+ ||+|.+++.. .+.+++..+..++.+++.|+.|+|+++|+||||||+|+++ +..+.+|+.+.........
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 589999 9999999974 5579999999999999999999999999999999999999 4778889877543322111
Q ss_pred cc---------ccccCccceeehhhhhcc
Q psy3182 77 LY---------KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~---------~~~~~~~~~ylv~E~~~g 96 (255)
-. ......+..|+.+|...+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred cccccccccccccccccccccCChhhhcC
Confidence 00 012234556888887654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=7.5e-13 Score=111.88 Aligned_cols=70 Identities=24% Similarity=0.423 Sum_probs=62.6
Q ss_pred CeeeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTC---FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~---~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
||||||.||+|.++++.... .++..+..++.|++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 138 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 210 (332)
T 3qd2_B 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 210 (332)
T ss_dssp EEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCc
Confidence 58999999999999987654 45556889999999999999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.4e-12 Score=109.27 Aligned_cols=96 Identities=27% Similarity=0.425 Sum_probs=75.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee---cccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL---DNRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~---~~~~~vkl~~~~~h~~iv~l 77 (255)
+||||+.||+|.+.+.+.+.+++..+..++.+++.|+.|+|++||+||||||+|+++ +..+.+++.+.........-
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 589999999999999888889999999999999999999999999999999999999 67778888775432211110
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|...+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSS
T ss_pred ccccccCCCCccChHHhcc
Confidence 0111123456888886654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=110.88 Aligned_cols=95 Identities=17% Similarity=0.301 Sum_probs=75.1
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC--ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG--YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~--~vkl~~~~~h~~iv~ 76 (255)
|||||+ ||+|.+++... ..+++..+..++.+++.|+.|||+++|+||||||+|++++.++ .+|+.+.........
T Consensus 135 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 135 LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSG
T ss_pred EEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccC
Confidence 689999 99999999886 7899999999999999999999999999999999999999988 888877654322111
Q ss_pred c---------cccccCccceeehhhhhcc
Q psy3182 77 L---------YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l---------~~~~~~~~~~ylv~E~~~g 96 (255)
- .......+..|+.+|...+
T Consensus 214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp GGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred CCccccccccccccccCCccccCHHHHcc
Confidence 0 0011134456888886654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.34 E-value=3.6e-12 Score=105.99 Aligned_cols=95 Identities=19% Similarity=0.349 Sum_probs=73.8
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee---cccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL---DNRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~---~~~~~vkl~~~~~h~~iv~ 76 (255)
+||||+ ||+|.+++.. .+.+++..+..++.+++.|+.|+|+++|+||||||+|+++ +..+.+|+.+.........
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 589999 9999999984 4579999999999999999999999999999999999999 7888899877543322111
Q ss_pred c---------cccccCccceeehhhhhcc
Q psy3182 77 L---------YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l---------~~~~~~~~~~ylv~E~~~g 96 (255)
- .......+..|+.+|...+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred cccCccCCCCcccccCCCccccchHHhcC
Confidence 0 0011234556888886654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.8e-12 Score=107.99 Aligned_cols=96 Identities=20% Similarity=0.236 Sum_probs=72.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
||||||.|+.+..+....+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+......... ..
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 6899997654444445567899999999999999999999999999999999999999999999987654322110 01
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 158 ~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT
T ss_pred ccCCccccCCcChHHHcC
Confidence 111233556888887644
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.2e-12 Score=106.20 Aligned_cols=70 Identities=23% Similarity=0.285 Sum_probs=64.3
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.. ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccc
Confidence 58999999999999975 44599999999999999999999999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=107.32 Aligned_cols=70 Identities=21% Similarity=0.260 Sum_probs=64.6
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++...+ .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+++.+...
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcc
Confidence 5899999999999997654 499999999999999999999999999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=115.54 Aligned_cols=95 Identities=21% Similarity=0.213 Sum_probs=73.4
Q ss_pred CeeeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~--~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
||||||.||+|.++++..+. +++.....++.+++.|+.|||+++|+||||||+|++++.++.+|+.+...........
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 68999999999999986543 7999999999999999999999999999999999999999999998765432211111
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
. ......-|+.+|.+.+
T Consensus 344 ~-~~~~~~~y~aPE~~~~ 360 (450)
T 1k9a_A 344 D-TGKLPVKWTAPEALRE 360 (450)
T ss_dssp ----CCCTTTSCHHHHHS
T ss_pred c-CCCCCcceeCHHHhcC
Confidence 1 1122344778886543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=112.92 Aligned_cols=71 Identities=21% Similarity=0.355 Sum_probs=65.3
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
|||||+.||+|.++++..+ .+++..+..++.+++.|+.|||+++|+||||||+|++++.++.+|+.+....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 6899999999999998654 5999999999999999999999999999999999999999999999886543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=110.57 Aligned_cols=70 Identities=24% Similarity=0.401 Sum_probs=64.8
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.. ...+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 58999999999999976 45699999999999999999999999999999999999999999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.1e-12 Score=114.38 Aligned_cols=69 Identities=16% Similarity=0.376 Sum_probs=63.1
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee---cccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL---DNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~---~~~~~vkl~~~~~ 70 (255)
|||||+ ||+|.+++.. .+.+++..+..++.+++.||+|||.++|+||||||+||++ +..+.+||.+...
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 689999 9999999985 5679999999999999999999999999999999999999 5788899987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.2e-12 Score=109.31 Aligned_cols=95 Identities=24% Similarity=0.337 Sum_probs=74.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
|||||+.||+|.++.. .+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........- .
T Consensus 115 lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 193 (298)
T 2zv2_A 115 MVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193 (298)
T ss_dssp EEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE
T ss_pred EEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccccccc
Confidence 5899999999998654 467999999999999999999999999999999999999999999999876533221110 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|.+.+
T Consensus 194 ~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 194 LSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp ECCCCSCGGGCCGGGCCT
T ss_pred ccCCcCCccccChhhhcc
Confidence 111234567888887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.6e-12 Score=108.76 Aligned_cols=95 Identities=24% Similarity=0.371 Sum_probs=75.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
|||||+.||+|.+++.. ..+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........-.
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 58999999999999865 569999999999999999999999999999999999999999999998765322211100
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|...+
T Consensus 198 ~~~~~gt~~y~aPE~~~~ 215 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISR 215 (321)
T ss_dssp BCCCCSCGGGCCHHHHTT
T ss_pred cccccCCccccCHhhhcC
Confidence 111234556888887654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.9e-12 Score=109.21 Aligned_cols=96 Identities=22% Similarity=0.329 Sum_probs=76.2
Q ss_pred CeeeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGG-EVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg-~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
+||||+.+| +|..++.....+++..+..++.+++.|+.|||.+||+||||||+||+++.++.+|+.+.........-.
T Consensus 106 lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 185 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc
Confidence 589998777 999999998899999999999999999999999999999999999999999999998765332211100
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 186 ~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 186 FYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp BCEECSCGGGCCHHHHTT
T ss_pred eeccCCCccccChhhhcC
Confidence 011124556888886643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.5e-12 Score=107.94 Aligned_cols=70 Identities=21% Similarity=0.375 Sum_probs=64.5
Q ss_pred CeeeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc
Q psy3182 1 MLLEACLGGEVWTILRERT------------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~------------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~ 62 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 183 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCC
Confidence 5899999999999998754 3999999999999999999999999999999999999999999
Q ss_pred eeeecccc
Q psy3182 63 VKLVSRKK 70 (255)
Q Consensus 63 vkl~~~~~ 70 (255)
+|+.+...
T Consensus 184 ~kl~Dfg~ 191 (313)
T 1t46_A 184 TKICDFGL 191 (313)
T ss_dssp EEECCCGG
T ss_pred EEEccccc
Confidence 99987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3e-12 Score=106.66 Aligned_cols=95 Identities=18% Similarity=0.303 Sum_probs=73.6
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc-----eeeecccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY-----VKLVSRKKKTRQ 74 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~-----vkl~~~~~h~~i 74 (255)
+||||+ ||+|.++++..+ .+++..+..++.+++.|+.|+|++||+||||||+|++++.++. +|+.+.......
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 589999 999999998754 5999999999999999999999999999999999999987765 888775433221
Q ss_pred ccc---------cccccCccceeehhhhhcc
Q psy3182 75 TRL---------YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 75 v~l---------~~~~~~~~~~ylv~E~~~g 96 (255)
..- .......+..|+.+|...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLG 192 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred ccccccccccccCccCCCCCcccCCchhhcC
Confidence 110 0111224456888887654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.32 E-value=3.6e-12 Score=106.38 Aligned_cols=71 Identities=21% Similarity=0.247 Sum_probs=64.8
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+||||+.||+|.+++++ ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccc
Confidence 58999999999999976 445999999999999999999999999999999999999999999999876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3e-12 Score=114.45 Aligned_cols=96 Identities=28% Similarity=0.398 Sum_probs=73.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc---cCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN---RGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~---~~~vkl~~~~~h~~iv~l 77 (255)
+|||||.||+|.+.+.+.+.+++..+..++.+++.|+.|+|++||+||||||+|++++. .+.+|+.+.........-
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 58999999999999988889999999999999999999999999999999999999954 446888775432211100
Q ss_pred c-ccccCccceeehhhhhcc
Q psy3182 78 Y-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~-~~~~~~~~~ylv~E~~~g 96 (255)
. ......+..|+.+|...|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS
T ss_pred CccCCCcCCCCCCCHHHhCC
Confidence 0 011224556888886654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-12 Score=108.13 Aligned_cols=95 Identities=23% Similarity=0.248 Sum_probs=73.6
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR-LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~-l~ 78 (255)
|||||+ ||+|.+.+.. ...+++..+..++.+++.|+.|||+++|+||||||+||+++.++.+|+.+......... -.
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 589999 7889888865 44699999999999999999999999999999999999999999999987654221111 01
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...|
T Consensus 213 ~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp --CCCCCGGGCCGGGGGT
T ss_pred CcccCCCccccCHhHhcC
Confidence 112234567888887643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=9.4e-13 Score=112.57 Aligned_cols=96 Identities=23% Similarity=0.294 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC--ceeeecccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG--YVKLVSRKKKTRQTR-- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~--~vkl~~~~~h~~iv~-- 76 (255)
|||||| ||+|.+++...+.+++..+..++.+++.|+.|||+++|+||||||+||+++.++ .+|+.+.........
T Consensus 129 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~ 207 (345)
T 2v62_A 129 MVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207 (345)
T ss_dssp EEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGG
T ss_pred EEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccc
Confidence 689999 999999998877899999999999999999999999999999999999999887 899877544322110
Q ss_pred ---c----cccccCccceeehhhhhcch
Q psy3182 77 ---L----YKTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 77 ---l----~~~~~~~~~~ylv~E~~~gg 97 (255)
. .......+..|+.+|...++
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (345)
T 2v62_A 208 NHKQYQENPRKGHNGTIEFTSLDAHKGV 235 (345)
T ss_dssp CCCCCCCCGGGCSCSCTTTCCHHHHHTC
T ss_pred ccccchhccccccCCCccccCHHHhcCC
Confidence 0 00122345568888876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.6e-12 Score=109.81 Aligned_cols=70 Identities=19% Similarity=0.220 Sum_probs=63.9
Q ss_pred CeeeccCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccc
Confidence 5899999999999996533 599999999999999999999999999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4e-12 Score=106.91 Aligned_cols=70 Identities=20% Similarity=0.191 Sum_probs=63.9
Q ss_pred CeeeccCCCchHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILR------ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~------~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++. ....+++..+..++.+++.|+.|+|+++|+||||||+||+++.++.+|+.+...
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 5899999999999994 345699999999999999999999999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-12 Score=108.50 Aligned_cols=96 Identities=23% Similarity=0.353 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC----ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG----YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~----~vkl~~~~~h~~iv~ 76 (255)
+||||+.||+|.+++...+.+++..+..++.+++.|+.|+|++||+||||||+|++++..+ .+|+.+.........
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 5899999999999999888899999999999999999999999999999999999999887 688877543322111
Q ss_pred ccc-cccCccceeehhhhhcc
Q psy3182 77 LYK-TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~-~~~~~~~~ylv~E~~~g 96 (255)
-.. .....+..|+.+|...+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~ 192 (321)
T 2a2a_A 172 GVEFKNIFGTPEFVAPEIVNY 192 (321)
T ss_dssp TCCCCCCCSCGGGCCHHHHTT
T ss_pred cccccccCCCCCccCcccccC
Confidence 000 11123456888886644
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.2e-12 Score=105.54 Aligned_cols=95 Identities=26% Similarity=0.400 Sum_probs=74.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee---cccCceeeecccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL---DNRGYVKLVSRKKKTRQTR- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~---~~~~~vkl~~~~~h~~iv~- 76 (255)
+||||+.||+|.+.+...+.+++..+..++.+++.|+.|+|++||+||||||+|+++ +.++.+++.+.........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 589999999999999888889999999999999999999999999999999999999 7778899877543221110
Q ss_pred ccccccCccceeehhhhhc
Q psy3182 77 LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~ 95 (255)
-.......+..|+.+|...
T Consensus 163 ~~~~~~~~t~~y~aPE~~~ 181 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLE 181 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHT
T ss_pred cchhccCCCCCccChHHhc
Confidence 0011122345578888653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.8e-12 Score=109.18 Aligned_cols=95 Identities=22% Similarity=0.286 Sum_probs=76.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
+||||+.||+|.+++...+.+++.++..++.+++.|+.|||++||+||||||+||+++.++.+|+.+......... -.
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 5899999999999998888899999999999999999999999999999999999999999999987654322110 00
Q ss_pred ccccCccceeehhhhhc
Q psy3182 79 KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~ 95 (255)
......+..|+.+|...
T Consensus 198 ~~~~~gt~~y~aPE~~~ 214 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLS 214 (335)
T ss_dssp BCCCCSCCSSCCHHHHH
T ss_pred ccccCCCccccCHHHhc
Confidence 11122344578888654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.4e-12 Score=112.57 Aligned_cols=70 Identities=24% Similarity=0.331 Sum_probs=62.4
Q ss_pred CeeeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc---eeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~---vkl~~~~~ 70 (255)
||||||.||+|.++++.. ..+++..+..++.+++.|+.|||++||+||||||+||+++.++. +|+.+...
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 689999999999999764 35999999999999999999999999999999999999996654 88877654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.32 E-value=1.9e-12 Score=108.82 Aligned_cols=70 Identities=26% Similarity=0.385 Sum_probs=64.5
Q ss_pred CeeeccCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRERTC----------------FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~----------------~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
+||||+.||+|.+++..... +++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 58999999999999987554 89999999999999999999999999999999999999999999
Q ss_pred eecccc
Q psy3182 65 LVSRKK 70 (255)
Q Consensus 65 l~~~~~ 70 (255)
+.+...
T Consensus 189 l~Dfg~ 194 (316)
T 2xir_A 189 ICDFGL 194 (316)
T ss_dssp ECCCGG
T ss_pred ECCCcc
Confidence 987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.7e-12 Score=109.92 Aligned_cols=93 Identities=20% Similarity=0.338 Sum_probs=74.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+ |++|.++++. ..+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.........- ..
T Consensus 107 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 183 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MT 183 (367)
T ss_dssp EEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-CC
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-cC
Confidence 589999 9999999987 57999999999999999999999999999999999999999999999876543322111 11
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
....+..|+.+|.+.+
T Consensus 184 ~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 184 GYVVTRWYRAPEVILN 199 (367)
T ss_dssp SSCSCGGGCCTHHHHT
T ss_pred cCcCCCCcCCHHHHhC
Confidence 1223456888886644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.6e-12 Score=111.82 Aligned_cols=96 Identities=20% Similarity=0.260 Sum_probs=74.1
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc--cCceeeecccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN--RGYVKLVSRKKKTRQTR- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~--~~~vkl~~~~~h~~iv~- 76 (255)
||||||.||+|.+.+.... .+++..+..++.+++.|++|||++||+||||||+||+++. .+.+|+.+.........
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 6899999999999997654 6999999999999999999999999999999999999974 35688877653322111
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
-.......+..|+.+|...+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTT
T ss_pred cceeeeccCCCccCchhccC
Confidence 00112234566888887654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.4e-12 Score=109.00 Aligned_cols=70 Identities=20% Similarity=0.339 Sum_probs=65.1
Q ss_pred CeeeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRERT----------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~----------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
|||||+.||+|.+++.+.+ .+++.++..++.+++.|+.|+|++||+||||||+|++++.++.+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 5899999999999998764 699999999999999999999999999999999999999999999
Q ss_pred eecccc
Q psy3182 65 LVSRKK 70 (255)
Q Consensus 65 l~~~~~ 70 (255)
+.+...
T Consensus 183 L~Dfg~ 188 (327)
T 1fvr_A 183 IADFGL 188 (327)
T ss_dssp ECCTTC
T ss_pred EcccCc
Confidence 987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.5e-12 Score=114.89 Aligned_cols=95 Identities=28% Similarity=0.384 Sum_probs=74.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee---cccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL---DNRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~---~~~~~vkl~~~~~h~~iv~l 77 (255)
+|||||.||+|.+.+...+.+++..+..++.+++.|+.|||++||+||||||+|+++ +..+.+|+.+.........-
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 589999999999999998999999999999999999999999999999999999999 45678898875432211100
Q ss_pred -cccccCccceeehhhhhc
Q psy3182 78 -YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~ 95 (255)
.......+..|+.+|.+.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~ 201 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLH 201 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHH
T ss_pred cccccCCCCccccCceeec
Confidence 001122455688888654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.3e-12 Score=109.09 Aligned_cols=94 Identities=27% Similarity=0.359 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR---- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~---- 76 (255)
|||| +.||+|.+++...+.+++..+..++.+++.|+.|+|+++|+||||||+||+++ ++.+|+.+.........
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 5899 67999999999989999999999999999999999999999999999999996 57789887653322111
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
........+..|+.+|...+
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp ------CCCCSSCCHHHHHH
T ss_pred ccCCCCcCCcCcCCHHHHhh
Confidence 11112234567888887643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.7e-12 Score=113.15 Aligned_cols=70 Identities=23% Similarity=0.371 Sum_probs=64.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
|||||+. |+|.++++....+++..+..++.|++.|++|||++||+||||||+||+++.++.+|+.+....
T Consensus 107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 5899985 699999999888999999999999999999999999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.3e-12 Score=114.50 Aligned_cols=95 Identities=29% Similarity=0.439 Sum_probs=73.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+.+.....+++..+..++.+++.|+.|||++||+||||||+|++++..+ .+|+.+.........-
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 5899999999999998888999999999999999999999999999999999999997654 4888775432211100
Q ss_pred -cccccCccceeehhhhhc
Q psy3182 78 -YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~ 95 (255)
.......+..|+.+|.+.
T Consensus 193 ~~~~~~~gt~~y~aPE~l~ 211 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR 211 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT
T ss_pred ccccccCCCcCeeCHHHHc
Confidence 001122455688888654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4e-12 Score=107.40 Aligned_cols=69 Identities=25% Similarity=0.346 Sum_probs=64.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.+. .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence 589999999999999774 499999999999999999999999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.4e-12 Score=114.65 Aligned_cols=95 Identities=29% Similarity=0.443 Sum_probs=74.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+.+.+.+.+++..+..++.+++.|+.|||++||+||||||+|++++..+ .+|+.+.........-
T Consensus 123 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence 6899999999999999888999999999999999999999999999999999999998876 4788775433211110
Q ss_pred c-ccccCccceeehhhhhc
Q psy3182 78 Y-KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~-~~~~~~~~~ylv~E~~~ 95 (255)
. .....++..|+.+|.+.
T Consensus 203 ~~~~~~~gt~~y~aPE~~~ 221 (504)
T 3q5i_A 203 YKLRDRLGTAYYIAPEVLK 221 (504)
T ss_dssp SCBCCCCSCTTTCCHHHHT
T ss_pred CccccccCCcCCCCHHHhc
Confidence 0 01122445678887654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.30 E-value=5e-12 Score=109.75 Aligned_cols=69 Identities=22% Similarity=0.484 Sum_probs=63.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
||||||. |+|...++. ..+++..+..++.|++.|++|||++||+||||||+|++++.++.+|+.+....
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 6899996 699999987 57999999999999999999999999999999999999999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.30 E-value=4.9e-12 Score=108.47 Aligned_cols=94 Identities=24% Similarity=0.360 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc-------------------
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN------------------- 59 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~------------------- 59 (255)
|||||+ ||+|.+++.... .+++..+..++.|++.|+.|||++||+||||||+||+++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 589999 999999998754 4999999999999999999999999999999999999975
Q ss_pred ------cCceeeeccccccccccccccccCccceeehhhhhcc
Q psy3182 60 ------RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 60 ------~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.+.+|+.+.......... .....++..|+.+|.+.+
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDY-HGSIINTRQYRAPEVILN 233 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSC-CCSCCSCGGGCCHHHHTT
T ss_pred cccccCCCCEEEEeccCceecCCC-CcCccCcccccCcHHHcC
Confidence 667888765433221111 111223556888887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=4.5e-12 Score=105.65 Aligned_cols=96 Identities=22% Similarity=0.279 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
+||||+.||+|.+++...+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+......... -.
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 5899999999999998888899999999999999999999999999999999999999999999987543322110 00
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 172 ~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp BCCCCSCCSSCCHHHHTT
T ss_pred cccccCCCCcCCcchhcc
Confidence 111223445788886543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-12 Score=113.74 Aligned_cols=69 Identities=23% Similarity=0.400 Sum_probs=64.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
|||||+ +|+|..+++....+++..+..++.|++.|++|||++||+||||||+||+++.++.+|+.+...
T Consensus 134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 589987 789999999988999999999999999999999999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.30 E-value=3.7e-12 Score=105.30 Aligned_cols=96 Identities=23% Similarity=0.299 Sum_probs=74.9
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l- 77 (255)
+||||+.||+|.+++.+. ..+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........-
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176 (284)
T ss_dssp EEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS
T ss_pred EEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc
Confidence 589999999999999754 57999999999999999999999999999999999999999999999875432221110
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|...+
T Consensus 177 ~~~~~~~~~~y~aPE~~~~ 195 (284)
T 2a19_B 177 KRTRSKGTLRYMSPEQISS 195 (284)
T ss_dssp CCCCCCSCCTTSCHHHHHC
T ss_pred cccccCCcccccChhhhcc
Confidence 0111224456888886543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-12 Score=108.79 Aligned_cols=70 Identities=20% Similarity=0.267 Sum_probs=64.7
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.+ ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 58999999999999987 45699999999999999999999999999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.30 E-value=2.4e-12 Score=114.26 Aligned_cols=95 Identities=16% Similarity=0.149 Sum_probs=74.0
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l- 77 (255)
||||||.||+|.++++.. ..+++.....++.+++.|+.|||+++|+||||||+|++++.++.+|+.+.........-
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 689999999999999754 36899999999999999999999999999999999999999999999886543322110
Q ss_pred cc--cccCccceeehhhhhc
Q psy3182 78 YK--TFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~~--~~~~~~~~ylv~E~~~ 95 (255)
+. .....+.-|+.+|.+.
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~ 358 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAIN 358 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHH
T ss_pred eeccCCCcccccccCHHHhc
Confidence 00 1111223488888654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=4.4e-12 Score=107.24 Aligned_cols=95 Identities=23% Similarity=0.164 Sum_probs=74.4
Q ss_pred CeeeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCcceeecccCceeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT----CFDDNAASFITACVIEALEYLHTR---GIVFRDLKPENLLLDNRGYVKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~----~~~~~~~~~~~~~v~~~l~~lh~~---~i~~rdiK~~nil~~~~~~vkl~~~~~h~~ 73 (255)
+||||+.||+|.+++++.. .+++..+..++.+++.|+.|+|++ +|+||||||+|++++.++.+|+.+......
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 5899999999999998654 399999999999999999999999 999999999999999999999987653321
Q ss_pred ccc---ccccccCccceeehhhhhc
Q psy3182 74 QTR---LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 74 iv~---l~~~~~~~~~~ylv~E~~~ 95 (255)
... ........+..|+.+|...
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLS 208 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred cCcccccccccccCCcCccCHHHhc
Confidence 110 0011112455688888653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.30 E-value=4.9e-12 Score=105.35 Aligned_cols=70 Identities=27% Similarity=0.512 Sum_probs=63.8
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred EEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 5899999999999998544 588999999999999999999999999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.4e-12 Score=104.30 Aligned_cols=93 Identities=22% Similarity=0.313 Sum_probs=68.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccCCCCcceeecc--------cCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG---IVFRDLKPENLLLDN--------RGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~---i~~rdiK~~nil~~~--------~~~vkl~~~~ 69 (255)
+||||+.||+|.+++.. +.+++..+..++.+++.|+.|+|+++ |+||||||+|++++. .+.+|+.+..
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 58999999999999864 67999999999999999999999999 889999999999986 5668887754
Q ss_pred cccccccccccccCccceeehhhhh
Q psy3182 70 KKTRQTRLYKTFKDSKYVYMLLEAC 94 (255)
Q Consensus 70 ~h~~iv~l~~~~~~~~~~ylv~E~~ 94 (255)
.......-.......+..|+.+|..
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~ 186 (271)
T 3dtc_A 162 LAREWHRTTKMSAAGAYAWMAPEVI 186 (271)
T ss_dssp C-------------CCGGGSCHHHH
T ss_pred cccccccccccCCCCccceeCHHHh
Confidence 3322111111122344567777755
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=4.9e-12 Score=104.71 Aligned_cols=96 Identities=27% Similarity=0.382 Sum_probs=74.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc---eeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~---vkl~~~~~h~~iv~l 77 (255)
+||||+.||+|.+.+...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++. +|+.+.........-
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 58999999999999988888999999999999999999999999999999999999987665 888775433211110
Q ss_pred cc-cccCccceeehhhhhcc
Q psy3182 78 YK-TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~-~~~~~~~~ylv~E~~~g 96 (255)
.. .....+..|+.+|...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~ 181 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKK 181 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTT
T ss_pred ccccCCCCCcCCcCchhhcC
Confidence 00 11224456888886544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.1e-12 Score=107.43 Aligned_cols=95 Identities=20% Similarity=0.223 Sum_probs=74.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
+||||+.||.|..+++..+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........-.
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 589999999999999988889999999999999999999999999999999999999999999998765432211110
Q ss_pred ccccCccceeehhhhhc
Q psy3182 79 KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~ 95 (255)
......+..|+.+|...
T Consensus 159 ~~~~~~~~~y~aPE~~~ 175 (311)
T 4agu_A 159 YDDEVATRWYRSPELLV 175 (311)
T ss_dssp -------GGGCCHHHHH
T ss_pred cCCCcCCccccChHHHh
Confidence 11122345578888654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=5.4e-12 Score=109.84 Aligned_cols=94 Identities=27% Similarity=0.357 Sum_probs=74.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR---- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~---- 76 (255)
|||| +.||+|.+++.+...+++..+..++.+++.|+.|+|+++|+||||||+||+++ ++.+|+.+.........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 5899 67999999999988999999999999999999999999999999999999995 57889987654322111
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
........+..|+.+|.+.+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHC
T ss_pred ccCCCCCcCCCccChHHhhh
Confidence 11112235667999997754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.30 E-value=4.7e-12 Score=107.61 Aligned_cols=70 Identities=21% Similarity=0.299 Sum_probs=64.3
Q ss_pred CeeeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRERT----------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~----------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|+++|+||||||+||+++.++.+|
T Consensus 118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 197 (334)
T 2pvf_A 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197 (334)
T ss_dssp EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEE
Confidence 5899999999999998754 389999999999999999999999999999999999999999999
Q ss_pred eecccc
Q psy3182 65 LVSRKK 70 (255)
Q Consensus 65 l~~~~~ 70 (255)
+.+...
T Consensus 198 L~Dfg~ 203 (334)
T 2pvf_A 198 IADFGL 203 (334)
T ss_dssp ECCCTT
T ss_pred Eccccc
Confidence 987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.4e-12 Score=112.16 Aligned_cols=95 Identities=20% Similarity=0.311 Sum_probs=72.5
Q ss_pred CeeeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee----cccCceeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT---CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL----DNRGYVKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~---~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~----~~~~~vkl~~~~~h~~ 73 (255)
||||||.||+|.++++... .+++..+..++.+++.|++|+|++||+||||||+||++ +..+.+|+.+......
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 5899999999999997643 39999999999999999999999999999999999998 7777788887654322
Q ss_pred cccccc-cccCccceeehhhhhc
Q psy3182 74 QTRLYK-TFKDSKYVYMLLEACL 95 (255)
Q Consensus 74 iv~l~~-~~~~~~~~ylv~E~~~ 95 (255)
...-.. .....+..|+.+|...
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHH
T ss_pred ccCCCccccccCCccccCHHHhh
Confidence 111000 0112345678888654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=7.1e-12 Score=105.18 Aligned_cols=95 Identities=25% Similarity=0.283 Sum_probs=73.7
Q ss_pred CeeeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc-c
Q psy3182 1 MLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR-L 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~--~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~-l 77 (255)
+||||+. |+|.+++..... +++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+......... .
T Consensus 96 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 174 (308)
T 3g33_A 96 LVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174 (308)
T ss_dssp EEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC
T ss_pred EEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc
Confidence 5899996 699999987654 99999999999999999999999999999999999999999999987654321110 0
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|...+
T Consensus 175 ~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 175 ALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp CSGGGGCCCSSCCHHHHHT
T ss_pred ccCCccccccccCchHHcC
Confidence 0111223456888886643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5.3e-12 Score=107.16 Aligned_cols=96 Identities=20% Similarity=0.183 Sum_probs=75.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
+||||+.||.|..+....+.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........-.
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 589999999999998888889999999999999999999999999999999999999999999998765432211100
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 181 ~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVG 198 (331)
T ss_dssp ---CCCCCTTCCHHHHTT
T ss_pred cCCCcCCccccCcccccC
Confidence 111223455888886644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.9e-12 Score=106.42 Aligned_cols=69 Identities=36% Similarity=0.609 Sum_probs=63.2
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc---cCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN---RGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~---~~~vkl~~~~ 69 (255)
|||||+.||+|.+++.+.. .+++..+..++.+++.|+.|+|+++|+||||||+|++++. .+.+|+.+..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 5899999999999998754 6999999999999999999999999999999999999998 6778887754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.29 E-value=3.1e-12 Score=106.67 Aligned_cols=64 Identities=17% Similarity=0.169 Sum_probs=58.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeee
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~ 66 (255)
|||||+.||+|.+++++ + ..+.++..++.+++.|++|+|++||+||||||+|++++.++.+|+.
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEE
Confidence 68999999999999955 3 4666788899999999999999999999999999999999988875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.29 E-value=4.1e-12 Score=105.42 Aligned_cols=70 Identities=23% Similarity=0.332 Sum_probs=64.3
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.+. ..+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+++.+...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 589999999999999863 4499999999999999999999999999999999999999999999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.2e-12 Score=104.82 Aligned_cols=95 Identities=25% Similarity=0.307 Sum_probs=75.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
+||||+.||+|.+++.+...+++..+..++.+++.|+.|+|++|++||||||+|++++.++.+|+.+.........- ..
T Consensus 101 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 180 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180 (298)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCccc
Confidence 58999999999999998888999999999999999999999999999999999999999999999875432211100 00
Q ss_pred cccCccceeehhhhhc
Q psy3182 80 TFKDSKYVYMLLEACL 95 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~ 95 (255)
.....+..|+.+|...
T Consensus 181 ~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 181 REVCGTPSYLAPEIIE 196 (298)
T ss_dssp CCCCSCGGGCCHHHHH
T ss_pred ccccCCccccCHHHhc
Confidence 1112345677777653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.6e-12 Score=104.21 Aligned_cols=71 Identities=24% Similarity=0.259 Sum_probs=65.0
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+||||+.||+|.+++.. ...+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 58999999999999987 456999999999999999999999999999999999999999999999876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.9e-12 Score=107.89 Aligned_cols=71 Identities=20% Similarity=0.345 Sum_probs=64.1
Q ss_pred CeeeccCCCchHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeee
Q psy3182 1 MLLEACLGGEVWTILRE--------------RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--------------~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~ 66 (255)
|||||+.||+|.+++.. ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBC
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEEC
Confidence 58999999999999975 2458999999999999999999999999999999999999999999998
Q ss_pred ccccc
Q psy3182 67 SRKKK 71 (255)
Q Consensus 67 ~~~~h 71 (255)
+....
T Consensus 207 Dfg~~ 211 (333)
T 2i1m_A 207 DFGLA 211 (333)
T ss_dssp CCGGG
T ss_pred ccccc
Confidence 76543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.29 E-value=4.3e-12 Score=113.84 Aligned_cols=71 Identities=21% Similarity=0.316 Sum_probs=64.9
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
|||||+.||+|.+++++. ..+++.....++.+++.|++|||+++|+||||||+|++++.++.+|+.+....
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence 699999999999999863 45999999999999999999999999999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.29 E-value=3.7e-12 Score=106.01 Aligned_cols=95 Identities=23% Similarity=0.343 Sum_probs=69.8
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
+|||||.||+|.+.+.. ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 58999999999999964 4569999999999999999999999999999999999999999999998764322111100
Q ss_pred ---ccccCccceeehhhhhc
Q psy3182 79 ---KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 ---~~~~~~~~~ylv~E~~~ 95 (255)
......+..|+.+|...
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp --------CCCTTCCHHHHC
T ss_pred cccccccCCCccccCchhhc
Confidence 01112345678888654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.29 E-value=3.7e-12 Score=107.72 Aligned_cols=95 Identities=28% Similarity=0.337 Sum_probs=75.3
Q ss_pred CeeeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec-ccCceeeecccccccccccc
Q psy3182 1 MLLEACLG-GEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD-NRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~g-g~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~-~~~~vkl~~~~~h~~iv~l~ 78 (255)
+|||++.+ |+|.+++.+.+.+++..+..++.+++.|+.|+|+++|+||||||+||+++ .++.+|+.+.........-.
T Consensus 125 lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~ 204 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC
T ss_pred EEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc
Confidence 58999987 99999999888999999999999999999999999999999999999998 67889998765332221111
Q ss_pred ccccCccceeehhhhhc
Q psy3182 79 KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~ 95 (255)
......+..|+.+|...
T Consensus 205 ~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 205 YTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp BCCCCSCGGGSCHHHHH
T ss_pred ccCCCCCccCCChHHhc
Confidence 11123455688888653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=4.3e-12 Score=107.73 Aligned_cols=70 Identities=20% Similarity=0.267 Sum_probs=64.6
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.+ ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 58999999999999986 45699999999999999999999999999999999999999999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.7e-12 Score=106.70 Aligned_cols=95 Identities=18% Similarity=0.208 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCcceeecccCceeeecccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLH--------TRGIVFRDLKPENLLLDNRGYVKLVSRKKKT 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh--------~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~ 72 (255)
+||||+.||+|.+++.+ ..+++..+..++.+++.|+.|+| +++|+||||||+|++++.++.+|+.+.....
T Consensus 117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 195 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195 (342)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence 58999999999999977 46999999999999999999999 8999999999999999999999998765332
Q ss_pred ccccc------cccccCccceeehhhhhcc
Q psy3182 73 RQTRL------YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 73 ~iv~l------~~~~~~~~~~ylv~E~~~g 96 (255)
....- .......+..|+.+|...+
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred eccccccccccccccCCcCcccCCHhhhcc
Confidence 11110 1112234567888887654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=5.6e-12 Score=109.08 Aligned_cols=70 Identities=21% Similarity=0.271 Sum_probs=64.0
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
|||||+.||+|.+++++.+ .+++.++..++.+++.|+.|||+++|+||||||+||+++.++.+|+.+...
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 6899999999999998754 699999999999999999999999999999999999999999999987643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.6e-12 Score=117.25 Aligned_cols=71 Identities=24% Similarity=0.355 Sum_probs=65.2
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
||||||.||+|.+++... ..+++..+..++.+++.|++|||+++|+||||||+||+++.++.+|+.+....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 699999999999999754 45999999999999999999999999999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=4.7e-12 Score=109.58 Aligned_cols=96 Identities=18% Similarity=0.219 Sum_probs=73.2
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee--cccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL--DNRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~--~~~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+.+... ..+++..+..++.+++.|+.|||+++|+||||||+||++ +..+.+|+.+.........-
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 699999999999998754 469999999999999999999999999999999999998 45667898876533221110
Q ss_pred c-ccccCccceeehhhhhcc
Q psy3182 78 Y-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~-~~~~~~~~~ylv~E~~~g 96 (255)
. ......+..|+.+|.+.+
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNY 262 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTT
T ss_pred cccccccCCCcEeChhhccC
Confidence 0 011124556888887644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=6.3e-12 Score=103.66 Aligned_cols=96 Identities=25% Similarity=0.340 Sum_probs=71.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
+||||+.||+|.+++...+.+++..+..++.+++.|+.|+|++|++||||||+|++++.++.+|+.+.........- ..
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 58999999999999988888999999999999999999999999999999999999999999999875432211100 00
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|...+
T Consensus 168 ~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISG 184 (276)
T ss_dssp ---------CCTGGGTT
T ss_pred ecccCCccccCHHHHcC
Confidence 11123445777776543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.6e-12 Score=106.09 Aligned_cols=69 Identities=26% Similarity=0.505 Sum_probs=64.2
Q ss_pred CeeeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~----~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
+||||+.||+|.+++.. ...+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 58999999999999975 4679999999999999999999999999999999999999999999998765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=6.8e-12 Score=105.83 Aligned_cols=70 Identities=19% Similarity=0.229 Sum_probs=63.8
Q ss_pred CeeeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER----------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.++++.. ..+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 589999999999999752 4579999999999999999999999999999999999999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.3e-12 Score=104.27 Aligned_cols=96 Identities=28% Similarity=0.371 Sum_probs=65.8
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
+||||+.||+|.+++.+. ..+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........-.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 589999999999999875 569999999999999999999999999999999999999999999998754322111000
Q ss_pred -ccccCccceeehhhhhcc
Q psy3182 79 -KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp -------------------
T ss_pred cceeccCCCCcCCcchhcC
Confidence 011123445777776543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.9e-12 Score=105.90 Aligned_cols=96 Identities=23% Similarity=0.223 Sum_probs=74.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
+||||+.||+|.+++.+.+.+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........- .
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 58999999999999998888999999999999999999999999999999999999999999999875432211100 0
Q ss_pred -ccccCccceeehhhhhcc
Q psy3182 79 -KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 191 ~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp ------CCGGGCCGGGTCC
T ss_pred cccccCCCcCccCHHHHcC
Confidence 001123456888887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=3.6e-12 Score=108.15 Aligned_cols=96 Identities=25% Similarity=0.348 Sum_probs=73.1
Q ss_pred CeeeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc---cCceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN---RGYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~---~~~vkl~~~~~h~~iv 75 (255)
+|||||.||+|.+++.. .+.+++.++..++.+++.|+.|||++||+||||||+|++++. .+.+|+.+........
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 58999999999999865 367999999999999999999999999999999999999988 7789998765433221
Q ss_pred cccc-cccCccceeehhhhhcc
Q psy3182 76 RLYK-TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ~l~~-~~~~~~~~ylv~E~~~g 96 (255)
.-.. .....+..|+.+|...+
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~ 207 (327)
T 3lm5_A 186 HACELREIMGTPEYLAPEILNY 207 (327)
T ss_dssp --------CCCGGGCCHHHHTT
T ss_pred CccccccccCCcCccCCeeecC
Confidence 1100 11224556888886643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=5.5e-12 Score=107.28 Aligned_cols=70 Identities=21% Similarity=0.247 Sum_probs=64.9
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
|||||+.||+|.+++.+. ..+++.++..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 689999999999999764 5799999999999999999999999999999999999999999999987643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=8.5e-12 Score=105.41 Aligned_cols=95 Identities=22% Similarity=0.353 Sum_probs=73.6
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
+||||+.||+|.+++... ..+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...........
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence 589999999999999864 469999999999999999999999999999999999999999999998765332211111
Q ss_pred --ccccCccceeehhhhhc
Q psy3182 79 --KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 --~~~~~~~~~ylv~E~~~ 95 (255)
......+..|+.+|...
T Consensus 184 ~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp -------CCGGGCCHHHHC
T ss_pred cccccccCCccccChhhhc
Confidence 11112455688888765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=4.5e-12 Score=106.80 Aligned_cols=95 Identities=22% Similarity=0.283 Sum_probs=72.4
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--L 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l 77 (255)
|||||+.| +|.+.+.+. ..+++..+..++.+++.|+.|||++||+||||||+|++++.++.+|+.+......... -
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 68999975 788877654 4599999999999999999999999999999999999999999999987654322110 0
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|...+
T Consensus 175 ~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp ---CCCCCCTTCCHHHHTT
T ss_pred cccCCcccCCcCCHHHhcC
Confidence 0111223556888886643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=7.7e-12 Score=102.52 Aligned_cols=70 Identities=21% Similarity=0.254 Sum_probs=64.5
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.++++.. ..+++..+..++.+++.|+.|+|+++++||||||+|++++.++.+|+.+...
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccc
Confidence 589999999999999865 5699999999999999999999999999999999999999999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=4.9e-12 Score=107.41 Aligned_cols=95 Identities=20% Similarity=0.203 Sum_probs=70.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec-----ccCceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD-----NRGYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~-----~~~~vkl~~~~~h~~iv 75 (255)
|||||+. |+|.+++.....+++..+..++.+++.|+.|||+++|+||||||+||+++ ..+.+|+.+........
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 6899997 59999999988999999999999999999999999999999999999995 44458887754332111
Q ss_pred ccc--ccccCccceeehhhhhcc
Q psy3182 76 RLY--KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ~l~--~~~~~~~~~ylv~E~~~g 96 (255)
.-. ......+..|+.+|...+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp -----------CCTTCCHHHHTT
T ss_pred CcccccCCCcCCccccCHHHhcC
Confidence 000 011122455888886644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=4.3e-12 Score=104.59 Aligned_cols=96 Identities=28% Similarity=0.364 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR---- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~---- 76 (255)
+||||+.||+|.+.+.....+++..+..++.+++.|+.|+|++|++||||||+|++++.++.+|+.+.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 5899999999999998878899999999999999999999999999999999999999999999977543221100
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
-.......+..|+.+|...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~ 181 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKR 181 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTC
T ss_pred hcccCCccccCccChHHHhc
Confidence 00111223456888887654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.27 E-value=3.2e-12 Score=108.98 Aligned_cols=97 Identities=22% Similarity=0.317 Sum_probs=77.1
Q ss_pred CeeeccCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTI------LRE--RTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~------~~~--~~~~~~~~~~~~~~~v~~~l~~lh~-~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+||||+.||+|.++ +.+ ...+++..+..++.+++.|+.|+|+ +||+||||||+|++++.++.+|+.+....
T Consensus 120 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 199 (348)
T 2pml_X 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199 (348)
T ss_dssp EEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccc
Confidence 58999999999998 665 6779999999999999999999999 99999999999999999999999875543
Q ss_pred cccccccccccCccceeehhhhhcch
Q psy3182 72 TRQTRLYKTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 72 ~~iv~l~~~~~~~~~~ylv~E~~~gg 97 (255)
.....-.......+..|+.+|.+.++
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 200 EYMVDKKIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp EECBTTEECSSCSCGGGCCGGGGSSC
T ss_pred cccccccccCCCCCcCccCchhhcCC
Confidence 32211111223345668888876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.27 E-value=3.9e-12 Score=111.74 Aligned_cols=95 Identities=24% Similarity=0.361 Sum_probs=72.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc---eeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~---vkl~~~~~h~~iv~l 77 (255)
|||||+.||+|.+.+...+.+++..+..++.+++.|+.|||+++|+||||||+|++++..+. +|+.+.........-
T Consensus 216 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~ 295 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295 (419)
T ss_dssp EEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC
Confidence 68999999999999988889999999999999999999999999999999999999976654 888775433221110
Q ss_pred c-ccccCccceeehhhhhc
Q psy3182 78 Y-KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~-~~~~~~~~~ylv~E~~~ 95 (255)
. ......+..|+.+|.+.
T Consensus 296 ~~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 296 SLMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp ---------CTTCCTTTTC
T ss_pred ccccccCCCCCccCceeee
Confidence 0 01112345688888764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=104.86 Aligned_cols=94 Identities=21% Similarity=0.298 Sum_probs=72.2
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc-------------------
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN------------------- 59 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~------------------- 59 (255)
|||||+ ||+|.+++.+.+ .+++..+..++.+++.|+.|+|++||+||||||+|++++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 589999 999999998765 6899999999999999999999999999999999999987
Q ss_pred cCceeeeccccccccccccccccCccceeehhhhhcc
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.+.+|+.+.......... ......+..|+.+|...+
T Consensus 173 ~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp CCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTT
T ss_pred CCCceEeeCcccccCccc-cccccCCccccChHHhhC
Confidence 445777665432211110 111223556888887654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=6.7e-12 Score=103.88 Aligned_cols=70 Identities=21% Similarity=0.266 Sum_probs=64.2
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++... ..+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence 589999999999999764 4599999999999999999999999999999999999999999999987543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=3.4e-12 Score=107.84 Aligned_cols=95 Identities=24% Similarity=0.253 Sum_probs=74.1
Q ss_pred CeeeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT----CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~----~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~ 76 (255)
+||||+.||+|.+++.... .+++.++..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 5899999999999996543 599999999999999999999999999999999999999999999987654322111
Q ss_pred cc----ccccCccceeehhhhhc
Q psy3182 77 LY----KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 l~----~~~~~~~~~ylv~E~~~ 95 (255)
.. ......+..|+.+|...
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~ 214 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFI 214 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHH
T ss_pred ccccccccccCCCccccCHHHhc
Confidence 10 11112345688888653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.4e-11 Score=102.23 Aligned_cols=93 Identities=17% Similarity=0.238 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCcceeecccCc-----eeeecccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLDNRGY-----VKLVSRKKKT 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~--i~~rdiK~~nil~~~~~~-----vkl~~~~~h~ 72 (255)
+||||+.||+|.+.+.+. ..+++..+..++.+++.|+.|+|+++ |+||||||+|++++..+. +|+.+.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 589999999999988654 46999999999999999999999999 999999999999988776 8888765433
Q ss_pred ccccccccccCccceeehhhhh
Q psy3182 73 RQTRLYKTFKDSKYVYMLLEAC 94 (255)
Q Consensus 73 ~iv~l~~~~~~~~~~ylv~E~~ 94 (255)
....- ......+..|+.+|..
T Consensus 178 ~~~~~-~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 178 QSVHS-VSGLLGNFQWMAPETI 198 (287)
T ss_dssp CCSSC-EECCCCCCTTSCGGGS
T ss_pred ccccc-ccccCCCccccCchhh
Confidence 22111 1112234567888866
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=7.9e-12 Score=108.16 Aligned_cols=71 Identities=21% Similarity=0.250 Sum_probs=63.5
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+||||+.||+|.+++++.. .+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccc
Confidence 5899999999999998654 5899999999999999999999999999999999999999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.3e-11 Score=107.10 Aligned_cols=94 Identities=22% Similarity=0.339 Sum_probs=73.4
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc--eeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY--VKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~--vkl~~~~~h~~iv~ 76 (255)
|||||+. |+|.+++.... .+++..+..++.+++.|+.|||+++|+||||||+||+++.++. +|+.+.........
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 5899994 79999997654 4999999999999999999999999999999999999999887 89987654322111
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
-. .....+..|+.+|.+.+
T Consensus 255 ~~-~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 255 RV-YTYIQSRFYRAPEVILG 273 (429)
T ss_dssp CC-CSSCSCGGGCCHHHHHT
T ss_pred cc-cccCCCCCccChHHHhC
Confidence 11 11223556899987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.7e-12 Score=105.94 Aligned_cols=70 Identities=24% Similarity=0.332 Sum_probs=64.6
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++... ..+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 589999999999999875 4599999999999999999999999999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=9.4e-12 Score=105.10 Aligned_cols=95 Identities=21% Similarity=0.309 Sum_probs=73.3
Q ss_pred CeeeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccc
Q psy3182 1 MLLEACLGGEVWTILRER------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQ 74 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~i 74 (255)
|||||+. |+|.+++... ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.+|+.+.......
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 6899997 5999998653 35999999999999999999999999999999999999999999999876543221
Q ss_pred ccccc--cccCccceeehhhhhcc
Q psy3182 75 TRLYK--TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 75 v~l~~--~~~~~~~~ylv~E~~~g 96 (255)
..-.. .....+..|+.+|.+.+
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred CCCcccCCCCcccccccCchHhhC
Confidence 10001 11223556888887643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=102.93 Aligned_cols=94 Identities=23% Similarity=0.401 Sum_probs=69.9
Q ss_pred CeeeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec---ccCceeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD---NRGYVKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~----~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~---~~~~vkl~~~~~h~~ 73 (255)
+||||+.||+|.+.+.. ...+++..+..++.+++.|++|||++||+||||||+|++++ ..+.+|+.+......
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 58999999999999854 36799999999999999999999999999999999999994 456788877543321
Q ss_pred cccc-cccccCccceeehhhhh
Q psy3182 74 QTRL-YKTFKDSKYVYMLLEAC 94 (255)
Q Consensus 74 iv~l-~~~~~~~~~~ylv~E~~ 94 (255)
...- .......+..|+.+|..
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~ 198 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVF 198 (285)
T ss_dssp ----------CTTGGGCCHHHH
T ss_pred cCCcccCcCcccccCcCChHHh
Confidence 1100 01112234567777754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.25 E-value=4.6e-12 Score=104.71 Aligned_cols=70 Identities=19% Similarity=0.289 Sum_probs=64.1
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 5899999999999997543 699999999999999999999999999999999999999999999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.25 E-value=5.5e-12 Score=111.87 Aligned_cols=71 Identities=17% Similarity=0.222 Sum_probs=64.8
Q ss_pred CeeeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
|||||+.||+|.++++. ...+++..+..++.+++.|++|||+++|+||||||+|++++.++.+|+.+....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 68999999999999964 346999999999999999999999999999999999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.25 E-value=8.5e-12 Score=103.77 Aligned_cols=95 Identities=20% Similarity=0.277 Sum_probs=72.3
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
+||||+.| +|.+.+... +.+++..+..++.|++.|+.|+|++||+||||||+|++++.++.+|+.+.........-.
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 58999975 999998764 679999999999999999999999999999999999999999999998765332111000
Q ss_pred -ccccCccceeehhhhhcc
Q psy3182 79 -KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMG 174 (288)
T ss_dssp ------CCCTTCCHHHHTT
T ss_pred ccccccccccccCchheeC
Confidence 011223456888886643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=8e-12 Score=103.82 Aligned_cols=70 Identities=26% Similarity=0.371 Sum_probs=64.3
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++... ..+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence 589999999999999654 5699999999999999999999999999999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=102.44 Aligned_cols=96 Identities=23% Similarity=0.347 Sum_probs=73.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC----ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG----YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~----~vkl~~~~~h~~iv~ 76 (255)
+||||+.||+|.+++.+...+++..+..++.+++.|+.|+|+++++||||||+|++++..+ .+|+.+.........
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 5899999999999998888899999999999999999999999999999999999998877 688876543221110
Q ss_pred cc-ccccCccceeehhhhhcc
Q psy3182 77 LY-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~-~~~~~~~~~ylv~E~~~g 96 (255)
-. ......+..|+.+|...+
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~ 185 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNY 185 (283)
T ss_dssp -------CCCGGGCCHHHHTT
T ss_pred CCcccccCCCcCccCcceecC
Confidence 00 001123445778886543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=7.3e-12 Score=111.45 Aligned_cols=93 Identities=20% Similarity=0.300 Sum_probs=69.0
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
|||||+.|+ +...+.. .+++..+..++.|++.|++|+|++||+||||||+||+++.++.+|+.+.........- ..
T Consensus 144 lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 220 (464)
T 3ttj_A 144 LVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220 (464)
T ss_dssp EEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC
T ss_pred EEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCccc
Confidence 689999765 7676644 5999999999999999999999999999999999999999999999886543221110 01
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|.+.+
T Consensus 221 ~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 221 TPYVVTRYYRAPEVILG 237 (464)
T ss_dssp ----CCCTTCCHHHHTT
T ss_pred CCCcccccccCHHHHcC
Confidence 11223456888887654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1e-11 Score=104.59 Aligned_cols=95 Identities=20% Similarity=0.362 Sum_probs=71.5
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT---- 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv---- 75 (255)
+||||+.||+|.+++...+ .+++..+..++.+++.|+.|+|++||+||||||+||+++ ++.+|+.+........
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 5899999999999998755 699999999999999999999999999999999999998 6788887754321110
Q ss_pred ---cccccccCccceeehhhhhcc
Q psy3182 76 ---RLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ---~l~~~~~~~~~~ylv~E~~~g 96 (255)
.-.......+..|+.+|...+
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccCCCcccccChHHhhh
Confidence 001112234456888887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=103.68 Aligned_cols=95 Identities=24% Similarity=0.376 Sum_probs=71.4
Q ss_pred CeeeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCcccCCCCcceeecccCc-eeeeccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT---CFDDNAASFITACVIEALEYLHT---RGIVFRDLKPENLLLDNRGY-VKLVSRKKKTR 73 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~---~~~~~~~~~~~~~v~~~l~~lh~---~~i~~rdiK~~nil~~~~~~-vkl~~~~~h~~ 73 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|+ ++|+||||||+|++++.++. +|+.+......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 5899999999999998765 37889999999999999999999 89999999999999988876 68877654322
Q ss_pred cccccccccCccceeehhhhhcc
Q psy3182 74 QTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 74 iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.... ......+..|+.+|...+
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 156 IQTH-MTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp ----------CCTTSSCHHHHTC
T ss_pred cccc-cccCCCCCceEChhhhCC
Confidence 1111 111224556888887654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.9e-11 Score=104.78 Aligned_cols=95 Identities=23% Similarity=0.314 Sum_probs=70.8
Q ss_pred CeeeccCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec-ccCceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTIL----RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD-NRGYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~----~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~-~~~~vkl~~~~~h~~iv 75 (255)
|||||+.| +|.+.+ ...+.+++..+..++.|++.|+.|||++||+||||||+|++++ ..+.+|+.+........
T Consensus 115 lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 193 (383)
T 3eb0_A 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193 (383)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccC
Confidence 58999985 666655 4467899999999999999999999999999999999999997 67889998765432211
Q ss_pred cc-cccccCccceeehhhhhcc
Q psy3182 76 RL-YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ~l-~~~~~~~~~~ylv~E~~~g 96 (255)
.- .......+..|+.+|...+
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 194 PSEPSVAYICSRFYRAPELMLG 215 (383)
T ss_dssp TTSCCCCCCCCSSCCCHHHHTT
T ss_pred CCCCCcCcccCCCccCHHHhcC
Confidence 10 0111223455888886544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=4.7e-12 Score=104.66 Aligned_cols=70 Identities=26% Similarity=0.324 Sum_probs=64.1
Q ss_pred CeeeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~--~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.+.+. +++..+..++.+++.|+.|+|+++++||||||+|++++.++.+|+.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence 58999999999999976543 89999999999999999999999999999999999999999999987643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=9.7e-12 Score=115.17 Aligned_cols=70 Identities=27% Similarity=0.421 Sum_probs=64.9
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
|||||+.||+|.++++..+ .+++..+..++.+++.|+.|+|++||+||||||+||+++.++.+|+.+...
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC
Confidence 6899999999999998654 699999999999999999999999999999999999999999999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-11 Score=102.25 Aligned_cols=95 Identities=18% Similarity=0.171 Sum_probs=74.2
Q ss_pred CeeeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE---RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~---~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l 77 (255)
+||||+.||+|.+++.. ...+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+..........
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 58999999999999973 346999999999999999999999999999999999999999999999876533221111
Q ss_pred c----ccccCccceeehhhhhc
Q psy3182 78 Y----KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ~----~~~~~~~~~ylv~E~~~ 95 (255)
. ......+..|+.+|...
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHT
T ss_pred cccccccccCCCcCcCChHHhc
Confidence 1 11122455688888654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=102.61 Aligned_cols=96 Identities=25% Similarity=0.364 Sum_probs=75.8
Q ss_pred CeeeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~-~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
+||||+.||+|.+++. ....+++..+..++.+++.|+.|+|.+|++|+||||+|++++.++.+|+.+.........-.
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 5899999999999997 45679999999999999999999999999999999999999999999998765432221110
Q ss_pred -ccccCccceeehhhhhcc
Q psy3182 79 -KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 181 ~~~~~~~~~~y~aPE~~~~ 199 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE 199 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS
T ss_pred ccCccCCCCCccChhhcCC
Confidence 111223456888886654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=6.4e-12 Score=113.75 Aligned_cols=71 Identities=17% Similarity=0.222 Sum_probs=64.8
Q ss_pred CeeeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
|||||+.||+|.++++. ...+++.++..++.+++.|++|||+++|+||||||+||+++.++.+|+.+....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 69999999999999964 346999999999999999999999999999999999999999999999886543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=6.6e-12 Score=105.52 Aligned_cols=95 Identities=26% Similarity=0.346 Sum_probs=74.3
Q ss_pred Ceeec-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec-ccCceeeecccccccccccc
Q psy3182 1 MLLEA-CLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD-NRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~-~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~-~~~~vkl~~~~~h~~iv~l~ 78 (255)
+|||| +.||+|.+++.+.+.+++..+..++.+++.|+.|+|++||+||||||+|++++ .++.+|+.+.........-.
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~ 194 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc
Confidence 58999 89999999999888899999999999999999999999999999999999998 78889987754322111111
Q ss_pred ccccCccceeehhhhhc
Q psy3182 79 KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~ 95 (255)
......+..|+.+|...
T Consensus 195 ~~~~~~~~~y~aPE~~~ 211 (312)
T 2iwi_A 195 YTDFDGTRVYSPPEWIS 211 (312)
T ss_dssp BCCCCSCTTTSCHHHHH
T ss_pred ccccCCcccccCceeee
Confidence 11122345577777553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=106.10 Aligned_cols=60 Identities=30% Similarity=0.487 Sum_probs=53.2
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCcceeecccC
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRG 61 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~-~i~~rdiK~~nil~~~~~ 61 (255)
|||||+ ||++.+.+... +.+++..+..++.|++.|+.|||++ ||+||||||+||+++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred EEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 689999 67777766543 4699999999999999999999999 999999999999998775
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=104.79 Aligned_cols=94 Identities=24% Similarity=0.358 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc---eeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY---VKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~---vkl~~~~~h~~iv~l 77 (255)
+||||+.||+|.+.+...+.+++..+..++.+++.|+.|+|++||+||||||+||+++..+. +|+.+.........-
T Consensus 91 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 170 (322)
T 2ycf_A 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170 (322)
T ss_dssp EEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC
T ss_pred EEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc
Confidence 58999999999999998889999999999999999999999999999999999999987665 888775432211100
Q ss_pred c-ccccCccceeehhhhh
Q psy3182 78 Y-KTFKDSKYVYMLLEAC 94 (255)
Q Consensus 78 ~-~~~~~~~~~ylv~E~~ 94 (255)
. ......+..|+.+|..
T Consensus 171 ~~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 171 SLMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp HHHHHHHSCCTTCCHHHH
T ss_pred cccccccCCcCccCchhh
Confidence 0 0011234457777764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.3e-11 Score=104.23 Aligned_cols=91 Identities=24% Similarity=0.389 Sum_probs=72.1
Q ss_pred CeeeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~-~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
|||||+. |++.+.+. ....+++..+..++.+++.|+.|+|+++|+||||||+||+++.++.+|+.+......... .
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~ 207 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--A 207 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--B
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--C
Confidence 6899997 57777774 466799999999999999999999999999999999999999999999987654322111 1
Q ss_pred cccCccceeehhhhh
Q psy3182 80 TFKDSKYVYMLLEAC 94 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~ 94 (255)
.....+..|+.+|.+
T Consensus 208 ~~~~gt~~y~aPE~~ 222 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVI 222 (348)
T ss_dssp CCCCSCGGGCCHHHH
T ss_pred CcccCCcceeCHhhh
Confidence 112345668888876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.5e-11 Score=104.17 Aligned_cols=95 Identities=22% Similarity=0.306 Sum_probs=71.3
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
|||||+. |+|.+.+...+ .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........-..
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 6899997 58999887654 599999999999999999999999999999999999999999999987653321110000
Q ss_pred --cccCccceeehhhhhcc
Q psy3182 80 --TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 --~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|.+.+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp -------CGGGCCHHHHTT
T ss_pred ccccccCcccccChhhhcC
Confidence 11123456888886644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=106.67 Aligned_cols=93 Identities=22% Similarity=0.332 Sum_probs=65.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+ ||+|.++++. +.+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.........-. .
T Consensus 111 lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-~ 187 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-T 187 (367)
T ss_dssp EEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------
T ss_pred EEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccccC-C
Confidence 578998 8999999976 679999999999999999999999999999999999999999999998765433221111 1
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
....+..|+.+|.+.+
T Consensus 188 ~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 188 GYVATRWYRAPEIMLN 203 (367)
T ss_dssp ---CCCTTCCHHHHTT
T ss_pred CcCcCcCccChHHHcC
Confidence 1123456888886654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.3e-11 Score=101.80 Aligned_cols=95 Identities=24% Similarity=0.345 Sum_probs=74.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--LY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l~ 78 (255)
+||||+.||+|.+++.. +.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+......... ..
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 58999999999999965 6799999999999999999999999999999999999999999999987543322111 01
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 176 ~~~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT
T ss_pred cCccCCCcCccCHHHHhc
Confidence 112234456888886644
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.5e-11 Score=103.41 Aligned_cols=94 Identities=21% Similarity=0.279 Sum_probs=70.6
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee-------------------cc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL-------------------DN 59 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~-------------------~~ 59 (255)
|||||+ +|++.+.+.+.. .+++..+..++.|++.|+.|||++||+||||||+||++ +.
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence 589999 778888876654 69999999999999999999999999999999999999 45
Q ss_pred cCceeeeccccccccccccccccCccceeehhhhhcc
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.+.+|+.+.........- ......+..|+.+|...+
T Consensus 178 ~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 178 NTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILE 213 (355)
T ss_dssp CCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTT
T ss_pred CCcEEEeecCcccccccc-ccCCcCCCcccCCeeeec
Confidence 667888765433211110 111234556888887644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=104.88 Aligned_cols=95 Identities=21% Similarity=0.285 Sum_probs=71.9
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
||||||.| ++.+.+.. ...+++.++..++.+++.|+.|||++||+||||||+|++++.++.+|+.+.........
T Consensus 101 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 179 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179 (351)
T ss_dssp EEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSS
T ss_pred EEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccc
Confidence 58999975 77777765 35799999999999999999999999999999999999999999999987653321110
Q ss_pred ---ccccccCccceeehhhhhcc
Q psy3182 77 ---LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 ---l~~~~~~~~~~ylv~E~~~g 96 (255)
........+..|+.+|...+
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 180 SQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp SSCCCCCSSCSCGGGCCHHHHTT
T ss_pred ccccccCCcccccCccCchhhcC
Confidence 00011123456888886643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=102.67 Aligned_cols=70 Identities=30% Similarity=0.348 Sum_probs=64.4
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+.+... ..+++..+..++.+++.|+.|+|+++++||||||+|++++.++.+|+.+...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence 589999999999999764 5699999999999999999999999999999999999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.6e-11 Score=101.11 Aligned_cols=69 Identities=32% Similarity=0.572 Sum_probs=63.8
Q ss_pred CeeeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRE--------RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--------~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
+||||+.||+|.+++.. ...+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+..
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 58999999999999974 4569999999999999999999999999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3.6e-11 Score=100.88 Aligned_cols=96 Identities=21% Similarity=0.243 Sum_probs=71.1
Q ss_pred CeeeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~----~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~ 76 (255)
+||||+.||+|.+++.. ...+++..+..++.+++.|+.|+|++|++||||||+|++++.++.+|+.+.........
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 58999999999999964 56699999999999999999999999999999999999999999999987543221111
Q ss_pred c--cccccCccceeehhhhhcc
Q psy3182 77 L--YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l--~~~~~~~~~~ylv~E~~~g 96 (255)
- .......+..|+.+|...+
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp ----------CCSSCCHHHHTT
T ss_pred CCccccccCCCeeEeChHHhCC
Confidence 0 0011123455788886543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.4e-11 Score=105.85 Aligned_cols=96 Identities=23% Similarity=0.252 Sum_probs=70.3
Q ss_pred CeeeccCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec-ccCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD-NRGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~---~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~-~~~~vkl~~~~~h~~iv~ 76 (255)
||||||.|+.+.... .....+++..+..++.|++.|+.|+|++||+||||||+|++++ ..+.+|+.+.........
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 589999876443332 2367899999999999999999999999999999999999998 788999987654322111
Q ss_pred c-cccccCccceeehhhhhcc
Q psy3182 77 L-YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l-~~~~~~~~~~ylv~E~~~g 96 (255)
- .......+..|+.+|.+.+
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFG 215 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTT
T ss_pred CCCCcccccCcCccCHHHHcC
Confidence 0 0111123456888886643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.20 E-value=3.1e-11 Score=102.11 Aligned_cols=93 Identities=18% Similarity=0.290 Sum_probs=71.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC-ceeeeccccccccccc-c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG-YVKLVSRKKKTRQTRL-Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~-~vkl~~~~~h~~iv~l-~ 78 (255)
+||||+.||+|.++++. +++..+..++.+++.|+.|||++||+||||||+|++++.++ .+|+.+.........- .
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 58999999999998854 99999999999999999999999999999999999999777 7888776533211100 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 187 ~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVD 204 (330)
T ss_dssp CCSCCSCGGGCCHHHHTT
T ss_pred cccccccccccChhhhcC
Confidence 111223455778886644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.2e-11 Score=115.18 Aligned_cols=91 Identities=23% Similarity=0.304 Sum_probs=69.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||+.||+|.+.+.. .+++.++..++.+++.|+.|+|++||+||||||+||+++.. .+|+.+.......... .
T Consensus 161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--~ 235 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--G 235 (681)
T ss_dssp EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--S
T ss_pred EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC--C
Confidence 69999999999998765 79999999999999999999999999999999999999874 7888876543322211 1
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
....+..|+.+|...+
T Consensus 236 ~~~gt~~y~aPE~~~~ 251 (681)
T 2pzi_A 236 YLYGTPGFQAPEIVRT 251 (681)
T ss_dssp CCCCCTTTSCTTHHHH
T ss_pred ccCCCccccCHHHHcC
Confidence 2234556888886644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.19 E-value=3.4e-11 Score=103.61 Aligned_cols=92 Identities=18% Similarity=0.288 Sum_probs=71.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY-- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~-- 78 (255)
+||||+. |+|.++++. +.+++..+..++.+++.|+.|||++||+||||||+|++++.++.+|+.+.........-.
T Consensus 107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 5899996 699999977 569999999999999999999999999999999999999999999998765332211100
Q ss_pred ---ccccCccceeehhhhh
Q psy3182 79 ---KTFKDSKYVYMLLEAC 94 (255)
Q Consensus 79 ---~~~~~~~~~ylv~E~~ 94 (255)
......+..|+.+|.+
T Consensus 185 ~~~~~~~~gt~~y~aPE~~ 203 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIM 203 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHH
T ss_pred cccccccccccCCCCCHHh
Confidence 0111235568888864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.4e-11 Score=100.69 Aligned_cols=95 Identities=28% Similarity=0.388 Sum_probs=72.6
Q ss_pred CeeeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--- 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--- 75 (255)
|||||+.|| +.+.+.. ...+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+........
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 589999888 7777765 4569999999999999999999999999999999999999999999997754332211
Q ss_pred -cccccccCccceeehhhhhcc
Q psy3182 76 -RLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 -~l~~~~~~~~~~ylv~E~~~g 96 (255)
.........+..|+.+|...+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTC
T ss_pred cccccccCCCCCCCcChhhccC
Confidence 011112234566888887654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.5e-11 Score=105.98 Aligned_cols=95 Identities=22% Similarity=0.361 Sum_probs=68.2
Q ss_pred CeeeccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee----cccCceeeec
Q psy3182 1 MLLEACLGGEVWTILRER---------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL----DNRGYVKLVS 67 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~---------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~----~~~~~vkl~~ 67 (255)
|||||+. |+|++.+... ..+++..+..++.+++.|+.|||+++|+||||||+||++ +..+.+|+.+
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 5899995 6888888532 249999999999999999999999999999999999999 6778899987
Q ss_pred ccccccccccc-----ccccCccceeehhhhhcc
Q psy3182 68 RKKKTRQTRLY-----KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 68 ~~~h~~iv~l~-----~~~~~~~~~ylv~E~~~g 96 (255)
.........-. ......+..|+.+|.+.+
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTT
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 65432211100 011123455888886654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-11 Score=99.45 Aligned_cols=93 Identities=22% Similarity=0.295 Sum_probs=68.2
Q ss_pred CeeeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCcceeecccCceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILR----ERTCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~----~~~~~~~~~~~~~~~~v~~~l~~lh~~-~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv 75 (255)
+||||+. |+|.+.+. ....+++..+..++.+++.|+.|+|++ ||+||||||+|++++..+.+|+.+........
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 5899997 47777664 356799999999999999999999998 99999999999999999999998765332211
Q ss_pred cc-cccccCccceeehhhhh
Q psy3182 76 RL-YKTFKDSKYVYMLLEAC 94 (255)
Q Consensus 76 ~l-~~~~~~~~~~ylv~E~~ 94 (255)
.- .......+..|+.+|..
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERI 181 (290)
T ss_dssp --------CCCCCCSCHHHH
T ss_pred ccccccccCCCccccChhhc
Confidence 11 11122345568888875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.1e-11 Score=105.61 Aligned_cols=95 Identities=29% Similarity=0.403 Sum_probs=69.8
Q ss_pred CeeeccCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q psy3182 1 MLLEACLGGEVWTILRE----------------------------------------RTCFDDNAASFITACVIEALEYL 40 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~----------------------------------------~~~~~~~~~~~~~~~v~~~l~~l 40 (255)
||||||.||+|.+.+.. ...+++..+..++.+++.|+.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 68999999999999852 12246777889999999999999
Q ss_pred HhCCCcccCCCCcceeecccC--ceeeeccccccccccc------cccccCccceeehhhhhc
Q psy3182 41 HTRGIVFRDLKPENLLLDNRG--YVKLVSRKKKTRQTRL------YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 41 h~~~i~~rdiK~~nil~~~~~--~vkl~~~~~h~~iv~l------~~~~~~~~~~ylv~E~~~ 95 (255)
|+++|+||||||+|++++.++ .+|+.+.......... .......+..|+.+|.+.
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence 999999999999999998776 7888776433221110 011223455688888764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=3.7e-11 Score=103.07 Aligned_cols=95 Identities=19% Similarity=0.294 Sum_probs=69.8
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-c
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~ 78 (255)
+||||+. |+|.+.+... ..+++..+..++.+++.|+.|+|++||+||||||+||+++.++.+|+.+.........- .
T Consensus 111 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (362)
T 3pg1_A 111 LVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189 (362)
T ss_dssp EEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------
T ss_pred EEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccc
Confidence 5899997 6888888654 46999999999999999999999999999999999999999999999876543211110 0
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 190 ~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 190 KTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp ------CGGGCCHHHHTT
T ss_pred cceecccceecCcHHhcC
Confidence 111223445888886654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.2e-11 Score=101.69 Aligned_cols=64 Identities=20% Similarity=0.178 Sum_probs=46.9
Q ss_pred cceeehhhhhcc-h----hHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH-HcCcccccCCCCceeeCC
Q psy3182 85 KYVYMLLEACLG-G----EVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH-TRGIVFRDLKPENLLLDN 158 (255)
Q Consensus 85 ~~~ylv~E~~~g-g----~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH-~~~iiHrdlkp~nil~~~ 158 (255)
+..++||||+.+ | .|.+.... .++ ..+..++.|++.||.||| ++||+||||||+|||++.
T Consensus 141 ~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~-----------~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~ 206 (258)
T 1zth_A 141 MKNVLLMEFIGEDELPAPTLVELGRE---LKE-----------LDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID 206 (258)
T ss_dssp ETTEEEEECCEETTEECCBHHHHGGG---GGG-----------SCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS
T ss_pred CCCEEEEEecCCCCCccccHHHHhhc---cCh-----------HHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC
Confidence 456899999942 3 55554321 111 123456788999999999 999999999999999987
Q ss_pred CCceee
Q psy3182 159 RGYVKL 164 (255)
Q Consensus 159 ~~~~~l 164 (255)
.+++
T Consensus 207 --~~~l 210 (258)
T 1zth_A 207 --KVYF 210 (258)
T ss_dssp --SEEE
T ss_pred --cEEE
Confidence 5666
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.18 E-value=4.7e-11 Score=104.87 Aligned_cols=95 Identities=24% Similarity=0.328 Sum_probs=70.0
Q ss_pred CeeeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeeccc-Cceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILR----ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR-GYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~----~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~-~~vkl~~~~~h~~iv 75 (255)
|||||+.| ++...+. ....+++..+..++.|++.|+.|||++||+||||||+||+++.+ +.+|+.+........
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 58999975 5666553 35679999999999999999999999999999999999999965 567998765433211
Q ss_pred ccc-ccccCccceeehhhhhcc
Q psy3182 76 RLY-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 76 ~l~-~~~~~~~~~ylv~E~~~g 96 (255)
.-. ......+..|+.+|.+.+
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFG 230 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTT
T ss_pred cCCCceeeeeCCCcCCHHHHcC
Confidence 100 011123456888887654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=3e-11 Score=102.25 Aligned_cols=69 Identities=23% Similarity=0.339 Sum_probs=61.3
Q ss_pred CeeeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERT-------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~ 69 (255)
|||||+.||+|.+++.+.. .+++..+..++.+++.|+.|||++||+||||||+||+++..+ .+|+.+..
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 5899999999999998753 499999999999999999999999999999999999998544 47887654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=4.2e-11 Score=99.96 Aligned_cols=94 Identities=24% Similarity=0.411 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
+||||+.||+|.+++.+ ...+++..+..++.+++.|+.|+|++|++||||||+|++++.++.+|+.+.........-.
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 58999999999999875 5679999999999999999999999999999999999999999999998754321111000
Q ss_pred -ccccCccceeehhhhh
Q psy3182 79 -KTFKDSKYVYMLLEAC 94 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~ 94 (255)
......+..|+.+|..
T Consensus 173 ~~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVV 189 (302)
T ss_dssp C-----CCGGGCCHHHH
T ss_pred ccccccCChhhcCCeee
Confidence 0111234568888865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.9e-11 Score=99.76 Aligned_cols=96 Identities=26% Similarity=0.417 Sum_probs=72.8
Q ss_pred CeeeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc-cCceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT---CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN-RGYVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~---~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~-~~~vkl~~~~~h~~iv~ 76 (255)
+||||+.||+|.+++.... .+++..+..++.+++.|+.|+|++||+||||||+|++++. .+.+|+.+.........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 5899999999999998652 4678999999999999999999999999999999999987 78889877543322111
Q ss_pred c--cccccCccceeehhhhhcc
Q psy3182 77 L--YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l--~~~~~~~~~~ylv~E~~~g 96 (255)
. .......+..|+.+|...+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~ 197 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDK 197 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHH
T ss_pred CCCcccccCCCccccChhhhcC
Confidence 0 0111223456788886543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.17 E-value=7.5e-11 Score=99.48 Aligned_cols=95 Identities=22% Similarity=0.252 Sum_probs=73.1
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l- 77 (255)
+||||+. |+|.+++.... .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........-
T Consensus 96 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG
T ss_pred EEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC
Confidence 5899997 69999998744 4999999999999999999999999999999999999999999999875432211100
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|.+.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 175 ALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp GGCCCCCCCTTCCHHHHTT
T ss_pred CccccccccceeCHHHHhc
Confidence 0111223456888886644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-10 Score=99.62 Aligned_cols=94 Identities=24% Similarity=0.271 Sum_probs=71.9
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCcceeec--ccCceeeecccccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLH--TRGIVFRDLKPENLLLD--NRGYVKLVSRKKKTRQ 74 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh--~~~i~~rdiK~~nil~~--~~~~vkl~~~~~h~~i 74 (255)
|||||+. |+|.+++... +.+++..+..++.+++.|+.|+| ..||+||||||+||++. .++.+|+.+.......
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 6899995 5999999865 45999999999999999999999 57999999999999995 4677899876543222
Q ss_pred ccccccccCccceeehhhhhcc
Q psy3182 75 TRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 75 v~l~~~~~~~~~~ylv~E~~~g 96 (255)
..-. .....+..|+.+|.+.+
T Consensus 212 ~~~~-~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 212 GQRI-YQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp TCCC-CSSCSCGGGCCHHHHTT
T ss_pred cccc-ccccCCccccChHHHcC
Confidence 1111 11233556899987755
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=3.5e-11 Score=102.81 Aligned_cols=95 Identities=25% Similarity=0.340 Sum_probs=73.3
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-- 77 (255)
+||||+.| +|...+.... .+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........-
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 58999976 8888887644 5999999999999999999999999999999999999999999999876543221110
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|...+
T Consensus 168 ~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTT
T ss_pred cCCcccccccccCchHhhC
Confidence 0111223556888887643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=8e-11 Score=98.95 Aligned_cols=94 Identities=27% Similarity=0.368 Sum_probs=71.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR---- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~---- 76 (255)
|||| +.||+|.+++...+.+++..+..++.+++.|+.|+|+++|+||||||+|++++. +.+|+.+.........
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 5899 679999999999889999999999999999999999999999999999999964 7888877543322111
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
........+..|+.+|...+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp -------CCGGGCCHHHHTT
T ss_pred ccccCCCCCCCcCCHHHHhh
Confidence 01111234567888887654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.15 E-value=5.4e-11 Score=102.66 Aligned_cols=93 Identities=20% Similarity=0.301 Sum_probs=68.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
||||||. |+|.+.+.. .+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........- ..
T Consensus 107 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 183 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183 (371)
T ss_dssp EEEECCS-EEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred EEEEcCC-CCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccccc
Confidence 5899996 578888863 5999999999999999999999999999999999999999999999876543221110 01
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|.+.+
T Consensus 184 ~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 184 TPYVVTRYYRAPEVILG 200 (371)
T ss_dssp ------CTTCCHHHHTT
T ss_pred CCceecCCccCHHHhcC
Confidence 11223456888887654
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.15 E-value=7e-11 Score=98.46 Aligned_cols=95 Identities=21% Similarity=0.266 Sum_probs=73.1
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
+||||+. |+|.+++... ..+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+.........-.
T Consensus 79 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 157 (299)
T 2r3i_A 79 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157 (299)
T ss_dssp EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence 5899997 6999999765 469999999999999999999999999999999999999999999998754322111000
Q ss_pred c--cccCccceeehhhhhcc
Q psy3182 79 K--TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~--~~~~~~~~ylv~E~~~g 96 (255)
. .....+..|+.+|...+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (299)
T 2r3i_A 158 RTYTHEVVTLWYRAPEILLG 177 (299)
T ss_dssp BCTTSCBCCCTTCCHHHHTT
T ss_pred cccCcccccccccCcHHhhc
Confidence 1 11223456888886644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.14 E-value=6.1e-11 Score=101.91 Aligned_cols=94 Identities=23% Similarity=0.325 Sum_probs=71.4
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCcceeecc------cCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDN------RGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~-~i~~rdiK~~nil~~~------~~~vkl~~~~~h 71 (255)
|||||+ ||+|.+++.+. +.+++..+..++.+++.|+.|+|++ ||+||||||+||+++. .+.+|+.+....
T Consensus 107 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a 185 (373)
T 1q8y_A 107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185 (373)
T ss_dssp EEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTC
T ss_pred EEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccc
Confidence 589999 99999999863 4599999999999999999999998 9999999999999954 336888775433
Q ss_pred cccccccccccCccceeehhhhhcc
Q psy3182 72 TRQTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 72 ~~iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.....- ......+..|+.+|...+
T Consensus 186 ~~~~~~-~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 186 CWYDEH-YTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp EETTBC-CCSCCSCGGGCCHHHHHT
T ss_pred cccCCC-CCCCCCCccccCcHHHhC
Confidence 221111 111234556888887654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.14 E-value=7.6e-11 Score=101.74 Aligned_cols=92 Identities=21% Similarity=0.311 Sum_probs=69.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+. |+|...+.. .+++..+..++.+++.|+.|||++||+||||||+|++++.++.+|+.+.........-. .
T Consensus 124 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~ 199 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-T 199 (371)
T ss_dssp EEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred EEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCc-C
Confidence 5899996 688887743 59999999999999999999999999999999999999999999998765432211111 1
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
....+..|+.+|...+
T Consensus 200 ~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 200 GYVVTRWYRAPEVILS 215 (371)
T ss_dssp CTTCCCTTSCHHHHSC
T ss_pred CcccCccccCHHHhcC
Confidence 1123455788886654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=3e-11 Score=99.68 Aligned_cols=96 Identities=24% Similarity=0.325 Sum_probs=71.7
Q ss_pred CeeeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALEYLHTRG-----IVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----~~~~~~~~~~~~~~v~~~l~~lh~~~-----i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+||||+.||+|.+++... ..+++..+..++.+++.|++|+|.++ |+||||||+|++++.++.+|+.+....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 589999999999999653 34999999999999999999999999 999999999999999999999875432
Q ss_pred cccccc--cccccCccceeehhhhhcc
Q psy3182 72 TRQTRL--YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 72 ~~iv~l--~~~~~~~~~~ylv~E~~~g 96 (255)
.....- .......+..|+.+|...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred eeeccccccccccCCCccccChHHhcc
Confidence 211100 0001123345777776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-11 Score=112.44 Aligned_cols=61 Identities=15% Similarity=0.227 Sum_probs=55.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
||||||.||+|.+++++ +..++.|++.+++|+|+++|+||||||+|++++. .+|+.+....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccC
Confidence 68999999999999976 5589999999999999999999999999999998 8898876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=99.54 Aligned_cols=68 Identities=21% Similarity=0.397 Sum_probs=62.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+. |+|.+.+.. +.+++..+..++.+++.|+.|+|++||+||||||+|++++.++.+|+.+...
T Consensus 91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 5899996 699999977 5799999999999999999999999999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.5e-10 Score=97.15 Aligned_cols=68 Identities=21% Similarity=0.357 Sum_probs=60.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec-ccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD-NRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~-~~~~vkl~~~~~ 70 (255)
+||||+. |+|.++++. +.+++..+..++.+++.|+.|+|++||+||||||+|++++ .++.+|+.+...
T Consensus 99 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 99 IVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp EEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 5899997 699999865 6799999999999999999999999999999999999997 456788877543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=5.7e-11 Score=104.74 Aligned_cols=95 Identities=17% Similarity=0.198 Sum_probs=63.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHH-------HHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC------------
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDN-------AASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG------------ 61 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~-------~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~------------ 61 (255)
||||||. |+|.+++.......+. .+..++.+++.|+.|||+++|+||||||+||+++..+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 6899995 6999999876544333 3456999999999999999999999999999997653
Q ss_pred -ceeeeccccccccccccc------cccCccceeehhhhhcc
Q psy3182 62 -YVKLVSRKKKTRQTRLYK------TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 62 -~vkl~~~~~h~~iv~l~~------~~~~~~~~ylv~E~~~g 96 (255)
.+|+.+.........-.. .....+..|+.+|.+.+
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 678876543222111000 11224556888887755
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1e-10 Score=100.00 Aligned_cols=92 Identities=21% Similarity=0.304 Sum_probs=70.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+. |+|.+.+.. .+++..+..++.+++.|+.|||++||+||||||+|++++.++.+|+.+.........- ..
T Consensus 106 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~ 181 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MT 181 (353)
T ss_dssp EEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred EEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-cc
Confidence 5899996 688887744 5999999999999999999999999999999999999999999999876433221110 11
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
....+..|+.+|.+.+
T Consensus 182 ~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 182 GYVVTRWYRAPEVILS 197 (353)
T ss_dssp --CCSBCCSCHHHHSC
T ss_pred ccccCcCcCCHHHHhC
Confidence 1223556888886654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=2.2e-11 Score=101.46 Aligned_cols=62 Identities=21% Similarity=0.337 Sum_probs=53.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+|||||.||+|.+ +. . .....++.+++.|+.|+|++||+||||||+|++++ ++.+|+.+...
T Consensus 177 lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 177 VLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp EEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred EEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 6999999999998 42 2 23457999999999999999999999999999999 89999987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.7e-10 Score=98.74 Aligned_cols=95 Identities=17% Similarity=0.183 Sum_probs=69.7
Q ss_pred CeeeccCCCchH---HHHHhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCcceeecc-cCceeeecccccccc
Q psy3182 1 MLLEACLGGEVW---TILRERTCFDDNAASFITACVIEALEYLH--TRGIVFRDLKPENLLLDN-RGYVKLVSRKKKTRQ 74 (255)
Q Consensus 1 ~~~e~~~gg~l~---~~~~~~~~~~~~~~~~~~~~v~~~l~~lh--~~~i~~rdiK~~nil~~~-~~~vkl~~~~~h~~i 74 (255)
+||||+.|+-+. ........+++..+..++.+++.|+.|+| ++||+||||||+||+++. ++.+|+.+.......
T Consensus 103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 589999876333 33345677999999999999999999999 999999999999999997 888999876543221
Q ss_pred cccc-ccccCccceeehhhhhc
Q psy3182 75 TRLY-KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 75 v~l~-~~~~~~~~~ylv~E~~~ 95 (255)
..-. ......+..|+.+|.+.
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~ 204 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIF 204 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHT
T ss_pred CCCCCcccccCCcceeCHHHHc
Confidence 1100 11122355688888664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 255 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-15 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-11 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-31 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-13 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-15 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-13 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-28 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-11 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-10 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-13 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-15 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-12 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-14 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-11 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-09 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-25 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-09 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-25 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-10 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-10 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-07 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-24 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-12 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-11 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-07 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-23 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-07 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-12 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-08 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-09 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-08 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-09 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-10 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-06 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-10 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-21 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-10 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-21 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-09 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-21 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-09 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-20 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-07 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-20 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-10 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-20 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-08 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-11 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-20 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-09 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-07 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-08 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-11 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-19 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-07 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-09 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-19 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-09 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-09 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-19 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-08 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-19 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-10 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-08 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-07 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-18 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-07 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-18 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-08 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-17 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-06 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-08 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-17 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-07 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-06 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-17 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-08 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-16 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-08 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-08 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-15 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-04 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-04 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-07 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-04 | |
| d1o7fa3 | 124 | b.82.3.2 (A:322-445) Regulatory domain of Epac2, d | 0.001 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-34
Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 41/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY F D+ VY++LE G V+ L++ + FD+ + + AL
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL---------- 119
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
Y H++ ++ RD+KPENLLL + G +K+ DF
Sbjct: 120 -SYCHSKRVIHRDIKPENLLLGSAGELKI----------------------------ADF 150
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G+S H S + T CGT +Y+ PE+I+ R HD VD W+LG+L +E L G
Sbjct: 151 GWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.6 bits (170), Expect = 8e-15
Identities = 22/65 (33%), Positives = 39/65 (60%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE G V+ L++ + FD+ + + AL Y H++ ++ RD+KPENLLL +
Sbjct: 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 142
Query: 61 GYVKL 65
G +K+
Sbjct: 143 GELKI 147
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-31
Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 40/172 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
++ +++++E GG + ++ E + A + ++A
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------------AVCRECLQA 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LE+LH+ ++ RD+K +N+LL G VK DF
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVK----------------------------LTDF 160
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF + K T GTP ++APE++ + + VD W+LGI+ E++ G
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.2 bits (148), Expect = 1e-11
Identities = 26/102 (25%), Positives = 48/102 (47%), Gaps = 5/102 (4%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E GG + ++ E C D+ + + ++ALE+LH+ ++ RD+K +N+LL
Sbjct: 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 61 GYVKLVSR---KKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
G VKL + T + T + Y +M E
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAY 193
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-31
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 42/173 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
Y F + + +E GG + +L++ + ++ VI+ L
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL---------- 117
Query: 136 LEYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
YL + I+ RD+KP N+L+++RG +KL D
Sbjct: 118 -TYLREKHKIMHRDVKPSNILVNSRGEIKL----------------------------CD 148
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG S L S ++ GT Y++PE ++ + D W++G+ + E+ G
Sbjct: 149 FGVSGQLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (161), Expect = 2e-13
Identities = 20/66 (30%), Positives = 38/66 (57%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDN 59
+ +E GG + +L++ + ++ VI+ L YL + I+ RD+KP N+L+++
Sbjct: 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140
Query: 60 RGYVKL 65
RG +KL
Sbjct: 141 RGEIKL 146
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 7e-30
Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 42/175 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ Y ++ Y+ LE C GGE++ + + A ++ +
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV---------- 116
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH GI RD+KPENLLLD R +K+ DF
Sbjct: 117 -VYLHGIGITHRDIKPENLLLDERDNLKI----------------------------SDF 147
Query: 196 GFSKHLGHSGCK--TWTFCGTPEYVAPEIIKNRG-HDRAVDYWALGILMHELLTG 247
G + ++ + CGT YVAPE++K R H VD W+ GI++ +L G
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.2 bits (174), Expect = 3e-15
Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ LE C GGE++ + + A ++ + YLH GI RD+KPENLLLD R
Sbjct: 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 139
Query: 61 GYVKLV-----SRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
+K+ + + + RL + Y+ E E
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGT-LPYVAPELLKRREFHA 184
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 8e-30
Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 45/178 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIE 134
+L F +++L+E C GG V ++ E ++ + ++AL
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL--------- 123
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
YLH I+ RDLK N+L G +KL D
Sbjct: 124 --NYLHDNKIIHRDLKAGNILFTLDGDIKL----------------------------AD 153
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEII-----KNRGHDRAVDYWALGILMHELLTG 247
FG S + + +F GTP ++APE++ K+R +D D W+LGI + E+
Sbjct: 154 FGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.5 bits (162), Expect = 1e-13
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+L+E C GG V ++ E ++ + ++AL YLH I+ RDLK N+L
Sbjct: 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145
Query: 60 RGYVKL 65
G +KL
Sbjct: 146 DGDIKL 151
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 108 bits (270), Expect = 3e-28
Identities = 39/174 (22%), Positives = 67/174 (38%), Gaps = 41/174 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALDFITACVIE 134
L+ F+D + M+ E GGE++ + E ++ A V + L
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL--------- 137
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV- 193
++H V DLKPEN++ + ++K+
Sbjct: 138 --CHMHENNYVHLDLKPENIMFTTKR---------------------------SNELKLI 168
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG + HL GT E+ APE+ + + D W++G+L + LL+G
Sbjct: 169 DFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 59.7 bits (144), Expect = 4e-11
Identities = 19/69 (27%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 1 MLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
M+ E GGE++ + E ++ A V + L ++H V DLKPEN++
Sbjct: 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159
Query: 60 R--GYVKLV 66
+ +KL+
Sbjct: 160 KRSNELKLI 168
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-28
Identities = 52/172 (30%), Positives = 90/172 (52%), Gaps = 39/172 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
++ TF+ + ++ ++E GG++ ++ FD + A+F A +I L
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL---------- 116
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++LH++GIV+RDLK +N+LLD G++K+ DF
Sbjct: 117 -QFLHSKGIVYRDLKLDNILLDKDGHIKI----------------------------ADF 147
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G K KT TFCGTP+Y+APEI+ + ++ +VD+W+ G+L++E+L G
Sbjct: 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (140), Expect = 1e-10
Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 2/101 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GG++ ++ FD + A+F A +I L++LH++GIV+RDLK +N+LLD
Sbjct: 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 139
Query: 61 GYVKLV--SRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
G++K+ K+ Y+ E LG +
Sbjct: 140 GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 8e-28
Identities = 39/175 (22%), Positives = 65/175 (37%), Gaps = 46/175 (26%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ + ++++E CLG + + + + +T ++ L
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL---------- 128
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH+ ++ RD+K N+LL G VKL DF
Sbjct: 129 -AYLHSHNMIHRDVKAGNILLSEPGLVKL----------------------------GDF 159
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEII---KNRGHDRAVDYWALGILMHELLTG 247
G + + +F GTP ++APE+I +D VD W+LGI EL
Sbjct: 160 GSASIM----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 66.6 bits (162), Expect = 2e-13
Identities = 19/65 (29%), Positives = 34/65 (52%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E CLG + + + + +T ++ L YLH+ ++ RD+K N+LL
Sbjct: 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
Query: 61 GYVKL 65
G VKL
Sbjct: 152 GLVKL 156
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 107 bits (267), Expect = 9e-28
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 42/202 (20%)
Query: 47 FRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER 106
+ + E L L+ R + LVS + F + +L+ GG++ L +
Sbjct: 42 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 101
Query: 107 TCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEF 166
F + F A +I L E++H R +V+RDLKP N+LLD G+V++
Sbjct: 102 GVFSEADMRFYAAEIILGL-----------EHMHNRFVVYRDLKPANILLDEHGHVRI-- 148
Query: 167 YPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEII-KN 225
D G + K GT Y+APE++ K
Sbjct: 149 --------------------------SDLGLACDFSKK--KPHASVGTHGYMAPEVLQKG 180
Query: 226 RGHDRAVDYWALGILMHELLTG 247
+D + D+++LG ++ +LL G
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRG 202
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.7 bits (175), Expect = 4e-15
Identities = 28/101 (27%), Positives = 47/101 (46%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+L+ GG++ L + F + F A +I LE++H R +V+RDLKP N+LLD
Sbjct: 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 143
Query: 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
G+V++ ++ + YM E G +
Sbjct: 144 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-27
Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 41/174 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY TF+D + +Y L GE+ +R+ FD+ F TA ++ AL
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL---------- 121
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH +GI+ RDLKPEN+LL+ ++++ DF
Sbjct: 122 -EYLHGKGIIHRDLKPENILLNEDMHIQIT----------------------------DF 152
Query: 196 GFSKHLGHSG--CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G +K L + +F GT +YV+PE++ + ++ D WALG ++++L+ G
Sbjct: 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.6 bits (149), Expect = 9e-12
Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 4/103 (3%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
L GE+ +R+ FD+ F TA ++ ALEYLH +GI+ RDLKPEN+LL+
Sbjct: 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144
Query: 61 GYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
++++ ++ + Y+ E
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 102 bits (256), Expect = 7e-27
Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 46/178 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L T++ + + +++ + GE++ L E+ + I ++E +
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI---------- 123
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LH IV RDLKPEN+LLD+ +KL DF
Sbjct: 124 -CALHKLNIVHRDLKPENILLDDDMNIKL----------------------------TDF 154
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEII------KNRGHDRAVDYWALGILMHELLTG 247
GFS L G K CGTP Y+APEII + G+ + VD W+ G++M+ LL G
Sbjct: 155 GFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 67.4 bits (164), Expect = 7e-14
Identities = 22/66 (33%), Positives = 35/66 (53%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + GE++ L E+ + I ++E + LH IV RDLKPEN+LLD+
Sbjct: 87 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 146
Query: 61 GYVKLV 66
+KL
Sbjct: 147 MNIKLT 152
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 1e-25
Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 50/184 (27%)
Query: 76 RLYKTFKD--SKYVYMLLEACLGGEVWTIL----RERTCFDDNAASFITACVIEALDFIT 129
R Y D + +Y+++E C GG++ +++ +ER D+ + + AL
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL---- 122
Query: 130 ACVIEALEYLHTRG-----IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFF 184
+ H R ++ RDLKP N+ LD + VKL
Sbjct: 123 -------KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL-------------------- 155
Query: 185 IISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHEL 244
DFG ++ L H F GTP Y++PE + ++ D W+LG L++EL
Sbjct: 156 --------GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 207
Query: 245 LTGM 248
M
Sbjct: 208 CALM 211
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.5 bits (141), Expect = 9e-11
Identities = 29/111 (26%), Positives = 48/111 (43%), Gaps = 13/111 (11%)
Query: 1 MLLEACLGGEVWTIL----RERTCFDDNAASFITACVIEALEYLHTRG-----IVFRDLK 51
+++E C GG++ +++ +ER D+ + + AL+ H R ++ RDLK
Sbjct: 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141
Query: 52 PENLLLDNRGYVKLV---SRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
P N+ LD + VKL + T K F + Y YM E
Sbjct: 142 PANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY-YMSPEQMNRMSY 191
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 1e-25
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 45/171 (26%)
Query: 80 TFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139
T K K + ++ E G + T L+ I+ L +++ L++L
Sbjct: 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMK-----------IKVLRSWCRQILKGLQFL 128
Query: 140 HTRG--IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-DFG 196
HTR I+ RDLK +N+ + G VK+ D G
Sbjct: 129 HTRTPPIIHRDLKCDNIFITG----------------------------PTGSVKIGDLG 160
Query: 197 FSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ S GTPE++APE+ + + +D +VD +A G+ M E+ T
Sbjct: 161 LATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATS 208
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (130), Expect = 2e-09
Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 3/68 (4%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLD 58
++ E G + T L+ +++ L++LHTR I+ RDLK +N+ +
Sbjct: 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 148
Query: 59 NR-GYVKL 65
G VK+
Sbjct: 149 GPTGSVKI 156
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 100 bits (250), Expect = 2e-25
Identities = 40/174 (22%), Positives = 65/174 (37%), Gaps = 41/174 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWT-ILRERTCFDDNAASFITACVIEALDFITACVIE 134
L+ F+D + ++LE GGE++ I E + E L
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL--------- 140
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV- 193
+++H IV D+KPEN++ + + VK+
Sbjct: 141 --KHMHEHSIVHLDIKPENIMCETKK---------------------------ASSVKII 171
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG + L + T E+ APEI+ D WA+G+L + LL+G
Sbjct: 172 DFGLATKL-NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 54.7 bits (131), Expect = 2e-09
Identities = 19/69 (27%), Positives = 34/69 (49%), Gaps = 3/69 (4%)
Query: 1 MLLEACLGGEVWT-ILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++LE GGE++ I E + E L+++H IV D+KPEN++ +
Sbjct: 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162
Query: 60 R--GYVKLV 66
+ VK++
Sbjct: 163 KKASSVKII 171
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 3e-25
Identities = 37/173 (21%), Positives = 69/173 (39%), Gaps = 39/173 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+++F+ + + M+ E G +++ + + + V EA
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNE----------REIVSYVHQVCEA 114
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
L++LH+ I D++PEN++ R +K+ +
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRS---------------------------STIKIIE 147
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG ++ L G PEY APE+ ++ A D W+LG L++ LL+G
Sbjct: 148 FGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.2 bits (135), Expect = 7e-10
Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
M+ E G +++ + ++ V EAL++LH+ I D++PEN++
Sbjct: 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137
Query: 60 RGYVKL 65
R +
Sbjct: 138 RRSSTI 143
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 4e-25
Identities = 55/172 (31%), Positives = 84/172 (48%), Gaps = 39/172 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L F+ + ++E GGE++ L F + E F A ++ A
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-----------ERARFYGAEIVSA 117
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LEYLH+R +V+RD+K ENL+LD G++K+ DF
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKI----------------------------TDF 149
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G K G TFCGTPEY+APE++++ + RAVD+W LG++M+E++ G
Sbjct: 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 1e-10
Identities = 27/66 (40%), Positives = 42/66 (63%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++E GGE++ L F + A F A ++ ALEYLH+R +V+RD+K ENL+LD
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141
Query: 61 GYVKLV 66
G++K+
Sbjct: 142 GHIKIT 147
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.2 bits (244), Expect = 7e-25
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 39/173 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L ++ ++Y++++ GGE++ + E+ + + AS + V++A+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV---------- 120
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV-D 194
+YLH GIV RDLKPENLL + ++ + D
Sbjct: 121 -KYLHDLGIVHRDLKPENLLYYSLD--------------------------EDSKIMISD 153
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
FG SK G T CGTP YVAPE++ + + +AVD W++G++ + LL G
Sbjct: 154 FGLSKME-DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 24/68 (35%), Positives = 41/68 (60%), Gaps = 3/68 (4%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL--- 57
++++ GGE++ + E+ + + AS + V++A++YLH GIV RDLKPENLL
Sbjct: 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143
Query: 58 DNRGYVKL 65
D + +
Sbjct: 144 DEDSKIMI 151
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 2e-24
Identities = 36/177 (20%), Positives = 68/177 (38%), Gaps = 45/177 (25%)
Query: 77 LYKTFKDSKYVYMLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ + + + ++ + C G ++ L T F+ + L I +
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFE-----------MIKLIDIARQTAQG 116
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++YLH + I+ RDLK N+ L VK+ DF
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKI----------------------------GDF 148
Query: 196 GFSKHLGHSG--CKTWTFCGTPEYVAPEIIKNRG---HDRAVDYWALGILMHELLTG 247
G + + G+ ++APE+I+ + + D +A GI+++EL+TG
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.5 bits (149), Expect = 8e-12
Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++ + C G ++ L T F+ I + ++YLH + I+ RDLK N+ L
Sbjct: 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE 139
Query: 60 RGYVKL 65
VK+
Sbjct: 140 DLTVKI 145
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 8e-24
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 45/179 (25%)
Query: 76 RLYKTFKDS----KYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALDFIT 129
R+ +++ K + +++E GGE+++ +++R F + AS I + EA+
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI---- 124
Query: 130 ACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGG 189
+YLH+ I RD+KPENLL ++
Sbjct: 125 -------QYLHSINIAHRDVKPENLLYTSKR--------------------------PNA 151
Query: 190 QVKV-DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+K+ DFGF+K S T C TP YVAPE++ +D++ D W+LG++M+ LL G
Sbjct: 152 ILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 209
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 1e-11
Identities = 31/106 (29%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
+++E GGE+++ +++R F + AS I + EA++YLH+ I RD+KPENLL
Sbjct: 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 145
Query: 59 ---NRGYVKLV--SRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
+KL K+T T + Y Y+ E +
Sbjct: 146 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKY 190
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.9 bits (235), Expect = 1e-23
Identities = 24/172 (13%), Positives = 53/172 (30%), Gaps = 27/172 (15%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+Y ++ + ++++ + F + ++ +
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV---------- 114
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ +H + +V+RD+KP+N L+ + +++ G VK
Sbjct: 115 -QSIHEKSLVYRDIKPDNFLIGRPNS----------------KNANMIYVVDFGMVKFYR 157
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ GT Y++ R R D ALG + L G
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.0 bits (116), Expect = 1e-07
Identities = 17/113 (15%), Positives = 45/113 (39%), Gaps = 14/113 (12%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN- 59
++++ + F + ++ ++ +H + +V+RD+KP+N L+
Sbjct: 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP 137
Query: 60 ----RGYVKLV----SRKKKTRQTRLYKTFKDSKYV-----YMLLEACLGGEV 99
+ +V + + T+ + +++ K + YM + LG E
Sbjct: 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ 190
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 2e-23
Identities = 32/179 (17%), Positives = 58/179 (32%), Gaps = 34/179 (18%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALD-----FITA 130
L + Y+Y+ +E G + LR+ + + A I L A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
V ++YL + + RDL N+L+ K+
Sbjct: 135 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKI-------------------------- 168
Query: 191 VKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
DFG S+ K ++A E + + D W+ G+L+ E+++
Sbjct: 169 --ADFGLSRG-QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (114), Expect = 3e-07
Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 16/81 (19%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAAS----------------FITACVIEALEYLHTRG 44
+ +E G + LR+ + + A A V ++YL +
Sbjct: 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 147
Query: 45 IVFRDLKPENLLLDNRGYVKL 65
+ RDL N+L+ K+
Sbjct: 148 FIHRDLAARNILVGENYVAKI 168
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.4 bits (234), Expect = 2e-23
Identities = 57/172 (33%), Positives = 100/172 (58%), Gaps = 42/172 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
R++ TF+D++ ++M+++ GGE++++LR+ F + A F A V AL
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL---------- 117
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH++ I++RDLKPEN+LLD G++K+ DF
Sbjct: 118 -EYLHSKDIIYRDLKPENILLDKNGHIKI----------------------------TDF 148
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
GF+K++ T+T CGTP+Y+APE++ + +++++D+W+ GIL++E+L G
Sbjct: 149 GFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 61.6 bits (149), Expect = 9e-12
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 1/99 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M+++ GGE++++LR+ F + A F A V ALEYLH++ I++RDLKPEN+LLD
Sbjct: 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 140
Query: 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
G++K+ + T + Y+ E
Sbjct: 141 GHIKITDFGFAKYVPDVTYTLCGTPD-YIAPEVVSTKPY 178
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 4e-23
Identities = 34/188 (18%), Positives = 64/188 (34%), Gaps = 42/188 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALD-------- 126
L S +Y++ E C G++ LR R F ++ + +E +
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 127 ---FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSF 183
V + +E+L + V RDL N+L+ + VK+
Sbjct: 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI------------------- 205
Query: 184 FIISGGQVKVDFGFSKHLGHSGCKT--WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILM 241
DFG ++ + +++APE + + D W+ GIL+
Sbjct: 206 ---------CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256
Query: 242 HELLTGMK 249
E+ +
Sbjct: 257 WEIFSLGV 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (122), Expect = 3e-08
Identities = 11/51 (21%), Positives = 20/51 (39%)
Query: 16 RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLV 66
+ V + +E+L + V RDL N+L+ + VK+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 8e-23
Identities = 41/173 (23%), Positives = 57/173 (32%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L F + ++ + I + ++ L
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL---------- 113
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EYLH I+ RDLKP NLLLD G +KL DF
Sbjct: 114 -EYLHQHWILHRDLKPNNLLLDENGVLKL----------------------------ADF 144
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
G +K G T Y APE++ R + VD WA+G ++ ELL
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 197
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (128), Expect = 4e-09
Identities = 20/66 (30%), Positives = 28/66 (42%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + I + ++ LEYLH I+ RDLKP NLLLD
Sbjct: 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 136
Query: 61 GYVKLV 66
G +KL
Sbjct: 137 GVLKLA 142
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 2e-22
Identities = 30/175 (17%), Positives = 57/175 (32%), Gaps = 39/175 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY + + ++ E G + LR + E L + V E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA----------ETLLGMCLDVCEG 113
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ YL ++ RDL N L+ +K+ DF
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKV----------------------------SDF 145
Query: 196 GFSKHLGHSGCK-TWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G ++ + + ++ +PE+ + D W+ G+LM E+ + K
Sbjct: 146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (124), Expect = 1e-08
Identities = 15/66 (22%), Positives = 26/66 (39%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++ E G + LR + F + V E + YL ++ RDL N L+
Sbjct: 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136
Query: 60 RGYVKL 65
+K+
Sbjct: 137 NQVIKV 142
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.4 bits (221), Expect = 5e-22
Identities = 36/175 (20%), Positives = 64/175 (36%), Gaps = 39/175 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY + ++++ E G + LRE + L + V EA
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT----------QQLLEMCKDVCEA 112
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+EYL ++ + RDL N L++++G VK+ DF
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKV----------------------------SDF 144
Query: 196 GFSKHLGHSGCKTWT-FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G S+++ + + PE++ D WA G+LM E+ + K
Sbjct: 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.5 bits (128), Expect = 4e-09
Identities = 24/104 (23%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++ E G + LR R F + V EA+EYL ++ + RDL N L+++
Sbjct: 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135
Query: 60 RGYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
+G VK+ +SR + K + E + +
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKF 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 5e-22
Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 44/175 (25%)
Query: 76 RLYKTFKDSKYVYMLLEACLGG-EVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
RL F+ ++LE +++ + ER + A V+EA+
Sbjct: 73 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV--------- 123
Query: 135 ALEYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
+ H G++ RD+K EN+L+D NRG +KL +
Sbjct: 124 --RHCHNCGVLHRDIKDENILIDLNRGELKL----------------------------I 153
Query: 194 DFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
DFG L + F GT Y PE I+ R H R+ W+LGIL+++++ G
Sbjct: 154 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (134), Expect = 6e-10
Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 1/102 (0%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD-N 59
+L +++ + ER + A V+EA+ + H G++ RD+K EN+L+D N
Sbjct: 87 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 146
Query: 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
RG +KL+ T D VY E
Sbjct: 147 RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHG 188
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 6e-22
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 36/172 (20%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L++ +++ V ++LE GGE++ L E+ + A+ ++ +
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV---------- 126
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YLH+ I DLKPEN++L +R K DF
Sbjct: 127 -YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII------------------------DF 161
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G + + G + GTPE+VAPEI+ D W++G++ + LL+G
Sbjct: 162 GLAHKI-DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 21/64 (32%), Positives = 35/64 (54%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++LE GGE++ L E+ + A+ ++ + YLH+ I DLKPEN++L +R
Sbjct: 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149
Query: 61 GYVK 64
K
Sbjct: 150 NVPK 153
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.6 bits (219), Expect = 2e-21
Identities = 33/174 (18%), Positives = 53/174 (30%), Gaps = 43/174 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
R+ + + +++E G + L++ D + V +
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM---------- 120
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+YL V RDL N+LL + Y K+ DF
Sbjct: 121 -KYLEESNFVHRDLAARNVLLVTQHYAKI----------------------------SDF 151
Query: 196 GFSKHLGHSGC---KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
G SK L ++ APE I D W+ G+LM E +
Sbjct: 152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (139), Expect = 1e-10
Identities = 16/66 (24%), Positives = 28/66 (42%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E G + L++ D + V ++YL V RDL N+LL +
Sbjct: 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143
Query: 61 GYVKLV 66
Y K+
Sbjct: 144 HYAKIS 149
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (218), Expect = 2e-21
Identities = 35/175 (20%), Positives = 58/175 (33%), Gaps = 41/175 (23%)
Query: 76 RLYKTFKDSK-YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134
+L + K +Y++ E G + LR R + + V E
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL---------KFSLDVCE 114
Query: 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVD 194
A+EYL V RDL N+L+ K D
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAK----------------------------VSD 146
Query: 195 FGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
FG +K + T ++ APE ++ + D W+ GIL+ E+ + +
Sbjct: 147 FGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (139), Expect = 1e-10
Identities = 22/101 (21%), Positives = 35/101 (34%), Gaps = 3/101 (2%)
Query: 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
++ E G + LR R + + + V EA+EYL V RDL N+L+
Sbjct: 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 137
Query: 59 NRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
K+ + T K + EA +
Sbjct: 138 EDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKF 177
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 89.0 bits (220), Expect = 2e-21
Identities = 34/179 (18%), Positives = 59/179 (32%), Gaps = 43/179 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L S V ++ E G + + LR+ + L + +
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT----------VIQLVGMLRGIAAG 140
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++YL V RDL N+L+++ K+ DF
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKV----------------------------SDF 172
Query: 196 GFSKHLG-----HSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G S+ L + + APE I+ R A D W+ GI+M E+++ +
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.6 bits (128), Expect = 4e-09
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 1/67 (1%)
Query: 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++ E G + + LR+ F + + ++YL V RDL N+L+++
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163
Query: 60 RGYVKLV 66
K+
Sbjct: 164 NLVCKVS 170
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 87.5 bits (216), Expect = 4e-21
Identities = 36/176 (20%), Positives = 64/176 (36%), Gaps = 40/176 (22%)
Query: 76 RLYKTFKD----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITAC 131
+Y T + Y+++E G + I+ A + A +AL
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL------ 124
Query: 132 VIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQV 191
+ H GI+ RD+KP N+++ VK+
Sbjct: 125 -----NFSHQNGIIHRDVKPANIMISATNAVKV-------------------------MD 154
Query: 192 KVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G+S +T GT +Y++PE + D D ++LG +++E+LTG
Sbjct: 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 54.7 bits (131), Expect = 2e-09
Identities = 22/104 (21%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E G + I+ A + A +AL + H GI+ RD+KP N+++
Sbjct: 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 147
Query: 61 GYVKLVSRKKKTRQTRLYKTFKDSKYV-----YMLLEACLGGEV 99
VK++ + + V Y+ E G V
Sbjct: 148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.7 bits (211), Expect = 2e-20
Identities = 34/202 (16%), Positives = 59/202 (29%), Gaps = 43/202 (21%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI 122
L++ +L K + +L E G++ LR + + S
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 EALD-------------FITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPA 169
+ I V + YL R V RDL N L+ VK+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI----- 181
Query: 170 GHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYVAPEIIKNRG 227
DFG S+++ + ++ PE I
Sbjct: 182 -----------------------ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218
Query: 228 HDRAVDYWALGILMHELLTGMK 249
+ D WA G+++ E+ +
Sbjct: 219 YTTESDVWAYGVVLWEIFSYGL 240
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.3 bits (114), Expect = 2e-07
Identities = 15/64 (23%), Positives = 19/64 (29%)
Query: 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG 61
L + L I V + YL R V RDL N L+
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 177
Query: 62 YVKL 65
VK+
Sbjct: 178 VVKI 181
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 3e-20
Identities = 38/177 (21%), Positives = 58/177 (32%), Gaps = 42/177 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL + +++E GG + L + + + + V
Sbjct: 73 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP----------VSNVAELLHQVSMG 121
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
++YL + V RDL N+LL NR Y K+ DF
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKIS----------------------------DF 153
Query: 196 GFSKHLGHSG---CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G SK LG ++ APE I R D W+ G+ M E L+ +
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (135), Expect = 5e-10
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E GG + L +R + + + V ++YL + V RDL N+LL N
Sbjct: 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144
Query: 60 RGYVKL 65
R Y K+
Sbjct: 145 RHYAKI 150
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 3e-20
Identities = 31/188 (16%), Positives = 62/188 (32%), Gaps = 39/188 (20%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI 122
+++ + + + +LY + +Y++ E G + L+ T +
Sbjct: 63 AQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG---------KYLRL 112
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
L + A + + Y+ V RDL+ N+L+ K+
Sbjct: 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV------------------ 154
Query: 183 FFIISGGQVKVDFGFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILM 241
DFG ++ + + ++ APE D W+ GIL+
Sbjct: 155 ----------ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204
Query: 242 HELLTGMK 249
EL T +
Sbjct: 205 TELTTKGR 212
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (122), Expect = 3e-08
Identities = 13/67 (19%), Positives = 25/67 (37%), Gaps = 2/67 (2%)
Query: 1 MLLEACLGGEVWTILRERTC--FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
++ E G + L+ T + A + + Y+ V RDL+ N+L+
Sbjct: 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 147
Query: 59 NRGYVKL 65
K+
Sbjct: 148 ENLVCKV 154
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.0 bits (212), Expect = 3e-20
Identities = 60/185 (32%), Positives = 98/185 (52%), Gaps = 42/185 (22%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI 122
+++ +L +FKD+ +YM++E GGE+++ LR F + A F A ++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
EYLH+ +++RDLKPENLL+D +GY+++
Sbjct: 152 LTF-----------EYLHSLDLIYRDLKPENLLIDQQGYIQVTD---------------- 184
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMH 242
FGF+K + +TWT CGTPE +APEII ++G+++AVD+WALG+L++
Sbjct: 185 ------------FGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 243 ELLTG 247
E+ G
Sbjct: 230 EMAAG 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.6 bits (146), Expect = 2e-11
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 1/93 (1%)
Query: 6 CLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 65
GGE+++ LR F + A F A ++ EYLH+ +++RDLKPENLL+D +GY+++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 66 VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGE 98
R T + + E L
Sbjct: 183 TDFGFAKRVKGRTWTLCGTPE-ALAPEIILSKG 214
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 4e-20
Identities = 32/176 (18%), Positives = 62/176 (35%), Gaps = 35/176 (19%)
Query: 81 FKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALD-----FITACVIEA 135
K + +++E C G + T LR + + L + V +
Sbjct: 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+E+L +R + RDL N+LL + VK+ F
Sbjct: 147 MEFLASRKCIHRDLAARNILLSEKNVVKICD----------------------------F 178
Query: 196 GFSKHLGHSG--CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G ++ + + +++APE I +R + D W+ G+L+ E+ +
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.9 bits (131), Expect = 2e-09
Identities = 18/81 (22%), Positives = 32/81 (39%), Gaps = 16/81 (19%)
Query: 1 MLLEACLGGEVWTILRE----------------RTCFDDNAASFITACVIEALEYLHTRG 44
+++E C G + T LR + + V + +E+L +R
Sbjct: 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154
Query: 45 IVFRDLKPENLLLDNRGYVKL 65
+ RDL N+LL + VK+
Sbjct: 155 CIHRDLAARNILLSEKNVVKI 175
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 5e-20
Identities = 34/181 (18%), Positives = 63/181 (34%), Gaps = 35/181 (19%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALD-----FITA 130
L +Y+++E G + L+ R + + E L
Sbjct: 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142
Query: 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
V +EYL ++ + RDL N+L+ +K+
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI-------------------------- 176
Query: 191 VKVDFGFSKHLGHSG--CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM 248
DFG ++ + H KT +++APE + +R + D W+ G+L+ E+ T
Sbjct: 177 --ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
Query: 249 K 249
Sbjct: 235 G 235
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 4e-07
Identities = 14/81 (17%), Positives = 27/81 (33%), Gaps = 16/81 (19%)
Query: 1 MLLEACLGGEVWTILRERTC----------------FDDNAASFITACVIEALEYLHTRG 44
+++E G + L+ R V +EYL ++
Sbjct: 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155
Query: 45 IVFRDLKPENLLLDNRGYVKL 65
+ RDL N+L+ +K+
Sbjct: 156 CIHRDLAARNVLVTEDNVMKI 176
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 84.5 bits (208), Expect = 7e-20
Identities = 27/179 (15%), Positives = 50/179 (27%), Gaps = 43/179 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+ + Y M++E F + +I +
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI---------- 116
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
EY+H++ + RD+KP+N L+ L + +DF
Sbjct: 117 -EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI-------------------------IDF 150
Query: 196 GFSKHLGHSG-------CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G +K + + GT Y + R D +LG ++ G
Sbjct: 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.8 bits (118), Expect = 8e-08
Identities = 17/96 (17%), Positives = 31/96 (32%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
M++E F + +I +EY+H++ + RD+KP+N L+
Sbjct: 80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139
Query: 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLG 96
LV + Y + G
Sbjct: 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 1e-19
Identities = 36/173 (20%), Positives = 74/173 (42%), Gaps = 45/173 (26%)
Query: 79 KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138
T + K VY++ +G +++ +L+ + +D+ + ++ L+Y
Sbjct: 78 PTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHIC------------YFLYQILRGLKY 124
Query: 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFS 198
+H+ ++ RDLKP NLLL+ +K+ DFG +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKI----------------------------CDFGLA 156
Query: 199 KHLGHSG---CKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
+ + T Y APEI+ N +G+ +++D W++G ++ E+L+
Sbjct: 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.8 bits (144), Expect = 4e-11
Identities = 16/66 (24%), Positives = 37/66 (56%), Gaps = 1/66 (1%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
L+ +G +++ +L+ + ++ + ++ L+Y+H+ ++ RDLKP NLLL+
Sbjct: 87 YLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 145
Query: 61 GYVKLV 66
+K+
Sbjct: 146 CDLKIC 151
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 83.4 bits (205), Expect = 2e-19
Identities = 32/173 (18%), Positives = 60/173 (34%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+LY K + ++ E + + A ++ +
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI---------- 113
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
Y H R ++ RDLKP+NLL++ G +K+ DF
Sbjct: 114 -AYCHDRRVLHRDLKPQNLLINREGELKI----------------------------ADF 144
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG-HDRAVDYWALGILMHELLTG 247
G ++ G K T Y AP+++ + +D W++G + E++ G
Sbjct: 145 GLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 49.1 bits (116), Expect = 2e-07
Identities = 18/105 (17%), Positives = 39/105 (37%), Gaps = 6/105 (5%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E + + A ++ + Y H R ++ RDLKP+NLL++
Sbjct: 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136
Query: 61 GYVKLV----SRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
G +K+ +R + Y + +G + ++
Sbjct: 137 GELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKYS 179
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 2e-19
Identities = 31/177 (17%), Positives = 61/177 (34%), Gaps = 44/177 (24%)
Query: 76 RLYKTFKDSK-----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITA 130
RL+ S+ + ++ E + + E + +
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP----------TETIKDMMF 123
Query: 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
++ L++LH+ +V RDLKP+N+L+ + G +K
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK--------------------------- 156
Query: 191 VKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
DFG ++ + T Y APE++ + VD W++G + E+
Sbjct: 157 -LADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 3e-09
Identities = 24/173 (13%), Positives = 55/173 (31%), Gaps = 15/173 (8%)
Query: 1 MLLEACLGGEV-WTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++ E + + ++ L++LH+ +V RDLKP+N+L+ +
Sbjct: 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151
Query: 60 RGYVKLV-----------SRKKKTRQTRLY---KTFKDSKYVYMLLEACLGGEVWTILRE 105
G +KL T Y + S Y + +G + R
Sbjct: 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211
Query: 106 RTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDN 158
+ F ++ +++ + L + + +P + +
Sbjct: 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 2e-19
Identities = 30/175 (17%), Positives = 59/175 (33%), Gaps = 39/175 (22%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY +Y++ E G + L+ + + + A + E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLL---------DMAAQIAEG 121
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ ++ R + RDL+ N+L+ + K+ DF
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKI----------------------------ADF 153
Query: 196 GFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G ++ + + ++ APE I D W+ GIL+ E++T +
Sbjct: 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (130), Expect = 2e-09
Identities = 13/67 (19%), Positives = 28/67 (41%), Gaps = 2/67 (2%)
Query: 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
++ E G + L+ N + A + E + ++ R + RDL+ N+L+
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 59 NRGYVKL 65
+ K+
Sbjct: 144 DTLSCKI 150
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.0 bits (204), Expect = 3e-19
Identities = 58/175 (33%), Positives = 90/175 (51%), Gaps = 42/175 (24%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
L+ F+ ++++L+ GGE++T L +R F ++ ++ A
Sbjct: 93 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-----------QIYVGEIVLA 141
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
LE+LH GI++RD+K EN+LLD+ G+V L DF
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVL----------------------------TDF 173
Query: 196 GFSKHL-GHSGCKTWTFCGTPEYVAPEII--KNRGHDRAVDYWALGILMHELLTG 247
G SK + + FCGT EY+AP+I+ + GHD+AVD+W+LG+LM+ELLTG
Sbjct: 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (131), Expect = 2e-09
Identities = 26/66 (39%), Positives = 43/66 (65%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++L+ GGE++T L +R F ++ ++ ALE+LH GI++RD+K EN+LLD+
Sbjct: 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 165
Query: 61 GYVKLV 66
G+V L
Sbjct: 166 GHVVLT 171
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 3e-19
Identities = 33/183 (18%), Positives = 61/183 (33%), Gaps = 37/183 (20%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALD-----FI 128
L ++ E C G++ LR + + + I ALD
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISG 188
+ V + + +L ++ + RDL N+LL + K+
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI------------------------ 186
Query: 189 GQVKVDFGFSKHLGHSGCKTWT--FCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT 246
DFG ++ + + +++APE I N + D W+ GI + EL +
Sbjct: 187 ----CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 247 GMK 249
Sbjct: 243 LGS 245
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 5e-08
Identities = 20/119 (16%), Positives = 40/119 (33%), Gaps = 22/119 (18%)
Query: 1 MLLEACLGGEVWTILR------------------ERTCFDDNAASFITACVIEALEYLHT 42
++ E C G++ LR + D + V + + +L +
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 43 RGIVFRDLKPENLLLDNRGYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGG 97
+ + RDL N+LL + K+ ++R K + K +M E+
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 8e-19
Identities = 31/174 (17%), Positives = 53/174 (30%), Gaps = 41/174 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL S + G + + + + + +
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM---------- 124
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
YL R +V RDL N+L+ +VK+ DF
Sbjct: 125 -NYLEDRRLVHRDLAARNVLVKTPQHVKIT----------------------------DF 155
Query: 196 GFSKHLGHSG--CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G +K LG +++A E I +R + D W+ G+ + EL+T
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 8e-10
Identities = 16/103 (15%), Positives = 35/103 (33%), Gaps = 4/103 (3%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ G + + + + + + YL R +V RDL N+L+
Sbjct: 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP 147
Query: 61 GYVKL----VSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEV 99
+VK+ +++ + + +M LE+ L
Sbjct: 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (201), Expect = 8e-19
Identities = 30/179 (16%), Positives = 57/179 (31%), Gaps = 44/179 (24%)
Query: 74 QTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVI 133
+T+ + +Y++ + C + F + + ++ L
Sbjct: 79 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL-------- 130
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKV 193
Y+H I+ RD+K N+L+ G +KL
Sbjct: 131 ---YYIHRNKILHRDMKAANVLITRDGVLKL----------------------------A 159
Query: 194 DFGFSKHLGHSGCKTW----TFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
DFG ++ + T Y PE++ R + +D W G +M E+ T
Sbjct: 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (122), Expect = 3e-08
Identities = 14/65 (21%), Positives = 28/65 (43%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ + C + F + + ++ L Y+H I+ RD+K N+L+
Sbjct: 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 153
Query: 61 GYVKL 65
G +KL
Sbjct: 154 GVLKL 158
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 2e-18
Identities = 24/175 (13%), Positives = 53/175 (30%), Gaps = 42/175 (24%)
Query: 85 KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGI 144
++++ + G ++ L T + + + +E + I
Sbjct: 74 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA----LSTASGLAHLHMEIVGTQGKPAI 129
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS 204
RDLK +N+L+ G + D G + +
Sbjct: 130 AHRDLKSKNILVKKNGTCCI----------------------------ADLGLAVRHDSA 161
Query: 205 G----CKTWTFCGTPEYVAPEIIKNRGH------DRAVDYWALGILMHELLTGMK 249
GT Y+APE++ + + + D +A+G++ E+
Sbjct: 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (117), Expect = 1e-07
Identities = 14/73 (19%), Positives = 25/73 (34%), Gaps = 9/73 (12%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT--------RGIVFRDLKP 52
++ + G ++ L T + L +LH I RDLK
Sbjct: 78 LVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 53 ENLLLDNRGYVKL 65
+N+L+ G +
Sbjct: 137 KNILVKKNGTCCI 149
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 4e-18
Identities = 38/188 (20%), Positives = 63/188 (33%), Gaps = 41/188 (21%)
Query: 63 VKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVI 122
++ + RL K + ++ E G + LRE+ +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS----------V 109
Query: 123 EALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDS 182
L + + ++YL V RDL N+L+++ K+
Sbjct: 110 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV------------------ 151
Query: 183 FFIISGGQVKVDFGFSKHLGHSGCKTWTFC---GTPEYVAPEIIKNRGHDRAVDYWALGI 239
DFG S+ L T+T + APE I R A D W+ GI
Sbjct: 152 ----------SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 201
Query: 240 LMHELLTG 247
+M E++T
Sbjct: 202 VMWEVMTY 209
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 3e-07
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++ E G + LRE+ F + + ++YL V RDL N+L+++
Sbjct: 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 145
Query: 60 RGYVKL----VSRKKKTRQTRLYKTFKDSKYV-YMLLEACLGGEVWT 101
K+ +SR + Y T + + EA + +
Sbjct: 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 192
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.0 bits (194), Expect = 6e-18
Identities = 34/175 (19%), Positives = 56/175 (32%), Gaps = 38/175 (21%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L Y++ E G + LRE + +A L ++ + A
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV---------VLLYMATQISSA 127
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+EYL + + RDL N L+ VK+ DF
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKV----------------------------ADF 159
Query: 196 GFSKHLGHSGCKTWTFC-GTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G S+ + ++ APE + D WA G+L+ E+ T
Sbjct: 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 52.4 bits (125), Expect = 1e-08
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 2/67 (2%)
Query: 1 MLLEACLGGEVWTIL--RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD 58
++ E G + L R ++ + A+EYL + + RDL N L+
Sbjct: 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 149
Query: 59 NRGYVKL 65
VK+
Sbjct: 150 ENHLVKV 156
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 1e-17
Identities = 26/176 (14%), Positives = 60/176 (34%), Gaps = 31/176 (17%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL + +++E G++ + LR N + + + + + +
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI-QMAGEIADG 145
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ YL+ V RDL N ++ VK+ +
Sbjct: 146 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDF---------------------------- 177
Query: 196 GFSKHLGHSG--CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
G ++ + + K +++PE +K+ D W+ G+++ E+ T +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 2e-06
Identities = 13/75 (17%), Positives = 28/75 (37%), Gaps = 10/75 (13%)
Query: 1 MLLEACLGGEVWTILR----------ERTCFDDNAASFITACVIEALEYLHTRGIVFRDL 50
+++E G++ + LR + + + + + YL+ V RDL
Sbjct: 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 159
Query: 51 KPENLLLDNRGYVKL 65
N ++ VK+
Sbjct: 160 AARNCMVAEDFTVKI 174
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 77.6 bits (190), Expect = 3e-17
Identities = 31/176 (17%), Positives = 72/176 (40%), Gaps = 47/176 (26%)
Query: 76 RLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVI 133
L KD S+ ++ E + + + T +D + F ++
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD--------------IRFYMYEIL 139
Query: 134 EALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVK- 192
+AL+Y H+ GI+ RD+KP N+++D+ +++
Sbjct: 140 KALDYCHSMGIMHRDVKPHNVMIDHE----------------------------HRKLRL 171
Query: 193 VDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
+D+G ++ H G + + + PE++ + + +D ++D W+LG ++ ++
Sbjct: 172 IDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 51.0 bits (121), Expect = 3e-08
Identities = 15/61 (24%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E + + + D F +++AL+Y H+ GI+ RD+KP N+++D+
Sbjct: 109 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 165
Query: 61 G 61
Sbjct: 166 H 166
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 4e-17
Identities = 39/178 (21%), Positives = 54/178 (30%), Gaps = 42/178 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RLY + M+ E G L +R T V E
Sbjct: 75 RLYGVVLT-PPMKMVTELAPLGS----LLDRLRKHQGHFLLGTLS------RYAVQVAEG 123
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
+ YL ++ + RDL NLLL R VK DF
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVK----------------------------IGDF 155
Query: 196 GFSKHLGHSG---CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKE 250
G + L + + APE +K R A D W G+ + E+ T +E
Sbjct: 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 20/65 (30%), Positives = 28/65 (43%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
M+ E G + L + + F S V E + YL ++ + RDL NLLL
Sbjct: 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 146
Query: 60 RGYVK 64
R VK
Sbjct: 147 RDLVK 151
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 4e-17
Identities = 39/204 (19%), Positives = 71/204 (34%), Gaps = 39/204 (19%)
Query: 45 IVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILR 104
+ D + E + + L+ +L +Y++ E
Sbjct: 34 KIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---------- 83
Query: 105 ERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKL 164
+ AS +T + + +++ L + H+ ++ RDLKP+NLL++ G +K
Sbjct: 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK- 142
Query: 165 EFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIK 224
DFG ++ G T Y APEI+
Sbjct: 143 ---------------------------LADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 225 NRGH-DRAVDYWALGILMHELLTG 247
+ AVD W+LG + E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTR 199
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 1e-06
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 2/89 (2%)
Query: 15 LRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK--KKT 72
T +++ L + H+ ++ RDLKP+NLL++ G +KL +
Sbjct: 93 ASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152
Query: 73 RQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
T + Y E LG + ++
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 8e-17
Identities = 39/173 (22%), Positives = 65/173 (37%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
+L + V++++E C GE+ + L+ R D + +L + A
Sbjct: 72 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLD----------LASLILYAYQLSTA 120
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L YL ++ V RD+ N+L+ + VK DF
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVK----------------------------LGDF 152
Query: 196 GFSKHLGHSG-CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
G S+++ S K +++APE I R A D W G+ M E+L
Sbjct: 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 205
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 5e-08
Identities = 18/65 (27%), Positives = 32/65 (49%), Gaps = 1/65 (1%)
Query: 1 MLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
+++E C GE+ + L+ R D + + AL YL ++ V RD+ N+L+ +
Sbjct: 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143
Query: 60 RGYVK 64
VK
Sbjct: 144 NDCVK 148
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 1e-16
Identities = 38/173 (21%), Positives = 61/173 (35%), Gaps = 45/173 (26%)
Query: 80 TFKDSKYVYMLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALDFITACVIEAL 136
KD Y+ ++L+ R + + +L
Sbjct: 87 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL----------- 135
Query: 137 EYLHTRGIVFRDLKPENLLLD-NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
Y+H+ GI RD+KP+NLLLD + +KL DF
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKL----------------------------CDF 167
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAP-EIIKNRGHDRAVDYWALGILMHELLTG 247
G +K L G ++ + Y AP I + ++D W+ G ++ ELL G
Sbjct: 168 GSAKQL-VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 7e-08
Identities = 17/70 (24%), Positives = 28/70 (40%), Gaps = 3/70 (4%)
Query: 1 MLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57
++L+ R + + +L Y+H+ GI RD+KP+NLLL
Sbjct: 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 58 DNRGYVKLVS 67
D V +
Sbjct: 156 DPDTAVLKLC 165
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (183), Expect = 1e-16
Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 40/173 (23%)
Query: 76 RLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135
RL+ K + ++ E C E + +++
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-----------LDPEIVKSFLFQLLKG 113
Query: 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDF 195
L + H+R ++ RDLKP+NLL++ G +KL +F
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKL----------------------------ANF 145
Query: 196 GFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG-HDRAVDYWALGILMHELLTG 247
G ++ G T Y P+++ + ++D W+ G + EL
Sbjct: 146 GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (121), Expect = 3e-08
Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 4/104 (3%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
++ E C D +++ L + H+R ++ RDLKP+NLL++
Sbjct: 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137
Query: 61 GYVKLVS---RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
G +KL + + R Y + + Y + G ++++
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLW-YRPPDVLFGAKLYS 180
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 6e-15
Identities = 28/173 (16%), Positives = 59/173 (34%), Gaps = 42/173 (24%)
Query: 81 FKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140
+ ++L G++ +R T V + + F + +++L
Sbjct: 98 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---------VKDLIGFGLQV-AKGMKFLA 147
Query: 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKH 200
++ V RDL N +LD + VK+ DFG ++
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKV----------------------------ADFGLARD 179
Query: 201 LGHSGCKTWTF----CGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK 249
+ + +++A E ++ + D W+ G+L+ EL+T
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 21/108 (19%), Positives = 43/108 (39%), Gaps = 7/108 (6%)
Query: 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN 59
++L G++ +R E V + +++L ++ V RDL N +LD
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165
Query: 60 RGYVKL----VSRKKKTRQTRLYKTFKDSK--YVYMLLEACLGGEVWT 101
+ VK+ ++R ++ +K +M LE+ + T
Sbjct: 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 213
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 4e-14
Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 43/169 (25%)
Query: 79 KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138
KT ++ + VY+++E I E E + ++ ++ +++
Sbjct: 89 KTLEEFQDVYLVMELMDANLCQVIQMELD--------------HERMSYLLYQMLCGIKH 134
Query: 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFS 198
LH+ GI+ RDLKP N+++ + +K +DFG +
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLK----------------------------ILDFGLA 166
Query: 199 KHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTG 247
+ G S T + T Y APE+I G+ VD W++G +M E++
Sbjct: 167 RTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 3e-04
Identities = 15/64 (23%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+++E I + D S++ ++ +++LH+ GI+ RDLKP N+++ +
Sbjct: 99 LVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155
Query: 61 GYVK 64
+K
Sbjct: 156 CTLK 159
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (158), Expect = 7e-13
Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 49/178 (27%)
Query: 76 RLYKTFKDSKYV-----YMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITA 130
L F ++ + L+ +G ++ I++ + DD+ F+
Sbjct: 81 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ------------FLIY 128
Query: 131 CVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQ 190
++ L+Y+H+ I+ RDLKP NL ++ +K
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELK--------------------------- 161
Query: 191 VKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGH-DRAVDYWALGILMHELLTG 247
+DFG ++H + + T Y APEI+ N H ++ VD W++G +M ELLTG
Sbjct: 162 -ILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (110), Expect = 8e-07
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 1/101 (0%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
+ L L G + + D+ F+ ++ L+Y+H+ I+ RDLKP NL ++
Sbjct: 98 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157
Query: 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
+K++ + +++ Y E L +
Sbjct: 158 CELKILDFGLARHTDDEMTGYVATRW-YRAPEIMLNWMHYN 197
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 8e-13
Identities = 37/170 (21%), Positives = 66/170 (38%), Gaps = 45/170 (26%)
Query: 79 KTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138
+T D Y+++ G L + ++ F+ +++ L Y
Sbjct: 90 ETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL-----------RY 136
Query: 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFS 198
+H GI+ RDLKP NL ++ +K +DFG +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELK----------------------------ILDFGLA 168
Query: 199 KHLGHSGCKTWTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTG 247
+ + + T Y APE+I N + + VD W++G +M E++TG
Sbjct: 169 RQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 2e-07
Identities = 21/101 (20%), Positives = 41/101 (40%), Gaps = 1/101 (0%)
Query: 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNR 60
L G L + ++ F+ +++ L Y+H GI+ RDLKP NL ++
Sbjct: 98 FYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157
Query: 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
+K++ + + +++ Y E L +T
Sbjct: 158 CELKILDFGLARQADSEMTGYVVTRW-YRAPEVILNWMRYT 197
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.5 bits (153), Expect = 3e-12
Identities = 25/122 (20%), Positives = 45/122 (36%), Gaps = 26/122 (21%)
Query: 127 FITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFI 185
I+ ++ L+Y+H R GI+ D+KPEN+L++
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP----------------------- 165
Query: 186 ISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELL 245
+++ + T EY +PE++ D W+ L+ EL+
Sbjct: 166 --ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 223
Query: 246 TG 247
TG
Sbjct: 224 TG 225
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.5 bits (101), Expect = 1e-05
Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 6/96 (6%)
Query: 12 WTILRERTCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLVSRKK 70
E I+ ++ L+Y+H R GI+ D+KPEN+L++ + + + K
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172
Query: 71 -----KTRQTRLYKTFKDSKYVYMLLEACLGGEVWT 101
+ T Y E LG
Sbjct: 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGC 208
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 40.9 bits (95), Expect = 4e-05
Identities = 11/39 (28%), Positives = 20/39 (51%)
Query: 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEF 166
+ ++E + + RGIV DL N+L+ G ++F
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDF 146
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 39.0 bits (90), Expect = 2e-04
Identities = 10/36 (27%), Positives = 17/36 (47%)
Query: 29 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64
+ ++E + + RGIV DL N+L+ G
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWI 143
|
| >d1o7fa3 b.82.3.2 (A:322-445) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 124 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 35.9 bits (82), Expect = 0.001
Identities = 10/66 (15%), Positives = 17/66 (25%)
Query: 145 VFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS 204
L + G + +G +G S++II G V V +
Sbjct: 17 ALSHLSTTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYGKGVVCTL 76
Query: 205 GCKTWT 210
Sbjct: 77 HEGDDF 82
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 255 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.98 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.98 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.98 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.98 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.98 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.98 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.98 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.74 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.72 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.72 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.7 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.7 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.7 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.68 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.68 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.67 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.67 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.67 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.66 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.66 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.65 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.65 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.65 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.64 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.62 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.62 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.62 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.62 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.61 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.61 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.61 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.6 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.6 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.59 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.58 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.58 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.58 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.57 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.57 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.53 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.52 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.48 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.48 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.48 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.48 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.47 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.47 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.45 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.45 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.45 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.45 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.45 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.45 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.44 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.43 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.43 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.42 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.42 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.41 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.41 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.41 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.41 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.4 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.39 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.38 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.37 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.36 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.34 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.33 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.04 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 92.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 86.5 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=287.75 Aligned_cols=153 Identities=36% Similarity=0.660 Sum_probs=138.8
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++++++.+.|||+++++++|++.+.+|+|||||.||+|.+++.+...+++.. ++.+++|++.||+|||
T Consensus 54 ~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~-----------~~~~~~qil~al~ylH 122 (337)
T d1o6la_ 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-----------ARFYGAEIVSALEYLH 122 (337)
T ss_dssp HHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHH-----------HHHHHHHHhhhhhhhh
Confidence 35677888899999999999999999999999999999999999887777643 4567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+|||++.++.+|+ +|||+|+..........+.+|||.||||
T Consensus 123 ~~~iiHRDlKP~NILl~~~g~vkl----------------------------~DFG~a~~~~~~~~~~~~~~GT~~Y~aP 174 (337)
T d1o6la_ 123 SRDVVYRDIKLENLMLDKDGHIKI----------------------------TDFGLCKEGISDGATMKTFCGTPEYLAP 174 (337)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEE----------------------------CCCTTCBCSCCTTCCBCCCEECGGGCCG
T ss_pred hcCccccccCHHHeEecCCCCEEE----------------------------eecccccccccCCcccccceeCHHHhhh
Confidence 999999999999999999999998 5999998776655566778999999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+.+|+.++||||+||++|||++|..||.
T Consensus 175 E~~~~~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp GGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence 99999999999999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=277.31 Aligned_cols=152 Identities=38% Similarity=0.644 Sum_probs=135.0
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||++++++.+++++.+|+|||||.||+|.+.+.+...+++. .+..++.|++.||.|||
T Consensus 55 ~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~-----------~~~~i~~qi~~al~~lH 123 (263)
T d2j4za1 55 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ-----------RTATYITELANALSYCH 123 (263)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3567788889999999999999999999999999999999999887766653 34567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+|||++.++.+|+ +|||+|+..... .....+||+.||||
T Consensus 124 ~~~ivHrDiKp~Nill~~~~~~kl----------------------------~DFG~a~~~~~~--~~~~~~Gt~~Y~AP 173 (263)
T d2j4za1 124 SKRVIHRDIKPENLLLGSAGELKI----------------------------ADFGWSVHAPSS--RRTTLCGTLDYLPP 173 (263)
T ss_dssp HTTCCCCCCCGGGEEECTTSCEEE----------------------------CCCCSCSCCCCC--CCEETTEEGGGCCH
T ss_pred HCCeeeeeeccccceecCCCCEee----------------------------cccceeeecCCC--cccccCCCCcccCH
Confidence 999999999999999999998888 599999776543 34467899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+.+|+.++||||+||++|+|++|..||..
T Consensus 174 E~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 999999999999999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=278.96 Aligned_cols=152 Identities=28% Similarity=0.557 Sum_probs=134.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|||++++++.|.+++.+|+|||||.||+|.+++.+ .++++. .+..+++|++.||.|||+
T Consensus 67 E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~-----------~~~~i~~qi~~aL~yLH~ 134 (293)
T d1yhwa1 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEG-----------QIAAVCRECLQALEFLHS 134 (293)
T ss_dssp HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHH-----------HHHHHHHHHHHHHHHHHH
Confidence 46677888999999999999999999999999999999998765 345443 345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+||+||||||+|||++.++.+|+ +|||+|+............+||+.|||||
T Consensus 135 ~~iiHrDiKp~NILl~~~~~vkl----------------------------~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE 186 (293)
T d1yhwa1 135 NQVIHRDIKSDNILLGMDGSVKL----------------------------TDFGFCAQITPEQSKRSTMVGTPYWMAPE 186 (293)
T ss_dssp TTEECCCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCSTTCCBCCCCSCGGGCCHH
T ss_pred CCCcccCCcHHHeEECCCCcEee----------------------------ccchhheeeccccccccccccCCCccChh
Confidence 99999999999999999998888 59999988766555566789999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+.+|+.++||||+||++|+|++|..||..
T Consensus 187 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp HHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 99999999999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=278.51 Aligned_cols=154 Identities=34% Similarity=0.622 Sum_probs=132.5
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||+++++++|++.+.+|+|||||.||+|.+++...+.+++.. +..++.|++.||.|||
T Consensus 57 ~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~-----------~~~~~~qi~~al~ylH 125 (288)
T d1uu3a_ 57 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----------TRFYTAEIVSALEYLH 125 (288)
T ss_dssp HHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHH-----------HHHHHHHHHHHHHhhc
Confidence 35677888899999999999999999999999999999999998877776543 4567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC--CccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS--GCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~--~~~~~~~~gt~~y~ 218 (255)
++||+||||||+||+++.++.+++ +|||+|+..... .....+.+||+.||
T Consensus 126 ~~~iiHrDiKp~NIll~~~~~vkl----------------------------~DFG~a~~~~~~~~~~~~~~~~GT~~Y~ 177 (288)
T d1uu3a_ 126 GKGIIHRDLKPENILLNEDMHIQI----------------------------TDFGTAKVLSPESKQARANSFVGTAQYV 177 (288)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEE----------------------------CCCTTCEECC----------CCCCGGGC
T ss_pred cccEEcCcCCccccccCCCceEEe----------------------------cccccceecccCCcccccccccCCcccc
Confidence 999999999999999999998888 599999876533 22344678999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+..|+.++||||+||++|+|++|..||..
T Consensus 178 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 99999999999999999999999999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=279.35 Aligned_cols=153 Identities=29% Similarity=0.539 Sum_probs=132.2
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||++++++++++++.+|+|||||.||+|++++.++..+++. .+..+++|++.||.|||
T Consensus 52 ~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~-----------~~~~i~~qi~~al~ylH 120 (271)
T d1nvra_ 52 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----------DAQRFFHQLMAGVVYLH 120 (271)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 4677888899999999999999999999999999999999998766656543 34567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~ 218 (255)
++||+||||||+|||++.++.+|+ +|||+|+...... ....+.+|||.||
T Consensus 121 ~~~IiHrDiKp~NILl~~~~~~KL----------------------------~DFG~a~~~~~~~~~~~~~~~~GT~~Y~ 172 (271)
T d1nvra_ 121 GIGITHRDIKPENLLLDERDNLKI----------------------------SDFGLATVFRYNNRERLLNKMCGTLPYV 172 (271)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEE----------------------------CCCTTCEECEETTEECCBCCCCSCGGGS
T ss_pred HcCCccCcccHHHEEECCCCCEEE----------------------------ccchhheeeccCCccccccceeeCcCcc
Confidence 999999999999999999998888 5999987654322 2234578999999
Q ss_pred ccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGH-DRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~-~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++.+..+ +.++||||+||++|+|++|..||.
T Consensus 173 APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp CTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred CHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 9999988776 567999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=281.14 Aligned_cols=151 Identities=26% Similarity=0.462 Sum_probs=132.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||+++++++|++.+.+|+|||||.||+|.+++.+...+++. .+..++.|++.||.|||
T Consensus 53 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~-----------~~~~~~~qil~aL~yLH 121 (322)
T d1s9ja_ 53 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ-----------ILGKVSIAVIKGLTYLR 121 (322)
T ss_dssp HHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 4688899999999999999999999999999999999999999877666543 35567889999999999
Q ss_pred H-cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 141 T-RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~-~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
+ +||+||||||+|||++.++.+|+ +|||+|+.... ....+.+||+.|||
T Consensus 122 ~~~~IiHRDiKP~NILl~~~~~vkl----------------------------~DFGla~~~~~--~~~~~~~GT~~Y~A 171 (322)
T d1s9ja_ 122 EKHKIMHRDVKPSNILVNSRGEIKL----------------------------CDFGVSGQLID--SMANSFVGTRSYMS 171 (322)
T ss_dssp HHHCCCCSCCSGGGEEECTTCCEEE----------------------------CCCCCCHHHHH--HTC---CCSSCCCC
T ss_pred HhCCEEccccCHHHeeECCCCCEEE----------------------------eeCCCccccCC--CccccccCCccccC
Confidence 7 59999999999999999999988 59999876533 23346799999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..|+.++||||+||++|||++|..||.
T Consensus 172 PEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp HHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred chHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-40 Score=275.65 Aligned_cols=153 Identities=31% Similarity=0.552 Sum_probs=121.5
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||++++++.+++++.+|+|||||.||+|.+++.++..+++. .+..++.|++.||.|||
T Consensus 56 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~-----------~~~~~~~qi~~al~ylH 124 (307)
T d1a06a_ 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER-----------DASRLIFQVLDAVKYLH 124 (307)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHH-----------HHHHHHHHHHHHHHhhh
Confidence 4678888999999999999999999999999999999999999877666654 34567789999999999
Q ss_pred HcCcccccCCCCceeeCC---CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDN---RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
++||+||||||+||++.. ++.+|+ +|||+|+..... ....+.+||+.|
T Consensus 125 ~~~iiHrDiKp~Nil~~~~~~~~~vkl----------------------------~DFG~a~~~~~~-~~~~~~~GT~~y 175 (307)
T d1a06a_ 125 DLGIVHRDLKPENLLYYSLDEDSKIMI----------------------------SDFGLSKMEDPG-SVLSTACGTPGY 175 (307)
T ss_dssp HTTCCCSCCCGGGEEESSSSTTCCEEE----------------------------CCC-------------------CTT
T ss_pred hceeeeEEecccceeecccCCCceEEE----------------------------eccceeEEccCC-CeeeeeeeCccc
Confidence 999999999999999853 566777 599999765433 234467899999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||||++.+.+|+.++||||+||++|+|++|..||..
T Consensus 176 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp SCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-39 Score=273.85 Aligned_cols=150 Identities=38% Similarity=0.773 Sum_probs=133.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++++++.+.|||++++++++++.+.+|+|||||.||++...+.....+++. .+..++.|++.||.|||
T Consensus 53 ~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~-----------~~~~~~~qi~~al~~lH 121 (316)
T d1fota_ 53 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----------VAKFYAAEVCLALEYLH 121 (316)
T ss_dssp HHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccccccc-----------HHHHHHHHHHHhhhhhc
Confidence 3567788889999999999999999999999999999999999877665543 34567789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+|||++.++.+|+ +|||+|+..... ..+.+||+.||||
T Consensus 122 ~~~iiHrDiKp~NILl~~~g~vkL----------------------------~DFG~a~~~~~~---~~~~~Gt~~Y~AP 170 (316)
T d1fota_ 122 SKDIIYRDLKPENILLDKNGHIKI----------------------------TDFGFAKYVPDV---TYTLCGTPDYIAP 170 (316)
T ss_dssp TTTEECCCCCGGGEEECTTSCEEE----------------------------CCCSSCEECSSC---BCCCCSCTTTCCH
T ss_pred cCcEEccccCchheeEcCCCCEEE----------------------------ecCccceEeccc---cccccCcccccCH
Confidence 999999999999999999999988 599999876442 3467999999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+.+|+.++||||+||++|+|++|..||.
T Consensus 171 E~l~~~~y~~~~DiwSlGvilyemltG~~Pf~ 202 (316)
T d1fota_ 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202 (316)
T ss_dssp HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred HHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence 99999999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=274.06 Aligned_cols=154 Identities=28% Similarity=0.488 Sum_probs=131.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|||++++++++.+.+.+|+|||||.||+|.+++.+. ..+++. .+..++.|++.||.||
T Consensus 58 ~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~-----------~~~~i~~qi~~gL~yl 126 (288)
T d2jfla1 58 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES-----------QIQVVCKQTLDALNYL 126 (288)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHH-----------HHHHHHHHHHHHHHHH
Confidence 4577788899999999999999999999999999999999987653 335543 3456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++||+||||||+|||++.++.+|+ +|||+|+..........+.+||+.|||
T Consensus 127 H~~~ivHrDiKp~NIll~~~~~~Kl----------------------------~DFG~a~~~~~~~~~~~~~~Gt~~y~A 178 (288)
T d2jfla1 127 HDNKIIHRDLKAGNILFTLDGDIKL----------------------------ADFGVSAKNTRTIQRRDSFIGTPYWMA 178 (288)
T ss_dssp HHTTEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECHHHHHHHTCCCSCCTTCC
T ss_pred HHCCEEEeecChhheeECCCCCEEE----------------------------EechhhhccCCCcccccccccccccCC
Confidence 9999999999999999999998888 599998765443334456789999999
Q ss_pred ccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 220 PEIIK-----NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 220 PE~~~-----~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||++. +.+|+.++||||+||++|+|++|..||..
T Consensus 179 PE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp HHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 99984 45689999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=268.58 Aligned_cols=154 Identities=31% Similarity=0.538 Sum_probs=119.3
Q ss_pred CceeeeccccccccccccccccC--ccceeehhhhhcchhHHHHHHhc----cCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRER----TCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~----~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
.+++++..+.|||++++++.+.+ .+.+|+|||||.||+|.+++.+. ..+++ +.+..++.|++.
T Consensus 52 ~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e-----------~~~~~i~~qi~~ 120 (269)
T d2java1 52 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-----------EFVLRVMTQLTL 120 (269)
T ss_dssp HHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCH-----------HHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCH-----------HHHHHHHHHHHH
Confidence 35677888999999999998854 56789999999999999988642 23333 334567889999
Q ss_pred HHHHHHHcC-----cccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccc
Q psy3182 135 ALEYLHTRG-----IVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTW 209 (255)
Q Consensus 135 ~l~ylH~~~-----iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~ 209 (255)
||.|||+++ |+||||||+|||++.++.+|+ .|||+|+..........
T Consensus 121 al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl----------------------------~DFG~a~~~~~~~~~~~ 172 (269)
T d2java1 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL----------------------------GDFGLARILNHDTSFAK 172 (269)
T ss_dssp HHHHHHHHCC---------CCGGGEEECTTSCEEE----------------------------CCHHHHHHC--------
T ss_pred HHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE----------------------------eeccceeecccCCCccc
Confidence 999999976 999999999999999999988 59999988766555556
Q ss_pred ccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 210 TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.+|||.|||||++.+..|+.++||||+||++|||++|..||..
T Consensus 173 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp ---CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 78999999999999999999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=263.14 Aligned_cols=151 Identities=26% Similarity=0.433 Sum_probs=128.6
Q ss_pred CceeeeccccccccccccccccC----ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
.+++++..+.|||++++++++++ ...+|++||||.||+|.+++.+...+++. .+..+++|++.||
T Consensus 57 ~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~qi~~gl 125 (270)
T d1t4ha_ 57 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK-----------VLRSWCRQILKGL 125 (270)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHH-----------HHHHHHHHHHHHH
Confidence 46778889999999999998765 46789999999999999999877666543 3455778999999
Q ss_pred HHHHHcC--cccccCCCCceeeCC-CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcccccccc
Q psy3182 137 EYLHTRG--IVFRDLKPENLLLDN-RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~--iiHrdlkp~nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~g 213 (255)
.|||+++ |+||||||+|||++. ++.+|+ +|||+|+..... ...+.+|
T Consensus 126 ~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl----------------------------~DFGla~~~~~~--~~~~~~G 175 (270)
T d1t4ha_ 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKI----------------------------GDLGLATLKRAS--FAKAVIG 175 (270)
T ss_dssp HHHHTSSSCCCCSCCCGGGEEESSTTSCEEE----------------------------CCTTGGGGCCTT--SBEESCS
T ss_pred HHHHHCCCCEEeCCcChhhceeeCCCCCEEE----------------------------eecCcceeccCC--ccCCccc
Confidence 9999999 999999999999964 677888 599999765433 3456799
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||.|||||++.+ +|+.++||||+||++|+|++|..||..
T Consensus 176 T~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 176 TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp SCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 999999999876 599999999999999999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-38 Score=273.69 Aligned_cols=151 Identities=29% Similarity=0.513 Sum_probs=132.1
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
++++++...|||+++++++|++.+.+|+|||||.||+|.+++.+...+++. .+..++.||+.||.|||+
T Consensus 57 ~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~-----------~~~~~~~qi~~aL~ylH~ 125 (364)
T d1omwa3 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----------DMRFYAAEIILGLEHMHN 125 (364)
T ss_dssp HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHH-----------HHHHHHHHHHHHHHHHHH
Confidence 356677778999999999999999999999999999999999887666543 345677889999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|||||||||+|||++..+.+|+ +|||+|+..... ...+.+||+.|||||
T Consensus 126 ~~iiHrDlKP~NILl~~~g~iKl----------------------------~DFGla~~~~~~--~~~~~~GT~~y~APE 175 (364)
T d1omwa3 126 RFVVYRDLKPANILLDEHGHVRI----------------------------SDLGLACDFSKK--KPHASVGTHGYMAPE 175 (364)
T ss_dssp TTEECCCCSGGGEEECSSSCEEE----------------------------CCCTTCEECSSS--CCCSCCSCGGGCCHH
T ss_pred CCccceeeccceeEEcCCCcEEE----------------------------eeeceeeecCCC--cccccccccccchhH
Confidence 99999999999999999999988 599999876543 344678999999999
Q ss_pred ccc-CCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIK-NRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~-~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++. +..|+.++||||+||++|+|++|..||..
T Consensus 176 ~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp HHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred HhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 996 46799999999999999999999999963
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-38 Score=272.83 Aligned_cols=150 Identities=40% Similarity=0.771 Sum_probs=133.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHT 141 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~ 141 (255)
+++++..+.|||++++++.+++...+|++|||+.||+|...+.+...+++. .+..++.||+.||.|||+
T Consensus 91 E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~-----------~~~~i~~qi~~aL~yLH~ 159 (350)
T d1rdqe_ 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----------HARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp HHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHH-----------HHHHHHHHHHHHHHHHHh
Confidence 455677889999999999999999999999999999999999887777653 345678899999999999
Q ss_pred cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccc
Q psy3182 142 RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPE 221 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE 221 (255)
+|||||||||+|||++.++.+|+ +|||+|+.... ...+.+||+.|||||
T Consensus 160 ~~iiHRDIKP~NILl~~~g~ikL----------------------------~DFG~a~~~~~---~~~~~~Gt~~Y~APE 208 (350)
T d1rdqe_ 160 LDLIYRDLKPENLLIDQQGYIQV----------------------------TDFGFAKRVKG---RTWTLCGTPEALAPE 208 (350)
T ss_dssp TTEECCCCSGGGEEECTTSCEEE----------------------------CCCTTCEECSS---CBCCCEECGGGCCHH
T ss_pred CCEecCcCCHHHcccCCCCCEEe----------------------------eeceeeeeccc---ccccccCccccCCHH
Confidence 99999999999999999998888 59999987643 234678999999999
Q ss_pred cccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 222 IIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 222 ~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
++.+.+|+.++|||||||++|+|++|..||..
T Consensus 209 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=268.10 Aligned_cols=150 Identities=27% Similarity=0.461 Sum_probs=130.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|||++++++++.+.+.+|+|||||.||++...+..+..+++. .+..++.||+.||.|||
T Consensus 64 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~-----------~~~~i~~qi~~aL~yLH 132 (309)
T d1u5ra_ 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----------EIAAVTHGALQGLAYLH 132 (309)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHH-----------HHHHHHHHHHHHHHHHH
Confidence 3577888899999999999999999999999999999998777766666543 34567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+|||++.++.+|+ +|||+|+.... ..+.+|||.||||
T Consensus 133 ~~~iiHrDiKp~NILl~~~~~~Kl----------------------------~DFG~a~~~~~----~~~~~GT~~Y~AP 180 (309)
T d1u5ra_ 133 SHNMIHRDVKAGNILLSEPGLVKL----------------------------GDFGSASIMAP----ANSFVGTPYWMAP 180 (309)
T ss_dssp HTTCBCCCCSGGGEEEETTTEEEE----------------------------CCCTTCBSSSS----BCCCCSCGGGCCH
T ss_pred hCCEeccCCCcceEEECCCCCEEE----------------------------eecccccccCC----CCccccCccccCH
Confidence 999999999999999999998888 59999876543 2356899999999
Q ss_pred ccccC---CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 221 EIIKN---RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 221 E~~~~---~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|++.+ ..|+.++||||+||++|||++|..||..
T Consensus 181 E~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp HHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 99964 4589999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=266.15 Aligned_cols=146 Identities=36% Similarity=0.671 Sum_probs=132.1
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
...|||++++++++++.+.+|+|||||.||+|.+++.....+++. .+..++.||+.||.|||++||+||
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~-----------~~~~~~~qi~~al~ylH~~~iiHr 127 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----------RATFYAAEIILGLQFLHSKGIVYR 127 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHH-----------HHHHHHHHHHHHHHHHHhCCeeec
Confidence 568999999999999999999999999999999999887776653 345678899999999999999999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcccccccCCC
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAPEIIKNRG 227 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (255)
||||+|||++..+.+++ +|||+++............+||+.|+|||++.+.+
T Consensus 128 Dikp~NiL~~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 179 (320)
T d1xjda_ 128 DLKLDNILLDKDGHIKI----------------------------ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179 (320)
T ss_dssp CCCGGGEEECTTSCEEE----------------------------CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred cCcccceeecCCCceec----------------------------cccchhhhcccccccccccCCCCCcCCHHHHcCCC
Confidence 99999999999998888 59999987766555566679999999999999999
Q ss_pred CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 228 HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 228 ~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.++||||+||++|+|++|..||.
T Consensus 180 ~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 180 YNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCchhhhhhhhHHHHHHHhCCCCCC
Confidence 9999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-38 Score=262.82 Aligned_cols=153 Identities=27% Similarity=0.505 Sum_probs=132.8
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..++|||+++++++|++.+.+|+|||||.||+|.+++.+...+++. .+..++.|++.||.|||
T Consensus 62 ~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~-----------~~~~~~~qi~~al~yLH 130 (293)
T d1jksa_ 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-----------EATEFLKQILNGVYYLH 130 (293)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchh-----------HHHHHHHHHHHHHHhhh
Confidence 3567788889999999999999999999999999999999999877666643 34567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCc----eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGY----VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
+++|+||||||+||+++..+. +|+ +|||+|+...... ...+.+||+.
T Consensus 131 ~~~ivHrDiKp~Nill~~~~~~~~~vkl----------------------------~DfG~a~~~~~~~-~~~~~~~t~~ 181 (293)
T d1jksa_ 131 SLQIAHFDLKPENIMLLDRNVPKPRIKI----------------------------IDFGLAHKIDFGN-EFKNIFGTPE 181 (293)
T ss_dssp HTTEECCCCSGGGEEESCSSSSSCCEEE----------------------------CCCTTCEECTTSC-BCSCCCCCGG
T ss_pred hcceeecccccceEEEecCCCcccceEe----------------------------cchhhhhhcCCCc-cccccCCCCc
Confidence 999999999999999987663 455 5999988765432 3446789999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||||++.+..|+.++||||+||++|+|++|..||..
T Consensus 182 y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-38 Score=270.04 Aligned_cols=153 Identities=25% Similarity=0.415 Sum_probs=132.0
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|||+++++++|++++.+|+|||||.||+|++.+.+.. .+++. .+..++.||+.||.||
T Consensus 75 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~-----------~~~~i~~qi~~aL~yl 143 (352)
T d1koba_ 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-----------EVINYMRQACEGLKHM 143 (352)
T ss_dssp HHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHH-----------HHHHHHHHHHHHHHHH
Confidence 35777888999999999999999999999999999999998876543 34443 3456788999999999
Q ss_pred HHcCcccccCCCCceeeC--CCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLD--NRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
|++||+||||||+|||++ ..+.+|+ +|||+|+...... ...+.+||+.|
T Consensus 144 H~~~iiHRDiKp~NILl~~~~~~~vkL----------------------------~DFGla~~~~~~~-~~~~~~gt~~y 194 (352)
T d1koba_ 144 HEHSIVHLDIKPENIMCETKKASSVKI----------------------------IDFGLATKLNPDE-IVKVTTATAEF 194 (352)
T ss_dssp HHTTEECCCCCGGGEEESSTTCCCEEE----------------------------CCCTTCEECCTTS-CEEEECSSGGG
T ss_pred HHCCeeecccccccccccccCCCeEEE----------------------------eecccceecCCCC-ceeeccCcccc
Confidence 999999999999999997 4566777 5999998775533 34467899999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||||++.+..|+.++||||+||++|+|++|..||..
T Consensus 195 ~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-38 Score=270.14 Aligned_cols=152 Identities=26% Similarity=0.424 Sum_probs=130.7
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..++|||++++++++++.+.+|+|||||.||+|.+.+.+. ..+++ +.+..++.||+.||.|||
T Consensus 73 E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e-----------~~~~~i~~qi~~aL~ylH 141 (350)
T d1koaa2 73 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----------DEAVEYMRQVCKGLCHMH 141 (350)
T ss_dssp HHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 567788889999999999999999999999999999999998543 33443 345667889999999999
Q ss_pred HcCcccccCCCCceeeCC--CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDN--RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~ 218 (255)
++|||||||||+|||+.. ++.+|+ +|||+|+...... ...+.+||+.||
T Consensus 142 ~~~iiHrDiKp~NIll~~~~~~~vkL----------------------------~DFG~a~~~~~~~-~~~~~~gT~~Y~ 192 (350)
T d1koaa2 142 ENNYVHLDLKPENIMFTTKRSNELKL----------------------------IDFGLTAHLDPKQ-SVKVTTGTAEFA 192 (350)
T ss_dssp HTTEECCCCCGGGEEESSTTSCCEEE----------------------------CCCTTCEECCTTS-CEEEECSCTTTC
T ss_pred hcCCeeeeechhHeeeccCCCCeEEE----------------------------eecchheeccccc-ccceecCccccc
Confidence 999999999999999964 456777 5999998765433 344678999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|||++.+.+|+.++||||+||++|+|++|..||..
T Consensus 193 aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp CHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999999999999863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-38 Score=261.90 Aligned_cols=153 Identities=28% Similarity=0.395 Sum_probs=133.9
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++++.+++.+|+|||||.|+++..+......+++.. +..+++|++.||+|||
T Consensus 49 ~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~-----------~~~~~~qil~aL~~lH 117 (299)
T d1ua2a_ 49 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH-----------IKAYMLMTLQGLEYLH 117 (299)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHH-----------HHHHHHHHHHHHHHhh
Confidence 35778888999999999999999999999999999999887776666666543 4567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++..+.+|+ +|||.|+..........+.+||+.||||
T Consensus 118 ~~~iiHrDiKp~NIli~~~~~~KL----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~aP 169 (299)
T d1ua2a_ 118 QHWILHRDLKPNNLLLDENGVLKL----------------------------ADFGLAKSFGSPNRAYTHQVVTRWYRAP 169 (299)
T ss_dssp HTTCCCCCCCGGGEEECTTCCEEE----------------------------CCCGGGSTTTSCCCCCCCSCCCCTTCCH
T ss_pred ccceecccCCcceEEecCCCcccc----------------------------ccCccccccCCCcccccceecChhhccH
Confidence 999999999999999999998888 5999998776655555677899999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..|+.++||||+||++|||++|..||.
T Consensus 170 E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 99875 568999999999999999999999885
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-38 Score=265.52 Aligned_cols=150 Identities=34% Similarity=0.594 Sum_probs=125.3
Q ss_pred eeeecc-ccccccccccccccC----ccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSR-KKKTRQTRLYKTFKD----SKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 63 vkl~~~-~~h~~iv~l~~~~~~----~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
++++.+ ..|||++++++.|++ .+.+|+|||||.||+|.+++.++. .+++ +.+..++.|++.|
T Consensus 55 ~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e-----------~~~~~i~~qi~~a 123 (335)
T d2ozaa1 55 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-----------REASEIMKSIGEA 123 (335)
T ss_dssp HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCH-----------HHHHHHHHHHHHH
Confidence 444433 479999999999876 577999999999999999998643 2333 3456788899999
Q ss_pred HHHHHHcCcccccCCCCceeeCCC---CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccc
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNR---GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFC 212 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~ 212 (255)
|.|||++||+||||||+|||++.. +.+|+ +|||+|+...... ...+.+
T Consensus 124 l~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl----------------------------~DFG~a~~~~~~~-~~~~~~ 174 (335)
T d2ozaa1 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKL----------------------------TDFGFAKETTSHN-SLTTPC 174 (335)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCSSTTCCEEE----------------------------CCCTTCEECCCCC-CCCCCS
T ss_pred HHHHHHcCCccccccccccccccccccccccc----------------------------cccceeeeccCCC-cccccc
Confidence 999999999999999999999863 44666 5999998765533 344678
Q ss_pred cCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 213 GTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 213 gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||.|||||++.+..|+.++||||+||++|+|++|..||.
T Consensus 175 gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp CCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred CCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 9999999999999999999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=264.55 Aligned_cols=164 Identities=22% Similarity=0.378 Sum_probs=130.5
Q ss_pred ceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhh-----------HHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASF-----------ITACVIEALDFI 128 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~-----------~~~~~~~~~~~i 128 (255)
+++++..+ .|||++++++.+.+.+.+|+|||||.||+|.++++++.. +.+....+ ........+..+
T Consensus 90 E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 169 (325)
T d1rjba_ 90 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 169 (325)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHH
T ss_pred HHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHH
Confidence 34555565 799999999999999999999999999999999976432 22211111 111233456678
Q ss_pred HHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--
Q psy3182 129 TACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-- 206 (255)
Q Consensus 129 ~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-- 206 (255)
+.|++.||.|||+++||||||||+||+++.++.+|+ .|||+|+.......
T Consensus 170 ~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl----------------------------~DFGla~~~~~~~~~~ 221 (325)
T d1rjba_ 170 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI----------------------------CDFGLARDIMSDSNYV 221 (325)
T ss_dssp HHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEE----------------------------CCCGGGSCGGGCTTSE
T ss_pred HHHHHHHHHHHHhCCeeeccCchhccccccCCeEEE----------------------------eeccccccccCCCcee
Confidence 899999999999999999999999999999998988 49999976544322
Q ss_pred cccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
...+.+||+.|||||++.+..|+.++||||+||++|||++ |..||..
T Consensus 222 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 2335678999999999999999999999999999999997 8999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-37 Score=255.79 Aligned_cols=153 Identities=23% Similarity=0.338 Sum_probs=122.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++.+++|||++++++.. +.+.+|++||||.||+|.+++.... .+++ ..+..++.|++.||.||
T Consensus 53 ~E~~~l~~l~HpnIv~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~-----------~~~~~i~~qi~~gl~yL 120 (276)
T d1uwha_ 53 NEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEM-----------IKLIDIARQTAQGMDYL 120 (276)
T ss_dssp HHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHHTSCCCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeeeEEE-eccEEEEEEecCCCCCHHHHHhhccCCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 357788899999999999865 4467899999999999999997542 2332 23445788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y 217 (255)
|+++||||||||+|||++.++.+|+ +|||+|+...... ....+.+||+.|
T Consensus 121 H~~~ivHrDlKp~NiLl~~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~~gt~~y 172 (276)
T d1uwha_ 121 HAKSIIHRDLKSNNIFLHEDLTVKI----------------------------GDFGLATVKSRWSGSHQFEQLSGSILW 172 (276)
T ss_dssp HHTTCCCSCCCGGGEEEETTSSEEE----------------------------CCCCCSCC------------CCCCGGG
T ss_pred hcCCEeccccCHHHEEEcCCCCEEE----------------------------ccccceeeccccCCcccccccccCccc
Confidence 9999999999999999999998888 4999987664322 233457899999
Q ss_pred cccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKN---RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~---~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||||++.+ ..|+.++||||+||++|||+||..||..
T Consensus 173 ~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp CCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 99999964 3588899999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-37 Score=255.55 Aligned_cols=154 Identities=24% Similarity=0.376 Sum_probs=122.0
Q ss_pred CceeeeccccccccccccccccCcc----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
.+++++....|||++++++.+.+.+ .+|+|||||.||+|...+.....+++. .+..++.|++.||
T Consensus 56 ~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~-----------~~~~i~~qi~~al 124 (277)
T d1o6ya_ 56 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-----------RAIEVIADACQAL 124 (277)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHH-----------HHHHHHHHHHHHH
Confidence 4567788889999999999887654 489999999999999999877766653 3455778999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC---Ccccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS---GCKTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~---~~~~~~~~g 213 (255)
.|||++||+||||||+||+++.++..++ .|||.++..... .....+.+|
T Consensus 125 ~~lH~~~iiHrDiKP~NIll~~~~~~~l----------------------------~d~~~~~~~~~~~~~~~~~~~~~G 176 (277)
T d1o6ya_ 125 NFSHQNGIIHRDVKPANIMISATNAVKV----------------------------MDFGIARAIADSGNSVTQTAAVIG 176 (277)
T ss_dssp HHHHHTTEECCCCSGGGEEEETTSCEEE----------------------------CCCTTCEECC--------------
T ss_pred HHHHhCCccCccccCcccccCcccccee----------------------------ehhhhhhhhccccccccccccccC
Confidence 9999999999999999999999888877 377766543222 123445789
Q ss_pred CCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 214 TPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 214 t~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+.|||||++.+..|+.++||||+||++|+|++|..||..
T Consensus 177 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp --TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-37 Score=260.79 Aligned_cols=153 Identities=24% Similarity=0.437 Sum_probs=131.2
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..++|+|+++++++|++.+.+|+|||||.||+|++.+.++. .+++. .+..++.||+.||.||
T Consensus 50 ~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~-----------~~~~i~~qi~~al~yL 118 (321)
T d1tkia_ 50 KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER-----------EIVSYVHQVCEALQFL 118 (321)
T ss_dssp HHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHH-----------HHHHHHHHHHHHHHHH
Confidence 45777888899999999999999999999999999999999997654 35543 3456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCC--ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRG--YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
|++||+||||||+||+++.++ .+++ +|||+++...... ...+.+|||.|
T Consensus 119 H~~~iiHrDlKp~NIll~~~~~~~ikl----------------------------~DFG~~~~~~~~~-~~~~~~~t~~y 169 (321)
T d1tkia_ 119 HSHNIGHFDIRPENIIYQTRRSSTIKI----------------------------IEFGQARQLKPGD-NFRLLFTAPEY 169 (321)
T ss_dssp HHTTEECCCCCGGGEEESSSSCCCEEE----------------------------CCCTTCEECCTTC-EEEEEESCGGG
T ss_pred HHcCCCcccccccceeecCCCceEEEE----------------------------cccchhhccccCC-ccccccccccc
Confidence 999999999999999998654 4555 5999988765433 34467899999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+|||++.+..|+.++||||+||++|+|++|..||..
T Consensus 170 ~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp SCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-37 Score=256.67 Aligned_cols=153 Identities=24% Similarity=0.316 Sum_probs=119.8
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++..++|||++++++++.+.+.+|++||||.||+|.+++.... .+++ ..+..++.||+.||.|||
T Consensus 77 E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~-----------~~~~~i~~qia~gl~yLH 145 (299)
T d1jpaa_ 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV-----------IQLVGMLRGIAAGMKYLA 145 (299)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCH-----------HHHHHHHHHHHHHHHHHh
Confidence 5667888899999999999999999999999999999999887643 2332 223457789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-----ccccccCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-----TWTFCGTP 215 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-----~~~~~gt~ 215 (255)
+++|+||||||+|||++.++.+|+ .|||+|+........ .....||+
T Consensus 146 ~~~iiHrDlKp~NILl~~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~~~~~~t~ 197 (299)
T d1jpaa_ 146 DMNYVHRDLAARNILVNSNLVCKV----------------------------SDFGLSRFLEDDTSDPTYTSALGGKIPI 197 (299)
T ss_dssp HTTCCCSCCCGGGEEECTTCCEEE----------------------------CCC-----------------------CG
T ss_pred hCCCccCccccceEEECCCCcEEE----------------------------CCcccceEccCCCCcceeeecccccCCc
Confidence 999999999999999999999998 499998766433211 12246899
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
.|||||++.+..|+.++||||+||++|||+| |..||..
T Consensus 198 ~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp GGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999998 8999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-37 Score=254.20 Aligned_cols=155 Identities=22% Similarity=0.298 Sum_probs=129.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..++|||++++++.+.+.+.+|++||||.+|+|.+++.+.....- ....+..++.|++.||.|||
T Consensus 62 ~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~---------~~~~~~~i~~qi~~gL~yLH 132 (287)
T d1opja_ 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV---------SAVVLLYMATQISSAMEYLE 132 (287)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTS---------CHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccch---------HHHHHHHHHHHHHHHHHHHH
Confidence 457788899999999999999999999999999999999999876432111 11234567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~a 219 (255)
++||+||||||+|||++.++.+|+ .|||+|+........ .....||+.|||
T Consensus 133 ~~~iiHrDlKp~NILl~~~~~~Kl----------------------------~DFG~a~~~~~~~~~~~~~~~g~~~y~a 184 (287)
T d1opja_ 133 KKNFIHRDLAARNCLVGENHLVKV----------------------------ADFGLSRLMTGDTYTAHAGAKFPIKWTA 184 (287)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCCCTTTCCSSSSEEETTEEECGGGCC
T ss_pred HCCcccCccccCeEEECCCCcEEE----------------------------ccccceeecCCCCceeeccccccccccC
Confidence 999999999999999999998888 499999876544322 223458999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.+..|+.++||||+||++|||++|..||.
T Consensus 185 PE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred hHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999766543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-36 Score=251.35 Aligned_cols=151 Identities=34% Similarity=0.607 Sum_probs=130.7
Q ss_pred ceeeecccc-ccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKK-KTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 62 ~vkl~~~~~-h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+++++.++. |+|++++++.+++++.+|+|||||.||+|.++++.+..+++.. +..++.||+.||.|||
T Consensus 59 E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~-----------~~~~~~qi~~al~~lH 127 (277)
T d1phka_ 59 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE-----------TRKIMRALLEVICALH 127 (277)
T ss_dssp HHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHH-----------HHHHHHHHHHHHHHHH
Confidence 455666665 9999999999999999999999999999999998877766543 4567788999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+|+ +|||+++...... .....+||+.|+||
T Consensus 128 ~~~ivHrDlkp~Nill~~~~~~kl----------------------------~DFG~a~~~~~~~-~~~~~~gt~~y~~P 178 (277)
T d1phka_ 128 KLNIVHRDLKPENILLDDDMNIKL----------------------------TDFGFSCQLDPGE-KLREVCGTPSYLAP 178 (277)
T ss_dssp HTTEECSCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCTTC-CBCCCCSCGGGCCH
T ss_pred HcCCcccccccceEEEcCCCCeEE----------------------------ccchheeEccCCC-ceeeeeccCCCCCH
Confidence 999999999999999999998888 5999998765533 34457899999999
Q ss_pred ccccC------CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN------RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~------~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++||||+||++|+|++|..||.
T Consensus 179 E~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~ 216 (277)
T d1phka_ 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216 (277)
T ss_dssp HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHhhccccccCCCCCchheEcccchhhhhhccCCCCCC
Confidence 99863 457889999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-37 Score=253.53 Aligned_cols=153 Identities=23% Similarity=0.309 Sum_probs=127.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++.+++|||++++++.++++ ..|+|||||.||+|.+++.+...+++. .+..++.||+.||.|||
T Consensus 57 ~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~-----------~~~~i~~qi~~gl~ylH 124 (277)
T d1xbba_ 57 AEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDK-----------NIIELVHQVSMGMKYLE 124 (277)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHH-----------HHHHHHHHHHHHHhhHH
Confidence 356778889999999999998764 578999999999999999876665543 23457789999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc---ccccccCCCC
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK---TWTFCGTPEY 217 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~---~~~~~gt~~y 217 (255)
+++|+||||||+||+++.++.+++ .|||+|+........ .....||+.|
T Consensus 125 ~~~iiHrDlKp~Nill~~~~~~kl----------------------------~DFGla~~~~~~~~~~~~~~~~~gt~~y 176 (277)
T d1xbba_ 125 ESNFVHRDLAARNVLLVTQHYAKI----------------------------SDFGLSKALRADENYYKAQTHGKWPVKW 176 (277)
T ss_dssp HTTEECSCCSGGGEEEEETTEEEE----------------------------CCCTTCEECCTTCSEEEC----CCCGGG
T ss_pred hCCcccCCCcchhhcccccCcccc----------------------------cchhhhhhccccccccccccccCCCcee
Confidence 999999999999999999988888 499998765443221 2235799999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||||++.+..|+.++||||+||++|||++ |..||..
T Consensus 177 ~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence 99999999899999999999999999997 8999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-36 Score=246.16 Aligned_cols=153 Identities=20% Similarity=0.308 Sum_probs=119.0
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|||++++++.+.+++.+|+|||||.+|+|.+++..... +++ +.+..++.|++.||.|+
T Consensus 49 ~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~-----------~~~~~i~~qia~gl~~l 117 (263)
T d1sm2a_ 49 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYL 117 (263)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCH-----------HHHHHHHHHHHHHHHhh
Confidence 356778889999999999999999999999999999999998875432 222 23445788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYV 218 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~ 218 (255)
|+++|+||||||+||+++.++.+|+ .|||+|+....... ......||+.||
T Consensus 118 H~~~iiHrDlKp~Nill~~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~gt~~y~ 169 (263)
T d1sm2a_ 118 EEACVIHRDLAARNCLVGENQVIKV----------------------------SDFGMTRFVLDDQYTSSTGTKFPVKWA 169 (263)
T ss_dssp HHTTCCCTTCSGGGEEECGGGCEEE----------------------------CSCC------------------CTTSC
T ss_pred hccceeecccchhheeecCCCCeEe----------------------------cccchheeccCCCceeecceecCcccC
Confidence 9999999999999999999998988 49999876644322 223467999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCC-CCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGM-KESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~-~~~~ 252 (255)
|||++.+..|+.++||||+||++|||+||. +||.
T Consensus 170 aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred ChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999999964 5543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-36 Score=251.31 Aligned_cols=153 Identities=24% Similarity=0.329 Sum_probs=129.3
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHh-ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~-~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.++++++.+.|+|++++++.|++.+.+|+|||||.|+.+...... ...+++ +.+..++.|++.||.||
T Consensus 50 ~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e-----------~~~~~~~~qil~~L~yL 118 (298)
T d1gz8a_ 50 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL-----------PLIKSYLFQLLQGLAFC 118 (298)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCH-----------HHHHHHHHHHHHHHHHh
Confidence 467888999999999999999999999999999987655443332 222333 34567888999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++|||||||||+||+++.++..|+ +|||.|+............+||+.|+|
T Consensus 119 H~~~IiHrDiKpeNIl~~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~gt~~y~a 170 (298)
T d1gz8a_ 119 HSHRVLHRDLKPQNLLINTEGAIKL----------------------------ADFGLARAFGVPVRTYTHEVVTLWYRA 170 (298)
T ss_dssp HHTTCCCSCCCGGGEEECTTSCEEE----------------------------CSTTHHHHHCCCSBCTTCCBCCCTTCC
T ss_pred hcCCEEccccCchheeecccCccee----------------------------ccCCcceeccCCcccceeecccceeee
Confidence 9999999999999999999888888 599999877666556667789999999
Q ss_pred cccccCCC-CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 220 PEIIKNRG-HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 220 PE~~~~~~-~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
||++.... ++.++|+||+||++|+|++|..||.
T Consensus 171 pE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 99987765 5789999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-36 Score=248.57 Aligned_cols=151 Identities=28% Similarity=0.420 Sum_probs=125.3
Q ss_pred ceeeecccc--ccccccccccccCccceeehhhhhcc-hhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKK--KTRQTRLYKTFKDSKYVYMLLEACLG-GEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~~--h~~iv~l~~~~~~~~~~ylv~E~~~g-g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++.... |+|++++++++++.+.+|++||++.| +++.++++++..+++. .+..++.|++.||.|
T Consensus 57 E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~-----------~~~~~~~qi~~al~~ 125 (273)
T d1xwsa_ 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE-----------LARSFFWQVLEAVRH 125 (273)
T ss_dssp HHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHH-----------HHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHH-----------HHHHHHHHHHHHHHH
Confidence 344555544 89999999999999999999999976 6888888877766653 345677899999999
Q ss_pred HHHcCcccccCCCCceeeCCC-CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNR-GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
||++||+||||||+||+++.+ +.+++ +|||+|+..... ...+.+||+.|
T Consensus 126 lH~~~iiHrDiKp~NIll~~~~~~vkl----------------------------~DFG~a~~~~~~--~~~~~~GT~~y 175 (273)
T d1xwsa_ 126 CHNCGVLHRDIKDENILIDLNRGELKL----------------------------IDFGSGALLKDT--VYTDFDGTRVY 175 (273)
T ss_dssp HHHTTEECSCCSGGGEEEETTTTEEEE----------------------------CCCTTCEECCSS--CBCCCCSCGGG
T ss_pred HHHCCCccccCcccceEEecCCCeEEE----------------------------Cccccceecccc--cccccccCCCc
Confidence 999999999999999999754 67777 599998765433 34467899999
Q ss_pred cccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 218 VAPEIIKNRGH-DRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~-~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
||||++.+..+ +.++||||+||++|+|++|..||..
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 99999987665 5678999999999999999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-36 Score=250.71 Aligned_cols=153 Identities=26% Similarity=0.376 Sum_probs=127.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..++|||++++++.++++ .+|+|||||.||+|.+++... ..+++ ..+..++.|++.||.||
T Consensus 58 ~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~-----------~~~~~i~~qi~~gL~yl 125 (285)
T d1u59a_ 58 REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPV-----------SNVAELLHQVSMGMKYL 125 (285)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 357778889999999999988764 589999999999999987543 33332 23445778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~ 216 (255)
|+++|+||||||+||+++.++.+|+ .|||+|+....... .....+||+.
T Consensus 126 H~~~iiHrDlKp~Nill~~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~~~gt~~ 177 (285)
T d1u59a_ 126 EEKNFVHRDLAARNVLLVNRHYAKI----------------------------SDFGLSKALGADDSYYTARSAGKWPLK 177 (285)
T ss_dssp HHTTEECCCCSGGGEEEEETTEEEE----------------------------CCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred HhCCeecCcCchhheeeccCCceee----------------------------ccchhhhcccccccccccccccccCcc
Confidence 9999999999999999999998888 49999876654322 2234578999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||||++.+..++.++||||+||++|||+| |..||..
T Consensus 178 y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 999999998899999999999999999998 8999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=246.65 Aligned_cols=146 Identities=21% Similarity=0.360 Sum_probs=120.3
Q ss_pred cccccccccccccccc-----CccceeehhhhhcchhHHHHHHhc-cCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 67 SRKKKTRQTRLYKTFK-----DSKYVYMLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 67 ~~~~h~~iv~l~~~~~-----~~~~~ylv~E~~~gg~l~~~l~~~-~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
+...|||++++++.|. ....+|++||+|.||.+....... ..+++ +.+..++.|++.||+|||
T Consensus 65 ~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~qi~~aL~yLH 133 (305)
T d1blxa_ 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT-----------ETIKDMMFQLLRGLDFLH 133 (305)
T ss_dssp HHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred hhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCH-----------HHHHHHHHHHHHHHHHHH
Confidence 3447999999999875 446789999999998876544332 22222 345668889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
+++|+||||||+|||++..+..++ .|||.++..... ....+.+||+.||||
T Consensus 134 ~~~ivHrDiKp~NILi~~~~~~kl----------------------------~dfg~~~~~~~~-~~~~~~~gT~~Y~AP 184 (305)
T d1blxa_ 134 SHRVVHRDLKPQNILVTSSGQIKL----------------------------ADFGLARIYSFQ-MALTSVVVTLWYRAP 184 (305)
T ss_dssp HTTCCCCCCCGGGEEECTTCCEEE----------------------------CSCCSCCCCCGG-GGGCCCCCCCTTCCH
T ss_pred hCCEEecCCCccEEEEcCCCCeee----------------------------cchhhhhhhccc-ccCCCcccChhhcCc
Confidence 999999999999999999998888 489987755332 234467899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+.+|+.++||||+||++|||++|..||.
T Consensus 185 E~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred chhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 99999999999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-35 Score=245.22 Aligned_cols=153 Identities=21% Similarity=0.361 Sum_probs=128.4
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.++++++.+.|+|++++++.+.+.+..|+++|++.|+.+..+...+..+++. .+..+++||+.||+|||
T Consensus 49 ~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~-----------~~~~i~~qi~~~L~~LH 117 (286)
T d1ob3a_ 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-----------TAKSFLLQLLNGIAYCH 117 (286)
T ss_dssp HHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchh-----------hhHHHHHHHHHHHHHhc
Confidence 4678889999999999999999999999999999999888887766666553 34567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP 220 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP 220 (255)
++||+||||||+||+++.++.+|+ +|||.|..............||+.|+||
T Consensus 118 ~~~IvHrDiKp~NIll~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~~~y~~p 169 (286)
T d1ob3a_ 118 DRRVLHRDLKPQNLLINREGELKI----------------------------ADFGLARAFGIPVRKYTHEIVTLWYRAP 169 (286)
T ss_dssp HTTCCCSCCCGGGEEECTTSCEEE----------------------------CCTTHHHHHCC---------CCCTTCCH
T ss_pred cCcEEecCCCCceeeEcCCCCEEe----------------------------cccccceecccCccccceecccchhhhH
Confidence 999999999999999999998888 5999998766555555567899999999
Q ss_pred ccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 221 EIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 221 E~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|++.+ ..++.++|+||+||++|||++|..||.
T Consensus 170 E~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 99976 467899999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-35 Score=243.04 Aligned_cols=152 Identities=26% Similarity=0.319 Sum_probs=121.1
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..++|+|++++++.+.+.+..|++||||.+|++.+.+.... .++. ..+..++.|++.||.||
T Consensus 58 ~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~-----------~~~~~i~~~i~~gl~~l 126 (283)
T d1mqba_ 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV-----------LQLVGMLRGIAAGMKYL 126 (283)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccH-----------HHHHHHHHHHHHhhhhc
Confidence 45678888999999999999999999999999999999998876543 2332 23345788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~ 216 (255)
|+++|+||||||+|||++.++.+|+ .|||+|+....... ......||+.
T Consensus 127 H~~~iiHrDlKp~NILl~~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~~~gt~~ 178 (283)
T d1mqba_ 127 ANMNYVHRDLAARNILVNSNLVCKV----------------------------SDFGLSRVLEDDPEATYTTSGGKIPIR 178 (283)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEE----------------------------CCCCC-----------------CCCGG
T ss_pred cccccccCccccceEEECCCCeEEE----------------------------cccchhhcccCCCccceEeccCCCCcc
Confidence 9999999999999999999999998 49999876544322 1223568999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
|||||++.+..++.++||||+||++|||++|..|+
T Consensus 179 Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp GSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 99999999999999999999999999999976554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=243.97 Aligned_cols=153 Identities=22% Similarity=0.377 Sum_probs=124.5
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++..+.|+|++++++.+.+ +.+|+|||||.+|+|.+.+...... ......+..++.||+.||.|||
T Consensus 57 ~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~---------~l~~~~~~~i~~qi~~gl~~lH 126 (272)
T d1qpca_ 57 AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI---------KLTINKLLDMAAQIAEGMAFIE 126 (272)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH---------TCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCC---------CCCHHHHHHHHHHHHHHHHHHH
Confidence 45777888999999999997755 5679999999999999877543210 0112334567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCcc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYVA 219 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~a 219 (255)
+++|+||||||+||+++.++.+|+ .|||+|+....... ......||+.|||
T Consensus 127 ~~~ivHrDiKp~NIll~~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~gt~~y~A 178 (272)
T d1qpca_ 127 ERNYIHRDLRAANILVSDTLSCKI----------------------------ADFGLARLIEDNEYTAREGAKFPIKWTA 178 (272)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEE----------------------------CCCTTCEECSSSCEECCTTCCCCTTTSC
T ss_pred hCCcccCccchhheeeecccceee----------------------------ccccceEEccCCccccccccCCcccccC
Confidence 999999999999999999999988 49999987654332 2334579999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
||++.+..|+.++||||+||++|||+||..|+
T Consensus 179 PE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred hHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 99999888999999999999999999975544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-35 Score=243.32 Aligned_cols=153 Identities=27% Similarity=0.408 Sum_probs=117.1
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|||++++++++.+ +.+|+|||||.+|++.+++.... .+++ +.+..++.|++.||.||
T Consensus 57 ~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~-----------~~~~~~~~qi~~gl~yl 124 (273)
T d1mp8a_ 57 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL-----------ASLILYAYQLSTALAYL 124 (273)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccCCCCCH-----------HHHHHHHHHHHHHhhhh
Confidence 35667788899999999999864 67899999999999999876533 2332 23456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYV 218 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~ 218 (255)
|+++|+||||||+||+++.++.+|+ .|||+|+....... ......||+.|+
T Consensus 125 H~~~iiHrDlKp~NIll~~~~~~Kl----------------------------~DfG~a~~~~~~~~~~~~~~~gt~~y~ 176 (273)
T d1mp8a_ 125 ESKRFVHRDIAARNVLVSSNDCVKL----------------------------GDFGLSRYMEDSTYYKASKGKLPIKWM 176 (273)
T ss_dssp HHTTCCCSCCSGGGEEEEETTEEEE----------------------------CC-------------------CCGGGC
T ss_pred cccCeeccccchhheeecCCCcEEE----------------------------ccchhheeccCCcceeccceecCcccc
Confidence 9999999999999999999998888 49999887654322 333457899999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..|+.++||||+||++|||++ |.+||..
T Consensus 177 apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999999997 8888864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-35 Score=238.42 Aligned_cols=154 Identities=25% Similarity=0.400 Sum_probs=130.1
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++....|+|++++++.+.++..+|+||||+.+|++..++.... .+++ ..+..++.|++.||.||
T Consensus 48 ~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~-----------~~~~~i~~qi~~gl~~L 116 (258)
T d1k2pa_ 48 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYL 116 (258)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcH-----------HHHHHHHHHHHHHHHHH
Confidence 35778888999999999999999999999999999999998876432 2222 23446788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCcc-ccccccCCCCc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCK-TWTFCGTPEYV 218 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~-~~~~~gt~~y~ 218 (255)
|++||+||||||+||+++.++.+|+ .|||+|+........ .....||+.|+
T Consensus 117 H~~~iiH~dlk~~Nill~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~t~~y~ 168 (258)
T d1k2pa_ 117 ESKQFLHRDLAARNCLVNDQGVVKV----------------------------SDFGLSRYVLDDEYTSSVGSKFPVRWS 168 (258)
T ss_dssp HHTTBCCSCCSGGGEEECTTCCEEE----------------------------CCCSSCCBCSSSSCCCCCCSCCCGGGC
T ss_pred hhcCcccccccceeEEEcCCCcEEE----------------------------CcchhheeccCCCceeecccCCCCCcC
Confidence 9999999999999999999998888 499998765443322 22467899999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|||++.+..|+.++||||+||++|||+| |..||..
T Consensus 169 aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 9999999999999999999999999998 7888864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-34 Score=238.94 Aligned_cols=157 Identities=22% Similarity=0.301 Sum_probs=116.4
Q ss_pred cccccccccccccc-CccceeehhhhhcchhHHHHHHhccCCCccc--h---hhHHHHHHHHHHHHHHHHHHHHHHHHHc
Q psy3182 69 KKKTRQTRLYKTFK-DSKYVYMLLEACLGGEVWTILRERTCFDDNA--A---SFITACVIEALDFITACVIEALEYLHTR 142 (255)
Q Consensus 69 ~~h~~iv~l~~~~~-~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~--~---~~~~~~~~~~~~~i~~~il~~l~ylH~~ 142 (255)
..|+|++.++..+. +...+|++||||.||+|.++++.+....... . ..-.....+.+..++.|++.||.|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35788988888754 4567899999999999999997643211100 0 0001112344567889999999999999
Q ss_pred CcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCCCccc
Q psy3182 143 GIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPEYVAP 220 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~y~aP 220 (255)
+|+||||||+|||++.++.+|+ .|||+|+...... ....+.+||+.||||
T Consensus 154 ~ivHrDlKp~NILl~~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 205 (299)
T d1ywna1 154 KCIHRDLAARNILLSEKNVVKI----------------------------CDFGLARDIYKDPDYVRKGDARLPLKWMAP 205 (299)
T ss_dssp TCCCSCCCGGGEEECGGGCEEE----------------------------CC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred CCcCCcCCccceeECCCCcEEE----------------------------ccCcchhhccccccccccCceeeCccccch
Confidence 9999999999999999998988 4999997654432 233456899999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHhcCC-CCCcC
Q psy3182 221 EIIKNRGHDRAVDYWALGILMHELLTGM-KESNV 253 (255)
Q Consensus 221 E~~~~~~~~~~~DiWslGvil~ell~G~-~~~~~ 253 (255)
|++.+..|+.++||||+||++|||++|. +||..
T Consensus 206 E~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 206 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999875 56653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-34 Score=234.47 Aligned_cols=152 Identities=24% Similarity=0.366 Sum_probs=118.9
Q ss_pred Cceeeeccccccccccccccc-cCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTF-KDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~-~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.++++++.++|||++++++.+ .+.+.+|+||||+.+|+|.+++.++.. .....+.+..++.||+.||.||
T Consensus 49 ~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~al~yl 119 (262)
T d1byga_ 49 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---------SVLGGDCLLKFSLDVCEAMEYL 119 (262)
T ss_dssp HTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH---------HHCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHhhcccc
Confidence 567889999999999999977 445678999999999999999975321 0112234556788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|+++|+||||||+||+++.++..++ .|||.++..... ..+..||+.|+|
T Consensus 120 H~~~ivH~dlkp~Nil~~~~~~~kl----------------------------~dfg~s~~~~~~---~~~~~~~~~y~a 168 (262)
T d1byga_ 120 EGNNFVHRDLAARNVLVSEDNVAKV----------------------------SDFGLTKEASST---QDTGKLPVKWTA 168 (262)
T ss_dssp HHTTCCCSCCSGGGEEECTTSCEEE----------------------------CCCCC---------------CCTTTSC
T ss_pred ccCceeccccchHhheecCCCCEee----------------------------cccccceecCCC---CccccccccCCC
Confidence 9999999999999999999998888 499988765432 234578999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 220 PEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 220 PE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||++.+..++.++||||+||++|||++ |..||.
T Consensus 169 PE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred hHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 999998899999999999999999998 677664
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.4e-33 Score=238.50 Aligned_cols=153 Identities=38% Similarity=0.679 Sum_probs=129.4
Q ss_pred Cceeeeccccc-cccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKK-TRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h-~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++.+.+| +|++++++.+++...+|++|||+.||+|.+.+.....+.+. .+..+++|++.||.|+
T Consensus 77 ~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~-----------~~~~~~~Qi~~al~~l 145 (322)
T d1vzoa_ 77 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----------EVQIYVGEIVLALEHL 145 (322)
T ss_dssp CHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHH-----------HHHHHHHHHHHHHHHh
Confidence 56777888877 79999999999999999999999999999999877665543 2345678999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCC-CccccccccCCCCc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHS-GCKTWTFCGTPEYV 218 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~-~~~~~~~~gt~~y~ 218 (255)
|+++|+||||||+||+++.++.+++ .|||+++..... .....+..||+.|+
T Consensus 146 H~~~ivHrDiKp~Nill~~~~~vkL----------------------------~DFG~a~~~~~~~~~~~~~~~g~~~~~ 197 (322)
T d1vzoa_ 146 HKLGIIYRDIKLENILLDSNGHVVL----------------------------TDFGLSKEFVADETERAYDFCGTIEYM 197 (322)
T ss_dssp HHTTCCCCCCCGGGEEECTTSCEEE----------------------------SCSSEEEECCGGGGGGGCGGGSCCTTC
T ss_pred hcCCEEeccCCccceeecCCCCEEE----------------------------eeccchhhhcccccccccccccccccc
Confidence 9999999999999999999998888 499998765432 22344678999999
Q ss_pred ccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNR--GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~--~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||.+.+. .++.++||||+||++|+|++|..||.
T Consensus 198 ~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred hhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999764 46789999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.2e-33 Score=240.10 Aligned_cols=152 Identities=26% Similarity=0.406 Sum_probs=122.3
Q ss_pred Cceeeecccccccccccccccc------CccceeehhhhhcchhHHHHH---HhccCCCccchhhHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFK------DSKYVYMLLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALDFITAC 131 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~------~~~~~ylv~E~~~gg~l~~~l---~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (255)
.+++++..++|+|++++++.|. +..++|++||||.+|.+..+. .....+++ ..++.++.|
T Consensus 62 ~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~-----------~~~~~i~~q 130 (350)
T d1q5ka_ 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-----------IYVKLYMYQ 130 (350)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCH-----------HHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCH-----------HHHHHHHHH
Confidence 4678888999999999998873 445689999999877544333 22223333 345678899
Q ss_pred HHHHHHHHHHcCcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccc
Q psy3182 132 VIEALEYLHTRGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWT 210 (255)
Q Consensus 132 il~~l~ylH~~~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~ 210 (255)
++.||+|||++||+||||||+|||++.++ .+|+ +|||+++...... ...+
T Consensus 131 il~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl----------------------------~DFG~a~~~~~~~-~~~~ 181 (350)
T d1q5ka_ 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL----------------------------CDFGSAKQLVRGE-PNVS 181 (350)
T ss_dssp HHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEE----------------------------CCCTTCEECCTTS-CCCS
T ss_pred HHHHHHHHHhcCCcccCCCcceEEEecCCCceeE----------------------------ecccchhhccCCc-cccc
Confidence 99999999999999999999999998765 6677 5999987765433 3446
Q ss_pred cccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 211 FCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 211 ~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+||+.|+|||++.+ ..|+.++||||+||++|||++|..||.
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 789999999999875 578999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-33 Score=238.79 Aligned_cols=153 Identities=24% Similarity=0.294 Sum_probs=124.1
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..+.|||++++++.+.++ ..++++|++.+|+|.+.+..+. .+++ +.+..++.||+.||.||
T Consensus 60 ~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~-----------~~~~~i~~qi~~gl~yL 127 (317)
T d1xkka_ 60 DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGS-----------QYLLNWCVQIAKGMNYL 127 (317)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCH-----------HHHHHHHHHHHHHHHHH
Confidence 357788889999999999998875 5678889999999998887543 2332 23445778999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEY 217 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y 217 (255)
|+++|+||||||+||+++.++.+|+ .|||+|+....... ......||+.|
T Consensus 128 H~~~iiHrDlKp~NIll~~~~~~kl----------------------------~DFGla~~~~~~~~~~~~~~~~gt~~y 179 (317)
T d1xkka_ 128 EDRRLVHRDLAARNVLVKTPQHVKI----------------------------TDFGLAKLLGAEEKEYHAEGGKVPIKW 179 (317)
T ss_dssp HHTTCCCSCCCGGGEEEEETTEEEE----------------------------CCCSHHHHTTTTCC--------CCTTT
T ss_pred HHcCcccCcchhhcceeCCCCCeEe----------------------------eccccceecccccccccccccccCccc
Confidence 9999999999999999999998888 49999987654322 22345689999
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 218 VAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 218 ~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
||||++.+..|+.++||||+||++|||+| |.+||..
T Consensus 180 ~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999999998 7788763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=6.1e-34 Score=238.75 Aligned_cols=164 Identities=21% Similarity=0.235 Sum_probs=128.9
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhH-------------HHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI-------------TACVIEALDF 127 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~-------------~~~~~~~~~~ 127 (255)
.++.+++.+.|+|++++++++.+....+++|||+.+|+|.+++.............. .......+..
T Consensus 65 ~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (301)
T d1lufa_ 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144 (301)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHH
T ss_pred HHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHH
Confidence 456778889999999999999999999999999999999999976543221111110 0112334566
Q ss_pred HHHHHHHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--
Q psy3182 128 ITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-- 205 (255)
Q Consensus 128 i~~~il~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-- 205 (255)
++.|++.||+|||++++|||||||+|||++.++.+|+ .|||+|+......
T Consensus 145 i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl----------------------------~DFGls~~~~~~~~~ 196 (301)
T d1lufa_ 145 IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI----------------------------ADFGLSRNIYSADYY 196 (301)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCSCHHHHTGGGCB
T ss_pred HHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEE----------------------------ccchhheeccCCccc
Confidence 7899999999999999999999999999999988888 4999987553322
Q ss_pred ccccccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCC-CCCc
Q psy3182 206 CKTWTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGM-KESN 252 (255)
Q Consensus 206 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~-~~~~ 252 (255)
....+.+||+.|||||.+.+..|+.++||||+||++|||++|. +||.
T Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 2233567999999999999999999999999999999999996 5665
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.5e-34 Score=235.76 Aligned_cols=153 Identities=27% Similarity=0.345 Sum_probs=124.6
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc-CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.+++++..++|+|++++++++.+. ..|++||||.+|++.+.+..+. .+++ ..+..++.|++.||.||
T Consensus 60 ~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~-----------~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 60 REVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-----------GTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCH-----------HHHHHHHHHHHHHHHHh
Confidence 456778888999999999999764 6799999999999998776543 2332 33456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc---cccccccCCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC---KTWTFCGTPE 216 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~---~~~~~~gt~~ 216 (255)
|+++|+||||||+||+++.++.+|+ .|||+++....... ......||+.
T Consensus 128 H~~~iiHrDikp~NIll~~~~~vkl----------------------------~DfGl~~~~~~~~~~~~~~~~~~~~~~ 179 (273)
T d1u46a_ 128 ESKRFIHRDLAARNLLLATRDLVKI----------------------------GDFGLMRALPQNDDHYVMQEHRKVPFA 179 (273)
T ss_dssp HHTTEECSCCCGGGEEEEETTEEEE----------------------------CCCTTCEECCC-CCEEEC-----CCGG
T ss_pred hhCCEeeeeecHHHhccccccceee----------------------------ccchhhhhcccCCCcceecCccccCcc
Confidence 9999999999999999999988888 49998887644322 2223467889
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~~ 253 (255)
|+|||++.+..++.++||||+||++|||++ |..||..
T Consensus 180 ~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999999998 8999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.4e-33 Score=236.34 Aligned_cols=160 Identities=22% Similarity=0.307 Sum_probs=126.3
Q ss_pred eeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccc-----hhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 65 LVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNA-----ASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 65 l~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
.+.+. .|+|++++++++.++..+|+|||||.+|+|.++++.+....... ...........+..++.|++.||.|
T Consensus 71 ~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 34444 79999999999999999999999999999999998654321100 0000011234456688999999999
Q ss_pred HHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC--ccccccccCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG--CKTWTFCGTPE 216 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~--~~~~~~~gt~~ 216 (255)
||+++|+||||||+|||++.++..|+ .|||.++...... ......+||+.
T Consensus 151 lH~~~ivHrDiKp~NiLl~~~~~~kl----------------------------~dfg~~~~~~~~~~~~~~~~~~~~~~ 202 (299)
T d1fgka_ 151 LASKKCIHRDLAARNVLVTEDNVMKI----------------------------ADFGLARDIHHIDYYKKTTNGRLPVK 202 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECTTCCEEE----------------------------CSTTCCCCGGGCCTTCCCTTSCCGGG
T ss_pred hhhCCEEeeeecccceeecCCCCeEe----------------------------ccchhhccccccccccccccCCCChh
Confidence 99999999999999999999999888 4888887654322 22344679999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
|+|||++.+..|+.++||||+||++|||++ |..||.
T Consensus 203 y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 999999999999999999999999999998 677775
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.8e-34 Score=235.52 Aligned_cols=151 Identities=21% Similarity=0.332 Sum_probs=118.9
Q ss_pred ceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhcc--CCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~--~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
++.++....|+|++++++.+.+ +..|+|||||.+|++...+.... .+++ ..+..++.||+.||.||
T Consensus 62 E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~-----------~~~~~i~~~i~~gl~~L 129 (285)
T d1fmka3 62 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL-----------PQLVDMAAQIASGMAYV 129 (285)
T ss_dssp HHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchH-----------HHHHHHHHHHHHHHHHH
Confidence 4667788899999999999865 45799999999999998876432 2332 33456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-cccccccCCCCc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-KTWTFCGTPEYV 218 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-~~~~~~gt~~y~ 218 (255)
|++||+||||||+|||++.++.+|+ .|||+|+....... ......||+.|+
T Consensus 130 H~~~ivH~DlKp~NIll~~~~~~kl----------------------------~DfGla~~~~~~~~~~~~~~~gt~~y~ 181 (285)
T d1fmka3 130 ERMNYVHRDLRAANILVGENLVCKV----------------------------ADFGLARLIEDNEYTARQGAKFPIKWT 181 (285)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEE----------------------------CCCCTTC--------------CCGGGS
T ss_pred hhhheecccccceEEEECCCCcEEE----------------------------cccchhhhccCCCceeecccccccccc
Confidence 9999999999999999999888888 49999876643322 223467999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|||++....++.++||||+||++|||++|..|+.
T Consensus 182 aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999765543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8e-34 Score=238.86 Aligned_cols=163 Identities=20% Similarity=0.308 Sum_probs=127.4
Q ss_pred Cceeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhH-----HHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFI-----TACVIEALDFITACVIE 134 (255)
Q Consensus 61 ~~vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~i~~~il~ 134 (255)
.+++++.++ +|+|++++++.+.+.+.+|+|||||.||+|.+++.++........... .......+..++.||+.
T Consensus 59 ~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~ 138 (309)
T d1fvra_ 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 138 (309)
T ss_dssp HHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHH
Confidence 356777776 699999999999999999999999999999999976532211100000 01122345667899999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
||.|+|+++|+||||||+|||++..+.+|+ .|||+|+...... .....+||
T Consensus 139 gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl----------------------------~DfG~a~~~~~~~-~~~~~~gt 189 (309)
T d1fvra_ 139 GMDYLSQKQFIHRDLAARNILVGENYVAKI----------------------------ADFGLSRGQEVYV-KKTMGRLP 189 (309)
T ss_dssp HHHHHHHTTEECSCCSGGGEEECGGGCEEE----------------------------CCTTCEESSCEEC-CC----CC
T ss_pred HHHhhhcCCccccccccceEEEcCCCceEE----------------------------ccccccccccccc-cccceecC
Confidence 999999999999999999999999988888 4999987654322 23356799
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCC-CCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMK-ESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~-~~~ 252 (255)
+.|+|||.+.+..|+.++||||+||++|||++|.. ||.
T Consensus 190 ~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp TTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999999999999864 554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-33 Score=238.56 Aligned_cols=149 Identities=25% Similarity=0.504 Sum_probs=124.9
Q ss_pred CceeeeccccccccccccccccCcc------ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSK------YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~------~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
.++++++.+.|+|++++++.|.+.+ .+|++|||| |+++..+++. ..+++. .+..++.|++.
T Consensus 66 ~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~-----------~~~~~~~qi~~ 132 (346)
T d1cm8a_ 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGED-----------RIQFLVYQMLK 132 (346)
T ss_dssp HHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHH-----------HHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHH-----------HHHHHHHHHHH
Confidence 4577788899999999999987655 579999999 7778777654 445443 35667889999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
||.|||++||+||||||+|||++.++..++ .|||.|+.... .....+||
T Consensus 133 aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl----------------------------~Dfg~a~~~~~---~~~~~~~t 181 (346)
T d1cm8a_ 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKI----------------------------LDFGLARQADS---EMTGYVVT 181 (346)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTCCEEE----------------------------CCCTTCEECCS---SCCSSCSC
T ss_pred HHHHHHhCCCcccccCcchhhccccccccc----------------------------ccccceeccCC---cccccccc
Confidence 999999999999999999999999998888 49999877643 23457899
Q ss_pred CCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 215 PEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 215 ~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.|+|||++.+ ..++.++|+||+||++|+|++|..||..
T Consensus 182 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp GGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 99999999976 4578999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.9e-33 Score=236.22 Aligned_cols=153 Identities=21% Similarity=0.358 Sum_probs=122.9
Q ss_pred CceeeeccccccccccccccccC--------ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKD--------SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACV 132 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~--------~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 132 (255)
.+++++..+.|+|++++++.+.+ ...+|++||+|.++.+.........+.+ +.+..+++|+
T Consensus 58 ~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~-----------~~~~~i~~qi 126 (318)
T d3blha1 58 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL-----------SEIKRVMQML 126 (318)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCH-----------HHHHHHHHHH
T ss_pred HHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccccccc-----------HHHHHHHHHH
Confidence 45778889999999999988754 4568999999998887665544443333 3345678999
Q ss_pred HHHHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----ccc
Q psy3182 133 IEALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----CKT 208 (255)
Q Consensus 133 l~~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~~~ 208 (255)
+.||.|||++||+||||||+|||++.++.+++. |||+++...... ...
T Consensus 127 l~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~----------------------------dfg~~~~~~~~~~~~~~~~ 178 (318)
T d3blha1 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLA----------------------------DFGLARAFSLAKNSQPNRY 178 (318)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC----------------------------CCTTCEECCC-----CCCC
T ss_pred HHHHHHhccCCEEecCcCchheeecCCCcEEee----------------------------ecceeeecccccccccccc
Confidence 999999999999999999999999999988884 888876543221 123
Q ss_pred cccccCCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 209 WTFCGTPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 209 ~~~~gt~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.+.+||+.|+|||++.+ ..|+.++||||+||++|||++|..||.
T Consensus 179 ~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 35689999999999976 478999999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-33 Score=235.24 Aligned_cols=162 Identities=22% Similarity=0.279 Sum_probs=126.8
Q ss_pred eeeeccc-cccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccch-------hhHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRK-KKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAA-------SFITACVIEALDFITACVIE 134 (255)
Q Consensus 63 vkl~~~~-~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~i~~~il~ 134 (255)
+.++.++ .|+|++++++.+.+....|++||||.||+|.+++++......... ..........+..++.||+.
T Consensus 77 ~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 156 (311)
T d1t46a_ 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (311)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHH
Confidence 4445555 699999999999999999999999999999999986543211100 00001122345668899999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccc
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFC 212 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~ 212 (255)
||.|||+++++||||||+||+++..+..++ .|||.++....... .....+
T Consensus 157 gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki----------------------------~DfG~~~~~~~~~~~~~~~~~~ 208 (311)
T d1t46a_ 157 GMAFLASKNCIHRDLAARNILLTHGRITKI----------------------------CDFGLARDIKNDSNYVVKGNAR 208 (311)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEEETTTEEEE----------------------------CCCGGGSCTTSCTTSEECSSSE
T ss_pred HHHHHHhCCeeecccccccccccccCcccc----------------------------cccchheeccCCCcceEeeecc
Confidence 999999999999999999999999888888 59999987654322 223468
Q ss_pred cCCCCcccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCc
Q psy3182 213 GTPEYVAPEIIKNRGHDRAVDYWALGILMHELLT-GMKESN 252 (255)
Q Consensus 213 gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~-G~~~~~ 252 (255)
||+.|+|||++.+..++.++||||+||++|||++ |.+||.
T Consensus 209 gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999998 455553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.5e-33 Score=231.10 Aligned_cols=153 Identities=22% Similarity=0.320 Sum_probs=131.8
Q ss_pred cCceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 60 RGYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 60 ~~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
..+++++..++|+|++++++.+.+....++++|++.|+++..++.....+++. .+..++.|++.||+||
T Consensus 49 ~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~-----------~~~~~~~q~~~aL~~l 117 (292)
T d1unla_ 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----------IVKSFLFQLLKGLGFC 117 (292)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchh-----------HHHHHHHHHHHHHHHh
Confidence 35677888899999999999999999999999999999999888766655533 3456788999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCcc
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVA 219 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~a 219 (255)
|++||+||||||+||+++..+..++ +|||.|+.............+++.|+|
T Consensus 118 H~~~IvHrDiKP~NIli~~~~~~kl----------------------------~DFG~a~~~~~~~~~~~~~~~~~~~~~ 169 (292)
T d1unla_ 118 HSRNVLHRDLKPQNLLINRNGELKL----------------------------ANFGLARAFGIPVRCYSAEVVTLWYRP 169 (292)
T ss_dssp HHTTEECCCCSGGGEEECTTCCEEE----------------------------CCCTTCEECCSCCSCCCSCCSCGGGCC
T ss_pred hcCCEeeecccCcccccccCCceee----------------------------eecchhhcccCCCccceeeccccchhh
Confidence 9999999999999999999888888 599999877655544555678889999
Q ss_pred cccccCC-CCCCcchHHHHHHHHHHHhcCCCCC
Q psy3182 220 PEIIKNR-GHDRAVDYWALGILMHELLTGMKES 251 (255)
Q Consensus 220 PE~~~~~-~~~~~~DiWslGvil~ell~G~~~~ 251 (255)
||++.+. .++.++|+||+||++|||++|..||
T Consensus 170 pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred hhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 9999865 4689999999999999999999886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=235.17 Aligned_cols=152 Identities=22% Similarity=0.469 Sum_probs=122.7
Q ss_pred CceeeeccccccccccccccccCccc----eeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKY----VYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEAL 136 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~----~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l 136 (255)
.++.++..+.|+++++++..+..... .++++|++.||+|.+++..+ .+++ +.+..++.|++.||
T Consensus 55 ~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~-~l~~-----------~~i~~i~~qil~al 122 (345)
T d1pmea_ 55 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSN-----------DHICYFLYQILRGL 122 (345)
T ss_dssp HHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC-CCCH-----------HHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC-CCCH-----------HHHHHHHHHHHHHH
Confidence 35777888899999999998876542 23445567799999999753 3433 34567889999999
Q ss_pred HHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC---cccccccc
Q psy3182 137 EYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG---CKTWTFCG 213 (255)
Q Consensus 137 ~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~---~~~~~~~g 213 (255)
.|||++|||||||||+|||++.++.+|+ .|||+|+...... ......+|
T Consensus 123 ~yLH~~~iiHRDIKp~NILl~~~~~~kl----------------------------~DfG~a~~~~~~~~~~~~~~~~~g 174 (345)
T d1pmea_ 123 KYIHSANVLHRDLKPSNLLLNTTCDLKI----------------------------CDFGLARVADPDHDHTGFLTEYVA 174 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCCEEE----------------------------CCCTTCEECCGGGCBCCTTCCCCS
T ss_pred HHHHHCCCcCCCCCcceEEECCCCCEEE----------------------------cccCceeeccCCCccceeeccccc
Confidence 9999999999999999999999998888 4888886543321 12345789
Q ss_pred CCCCcccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 214 TPEYVAPEIIKN-RGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 214 t~~y~aPE~~~~-~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
|+.|+|||++.. ..++.++|+||+||++|+|++|..||.
T Consensus 175 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp CGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 999999999854 578899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=1.8e-32 Score=228.88 Aligned_cols=151 Identities=19% Similarity=0.287 Sum_probs=121.0
Q ss_pred eeeeccccc-cccccccccccCccceeehhhhhcchhHHHHHHhccC-CCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKK-TRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTC-FDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 63 vkl~~~~~h-~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
++.+..+.| ++++.++..+.+....|+||||| ||+|.+++..... ++. ..+..++.|++.||+|||
T Consensus 51 ~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~-----------~~~~~i~~q~~~~l~~lH 118 (293)
T d1csna_ 51 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV-----------KTVAMAAKQMLARVQSIH 118 (293)
T ss_dssp HHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhh-----------HHHHHHHHHHHHHHHHHH
Confidence 344444444 78889999999999999999998 7899888875432 322 234457889999999999
Q ss_pred HcCcccccCCCCceeeCC-----CCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC-------ccc
Q psy3182 141 TRGIVFRDLKPENLLLDN-----RGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG-------CKT 208 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~-----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~-------~~~ 208 (255)
++||+||||||+||+++. .+.+++ +|||+|+...... ...
T Consensus 119 ~~giiHrDiKp~Nili~~~~~~~~~~vkl----------------------------~DFG~a~~~~~~~~~~~~~~~~~ 170 (293)
T d1csna_ 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYV----------------------------VDFGMVKFYRDPVTKQHIPYREK 170 (293)
T ss_dssp TTTEECCCCCGGGEEECCSSSTTTTCEEE----------------------------CCCTTCEESBCTTTCCBCCCCCC
T ss_pred HCCceeccCCccceeecCcccccCCceEE----------------------------cccceeEEcccCccccceeeccc
Confidence 999999999999999975 344555 5999887654321 123
Q ss_pred cccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 209 WTFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 209 ~~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
.+.+|||.|||||++.+..++.++|+||+||++|||++|..||..
T Consensus 171 ~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 457899999999999999999999999999999999999999963
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.9e-32 Score=227.95 Aligned_cols=154 Identities=19% Similarity=0.255 Sum_probs=125.4
Q ss_pred Cceeeecccccccccccccccc-CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFK-DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~-~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
.++++++++.|||++++++.+. .+...|+|||||.+|+|.+++........ ...+..++.|++.||.|+
T Consensus 77 ~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~----------~~~~~~i~~qia~gL~~l 146 (311)
T d1r0pa_ 77 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT----------VKDLIGFGLQVAKGMKFL 146 (311)
T ss_dssp HHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCB----------HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccch----------HHHHHHHHHHHHHhhhhh
Confidence 4567788889999999999865 45689999999999999998875432111 112335678999999999
Q ss_pred HHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc----cccccccCC
Q psy3182 140 HTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC----KTWTFCGTP 215 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~----~~~~~~gt~ 215 (255)
|+++|+||||||+|||++.++.+|+ .|||+++....... ......||+
T Consensus 147 H~~~iiHrDLK~~NILl~~~~~~kL----------------------------~DFG~~~~~~~~~~~~~~~~~~~~gt~ 198 (311)
T d1r0pa_ 147 ASKKFVHRDLAARNCMLDEKFTVKV----------------------------ADFGLARDMYDKEFDSVHNKTGAKLPV 198 (311)
T ss_dssp HHTTCCCSCCSGGGEEECTTCCEEE----------------------------CSSGGGCCTTTTTCCCTTCTTCSSCCG
T ss_pred cccCcccCCccHHhEeECCCCCEEE----------------------------ecccchhhccccccccceecccccccc
Confidence 9999999999999999999988888 49999986644322 222356899
Q ss_pred CCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||.+....++.++||||+||++|||++|..||.
T Consensus 199 ~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred cccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 9999999998899999999999999999999877664
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=234.23 Aligned_cols=149 Identities=25% Similarity=0.425 Sum_probs=115.1
Q ss_pred Cceeeecccccccccccccccc------CccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFK------DSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIE 134 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~------~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~ 134 (255)
.++++++...|+|+++++++|. +.+.+|++||||.|+.+. .+. ..+++ ..++.+++|++.
T Consensus 65 ~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~~--~~~~~-----------~~i~~~~~qil~ 130 (355)
T d2b1pa1 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VIQ--MELDH-----------ERMSYLLYQMLC 130 (355)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HHT--SCCCH-----------HHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hhh--cCCCH-----------HHHHHHHHHHHH
Confidence 4567788889999999999986 446889999999776554 332 23332 345678899999
Q ss_pred HHHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccC
Q psy3182 135 ALEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGT 214 (255)
Q Consensus 135 ~l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt 214 (255)
||.|||++||+||||||+||+++.++..++ .|||.++...... .....+||
T Consensus 131 gl~~LH~~giiHrDlKP~Nil~~~~~~~kl----------------------------~df~~~~~~~~~~-~~~~~~~t 181 (355)
T d2b1pa1 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKI----------------------------LDFGLARTAGTSF-MMTPYVVT 181 (355)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTCCEEE----------------------------CCCCC----------------C
T ss_pred HHHHhhhcccccccCCccccccccccceee----------------------------echhhhhcccccc-cccccccc
Confidence 999999999999999999999999888887 4888776554432 33456899
Q ss_pred CCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 215 PEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 215 ~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+.|+|||++.+..++.++|+||+||++|+|++|..||.
T Consensus 182 ~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 99999999999999999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=8e-32 Score=225.48 Aligned_cols=152 Identities=18% Similarity=0.267 Sum_probs=115.6
Q ss_pred ceeeecccccccc-ccccccccCccceeehhhhhcchhHHHHHH-hccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRKKKTRQ-TRLYKTFKDSKYVYMLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALDFITACVIEALEYL 139 (255)
Q Consensus 62 ~vkl~~~~~h~~i-v~l~~~~~~~~~~ylv~E~~~gg~l~~~l~-~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~yl 139 (255)
+++++....|+++ +.++..+.+.+..|++||||.| ++...+. ....+++ ..+..++.|++.||+||
T Consensus 52 E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~~~~~~~~~~-----------~~~~~~~~qi~~~l~~l 119 (299)
T d1ckia_ 52 ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSL-----------KTVLLLADQMISRIEYI 119 (299)
T ss_dssp HHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCH-----------HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhhhhccCCCcH-----------HHHHHHHHHHHHHHHHH
Confidence 4556666766654 4555667788899999999855 4544443 3333433 23456788999999999
Q ss_pred HHcCcccccCCCCceeeCCC---CceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc-------ccc
Q psy3182 140 HTRGIVFRDLKPENLLLDNR---GYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC-------KTW 209 (255)
Q Consensus 140 H~~~iiHrdlkp~nil~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~-------~~~ 209 (255)
|++||+||||||+||++... ..+++ +|||+|+....... ...
T Consensus 120 H~~~iiHrDiKp~NIl~~~~~~~~~vkl----------------------------~DFG~a~~~~~~~~~~~~~~~~~~ 171 (299)
T d1ckia_ 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYI----------------------------IDFGLAKKYRDARTHQHIPYRENK 171 (299)
T ss_dssp HHTTEECSCCCGGGEEECCGGGTTCEEE----------------------------CCCSSCEECBCTTTCCBCCCCBCC
T ss_pred HHCCeeeccCCHhhccccccCCCceeee----------------------------eccCcceeccccccccceeccccC
Confidence 99999999999999987643 34555 59998876543221 234
Q ss_pred ccccCCCCcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 210 TFCGTPEYVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
+.+||+.|||||++.+.+++.++|+||+||++|||++|..||..
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp SCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccc
Confidence 56899999999999999999999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-32 Score=229.43 Aligned_cols=150 Identities=18% Similarity=0.285 Sum_probs=117.5
Q ss_pred eeeeccccccccccccccccCcc----ceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 63 VKLVSRKKKTRQTRLYKTFKDSK----YVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 63 vkl~~~~~h~~iv~l~~~~~~~~----~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
+..+....|||++++++.+.+.+ .+|+|||||.+|+|.+++++.. ++. +....++.|++.||.|
T Consensus 48 i~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-l~~-----------~~~~~~~~~ia~gl~~ 115 (303)
T d1vjya_ 48 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTV-----------EGMIKLALSTASGLAH 115 (303)
T ss_dssp HHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC-CCH-----------HHHHHHHHHHHHHHHH
Confidence 34455678999999999876543 6899999999999999998642 222 2233467789999999
Q ss_pred HHH--------cCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCC----c
Q psy3182 139 LHT--------RGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSG----C 206 (255)
Q Consensus 139 lH~--------~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~----~ 206 (255)
+|+ +||+||||||+|||++.++.+|++ |||+++...... .
T Consensus 116 lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~----------------------------DFGl~~~~~~~~~~~~~ 167 (303)
T d1vjya_ 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA----------------------------DLGLAVRHDSATDTIDI 167 (303)
T ss_dssp HHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC----------------------------CCTTCEEEETTTTEECC
T ss_pred HHHhhhhhccCCCeeccccCccceEEcCCCCeEEE----------------------------ecCccccccCCCcceec
Confidence 996 699999999999999999999984 898887653322 1
Q ss_pred cccccccCCCCcccccccCCC------CCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 207 KTWTFCGTPEYVAPEIIKNRG------HDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 207 ~~~~~~gt~~y~aPE~~~~~~------~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.....+||+.|||||++.+.. ++.++||||+||++|||+||..||.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp ----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 233568999999999987643 4668999999999999999987763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=5.6e-32 Score=229.24 Aligned_cols=148 Identities=20% Similarity=0.387 Sum_probs=121.1
Q ss_pred ceeeeccc-cccccccccccccC--ccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 62 YVKLVSRK-KKTRQTRLYKTFKD--SKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEY 138 (255)
Q Consensus 62 ~vkl~~~~-~h~~iv~l~~~~~~--~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~y 138 (255)
++.++..+ .|+|++++++.|.+ ...+|++||||.+|+|....+ .+++ ..++.+++||+.||.|
T Consensus 79 Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~l~e-----------~~i~~i~~qil~aL~~ 144 (328)
T d3bqca1 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTD-----------YDIRFYMYEILKALDY 144 (328)
T ss_dssp HHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT---SCCH-----------HHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc---CCCH-----------HHHHHHHHHHHHHHHH
Confidence 45666666 49999999999874 467999999999999865532 2332 3456788999999999
Q ss_pred HHHcCcccccCCCCceeeCCCC-ceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCC
Q psy3182 139 LHTRGIVFRDLKPENLLLDNRG-YVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEY 217 (255)
Q Consensus 139 lH~~~iiHrdlkp~nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y 217 (255)
||++||+||||||+|||++.++ .+++ +|||.|+...... .....+||+.|
T Consensus 145 LH~~gIvHrDiKp~NILi~~~~~~vkl----------------------------~DFG~a~~~~~~~-~~~~~~~t~~y 195 (328)
T d3bqca1 145 CHSMGIMHRDVKPHNVMIDHEHRKLRL----------------------------IDWGLAEFYHPGQ-EYNVRVASRYF 195 (328)
T ss_dssp HHHTTEECCCCSGGGEEEETTTTEEEE----------------------------CCGGGCEECCTTC-CCCSCCSCGGG
T ss_pred HhhcccccccccccceEEcCCCCeeee----------------------------cccccceeccCCC-cccccccCccc
Confidence 9999999999999999998655 4676 5999998765432 34467899999
Q ss_pred cccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 218 VAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 218 ~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
+|||++.+. .|+.++|+||+||++|+|++|..||.
T Consensus 196 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 999998764 58999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.2e-32 Score=228.16 Aligned_cols=163 Identities=17% Similarity=0.263 Sum_probs=129.7
Q ss_pred CceeeeccccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLH 140 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH 140 (255)
.+++++.+..|+|++++++.+...+..++|||||.+|+|.+++........... .........+..++.|++.||.|||
T Consensus 72 ~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~ia~gl~~LH 150 (308)
T d1p4oa_ 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP-VLAPPSLSKMIQMAGEIADGMAYLN 150 (308)
T ss_dssp HHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCT-TCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccccccccc-ccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 457788899999999999999999999999999999999998865321100000 0000122345567889999999999
Q ss_pred HcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCc--cccccccCCCCc
Q psy3182 141 TRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGC--KTWTFCGTPEYV 218 (255)
Q Consensus 141 ~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~--~~~~~~gt~~y~ 218 (255)
+++|+||||||+|||++.++.+|+ .|||+|+....... .....+||+.|+
T Consensus 151 ~~~ivHrDlk~~NiLld~~~~~Kl----------------------------~DFGla~~~~~~~~~~~~~~~~~t~~y~ 202 (308)
T d1p4oa_ 151 ANKFVHRDLAARNCMVAEDFTVKI----------------------------GDFGMTRDIYETDYYRKGGKGLLPVRWM 202 (308)
T ss_dssp HTTCBCSCCSGGGEEECTTCCEEE----------------------------CCTTCCCGGGGGGCEEGGGSSEECGGGC
T ss_pred hCCeeeceEcCCceeecCCceEEE----------------------------eecccceeccCCcceeeccceecccccC
Confidence 999999999999999999999988 49999876543321 233457999999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCC-CCCc
Q psy3182 219 APEIIKNRGHDRAVDYWALGILMHELLTGM-KESN 252 (255)
Q Consensus 219 aPE~~~~~~~~~~~DiWslGvil~ell~G~-~~~~ 252 (255)
|||.+.+..++.++|+||+||++|||++|. .||.
T Consensus 203 aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred CHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999999996 5664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-31 Score=226.58 Aligned_cols=149 Identities=28% Similarity=0.502 Sum_probs=119.5
Q ss_pred CceeeeccccccccccccccccCc-----cceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHH
Q psy3182 61 GYVKLVSRKKKTRQTRLYKTFKDS-----KYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEA 135 (255)
Q Consensus 61 ~~vkl~~~~~h~~iv~l~~~~~~~-----~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~ 135 (255)
.+++++..+.|+|++++++.+... ...++++|++.||+|.+++.. ..+++ ..+..++.|++.|
T Consensus 66 ~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e-----------~~~~~i~~qil~a 133 (348)
T d2gfsa1 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTD-----------DHVQFLIYQILRG 133 (348)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCH-----------HHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccH-----------HHHHHHHHHHHHH
Confidence 356778888999999999988643 234666778899999998864 34443 3456788999999
Q ss_pred HHHHHHcCcccccCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCC
Q psy3182 136 LEYLHTRGIVFRDLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTP 215 (255)
Q Consensus 136 l~ylH~~~iiHrdlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~ 215 (255)
|.|||++||+||||||+|||++.++..++ .|||.+..... ...+..||+
T Consensus 134 L~~LH~~giiHrDiKp~NILi~~~~~~kl----------------------------~dfg~a~~~~~---~~~~~~g~~ 182 (348)
T d2gfsa1 134 LKYIHSADIIHRDLKPSNLAVNEDCELKI----------------------------LDFGLARHTDD---EMTGYVATR 182 (348)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCCEEE----------------------------CCC----CCTG---GGSSSCHHH
T ss_pred HHHHHhCCCcccccCCccccccccccccc----------------------------cccchhcccCc---ccccccccc
Confidence 99999999999999999999999988888 48998865532 344678999
Q ss_pred CCcccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCc
Q psy3182 216 EYVAPEIIKNR-GHDRAVDYWALGILMHELLTGMKESN 252 (255)
Q Consensus 216 ~y~aPE~~~~~-~~~~~~DiWslGvil~ell~G~~~~~ 252 (255)
.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 183 ~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp HTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 99999998765 56889999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=4.5e-26 Score=194.87 Aligned_cols=143 Identities=22% Similarity=0.350 Sum_probs=105.5
Q ss_pred ccccccccccccccCc--cceeehhhhhcchhHH-HHHHh--ccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHH-c
Q psy3182 69 KKKTRQTRLYKTFKDS--KYVYMLLEACLGGEVW-TILRE--RTCFDDNAASFITACVIEALDFITACVIEALEYLHT-R 142 (255)
Q Consensus 69 ~~h~~iv~l~~~~~~~--~~~ylv~E~~~gg~l~-~~l~~--~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~-~ 142 (255)
..|++++++++.+... ...+++++++.+++.. ..... ...++ ...+..++.|++.||.|||+ .
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~i~~i~~qil~al~~lh~~~ 145 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP-----------LIYVKQISKQLLLGLDYMHRRC 145 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCC-----------HHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCc-----------HHHHHHHHHHHHHHHHHHhhhc
Confidence 3578899998877543 4556666665544322 22221 11222 23456788999999999998 8
Q ss_pred CcccccCCCCceeeCCCCc------eeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCC
Q psy3182 143 GIVFRDLKPENLLLDNRGY------VKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPE 216 (255)
Q Consensus 143 ~iiHrdlkp~nil~~~~~~------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~ 216 (255)
||+||||||+|||++..+. +++ .|||.|..... .....+||+.
T Consensus 146 ~IvHrDlKp~NIll~~~~~~~~~~~~kl----------------------------~dfg~s~~~~~---~~~~~~gt~~ 194 (362)
T d1q8ya_ 146 GIIHTDIKPENVLMEIVDSPENLIQIKI----------------------------ADLGNACWYDE---HYTNSIQTRE 194 (362)
T ss_dssp CEECSCCSGGGEEEEEEETTTTEEEEEE----------------------------CCCTTCEETTB---CCCSCCSCGG
T ss_pred CcccccCChhHeeeeccCcccccceeeE----------------------------eeccccccccc---cccccccccc
Confidence 9999999999999976442 233 59998875533 2345789999
Q ss_pred CcccccccCCCCCCcchHHHHHHHHHHHhcCCCCCcC
Q psy3182 217 YVAPEIIKNRGHDRAVDYWALGILMHELLTGMKESNV 253 (255)
Q Consensus 217 y~aPE~~~~~~~~~~~DiWslGvil~ell~G~~~~~~ 253 (255)
|+|||++.+..|+.++|+||+||++++|++|..||..
T Consensus 195 y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp GCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.3e-18 Score=141.94 Aligned_cols=96 Identities=27% Similarity=0.384 Sum_probs=80.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
||||||.||+|.+++.+.+.+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.........-...
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 69999999999999998889999999999999999999999999999999999999999999999887654332222222
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.|
T Consensus 163 ~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEG 178 (263)
T ss_dssp ETTEEGGGCCHHHHTT
T ss_pred ccCCCCcccCHHHHcC
Confidence 2345678999997654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.5e-18 Score=142.16 Aligned_cols=96 Identities=28% Similarity=0.372 Sum_probs=78.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc----c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT----R 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv----~ 76 (255)
||||||.||+|+++++.++.++|.++..++.|++.|++|+|++||+||||||+||+++.++.+|+.+........ .
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 699999999999999988899999999999999999999999999999999999999999999998865433211 1
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
-......++..|+.+|.+.+
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKR 179 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHC
T ss_pred ccccceeeCcCccCHhHhcC
Confidence 11112235677999996543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=6.5e-18 Score=142.43 Aligned_cols=96 Identities=30% Similarity=0.426 Sum_probs=80.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--~ 78 (255)
||||||.||+|+.++.+.+.++|..+.++++|++.|++|+|++||+||||||+|++++.+|.+|+.+.........- .
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 69999999999999999999999999999999999999999999999999999999999999999886654322211 1
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 162 ~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp BCCCEECGGGCCGGGGSS
T ss_pred cccceeCHHHhhhhhccC
Confidence 112234567999998755
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=4.8e-18 Score=142.48 Aligned_cols=96 Identities=25% Similarity=0.363 Sum_probs=79.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTR-GIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~-~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
||||||.||+|.+++.+.+.+++..+..++.|++.|++|+|++ ||+||||||+||+++.++.+|+.+.........-..
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 160 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence 6999999999999999888999999999999999999999975 999999999999999999999988765433222111
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.-..++..|+.+|.+.|
T Consensus 161 ~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQG 177 (322)
T ss_dssp ---CCSSCCCCHHHHHC
T ss_pred ccccCCccccCchHHcC
Confidence 22245677999997754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.70 E-value=1.1e-17 Score=142.46 Aligned_cols=95 Identities=28% Similarity=0.409 Sum_probs=80.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
||||||.||+|.+++.+...+++..+..++.|++.|++|+|++||+||||||+|++++..+.+|+.+.........-...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~ 163 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCC
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCccc
Confidence 69999999999999998899999999999999999999999999999999999999999999999887654333222222
Q ss_pred ccCccceeehhhhhc
Q psy3182 81 FKDSKYVYMLLEACL 95 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~ 95 (255)
...++..|+.+|.+.
T Consensus 164 ~~~GT~~y~APE~~~ 178 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQ 178 (364)
T ss_dssp SCCSCGGGCCHHHHS
T ss_pred ccccccccchhHHhh
Confidence 334677899999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.7e-17 Score=137.23 Aligned_cols=96 Identities=26% Similarity=0.407 Sum_probs=78.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc--ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--RLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--~l~ 78 (255)
||||||.||+|.+++.+ +.+++.++..++.|++.|++|||++||+||||||+|++++.++.+|+.+........ ...
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 69999999999998876 569999999999999999999999999999999999999999999998865443221 111
Q ss_pred ccccCccceeehhhhhcch
Q psy3182 79 KTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~gg 97 (255)
.....++..|+.+|.+.++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~ 191 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRK 191 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSS
T ss_pred ccccccCCCccChhhhcCC
Confidence 2223456779999977553
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.8e-17 Score=136.75 Aligned_cols=96 Identities=29% Similarity=0.404 Sum_probs=78.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR---- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~---- 76 (255)
||||||.||+|.+++...+.+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+.........
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 6999999999999999989999999999999999999999999999999999999999999999987654322110
Q ss_pred ccccccCccceeehhhhhcc
Q psy3182 77 LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l~~~~~~~~~~ylv~E~~~g 96 (255)
....-..++..|+.+|.+.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp -----CCCCGGGCCHHHHHT
T ss_pred cccccccCCccccCceeecc
Confidence 01111235678999997644
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=4.1e-17 Score=133.41 Aligned_cols=96 Identities=22% Similarity=0.258 Sum_probs=77.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCcceeec-ccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRG--IVFRDLKPENLLLD-NRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~--i~~rdiK~~nil~~-~~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+++++...+++..+..++.|++.|++|||+++ |+||||||+|++++ .++.+|+.+.........-
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 58999999999999998889999999999999999999999999 99999999999996 4788999876544321111
Q ss_pred cccccCccceeehhhhhcc
Q psy3182 78 YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~~g 96 (255)
......++..|+.+|.+.+
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~ 187 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE 187 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT
T ss_pred ccCCcccCccccCHHHhCC
Confidence 1122235667999997643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.67 E-value=1.2e-16 Score=131.16 Aligned_cols=96 Identities=25% Similarity=0.297 Sum_probs=79.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-cc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-YK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-~~ 79 (255)
||||||.||+|.+++++++.+++.++..++.|++.|++|+|.+||+||||||+|++++.++.+|+.+......+..- ..
T Consensus 87 ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 166 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 166 (277)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCB
T ss_pred EEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCce
Confidence 69999999999999999899999999999999999999999999999999999999999999999876543322211 11
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
....++..|+.+|.+.+
T Consensus 167 ~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 167 REVCGTPSYLAPEIIEC 183 (277)
T ss_dssp CCCCSCGGGCCHHHHHH
T ss_pred eeeeccCCCCCHHHhhc
Confidence 12234567888887754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.67 E-value=1.1e-16 Score=133.68 Aligned_cols=95 Identities=34% Similarity=0.506 Sum_probs=80.7
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
||||||.||++...+.....+++..+..++.|++.|++|+|++||+||||||+|++++.+|.+|+.+........... .
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-~ 159 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-Y 159 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-C
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc-c
Confidence 699999999999999999999999999999999999999999999999999999999999999998876543332221 1
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.+
T Consensus 160 ~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 160 TLCGTPDYIAPEVVST 175 (316)
T ss_dssp CCCSCTTTCCHHHHTT
T ss_pred cccCcccccCHHHHcC
Confidence 2345667999997754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=3.2e-17 Score=135.33 Aligned_cols=95 Identities=27% Similarity=0.432 Sum_probs=77.7
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
||||||.||+|..++.+ .+.+++.++..++.|++.|++|||++||+||||||+|++++.++.+|+.+...........
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 69999999999999765 4569999999999999999999999999999999999999999999998876543222211
Q ss_pred -ccccCccceeehhhhhc
Q psy3182 79 -KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 79 -~~~~~~~~~ylv~E~~~ 95 (255)
.....++..|+.+|.+.
T Consensus 166 ~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp HHTCCCSCCTTCCHHHHT
T ss_pred cccccccccccCCHHHHh
Confidence 11233566799999763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=6.3e-17 Score=134.79 Aligned_cols=94 Identities=23% Similarity=0.345 Sum_probs=79.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
||||||.||++..+....+.+++.++..++.|++.|++|||++||+||||||+|++++.++.+|+.+......... ..
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~ 169 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--AN 169 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BC
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CC
Confidence 6999999999998888888999999999999999999999999999999999999999999999988765433222 12
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.+
T Consensus 170 ~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILA 185 (309)
T ss_dssp CCCSCGGGCCHHHHTT
T ss_pred ccccCccccCHHHHhc
Confidence 2345678999997643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.66 E-value=8.4e-17 Score=136.27 Aligned_cols=95 Identities=32% Similarity=0.484 Sum_probs=80.2
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
+||||+.||+|...+.+.+.+++..+..++.|++.|++|||+++|+||||||+||+++.++.+||.+......+.... .
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-~ 196 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-W 196 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-C
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-c
Confidence 589999999999999998899999999999999999999999999999999999999999999998876544332211 1
Q ss_pred ccCccceeehhhhhcc
Q psy3182 81 FKDSKYVYMLLEACLG 96 (255)
Q Consensus 81 ~~~~~~~ylv~E~~~g 96 (255)
...++..|+.+|.+.|
T Consensus 197 ~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILS 212 (350)
T ss_dssp CCEECGGGCCHHHHTT
T ss_pred cccCccccCCHHHHcC
Confidence 2234567999997755
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.2e-16 Score=131.05 Aligned_cols=96 Identities=23% Similarity=0.284 Sum_probs=75.9
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~ 79 (255)
||||||.||+|.+++... ..+++.++..++.|++.|++|||+++|+||||||+|++++.++.+|+.+..........-.
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 699999999999999754 5699999999999999999999999999999999999999999999988654322211111
Q ss_pred ----cccCccceeehhhhhcc
Q psy3182 80 ----TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ----~~~~~~~~ylv~E~~~g 96 (255)
.-...+..||.+|.+.+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp ------CCCCGGGCCHHHHTT
T ss_pred cccccccccCcccCCHHHHhc
Confidence 11124567999997743
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.2e-16 Score=133.66 Aligned_cols=97 Identities=30% Similarity=0.432 Sum_probs=80.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccc--ccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQT--RLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv--~l~ 78 (255)
||||||.||+|.+++++.+.++|.++..++.|++.|++|+|+++|+||||||+|++++..+.+|+.+........ ...
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 699999999999999998999999999999999999999999999999999999999999999998765433221 122
Q ss_pred ccccCccceeehhhhhcch
Q psy3182 79 KTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~gg 97 (255)
.....++..|+.+|.+.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~ 178 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQ 178 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTC
T ss_pred ccccCCCCCcCCHHHHcCC
Confidence 2233456779999977553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=9.8e-17 Score=133.50 Aligned_cols=96 Identities=26% Similarity=0.359 Sum_probs=72.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec---ccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD---NRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~---~~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+++.+.+.+++..+..++.|++.|++|+|++||+||||||+|+++. .++.+|+.+.........-
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 6999999999999999989999999999999999999999999999999999999985 4678999876543211100
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
......++..|+.+|.+.+
T Consensus 164 ~~~~~~~GT~~y~APE~~~~ 183 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQ 183 (307)
T ss_dssp ---------CTTSCHHHHTT
T ss_pred CeeeeeeeCccccCcHHHcC
Confidence 0111234567999997654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1e-16 Score=134.99 Aligned_cols=97 Identities=30% Similarity=0.382 Sum_probs=76.6
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc---cCceeeeccccccccc
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN---RGYVKLVSRKKKTRQT 75 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~---~~~vkl~~~~~h~~iv 75 (255)
||||||.||+|++++.++ ..++|.++..++.|++.|++|||++||+||||||+|++++. .+.+|+.+........
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 699999999999999875 46999999999999999999999999999999999999986 3458988765432221
Q ss_pred c-ccccccCccceeehhhhhcch
Q psy3182 76 R-LYKTFKDSKYVYMLLEACLGG 97 (255)
Q Consensus 76 ~-l~~~~~~~~~~ylv~E~~~gg 97 (255)
. -......++..|+.+|.+.+.
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~ 188 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPE 188 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGG
T ss_pred CCCccccccCCcccCCcHHHcCC
Confidence 1 111233456779999977553
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.5e-16 Score=132.08 Aligned_cols=95 Identities=19% Similarity=0.239 Sum_probs=75.3
Q ss_pred CeeeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceee
Q psy3182 1 MLLEACLGGEVWTILRERT-----------------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLL 57 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-----------------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~ 57 (255)
||||||.||+|.+++++++ .+++..+..++.+++.|++|||+++|+||||||+|+++
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill 197 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 197 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc
Confidence 6999999999999997653 48899999999999999999999999999999999999
Q ss_pred cccCceeeecccccccccccccc----ccCccceeehhhhhc
Q psy3182 58 DNRGYVKLVSRKKKTRQTRLYKT----FKDSKYVYMLLEACL 95 (255)
Q Consensus 58 ~~~~~vkl~~~~~h~~iv~l~~~----~~~~~~~ylv~E~~~ 95 (255)
+.++.+|+.+............. ....+..||.+|.+.
T Consensus 198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239 (325)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc
Confidence 99999999887654332221111 111245688888653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.3e-16 Score=130.64 Aligned_cols=95 Identities=21% Similarity=0.256 Sum_probs=72.6
Q ss_pred CeeeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRER----------------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----------------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
+|||||.||+|.++++.. ..+++.++..++.|++.|++|+|+++|+||||||+|++++.++.+|
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEE
Confidence 589999999999999754 3489999999999999999999999999999999999999999999
Q ss_pred eeccccccccccccc----cccCccceeehhhhhc
Q psy3182 65 LVSRKKKTRQTRLYK----TFKDSKYVYMLLEACL 95 (255)
Q Consensus 65 l~~~~~h~~iv~l~~----~~~~~~~~ylv~E~~~ 95 (255)
+.+............ .....+..|+.+|.+.
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 209 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 209 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhh
Confidence 988764432211111 1122455688888654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.62 E-value=1.6e-16 Score=130.32 Aligned_cols=96 Identities=21% Similarity=0.264 Sum_probs=74.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc----
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR---- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~---- 76 (255)
||||||.||+|...+...+.+++.++..++.|++.|++|+|++||+||||||+|++++..+..++.+.........
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~ 167 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccc
Confidence 6999999999999999989999999999999999999999999999999999999999999988876443211111
Q ss_pred -ccccccCccceeehhhhhcc
Q psy3182 77 -LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 -l~~~~~~~~~~ylv~E~~~g 96 (255)
.......++..|+.+|...+
T Consensus 168 ~~~~~~~~Gt~~Y~aPE~~~~ 188 (277)
T d1o6ya_ 168 VTQTAAVIGTAQYLSPEQARG 188 (277)
T ss_dssp -----------TTCCHHHHTT
T ss_pred ccccccccCcccccCHHHHcC
Confidence 01111224567999997654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.4e-16 Score=129.30 Aligned_cols=95 Identities=19% Similarity=0.183 Sum_probs=76.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYK- 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~- 79 (255)
||||||.||+|.+++++.+.+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+.........-..
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 6999999999999999999999999999999999999999999999999999999999999999987654322111100
Q ss_pred ----cccCccceeehhhhhc
Q psy3182 80 ----TFKDSKYVYMLLEACL 95 (255)
Q Consensus 80 ----~~~~~~~~ylv~E~~~ 95 (255)
.....+..|+.+|.+.
T Consensus 164 ~~~~~~~~gt~~y~APE~l~ 183 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECIN 183 (277)
T ss_dssp EEC----CCCGGGCCHHHHH
T ss_pred cccccccCCCceecCchhhc
Confidence 1112334588888654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=2.3e-16 Score=128.87 Aligned_cols=96 Identities=25% Similarity=0.351 Sum_probs=69.6
Q ss_pred CeeeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRE----RTCFDDNAASFITACVIEALEYLHTRG-----IVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~----~~~~~~~~~~~~~~~v~~~l~~lh~~~-----i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
||||||.||+|.+++.+ .+.++|..+..++.|++.|++|+|+++ |+||||||+|++++.++.+|+.+....
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 58999999999999853 567999999999999999999999977 999999999999999999999876543
Q ss_pred ccccc--ccccccCccceeehhhhhcc
Q psy3182 72 TRQTR--LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 72 ~~iv~--l~~~~~~~~~~ylv~E~~~g 96 (255)
..... -...-..++..|+.+|.+.+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTT
T ss_pred eecccCCCccccCCCCcccCCHHHHcC
Confidence 22111 01111234566999997654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=4.7e-16 Score=128.50 Aligned_cols=96 Identities=23% Similarity=0.300 Sum_probs=76.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc----eeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY----VKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~----vkl~~~~~h~~iv~ 76 (255)
||||||.||+|.+++.+.+.+++..+..++.|++.|++|||+++|+||||||+|++++.++. +|+.+.........
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 69999999999999998889999999999999999999999999999999999999988774 78877554322211
Q ss_pred c-cccccCccceeehhhhhcc
Q psy3182 77 L-YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l-~~~~~~~~~~ylv~E~~~g 96 (255)
- .......+..|+.+|.+.+
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTT
T ss_pred CccccccCCCCcccCHHHHcC
Confidence 0 0111234556899997654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.61 E-value=3.4e-16 Score=132.44 Aligned_cols=96 Identities=22% Similarity=0.275 Sum_probs=75.6
Q ss_pred CeeeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc--cCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN--RGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~-~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~--~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|.+++. ..+.+++..+..++.|++.|++|||++||+||||||+||++.. .+.+|+.+......+...
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 6999999999999995 4567999999999999999999999999999999999999954 578999886643322111
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|.+.+
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHT
T ss_pred cccceecCcccccCHHHHcC
Confidence 1112234567899997654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.60 E-value=5.1e-16 Score=131.47 Aligned_cols=96 Identities=20% Similarity=0.257 Sum_probs=75.5
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeec--ccCceeeeccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLD--NRGYVKLVSRKKKTRQTRL 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~--~~~~vkl~~~~~h~~iv~l 77 (255)
||||||.||+|++.+...+ .++|.++..++.|++.|++|+|++||+||||||+||+++ ..+.+|+.+.........-
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 6999999999999886654 699999999999999999999999999999999999997 5678999876543322110
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|.+.+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~ 202 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDR 202 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTT
T ss_pred CceeeccCcccccCHHHHcC
Confidence 1112234567888887654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=8.8e-16 Score=128.44 Aligned_cols=70 Identities=23% Similarity=0.420 Sum_probs=63.0
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC--ceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG--YVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~--~vkl~~~~~ 70 (255)
||||||.||+|++.+++.+ .++|.++..++.|++.|++|||++||+||||||+|++++.++ .+|+.+...
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccch
Confidence 6999999999999998765 699999999999999999999999999999999999998654 677877543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.59 E-value=7.1e-16 Score=127.04 Aligned_cols=96 Identities=19% Similarity=0.174 Sum_probs=75.9
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l- 77 (255)
||||||.||+|..++.+. ..+++..+..++.|++.|++|+|+++|+||||||+||+++.++.+|+.+.........-
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 689999999999999754 56999999999999999999999999999999999999999999999886643322110
Q ss_pred --cccccCccceeehhhhhcc
Q psy3182 78 --YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 --~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|.+.+
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~ 190 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAY 190 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHH
T ss_pred ceeeccccccccccChHHHcC
Confidence 1111123456888886643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.9e-15 Score=122.86 Aligned_cols=96 Identities=18% Similarity=0.108 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-- 77 (255)
||||||.||+|.+++... ..+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+.........-
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 689999999999998754 56899999999999999999999999999999999999999999999876543222111
Q ss_pred -cccccCccceeehhhhhcc
Q psy3182 78 -YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|.+.+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSF 176 (263)
T ss_dssp --------CTTSCCHHHHTT
T ss_pred eeecceecCcccCChHHhcC
Confidence 0111223456899997755
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.58 E-value=1.1e-15 Score=126.63 Aligned_cols=71 Identities=20% Similarity=0.230 Sum_probs=64.0
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
||||||.||+|.+++... +.+++.++..++.+++.|++|||+++|+||||||+|++++.++.+|+.+....
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 689999999999988764 46999999999999999999999999999999999999999999999886643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=5.7e-16 Score=128.25 Aligned_cols=95 Identities=23% Similarity=0.256 Sum_probs=77.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
||||||.||.+..+....+.+++.++..++.|++.|++|+|++||+||||||+||+++..+.+|+.+.........-...
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 69999999999888887888999999999999999999999999999999999999999999999887654322221111
Q ss_pred --ccCccceeehhhhhc
Q psy3182 81 --FKDSKYVYMLLEACL 95 (255)
Q Consensus 81 --~~~~~~~ylv~E~~~ 95 (255)
....+..|+.+|.+.
T Consensus 157 ~~~~~gt~~y~aPE~~~ 173 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLF 173 (299)
T ss_dssp CCCSCCCCTTCCHHHHT
T ss_pred ccceecChhhccHHHHc
Confidence 122456788898664
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.2e-15 Score=124.85 Aligned_cols=96 Identities=27% Similarity=0.296 Sum_probs=75.9
Q ss_pred CeeeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc-cCceeeecccccccccccc
Q psy3182 1 MLLEACLG-GEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN-RGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~g-g~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~-~~~vkl~~~~~h~~iv~l~ 78 (255)
+||||+.| |++.+++.+++.++|..+..++.|++.|++|+|++||+||||||+|++++. ++.+|+.+.........-.
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~ 165 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC
T ss_pred EEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccccc
Confidence 58999986 688899988889999999999999999999999999999999999999985 4789998865432211111
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
..-..++..|+.+|.+.+
T Consensus 166 ~~~~~GT~~y~aPE~~~~ 183 (273)
T d1xwsa_ 166 YTDFDGTRVYSPPEWIRY 183 (273)
T ss_dssp BCCCCSCGGGSCHHHHHH
T ss_pred ccccccCCCcCCHHHHcC
Confidence 112235677999996643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.2e-15 Score=125.55 Aligned_cols=95 Identities=21% Similarity=0.242 Sum_probs=75.4
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
||||||.||+|.+++.. ++.+++.++..++.|++.|+.|+|+++|+||||||+|++++.++.+|+.+.........
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 69999999999999865 45799999999999999999999999999999999999999999999988654332211
Q ss_pred --ccccccCccceeehhhhhc
Q psy3182 77 --LYKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 77 --l~~~~~~~~~~ylv~E~~~ 95 (255)
........+..|+.+|.+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~ 185 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECIN 185 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHH
T ss_pred ccccccccccCccccChHHHh
Confidence 1111112344688888654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=2.2e-15 Score=123.15 Aligned_cols=96 Identities=16% Similarity=0.133 Sum_probs=75.1
Q ss_pred CeeeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRER--TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~--~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l- 77 (255)
||||||.||+|.+++... ..+++.++..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........-
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 699999999999977543 35999999999999999999999999999999999999999999999876544322110
Q ss_pred --cccccCccceeehhhhhcc
Q psy3182 78 --YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 --~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|.+.+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHH
T ss_pred cccccccCCcccccChHHHhC
Confidence 1111223445888886643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.1e-14 Score=120.58 Aligned_cols=95 Identities=19% Similarity=0.239 Sum_probs=73.7
Q ss_pred CeeeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRERT----------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~----------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
+|||||.||+|.+++..++ .+++.++..++.|++.|++|+|+++|+||||||+|++++.++.+|
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeE
Confidence 5899999999999997653 489999999999999999999999999999999999999999999
Q ss_pred eeccccccccccc----cccccCccceeehhhhhc
Q psy3182 65 LVSRKKKTRQTRL----YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 65 l~~~~~h~~iv~l----~~~~~~~~~~ylv~E~~~ 95 (255)
+.+.......... .......+..|+.+|.+.
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 210 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhc
Confidence 9765432211111 111122344577777553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=3.1e-14 Score=120.02 Aligned_cols=68 Identities=24% Similarity=0.541 Sum_probs=62.9
Q ss_pred eeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 2 LLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 2 ~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+|||+.||+|+++++. +.+++..+..++.|++.|++|+|++||+||||||+||+++..+.+|+.+...
T Consensus 88 l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 6788889999999977 4699999999999999999999999999999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.8e-14 Score=117.53 Aligned_cols=95 Identities=21% Similarity=0.269 Sum_probs=70.2
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--L 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l 77 (255)
||||||.||++..++.. ...+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+......... .
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 69999999999998765 44699999999999999999999999999999999999999999999988654322111 1
Q ss_pred -cccccCccceeehhhhhc
Q psy3182 78 -YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 -~~~~~~~~~~ylv~E~~~ 95 (255)
.......+..|+.+|...
T Consensus 164 ~~~~~~~gt~~y~apE~l~ 182 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESIN 182 (273)
T ss_dssp -------CCGGGCCHHHHH
T ss_pred eeccceecCcccchhhHhc
Confidence 111122345577777553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.48 E-value=1.2e-15 Score=118.08 Aligned_cols=114 Identities=19% Similarity=0.211 Sum_probs=73.6
Q ss_pred cccccccccccccccCccceeehhhhhcchhHHHHHHhccCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy3182 68 RKKKTRQTRLYKTFKDSKYVYMLLEACLGGEVWTILRERTCFDDNAASFITACVIEALDFITACVIEALEYLHTRGIVFR 147 (255)
Q Consensus 68 ~~~h~~iv~l~~~~~~~~~~ylv~E~~~gg~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~il~~l~ylH~~~iiHr 147 (255)
+..+.+++..+... .-+++||++.++.+.+ ++... ...++.|++.++.|||++||+||
T Consensus 70 ~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~-------l~~~~-----------~~~i~~ql~~~l~~lH~~giiHr 127 (191)
T d1zara2 70 KLQGLAVPKVYAWE----GNAVLMELIDAKELYR-------VRVEN-----------PDEVLDMILEEVAKFYHRGIVHG 127 (191)
T ss_dssp HTTTSSSCCEEEEE----TTEEEEECCCCEEGGG-------CCCSC-----------HHHHHHHHHHHHHHHHHTTEECS
T ss_pred HccCCCcceEEEec----CCEEEEEeeccccccc-------hhhHH-----------HHHHHHHHHHHHHHHhhCCEEEc
Confidence 33455555544332 2378999998875422 22221 23467889999999999999999
Q ss_pred cCCCCceeeCCCCceeecccCCcceeeecCCCCCceeeeeCCeeeeeccccccCCCCCccccccccCCCCccc--cc---
Q psy3182 148 DLKPENLLLDNRGYVKLEFYPAGHYIIREGAKGDSFFIISGGQVKVDFGFSKHLGHSGCKTWTFCGTPEYVAP--EI--- 222 (255)
Q Consensus 148 dlkp~nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dfg~s~~~~~~~~~~~~~~gt~~y~aP--E~--- 222 (255)
||||+|||++..+ +++ +|||.|....++.... |... +.
T Consensus 128 DiKP~NILv~~~~-~~l----------------------------iDFG~a~~~~~~~~~~--------~l~rd~~~~~~ 170 (191)
T d1zara2 128 DLSQYNVLVSEEG-IWI----------------------------IDFPQSVEVGEEGWRE--------ILERDVRNIIT 170 (191)
T ss_dssp CCSTTSEEEETTE-EEE----------------------------CCCTTCEETTSTTHHH--------HHHHHHHHHHH
T ss_pred cCChhheeeeCCC-EEE----------------------------EECCCcccCCCCCcHH--------HHHHHHHHHHH
Confidence 9999999998644 444 6999887665433211 1111 00
Q ss_pred ccCCCCCCcchHHHHHHH
Q psy3182 223 IKNRGHDRAVDYWALGIL 240 (255)
Q Consensus 223 ~~~~~~~~~~DiWslGvi 240 (255)
.-.+.|+.++|+||+.--
T Consensus 171 ~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 171 YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp HHHHHHCCCCCHHHHHHH
T ss_pred HHcCCCCCcccHHHHHHH
Confidence 113568899999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=2e-14 Score=118.14 Aligned_cols=96 Identities=16% Similarity=0.125 Sum_probs=74.0
Q ss_pred CeeeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRE--RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~--~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l- 77 (255)
||||||.||+|..++.. ...+++.++..++.+++.|+.|||+++|+||||||+|++++.++.+|+.+.........-
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 69999999999998853 457999999999999999999999999999999999999999999999876654322111
Q ss_pred --cccccCccceeehhhhhcc
Q psy3182 78 --YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 --~~~~~~~~~~ylv~E~~~g 96 (255)
.......+..|+.+|+..+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp --------CCGGGSCHHHHHH
T ss_pred ceeeccccccccccChHHHhC
Confidence 1112234456888887644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.3e-14 Score=118.17 Aligned_cols=72 Identities=21% Similarity=0.361 Sum_probs=65.5
Q ss_pred CeeeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCc
Q psy3182 1 MLLEACLGGEVWTILRERT------------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGY 62 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~------------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~ 62 (255)
||||||.||+|.+++++.. .+++..+..++.|++.|++|||.++++||||||+|++++..+.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~ 183 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCc
Confidence 6899999999999997654 5899999999999999999999999999999999999999999
Q ss_pred eeeecccccc
Q psy3182 63 VKLVSRKKKT 72 (255)
Q Consensus 63 vkl~~~~~h~ 72 (255)
+|+.+.....
T Consensus 184 ~ki~DfG~~~ 193 (311)
T d1t46a_ 184 TKICDFGLAR 193 (311)
T ss_dssp EEECCCGGGS
T ss_pred ccccccchhe
Confidence 9998765443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.5e-14 Score=116.46 Aligned_cols=96 Identities=19% Similarity=0.144 Sum_probs=74.0
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-- 77 (255)
+|||||.+|.+...+.+. ..+++.++..++.+++.|++|+|+++|+||||||+|++++.++.+|+.+.........-
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 589999999999988754 56999999999999999999999999999999999999999999999876544322111
Q ss_pred --c-ccccCccceeehhhhhcc
Q psy3182 78 --Y-KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 78 --~-~~~~~~~~~ylv~E~~~g 96 (255)
+ ......+..|+.+|...+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~ 187 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISY 187 (283)
T ss_dssp --------CCCGGGSCHHHHHS
T ss_pred cceEeccCCCCccccCHHHHcc
Confidence 0 111123456999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=5.6e-14 Score=117.33 Aligned_cols=70 Identities=37% Similarity=0.594 Sum_probs=66.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+.+...+.+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence 5899999999999999989999999999999999999999999999999999999999999999987653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=4.5e-14 Score=119.27 Aligned_cols=94 Identities=22% Similarity=0.232 Sum_probs=69.4
Q ss_pred CeeeccCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC-ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTI---LRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG-YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~---~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~-~vkl~~~~~h~~iv~ 76 (255)
||||||.||.+..+ ......+++.++..++.|++.|++|||++||+||||||+||+++.++ .+|+.+.........
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 58999977643333 24566799999999999999999999999999999999999999775 789987664332211
Q ss_pred c-cccccCccceeehhhhh
Q psy3182 77 L-YKTFKDSKYVYMLLEAC 94 (255)
Q Consensus 77 l-~~~~~~~~~~ylv~E~~ 94 (255)
- .......+..|+.+|.+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~ 194 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELI 194 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHH
T ss_pred CcccccccccccccChHHh
Confidence 0 11112345567777754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=6.5e-14 Score=115.95 Aligned_cols=95 Identities=18% Similarity=0.211 Sum_probs=76.3
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccCCCCcceeecccCceeeecccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHT--------RGIVFRDLKPENLLLDNRGYVKLVSRKKKT 72 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~--------~~i~~rdiK~~nil~~~~~~vkl~~~~~h~ 72 (255)
||||||.+|+|..++++. .+++.+...++.+++.|+.|+|+ ++|+||||||+|++++.++.+|+.+.....
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 699999999999999874 69999999999999999999996 699999999999999999999998875433
Q ss_pred ccccccc------cccCccceeehhhhhcc
Q psy3182 73 RQTRLYK------TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 73 ~iv~l~~------~~~~~~~~ylv~E~~~g 96 (255)
....-.. .-..++..|+.+|++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred cccCCCcceeccccceecccCcCChhhccc
Confidence 2221111 11234577999998765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=9e-14 Score=114.99 Aligned_cols=96 Identities=20% Similarity=0.225 Sum_probs=74.7
Q ss_pred CeeeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccc-cccc
Q psy3182 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQ-TRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~-~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~i-v~l~ 78 (255)
|+||||.||.+..... ....+++..+..++.|++.|++|||+++|+||||||+||+++..+.+|+.+....... ..-.
T Consensus 92 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~ 171 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 171 (305)
T ss_dssp EEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG
T ss_pred EEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccccc
Confidence 5899999988765554 4556999999999999999999999999999999999999999999999875432211 1111
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
.....++..|+.+|.+.+
T Consensus 172 ~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 172 LTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp GCCCCCCCTTCCHHHHTT
T ss_pred CCCcccChhhcCcchhcC
Confidence 223345678999997644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=5.1e-14 Score=116.90 Aligned_cols=95 Identities=19% Similarity=0.279 Sum_probs=74.8
Q ss_pred CeeeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCcee
Q psy3182 1 MLLEACLGGEVWTILRER----------------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVK 64 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----------------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vk 64 (255)
||||||.||+|.+++++. ..+++.+...++.+++.|++|+|+++|+||||||+|++++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 689999999999999764 5799999999999999999999999999999999999999999999
Q ss_pred eecccccccccccccc-ccCccceeehhhhhc
Q psy3182 65 LVSRKKKTRQTRLYKT-FKDSKYVYMLLEACL 95 (255)
Q Consensus 65 l~~~~~h~~iv~l~~~-~~~~~~~ylv~E~~~ 95 (255)
+.+............. ....+..|+.+|.+.
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~ 199 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 199 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred EccccccccccccccccceecCCcccchHHhc
Confidence 9876543221111111 122445688888653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=4.9e-14 Score=116.41 Aligned_cols=94 Identities=19% Similarity=0.145 Sum_probs=70.3
Q ss_pred CeeeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc--c
Q psy3182 1 MLLEACLGGEVWTILR-ERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--L 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~-~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--l 77 (255)
||||||.||.+..... ...++++..+..++.|++.|++|||++||+||||||+||+++.++.+|+.+......... -
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 6899997665544433 355699999999999999999999999999999999999999999999987654322211 1
Q ss_pred cccccCccceeehhhhh
Q psy3182 78 YKTFKDSKYVYMLLEAC 94 (255)
Q Consensus 78 ~~~~~~~~~~ylv~E~~ 94 (255)
.......+..|+.+|..
T Consensus 158 ~~~~~~gt~~y~apE~~ 174 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEIL 174 (298)
T ss_dssp CTTCCBCCCTTCCHHHH
T ss_pred cceeecccceeeehhhh
Confidence 11122345567777754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.44 E-value=5.8e-14 Score=117.43 Aligned_cols=93 Identities=18% Similarity=0.283 Sum_probs=70.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC-ceeeeccccccccccc-c
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG-YVKLVSRKKKTRQTRL-Y 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~-~vkl~~~~~h~~iv~l-~ 78 (255)
+|||||.||+|.... +.+++..+..++.|++.||+|||++||+||||||+||+++.++ .+|+.+.........- .
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 589999999998753 5699999999999999999999999999999999999998765 5888776543222111 1
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
......+..|+.+|...+
T Consensus 186 ~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVD 203 (328)
T ss_dssp CCSCCSCGGGCCHHHHTT
T ss_pred ccccccCccccCcccccC
Confidence 112223556788886544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=5.8e-14 Score=116.97 Aligned_cols=96 Identities=19% Similarity=0.185 Sum_probs=74.4
Q ss_pred CeeeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRER-TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTR--- 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~-~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~--- 76 (255)
++|||+.+|+|.+.+... ..+++..+..++.|++.|++|||+++|+||||||+|++++.++.+|+.+.........
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 589999999999988764 5699999999999999999999999999999999999999999999987654332211
Q ss_pred -ccccccCccceeehhhhhcc
Q psy3182 77 -LYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 -l~~~~~~~~~~ylv~E~~~g 96 (255)
........+..|+.+|.+.+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~ 187 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILH 187 (317)
T ss_dssp --------CCTTTSCHHHHHH
T ss_pred cccccccccCccccChHHHhc
Confidence 11111123457899986644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=3.3e-14 Score=115.35 Aligned_cols=95 Identities=21% Similarity=0.220 Sum_probs=72.3
Q ss_pred CeeeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT--CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~--~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~ 78 (255)
||||||.||+|.+++.+++ .+++.....++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.......-...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 6999999999999996643 49999999999999999999999999999999999999999999997755433221111
Q ss_pred ccccCccceeehhhhhcc
Q psy3182 79 KTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 79 ~~~~~~~~~ylv~E~~~g 96 (255)
. ....+..|+.+|++.+
T Consensus 158 ~-~~~~~~~y~aPE~l~~ 174 (262)
T d1byga_ 158 D-TGKLPVKWTAPEALRE 174 (262)
T ss_dssp -----CCTTTSCHHHHHH
T ss_pred c-cccccccCCChHHHhC
Confidence 1 1123456888886543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.42 E-value=8.2e-14 Score=114.29 Aligned_cols=70 Identities=21% Similarity=0.302 Sum_probs=65.5
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
++|||+.||.+..+.+..+.+++.++..++.|++.|++|+|+++|+||||||+||+++.++.+|+.+...
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccc
Confidence 5899999999988888888999999999999999999999999999999999999999999999987654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.3e-13 Score=116.18 Aligned_cols=91 Identities=20% Similarity=0.333 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLYKT 80 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~~~ 80 (255)
|||||| |+++..+.+. +.+++..+..++.|++.|++|||++||+||||||+||+++.++.+|+.+.......-.-. +
T Consensus 100 lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-~ 176 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-T 176 (346)
T ss_dssp EEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred EEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCcc-c
Confidence 589999 7888887765 679999999999999999999999999999999999999999999998765443222111 2
Q ss_pred ccCccceeehhhhh
Q psy3182 81 FKDSKYVYMLLEAC 94 (255)
Q Consensus 81 ~~~~~~~ylv~E~~ 94 (255)
....+..|+.+|.+
T Consensus 177 ~~~~t~~y~aPE~~ 190 (346)
T d1cm8a_ 177 GYVVTRWYRAPEVI 190 (346)
T ss_dssp SSCSCGGGCCTHHH
T ss_pred cccccccccCHHHH
Confidence 23345668888865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.3e-13 Score=111.61 Aligned_cols=95 Identities=23% Similarity=0.253 Sum_probs=74.5
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccccccc-
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRLY- 78 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l~- 78 (255)
|||||+.||++..++.. ...+++.....++.+++.|++|+|++||+||||||+|++++.++.+|+.+......+....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 58999999999999754 4579999999999999999999999999999999999999999999998765433222111
Q ss_pred -cc-ccCccceeehhhhhc
Q psy3182 79 -KT-FKDSKYVYMLLEACL 95 (255)
Q Consensus 79 -~~-~~~~~~~ylv~E~~~ 95 (255)
.. ....+..|+.+|.+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~ 174 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLM 174 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHH
T ss_pred eeecccCCCCCcCCcHHhc
Confidence 11 122344578888654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.41 E-value=2e-13 Score=112.86 Aligned_cols=95 Identities=21% Similarity=0.198 Sum_probs=73.7
Q ss_pred CeeeccCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCccee
Q psy3182 1 MLLEACLGGEVWTILRERT------------------------CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLL 56 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~------------------------~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil 56 (255)
+||||+.+|+|.++++... .+++..+..++.+++.|+.|+|+++|+||||||+||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 5899999999999997643 3889999999999999999999999999999999999
Q ss_pred ecccCceeeecccccccccccc----ccccCccceeehhhhhc
Q psy3182 57 LDNRGYVKLVSRKKKTRQTRLY----KTFKDSKYVYMLLEACL 95 (255)
Q Consensus 57 ~~~~~~vkl~~~~~h~~iv~l~----~~~~~~~~~ylv~E~~~ 95 (255)
++.++.+|+.+.........-- ..-...+..|+.+|...
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc
Confidence 9999999998766433221111 11112334578888654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=2.8e-13 Score=111.49 Aligned_cols=95 Identities=18% Similarity=0.311 Sum_probs=72.9
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecc-----cCceeeecccccccc
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDN-----RGYVKLVSRKKKTRQ 74 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~-----~~~vkl~~~~~h~~i 74 (255)
+||||| ||+|.+.++..+ .+++.++..++.+++.|++|+|++||+||||||+|++++. .+.+|+.+.......
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 589998 899999997654 6999999999999999999999999999999999999964 467888776543221
Q ss_pred cc-----c----cccccCccceeehhhhhcc
Q psy3182 75 TR-----L----YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 75 v~-----l----~~~~~~~~~~ylv~E~~~g 96 (255)
.. . ......++..|+.+|...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcC
Confidence 10 0 0111124667999997655
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.3e-13 Score=116.17 Aligned_cols=69 Identities=25% Similarity=0.491 Sum_probs=62.4
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
+||||+.||+|.+++.. +.+++..+..++.|++.|++|||++||+||||||+|++++.++.+|+.+...
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence 47899999999999965 5799999999999999999999999999999999999999999999877543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1e-13 Score=113.07 Aligned_cols=70 Identities=30% Similarity=0.352 Sum_probs=64.1
Q ss_pred CeeeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRE-RTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~-~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
||||||.+|++.+.+.. .+.+++..+..++.|++.|++|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchh
Confidence 58999999999988765 44699999999999999999999999999999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=3.6e-13 Score=111.81 Aligned_cols=95 Identities=21% Similarity=0.190 Sum_probs=74.0
Q ss_pred CeeeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc--
Q psy3182 1 MLLEACLGGEVWTILRERT-CFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL-- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~-~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l-- 77 (255)
+|||||.||+|.+++.... .+++..+..++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+.........-
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 5899999999999998544 5888888999999999999999999999999999999999999999876544322110
Q ss_pred ----cccccCccceeehhhhhc
Q psy3182 78 ----YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ----~~~~~~~~~~ylv~E~~~ 95 (255)
.......+..|+.+|.+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~ 207 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQ 207 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHH
T ss_pred ccceecccccccccccChHHHh
Confidence 111122345678787654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.2e-13 Score=113.33 Aligned_cols=95 Identities=19% Similarity=0.212 Sum_probs=74.1
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccccccccc---
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQTRL--- 77 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~iv~l--- 77 (255)
||||||.+|.+.........+++..+..++.|++.|++|+|++||+||||||+||+++.++.+|+.+......+...
T Consensus 94 iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173 (318)
T ss_dssp EEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC----
T ss_pred EEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccc
Confidence 58999998888877777888999999999999999999999999999999999999999999998765433211110
Q ss_pred ---cccccCccceeehhhhhc
Q psy3182 78 ---YKTFKDSKYVYMLLEACL 95 (255)
Q Consensus 78 ---~~~~~~~~~~ylv~E~~~ 95 (255)
.......+..|+.+|.+.
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~ 194 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLL 194 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHT
T ss_pred ccccccceecCHHHhhHHHHc
Confidence 011112455688888653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.8e-13 Score=111.10 Aligned_cols=71 Identities=24% Similarity=0.348 Sum_probs=66.6
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKK 71 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h 71 (255)
+|||++.|+++..+.+..+.+++..+..++.|++.|++|+|.+||+||||||+|++++..+.+|+.+....
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchh
Confidence 58999999999999999999999999999999999999999999999999999999999999999876543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.36 E-value=6e-13 Score=109.71 Aligned_cols=95 Identities=19% Similarity=0.320 Sum_probs=68.4
Q ss_pred CeeeccCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccC---ceeeecccccccccc
Q psy3182 1 MLLEACLGGEVWTIL-RERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRG---YVKLVSRKKKTRQTR 76 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~-~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~---~vkl~~~~~h~~iv~ 76 (255)
+||||| ||++...+ ...+.+++..+..++.|++.|++|+|++||+||||||+|+++...+ .+++.+.........
T Consensus 80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 589999 55555555 4566799999999999999999999999999999999999876543 588876543322111
Q ss_pred c---------cccccCccceeehhhhhcc
Q psy3182 77 L---------YKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 77 l---------~~~~~~~~~~ylv~E~~~g 96 (255)
. ......++..|+.+|...|
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred cccccceeccccCCcCCCccccCHHHHhC
Confidence 0 0111234567899997654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=9e-13 Score=109.20 Aligned_cols=70 Identities=19% Similarity=0.229 Sum_probs=63.1
Q ss_pred CeeeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccc
Q psy3182 1 MLLEACLGGEVWTILRER----------TCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKK 70 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~----------~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~ 70 (255)
||||||.+|+|.+++... ..+++.+...++.+++.|+.|+|+++|+||||||+|++++.++.+|+.+...
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 689999999999998542 3478889999999999999999999999999999999999999999987654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=7.1e-13 Score=111.96 Aligned_cols=93 Identities=22% Similarity=0.316 Sum_probs=65.8
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeecccccccc-ccccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRKKKTRQ-TRLYK 79 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~~h~~i-v~l~~ 79 (255)
+|||||.||. ...+. ..+++..+..++.|++.|++|+|++||+||||||+|++++.++.+|+.+....... .....
T Consensus 99 iv~Ey~~~~l-~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~ 175 (355)
T d2b1pa1 99 LVMELMDANL-CQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175 (355)
T ss_dssp EEEECCSEEH-HHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEeccchHH-HHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccccc
Confidence 5899996654 44443 46999999999999999999999999999999999999999999988764321111 11111
Q ss_pred cccCccceeehhhhhcc
Q psy3182 80 TFKDSKYVYMLLEACLG 96 (255)
Q Consensus 80 ~~~~~~~~ylv~E~~~g 96 (255)
.....+..|+.+|.+.|
T Consensus 176 ~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 176 TPYVVTRYYRAPEVILG 192 (355)
T ss_dssp -----CCTTCCHHHHTT
T ss_pred ccccccccccChhhhcC
Confidence 22234456788887654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.04 E-value=3.8e-11 Score=92.26 Aligned_cols=61 Identities=21% Similarity=0.349 Sum_probs=50.9
Q ss_pred CeeeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCcceeecccCceeeeccc
Q psy3182 1 MLLEACLGGEVWTILRERTCFDDNAASFITACVIEALEYLHTRGIVFRDLKPENLLLDNRGYVKLVSRK 69 (255)
Q Consensus 1 ~~~e~~~gg~l~~~~~~~~~~~~~~~~~~~~~v~~~l~~lh~~~i~~rdiK~~nil~~~~~~vkl~~~~ 69 (255)
|+|||+.|+.+.. +++..+..++.+++.++.|+|.+||+||||||+|++++..+ +++++..
T Consensus 87 lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 87 VLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp EEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCT
T ss_pred EEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECC
Confidence 5899998876543 55566778999999999999999999999999999998654 6777654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.83 E-value=2.5e-09 Score=89.70 Aligned_cols=94 Identities=23% Similarity=0.234 Sum_probs=64.5
Q ss_pred eeeccCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCcceeecccCc------eeeeccccc
Q psy3182 2 LLEACLGGEVWTIL---RERTCFDDNAASFITACVIEALEYLHT-RGIVFRDLKPENLLLDNRGY------VKLVSRKKK 71 (255)
Q Consensus 2 ~~e~~~gg~l~~~~---~~~~~~~~~~~~~~~~~v~~~l~~lh~-~~i~~rdiK~~nil~~~~~~------vkl~~~~~h 71 (255)
+|+++.+++..... .....+++..+..++.+++.|+.|+|+ +||+||||||+|++++..+. +++.+....
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s 179 (362)
T d1q8ya_ 100 VMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179 (362)
T ss_dssp EEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTC
T ss_pred eeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccc
Confidence 45665554433322 345679999999999999999999998 89999999999999987653 666655433
Q ss_pred cccccccccccCccceeehhhhhcc
Q psy3182 72 TRQTRLYKTFKDSKYVYMLLEACLG 96 (255)
Q Consensus 72 ~~iv~l~~~~~~~~~~ylv~E~~~g 96 (255)
.... -.......+..|+.+|...+
T Consensus 180 ~~~~-~~~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 180 CWYD-EHYTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp EETT-BCCCSCCSCGGGCCHHHHHT
T ss_pred cccc-cccccccccccccChhhccc
Confidence 2111 11222334556888886644
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=92.72 E-value=0.042 Score=42.03 Aligned_cols=28 Identities=7% Similarity=0.064 Sum_probs=20.7
Q ss_pred cccccccccCccceeehhhhhcchhHHH
Q psy3182 74 QTRLYKTFKDSKYVYMLLEACLGGEVWT 101 (255)
Q Consensus 74 iv~l~~~~~~~~~~ylv~E~~~gg~l~~ 101 (255)
+.+++....+.+..|++||++.|..+.+
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred CCcEEEEEecCCceEEEEEecccccccc
Confidence 3455666667778899999998877644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=86.50 E-value=0.069 Score=42.12 Aligned_cols=20 Identities=20% Similarity=0.406 Sum_probs=17.1
Q ss_pred cCcccccCCCCceeeCCCCc
Q psy3182 142 RGIVFRDLKPENLLLDNRGY 161 (255)
Q Consensus 142 ~~iiHrdlkp~nil~~~~~~ 161 (255)
.|+||.|+.+.|++++.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v 202 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL 202 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE
T ss_pred cccccCCcchhhhhcccccc
Confidence 57999999999999986643
|